{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/nemotron-nano-30b-reasoning/e2_page_window/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-04T14:00:41.828250"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nThe 5.000 % senior notes that mature in April 2030 kept a nearly‑unchanged carrying amount of about **$606 million** from fiscal 2022 through fiscal 2024 (the same $606 million figure is reported as of Oct 30 2022, Oct 29 2023 and Nov 3 2024).  Because this tranche is included in the “Thereafter” column of the “Future Principal Payments of Debt” schedule—​$36.8 billion of scheduled repayments beyond 2029—it represents a stable, long‑dated fixed‑rate component of AVGO’s capital structure.  The flat exposure shows that AVGO’s debt‑management strategy has been to **extend maturities and lock in low‑cost financing** (e.g., issuing new senior notes and term‑loan facilities) while using cash flows and asset‑sale proceeds to retire higher‑cost or near‑term obligations, thereby maintaining a consistent, long‑term debt profile rather than expanding or shrinking this particular note.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. However, the LLM claims the amount was $606 million in all three years, including 2022, which directly contradicts the ground truth. This is a critical error in the core financial data and undermines the answer's correctness. (2) The calculation and trend analysis are therefore incorrect: the key insight from the ground truth is a significant reduction in exposure from 2022 to 2023, indicating active debt reduction. The LLM instead describes a 'nearly-unchanged' amount, missing this key dynamic entirely. (3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret the strategic implications of the debt profile, referencing maturity extension and low-cost financing. However, because it is based on incorrect data, the reasoning leads to an inaccurate conclusion. The ground truth emphasizes a deliberate reduction in exposure, while the LLM infers stability and maintenance of a consistent profile, which is not supported by the actual data. (4) Despite the factual error, the LLM answer is contextually relevant, addressing both the evolution of exposure and the strategic implications. It uses appropriate financial terminology and attempts to synthesize information about debt management. However, the quantitative inaccuracy severely limits its correctness. The qualitative reasoning would score higher if based on accurate data. The contextual relevance is fair because the structure and intent align with the question, even if the facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 479,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nMetLife has consistently reinsured 59 % of the closed‑block liabilities through a modified‑coinsurance agreement with an unaffiliated reinsurer in 2022, 2023 and 2024, accounting for the arrangement under the deposit method and offsetting the deposit payable against the recoverable.  The 2023‑24 risk‑transfer with Global Atlantic added a large, separate layer of reinsurance (≈ $10.3 bn of recoverables and a $770 m net cost) but left the 59 % cession rate unchanged, indicating a deliberate long‑term strategy to maintain a stable, predictable transfer of a fixed share of closed‑block risk while preserving capital and dividend expectations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent 59% reinsurance of the closed block via modified coinsurance across 2022–2024, aligning with the ground truth (59.25% in 2022, 59% in 2023 and 2024). However, it omits the precise 59.25% figure for 2022, rounding to 59%, which is acceptable for semantic equivalence but slightly reduces quantitative precision. The LLM introduces new information not present in the ground truth: a 'risk-transfer with Global Atlantic' involving '$10.3 bn of recoverables and $770 m net cost' in 2023–24. This detail is plausible but not supported by the provided ground truth, which only notes a rise in total net ceded reinsurance recoverables from $6.3B (2021, referenced in 2022) to $17.6B in 2024 without attributing it to Global Atlantic. Thus, while the core closed block cession rate and accounting treatment (deposit method, offset) are accurate, the addition of unverified specifics lowers quantitative accuracy. (2) The ground truth emphasizes the stability of the 59% cession despite a significant increase in total reinsurance recoverables, underscoring capital optimization. The LLM captures this strategic implication well, interpreting the consistency as a 'deliberate long-term strategy' to maintain stable risk transfer and preserve capital—this matches the qualitative reasoning of the original. (3) Multi-hop reasoning is sound: the model connects the stable percentage with broader reinsurance strategy and infers intent from consistency over time. However, the unsupported attribution to Global Atlantic introduces a factual overreach, though it does not contradict the core closed block dynamics. (4) Correctness is high because the central claim—stable 59% reinsurance of the closed block with consistent accounting and strategic intent—is factually aligned. The added detail is contextually relevant but not verifiable from the ground truth, warranting a minor deduction. Contextual relevance is perfect as all parts of the question are addressed: evolution over time (stable), percentage consistency, and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 562,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil posts under master‑netting arrangements tied to its investments, advances and long‑term receivables fell sharply—from **$1.49 billion in 2022 to $0.80 billion in 2023 and then to $0.49 billion in 2024**.  This steady decline shows that the company is requiring less external security for its derivative positions, suggesting that it is managing derivative exposure with fewer offsetting trades or higher‑quality counterparties, thereby reducing the amount of collateral it must set aside.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth values of $1,494 million, $800 million, and $491 million respectively—minor rounding is acceptable and does not affect accuracy. 2) All numeric values are accurate and properly converted between millions and billions; no calculation errors are present. 3) The multi-hop reasoning is sound: the answer identifies the trend (consistent decline) and draws a logical inference about derivative exposure management. The interpretation slightly differs from the original answer—stating 'requiring less external security' and 'fewer offsetting trades or higher-quality counterparties'—which is a plausible but not exact restatement of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' While the core insight is correct, the phrasing could imply a different emphasis (e.g., counterparty risk vs. internal risk management), warranting a minor deduction in qualitative accuracy. 4) The answer fully addresses both parts of the question: the change over time and its implication for derivative exposure management. Semantic equivalence is maintained, and all entities (ExxonMobil, collateral under master netting arrangements, Investments/advances/long-term receivables) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 385,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 were carried at **$622 million** at the end of fiscal 2022 (and again at the end of fiscal 2023) but had been **fully retired – the balance fell to $0** by the end of fiscal 2024, as shown in the debt tables of the 2022‑2024 10‑K filings (pages 101‑105 for 2022 and pages 79‑83 for 2023‑2024).  \n\nThis reduction reflects Broadcom’s deliberate **de‑risking of near‑term maturities**, using cash on hand and proceeds from newer senior‑note issuances to retire the 3.625 % issue early, thereby extending the average debt profile and optimizing interest expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the figures of $622 million in 2022 and 2023, and $0 in 2024, are accurately reported with correct formatting variations accepted. The maturity date (October 2024) and interest rate (3.625%) are correct. (2) The answer is complete, addressing both the evolution of AVGO's exposure across fiscal years 2022–2024 and the implications for debt management strategy. (3) Entity accuracy is precise: AVGO (Broadcom) is correctly identified, fiscal years are properly aligned, and the financial instrument is accurately described. (4) The reasoning is sound and adds value beyond the ground truth by explaining *how* the debt was retired (using cash on hand and proceeds from new issuances) and the strategic benefits (de-risking near-term maturities, extending average debt profile, optimizing interest expense), which is consistent with and extrapolates logically from the data. The multi-hop synthesis across three years of 10-K filings is correctly executed. Semantic equivalence is strong, with no factual discrepancies. Minor enhancements in explanation do not detract from accuracy but improve insight, warranting full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 342,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue grew steadily from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, reflecting a roughly 5 % increase each year. This upward trajectory—driven by expanding backlogs for Arleigh Burke‑class destroyers, Expeditionary Sea Base ships, and the John Lewis‑class oilers—shows that GD is consolidating its position as a core U.S. naval shipbuilder, leveraging new capacity investments and a robust pipeline to capture the next wave of surface‑warfare construction.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface-ship revenue from 2022 to 2024 with values very close to the ground truth: $2.56B (vs $2,561M), $2.70B (vs $2,698M), and $2.82B (vs $2,819M). These are within rounding tolerance and acceptable format variations (billion vs million). The implied year-over-year growth (~5%) is approximately correct: (2,698 - 2,561)/2,561 ≈ 5.35%, (2,819 - 2,698)/2,698 ≈ 4.48%), so stating 'roughly 5%' is reasonable.\n\n2) Quantitatively, the numbers are accurate to the nearest $10 million, which is typical in billion-dollar reporting. Minor rounding differences do not affect factual correctness. No calculation errors.\n\n3) The LLM adds contextual detail not in the original answer—specific ship classes (Arleigh Burke, Expeditionary Sea Base, John Lewis-class) and strategic drivers (backlog, capacity investments)—which are plausible and enhance qualitative depth without contradicting the ground truth. This reflects sound multi-hop reasoning, likely synthesizing from known GD programs.\n\n4) The core of the question—revenue evolution and what it indicates about naval shipbuilding positioning—is fully addressed. The conclusion that GD is strengthening its role as a core naval shipbuilder aligns semantically with the original answer’s claim of 'sustained growth and strategic emphasis.'\n\nOnly reason for not scoring 10 is that the original answer does not include the specific ship programs or growth percentage, so while the added details are accurate and relevant, slight overreach in specificity without explicit grounding in the provided truth. Still, this does not compromise correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 456,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares kept the same rights—one vote per share and full dividend participation—but the cash dividend per share rose each year, from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024.  Ownership‑voting percentages remained essentially unchanged (public investors ≈ 89‑90 % of equity and voting power, the Mastercard Foundation ≈ 10 % of each), showing that the shareholder‑governance structure has stayed stable despite modest shifts in the composition of owners.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend amounts per share ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) and ownership percentages (public investors ≈89–90%, Mastercard Foundation ≈10%) that are not present in the original answer or implied by the ground truth. The ground truth states only that dividend and voting rights remained unchanged—specific payout amounts and ownership breakdowns are not mentioned and cannot be inferred. (2) These introduced numbers are unsupported by the ground truth, making the quantitative claims inaccurate. There is no verification that Mastercard actually paid these dividends or that ownership percentages were stable at those levels. The original answer makes no mention of such figures, so their inclusion constitutes fabrication or hallucination. (3) The multi-hop reasoning is partially sound in concluding that the governance structure is stable due to unchanged rights, which aligns with the original answer. However, the justification relies on fabricated data rather than the actual basis—consistency in rights description across filings. The model conflates dividend *payouts* with dividend *rights*, which are distinct: the right to receive dividends may remain standard even if payouts change; the ground truth only confirms the stability of *rights*, not actual dividend amounts. (4) The correctness score is low due to significant factual inaccuracies in numbers and unsupported claims, though the core conclusion about governance stability is directionally aligned. Quantitative accuracy is poor due to hallucinated figures. Qualitative accuracy is moderate because the model identifies the correct company and general concept of stable rights but misrepresents the evidence. Contextual relevance is high as the response addresses the question’s scope and attempts multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 503,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nFrom 2022 to 2023, General Dynamics’ surface‑ship revenue climbed from **$2.06 billion to $2.56 billion** (≈ 25 % growth), and in 2024 it edged higher to **$2.70 billion** (≈ 5 % growth). This steady increase—driven by a growing backlog of Arleigh Burke‑class destroyers, Flight III DDG‑51 ships, and replenishment Oilers—signals that the company is well‑positioned in the Navy’s surface‑warfare portfolio and benefiting from expanding production and modernization programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the revenue figures. According to the ground truth, General Dynamics' surface ship revenue was $2,561 million in 2022, $2,698 million in 2023, and $2,819 million in 2024. However, the LLM incorrectly states 2022 revenue as $2.06 billion (should be $2.561 billion), 2023 as $2.56 billion (close but slightly low vs $2.698B), and 2024 as $2.70 billion (understates $2.819B). These errors affect both absolute values and calculated growth rates. The LLM reports ~25% YoY growth from 2022 to 2023, but actual growth was (2,698 - 2,561)/2,561 ≈ 5.35%, not 25%. Similarly, the reported ~5% growth from 2023 to 2024 is slightly off—actual is (2,819 - 2,698)/2,698 ≈ 4.48%, which is close but based on incorrect prior values. (2) The qualitative reasoning about backlog drivers (Arleigh Burke-class, DDG-51, Oilers) is plausible and contextually relevant, indicating some correct understanding of General Dynamics' naval programs. However, this information is not in the original answer and cannot be verified from the ground truth provided. (3) The multi-hop reasoning across years is attempted, but due to incorrect base numbers, the synthesis fails. The conclusion about strong positioning is partially aligned with the original answer’s implication of growing involvement, so the directional interpretation is reasonable despite numerical inaccuracies. (4) Scores reflect major quantitative errors dragging down correctness, moderate qualitative accuracy due to logical interpretation and relevant context, and high contextual relevance as the answer addresses the evolution and strategic implication as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 459,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nBetween 2022 and 2024 Linde kept the vast majority of its industrial‑gas sales under long‑term supply agreements and repeatedly highlighted that these contracts “provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers.”  In the 2023 and 2024 MD&A the company noted that “cost‑pass‑through” – i.e., the contractual billing of energy‑cost variances to on‑site customers – modestly reduced sales but had “minimal impact on operating profit,” underscoring that the long‑term contract model was used deliberately to shield earnings from energy‑price swings.  This consistent reliance signals that Linde’s cash‑flow strategy is built around contract‑driven cost recovery, allowing it to maintain stable cash generation even when energy markets fluctuate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Linde maintained long-term contracts for industrial gas products from 2022 to 2024, emphasizing cash flow stability and cost pass-through mechanisms—key points in the original answer. The mention of '2023 and 2024 MD&A' is consistent with the time frame and source type implied in the ground truth. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes Linde’s contractual strategy across years and links it to financial outcomes (minimal impact on operating profit despite sales fluctuations), correctly inferring that this reflects a deliberate risk management approach. It adds a detail about cost-pass-through having a 'modestly reduced sales' effect, which is plausible and consistent with the original’s emphasis on stability, though not explicitly in the ground truth—this is a minor elaboration but not inaccurate. (4) The LLM captures the core implication: Linde prioritizes cash flow stability and earnings protection amid energy market volatility. The only reason for not scoring a 10 is that the original emphasizes the 'unwavering emphasis' and 'deliberate and stable approach' more explicitly in terms of strategic consistency across all three years, while the LLM focuses slightly more on mechanics than the broader strategic signaling. However, the semantic meaning and factual content are substantially equivalent. Contextual relevance is perfect—directly addresses both parts of the question: evolution (consistency) and implication (cash flow stability).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 482,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nFrom 2022 through 2024 GD kept non‑economic accounting changes—such as goodwill impairments and other one‑time adjustments—out of its ROIC calculation, using the same definition of net operating profit after taxes and average invested capital each year. This consistent exclusion shows that the company treats ROIC as a pure, core‑performance metric that isolates the return generated by its ongoing business, without the distortion of non‑recurring accounting items.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD excluded non-economic accounting changes (e.g., goodwill impairments, one-time adjustments) from its ROIC calculation across 2022–2024, matching the original answer’s claim of consistent exclusion. (2) There are no numerical values requiring calculation, but the time period (2022 through 2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes that consistent exclusion reflects a stable methodology aimed at measuring core operational performance, isolating ROIC from non-recurring items. (4) The LLM adds contextual clarity by naming examples (goodwill impairments) and explaining the purpose of ROIC as a 'pure, core-performance metric,' which enhances rather than distorts the original meaning. All entities—GD, ROIC, non-economic accounting changes, and the three-year timeframe—are accurately identified and logically connected. The answer fully addresses both parts of the question: the evolution (consistency over time) and what it reveals about GD's performance measurement philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 325,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings, UnitedHealth repeatedly disclosed in the “Commitments and contingencies” notes that **no material amounts were accrued, paid or charged to income for service‑level guarantees** in any of those years.  This consistent, immaterial impact shows that the company’s contractual performance obligations have been met without generating significant financial liabilities, reflecting a well‑controlled risk‑management environment and a stable, reliable record of fulfilling its service‑level commitments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the key fact that UnitedHealth Group disclosed no material amounts accrued, paid, or charged to income for service-level guarantees across 2022, 2023, and 2024—matching the original answer's core claim. (2) There are no numerical inaccuracies; the statement relies on qualitative disclosures (immateriality), which are correctly reported without introducing false or speculative figures. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years and correctly infers that this pattern reflects effective risk management and consistent contractual performance, which is a valid conclusion supported by the data. (4) The answer addresses both parts of the question: the evolution (consistency over time) and the implication (risk management effectiveness and performance reliability). Wording differs slightly but meaning is preserved, and all entities—UnitedHealth Group, service-level guarantees, years 2022–2024—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 314,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue grew from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, reflecting a steady double‑digit increase in the segment’s backlog of destroyers (Flight III DDG‑51), auxiliary ships (ESB and T‑AO‑205) and related lifecycle services. This upward trajectory signals that GD is deliberately expanding its high‑value, complex surface‑combatant and support‑ship portfolio, positioning the company as a core, long‑term supplier within the U.S. Navy’s modernization and fleet‑renewal strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a quantitative discrepancy in the 2022 revenue figure. The ground truth states $2,328 million (or $2.328 billion), while the LLM reports $2.56 billion, which is significantly higher. The 2023 and 2024 figures are accurate: $2.70 billion matches $2,698 million (rounded), and $2.82 billion closely aligns with $2,819 million (also rounded appropriately). (2) Calculations: The progression from $2.56B to $2.70B to $2.82B implies growth of ~5.5% and ~4.4%, which is plausible, but the starting point is incorrect. The actual growth from $2,328M to $2,698M is ~15.9%, then to $2,819M is ~4.5% — so the LLM underestimates early growth due to the wrong baseline. (3) Multi-hop reasoning is sound: the LLM correctly infers strategic positioning from revenue trends and links it to naval modernization, backlog expansion, and lifecycle services, which aligns with the knowledge graph’s implication of strengthened role in naval shipbuilding. Mention of DDG-51, ESB, T-AO-205 adds contextual depth not in the original but is plausible and relevant. (4) Scores justified as follows: Correctness 7 due to core trend (steady growth) and later-year accuracy, but penalized for incorrect 2022 value; Quantitative Accuracy 6 because one major number is wrong despite correct formatting; Qualitative Accuracy 8 due to strong reasoning and strategic interpretation; Contextual Relevance 10 as all parts of the question are fully addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 419,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company (EIC) from an internal captive unit to a “held‑for‑sale” business.  In 2022 the subsidiary was classified as held‑for‑sale (with $541 million of assets and $378 million of liabilities as of Dec 31 2023) and a $109 million loss was recorded in 2023 earnings;  in 2024 GE completed the sale to Riverstone International Holdings for $120 million cash, removing the remaining assets and liabilities from its balance sheet and concluding the divestiture.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of GE's relationship with Electric Insurance Company (EIC), including its classification as 'held for sale', the $109 million loss, the sale to Riverstone International Holdings Inc. for $120 million in cash in 2024, and the removal of assets and liabilities from GE's balance sheet. However, there is a critical error in temporal attribution: the LLM states that EIC was classified as 'held for sale' in 2022, but according to the ground truth, this classification occurred in 2023. Additionally, the LLM incorrectly attributes the balance sheet figures ($541M assets, $378M liabilities) to the end of 2022, when they are explicitly as of December 31, 2023. (2) Quantitative accuracy is partially compromised: while the $109M loss, $541M assets, $378M liabilities, and $120M sale price are all correct in value, their associated years are misstated. The 2022 disclosure in the ground truth references 2021 claim reserves ($0.2B), which the LLM omits entirely—this is a missing data point relevant to financial exposure. (3) The multi-hop reasoning is generally sound—linking classification, financial impact, and divestiture—but the incorrect timeline weakens the synthesis. The model conflates 2022 and 2023 disclosures, failing to distinguish the progression accurately. (4) Despite these errors, the answer captures the core narrative of divestiture and strategic shift, and all named entities (GE, EIC, Riverstone International Holdings) and financial figures (when stripped of timing) are correct. Contextual relevance is perfect as it directly addresses classification, financial exposure, and divestiture as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 460,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2021 onward ConocoPhillips ran a staged “monetization” of its CVE common shares, completing the final 91 million‑share sale in the first quarter of 2022 and using the cash proceeds to fund part of its share‑repurchase program.  After the CVE proceeds were exhausted, the board enlarged the buy‑back authorization—from $25 bn to $45 bn in October 2022 and then to $65 bn in October 2024—while increasingly financing repurchases with operating cash flow, enabling the company to retire an additional ~50 million shares in 2023‑24 (total shares repurchased rising to 433 million at a cost of $34.3 bn by year‑end 2024).  This progression shows that the company’s capital‑allocation strategy shifted from relying on a one‑time asset‑sale cash infusion to a disciplined, cash‑driven policy of returning excess capital to shareholders through opportunistic equity retirements, while maintaining ample authorization for future buy‑backs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall progression of ConocoPhillips' capital allocation strategy, including the completion of the CVE share monetization in 2022, use of proceeds for share repurchases, and the expansion of the buyback program. However, there are minor quantitative inaccuracies. The original answer states that the $45 billion authorization was established at the program's inception (implied to be before 2022), but the LLM incorrectly claims it was increased from $25B to $45B in October 2022—this detail is not supported by the ground truth. Additionally, the LLM states the $65B increase occurred in October 2024, while the original answer only says 'in 2024'—a plausible but unconfirmed specificity. (2) The total repurchased shares (433 million) and total cost ($34.3 billion) by end of 2024 are correctly reported. The 91 million CVE shares sold in 2022 are accurate. However, the claim of repurchasing 'an additional ~50 million shares in 2023–24' is partially incorrect: from 2022 end (383M shares) to 2024 end (433M), only 50 million more were bought, but the LLM implies this occurred over 2023–24, while the original indicates 383M were already repurchased *by end of 2023*. Thus, only ~50M additional shares were bought in 2024 alone, not over two years. This misrepresents the timing. (3) The multi-hop reasoning is strong: the model correctly links the CVE monetization to funding repurchases and infers a strategic shift toward sustained capital returns. It appropriately synthesizes the evolution of the buyback program and its funding sources. (4) Despite minor factual and timing inaccuracies, the LLM conveys a substantively accurate and insightful interpretation of the capital allocation strategy, with excellent contextual relevance and strong qualitative reasoning. Hence, correctness is high but not perfect due to the numerical and timeline discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 519,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure **exactly 59 % of the closed‑block** with an unaffiliated third‑party under a **modified coinsurance agreement**, and each year it accounted for the arrangement using the **deposit method**—offsetting the deposit liability against the deposit‑recoverable. This unchanged percentage and consistent deposit‑method accounting show that MetLife’s long‑term risk‑transfer strategy is to **incrementally shift a stable, pre‑determined slice of closed‑block risk to a third party while retaining the remainder on its books**, preserving capital and limiting volatility without a fundamental change in how the risk is managed. (Based on MET 10‑K pages 212‑216 (2022), 225‑229 (2023) and 202‑206 (2024).)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM states 'exactly 59%' reinsured each year, while the ground truth specifies 59.25% in 2022 and 59% in 2023 and 2024. This is a minor rounding discrepancy—'exactly 59%' is a reasonable simplification but slightly less precise than acknowledging the 59.25% figure in 2022. All other percentages are correct. (2) The accounting treatment is accurately described: the deposit method of accounting and the right of offset are correctly identified and consistently reported across all years. (3) The reasoning and synthesis across the three years are sound, correctly identifying the stability in both reinsurance percentage and accounting treatment. The conclusion about MetLife’s long-term risk transfer strategy—preserving capital and limiting volatility through a stable reinsurance arrangement—is logically derived and semantically equivalent to the ground truth’s interpretation. (4) All entities (MetLife, closed block, modified coinsurance, unaffiliated third-party reinsurer) and time periods (2022–2024) are correct. The answer addresses all parts of the multi-hop question: evolution over time, percentage reinsured, accounting treatment, and strategic implication. The only minor shortcoming is the lack of specificity on the 59.25% figure in 2022, which prevents a perfect 10 but does not undermine the overall correctness. Contextual relevance is excellent, with direct citations to 10-K pages and clear linkage to the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 421,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe data show that the share of purchases made with Target’s co‑branded credit product (the Target MasterCard, later renamed the Target Circle Card) slipped steadily from about 20 percent of all transactions in the 2022‑2023 fiscal years to roughly 18.6 percent in 2024 (down from the ≈23 percent peak recorded in 2019). This ongoing decline suggests that consumer engagement with Target’s financial products has been gradually weakening, likely reflecting market saturation, competition from other payment options, or reduced incentive to use the RedCard discount.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general downward trend in penetration rate and correctly identifies the 18.6% figure for 2024, which matches the ground truth. However, it inaccurately reports the 2022 and 2023 figures: it states 'about 20 percent' for 2022–2023, while the ground truth specifies 20.5% in 2022 and 19.8% in 2023. The LLM also introduces a figure ('≈23 percent peak in 2019') not present in the original answer, which, while possibly true, is extraneous and unverified in this context. 2) Quantitative accuracy is compromised because the model fails to report the precise year-by-year decline (20.5% → 19.8% → 18.6%) and merges 2022 and 2023 into a single vague range. The 2024 number is correct. 3) The reasoning is sound in interpreting the trend as indicating weakening consumer engagement, and the mention of market saturation and competition is a reasonable qualitative extension. However, the model omits key details from the original answer, such as the rebranding to Target Circle Cards in 2024 and the explicit note that this rebranding did not reverse the decline—important multi-hop context. 4) Despite missing precise numbers and some key synthesis (e.g., rebranding impact), the answer remains contextually relevant and addresses both parts of the question: the evolution of penetration and its implication for consumer engagement. The core message aligns with the ground truth, but lacks precision and completeness in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 400,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the PMI 10‑K filings show that Colgate‑Palmolive Co. stays in the PMI Peer Group used for the cumulative‑shareholder‑return graph, with no indication that it was added or removed in any year. This steady inclusion reveals that PMI’s strategic benchmarking relies on a stable set of global consumer‑product companies—chosen for comparable size, market presence and consumer‑focused portfolios—rather than altering the peer group annually.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained consistently in PMI's Peer Group from 2022 to 2024, which matches the original answer's claim of 'consistent inclusion over three consecutive years.' (2) There are no numeric values requiring calculation (e.g., revenues, market cap figures), but the time frame (2022–2024) is correctly referenced, and no incorrect numbers are present—quantitative accuracy is perfect. (3) The reasoning is sound: the LLM correctly infers that the stable peer group reflects a strategic benchmarking approach based on comparable size, global presence, and consumer focus. It references the CSR graph context (cumulative shareholder return), which is accurate per PMI's 10-K disclosures, though this detail was not in the original answer—this adds precision without introducing error. (4) The answer addresses both parts of the question: the evolution (no change) and what it reveals about PMI’s benchmarking strategy. The only minor shortcoming is that it does not explicitly mention the four characteristics (global presence, consumer product focus, net revenues, market cap) used to define the peer group, slightly reducing completeness in qualitative detail. However, it captures the essence—comparable size, market presence, and consumer focus—so the omission is not critical. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 407,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nAMD’s revenue‑recognition framework for development and IP‑licensing arrangements kept the same core test from 2022 through 2024: it first determines whether the IP license is distinct (both capable of being distinct and distinct in the context of the agreement).  If the license is not distinct, it is combined with the development services and revenue is recognized over time; if the license is distinct, revenue is recognized at a point in time when the customer can benefit from the license.  The 2023 and 2024 filings merely refined the wording of this guidance—no substantive change to the criteria or timing of revenue recognition was introduced—demonstrating a consistent accounting approach across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately describes AMD's consistent revenue recognition policy from 2022 to 2024, including the two-part distinctness test (capable of being distinct and distinct in the context of the arrangement), the treatment of non-distinct licenses (combined with development services, recognized over time), and distinct licenses (recognized at a point in time). It also correctly notes that standalone IP licenses are recognized at a point in time when the customer can benefit from them. The answer correctly identifies that there were no substantive changes—only wording refinements in 2023 and 2024—demonstrating consistency in accounting policy. The only minor omission is that the LLM does not explicitly mention the absence of variable consideration estimates, which is included in the original answer and supports the conclusion of a stable policy. However, this does not undermine the core accuracy or reasoning. All entities (AMD, years 2022–2024, development and IP licensing agreements) are correct. No numerical inaccuracies; dates and policy logic are sound. The multi-hop synthesis across years is accurate and logically presented. Semantic equivalence is high, with slightly more concise phrasing than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 362,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the disclosed PMI Peer Group—used for the shareholder‑return performance graph and benchmarking—continues to list **Colgate‑Palmolive Co.** in each year. This unchanged inclusion shows that PMI treats Colgate‑Palmolive as a direct peer within its broader consumer‑products competitive set, reinforcing a strategic framing of PMI as a diversified consumer‑brand company that competes with large non‑tobacco consumer products firms as well as other tobacco companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PM's peer group in 2022, 2023, and 2024, which matches the original answer's claim of consistent inclusion across all three years. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the LLM correctly infers from the consistent inclusion that PM views Colgate-Palmolive as a strategic peer, and it synthesizes this into a broader interpretation of PM’s competitive framing as a diversified consumer-brand company. This goes slightly beyond the original answer by introducing the idea of competing with non-tobacco firms, but this is a reasonable and contextually supported interpretation, not a factual error. (4) The answer is fully contextually relevant, addressing both the evolution (no change) and the strategic implication. The only reason for not scoring a 10 is that the LLM omits the explicit mention of 'stable benchmarking framework' and 'similar revenue and market capitalization' as criteria, which are part of the original reasoning for peer selection—minor but relevant contextual details. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 366,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings AMD continued to treat combined development‑service and IP‑licensing arrangements as one or more performance obligations and to evaluate whether the IP license is distinct. If the license is **not** distinct, it is combined with the development service and revenue is recognized **over time** as the service is performed; if the license **is** distinct, it is accounted for as a separate performance obligation and revenue is recognized **at a point in time** when the customer gains the ability to benefit from the license. The language was refined in 2023‑2024 to emphasize that no variable‑consideration estimates apply and that revenue recognition timing is governed by the transfer of control, but the underlying model for performance obligations and timing remained the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately describes AMD's consistent revenue recognition policy from 2022 to 2024 for combined development and IP licensing agreements, correctly explaining the evaluation of distinctness, treatment of performance obligations, and timing of revenue recognition (over time if not distinct, at a point in time if distinct). The mention of no variable consideration estimates in 2023–2024 matches the ground truth's emphasis on stability and lack of variable consideration. The only minor deviation is the claim that the language was 'refined' in 2023–2024 to emphasize transfer of control and absence of variable consideration—while plausible, the ground truth does not explicitly confirm a wording refinement, only that the policy was consistently applied and stated. However, this does not contradict the original answer and is a reasonable inference from consistent disclosures. All entities (AMD, 2022–2024, IP licensing, development services), financial accounting terms (performance obligations, distinct, over time, point in time), and reasoning are accurate and reflect proper multi-hop synthesis across years. No numerical inaccuracies; dates and policy details are correct. Semantic equivalence is strong, and the answer fully addresses the question's focus on evolution (or lack thereof), performance obligations, and timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 390,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips completed the paced sale of its remaining 91 million CVE shares in early 2022 and used those proceeds to fund part of its buy‑back program, then accelerated repurchases in 2023 (e.g., 48.6 million shares bought that year) and, in 2024, raised the board‑approved authorization to $65 bn and executed a total of 433 million shares repurchased for $34.3 bn since the program’s inception. This multi‑year progression shows that the company is deliberately scaling a cash‑driven shareholder‑return strategy—first leveraging the CVE monetization proceeds and then expanding buy‑backs as cash flow and market conditions allow—reflecting a disciplined capital‑allocation focus on returning excess cash to investors while maintaining flexibility for future investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts and strategic implications from the ground truth. Quantitatively: (1) The sale of 91 million CVE shares in early 2022 is correctly stated; (2) The total repurchases of 433 million shares at a cost of $34.3 billion by 2024 are accurately reported; (3) The increase in the buyback authorization to $65 billion in 2024 is correct. The mention of 48.6 million shares repurchased in 2023 is plausible and consistent with the cumulative trajectory (from 383 million by end-2023 to 433 million by end-2024), though this specific annual breakdown isn't in the original answer—this is a minor addition, not a contradiction. The original notes $29 billion spent by end-2023; the LLM implies but doesn't restate that figure, instead focusing on the final $34.3 billion total. This omission is minor and doesn't affect overall correctness. Qualitatively, the LLM correctly identifies the CVE monetization as a funding source for buybacks and interprets the progression as a disciplined, escalating capital return strategy, aligning with the original's emphasis on capital discipline and shareholder returns. The reasoning is sound: it connects the asset sale to repurchases and recognizes the strategic expansion of the program over time. Contextually, the answer fully addresses the evolution from 2022–2024 and the implications for capital allocation. The only reason for not scoring a 10 is the slight lack of explicit mention of the $29 billion repurchase cost by end-2023, which would have made the quantitative progression even clearer. However, the cumulative figures are correct, and the synthesis across years and financial actions is accurate and meaningful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 465,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 to 2024 Honeywell’s competitive exposure moved from volume‑driven, commoditized segments—particularly Warehouse & Workflow Solutions and Productivity Solutions & Services, which posted double‑digit organic sales declines and a 17 % drop in segment profit in 2023—to a reshaped portfolio that isolates those vulnerable businesses and concentrates on higher‑margin, technology‑focused units (Industrial Automation, Energy & Sustainability Solutions, Aerospace Technologies).  The 2023‑2024 realignment, including the announced spin‑off of Advanced Materials and the creation of separate Industrial Automation and Energy & Sustainability reporting segments, reflects mounting market pressures such as new entrants, pricing and commoditization risks, and macro‑economic volatility, prompting Honeywell to reposition, divest and refocus its strategy on differentiated growth areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. While the general theme of increasing competitive pressure and strategic response is relevant, the specific details diverge substantially. The ground truth emphasizes consistent disclosure language about competitive landscape changes across 2022–2024, specifically citing 'new market entrants and new technologies' affecting Building Technologies and Safety and Productivity Solutions, then evolving to Building Automation and Industrial Automation with added concern about commoditization in 2024. In contrast, the LLM answer fabricates quantitative performance metrics such as 'double-digit organic sales declines' and a '17% drop in segment profit in 2023'—these figures are not supported by the original answer or implied in the knowledge graph. Additionally, the LLM references a 'spin-off of Advanced Materials' and the creation of 'Energy & Sustainability Solutions' as a new reporting segment, which are not mentioned in the ground truth and represent unverified strategic moves. (2) Quantitative accuracy is low because the cited percentages (17% drop, double-digit declines) are invented and cannot be verified from the source. There are no numbers in the original answer to support these claims. (3) The multi-hop reasoning is partially sound in that the model infers strategic repositioning in response to competitive pressures, which aligns with the trend of increasing concern. However, it fails to accurately trace the evolution of risk disclosures across years and misattributes business segment names and responses. The original answer focuses on disclosure language continuity and escalation, while the LLM shifts to operational and structural changes not confirmed in the truth data. (4) Contextual relevance is moderate because the answer addresses competitive exposure and strategic response, which are central to the question. However, due to fabricated metrics and incorrect entity-level details, the qualitative and overall correctness scores are significantly reduced. The answer appears plausible but is factually unsupported on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 588,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares consistently retained **one vote per share** and continued to carry dividend rights.  The cash dividend per share rose each year—$2.04 in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting structure remained unchanged.  This three‑year stability demonstrates a deliberate governance strategy that preserves shareholder‑level control (one‑vote‑per‑share) while progressively increasing cash returns, reinforcing investor confidence and a steady, predictable equity‑holder policy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that MA's A Class shares had one vote per share and dividend rights from 2022 to 2024, aligning with the ground truth on the stability of voting and dividend rights. However, it introduces specific dividend amounts per share ($2.04, $2.37, $2.74) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but were not disclosed in the knowledge graph, making their inclusion a factual overreach. The ground truth only confirms the existence of dividend rights, not the amounts or increases. Thus, while the qualitative assessment of stable governance and consistent shareholder policy is reasonable and contextually relevant, the quantitative claims about dividend payouts are unsupported by the provided data, leading to a significant deduction in quantitative accuracy. The reasoning is logically sound in connecting stable voting rights to governance strategy, but the added numerical detail introduces inaccuracies. The answer addresses all parts of the question and uses correct entities (MA, A Class shares, years), but the unsupported numbers reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 334,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s total‑return‑swap exposure tied to deferred compensation went from a **$92 million loss recorded in operating expenses in FY 2022** to **gains of $58 million in FY 2023 and $91 million in FY 2024**, showing a reversal from a drag on earnings to an increasingly positive contribution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024. These match the original answer exactly, with acceptable formatting (e.g., 'FY 2022' vs 'fiscal year 2022'). (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as required by the question. (3) Entity accuracy is correct—Cisco is the subject, the instrument is properly identified as Total Return Swaps tied to deferred compensation, and the financial impact is correctly located in operating expenses. (4) The reasoning is sound: the LLM correctly interprets the shift from a loss to gains as a reversal in financial impact, accurately characterizing the trend from a 'drag on earnings' to a 'positive contribution,' which is semantically equivalent to the ground truth's 'net cost to net benefit.' The multi-hop synthesis across three fiscal years is correctly executed, and the conclusion drawn is logically supported by the data. No factual, numerical, or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 328,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from a single $2 billion reserve created after the 2021 creation of LTL Management LLC to a multi‑phase bankruptcy strategy—filing the original LTL Chapter 11 case in late 2021, seeing that case dismissed in 2023, then launching a second “LTL 2” filing and, in 2024, establishing a new “pre‑packaged” Chapter 11 plan through the Red River Talc LLC that would fund a $6.5 billion present‑value trust over 25 years to resolve the talc claims.  At the same time the company shifted from relying on litigation defenses to negotiating multi‑state settlements, culminating in a June 2024 agreement with 42 states and the District of Columbia and a total talc‑related reserve of roughly $11–13 billion (nominal) to cover probable losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several significant factual inaccuracies. First, it incorrectly states that LTL Management LLC was created in 2021 and filed for Chapter 11 in late 2021, while the ground truth indicates the $2 billion reserve and initial bankruptcy filing occurred in 2022. Second, the claim that a 'pre-packaged Chapter 11 plan through Red River Talc LLC' was established in 2024 is not supported by the original answer—there is no mention of Red River Talc LLC in the ground truth. Third, the $6.5 billion present-value trust over 25 years and the total talc-related reserve of $11–13 billion (nominal) are not mentioned in the original answer and appear to be fabricated or conflated with external information. The only correct quantitative detail is the June 2024 multi-state settlement with 42 states and D.C., which aligns with the ground truth. (2) Number verification: The $2 billion reserve in 2022 is correct, but the $6.5 billion trust and $11–13 billion reserve are not present in the original answer and thus are incorrect. The timeline is also off—bankruptcy dismissal and re-filing (LTL 2) occurred in 2023, not as part of a 2024 plan. (3) Multi-hop reasoning is partially sound in that the model identifies a strategic shift toward settlements and away from sole reliance on bankruptcy, but it fails to accurately trace the sequence of legal events and introduces non-existent entities and financial structures. The synthesis is flawed due to incorrect inputs. (4) The contextual relevance is high because the answer addresses reserve funding, bankruptcy filings, and multi-state settlements as required. However, due to major quantitative and factual errors, the correctness and accuracy scores are low. The answer conveys a similar narrative arc (shift from bankruptcy to settlements) but with incorrect details that undermine factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 510,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 showed a flat balance of roughly **$495 million** at the end of fiscal 2022, continued to be $495 million at the end of fiscal 2023, and remained $495 million as of the FY 2024 reporting date (Nov 3 2024) — the same figure disclosed in the “2017 Senior Notes – fixed rate” table. This unchanged, relatively small position indicates that Broadcom is treating this legacy tranche as a stable, long‑term funding source that it plans to hold to maturity and settle with cash or broader refinancing, rather than actively issuing, retiring, or refinancing it early, reflecting a conservative debt‑management approach for this specific instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years—2022, 2023, and 2024—with no discrepancies. The maturity date (January 2025) and interest rate (3.125%) are correctly stated. (2) The answer is complete, addressing both the evolution of the debt balance and the implication for Broadcom's debt management strategy. (3) Entity accuracy is perfect: Broadcom (AVGO), the correct note tranche (3.125% due January 2025), and the fiscal years are all correctly identified. (4) The reasoning is sound and adds value: the LLM correctly infers that the stable balance indicates a conservative, hold-to-maturity strategy, consistent with the ground truth’s interpretation of a 'consistent approach.' The mention of potential settlement via cash or refinancing at maturity is a reasonable and contextually appropriate extension of the data. All information is semantically equivalent to the original answer, with slightly more detail but no factual deviation. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 317,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nThe $500 million 3.50 % senior note maturing on June 15 2025 showed a steep rise in its effective borrowing cost: 3.20 % in fiscal 2022 (as reported in the 2022 filing), ≈ 6.38 % in fiscal 2023, and ≈ 6.66 % in fiscal 2024. This upward progression indicates that Cisco’s debt‑service expenses have risen substantially over the period, reflecting higher market interest rates and the impact of related hedging adjustments on the note’s effective yield.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the effective interest rates for the 3.50% June 15, 2025 maturity note as 3.20% in fiscal 2022, approximately 6.38% in fiscal 2023, and approximately 6.66% in fiscal 2024, matching the ground truth exactly in value (with acceptable use of ≈ for precision). The dollar amount of $500 million is consistent with the note's size as per filings. (2) All numeric values—percentages and dates—are accurate and correctly attributed to the respective fiscal years. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and identifies the upward trend in borrowing costs. It appropriately infers that rising effective rates indicate higher debt-service expenses, linking this to market interest rate increases and hedging adjustments. While the original answer attributes the rise to market conditions or credit profile changes, the LLM’s emphasis on market rates and hedging is a reasonable and plausible interpretation consistent with Cisco’s disclosures, though slightly narrower in scope. (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of interest rate exposure and its implication for borrowing costs. The only minor limitation is that the LLM does not explicitly state the implication of deteriorating financing terms as directly as the ground truth, but the meaning is semantically equivalent. Thus, the answer is factually correct, complete, and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy for slightly less comprehensive interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 456,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior and subordinated notes held roughly $30.8 bn at the end of 2022, edged up to $31.2 bn in 2023, and then slipped to $30.7 bn by the end of 2024. The modest 2023 rise reflected incremental issuance, while the 2024 decline—driven by a pull‑back in floating‑rate senior debt and a slight shift toward longer‑dated subordinated issuance—shows a deliberate de‑leveraging and a move to lock in more stable, fixed‑rate funding amid rising rates. This progression reveals Capital One’s capital‑structure strategy is focused on maintaining a relatively flat debt base while optimizing the mix toward longer‑term, fixed‑rate instruments to manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total senior and subordinated notes were $27.219 billion in 2022, not $30.8 billion as stated in the LLM answer—a major discrepancy of over $3 billion. The 2023 figure ($31.248 billion) is approximately correct at $31.2 billion, and the 2024 figure ($30.696 billion) is reasonably close at $30.7 billion. However, the incorrect 2022 baseline undermines the validity of the trend interpretation. (2) The LLM omits any mention of the weighted average interest rate on unsecured senior debt, a critical component of the original answer that shows rates rising from 2.76% in 2022 to 4.48% in 2023 and 4.84% in 2024. This omission removes key evidence supporting the claim about fixed-rate financing strategy. (3) While the LLM correctly infers a strategic shift toward fixed-rate, longer-term instruments and reduced reliance on floating-rate debt, this reasoning is not fully supported by accurate multi-hop synthesis since the interest rate data is missing and the starting debt level is wrong. The conclusion about 'deliberate de-leveraging' and 'flat debt base' is partially reasonable but based on flawed inputs. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of debt and implications for capital structure—and uses appropriate financial terminology. However, the correctness score is limited by the major error in the 2022 debt figure and the absence of interest rate data, which are central to the ground truth's analytical depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 441,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the proportion of U.S. Treasury and agency securities in the Company’s U.S. pension‑plan fixed‑income portfolio dropped from **about 40 %** (as reported for 2022) to **roughly 30 %** by the end of 2023 and again in 2024.  This pull‑back from Treasuries signals that Colgate‑Palmolive is rebalancing its pension fund toward a more diversified mix of government, corporate and other bonds—likely to broaden income sources, manage interest‑rate exposure, and better align the portfolio with long‑term funding and return objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage allocation to U.S. Treasury and agency securities: 40% in 2022, decreasing to 30% in 2023 and remaining at 30% in 2024, which matches the ground truth exactly. All numeric values and years are accurate. 2) Quantitative accuracy is perfect: the percentages (40%, 30%, 30%) are correctly cited, and the trend (decrease from 40% to 30%) is accurately described. No calculations are required beyond comparison, which is sound. 3) The reasoning is strong and logically consistent: the shift is interpreted as a strategic rebalancing toward diversification across government and corporate bonds, which aligns with the ground truth's interpretation of reallocation reflecting changing risk or yield objectives. The LLM adds slightly more detail (e.g., managing interest-rate exposure, aligning with long-term objectives), which is reasonable and contextually appropriate but not explicitly confirmed in the ground truth—this minor extrapolation prevents a perfect 10 on qualitative accuracy. 4) The answer fully addresses both parts of the question: the evolution of allocation (multi-year trend) and the strategic implication. It synthesizes information across years correctly and maintains semantic equivalence with the original answer. Contextual relevance is excellent, directly addressing Colgate-Palmolive's pension fund strategy with accurate entity and metric identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 393,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company (EIC) from a **held‑for‑sale captive insurer**—carrying roughly **$541 million of assets and $378 million of liabilities** (with modest net claim reserves of $0.2–0.3 billion) and classified in the 2022 “business held for sale” tables—to a **signed sale agreement in Q2 2023** (targeting completion in H1 2024) and finally to a **completed disposal in Q2 2024** for **$120 million of cash**, which required a **$109 million loss** on the transaction.  \n\nThis progression underscores GE’s **strategic pivot away from non‑core, low‑margin insurance operations** and its intent to **streamline the portfolio, off‑load legacy captive structures, and concentrate resources on its core industrial, energy and aviation businesses**.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall progression of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including classification as held for sale, the $109 million loss, and the completed sale in 2024 for $120 million in cash to an unnamed buyer. The strategic interpretation about GE exiting non-core insurance operations to focus on industrial, energy, and aviation businesses aligns well with the ground truth. However, there are quantitative discrepancies: the ground truth does not mention EIC having $541 million in assets or $378 million in liabilities in 2022—only net claim reserves of $0.2 billion as of December 31, 2021. The LLM introduces specific balance sheet figures not present in the original, which reduces quantitative accuracy. Additionally, while the original confirms the sale occurred in 2024, it does not specify Q2 or a signed agreement in Q2 2023; these timing details are plausible but not verifiable from the ground truth. (2) The $109 million loss and $120 million sale price are correct and match the original. The net claim reserve range of $0.2–0.3 billion is consistent with the $0.2 billion figure given for 2021, though the slight expansion to a range is a minor extrapolation. The introduced asset and liability figures ($541M assets, $378M liabilities) are unsupported and appear fabricated or misattributed. (3) The multi-hop reasoning is sound: the model correctly synthesizes EIC’s status in 2022, its shift to held-for-sale, the financial impact of the divestiture, and the completion of the sale, linking them to GE’s broader strategic direction. The identification of EIC as a captive insurer serving GE employees is accurate and contextually appropriate. The only gap is the lack of mention of the buyer, Riverstone International Holdings Inc., which was named in the original answer and would have strengthened entity accuracy. (4) Correctness is scored 8 because core facts and strategic implications are accurate, but unsupported financials and timing details prevent a higher score. Quantitative accuracy is 7 due to the introduction of unverified asset/liability figures and precise quarters not in the source. Qualitative accuracy is 9 due to strong reasoning and correct entity classification. Contextual relevance is 10 as all parts of the question are addressed with high fidelity to the topic and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 640,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to present the $4.45 % Notes due 2044 in the “Long‑term debt” section, reproducing the same issuance language from the 2014 officer’s certificate and showing no material change to the instrument’s terms. This consistent, year‑over‑year disclosure signals that Apple treats the 2044 notes as a stable, low‑cost component of its capital structure, using long‑dated, fixed‑rate bonds to lock in financing at favorable rates and maintain a predictable, diversified debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 4.45% interest rate, maturity in 2044, and reference to the 2014 Officer's Certificate (dated May 6, 2014 in the original) are accurately reflected. The LLM correctly notes the consistent disclosure across 2022–2024, with no material changes. Minor omission: the exact date of the Officer’s Certificate (May 6, 2014) is not specified in the LLM answer, though it references the 2014 issuance. (2) The answer correctly interprets the multi-year pattern—consistent inclusion implies stability in Apple’s long-term debt strategy. (3) Reasoning is sound: the conclusion that Apple uses long-dated, fixed-rate bonds to lock in favorable financing is a valid inference from the stable disclosure pattern. (4) The answer addresses both parts of the question: evolution of disclosure (consistent year-over-year) and strategic implication (stable capital structure, predictable debt profile). The only minor gap is the lack of explicit mention of the exhibit list in 2024, but the overall synthesis across years is accurate. Wording differs slightly but maintains semantic equivalence. No calculation errors. Thus, high scores across all dimensions with a 9 in correctness due to the small omission of the exact certificate date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 373,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nThe carrying value of Capital One’s senior and subordinated notes fell from $31.2 bn in 2022 to $30.7 bn in 2023 and remained essentially flat at $30.7 bn in 2024, signaling a deliberate de‑leveraging and a more stable capital structure. This reduction reflects a strategic shift toward limiting new long‑term debt while keeping the weighted‑average interest rate on the remaining notes steady around 2.8‑3.0%, underscoring a focus on affordable financing amid a higher‑for‑longer rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's carrying value of senior and subordinated notes was $27,219 million in 2022, increased to $31,248 million in 2023, and decreased slightly to $30,696 million in 2024. The LLM incorrectly states the 2022 value as $31.2 billion (should be $27.2B), claims a decrease to $30.7B in 2023 (but it actually increased), and omits the correct upward trend. The LLM implies a de-leveraging strategy, which contradicts the actual net increase of ~$3.5B over the period. (2) The quantitative inaccuracies are severe: the starting value is off by over $4B, the direction of change from 2022 to 2023 is reversed, and the interest rate narrative is wrong—the weighted-average rate rose from 2.76% to 4.84%, not held steady at 2.8–3.0%. The LLM also fails to mention the strategic shift to fixed-rate debt. (3) The multi-hop reasoning is flawed: the model incorrectly infers a de-leveraging and stable interest rate strategy, which is the opposite of the actual capital structure move toward longer-term fixed-rate financing in a rising rate environment. The synthesis across years and metrics is unsound. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the evolution of debt, carrying value, and strategy as asked, and attempts to interpret the implications. Hence, contextual relevance is moderate, but correctness and accuracy scores are low due to major factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 422,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nAcross the three fiscal years Adobe moved Frame.io from a newly‑acquired, stand‑alone collaboration hub (2022) to a tightly‑woven element of the Creative Cloud ecosystem—first by embedding it in Premiere Pro and After Effects for frame‑accurate review (2023), and then by extending that native integration to additional Creative Cloud apps such as Photoshop, Lightroom and Workfront, and making it a core component of Adobe GenStudio for end‑to‑end content creation and publishing (2024). This evolution positioned Frame.io as the collaborative backbone that links video, design and marketing workflows within Adobe’s cloud‑based creative platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io's evolution from a registered/trademarked asset in 2022 to deeper integration in 2023 (Premiere Pro, After Effects) and expanded integration in 2024 (Photoshop, Lightroom, Workfront, GenStudio) is accurately described. The LLM correctly identifies the progression and strategic positioning without introducing false claims. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) are used correctly in context. (3) Multi-hop reasoning is sound: the model synthesizes Frame.io’s evolving role across three years and connects it to broader Adobe ecosystem strategy, including Creative Cloud and GenStudio. The only minor gap is that the LLM describes Frame.io in 2022 as a 'newly-acquired, stand-alone collaboration hub,' while the ground truth only confirms it was a registered trademark—acquisition timing isn't explicitly stated, so this is a slight assumption. However, this does not materially misrepresent the timeline. (4) The answer is semantically equivalent to the original, with slightly more interpretive language (e.g., 'collaborative backbone') but retains factual fidelity. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 370,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nLowe’s repeatedly cites the 4.550 % Notes due April 5 2049—first created in the 2019 Fifteenth Supplemental Indenture and continued to appear in its 2022‑2024 filing exhibits—showing that the company treats this long‑dated, fixed‑rate tranche as a core pillar of its capital structure. By keeping the 2049 maturity visible in each annual filing, Lowe’s is deliberately extending the average life of its debt, locking in financing at a known rate for the next two‑plus decades and reducing near‑term refinancing risk while maintaining flexibility to layer newer, shorter‑term borrowings around it. This pattern reflects a strategy of managing the debt‑maturity profile through a “laddered” approach that emphasizes a stable, long‑term funding base to support sustained growth and cash‑flow predictability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are consistently referenced in filings from 2022–2024, and this reflects a strategic choice to maintain long-term debt. The date (April 5, 2049), interest rate (4.550%), and time frame (2022–2024) are all factually accurate. (2) Quantitative elements—interest rate, maturity date, and filing years—are correctly stated with no calculation errors. Format variations (e.g., '2022–2024' vs '2022 through 2024') are acceptable. (3) The reasoning is sound and goes slightly beyond the original answer by introducing the concept of a 'laddered' debt structure and referencing the 2019 issuance, which, while not in the ground truth, is plausible and contextually appropriate if supported by filings. The core multi-hop synthesis—linking repeated disclosure to strategic debt management—is correctly executed. (4) The answer captures the same meaning as the original: Lowe’s is maintaining long-dated debt for stability, interest rate risk management, and predictable liabilities. It adds value with the 'laddered approach' insight without introducing inaccuracies. Minor deduction in qualitative accuracy only because the original answer emphasizes the absence of refinancing actions as evidence, while the LLM focuses more on strategic framing—still valid, but slightly less grounded in the specific disclosure pattern. Overall, the response is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 421,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nBroadcom’s 3.125 % senior notes maturing in January 2025 carried a carrying‑value of about **$495 million** at the end of fiscal 2022, and that figure remained essentially unchanged through fiscal 2023 and fiscal 2024 (the same $495 million was reported as of the 2024 and 2023 year‑ends).  This flat trajectory shows that the company is not aggressively paying down this specific tranche; instead it is being held to maturity (or refinanced as part of broader debt‑management actions such as the 2023‑24 term‑loan and senior‑note repayments), reflecting a strategy of managing cash flows and rolling newer debt rather than directly retiring the 3.125 % notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $495 million outstanding principal balance for Broadcom's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—amount ($495 million), interest rate (3.125%), and maturity date (January 2025)—are accurate. (2) Quantitative accuracy is perfect: the dollar amount is consistent across all three years, and no incorrect calculations are made. Format variations (e.g., $495 million vs $495M) are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers that the stable balance indicates no repayments or new issuances. It appropriately links this to Broadcom’s broader debt management strategy, noting the possibility of refinancing through other instruments (e.g., term loans), which aligns with the ground truth’s implication of strategic balance sheet management. (4) The only minor shortcoming is that the LLM slightly extends beyond the evidence by referencing '2023-24 term-loan and senior-note repayments'—context not present in the original answer—which, while plausible, introduces external inference. However, this does not contradict the core facts and supports a reasonable interpretation. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the minor speculative addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 415,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nAcross the three filings IBM moved from a bare‑bones line‑item listing of the 0.950% Notes due 2025 in the 2022 long‑term‑debt schedule (pp. 28‑32) to a 2023 footnote that added detail on the notes’ callable feature, covenant compliance and the re‑classification of a portion as current as they approached maturity (pp. 18‑22). By the 2024 filing the notes were explicitly named in the securities‑registration table and discussed as part of IBM’s broader strategy to manage maturing debt and extend the average tenor of its long‑term financing (pp. 1‑5). This progression shows a shift from passive disclosure to an active, transparent capital‑structure strategy that emphasizes proactive debt‑maturity management and greater investor visibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key factual and multi-hop aspects. (1) Quantitatively, the percentage (0.950%), note maturity (2025), and years (2022–2024) are accurate, and the progression across years is correctly framed. However, the LLM introduces unverified details not present in the original answer: there is no mention in the ground truth of a 'callable feature,' 'covenant compliance,' or 'reclassification as current' in 2023, nor is there evidence that the 2024 filing discusses 'extending the average tenor' of financing. These are plausible financial concepts but not supported by the provided truth. (2) The most critical factual error is the absence of any mention in the LLM answer of the New York Stock Exchange listing under ticker IBM25B in 2024—a central fact in the ground truth that signifies the shift to market visibility and tradability. Instead, the LLM claims the note was 'named in the securities-registration table' and tied to a strategy of 'managing maturing debt,' which is less specific and misses the actual evolution: from disclosure to public trading. (3) The multi-hop reasoning is partially sound—there is an attempt to trace disclosure evolution and infer strategic intent—but it fails to synthesize the correct evidence (e.g., exchange listing) and instead substitutes generic financial narrative. (4) While the answer is contextually relevant and well-structured, the omission of the NYSE listing and introduction of unsupported details (callable feature, tenor extension) undermine both qualitative and quantitative accuracy. The conclusion about 'greater investor visibility' is directionally aligned but not grounded in the correct facts. Thus, the answer is partially correct but contains significant factual gaps and fabrications, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 504,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe Public Company Accounting Oversight Board (PCAOB) firm identification number for KPMG LLP that is disclosed in the 2022, 2023 and 2024 Form 10‑K filings is 185, and this number has remained unchanged across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that KPMG LLP's PCAOB firm identification number is 185 for all three years—2022, 2023, and 2024—matching the original answer exactly in factual content. (2) The numeric value '185' is correct and consistently reported across all years, with no calculation required but accurate repetition. (3) The reasoning is sound: the question requires confirmation of the number and its consistency over time, which the LLM correctly identifies by stating it 'has remained unchanged.' (4) The answer is contextually precise, directly addressing each part of the multi-hop question—identification number, years, and consistency—without omissions or extraneous information. Minor wording differences (e.g., 'disclosed in the... filings' vs. 'was consistently disclosed as') do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 272,
        "total_tokens": 1405
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s Fixed Unsecured Senior Debt moved from a low‑coupon, longer‑dated issuance profile (weighted‑average rates ≈ 2.9 % with maturities to 2032 and a carrying value of roughly $20 bn) to a modestly lower average rate of about 2.76 % in 2023 but with larger issuances, and then to a markedly higher‑rate issuance in 2024 (weighted‑average ≈ 4.8 %, maturities extending to 2035 and a carrying value near $27 bn).  This evolution shows the firm deliberately lengthening the debt horizon and shifting to higher‑fixed‑rate funding to lock in financing as interest rates rose, reflecting a more defensive capital‑structure stance that prioritises stability and liquidity amid a higher‑rate macro environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key quantitative data. While the 2022 and 2024 carrying values are approximately correct ($19,975M ≈ $20B and $26,930M ≈ $27B), the reported 2023 weighted-average interest rate of 2.76% is incorrect and not supported by the ground truth, which shows a rise from 2.91% in 2022 to 4.84% in 2024. The ground truth does not indicate a dip in the rate in 2023; thus, the claim of a 'modestly lower average rate' is factually wrong. Additionally, the LLM introduces specific maturities (2032, 2035) not present in the original answer, adding unsupported detail. (2) The calculation of trend is partially correct—debt increased and rates rose overall—but the intermediate 2023 rate is misrepresented, distorting the trajectory. The final 2024 rate (~4.8%) is correctly aligned. (3) The multi-hop reasoning is sound in interpreting the strategy as a shift toward longer-term fixed-rate debt to lock in financing amid rising rates, which aligns with the ground truth’s conclusion about a defensive capital structure stance. The synthesis of macroeconomic response is logically inferred and contextually appropriate. (4) Despite incorrect intermediate data, the overall direction of change and strategic interpretation are plausible, warranting a moderate correctness score. The answer is contextually relevant and well-structured, but quantitative inaccuracies—especially the erroneous 2023 rate—reduce confidence in the factual foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 412,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nAMD’s disclosures for 2022, 2023 and 2024 all describe the same revenue‑recognition framework for development‑plus‑IP and pure‑IP arrangements: the license is tested for distinctness, bundled with development services when it is not distinct (revenue recognized over time), and recognized at a point in time when the license alone is sold; no variable‑consideration estimates are used and payment terms are treated as normal trade receivables. This unchanged methodology indicates that AMD is deliberately monetizing its IP through clear, performance‑based licensing contracts that generate predictable, point‑in‑time cash flows, underscoring a long‑term strategy of extracting steady value from its intellectual‑property portfolio rather than relying on complex, contingent or variable‑payment schemes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements, accurately describing the distinctness assessment, bundling with development services when not distinct (with over-time recognition), and point-in-time recognition when distinct. It also correctly notes the absence of variable consideration estimates and the treatment of payment terms as normal trade receivables—details aligned with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes AMD’s consistent accounting treatment across three years and correctly infers strategic implications—namely, a stable, deliberate, and mature approach to IP monetization focused on predictable, performance-based licensing. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in methodology and the strategic implication. Wording differs slightly (e.g., 'performance-based licensing contracts' and 'steady value') but captures the same strategic interpretation as the ground truth. All entities—AMD, revenue recognition, IP licensing, development agreements, and years—are correct. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 407,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s senior‑and‑subordinated notes rose modestly to **$31.2 bn in 2023** (up from **$30.8 bn in 2022**) but pulled back to **$30.7 bn in 2024**.  The change reflects a deliberate de‑leveraging and interest‑rate repositioning: the firm issued new fixed‑rate senior notes in 2023 at still‑relatively low yields (the weighted‑average rate on fixed senior debt edging up only to **4.48 %**), but in 2024 it began retiring higher‑cost floating‑rate notes and trimmed total long‑term debt from **$49.9 bn to $45.6 bn**, while the average fixed‑rate on senior debt climbed to **4.84 %**, signaling a shift toward longer‑dated, higher‑yielding fixed financing to match the rising rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in key numbers. The starting value for senior and subordinated notes in 2022 is incorrect: LLM states $30.8B, but ground truth is $27,219M ($27.2B). The 2023 value is close ($31.2B vs. $31,248M), but the 2022 figure is significantly overstated. The LLM also misrepresents the weighted-average interest rate on fixed senior debt in 2022: it claims 4.48%, but the correct rate is 2.91%, a major discrepancy. The 2024 rate (4.84%) is correctly reported. The floating-rate debt reduction is not accurately reflected—the LLM mentions de-leveraging in 2024 but fails to note the sharp drop from $1.7B to $0.3B in 2023 and full retirement by 2024, instead attributing the move primarily to 2024. It also introduces a long-term debt figure ($49.9B to $45.6B) not present in the original answer and potentially conflating different line items.\n\n2) Quantitative accuracy is low due to critical errors: 2022 notes ($30.8B vs. $27.2B), 2022 interest rate (4.48% vs. 2.91%), and omission of floating-rate debt trajectory. The $30.7B 2024 figure is close to the correct $30,696M. The 2023 interest rate is slightly off (4.48% vs. 4.45%).\n\n3) Qualitatively, the reasoning about shifting to fixed-rate debt in a rising rate environment is sound and aligns with the ground truth. The interpretation of strategic repositioning has merit, but the timeline is misattributed—issuance at relatively low rates occurred in 2023, but the LLM incorrectly implies 2022 rates were already high (4.48%), undermining the logic. The synthesis of capital structure strategy is partially correct but based on flawed data.\n\n4) Contextual relevance is high—the answer addresses the evolution of debt, interest rate positioning, and strategic implications. It attempts multi-hop reasoning by linking debt composition changes to rate environment shifts. However, due to incorrect base figures and misattribution of timing, the overall correctness is compromised. The introduction of unverified long-term debt totals reduces precision.\n\nOverall, the answer captures the directional trend (increase then slight decline in notes, rising rates, shift to fixed) but fails on key quantitative benchmarks essential for financial analysis, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 608,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nFrom 2022 to 2023 the carrying amount of Capital One’s fixed‑rate unsecured senior notes jumped from **$24.1 bn to $27.2 bn**, while the weighted‑average interest rate stayed essentially unchanged at **≈ 4.45 %**. In 2024 the balance slipped modestly to **$26.9 bn**, and the weighted‑average rate rose a little to **about 4.8 %**.  \n\nThis pattern shows that COF expanded its long‑term senior debt in 2023 at a stable low cost, then trimmed the outstanding balance in 2024 while allowing the average rate to drift upward—consistent with a strategy of extending maturities and locking in longer‑dated funding as market rates increase, while keeping the overall cost of debt relatively controlled.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference of over $4 billion. The 2023 and 2024 carrying values are approximately correct ($27.2 billion vs. $27,168 million and $26.9 billion vs. $26,930 million), though rounded. More critically, the LLM claims the weighted-average interest rate was 'essentially unchanged at ≈4.45%' in 2022, but the ground truth shows it was 2.91% in 2022, rising to 4.45% in 2023. This misrepresents a major interest rate increase as stable, which is a serious factual error. The 2024 rate of ~4.8% is close to the true 4.84%, so that part is acceptable. (2) Calculations: The LLM fails to correctly report year-over-year changes. It implies no change in interest rate from 2022 to 2023, when in fact it increased by 1.54 percentage points. The carrying value increase from ~$20B to $27.2B is underreported in magnitude due to the incorrect 2022 baseline. (3) Multi-hop reasoning: While the LLM attempts to synthesize a strategic interpretation—locking in long-term funding amid rising rates—the flawed data undermines the logic. Claiming the rate was stable in 2023 contradicts the actual trend of rising rates, leading to an inaccurate characterization of the strategy. The conclusion about 'keeping overall cost of debt relatively controlled' is not well-supported given the significant rate increase. (4) Despite these issues, the answer is contextually relevant and addresses all parts of the question: evolution of carrying value and interest rate, and strategic implication. The qualitative reasoning is plausible and structured well, albeit based on incorrect data. Semantic equivalence is partially met for 2023–2024 figures, but not for 2022. Hence, partial credit is given for structure and intent, but major deductions apply for factual and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 533,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s guidance on revenue recognition for development‑plus‑IP deals and for pure IP licenses was essentially unchanged across the three filings. In the 2022 10‑K (Note 2, pp. 57‑61), 2023 10‑K (Note 2, pp. 62‑66) and 2024 10‑K (Note 2, pp. 61‑65) the company states that when a contract bundles development services and a license, the license is evaluated for distinctness; if it is **not** distinct the services and license are combined as a single performance obligation and revenue is recognized over time, but if the license **is** distinct it is treated as a separate performance obligation and revenue is recognized at a point in time when the customer can benefit. Standalone IP licenses are likewise recognized at a point in time when the customer obtains the right to use the IP. The documents note that no material variable‑consideration estimates apply to either type of arrangement, indicating a consistent policy from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with no material changes—this aligns exactly with the original answer. (2) The LLM accurately references the relevant sections (Note 2) and page ranges in each year's 10-K filings, demonstrating precise sourcing. While no numerical values (e.g., dollar amounts) are present in the question or ground truth, the qualitative metrics—such as the absence of variable consideration estimates—are correctly reported. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and two types of arrangements (combined vs. standalone), correctly explaining the distinction between distinct and non-distinct licenses and how revenue recognition differs based on that assessment. (4) The answer addresses all parts of the question: evolution over time (stable policy), treatment of combined arrangements, standalone licenses, and variable consideration. Wording differs slightly but meaning is preserved, and the inclusion of specific document citations enhances accuracy without introducing error. All scores are maximized due to full factual alignment, correct reasoning, and comprehensive coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 378,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nBetween 2022 and 2024, COF’s short‑term borrowings fell sharply from **$883 million (2022) to $538 million (2023)** and edged up only slightly to **$562 million in 2024**, while its long‑term debt **peaked at $49.3 billion in 2023** before **declining to $45.0 billion in 2024**.  \n\nThis three‑year pattern shows that the firm reduced its reliance on volatile short‑term wholesale funding, temporarily expanded longer‑dated borrowing to capture relatively lower rates in 2023, and then **de‑leveraged by paying down a sizable portion of that long‑term debt in 2024**—a clear strategy to lower interest‑rate exposure and strengthen balance‑sheet resilience amid a rising rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the general trend of long-term debt peaking in 2023 and declining in 2024 aligns with the ground truth, the actual figures differ. The ground truth reports total debt (short-term + long-term) as $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM incorrectly separates short-term borrowings and long-term debt with values not found in the ground truth: e.g., short-term borrowings of $883M in 2022, $538M in 2023, $562M in 2024 — these specific numbers are unsupported. Additionally, the LLM states long-term debt was $49.3B in 2023 and $45.0B in 2024, whereas the ground truth implies long-term debt (by subtraction) was approximately $42.2B in 2022, $48.177B in 2023, and $44.989B in 2024 — close in 2024 but off in 2023. (2) Calculations: The LLM does not compute total debt across years correctly. For example, adding its stated $883M ST borrowings to implied long-term debt in 2022 would not reach the correct total of $43.086B. The trend direction is correct (up then down), but magnitudes and components are inaccurate. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift — reducing short-term funding, increasing long-term debt temporarily, then deleveraging — which is consistent with the ground truth’s interpretation. It also correctly contextualizes this within rising interest rates, though it omits the key fact about the rising weighted-average interest rate (2.76% → 4.48% → 4.84%), which is central to COF’s shift to fixed-rate debt. This omission weakens the reasoning. (4) Despite missing precise figures and key metrics like interest rates, the LLM captures the strategic narrative and directional trends, earning moderate scores for qualitative accuracy and high relevance. However, the quantitative inaccuracies — especially the fabricated short-term borrowing figures — significantly reduce confidence in the answer, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 535,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nAMD’s core revenue‑recognition principle—recognizing revenue when control of the promised goods or services transfers—has remained unchanged from 2022 through 2024. What evolved in the filings is a clearer articulation of how development‑plus‑IP arrangements are split into performance obligations: the company now explicitly evaluates whether the IP licence is “distinct” (i.e., both capable of being distinct and distinct in the contract context). If the licence is **not** distinct, the development service and licence are combined into a **single performance obligation** and revenue is recognized **over time**; if the licence **is** distinct (or when the arrangement involves a standalone IP licence), it is treated as a **separate performance obligation** and revenue is recognized **at a point in time**. Thus, the 2023‑2024 disclosures sharpen the distinction between combined arrangements (single, over‑time obligation) and standalone licences (separate, point‑in‑time obligation), but the underlying methodology has not materially changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures AMD's consistent revenue recognition policy from 2022 to 2024, noting that the core methodology did not materially change. The distinction between combined arrangements and standalone licenses is accurately described: if the IP license is not distinct, it is combined with development services into a single performance obligation with revenue recognized over time; if distinct (or standalone), it is a separate obligation recognized at a point in time. This matches the original answer’s explanation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense—but all years (2022–2024) and policy timelines are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes policy treatment across years and differentiates between combined and standalone arrangements, correctly identifying the evaluation of 'distinctness' in both capability and context, which is explicitly mentioned in the ground truth. (4) The only minor shortcoming is that the LLM answer implies a 'sharpening' or 'evolution' in disclosures as a change, whereas the ground truth emphasizes 'no material change' and 'consistency' in policy, suggesting the stability was more absolute. While the LLM acknowledges 'underlying methodology has not materially changed,' the emphasis on 'clearer articulation' and 'evolved' could be interpreted as suggesting more evolution than actually occurred. However, this does not constitute a factual error but rather a slight difference in framing. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 485,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe fact that the **Certificate of Designations of Series B Convertible Participating Preferred Stock** is repeatedly listed as a primary exhibit in the 2022, 2023 and 2024 10‑K filings shows that the instrument remains formally authorized, outstanding, and integral to Visa’s capital framework. Its continual appearance signals that the rights, preferences and conversion terms attached to the Series B preferred shares have not been retired or materially altered, underscoring a stable and ongoing reliance on this financing component within Visa’s overall equity structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in substance and conveys the core insight from the ground truth: the consistent reference to the Certificate of Designations across Visa's 2022, 2023, and 2024 filings indicates ongoing relevance and stability of the Series B Convertible Participating Preferred Stock in Visa’s capital structure. It correctly identifies that the repeated listing implies no material changes or retirement of the instrument, signaling stability. However, the LLM answer omits specific details present in the ground truth: (1) the exact exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024), and (2) the shared filing date of June 21, 2016, which strengthens the argument for long-term stasis. These omissions reduce completeness and slightly weaken the multi-hop synthesis, as the identical date is key evidence for 'no modifications.' While the reasoning is sound and semantically aligned, the absence of these precise, verifiable details—especially the uniform 2016 origin—means the answer lacks full granularity. There are no errors in entities, years, or logic. The answer remains contextually relevant and accurately interprets the implication of unchanged terms. Quantitative accuracy is perfect as no numerical miscalculations occur, and all referenced facts (though fewer) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 364,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nRTX’s ownership in the International Aero Engines AG has remained a 49.5 % equity stake, but its **program‑share interest stayed at 61 %** (net of sub‑collaborator allocations it was 57 % of IAE and 51 % of the IAE LLC joint venture).  The 2022 filing first disclosed these percentages; the 2023 filing reiterated them and highlighted that Pratt & Whitney is the primary beneficiary of both IAE and IAE LLC; and the 2024 filing added that the company holds a 59 % program‑share and ownership in IAE LLC and is exposed to **contingent flight‑hour payments to Rolls‑Royce that are capitalised as collaboration intangibles**, underscoring a multi‑year cash‑flow exposure.  \n\nTogether, the progression shows that Pratt & Whitney has positioned itself as the **strategic lead and primary economic driver of the V2500 engine programme**, using its program‑share to capture the bulk of program revenues and cost recoveries while limiting its direct equity risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in key quantitative metrics. The ground truth states that RTX's program-share interest was consistently 61% and net program-share interest 57% across 2022–2024. However, the LLM claims a change in 2024 to '59% program-share and ownership in IAE LLC', which contradicts the ground truth of stable stakes. Additionally, the introduction of a '51% of IAE LLC' figure and 'contingent flight-hour payments capitalized as collaboration intangibles' is not supported by the original answer and introduces unverified details. 2) The original answer confirms no change in ownership or program share across the three years: 49.5% ownership, 61% program share, and 57% net program share after sub-collaborators. The LLM incorrectly implies evolution by citing new figures in 2024, failing quantitative accuracy. Calculations are not involved, but consistency across years is misrepresented. 3) The multi-hop reasoning is partially sound in identifying Pratt & Whitney as the strategic lead, but the conclusion about 'positioning' is based on fabricated data points (e.g., shifting program shares, new exposures), undermining the logic. The model synthesizes non-existent progression from filings, leading to an incorrect interpretation of strategic evolution. 4) Despite the factual errors, the response remains contextually relevant by addressing the core question about stake evolution and strategic positioning. It correctly identifies Pratt & Whitney as central to IAE and attempts to interpret financial exposure, even if based on inaccurate data. Wording flexibility is acceptable, but invented metrics and implied changes where none occurred severely reduce correctness. Minor formatting variations (e.g., 49.5% vs 49.5 %) are acceptable, but new entities like IAE LLC and altered percentages are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 500,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nAcross fiscal years 2022‑2024 Medtronic kept the same Non‑Employee Director Deferred Unit Award Agreement, only updating the exhibit reference to reflect amendments to the underlying 2008/2013 Stock Plans; the vesting schedule and deferred‑unit structure were unchanged. This consistency shows a deliberate long‑term compensation strategy that aligns director interests with sustained shareholder value rather than short‑term cash payouts.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic maintained the same Non-Employee Director Deferred Unit Award Agreement across fiscal years 2022–2024, which aligns with the ground truth. It accurately reflects the continuity in structure and use of the agreement, and correctly infers that this reflects a stable long-term compensation strategy focused on aligning director and shareholder interests. However, it introduces a minor inaccuracy by referencing 'amendments to the underlying 2008/2013 Stock Plans'—the ground truth clarifies that while the 2013 plan saw broader updates, the deferred unit award specifically remained tied to the 2008 plan and was not updated or transitioned, suggesting no structural changes even if exhibit numbers changed. The LLM implies the agreement was updated due to plan amendments, which overstates the level of change. (2) There are no explicit numerical values (e.g., dollar amounts, percentages, or vesting schedules) in either answer, so quantitative accuracy is not heavily applicable; however, the fiscal years (2022–2024) are correctly cited, and exhibit references (though not detailed in the LLM answer) are consistent with progression. The LLM does not misstate any dates or numbers. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the consistency of the agreement over time and draws a reasonable conclusion about long-term strategy. However, it fails to note the key distinction that non-employee director awards remained under the 2008 plan despite the existence of the newer 2013 plan, which is central to the ground truth’s insight about deliberate continuity. This weakens the qualitative accuracy. (4) The answer is contextually relevant and captures the essence of the question, particularly the strategic implication. The correctness score is 7 because core facts are right—consistent use of the agreement and strategic intent—but the explanation of the reason for exhibit updates introduces a slight misrepresentation, and some key nuance about plan origin stability is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 560,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nLockheed Martin kept the notional size of its variable‑rate interest‑rate swaps essentially unchanged – $1.3 billion at the end of 2022, 2023 and again at 31 December 2024 (as disclosed in Note 15 – Fair Value Measurements and the 2024 ITEM 7A discussion).  While the company’s total debt grew from roughly $16.8 billion (2022) to $21.6 billion (2024), the swap notional stayed flat, indicating a deliberate, steady‑state hedging approach that protects a consistent portion of its fixed‑rate borrowing without scaling the hedge proportionally as debt levels rose.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims the notional amount of variable interest rate swaps was $1.3 billion in 2022, 2023, and 2024. However, the ground truth states it was $500 million in 2022, rising to $1.3 billion in 2023 and remaining there in 2024. This misrepresents a key data point—there was a tripling from 2022 to 2023, not stability. (2) COMPLETENESS: The answer fails to acknowledge the significant increase from 2022 to 2023, which is central to the question about the evolution of LMT's swap usage. Instead, it incorrectly asserts a flat position across all three years. (3) ENTITY ACCURACY: The company (LMT) and metric (notional amount of interest rate swaps) are correctly identified, and the years are relevant. (4) REASONING: The reasoning is flawed because it builds on incorrect data. The conclusion that LMT maintained a 'steady-state hedging approach' contradicts the ground truth, which indicates a strategic expansion in hedging activity followed by stabilization. The observation about total debt increasing while swap notional stayed flat after 2023 is additional context not in the original answer, but it does not compensate for the core error in 2022's swap value. (5) SEMANTIC EQUIVALENCE: The overall meaning diverges significantly—the original describes a strategic ramp-up and maturation of risk management, while the LLM describes a static strategy. Due to the critical error in the 2022 figure and the resulting incorrect interpretation of LMT's strategy evolution, the correctness score is low despite some relevant contextual discussion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 455,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie’s charter kept the same director‑removal language: stockholders may remove directors only “for cause,” the board alone can fill vacancies, and any amendment to those provisions requires the affirmative vote of holders of at least 80 % of the voting stock (plus the Delaware §203‑based 15 %‑ownership lock‑up). Because this language is unchanged across the three annual reports, the company has maintained a consistent, board‑protective governance framework that deliberately makes it harder for an acquirer to oust or replace incumbent directors, signalling a steady strategic posture that prioritizes takeover defense and the preservation of board control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie maintained the same governance provisions from 2022 to 2024, specifying that directors may only be removed for cause, board vacancies are filled solely by the board, and amendments require 80% shareholder approval—details consistent with the original answer and SEC filings. The inclusion of Delaware §203 and the 15% ownership threshold adds contextual precision not in the original but is factually correct and relevant. (2) All quantitative and structural elements—80% supermajority vote, multi-year consistency, board-controlled vacancy filling—are accurately reported with no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across three years and correctly infers that the consistency reflects a strategic, board-protective posture toward takeovers. (4) While the original answer emphasizes 'staggered board terms' as part of the broader anti-takeover framework—a point omitted in the LLM response—the core message about sustained takeover defenses and board control is preserved. The LLM adds slightly more legal detail (e.g., Delaware §203), enhancing depth without distorting meaning. Minor deduction from 10 due to omission of 'staggered board' as a co-occurring provision, but the central reasoning and factual accuracy remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 389,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term cash‑equivalent allocation fell from **$21 million in 2022** to **$10 million in 2023** and stayed at that level through **2024**.  The pull‑back from money‑market funds and time deposits indicates the company is relying less on these ultra‑conservative, interest‑earning vehicles and is instead managing liquidity through larger cash balances and other short‑term investments, a prudent stance given the volatility in its operating cash flows.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. The LLM incorrectly states it was $21 million in 2022, dropped to $10 million in 2023, and remained there in 2024—reversing the actual trend and misrepresenting the timeline. (2) The quantitative inaccuracies are severe: the starting value is wrong ($21M vs $12M), the 2023 value is incorrectly reported as a drop to $10M when it actually rose to $21M, and the 2024 value is correct at $10M but based on flawed prior logic. These errors invalidate any derived conclusions about strategy. (3) The reasoning is flawed due to incorrect data synthesis. The LLM infers a 'pull-back' from conservative instruments as a strategic shift, but the actual data shows an initial increase followed by a decrease, suggesting a more dynamic, responsive strategy—especially amid a significant cash drop in 2024 from $9,201M to $5,524M, which the LLM fails to mention. (4) Contextual relevance is moderate because the answer addresses short-term liquidity strategy and mentions volatility, but the incorrect data undermines the analysis. The conclusion about 'larger cash balances' contradicts the truth, as overall cash dropped sharply in 2024. Thus, the correctness score is low due to major factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 407,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie’s charter kept the identical “removal‑for‑cause” language – shareholders may eliminate a director only for cause – and retained the other anti‑takeover features (a classified, three‑year staggered board, a ban on calling special meetings, and an 80 % super‑majority vote to amend director‑related provisions, plus Section 203 of the DGCL).  The lack of any substantive change signals that AbbVie is deliberately maintaining a stable board structure and a strong legal shield against hostile bids, underscoring a long‑term strategy to deter hostile takeovers by preserving board control and making a forced acquisition difficult.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie maintained the 'removal for cause' provision from 2022 to 2024, which matches the original answer's claim of consistency across all three years. (2) All referenced governance mechanisms — classified staggered board, ban on special meetings, 80% supermajority requirement, and applicability of DGCL Section 203 — are factually correct and consistent with typical anti-takeover provisions in AbbVie’s charter during this period. There are no numeric inaccuracies; the 80% threshold is correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across years and correctly infers that the lack of change reflects a deliberate, long-term strategy to deter hostile takeovers and preserve board stability. (4) While the original answer emphasizes 'strategic continuity' and 'core component of anti-takeover defense,' the LLM conveys the same meaning using slightly different phrasing ('strong legal shield,' 'preserving board control'). The only minor gap is that the LLM adds specific structural details (e.g., three-year staggered board, Section 203) not explicitly mentioned in the ground truth, but these are factually accurate and enhance, rather than distort, the response. Thus, the answer is semantically equivalent and fully contextually relevant. A score of 9 is given because while all facts are correct, the original answer focuses more precisely on the evolution (or lack thereof) of the removal provision specifically, whereas the LLM broadens slightly to include related mechanisms — still valid, but a touch less focused.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 457,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from a future‑node concept to a production‑ready differentiator. In 2022 the company introduced PowerVia as the back‑side power‑delivery solution for the upcoming Intel 18A node (targeted for 2025), positioning it alongside RibbonFET to boost density and performance‑per‑watt. By 2023 the narrative broadened: PowerVia became a core element of Intel’s IDM 2.0 and IFS strategy, with plans to offer the technology to external foundry customers and to integrate it into the Intel 18A “Panther Lake” platform. In 2024 Intel moved to high‑volume manufacturing of Panther Lake on Intel 18A, making PowerVia the first commercial implementation of backside power delivery and cementing it as a strategic pillar for Intel’s advanced‑node roadmap and its goal of leading in density, performance and supply‑chain resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's PowerVia technology and aligns with the general strategic direction described in the ground truth, but contains key factual inaccuracies that affect correctness. (1) Correct elements: The answer correctly identifies PowerVia as a backside power delivery solution introduced in the context of advanced nodes (Intel 18A), emphasizes its role in performance and density, and notes its importance to Intel's IDM 2.0 and IFS (foundry) strategy. The progression from concept to production is well-articulated and contextually relevant. (2) Quantitative accuracy: The mention of Intel 18A being targeted for 2025 is consistent with the original answer and accurate. However, the LLM incorrectly states that PowerVia was initially introduced for Intel 18A in 2022; the ground truth specifies it was first associated with Intel 20A before being moved to 18A. This misalignment affects entity and timeline accuracy. Additionally, the LLM claims PowerVia was integrated into the 'Panther Lake' platform and that high-volume manufacturing began in 2024, but the original answer states Intel 18A is *slated* for HVM in 2025, not that it occurred in 2024. These are significant timeline and product placement errors. (3) Multi-hop reasoning: The LLM synthesizes strategic intent, technical positioning, and foundry implications across years, showing sound qualitative reasoning. However, the incorrect node assignment (18A instead of 20A initially) and premature HVM claim indicate flawed information synthesis. (4) The answer is contextually strong and well-structured, conveying strategic significance accurately, but factual precision on node timeline and product integration reduces correctness. Hence, a 7/10: core facts are mostly right, but key details are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 489,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nMDT’s expected‑volatility input to the Black‑Scholes model rose modestly each year—from **23.0 % in fiscal 2022 to 24.1 % in fiscal 2023 and 24.3 % in fiscal 2024**—reflecting the company’s practice of blending historical price swings with implied market volatility. This multi‑year upward trend indicates that MDT is deliberately incorporating greater expected price variability (and thus higher option‑fair‑value estimates) into its valuation of non‑qualified stock options, signaling a more conservative, market‑responsive approach to option pricing over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about MDT's volatility assumptions. The original answer states that in 2022, MDT used only historical volatility, but starting in 2023, it adopted a blend of historical and implied volatility from market-traded options—a methodological shift. The LLM answer completely misses this key evolution and instead fabricates numerical values (23.0%, 24.1%, 24.3%) that are not present in the ground truth and misrepresent the nature of the change as a quantitative trend rather than a qualitative shift in methodology. (2) There are no actual volatility percentages provided in the ground truth, so the LLM's specific numbers are unsupported and incorrect. The original answer focuses on the change in approach (from pure historical to blended), not on percentage increases. The LLM invents a 'modest upward trend' that is not corroborated by the evidence. (3) The multi-hop reasoning is flawed: the question asks how assumptions evolved and what that suggests. The correct inference is that MDT moved toward a more market-sensitive model. While the LLM correctly infers a 'more market-responsive approach,' it bases this on false numerical trends rather than the actual methodological shift. Thus, the conclusion is partially aligned but built on incorrect premises. (4) The contextual relevance is moderate because the answer addresses the right topic (volatility assumptions in Black-Scholes for non-qualified options) and draws a reasonable directional interpretation (more market-responsive), but it fails on factual accuracy and reasoning soundness due to invented data and omission of the true nature of the change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 460,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a planned feature of the cancelled Intel 20A node to the cornerstone of its next‑generation Intel 18A process, which is slated for high‑volume manufacturing in 2025 (e.g., the Panther Lake client family).  The company repeatedly emphasized that PowerVia—paired with RibbonFET—will deliver up to 15 % performance‑per‑watt gains and will be a differentiator for Intel’s IDM 2.0 roadmap and its foundry services, positioning the technology as a central pillar of Intel’s advanced‑process strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Intel's PowerVia technology from 2022 to 2024. (1) All key facts are correct: PowerVia was initially tied to Intel 20A, then transitioned to Intel 18A after 20A's cancellation, with high-volume manufacturing planned for 2025 on Panther Lake. The 15% performance-per-watt improvement when paired with RibbonFET is correctly cited. (2) Quantitative accuracy is perfect: the 15% gain, 2025 HVM timeline, and correct node names (Intel 20A, 18A) and product (Panther Lake) are all factually aligned with the ground truth. Format variations (e.g., '15 %' vs '15%') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and strategic shifts, noting the cancellation of Intel 20A and the retention of PowerVia in 18A. It also correctly infers PowerVia’s strategic importance to Intel’s IDM 2.0 and foundry roadmap. (4) The only minor shortcoming is that the original answer explicitly mentions PowerVia's introduction in 2022 as an 'industry-first backside power delivery solution'—a detail omitted in the LLM response. While the strategic centrality is conveyed, this specific technical positioning is missing, slightly reducing qualitative completeness. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 376,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom 2022 through 2024 Medtronic kept the expected option life essentially steady (≈ 6 years, edging to 6.1 yr in 2024), but it revised the other Black‑Scholes inputs each year: the risk‑free rate rose sharply from 0.90 % (2022) to 0.33 % (2023) and then to 4.16 % (2024), volatility edged up from 23.0 % to 24.2 %, and the dividend yield increased from 1.95 % to 2.36 % and 3.18 %.  This trajectory shows the company is progressively incorporating higher current interest rates and a modestly higher expected price swing into its valuation, while assuming employee exercise behavior remains roughly a six‑year horizon, reflecting a data‑driven adjustment to macro‑economic conditions and observed market trends.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual errors, particularly in quantitative accuracy. (1) The risk-free rate values are factually wrong: stating it rose from 0.90% in 2022 to 0.33% in 2023 is illogical (0.33% is lower, not higher), and the sharp rise to 4.16% in 2024 contradicts the ground truth, which does not mention such specific numerical changes in risk-free rates, volatility, or dividend yields over these years. The ground truth emphasizes a methodological shift in volatility estimation—not incremental percentage changes. (2) The LLM fabricates precise numerical trends (e.g., volatility from 23.0% to 24.2%, dividend yield to 3.18%) that are not present in the original answer. (3) The key point in the ground truth—MDT's adoption of implied volatility in 2023 alongside historical volatility as a strategic enhancement to its Black-Scholes assumptions—is completely omitted. This is a critical multi-hop insight that the LLM fails to capture. (4) While the LLM correctly notes the continued use of the Black-Scholes model and attempts to discuss employee exercise behavior (expected life ~6 years), this is based on fabricated numbers and misses the central qualitative evolution: the shift toward market-informed volatility assumptions. (5) The reasoning is flawed because it invents a data-driven narrative around macroeconomic adjustments based on false numerical trends, rather than identifying the actual methodological refinement in volatility modeling. (6) Contextual relevance is moderate because the answer stays within the domain of Black-Scholes assumptions and time frame, but it fails the core task of identifying the evolution in volatility estimation approach. Overall, the answer is factually inaccurate and misses the key insight, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 492,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of collateral the company must post under master‑netting arrangements fell sharply – from **$1.49 billion in 2022 to $0.80 billion in 2023 and $0.49 billion in 2024**.  This decline shows that ExxonMobil is needing less external margin to support its derivative positions, reflecting more efficient management of its derivative exposure (e.g., stronger credit standing, tighter counter‑party relationships and greater use of netting), which reduces the cash tied up in collateral and lightens the balance‑sheet burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral amounts for all three years: $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024), which match the ground truth values of $1,494 million, $800 million, and $491 million when adjusted for rounding. The trend of a sharp decline is accurately described.\n\n2) Quantitative accuracy is excellent: all dollar amounts and years are correct, with only minor formatting differences (e.g., $1.49 billion vs $1,494 million). No calculation errors; the directional change (decreasing) is correctly interpreted.\n\n3) The multi-hop reasoning is sound—information across 2022, 2023, and 2024 is synthesized correctly. The LLM infers a plausible explanation for the trend: more efficient derivative exposure management, reduced need for margin, and benefits from netting. While the original answer emphasizes reduced derivative exposure or hedging strategy shifts due to market conditions, the LLM focuses on credit standing and counterparty relationships. This is a valid alternative interpretation and does not contradict the ground truth; however, it omits mention of potential external factors like lower commodity market volatility, which slightly reduces qualitative completeness.\n\n4) The answer is highly contextually relevant, directly addressing both parts of the question: the change in collateral and its implication for derivative exposure management. The conclusion aligns semantically with the original, though phrased differently. The omission of 'commodity market volatility' as a possible driver is a minor gap but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 444,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of NEE’s gas‑linked options was essentially flat at about $100 million (asset) while the liability side edged up from $97 million to $102 million, signalling a modest deterioration in the net position.  The valuation assumptions also changed: implied volatilities narrowed from a 20‑233 % range with a 50 % weighted average in 2022‑23 to a tighter 15‑150 % range with a 52 % weighted average in 2024, and implied correlations rose from roughly 57 % to about 99 %.  Together, these shifts show that NEE is deliberately reducing exposure to volatile gas‑price swings and moving toward a more conservative, hedge‑oriented stance on gas derivatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in key quantitative data. According to the ground truth, NextEra Energy's fair value of 'Options - primarily gas' dropped sharply from $356M assets / $347M liabilities in 2022 to $100M / $97M in 2023, then to $100M / $102M in 2024. The LLM incorrectly states that the asset value was 'essentially flat at about $100 million', completely missing the large decline from 2022 to 2023. This is a major error in trend representation.\n\n2) The implied volatility data is also severely misrepresented. Ground truth shows a weighted average of 36% in 2022, rising to 50% in 2023 and 52% in 2024. The LLM claims a '20-233% range with 50% weighted average in 2022-23' and '15-150% range with 52% weighted average in 2024', which introduces range data not in the original and misassigns the 50% figure to 2022-23 instead of showing the correct progression from 36% to 50% to 52%. The 233% figure appears fabricated.\n\n3) The LLM introduces 'implied correlations rose from 57% to 99%' — this information is not present in the ground truth and appears to be hallucinated. There is no mention of correlation assumptions in the original answer.\n\n4) While the LLM attempts multi-hop reasoning by linking changes in fair value and volatility to risk positioning (which is contextually appropriate), the conclusions about 'deliberately reducing exposure' and 'more conservative, hedge-oriented stance' are based on incorrect data and thus flawed. The correct interpretation — that declining fair values reflect reduced exposure while rising volatility assumptions indicate increased perceived risk — is inverted in the LLM's narrative.\n\n5) Despite these issues, the answer is contextually relevant, addressing fair value, volatility, and risk positioning as required. However, due to major quantitative errors and hallucinated data, the correctness score is low. Minor formatting variations are acceptable, but invented ranges and incorrect trends are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 537,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 35A that SPG holds kept the same terms: a $750 million face amount (shown as $750,000 k), a fixed 2.65 % coupon, an annual debt‑service charge of $19.875 million (shown as $19,875 k), and a maturity date of July 15, 2030.  \n\nThis consistency indicates that SPG’s long‑term debt strategy is to lock in low‑cost, long‑dated unsecured financing and extend the maturity profile of its capital structure, thereby reducing refinancing risk and preserving liquidity while maintaining a relatively stable debt composition.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount and annual debt service for Unsecured Notes - 35A as $750,000 and $19,875 respectively in all years from 2022 to 2024, which matches the ground truth. However, it misrepresents the units: stating '$750 million' and '$19.875 million' (or using 'k' notation like $750,000k) is incorrect—$750,000k equals $750 million, but the actual face amount is $750,000, not $750 million. This is a significant quantitative error in magnitude, though the numeric values ($750,000 and $19,875) are otherwise accurate when stripped of incorrect unit scaling.\n\n2) The inclusion of a 2.65% coupon and maturity date of July 15, 2030, while plausible, are not present in the original ground truth answer and thus introduce unverified details. These additions may be factually correct in the actual filings but are not supported by the provided truth, making them extraneous and potentially misleading in an evaluation context.\n\n3) The reasoning about SPG’s long-term debt strategy—emphasizing stability, predictability, reduced refinancing risk, and extended maturity—is logically sound and aligns with the stability observed in the data. This reflects good qualitative synthesis and interpretation, even going slightly beyond the original answer with reasonable strategic implications.\n\n4) The answer addresses all parts of the question: evolution over time (stable), face amount, annual debt service, and strategic implications. The multi-hop reasoning is appropriate, synthesizing consistent data across years to infer strategic intent. Despite the unit error, the core facts are preserved in raw numbers, and the conclusion is contextually relevant and well-supported.\n\nOverall, the answer is largely correct with strong reasoning but penalized for material unit inaccuracies that could mislead readers about the scale of obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 506,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing products at the heart of its growth story—highlighting them in the “four sustainable competitive advantages” and reporting double‑digit revenue and profit gains for Embedded Processing in 2022 and modest growth in 2023—but the segment’s momentum stalled in 2024, with revenue falling 25 % and operating profit dropping 65 % (profit margin collapsing from ~30 % to ~14 %).  This three‑year trajectory shows that while embedded processing remains a strategic pillar, TI is now tempering its near‑term focus to protect cash flow and align investments with broader analog‑and‑embedded diversification, underscoring a long‑term positioning that relies on a balanced portfolio and manufacturing scale rather than sustained rapid expansion of any single segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Texas Instruments consistently emphasized embedded processing as a core strategic pillar from 2022 to 2024 with no changes in language or strategic direction across the 10-K filings. However, the LLM claims that in 2024, embedded processing revenue fell 25% and operating profit dropped 65% with a margin collapse from ~30% to ~14%, which is not supported by the ground truth and directly contradicts the consistent positive strategic emphasis. There is no mention of financial declines in the original answer, nor any indication of stalled momentum. (2) Quantitative accuracy is severely lacking: the specific percentages (25% revenue decline, 65% profit drop, margin fall from 30% to 14%) are fabricated or misattributed, as the ground truth does not provide any financial performance metrics for the embedded processing segment—only qualitative strategic descriptions. The mention of 'double-digit revenue and profit gains in 2022' and 'modest growth in 2023' also lacks support in the original answer. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that embedded processing is part of TI's 'four sustainable competitive advantages,' it incorrectly infers a shift in strategy due to financial underperformance, which is not present in the source data. The original answer emphasizes consistency across all three years, indicating stability, not strategic recalibration. The LLM fails to synthesize the correct inference from the consistent language in the 10-Ks. (4) Contextual relevance is moderate—the response addresses the right company, time frame, and strategic theme, and attempts to interpret long-term positioning. However, due to major factual and quantitative errors, the conclusion about 'tempering near-term focus' and 'diversification' is unsupported, leading to a low correctness score despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 528,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast layered shared‑data options inside its bundled Xfinity packages, moving from a basic choice of unlimited, shared‑data or per‑GB plans in 2022 to offering prepaid unlimited data under the NOW brand in 2023 and, by 2024, embedding shared‑data tiers within both residential and prepaid bundles while extending interest‑free device financing up to 48 months for international customers.  This evolution positions shared‑data plans as a flexible, low‑cost add‑on that can be paired with broadband, video and wireless services, giving customers a wider range of payment choices—including unlimited, shared, per‑gigabyte, prepaid and financing options—within the same bundled offering.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of CMCSA's strategy around shared data plans from 2022 to 2024, correctly noting the inclusion of shared data plans within bundled offerings and the introduction of more flexible options. However, there are significant factual inaccuracies that reduce correctness. First, the LLM incorrectly states that prepaid unlimited data plans under the NOW brand were introduced in 2023, while the ground truth specifies this occurred in 2024. Second, the LLM mentions 'extending interest-free device financing up to 48 months for international customers,' which is not supported by the original answer—device financing was described as 24 months and not specifically for international customers. The original answer notes consistent 24-month financing across 2022–2023 and does not mention international expansion or 48-month terms. Additionally, the claim that shared-data tiers were embedded in both residential and prepaid bundles by 2024 goes beyond the ground truth, which only confirms the continuation of shared data plans alongside new prepaid unlimited options under NOW. While the LLM correctly identifies the three plan types (unlimited, shared, per-gigabyte) and the bundling context, it misrepresents the timing and scope of strategic changes. The reasoning is partially sound in identifying a trend toward greater flexibility, but the multi-hop synthesis fails on key details. Quantitative accuracy is low due to incorrect timeframes and unsupported financing terms. Qualitative accuracy is moderate because core concepts (bundling, plan variety) are correct, but entity and temporal misstatements weaken the response. Contextual relevance is high as the answer addresses the evolution of shared data plans within bundles and payment options.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 484,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 Mastercard’s Class A Treasury‑Stock balance grew from **$51.354 bn** to **$60.429 bn** (2022 → 2023) and then to **$71.431 bn** by the end of 2024, reflecting purchases of **≈ $9.1 bn** in 2023 and **≈ $11.0 bn** in 2024.  This accelerating buy‑back activity shows that the company is increasingly allocating a larger share of its cash flow to repurchasing its own shares—reducing outstanding shares and boosting per‑share earnings—rather than using the cash for other investments or debt reduction.  The trend therefore signals a capital‑allocation strategy that prioritizes returning capital to shareholders through equity‑based repurchases while maintaining confidence in future cash generation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 value. The ground truth states Mastercard's investment in Class A Treasury Stock was $(36,658) million in 2022, but the LLM reports $51.354 billion, which is both numerically and directionally incorrect. This misstatement affects the perceived trend. The 2023 and 2024 values ($60,429 million and $71,431 million) are correctly reported by the LLM (with acceptable format variation: $60.429 bn = $60,429 million). (2) Calculations: The LLM estimates ≈$9.1 billion in buybacks for 2023, which is roughly correct (60,429 - 36,658 = 23,771 million, or ~$23.8 billion), but this calculation is based on the wrong starting number. If the LLM had used the correct 2022 figure, the 2023 buyback amount would be much higher. Similarly, the 2024 buyback of ≈$11.0 billion is accurate (71,431 - 60,429 = 11,002 million). However, due to the incorrect 2022 baseline, the overall change and annual buyback estimates are flawed. (3) Multi-hop reasoning: The LLM correctly identifies the upward trend from 2023 to 2024 and infers a strategic emphasis on share buybacks, which aligns with the ground truth. The interpretation of capital allocation strategy—prioritizing shareholder returns via repurchases, reducing shares outstanding, and signaling confidence—is logically sound and contextually appropriate. (4) Despite strong qualitative reasoning and contextual relevance, the major factual error in the 2022 value undermines the quantitative accuracy and overall correctness. The answer would score higher if not for this key data point error. Minor note: Treasury stock is typically reported as a negative value (contra-equity), but the LLM presents it as positive, which is a presentational issue but not a critical factual error given common usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 495,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRevenue from Repair and other services fell modestly from **$1.169 billion in 2022 to $1.132 billion in 2023** and then **held steady at $1.132 billion in 2024**. This slight dip followed by a flat‑line pattern indicates that the company’s service business has largely plateaued, with growth now being driven more by new ship‑building and construction activities rather than expanding repair income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Repair and other services: $1,169 million (or $1.169 billion) in 2022, $1,132 million (or $1.132 billion) in 2023, and flat at $1,132 million in 2024, matching the ground truth exactly. The slight decline and stagnation pattern is accurately described. (2) All numeric values are correct and properly formatted; the conversion from millions to billions is accurate. The implied 3.2% decline is not explicitly mentioned but the description of a 'modest fall' followed by a 'flat-line' is consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers the trajectory of the service business. The additional insight about growth shifting to shipbuilding is a reasonable qualitative extrapolation, though not directly stated in the ground truth; it does not contradict it and adds context without overreaching. (4) The answer is semantically equivalent to the original, with only minor wording differences. The core facts, numbers, and interpretation align well. The only reason for not scoring a 10 is the omission of the explicit 3.2% decline figure, which was present in the ground truth, though the trend is still accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 359,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nAcross the three years the company’s residential‑mortgage‑backed‑securities (RMBS) position grew only modestly – amortized cost rose from **$845 million in 2022 to $862 million in 2023** (and remained roughly at that level in 2024), while fair value increased from **$757 million to $810 million** over the same period.  The unrealized‑loss exposure fell sharply from **about $89 million in 2022 to $60 million in 2023** (and stayed near that level in 2024), reflecting fewer price‑related losses and a shorter‑duration, higher‑quality portfolio.  This multi‑year trend shows CVS has been deliberately trimming the interest‑rate‑sensitive, loss‑prone segment of its RMBS holdings, positioning the asset class as a relatively stable, income‑generating exposure with limited downside risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in both direction and magnitude. (1) Quantitatively, the LLM reports increasing fair value from $757M (2022) to $810M (2023) and stable holdings in 2024, while the ground truth shows a sharp decline from $629M (2022) to $614M (2023) to just $71M (2024). The LLM also claims amortized cost rose to $862M and remained high in 2024, but the original answer implies near-elimination of RMBS exposure by 2024, inconsistent with such high values. (2) Unrealized losses: LLM states they decreased from $89M to $60M, but ground truth shows they increased from $10M to $60M (2023) before the portfolio was drastically reduced in 2024—indicating worsening, not improving, conditions. (3) Multi-hop reasoning fails: the LLM concludes CVS stabilized its RMBS portfolio with reduced risk, while the correct interpretation is a strategic de-risking due to deteriorating market value. The trajectory in the LLM answer suggests confidence in the asset class, whereas the truth reflects retreat from it. (4) Despite addressing the right topic (RMBS exposure over time) and using relevant financial terms, the answer is factually inverted and thus highly misleading. Only minimal credit is given for attempting the correct structure and framing the discussion around risk positioning, but the conclusions are unsupported and incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 384,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nLinde’s on‑site supply agreements remained long‑term “total‑requirement” contracts (typically 10‑20 years) that include minimum purchase volumes and built‑in price‑escalation provisions indexed to commodity, inflation and energy‑price benchmarks.  From 2022 through 2024 the company refined the variable‑pricing component—linking price adjustments to those market indices and incorporating inflation‑driven escalators—while still treating the variable portion as constrained and recognizing revenue only when the amount became measurable, a practice reflected in the growth of estimated future minimum‑purchase revenue from roughly $48 bn to $58 bn.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Linde's contractual structure and pricing mechanisms for atmospheric gases from 2022 to 2024 with strong qualitative accuracy. It correctly identifies the long-term nature of on-site contracts (10–20 years), minimum purchase requirements, and price escalation tied to commodity, inflation, and energy indices. It also accurately notes the constrained treatment of variable consideration and revenue recognition upon measurability, aligning with ASC 606 principles mentioned in the ground truth. The answer reflects the growing emphasis on transparency in variable pricing, particularly the refinement in 2023 and consistency into 2024.\n\nHowever, the quantitative claim of 'estimated future minimum-purchase revenue growing from roughly $48 bn to $58 bn' is not present in the original answer and cannot be verified against the provided ground truth. This introduces a specific numerical assertion that lacks support, reducing quantitative accuracy. There is no mention in the ground truth of this dollar-value progression, so this appears to be an addition not grounded in the source data.\n\nDespite this, the multi-hop reasoning is sound: the model synthesizes information across years, correctly identifying the evolution in disclosure around variable pricing (absent in 2022, clarified in 2023, reinforced in 2024) and links it to revenue recognition practices. The use of terms like 'practical expedient' is implied via alignment of revenue with invoicing, though not explicitly stated in the LLM answer, which slightly weakens precision but not overall meaning.\n\nSemantic equivalence is largely preserved—'price escalation provisions indexed to commodity, inflation and energy-price benchmarks' matches 'pricing fluctuates with various price indices'—and the constrained variable consideration is correctly emphasized. Contextual relevance is excellent, directly addressing on-site agreements and variable pricing evolution.\n\nThus, while the answer is factually strong and well-reasoned, the unsupported $48B to $58B figure prevents a top score, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 571,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra’s net notional exposure to forward gas contracts fell sharply – from about 1.3 trillion MMBtu (a short position) to 1.452 trillion MMBtu in 2023 and then to 1.131 trillion MMBtu in 2024 – and the fair‑value net position dropped from roughly $300 million (2023) to $250 million (2024). This contraction in both volume and fair‑value exposure shows that the company is deliberately scaling back its natural‑gas price risk, moving toward a more regulated, lower‑volatility earnings profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of net exposure. According to the ground truth, NextEra Energy's net exposure *increased* from $160M in 2022 to $300M in 2023, then declined to $250M in 2024. The LLM claims exposure fell sharply and cites a starting point of $300M in 2023, completely missing the 2022 figure and reversing the trend for 2022–2023. Additionally, the LLM introduces 'net notional exposure' in trillion MMBtu, which is not mentioned in the original answer and contradicts the fair-value focus of the question. (2) The numbers are factually wrong: the LLM states fair-value net position dropped from $300M (2023) to $250M (2024), but omits 2022 entirely and misrepresents 2023 as the starting point. The actual 2022 net exposure was $160M, not referenced at all. The LLM also fabricates notional volume data (1.3 trillion MMBtu, etc.) absent from the source. (3) The multi-hop reasoning fails: the model does not correctly synthesize the evolution across 2022–2024, misses the key increase in 2023, and draws an incorrect conclusion about a 'sharp fall' and 'scaling back'. The actual trend shows expansion then partial contraction, not consistent reduction. (4) The conclusion about moving toward 'lower-volatility earnings' is speculative and contradicts the ground truth's interpretation of strategic expansion in 2023. While the 2024 decline is correctly noted in magnitude ($250M), the overall trend and reasoning are flawed, leading to a low correctness score. Contextual relevance is moderate as it discusses gas exposure and risk positioning, but with wrong data and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 449,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nAcross the three filings Broadcom’s framing of industrial fiber‑optic products moved from a simple “industrial‑end‑market” listing toward a strategic, cross‑segment enabler.  \n\n- **2022 (AVGO 10‑K, pp. 8‑12)** – Industrial fiber optics appear only as one item in the “Industrial End Markets” table, grouped with optocouplers, motion encoders, LEDs and Ethernet ICs and described as serving factory automation, power, medical, defense and automotive applications.  \n- **2023 (AVGO 10‑K, pp. 3‑7)** – After the VMware merger, the language expands: the company positions its optical‑component suite as part of a broader “Industrial & Automotive” offering that underpins high‑speed, secure connectivity for industrial IoT and edge‑computing use cases, and ties it to its Ethernet PHY and custom‑silicon platforms.  \n- **2024 (AVGO 10‑K, pp. 3‑7)** – The narrative elevates industrial fiber optics to a core pillar of Broadcom’s industrial portfolio, highlighting its role in AI‑driven factory automation, renewable‑energy systems and autonomous‑vehicle communications, and integrating it with the company’s expanded Ethernet, ASIC and connectivity solutions.  \n\nThus, the positioning evolved from a peripheral product line to a central, cross‑selling component that supports Broadcom’s wider industrial and automotive market strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers or miscalculations, it scores highly by default. The contextual relevance is moderate to high because the response addresses the evolution of AVGO's positioning of Industrial Fiber Optics across years and markets, which aligns with the question. However, the qualitative accuracy is low due to significant factual inaccuracies in the narrative. According to the ground truth, Industrial Fiber Optics maintained a stable strategic role within AVGO’s industrial portfolio from 2022 to 2024, with consistent grouping alongside optocouplers, sensors, and related components, and consistent application focus on factory automation, renewable energy, and automotive. The LLM incorrectly claims a narrative 'evolution' from 'peripheral' to 'central' status and attributes strategic shifts (e.g., integration with AI-driven automation, autonomous vehicles, edge computing, VMware merger impact) that are not supported by the original answer. The ground truth explicitly states there was 'no significant expansion or contraction' and a 'consistent inclusion' across years, contradicting the LLM’s assertion of elevation and strategic broadening. The LLM also introduces unverified details such as 'AI-driven factory automation' and 'autonomous-vehicle communications' not present in the original. While the entities (AVGO, Industrial Fiber Optics, industrial applications) and years are correct, the reasoning and synthesis are flawed, failing the multi-hop requirement to accurately compare across filings and infer stability rather than change. Thus, despite correct framing of some product categories and applications, the core conclusion is factually incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 492,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Unsecured Notes – 31B showed no change in size or cost: the notes remained a **$750 million (face amount) fixed‑rate tranche at a 3.25 % coupon**, which produced a **consistent annual debt‑service expense of about $24.4 million (≈$24,375 k)** each year.  This stability indicates that SPG is deliberately **maintaining a low‑cost, medium‑term fixed‑rate debt position** rather than issuing new notes or refinancing, using the 31B tranche as a steady component of its long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the face amount of $750 million, the 3.25% interest rate, and the annual debt service of $24,375,000 (rounded to $24.4 million or $24,375k, which is acceptable). These match the ground truth across all years (2022–2024), with no changes, confirming stability. 2) Quantitatively, all numbers are accurate. The rounding of $24,375,000 to 'about $24.4 million' or '$24,375k' is reasonable and commonly used in financial reporting. The face amount and interest rate are exact. 3) The reasoning is sound: the LLM correctly infers that the lack of change in face amount, rate, and debt service over three years indicates a stable, deliberate long-term debt strategy focused on maintaining low-cost fixed-rate debt. The term 'medium-term' is a slight interpretive stretch (the original does not specify term length), but 'low-cost, fixed-rate' and 'steady component' align well with the ground truth's conclusion of a stable strategy. 4) The answer fully addresses both parts of the question: evolution (no change) and strategic implication (stable, intentional capital structure). It synthesizes data across three years correctly. Only a minor deduction in qualitative accuracy due to 'medium-term' characterization, which isn't directly supported. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 384,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ U.S. defined‑contribution expense rose each year – $70 million in 2022, $75 million in 2023 and $76 million in 2024 – showing a consistent upward trend.  This steady increase indicates that the company is progressively expanding its investment in employee retirement benefits through the defined‑contribution plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These numbers are accurate and properly formatted. (2) The quantitative values are correct, and while the LLM does not explicitly calculate the total percentage increase (approximately 8.6% from 2022 to 2024), it correctly describes a 'consistent upward trend' and 'steady increase,' which aligns with the factual progression. The omission of the exact percentage is a minor gap but does not detract significantly from the overall correctness. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and draws a reasonable conclusion about the company's growing investment in retirement benefits. The characterization of a 'progressive expansion' is slightly stronger than the ground truth's 'steady and slightly growing commitment,' but remains within acceptable semantic bounds. (4) All entities—Texas Instruments, U.S. defined contribution plans, and the years 2022–2024—are correctly identified. The answer fully addresses both parts of the question: the evolution of expenses and the interpretation of the trend. Thus, the answer is factually complete and contextually appropriate, warranting a high correctness score with only minor room for improvement in precision of the trend characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 398,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has kept the same treatment of non‑economic accounting items in its ROIC calculation throughout 2022‑2024.  In each year’s filing the company explicitly states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance,” and the same definition of net operating profit after taxes and average invested capital is applied in the 2022, 2023 and 2024 ROIC tables.  This consistent exclusion shows that GD evaluates management performance on the basis of underlying, cash‑generating operating profitability rather than one‑time accounting adjustments, making ROIC a stable, comparable metric across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) There are no numerical values requiring calculation in this question, but the years (2022–2024) are correctly referenced and aligned with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that consistent exclusion reflects a disciplined performance evaluation approach focused on operational performance, not accounting noise. (4) The LLM adds contextual detail—such as mentioning goodwill impairments and the stability of NOPAT and invested capital definitions—that enriches the answer without introducing error. The conclusion about using ROIC as a comparable metric based on underlying profitability aligns perfectly with the original answer’s interpretation. All entities (GD, ROIC, non-economic accounting changes) are correctly identified and analyzed in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 312,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nCVS’s Separate‑Accounts assets slipped from $3.31 billion at the end of 2022 to $3.20 billion at the end of 2023 (and stayed roughly at that level through 2024), with the decline driven mainly by lower U.S. corporate‑security holdings and net outflows, while cash and collective‑trust positions edged higher.  The modest, sustained contraction indicates that CVS is gradually reshaping its long‑term insurance investment book toward more liquid, lower‑risk assets and trimming exposure to higher‑yield but more volatile securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's Separate Accounts Assets were $5,087 million in 2022, dropped to $3,250 million in 2023, and rose slightly to $3,311 million in 2024. The LLM incorrectly reports 2022 assets as $3.31 billion (should be $5.087 billion), 2023 as $3.20 billion (close but still off from $3.25 billion), and implies no change in 2024 when there was a small increase. These errors misrepresent the magnitude and direction of change, especially the large 2022–2023 drop. (2) Quantitative accuracy is severely compromised: the 2022 figure is off by nearly $1.8 billion, and the trend is misrepresented as a steady decline rather than a sharp drop followed by stabilization. Calculations of year-over-year changes are therefore incorrect. (3) The reasoning is partially sound in interpreting a strategic shift, but it is based on incorrect data. The conclusion about moving toward liquid, lower-risk assets may be plausible, but it does not align with the actual scale of devaluation suggested by the true 36% drop in one year, which points more strongly to market-driven or strategic divestment rather than gradual reshaping. (4) Contextual relevance is moderate—the answer addresses the right metric and time frame and attempts to interpret investment positioning—but due to major factual errors, the overall correctness score is low. The answer fails the core requirement of accurate financial reporting from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 416,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nTarget’s Credit Card Program Agreement with TD Bank USA, N.A. was first updated in the period under review by a **Third Amendment executed on November 1 2022** (see Exhibit 10.21.3+ in the 2024 Form 10‑K), which revised several program terms and conditions.  This was followed by a **Letter Agreement dated March 8 2023** (Exhibit 10.21.4+) that further modified the arrangement, after which no additional amendments are disclosed in the 2024 filing, marking the latest contractual milestone through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It claims a 'Third Amendment' was executed on November 1, 2022, and a 'Letter Agreement' on March 8, 2023, neither of which are supported by the ground truth. The Original Answer states that by 2024, the latest amendment explicitly listed was the second amendment dated November 19, 2019. There is no mention of amendments in 2022 or 2023 in the ground truth. Thus, the key dates (November 1, 2022; March 8, 2023) and the existence of a third amendment and letter agreement are factually wrong. (2) Quantitative accuracy is very low: the LLM introduces two specific dates and document types (Third Amendment, Letter Agreement) with exhibit numbers that are not present in the ground truth. These are precise but incorrect details, making the quantitative inaccuracies severe. (3) The reasoning is flawed as it fails to correctly synthesize the evolution of the agreement. Instead of noting continuity and reference to prior amendments (2012 original, 2015 first amendment, 2019 second amendment), it fabricates new amendments, indicating a failure in multi-hop reasoning or misreading of source material. (4) Contextual relevance is moderate because the answer addresses the right topic (evolution of the credit card agreement) and mentions TD Bank USA, N.A. and Target Corporation correctly, but the core factual trajectory is incorrect. The answer appears detailed and structured, but the information is not aligned with the ground truth, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 427,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022‑2024 Linde transformed rare‑gas production from a marginal co‑product into a strategic growth pillar by investing in advanced separation technologies (e.g., membrane and VPSA) and engineering‑driven on‑site plant designs that simultaneously yield oxygen, nitrogen, argon and rare gases.  These streams are now tightly integrated with Linde’s broader portfolio—linked to engineering contracts, hydrogen and low‑carbon gas projects, and specialty‑gas markets—creating cross‑selling opportunities across its industrial‑gases and engineering segments.  Capital spending and long‑term minimum‑purchase on‑site contracts have risen to support this differentiated, integrated approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Linde's rare gas strategy from 2022 to 2024, with accurate qualitative insights and no numerical inaccuracies. (1) There are no explicit numbers (e.g., dollar amounts, percentages, volumes) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score 10. (2) The LLM correctly identifies key technological differentiators such as membrane and VPSA separation, aligning with the 2024 emphasis in the original answer. It also accurately reflects the integration of rare gases into on-site production and broader product lines like hydrogen and low-carbon projects, which matches the ground truth’s theme of increased integration and cross-selling. (3) The multi-hop reasoning is sound: the LLM synthesizes Linde’s technological advancements, contract strategies, and portfolio integration across years, even though specific year-by-year progression (e.g., 2022 baseline, 2023 pricing clauses) is compressed rather than explicitly detailed. (4) Minor omission: the original answer highlights that rare gases were already a primary atmospheric gas in 2022 (not 'marginal' as implied by 'transformed from a marginal co-product'), and the 2023 emphasis on long-term contracts with price escalation is not reflected. The LLM overstates the shift by implying rare gases were previously insignificant, which slightly distorts the factual timeline. However, the strategic elevation by 2024 and technological differentiation are correctly conveyed. Thus, while the reasoning and context are strong, the slight mischaracterization of the starting point (2022) prevents a top score. Contextual relevance is perfect—directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 473,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nFrom 2022 to 2024 the amount of collateral the company posted under master‑netting arrangements that backs its **advances to equity‑company counterparties fell sharply – from about $1.49 billion in 2022 to $0.80 billion in 2023 and then to roughly $0.49 billion in 2024**.  This downward trend shows that ExxonMobil has been **reducing the amount of security it must set aside to offset derivative positions tied to those equity‑company relationships**, indicating a **decline in the outstanding derivative liabilities (or a lower reliance on such collateral) associated with its equity‑company exposures**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All numeric values are correct: $1.49 billion (matches $1,494 million), $0.80 billion (matches $800 million), and $0.49 billion (matches $491 million) — minor rounding is acceptable and common in financial reporting. (2) The answer fully addresses both parts of the question: the evolution of collateral from 2022 to 2024 and the implication regarding derivative liabilities tied to equity company relationships. (3) Entities are correctly identified: ExxonMobil, master netting arrangements, advances to equity companies, and the correct time frame (2022–2024). (4) The reasoning is sound: the decline in collateral is correctly interpreted as reflecting reduced derivative liabilities or lower reliance on such exposures, aligning with the ground truth's interpretation of de-risking or portfolio optimization. The multi-hop synthesis — connecting collateral levels to derivative exposure and inferring strategic intent — is logically and accurately presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 300,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral PPAs rose only modestly—from roughly 92 % of capacity (as reported for the 2021/2022 period) to about 94 % by the end of 2023 and it stayed at that level in 2024.  The remaining capacity is now increasingly sold into spot markets or hedged with shorter‑term (typically < 3‑year) bilateral contracts that protect a portion of expected revenue.  This pattern shows that NEER continues to lock in the bulk of its earnings through long‑term contracts while using limited short‑term hedges to manage price risk and retain flexibility in competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the percentages are correct: 92% in 2022, rising to 94% in 2023 and maintained in 2024. The LLM slightly rephrases the 2022 figure as '2021/2022 period', which is a minor imprecision but does not materially misrepresent the data. All other numbers (94% in 2023 and 2024) match exactly. (2) The answer addresses both parts of the question: the evolution of NEER's reliance on long-term bilateral contracts over time and the implication for risk mitigation. It correctly identifies the trend of increasing reliance and stable continuation at 94%. (3) Entity accuracy is strong: NEER is correctly identified, and the financial/contractual terms (long-term bilateral PPAs, short-term hedges, spot markets) are used appropriately. (4) The reasoning is sound: the LLM correctly infers that locking in the majority of capacity via long-term contracts reflects a strategy of revenue stability, while using short-term contracts as a hedge for price risk in competitive markets—directly mirroring the ground truth's conclusion. The only minor shortcoming is the slight ambiguity around the '2021/2022 period' phrasing, which could imply a blended figure, but given that 92% is correctly attributed to the starting point, this does not constitute a factual error. Overall, the answer is semantically equivalent, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 392,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 continued to show a flat $495 million outstanding from the end of fiscal 2022 through fiscal 2024 (the same $495 million reported as of Oct 29 2023 and Nov 3 2024).  Because no reduction is noted, the company is effectively holding the tranche to maturity and using newer borrowings—such as the 2023 Term Loans and the October/July 2024 senior‑note issuances—to refinance and extend its overall maturity profile, rather than actively retiring this specific legacy debt.  This reflects a debt‑management strategy that prioritizes rolling newer, larger‑scale financing while letting the 3.125 % notes amortize on their scheduled 2025 principal‑payment date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the outstanding principal balance for AVGO's 3.125% notes due January 2025 remained at $495 million from fiscal 2022 through fiscal 2024, which matches the ground truth. The dates (Oct 29, 2023, and Nov 3, 2024) are consistent with fiscal year-ends and confirm the balance was unchanged. (2) All numeric values—$495 million, 3.125%, January 2025 maturity—are accurate and correctly formatted. No calculations were required, but the consistency across years is properly reported. (3) The reasoning is sound: the LLM infers that the lack of principal reduction suggests a hold-to-maturity strategy with plans to refinance via newer debt (e.g., 2023 Term Loans, October/July 2024 notes), which aligns with the ground truth’s conclusion about refinancing or using cash reserves. The only minor gap is that the original answer emphasizes 'no amortization' as notable, while the LLM slightly overreaches by implying 'scheduled 2025 principal-payment date' as if amortization were expected, when zero amortization was the actual pattern. (4) Despite this nuance, the core facts, synthesis across fiscal years, and strategic interpretation are correct and relevant. The answer addresses both the evolution of the balance and the implied debt management strategy, fulfilling the multi-hop requirement. Thus, high scores across all dimensions with a 9 on correctness due to slight imprecision in characterizing the payment schedule.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 406,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Unsecured Notes 37B remained essentially unchanged: each filing lists a fixed 2.25 % coupon, a $700 million face amount and a maturity date of January 15 2032, with the same $15,750 k annual debt‑service figure disclosed in 2022, 2023 and 2024.  The lack of any rate, size or term modification over the three‑year span shows that SPG is deliberately locking in low‑cost, long‑dated unsecured financing and is not seeking to refinance or restructure this tranche, reflecting a strategy of maintaining a stable, predictable capital structure with extended maturities to manage interest‑rate risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest rate (2.25%), face amount ($700 million, correctly formatted as $700 million and $700,000,000), and maturity date (January 15, 2032) are consistent across 2022–2024. The annual debt-service figure ($15,750k) is an accurate derivation (2.25% of $700M = $15.75M), though not in the original answer, it is factually correct and adds detail without error. (2) Quantitative accuracy is perfect: all numbers match the ground truth, with acceptable formatting variations (e.g., $700 million = $700,000,000). (3) The multi-hop reasoning is sound—by observing no changes over three years, the model correctly infers a long-term debt strategy focused on stability, low-cost financing, and interest rate risk management, aligning with the company’s stable cash flow profile. (4) The answer addresses all parts of the question: evolution over time (no change), terms (rate, face, maturity), and strategic implication. The reasoning is logical, complete, and contextually appropriate, demonstrating strong qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 325,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom 2022 through 2024 the property tables list Melaka, Malaysia with an “X” only under the **Analog** column and no “X” under **Embedded Processing** in each year’s disclosure (the site is noted as partly leased/owned in 2022 and marked with an asterisk/ double‑asterisk in later years).  This consistent designation shows that TI’s Melaka campus has remained dedicated solely to analog‑chip manufacturing over the three‑year span, with no shift or expansion into embedded‑processing production.  The unchanged footprint therefore reveals that the company’s strategic focus at Melaka is firmly on scaling its analog portfolio—leveraging the location’s cost and supply‑chain advantages—while embedded processing continues to be served from other sites.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that from 2022 to 2024, Texas Instruments' Melaka, Malaysia site had an 'X' only under the Analog column and not under Embedded Processing, which matches the original answer's claim of a consistent, analog-only focus. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) and the consistent operational designation each year are correctly reported. Minor additional details—such as the site being partly leased/owned in 2022 and having asterisk annotations in later years—are factually consistent with typical 10-K disclosures and do not contradict the ground truth; they add contextual precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of disclosures to infer a stable strategic focus, concluding that the lack of change indicates a deliberate prioritization of analog over embedded processing. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the operational footprint and what it reveals about strategic focus. The conclusion about targeted investment in analog capabilities is logically derived and well-supported. All entities (Texas Instruments, Melaka, Malaysia, analog, embedded processing) are correctly identified and contextualized. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 399,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard tied its multi‑layered security model to the rollout of real‑time payment rails, first scaling real‑time clearing and settlement to 13 markets (2023) and then extending those rails into new jurisdictions—including a joint‑venture launch in China (2024) and the Alias‑Based Remittances platform that streamlines cross‑border disbursements.  With each geographic expansion the company deepened collaboration among issuers, acquirers, governments and standards bodies, added fraud‑scoring and tokenization services to its distributed architecture, and introduced programmatic safeguards such as Mastercard Receivables Manager and enhanced virtual‑card controls to protect the growing volume of instantaneous, cross‑border transactions across more than 200 countries.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach in response to real-time payment expansion from 2022 to 2024, including key developments like expansion into 13 markets by 2023 and the China joint venture in 2024. It accurately reflects collaboration with issuers, acquirers, and governments, and mentions relevant security enhancements such as fraud scoring, tokenization, and virtual card controls. However, it incorrectly states that real-time payment infrastructure expanded to 13 markets in 2023 without acknowledging the baseline of 12 markets in 2022 (implied but not explicitly stated), and exaggerates the geographic scope by claiming 'more than 200 countries'—a figure not supported in the ground truth and likely conflating transaction reach with real-time payment infrastructure deployment. (2) Quantitative accuracy is partially compromised: while '13 markets in 2023' aligns with the original answer, the absence of the 2022 baseline (12 markets) weakens comparative precision. The '200 countries' claim is unsupported and factually misleading in this context. No dollar amounts or percentages are misstated, but the overstatement of geographic deployment affects numerical fidelity. (3) Multi-hop reasoning is strong: the model correctly links security evolution to infrastructure expansion, integrates the China joint venture as a scaling challenge, and connects new platforms (e.g., Alias-Based Remittances, Receivables Manager) to security and operational needs in real-time payments. It synthesizes issuer/acquirer collaboration, technical standards, and programmatic safeguards across years and geographies. (4) The answer is highly contextually relevant, directly addressing how security evolved in tandem with real-time payment growth. Despite minor factual overreach on market count, the core narrative and qualitative progression match the ground truth. Correctness score is 8 due to accurate core facts but notable quantitative overstatement; qualitative and contextual accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 558,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nBetween 2022 and 2024 General Dynamics grew the Canadian LAV build‑rate from about **360 vehicles in 2022 to 399 in 2023 and to 449 in 2024** (the 2024 figure also includes an additional 66 LRSS‑equipped units).  This upward trajectory shows that GD is deliberately scaling up and sustaining its LAV program for Canada, treating the contract as a strategic growth area and investing in new variants and upgrades.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the production volumes for 2022 (360), 2023 (399), and 2024 (449), matching the ground truth exactly. These numbers are accurate and properly attributed to General Dynamics and the Canadian LAV program. 2) Quantitatively, all figures are correct, and no calculations are required beyond the progression, which is accurately presented. The mention of '66 LRSS-equipped units' in 2024 is an additional detail not present in the original answer; however, it does not contradict the total of 449 units and may provide context for the increase, so it does not count as an error. 3) The reasoning is sound: the upward trend is correctly interpreted as a sign of strategic focus and scaling, aligning with the ground truth's conclusion about growing emphasis and international demand. The LLM adds slightly more detail (e.g., 'investing in new variants and upgrades'), which is plausible and contextually appropriate, though not explicitly stated in the original. 4) The answer fully addresses both parts of the question: the evolution of production volume and the strategic implication. Semantic equivalence is maintained, with only minor elaboration beyond the original. The core facts, numbers, and synthesis are correct, warranting a high score. The qualitative accuracy is marked at 9 due to the slight addition of unverified detail (LRSS units), but this does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 394,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nThe pension‑plan’s exposure to hedge‑fund limited‑partnerships grew modestly but consistently: $225 million in 2022 → $252 million in 2023 → $280 million in 2024 (an approximate 25 % rise over the three‑year period). This upward trajectory suggests that CVS is deliberately increasing its allocation to alternative‑asset strategies—using hedge‑fund LP interests to enhance returns and diversify the plan’s portfolio while staying within its broader target‑allocation framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric values provided. According to the ground truth, CVS's allocation was $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly reports $225M in 2022 (should be 2023), $252M in 2023 (should be 2024), and introduces a completely incorrect figure of $280M in 2024 (no such data in ground truth). This misalignment affects all years and amounts. (2) The calculation of a 25% increase is incorrect; the actual increase from $214M to $252M is approximately 17.8%, as correctly stated in the original answer. The LLM’s calculation appears to be based on its own fabricated numbers. (3) While the LLM attempts multi-hop reasoning by identifying a trend and inferring strategic intent, the reasoning is built on false data, undermining the validity of the conclusion. The general idea of a gradual increase aligning with a strategic shift toward alternative investments is semantically plausible and aligns with the question’s intent, but the faulty numbers invalidate the analysis. (4) The contextual relevance is moderate because the answer addresses the right type of trend and strategic interpretation, but the qualitative accuracy is low due to incorrect entity-year mappings and invented figures. The answer fails the core requirement of factual fidelity to the source data, warranting a low correctness score despite structurally attempting the right kind of analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 410,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe Target MasterCard Credit‑Card penetration fell steadily from ≈ 20.5 % of all purchases in the fiscal year ended January 2022 to ≈ 19.8 % in 2023 and ≈ 18.6 % in 2024 (the company reports overall “RedCard” penetration of 20.5 %, 19.8 % and 18.6 % for those three years).  This modest decline indicates that while the card continues to be used by a meaningful share of shoppers, its growth has plateaued and even slipped slightly, pointing to slower consumer adoption or increasing competition rather than expanding engagement with Target’s financial products.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2024 penetration rate: it reports approximately 18.6%, while the ground truth is 17.8%. This discrepancy affects the quantitative accuracy and undermines the trend analysis. The 2022 (20.5%) and 2023 (19.8%) figures are correctly reported, matching the original answer. (2) The calculation of the trend is partially accurate—showing a decline is correct—but the magnitude of the drop in 2024 is understated. The actual decline from 19.8% to 17.8% (a 1.0 percentage point drop) is more severe than the reported drop to 18.6% (a 1.2 point drop from 19.8% would be required), misrepresenting the pace of decline. (3) The reasoning is sound in interpreting the trend as indicating plateaued or declining engagement and considers relevant factors like competition and adoption, which aligns with the original answer. It correctly identifies that RedCard penetration is used as a proxy for Target MasterCard usage, though it does not clarify that the MasterCard is part of the broader RedCard suite. (4) Contextually, the answer is well-framed and addresses both parts of the question—evolution of penetration and implications for consumer adoption. However, due to the incorrect 2024 figure, the conclusion about a 'modest decline' and 'slight slip' is overly soft compared to the steeper drop to 17.8%, which the original answer emphasizes as a consistent and meaningful decline. Thus, while the qualitative logic and relevance are strong, the quantitative inaccuracy reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 430,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value exposure recorded for FPL Cost Recovery Clauses rose from $16 million to $12 million and then to $38 million, with the net position expanding even though the observable‑input component stayed small and turned increasingly negative (≈$(6) million in 2022, ≈$(8)‑$(12) million in 2023‑2024).  At the same time the unobservable‑input contribution grew from roughly $16 million to about $24 million, showing a marked shift toward greater reliance on internal, non‑observable assumptions for the estimate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers, particularly for 2022. The ground truth states that the total fair value in 2022 was $1 million, with significant other observable inputs at -$5 million and significant unobservable inputs at +$6 million. However, the LLM incorrectly reports the 2022 total as $16 million and estimates the observable input as ≈$(6) million and unobservable as $16 million, which is both numerically and mathematically inconsistent (since -$6M + $16M = $10M, not $16M or $1M). The 2023 total is correctly stated as $12 million, but the breakdown is vague (e.g., '≈$(8)-$(12) million') and does not match the precise -$12 million observable and +$24 million unobservable from the ground truth. The 2024 total of $38 million is correct, and the direction of the shift toward unobservable inputs is correctly identified, though the LLM does not provide a precise breakdown for 2024. (2) Calculation verification: 2022 total should be -$5M + $6M = $1M (LLM says $16M — incorrect). 2023: -$12M + $24M = $12M (LLM says $12M — correct total, but input ranges are imprecise). 2024: +$4M + $34M = $38M (LLM mentions $38M total but omits exact inputs). (3) Multi-hop reasoning: The LLM correctly identifies the trend of increasing total fair value and growing reliance on unobservable inputs, showing some synthesis across years. However, due to incorrect base figures, the reasoning is built on flawed data. (4) Scores justified: Correctness is low (4/10) due to major numerical errors in 2022 and imprecise breakdowns. Quantitative accuracy is poor (3/10) because key dollar amounts are wrong. Qualitative accuracy is moderate (5/10) — the trend interpretation is reasonable, but entity-level details are inaccurate. Contextual relevance is high (8/10) — the answer addresses the right concepts, inputs, and time frame, just with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 518,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Nike’s competitive edge versus Anta was reinforced by a dual focus on high‑tech product innovation and deep‑level brand engagement.  While Anta has continued to grow its domestic market share in China with cost‑effective, performance‑oriented releases, Nike accelerated the rollout of its flagship cushioning and digital‑first platforms (Air, Zoom, React, Flyknit, FlyEase, Adapt) and expanded its athlete‑centric, social‑media‑driven marketing and direct‑to‑consumer retail network, thereby strengthening consumer connection and brand affinity worldwide.  This sustained innovation‑and‑engagement strategy has helped Nike maintain its position as the global leader in athletic footwear and apparel despite Anta’s rising presence.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of core competitive dynamics, innovation emphasis, and brand engagement strategies for NKE (Nike) relative to Anta from 2022 to 2024. It correctly identifies Nike’s sustained focus on product innovation—specifically naming key technologies like Air, Zoom, React, Flyknit, FlyEase, and Adapt—and highlights digital-first platforms and direct-to-consumer expansion, aligning with the original answer’s emphasis on digital experiences and innovation. It also accurately positions Nike as the global leader while acknowledging Anta’s growing presence, particularly in China, which matches the ground truth’s recognition of Anta as a named competitor gaining traction via localized strategies. However, the LLM answer omits the year-by-year evolution of Nike’s strategic emphasis detailed in the original answer: specifically, the shift in 2023 where 'innovation and development' surpassed 'performance and reliability' in priority, and the progressive intensification of innovation focus across 2022–2024. This nuanced progression is a key multi-hop insight from the knowledge graph and is not reflected in the LLM response. While the LLM captures the overall strategic direction, it synthesizes the timeline into a more static 'sustained' strategy rather than conveying the dynamic shift over the three years. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and all entities (NKE, Anta, product lines, engagement strategies) are correct. Contextual relevance is strong as all content directly addresses the question. The qualitative accuracy is slightly reduced due to the lack of temporal evolution in strategic emphasis, but the core reasoning remains sound and factually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 482,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nFrom the 2022, 2023 and 2024 proxy tables the number of shares still available for future issuance under the 2003 Director Compensation Plan fell – roughly 1.8 million shares were left in 2022, about 1.75 million in 2023 and just under 1.73 million by 2024.  This steady decline shows the plan’s reserve is being exhausted and that Texas Instruments is shifting its director‑compensation funding to newer, shareholder‑approved equity plans (e.g., the 2024 Long‑Term Incentive Plan) rather than relying on the 2003 plan for future grants.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not specify exact share numbers (e.g., 1.8 million, 1.75 million, 1.73 million), and in fact, the 2023 and 2024 filings indicate that the 2003 Director Compensation Plan was no longer listed as having shares available for future issuance—meaning the availability dropped to zero by 2023, not a gradual decline to 1.73 million by 2024. Thus, the specific numerical progression is factually incorrect and misrepresents the phase-out as gradual when it was effectively complete by 2023. (2) The calculation of a steady decline from 1.8M to 1.75M to 1.73M implies a minor usage of ~70k shares over two years, but the original answer states the plan was no longer active for future grants by 2023, contradicting ongoing issuances. This undermines the quantitative accuracy. (3) Qualitatively, the LLM correctly identifies the trend of phasing out the 2003 plan and shifting to newer plans like the 2024 LTIP, which aligns with the ground truth’s conclusion about strategic shift and honoring existing commitments. It also correctly references the use of updated shareholder-approved plans. (4) Contextually, the answer is relevant and addresses both parts of the question—evolution of share availability and what it indicates—though based on incorrect data. The reasoning is logical given the assumed numbers, but the factual foundation is flawed. Hence, correctness is partially compromised due to invented figures, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 424,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA layered data‑driven services onto its advertising offering by first modernizing the network (2022 – rolling out 2 Gbps downstream speeds and DOCSIS 4.0 while virtualizing core network functions), then adding streaming‑centric ad products such as the prepaid NOW broadband tier and the Xumo Stream Box that integrate DTC‑streaming commissions (2023), and finally consolidating a programmatic marketplace that unifies linear, digital and OTT inventory across X1, Sky Q and the ad‑supported NOW tier with advanced audience‑targeting, measurement and marketplace tools (2024).  These steps brought a unified, cloud‑based technology stack, richer data‑driven targeting capabilities, and expanded marketplace solutions that let advertisers buy and measure ads across the company’s full suite of video and streaming platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces specific technical details and product launches not present in the ground truth. While it correctly identifies a progression in CMCSA's advertising capabilities from 2022 to 2024, the specific claims about 2 Gbps downstream speeds, DOCSIS 4.0, virtualized core functions, prepaid NOW broadband tier, Xumo Stream Box, and DTC-streaming commissions are not supported by the original answer and appear to be hallucinated or inferred beyond available data. The ground truth mentions general enhancements to technology, tools, and marketplace solutions with increasing integration of data-driven services, cloud platforms, search functionality, and expanded representation agreements—but does not reference network modernization, specific hardware, or tiered broadband products as part of the advertising evolution. The 2024 consolidation of a programmatic marketplace unifying linear, digital, and OTT inventory is conceptually aligned with the original answer’s mention of enhanced digital tools and marketplace solutions, but the LLM over-specifies the implementation (e.g., X1, Sky Q) without evidence. No numeric values (dates aside) are present in either answer, so quantitative accuracy is penalized only for incorrect specificity (e.g., '2 Gbps') introduced without basis. The reasoning shows an attempt at multi-hop synthesis but is based on fabricated milestones, undermining factual correctness. Contextually, the answer addresses the evolution of advertising offerings and attempts to map enhancements year-by-year, maintaining relevance despite inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 444,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the amortized cost of CVS’s commercial mortgage‑backed securities fell from $1.17 bn to $1.07 bn, and fair value declined from $1.02 bn to $0.98 bn, while unrealized losses narrowed from $155 m to $100 m. The 2024 filing shows a comparable modest exposure and essentially unchanged unrealized losses, indicating the company has reduced its CMBS position and now carries a lower market‑risk profile in this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and trends. According to the ground truth, CVS held $574 million in CMBS in 2022 with $12 million in unrealized losses, but the LLM claims a fair value of $1.02 billion and unrealized losses of $155 million—both incorrect. In 2023, the ground truth shows CMBS fair value increased to $675 million (not decreased to $0.98 billion as claimed), while unrealized losses rose to $100 million (which matches the LLM’s number, but the context is wrong because the starting point is inaccurate). By 2024, the ground truth shows CMBS exposure dropped to just $6 million with no significant unrealized losses, but the LLM states there is 'comparable modest exposure' and 'essentially unchanged unrealized losses'—this contradicts the sharp drawdown indicated in the original answer. (2) The LLM uses amortized cost figures ($1.17B, $1.07B) not mentioned in the ground truth and introduces metrics not present in the original data, suggesting confusion or use of incorrect sources. The fair values and unrealized losses do not align with the ground truth at any point. (3) The multi-hop reasoning is flawed: the LLM incorrectly interprets the trend—claiming unrealized losses narrowed from $155M to $100M—while the ground truth shows they increased sharply from $12M to $100M, indicating deteriorating asset quality before the exit. The conclusion that CVS reduced exposure is correct, but the timing and rationale are misrepresented—the major reduction occurred in 2024, not gradually between 2022–2023 as implied. (4) The contextual relevance is moderate because the answer addresses CMBS exposure and risk positioning, but due to severe quantitative errors and mischaracterization of trends, the qualitative and correctness scores are low. The model fails to reflect the actual risk escalation in 2023 followed by near-complete divestment in 2024, which is central to the correct interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 531,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, Target repeatedly lists “merchandise and other discounts” as part of its Compensation and Benefits package, using essentially the same language and without disclosing any change in discount rate or eligibility. This consistent inclusion—alongside comparable wage, health, retirement and tuition‑assistance benefits—indicates that Target treats the employee discount as a stable, core element of its broader benefits strategy focused on reinforcing engagement, retention and the company’s purpose of helping families enjoy everyday life.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that merchandise discounts were consistently included in Target's 10-K filings from 2022 to 2024 and treated as a stable component of employee benefits, which aligns with the ground truth. There are no numeric inaccuracies, and the years and entities (Target, employee benefits, merchandise discounts) are correctly identified, supporting a high quantitative accuracy score. However, the LLM fails to capture the evolving framing and strategic layering of benefits described in the original answer. Specifically, it omits the wage progression from $15/hour in 2022 to $15–$24/hour in 2023, and the integration of merchandise discounts into a broader, expanding ecosystem of benefits such as 401(k) matching, tuition reimbursement, mental health, and virtual healthcare by 2024. These omissions represent a significant gap in qualitative accuracy, as the multi-hop synthesis of how the benefit's context evolved—despite consistent presence—is missing. The LLM instead emphasizes 'no change in discount rate or eligibility' and treats the benefit as static, which contradicts the ground truth's emphasis on strategic evolution in presentation and integration. While the answer is relevant and correctly interprets the discount as part of a retention-focused strategy, it does not reflect the nuanced progression that the question specifically asks about, resulting in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 397,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nFrom 2022 to 2024 Linde’s risk‑factor disclosures moved from a brief mention that “cultural challenges associated with integrating employees from the acquired company” could pose a problem, to a more detailed focus that places cultural integration alongside control harmonisation, system alignment and foreign‑market risks, and even describes concrete mitigation steps such as cross‑cultural training and retention programmes.  This progression shows that Linde now treats cultural compatibility as a core strategic priority—embedding it in due‑diligence, integration planning and governance—to proactively manage the cross‑border integration risks that can erode synergies and financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Linde's emphasis on cultural challenges from 2022 to 2024, noting an initial brief mention in 2022 (cultural challenges tied to integrating employees), a broader framing in 2023 (linking culture to control harmonization, system alignment, and foreign-market risks), and a sharper strategic focus by 2024 on financial and synergy risks. The LLM accurately captures the progression from operational concern to strategic priority. It adds value by specifying mitigation steps (e.g., cross-cultural training, retention programs) and embedding cultural integration in due diligence and governance—details consistent with the trajectory described in the original answer, though slightly more detailed. These additions are reasonable inferences given the trend and do not contradict the ground truth. There are no numerical inaccuracies (quantitative accuracy is 10). The qualitative reasoning is strong, correctly synthesizing multi-hop information across years and strategic dimensions. The only minor gap is that the original answer emphasizes the 2023 linkage to regulatory and compliance risks more explicitly, while the LLM frames it around systems and controls—related but not identical. This does not constitute an error but reflects a slight difference in emphasis. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with enhanced elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 416,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nExxonMobil’s collateral that is pledged under master‑netting arrangements fell sharply—from **$1.49 billion in 2022 to $0.49 billion in 2024**, a decline of about **$1.0 billion (≈ 67 %)**.  Because this collateral is netted against the derivative assets recorded in “Notes and accounts receivable – net,” the drop signals that the company is relying less on external security to offset derivative positions and is instead managing its derivative exposure through internal netting, stronger credit positioning, and possibly reduced notional exposure.  The trend therefore points to a more streamlined and lower‑risk approach to handling its derivative book.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the overall trend and direction of change in collateral under master netting arrangements from 2022 to 2024. It reports a decline from $1.49 billion in 2022 to $0.49 billion in 2024, which aligns with the ground truth values of $1,494 million (2022) and $491 million (2024). However, it omits the intermediate 2023 value of $800 million, which was explicitly stated in the original answer and part of the multi-year trend. While the omission does not invalidate the conclusion, it reduces completeness in capturing the full year-by-year progression.\n\n2) Quantitatively, the LLM rounds $1,494 million to $1.49 billion and $491 million to $0.49 billion—acceptable formatting variations. The calculated drop of $1.0 billion (~67%) is approximately correct: the actual decrease is $1,494M - $491M = $1,003M, or ~67.1%, so the calculation is accurate. However, the absence of the 2023 data point ($800M) means the answer skips a key step in the multi-hop timeline, slightly weakening quantitative precision.\n\n3) The reasoning is strong and logically sound: the LLM correctly infers that reduced collateral pledged under netting arrangements, when netted against derivative assets in 'Notes and accounts receivable - net', suggests improved exposure management. It plausibly attributes the trend to internal netting, better credit positioning, or reduced notional exposure—consistent with the original answer’s interpretation of a 'strategic reduction in derivative exposure or improved offsetting mechanisms'. No incorrect entities are introduced; ExxonMobil is correctly identified, and the financial context is accurate.\n\n4) The answer is contextually relevant and fully addresses both parts of the question: the change in collateral and its implication for derivative exposure management. The synthesis across years and financial concepts (collateral, netting, derivative exposure) is appropriate. The only shortcoming is the missing 2023 figure, which slightly affects completeness but not the overall correctness of the trend or interpretation. Hence, a high score of 9 is warranted for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 572,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform moved from a primarily internal, posture‑assessment tool for mainframe security into a centrally‑integrated component of Broadcom’s broader cybersecurity strategy.  In 2022 it delivered risk scores and remediation suggestions that could be consumed by in‑house SIEMs, but by 2023 Broadcom added native APIs and pre‑built connectors that let the platform feed data directly into external SOAR and ticketing systems, automating workflow‑driven remediation.  By 2024 the platform was positioned as a cross‑stack, zero‑trust enablement layer—leveraging AI‑driven threat intelligence from Symantec/Carbon Black, offering unified visibility across mainframe, cloud and edge environments, and aligning remediation actions with the company’s broader cybersecurity framework for holistic risk management.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of AVGO's Security Insights Platform from a standalone risk assessment tool to a more integrated component of a broader cybersecurity strategy, which aligns with the ground truth. It correctly identifies the 2022 functionality involving risk assessment and SIEM integration, and the progression toward greater integration by 2024. However, there are significant qualitative inaccuracies: (1) The claim that by 2023 'native APIs and pre-built connectors' enabled direct integration with SOAR and ticketing systems is not supported in the original answer, which only states data was available for in-house tools in 2022 and does not mention specific technical enhancements in 2023. (2) The 2024 characterization of the platform as a 'cross-stack, zero-trust enablement layer' leveraging 'AI-driven threat intelligence from Symantec/Carbon Black' introduces entities and capabilities (Symantec, Carbon Black, zero-trust, AI-driven threat intelligence) not mentioned or implied in the ground truth. (3) The original answer emphasizes structural integration into a broader software suite (Cybersecurity, AIOps, DevOps) and alignment with regulatory compliance, which the LLM answer omits or replaces with unsupported technical specifics. While the direction of evolution is correctly interpreted, the specific capabilities and integrations described are speculative and not grounded in the provided truth. Quantitative accuracy is high as there are no numerical claims to dispute. Contextual relevance is strong as the response directly addresses integration, remediation, and strategic alignment. The reasoning is partially sound but overreaches in synthesizing unverified technical details, failing on entity and factual accuracy for key claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 483,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the “Unsecured Notes – 32B” issue kept the same structural terms: a fixed face amount of **$750 million** and a **3.38 % coupon**, with maturity on **June 15, 2027** (see SPG 10‑K 2022 p. 51; SPG 10‑K 2023 p. 51; SPG 10‑K 2024 p. 51).  Its proportion of total consolidated unsecured debt stayed roughly 3½‑4 % (≈ $750 M of the $20‑$21 B unsecured pool), indicating a stable, long‑dated fixed‑rate component in the capital structure.  This underscores SPG’s long‑term debt‑management approach of locking in low‑to‑mid‑range rates and extending maturities to reduce refinancing risk while maintaining a predictable, low‑cost funding base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key quantitative details are correct: face value ($750 million), interest rate (3.38%), and maturity date (June 15, 2027) are consistently reported across 2022–2024, matching the original answer. Format variations like '$750 million' vs '$750,000,000' are acceptable and semantically equivalent. (2) The LLM adds contextual insight not in the original answer—specifically, that the note represents approximately 3.5–4% of total unsecured debt ($750M of $20–21B pool). While this specific percentage breakdown was not in the ground truth, it is a reasonable inference given the data and does not contradict it. However, since the original answer did not confirm the total unsecured debt figures, this addition, while plausible, introduces a minor assumption. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three years and filings (2022–2024 10-Ks), confirms no changes in terms, and draws a logical conclusion about SPG’s long-term debt strategy—emphasizing stability, fixed-rate locking, and refinancing risk mitigation. (4) The conclusion about SPG’s strategy is consistent with and expands upon the original answer’s interpretation, enhancing relevance without distorting facts. The only reason for not scoring a 10 is the slight extrapolation on total unsecured debt proportions, which, while reasonable, was not verifiable from the provided ground truth. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 426,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen accelerated its fiber‑to‑the‑premises rollout—moving from a few pilot zones to a nationwide footprint that now reaches a sizable share of Comcast’s market and can deliver symmetrical multi‑gigabit speeds.  This expansion has been coupled with bundled packages that combine high‑speed fiber internet with Lumen’s video (streaming) and voice services, directly competing with Comcast’s traditional broadband‑plus‑video bundles and pressuring the cable operator to speed up its own fiber upgrades and bundling strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing competitive threat from Lumen to CMCSA through fiber expansion and service bundling from 2022 to 2024, which aligns with the ground truth. It correctly identifies fiber deployment and bundled offerings as key competitive strategies. However, it introduces specific claims not supported by the original answer: (1) the characterization of Lumen's rollout as moving 'from a few pilot zones to a nationwide footprint' and reaching 'a sizable share of Comcast’s market' is more specific and assertive than the original, which only notes ongoing fiber deployment without quantifying scale or geographic reach; (2) the claim of delivering 'symmetrical multi-gigabit speeds' is not mentioned in the ground truth and adds technical detail absent from the source; (3) while bundling is correctly noted, the LLM specifies 'video (streaming)' services, whereas the original does not detail the nature of Lumen's bundled video offerings. These additions, while plausible, go beyond the verified information and introduce potential inaccuracies. The answer is contextually relevant and shows sound reasoning in connecting fiber expansion and bundling to competitive pressure, but lacks quantitative precision (no actual numbers in either answer, but LLM fabricates implied scale). The qualitative assessment is partially accurate but overreaches in specificity. Thus, the correctness score is reduced due to unsupported elaborations despite capturing the core trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 413,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nThe penetration rate of Target’s branded payment cards fell steadily from **≈20.5 % in fiscal 2022** to **≈18.6 % in fiscal 2023** and further to **≈17.8 % in fiscal 2024 (ended Feb 1 2025)**.  This downward trend indicates that the loyalty‑driven 5 % discount incentive for using RedCards/Target Circle Cards is losing traction, suggesting the current payment‑loyalty strategy is becoming less effective at driving incremental sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 2022 to 2024 and draws a reasonable qualitative conclusion about the weakening effectiveness of the loyalty-driven strategy, which aligns with the ground truth. However, the 2023 penetration rate is incorrect: the LLM reports ≈18.6%, while the ground truth is 19.8%. The 2022 (≈20.5%) and 2024 (≈17.8%) figures are accurate. 2) The quantitative inaccuracy in the 2023 figure affects the precision of the trend description, though the overall direction (declining) is correct. The fiscal year end note (Feb 1, 2025) is contextually appropriate for fiscal 2024 and does not detract from accuracy. 3) The multi-hop reasoning is sound—linking penetration trends to the effectiveness of the loyalty strategy is logically supported and consistent with the original answer. The mention of the 5% discount and RedCard/Circle integration adds relevant context not in the ground truth but does not contradict it. 4) Despite the numerical error in 2023, the answer is contextually complete and relevant, addressing both parts of the question: the evolution of penetration and its implication for strategy. The conclusion is semantically equivalent to the original. The correctness score is reduced due to the significant but not critical numerical inaccuracy in the 2023 data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 381,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nChevron’s exposure to the Republic of Congo from 2022‑2024 was limited to a non‑operated 31.5 % interest in the offshore Haute Mer permit and a 15.75 % stake in the Lianzi block, which were accounted for in its African upstream portfolio (Business Environment and Outlook, p. 31, 2022 10‑K; Note 15, p. 77).  The company made only modest exploration‑and‑evaluation outlays on these blocks and did not treat them as core growth assets, focusing instead on higher‑return projects elsewhere; this stance was underscored by the sale of the two interests in early 2025 (Noteworthy Developments, p. 41, 2024 10‑K), signalling a strategic withdrawal while retaining the country only as a passive, non‑operated holding.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's asset ownership in the Republic of Congo — a 31.5% nonoperated interest in the Haute Mer permit and a 15.75% stake in Lianzi — which matches the ground truth. However, it incorrectly states the sale occurred in 'early 2025' (per 2024 10-K), while the ground truth specifies the divestiture took place in 2024. This is a critical factual error affecting timeline accuracy. (2) Quantitatively, the percentages (31.5% and 15.75%) are correct, but the LLM omits the $0.7 billion investment figure from 2023 that was allocated to offshore development and natural gas projects in Africa, including Congo. This omission undermines completeness and quantitative accuracy. The claim of 'modest exploration-and-evaluation outlays' is not supported in the ground truth and introduces unsupported qualitative judgment. (3) The multi-hop reasoning is partially sound — the model correctly links Chevron’s nonoperated stakes to its broader African portfolio — but fails to accurately synthesize the temporal evolution: active presence in 2022, continued investment in 2023, and exit in 2024. Instead, it retroactively characterizes the assets as non-core and minimally funded, which contradicts the 2023 investment signal. The conclusion of 'strategic withdrawal' aligns with the ground truth, but the timing and supporting evidence are flawed. (4) Contextually, the answer addresses asset ownership and strategic positioning but misses investment levels — a key part of the question — and misrepresents the timeline. The reliance on correct document references (10-K pages) adds credibility but does not compensate for factual inaccuracies. Correctness score is 5 due to significant omissions and a major date error, despite some correct entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 490,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s gas‑related option book grew in size but remained a small net‑liability: the “options ‑ primarily gas” line showed assets of roughly $100 million and liabilities of about $102 million in both 2023 and 2024 (down from a near‑break‑even $9 million net asset in 2021), while the accompanying forward‑gas contracts expanded from about $191 million of assets (2021) to $377 million of assets (2023) and $296 million of assets (2024).  At the same time the range of implied volatilities used to price those options fell from a 17 %‑295 % spread in 2021 to roughly 15 %‑150 % by 2024, reflecting higher market‑expected price swings and higher option premiums.  Together, the rising fair‑value of forward gas positions and the increasingly volatile volatility inputs show that NEE has been deliberately scaling up its hedging of gas‑price risk—using more options and forwards to manage exposure as market volatility intensified.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The reported fair values for gas-related options are wrong. Ground truth shows $356M assets and $347M liabilities in 2022, dropping to $100M assets and $97M liabilities in 2023, then $100M assets and $102M liabilities in 2024. The LLM incorrectly states that the $100M asset level existed in both 2023 and 2024 without mentioning the significant 2022 figures, and falsely implies continuity from 2021. The implied volatility figures are also incorrect: ground truth reports averages of 36% (2022), 50% (2023), and 52% (2024), while the LLM cites a range of 17%-295% in 2021 falling to 15%-150% by 2024—data not present in the original answer and contradicting the trend of rising then stabilizing volatility. (2) Completeness: The answer fails to capture the key evolution—sharp reduction in exposure from 2022 to 2023—instead suggesting growth in the option book, which is the opposite of the truth. It introduces forward gas contracts and 2021 data not mentioned in the original, diverting from the question's focus. (3) Entity Accuracy: While NextEra Energy (NEE) is correctly identified, the years and financial metrics are misaligned. (4) Reasoning: The conclusion that NEE is 'scaling up' hedging contradicts the ground truth showing a strategic de-risking via reduced fair value exposure. The interpretation of volatility is also flawed—while volatility increased, it did so alongside reduced exposure, indicating risk reduction, not increased hedging activity. (5) Semantic Equivalence: The overall message is opposite to the original: de-risking vs. scaling up, decreasing exposure vs. growing positions. Despite addressing gas options and volatility, the core facts and interpretation are incorrect, severely undermining correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 499,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nFrom 2022 to 2024 Nike moved FlyEase from a peripheral entry in a long list of “Nike Air, Zoom, Free, Dri‑FIT, FlyEase…” technologies to a highlighted element of its innovation narrative, explicitly tying the platform to the company’s push for inclusive, high‑performance product design.  This shift shows that FlyEase has transitioned from an experimental capability to a strategic pillar of Nike’s innovation strategy, underscoring the firm’s focus on accessibility‑driven performance as a growth driver across its footwear and apparel categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: FlyEase evolved from a listed technology in 2022 to a central innovation by 2024. The timeline (2022 to 2024) is correctly referenced, and no numeric values are incorrect—dates are accurate and consistent with the original answer. (2) Quantitative accuracy is perfect: there are no financial figures or calculations to verify, but the years and progression across time are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of FlyEase across three years, correctly inferring its growing strategic importance. It accurately captures the shift from peripheral mention to strategic pillar, which matches the original answer’s claim of progression from introduction to foundational status. (4) The only minor gap is that the LLM emphasizes 'inclusive, high-performance product design' and 'accessibility-driven performance'—while consistent with FlyEase’s known purpose, this specific framing is not explicitly in the ground truth. However, this is a reasonable and contextually appropriate inference, not a factual error. The core progression—increasing integration and strategic elevation—is correctly conveyed. Thus, the answer is semantically equivalent and contextually relevant, meriting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 372,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 35A series stayed exactly the same: a $750 million (face) tranche carrying a fixed 2.65 % coupon, requiring an annual debt‑service payment of about $19.9 million and maturing on July 15, 2030.  No increase, amendment, or repayment of this note was reported in any of the 2022, 2023 or 2024 10‑K filings.  \n\nThis unchanged, long‑dated, low‑cost unsecured debt illustrates SPG’s deliberate strategy of locking in inexpensive financing for an extended horizon, thereby reducing refinancing risk and preserving liquidity for other growth and investment opportunities.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies despite correct qualitative reasoning. The original answer states the face amount is $750,000, not $750 million, and annual debt service is $19,875, not $19.9 million. The LLM incorrectly inflates all dollar figures by a factor of 1,000. This is a critical error in financial context. 2) Quantitative verification: $750,000 × 2.65% = $19,875 (correct in ground truth); LLM reports $750 million × 2.65% ≈ $19.9 million, which is mathematically consistent but factually wrong due to incorrect principal. Maturity date (07/15/30 vs July 15, 2030) is correctly interpreted. 3) Multi-hop reasoning is sound: LLM correctly identifies consistency across years and draws a logical conclusion about SPG's long-term debt strategy of locking in low-cost financing. It synthesizes the lack of amendments across filings appropriately. 4) While the reasoning and strategic interpretation are strong (qualitative accuracy and contextual relevance high), the magnitude of the dollar error severely undermines factual correctness. Such an error would mislead financial analysis. Hence, correctness score is reduced to 6—partially correct but with major numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 342,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nAcross 2022‑2024 Texas Instruments repeatedly placed embedded‑processing products alongside analog chips as one of the two core pillars of its business, citing them as key elements of the four sustainable competitive advantages that drive its strategy.  While embedded‑processing revenue rose modestly in 2022, slipped in 2023 and fell sharply in 2024, the company kept investing in capacity (e.g., the Lehi fab) and R&D, emphasizing that the segment’s cash‑generating power is essential to growing free‑cash‑flow per share.  This consistent positioning shows that TI’s long‑term growth strategy is not to chase short‑term sales spikes but to leverage the high‑margin, cash‑rich analog and embedded‑processing businesses to deliver sustained free‑cash‑flow growth for shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding financial performance. The claim that 'embedded-processing revenue rose modestly in 2022, slipped in 2023 and fell sharply in 2024' is not supported by the ground truth and contradicts the original answer, which makes no mention of revenue trends—especially not a sharp decline in 2024. This introduces false quantitative assertions unsupported by the source. (2) There are no actual numbers (e.g., revenue figures, percentages, growth rates) in the original answer, so the LLM’s introduction of qualitative revenue trends (rising, slipping, falling) constitutes fabrication rather than inference. This severely undermines quantitative accuracy. (3) The reasoning around strategy is partially sound: the LLM correctly identifies embedded processing as a core pillar alongside analog products and links it to TI’s competitive advantages and long-term free cash flow per share objectives. It also appropriately references capacity investments (e.g., Lehi fab) and R&D, which aligns with TI’s known capital allocation strategy. However, the synthesis is flawed because it bases strategic consistency on countervailing revenue performance not present in the original data, leading to a distorted narrative. (4) Contextually, the answer addresses the evolution of strategic emphasis and ties it to long-term growth in free cash flow per share, which matches the question’s intent. While the conceptual framework is relevant and partially accurate, the inclusion of unsupported financial trends reduces factual correctness. Thus, correctness is scored low due to invented data, despite correct strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 464,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved Marvel from a generic indefinite‑lived trademark listed alongside ESPN and Pixar to a **top‑level “Marvel” tile on Disney+**, promoting Marvel movies, series and related content as a primary navigation entry and retaining that prominence in 2024; this evolution shows that the company is using Marvel’s IP as a **strategic lever to acquire and retain DTC subscribers**, as reflected by the continued capitalization of Marvel‑related intangible assets and the equity‑based compensation expenses tied to Marvel‑focused programming.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Disney's strategic use of the Marvel brand from 2022 to 2024. It correctly identifies that Marvel was an indefinite-lived intangible asset alongside ESPN and Pixar in 2022 (implied by 'continued capitalization'), and accurately notes the key shift in 2023 when Marvel became a top-level tile on Disney+. The answer correctly states this prominence was retained in 2024 and links it to subscriber acquisition and retention in the DTC market, aligning with the financial strategy of leveraging high-equity brands. The mention of 'equity-based compensation expenses tied to Marvel-focused programming' adds a detail not in the original answer but does not contradict it and may reflect additional context from filings; however, this specific metric is not confirmed in the ground truth, slightly reducing qualitative accuracy. All entities (Marvel, ESPN, Pixar, Disney+) and timeframes (2022–2024) are correct. There are no numerical inaccuracies—while no specific subscriber number is mentioned (123 million as of Sept 28, 2024), the LLM does not make any false quantitative claims. The reasoning is sound: it connects brand asset valuation with platform strategy and subscriber growth, demonstrating proper multi-hop synthesis between financial reporting (intangible assets) and product strategy (UI design). The answer is semantically equivalent to the original in intent and factual core, though slightly less detailed in explicitly stating the planned ESPN+ tile for fiscal 2025 as evidence of a broader pattern. Overall, the response is factually correct, contextually relevant, and well-reasoned, warranting a high score with only minor room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 469,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure about 59 % of its closed block through a modified‑coinsurance agreement with an external reinsurer.  In 2022 the arrangement was accounted for under the deposit method, with the deposit and recoverable offset on the balance sheet, whereas after the November 2023 risk‑transfer transaction the company expanded the modified‑coinsurance to separate‑account products and recorded a much larger reinsurance‑recoverable balance (≈ $10.3 bn in 2023 and $17.6 bn of net ceded recoverables in 2024, 84 % of which was held by the five largest reinsurers).  Consequently, the percentage of the closed block covered remained roughly constant, but the associated recoverable balances grew substantially and were now disclosed as sizable, partially unsecured amounts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MetLife reinsured 59.25% of the closed block with $3.6 billion in unsecured reinsurance recoverable balances. In 2023, the reinsured percentage decreased slightly to 59%, and unsecured balances increased to $4.4 billion. In 2024, the percentage remained at 59% and unsecured balances declined to $4.2 billion. The LLM answer incorrectly states that recoverable balances were approximately $10.3 billion in 2023 and $17.6 billion in 2024—these figures are more than four times higher than the actual unsecured balances reported. Additionally, the LLM introduces a 'November 2023 risk-transfer transaction' and expansion to 'separate-account products,' which are not mentioned in the ground truth and represent fabricated details. (2) The percentages (59–59.25%) are approximately correct, but the financial figures are grossly inaccurate. The ground truth specifies unsecured recoverable balances, while the LLM cites total or net ceded recoverables (including secured portions), conflating different metrics. There is no support for $10.3B or $17.6B figures in the original data. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that the percentage reinsured remained stable, it fails to accurately track the actual evolution of the unsecured reinsurance recoverable balances as specified in the question. It introduces external concepts (deposit method, risk-transfer transaction, separate accounts) not present in the ground truth, indicating a failure to synthesize the correct information across years. (4) The contextual relevance is moderate because the answer addresses the general topic—MetLife’s use of modified coinsurance over time—but the severe quantitative inaccuracies and introduction of unsupported events and figures drastically reduce its correctness. The conclusion about growing recoverable balances contradicts the slight decline in 2024 noted in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 544,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nFrom 2022 through 2024 CVS trimmed its residential‑mortgage‑backed securities – amortized cost fell modestly from about $870 million to roughly $860 million and fair value slipped from $875 million to roughly $810 million – while the portfolio’s average duration lengthened from ~4.7 years to ~5.9 years.  This three‑year trend shows a deliberate reduction in MBS holdings and a shift toward longer‑dated, high‑grade fixed‑income assets, indicating that CVS is intentionally lowering its interest‑rate and credit‑risk exposure and repositioning its fixed‑income book toward a more conservative, rate‑sensitive profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. According to the ground truth, CVS's investment in RMBS was $629M in 2022, decreased slightly to $614M in 2023, and then dropped sharply to $71M in 2024. However, the LLM claims amortized cost was ~$870M in 2022 and ~$860M in 2024, with fair value falling from $875M to $810M—none of which aligns with the ground truth. These numbers are significantly off, indicating major quantitative inaccuracies. (2) The ground truth highlights a sharp reduction in RMBS exposure in 2024 following elevated levels, while the LLM describes only a modest decline over three years—missing the key inflection point in 2024. Additionally, the LLM introduces metrics not present in the original answer (e.g., average duration increasing from 4.7 to 5.9 years), which are unsupported by the ground truth. The unrealized losses rising from $10M to $60M in 2023—a critical indicator of increasing risk—are entirely omitted. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the strategic pivot or de-risking implied by the sharp 2024 drop. Instead, it infers a gradual, conservative shift toward longer-duration assets, which is not supported by the provided data. The synthesis of risk exposure and strategic intent is therefore based on incorrect data and misrepresents the trend. (4) While the LLM attempts to address the question’s intent—analyzing RMBS evolution and strategic implications—the factual foundation is so inaccurate that the conclusions are invalid. The contextual relevance is moderate because it discusses fixed-income strategy, but the incorrect numbers and missing key dynamics (sharp 2024 drop, unrealized losses) severely undermine correctness. Minor credit is given for addressing the general theme of portfolio repositioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 495,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure roughly **59 % of the closed block** via a modified‑coinsurance arrangement, but in **2023 it expanded the structure with a separate‑account modified‑coinsurance layer** as part of a risk‑transfer transaction.  The company accounts for this agreement under the **deposit method**: it records a deposit asset and a deposit liability, offsets the two, and amortizes the net cost of reinsurance (e.g., the $770 million net cost recognized in 2023) over the underlying policies; by 2024 the deposit asset was $4.6 billion and the deposit liability $1.2 billion, reflecting the same accounting treatment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that approximately 59% of the closed block was reinsured (with 59.25% in 2022 and 59% in 2023 and 2024), it introduces a false claim that in 2023 MetLife 'expanded the structure with a separate-account modified-coinsurance layer' as part of a risk-transfer transaction—this is not supported by the ground truth and represents a major fabrication. Additionally, the LLM cites specific dollar amounts such as a $770 million net cost in 2023 and deposit asset/liability figures of $4.6 billion and $1.2 billion in 2024, which are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be plausible but are not confirmed, making them misleading in a factual evaluation. (2) Quantitative accuracy is low because the introduced figures ($770M, $4.6B, $1.2B) are unverified and likely incorrect in context. The percentage figures (59%, 59.25%) are accurate, but the additional numbers undermine reliability. (3) The reasoning is partially sound in recognizing the use of the deposit method and offsetting, but the claim about structural expansion in 2023 breaks the logical chain and reflects poor synthesis or hallucination. The ground truth emphasizes consistency across years, which the LLM contradicts. (4) Contextual relevance is high because the answer addresses the core topics—percentage reinsured and accounting treatment—and attempts to provide detailed financial context. However, the inclusion of unsupported details reduces overall correctness. The qualitative accuracy is moderate due to correct identification of the accounting method and general stability, but the erroneous evolution narrative lowers the score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 482,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s net notional exposure to gas‑forward contracts first expanded – rising from about 1.3 trillion MMBtu in 2022 to a peak of roughly 1.45 trillion MMBtu in 2023 – and then contracted again to roughly 1.13 trillion MMBtu in 2024.  The associated Level‑3 fair‑value net asset moved from roughly $160 million (2022) to about $330 million (2023) before slipping to roughly $250 million (2024), reflecting the same rise‑then‑decline in hedged volume.  The trend indicates that NEE increased its hedging of natural‑gas price risk in 2023 but reduced that protection in 2024, suggesting a deliberate easing of its gas‑price risk posture as market conditions changed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NextEra Energy's net exposure was $160M in 2022, increased to $300M in 2023, and declined to $250M in 2024. However, the LLM states the 2023 net exposure was $330M (vs. correct $300M) and implies a rise from $160M to $330M to $250M, which misrepresents the magnitude of the increase and decrease. Additionally, the LLM introduces 'net notional exposure' in trillion MMBtu (1.3T, 1.45T, 1.13T), which is not present in the original answer and cannot be verified against the ground truth; this is extraneous and potentially misleading. (2) The correct net exposures are: 2022: $160M (assets $191M - liabilities $31M), 2023: $300M ($377M - $77M), 2024: $250M ($296M - $46M). The LLM’s $330M figure for 2023 is incorrect and likely results from misreading or miscalculating the fair value net asset. (3) The qualitative reasoning is sound: the LLM correctly identifies a rise-then-decline pattern and interprets it as increased hedging in 2023 followed by a reduction in 2024, aligning with the original conclusion of a more cautious or rebalanced risk posture. The multi-hop synthesis across years is logically structured and supports a coherent narrative about risk positioning. (4) Contextual relevance is high—the answer directly addresses the evolution of exposure and its implication for risk positioning. However, the inclusion of unverified notional volumes and incorrect fair value figures undermines factual accuracy. The core trend (increase then decrease) is correct, but precise values and calculations are flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 457,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom repeatedly listed industrial fiber‑optic components together with optocouplers, motion‑encoders and Ethernet ICs as part of a “broad variety of products for the general industrial and automotive markets.”  The 2023‑2024 filings broaden the description, emphasizing that these technologies serve an expanding set of end‑markets—including industrial automation, renewable‑energy, medical, defense and automotive subsystems—and are presented as integrated building blocks for end‑to‑end connectivity and control.  Consequently, AVGO’s positioning of industrial fiber optics evolved from a standalone product line to a core element of a diversified, tightly‑coupled industrial‑automation portfolio that combines fiber‑optic sensing, motion‑encoder feedback and Ethernet networking.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AVGO's positioning of Industrial Fiber Optics from 2022 to 2024. It correctly identifies the consistent grouping with optocouplers, motion encoders, and Ethernet ICs, and notes the expansion into broader industrial and automotive markets. The answer accurately reflects the shift from standalone components to integrated solutions, emphasizing end-to-end connectivity and control. It aligns with the ground truth in highlighting integration with motion encoders and Ethernet ICs, and the expansion into industrial automation, renewable energy, medical, defense, and automotive subsystems. The only minor omission is the lack of specific mention of 'camera microcontrollers' and 'switch ICs' in 2024, which are key indicators of deeper integration into vision-based and networked systems as noted in the original answer. However, the reference to 'tightly-coupled industrial-automation portfolio' and 'end-to-end connectivity' implies this trend, albeit less explicitly. No numeric or date inaccuracies are present—filings from 2022–2024 are correctly referenced, and no incorrect calculations are made. The reasoning is sound, demonstrating multi-hop synthesis across years and product groupings. The answer is semantically equivalent to the ground truth in intent and substance, with only slight reduction in specificity for 2024 developments. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 410,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the redeemable preferred stock that Sojitz America holds has kept the same terms: a $0.10 per share **cumulative dividend** is paid each May 31, and the shares are redeemable at the original $0.3 million par value.  The filings show **no changes** to the stock’s rights, redemption price, or dividend policy in 2022, 2023 or 2024, so the dividend obligation has remained constant and the stock structure has stayed stable throughout the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the dividend obligation is accurately stated as $0.10 per share annually, the par value is correctly reported as $0.3 million, and there is no change in the stock structure from 2022 to 2024. The mention of the dividend being paid each May 31 adds a specific detail not in the original but does not contradict it and may reflect actual filing language. (2) Quantitative accuracy is perfect: all numbers match the ground truth in value and meaning, with acceptable formatting. (3) The reasoning is sound—LLM correctly infers stability from the absence of changes across filings, demonstrating proper multi-hop synthesis across fiscal years. (4) The only minor omission is that the LLM does not mention the dividend priority (must be paid before common dividends) and Sojitz America’s non-exercise of redemption rights, which are part of the original answer and relevant to the financial implications. While these are important qualitative nuances, their absence does not undermine the core correctness. The answer remains factually precise, contextually relevant, and well-reasoned, warranting a high score but not perfect due to partial incompleteness on financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 357,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes‑31B listed in SPG’s 10‑K filings kept the same terms: a $750 million face amount, a fixed 3.25 % interest rate and a maturity date of 30 Nov 2026, with annual debt service of $24.375 million.  This unchanged profile shows that SPG’s long‑term financing strategy for this instrument is to lock in a stable, medium‑term, fixed‑rate debt that can be held on the balance sheet without refinancing, using it as a predictable source of liquidity and a consistent component of its diversified capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the unsecured debt amount ($750 million, equivalent to $750,000 thousand in financial reporting contexts), fixed interest rate (3.25%), maturity date (November 30, 2026), and consistency across 2022–2024. The annual debt service calculation ($750M × 3.25% = $24.375M) is accurate and consistent with the terms, though not mentioned in the original answer—it is a valid inference. (2) Quantitative accuracy is perfect: all numbers match or are correctly derived from the ground truth. Format variation ($750 million vs $750,000) is acceptable and common in financial reporting (where '000s are standard). (3) The multi-hop reasoning is sound—LLM correctly infers that no changes in terms over three years indicate a deliberate long-term financing strategy of stability and predictability. It appropriately contrasts this instrument’s stability with broader portfolio changes (implied in the original answer), though it doesn’t explicitly mention Unsecured Notes - 41A or retirements. This is a minor omission, not an error. (4) The answer is semantically equivalent and contextually complete. The slight expansion on 'predictable liquidity' and 'diversified capital structure' adds reasonable interpretation without contradicting the original. The only reason for not scoring 10 is the omission of broader portfolio context (e.g., new issuances in 2024), which slightly reduces qualitative completeness. However, the core multi-hop insight—unchanged terms indicate strategic stability—is fully supported and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 437,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe value of TI common stock held in the U.S. defined‑contribution plans fell from **$940 million at the end of 2022** (6 million shares) to **$873 million in 2023** (5 million shares) and further to **$852 million by the end of 2024** (again 5 million shares). This three‑year decline reflects a falling TI share price (and a modest reduction in the number of shares held) even though the fund has been frozen to new contributions since 2016. Consequently, the trend signals weaker stock performance for TI and means employees’ retirement balances are now increasingly tied to a shrinking equity position, likely prompting many to stay in the fund despite the decline or shift to other investment options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the value of TI common stock held in U.S. defined contribution plans as $940 million in 2022, $873 million in 2023, and $852 million in 2024, matching the ground truth exactly. It also accurately notes the share counts (6 million in 2022, 5 million in 2023 and 2024), which are not in the original answer but are factually consistent and add useful context without contradicting the ground truth. (2) All numeric values and trends are correct; the downward trajectory is accurately described. The dollar amounts are consistent with the original answer, and format variations (e.g., $940 million vs $940M) are acceptable. (3) The reasoning is sound: the LLM correctly identifies the freeze on new contributions since 2016 (a fact from broader knowledge of TI’s retirement plan policy) and links it to the observed trend, while also attributing the decline to falling share prices and reduced holdings. It goes beyond the original answer by inferring implications for employee behavior (e.g., staying in or shifting from the fund), which is a reasonable interpretation. (4) The answer fully addresses both parts of the question: the evolution of stock value (quantitative trend) and what it indicates about stock performance and employee investment behavior. The only minor gap is that the original answer presents three possible explanations (strategic reduction, freeze, or both), while the LLM emphasizes the freeze and market performance more strongly, slightly narrowing the range of interpretation. However, this does not make the answer incorrect—just slightly less balanced in presenting possibilities. Overall, the answer is factually accurate, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 481,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney’s total headcount rose modestly—from roughly 220,000 employees (about 166,000 U.S. and 54,000 international) to about 233,000 (≈ 171,000 U.S. and 62,000 international).  The share of seasonal workers stayed small, edging from roughly 7 percent of the global workforce to about 8 percent.  Throughout this period a large portion of park, studio and production staff have remained covered by collective‑bargaining agreements or works‑council representation, and the company has expanded its DEI‑focused programs and employee‑resource‑groups to broaden representation for under‑represented talent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: total employees (220,000 in 2022 → 233,000 in 2024), U.S. (166,000 → 171,000), international (54,000 → 62,000), and seasonal workforce percentages (7% → 8%) match exactly. Minor formatting variations (e.g., '≈' and 'roughly') are acceptable and do not affect factual accuracy. (2) Quantitative accuracy is perfect—no calculation errors, and all figures are consistent with the original data. (3) The multi-hop reasoning is sound: the model correctly synthesizes workforce trends across years, geographies, and employment types. It accurately notes the increase in seasonal staffing and maintains correct context about employee representation. (4) The only minor shortcoming is the addition of 'DEI-focused programs and employee-resource-groups,' which, while plausible, is not mentioned in the original answer and slightly extends beyond the provided ground truth. However, this does not contradict any facts and adds context without distorting the core response. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 325,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nFrom 2022 through 2024 GD kept the same practice of stripping out goodwill impairments and any other non‑economic accounting adjustments from both net operating profit after taxes and the invested‑capital base when calculating ROIC. By consistently excluding these items, the company signals that it views such changes as non‑recurring and wants ROIC to reflect the pure, ongoing cash‑generating performance of its core businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes (specifically mentioning goodwill impairments and other non-economic adjustments) from ROIC calculations across 2022–2024, which matches the original answer’s claim of consistent exclusion to reflect core performance. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in terms of math, but all years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly infers that consistent exclusion reflects a stable framework focused on economic, ongoing performance—this is a valid interpretation supported by the original answer. (4) The only minor gap is that the LLM specifies 'goodwill impairments' as an example not present in the original answer, which is plausible but slightly more specific than the source; however, this does not contradict the ground truth and adds reasonable detail. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 330,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde shifted rare‑gas production from a volume‑driven, merchant‑sales model toward an integrated, on‑site/engineering approach that locks in long‑term, high‑margin supply contracts for its most valuable customers.  The 2022 10‑K (pp. 94‑98) first identifies rare gases as part of the atmospheric‑gas portfolio, while the 2023 10‑K (pp. 98‑102) expands the discussion of on‑site contracts and engineering‑driven plant sales, and the 2024 10‑K (pp. 2‑6) highlights capital spending on new cryogenic and engineering projects that specifically support rare‑gas output.  This evolution shows that Linde’s competitive advantage lies in its ability to combine scale, proprietary cryogenic technology and long‑term engineering contracts to secure premium pricing and create high barriers to entry in the industrial‑gas market.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects of Linde's rare gas production strategy evolution. (1) Correctly identifies that rare gases were part of Linde’s atmospheric gas portfolio in 2022 and 2023, and references the correct sections of the 10-Ks (pp. 94–98 for 2022, pp. 98–102 for 2023), supporting contextual relevance. (2) However, the central claim—that Linde shifted from a merchant-sales model to an on-site/engineering-driven model with premium pricing—is not supported by the ground truth. The original answer emphasizes a technological evolution toward non-cryogenic air separation (e.g., VPSA, membrane separation) as a strategic differentiator by 2024, which the LLM answer omits entirely. Instead, the LLM incorrectly frames the shift around contract models and capital spending on cryogenic projects, while the truth highlights a move *beyond* traditional cryogenic methods. (3) The LLM mentions 'proprietary cryogenic technology' and 'engineering contracts' as competitive advantages, but the ground truth identifies *non-cryogenic* innovation as the key advancement, indicating a fundamental misinterpretation of the technological trajectory. (4) While the answer is logically structured and cites plausible document locations, it fails the multi-hop reasoning requirement by synthesizing incorrect inferences rather than accurately tracing the shift from broad portfolio inclusion (2022) to technological leadership (2024). Quantitative accuracy is high because no specific financial figures are misstated (and none were in the ground truth), but qualitative accuracy suffers due to incorrect strategic interpretation. The competitive advantage described—scale and long-term contracts—is not aligned with the actual emphasis on production efficiency via new separation technologies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 503,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral contracts rose modestly—from about 92 % of capacity (the level reported for the 2021/2022 period) to roughly 94 % by the end of 2023 and it stayed at that 94 % level in 2024.  This incremental increase reflects a deliberate shift toward locking in fixed‑price, long‑duration PPAs, thereby reducing exposure to daily spot‑market price swings and enhancing revenue stability in a volatile energy market.  The trend underscores NEER’s risk‑management strategy of securing contractual certainty and diversifying its portfolio through extended bilateral agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the percentages (92% in 2022, 94% in 2023 and 2024) are correct, though the LLM references '2021/2022 period' instead of specifically 2022, which introduces minor ambiguity but does not materially misstate the data. All subsequent values (94% in 2023 and 2024) match the original answer exactly. (2) The answer correctly captures the trend of a slight increase and stabilization, reflecting the evolution accurately. (3) The reasoning about risk management—emphasizing revenue stability, reduced exposure to spot-market volatility, and use of long-term PPAs—is logically sound and consistent with the ground truth’s interpretation. The LLM mentions 'non-qualifying hedges' indirectly via 'contractual certainty' and 'diversifying portfolio,' though it omits explicit mention of hedges, which is a minor omission but not a factual error. (4) Entities (NextEra Energy Resources, net generating capacity, long-term bilateral contracts) and time periods (2022–2024) are correctly identified. The answer is semantically equivalent to the original, with slightly different phrasing but full preservation of meaning. The only reason for not scoring a 10 is the slight imprecision in dating (referring to '2021/2022' instead of 2022), which slightly affects quantitative accuracy. Otherwise, the response is complete, contextually relevant, and demonstrates strong multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 404,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125 % notes maturing in January 2025 have been steadily trimmed: the company’s debt schedule shows a $1.245 billion principal amount earmarked for repayment in 2025 (the balance at the end of fiscal 2022), and by the end of fiscal 2024 that outstanding balance had fallen to roughly $0.495 billion.  This decline reflects Broadcom’s active debt‑management approach—using cash generated from the VMware merger and proceeds from new senior‑note issuances to retire the 2025 tranche early, thereby reducing future interest expense and improving the overall leverage profile of the 3.125 % instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim. The ground truth states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million across fiscal years 2022, 2023, and 2024. However, the LLM claims the balance decreased from $1.245 billion in fiscal 2022 to $0.495 billion in fiscal 2024, which contradicts the verified data. This major factual error undermines the entire response. (2) Quantitatively, the $1.245 billion figure is entirely unsupported by the ground truth and appears fabricated. The correct amount is $495 million in all three years. The LLM also misrepresents the trend as a decline when there was no change. Calculations or references to repayments are therefore invalid. (3) The reasoning is flawed: the LLM attributes the supposed reduction to proceeds from the VMware merger and new note issuances, but the ground truth indicates no retirement or refinancing of this specific instrument occurred during the period. This reflects a failure in multi-hop synthesis—instead of correctly identifying stable debt levels, the model infers active management based on incorrect data. (4) Contextually, the answer addresses the right instrument (3.125% notes due January 2025) and company (AVGO/Broadcom), so it is relevant. However, due to severe inaccuracies in numbers and interpretation, the qualitative and correctness scores are low. Minor credit is given for discussing debt management strategy, even if based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 419,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 37B grew from a **$550 million** issuance (1.38 % coupon, maturing 15 Jan 2027) to a **$700 million** issuance (2.25 % coupon, maturing 15 Jan 2032).  The extension of the maturity by five years and the modest increase in coupon reflect SPG’s strategy of lengthening the average life of its unsecured debt, locking in financing for the long term and reducing near‑term refinancing risk while still maintaining a relatively low‑cost capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that SPG's exposure to Unsecured Notes - 37B was consistently $700,000 (not million) in face amount from 2022 through 2024, with a maturity date of 01/15/32. The LLM incorrectly claims the note grew from $550 million to $700 million and changed maturity from 2027 to 2032, which contradicts the stable profile in the original answer. The coupon rates (1.38%, 2.25%) are also not present in the ground truth and are thus fabricated. (2) Quantitative accuracy is severely compromised: the face amount is off by a factor of 1,000 ($700,000 vs $700 million), the maturity date is incorrectly stated as changing from 2027 to 2032 (vs unchanged 2032 in truth), and the initial amount ($550M) and coupon rates are entirely incorrect. (3) The reasoning is flawed: the LLM infers a strategic shift toward extending debt duration and reducing refinancing risk based on non-existent changes in maturity and size. Since the actual note remained unchanged, no such strategic evolution can be inferred for this instrument. The multi-hop synthesis failed—instead of recognizing stability across years, the model invented a transformation. (4) Contextual relevance is moderate because the answer addresses the general topic of debt strategy and attempts to interpret maturity and face value trends, but the underlying data errors invalidate the conclusion. Correctness and quantitative accuracy are low due to fundamental factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 421,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings, Texas Instruments’ Melaka, Malaysia site appears in the property tables under the **Analog** column in each year, with no “X” under **Embedded Processing** in any of them.  This shows the facility has consistently been used for analog‑chip manufacturing and has not been part of the company’s embedded‑processing footprint.  The only evolution is a change in the footnote notation (from a single asterisk indicating “Portions of the facilities are leased and owned” in 2022‑23 to a double‑asterisk with a clarified lease‑ownership note in 2024), but the product‑line focus remains exclusively analog.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently involved in analog operations across 2022, 2023, and 2024, with no involvement in embedded processing—matching the original answer exactly in substance. (2) There are no numerical inaccuracies; while no specific financial figures are involved, the temporal data (years) and categorical data (analog vs. embedded processing) are correctly referenced. The mention of footnote notation changes (asterisk to double-asterisk) adds contextual detail without contradicting the core fact of operational consistency. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifies the consistent presence in analog and absence in embedded processing, and draws the correct conclusion of no expansion into embedded processing. (4) The answer is highly relevant, directly addressing the evolution (or lack thereof) in TI's operational footprint over time and by product line. Minor additional detail about footnote notation does not detract but rather enriches the response within the bounds of the filings. All evaluation criteria are met with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 357,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nDisney still records the post‑production work performed by Industrial Light & Magic (and Skywalker Sound) inside the **Content Sales/Licensing** segment, grouping the resulting income with the segment’s broader licensing, TV/SVOD, theatrical and home‑entertainment revenues. The company does not disclose a separate line‑item for ILM services, so the modest revenue generated by these services is aggregated and has not shown a material change in size or structure across fiscal 2022, 2023 or 2024. Thus, the segment’s makeup and the way ILM‑provided post‑production proceeds are reported remained essentially the same throughout the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Industrial Light & Magic (ILM) has remained within the Content Sales/Licensing segment from fiscal 2022 to 2024 and that its revenues are aggregated without separate disclosure—this aligns with the ground truth and supports a score of 10 for quantitative accuracy, as no specific numbers are contested and the absence of line-item disclosure is correctly noted. However, the LLM answer contradicts the original answer’s key qualitative insight: while it claims the segment’s structure and reporting 'remained essentially the same' across the three years, the ground truth describes an evolving narrative emphasis—from explicit inclusion in 2022, to a shifting focus toward TV/VOD and theatrical distribution in 2023, and further alignment with a DTC-first content model in 2024. This evolution indicates a strategic repositioning of ILM’s role, which the LLM answer fails to acknowledge, instead asserting stability in both structure and revenue significance. This omission or misrepresentation of the evolving strategic context results in a qualitative accuracy score of 5, as the model misses the multi-hop synthesis of structural trends over time. Contextual relevance is fair (7) because the answer addresses the core topic (ILM’s reporting within the segment) and correctly notes aggregation of revenue, but it does not engage with the question’s focus on *evolution* across years. Thus, while factually non-contradictory on static structure, the LLM answer underrepresents the dynamic strategic shifts described in the ground truth, leading to a correctness score of 5—partially correct but missing significant analytical depth and change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 463,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method income from operating joint ventures was about **$1.3 billion in 2022**, fell sharply to **$0.15 billion in 2023**, and then recovered to **$0.99 billion in 2024**. The steep 2023 drop reflects weaker earnings from its insurance‑underwriting joint ventures that year, while the rebound in 2024 indicates a recovery and improved performance of those joint‑venture underwriting results over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the equity method investment income values for 2022 ($1.3 billion vs. ground truth $1,305 million), 2023 ($0.15 billion vs. $151 million), and 2024 ($0.99 billion vs. $988 million). These are accurate within reasonable rounding (e.g., $1.3B ≈ $1,300M, close to $1,305M; $0.15B = $150M, very close to $151M; $0.99B = $990M, close to $988M). No calculation errors are present. (2) All numeric values are factually correct with acceptable formatting variations (e.g., $1.3 billion instead of $1,305 million). The slight rounding is common in financial reporting and does not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the trend (sharp decline in 2023, recovery in 2024) and links it to the performance of insurance underwriting joint ventures. It synthesizes across three years and interprets the implications correctly. (4) The answer is contextually complete and relevant, addressing both the evolution of income and what the trend suggests. The only minor shortcoming is that the original answer emphasizes 'volatility' more explicitly, while the LLM uses 'weaker earnings' and 'recovery', which captures the trend but slightly underemphasizes the volatility aspect. However, the reasoning remains strong. Thus, all scores are high, with correctness at 9 due to this slight nuance in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 386,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nGeneral Dynamics’ Light‑Armored‑Vehicle (LAV) production for the Canadian Army grew steadily from **360 units in 2022 → 399 units in 2023 → 449 units in 2024**.  This upward trajectory shows that the LAV platform is becoming a core growth engine within GD’s defense portfolio, underscoring its strategic importance for expanding land‑system capabilities, deepening international partnerships, and delivering recurring revenue from a high‑visibility, export‑friendly program.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the production volumes—360 units in 2022, 399 in 2023, and 449 in 2024—are accurately reported with no discrepancies. The upward trend is correctly identified. (2) The answer is complete, addressing both the evolution of production volume and the strategic implications for General Dynamics' defense portfolio. (3) Entities—General Dynamics, Light Armored Vehicles (LAVs), Canadian Army, and the correct time frame (2022–2024)—are all accurately referenced. (4) The reasoning is sound: the consistent increase in production is correctly interpreted as evidence of the LAV platform’s growing strategic importance, with logical inferences about international partnerships, recurring revenue, and the platform’s role in land-system capabilities. The wording differs slightly from the original answer but maintains semantic equivalence, emphasizing the platform's centrality and export value. No factual, numerical, or inferential errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 297,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure rose steadily from roughly **$214 million at the end of 2022** to **$252 million at the end of 2023** and then to **$280 million at the end of 2024** (the amounts disclosed as “hedge fund limited partnership investments” that are measured at NAV and excluded from the fair‑value hierarchy).  This modest but consistent increase shows that the company is gradually expanding its allocation to alternative‑asset strategies—consistent with its stated target of about 3 % of plan assets in hedge funds—to boost returns and diversify the pension portfolio while still representing only a small share of the overall fund.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM incorrectly states $252M in 2023 and $280M in 2024, which misrepresents both the values and the trend. The 2022 figure is correct. (2) The quantitative inaccuracies are severe: the 2023 value is overstated by $27M (from $225M to $252M), and 2024 is overstated by $28M (from $252M to $280M). These are not minor rounding differences but material deviations that distort the growth trajectory. Additionally, the LLM implies a continued acceleration in allocation that is not supported by the actual data. (3) While the LLM correctly identifies the general direction of the trend (increasing exposure to hedge funds) and infers a strategic shift toward alternative investments, this reasoning is based on incorrect data. The mention of a '3% target' and diversification rationale introduces unsupported details not present in the original answer or implied by the data provided, reducing qualitative accuracy. (4) Despite the factual errors, the answer remains contextually relevant by addressing both parts of the question—trend over time and strategic implication—and attempting multi-hop synthesis (linking annual figures to asset allocation strategy). However, due to the core numerical inaccuracies, the correctness score is low, as the answer conveys a misleading picture of the actual financial evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 421,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nOver the 2022‑2024 period Colgate‑Palmolive moved Sorriso from a primarily Brazil‑focused toothpaste into a core component of its global Oral Care portfolio.  The brand is now listed among the company’s “principal global and regional trademarks” in the 2023 and 2024 filings and its sales are aggregated within the Oral Care category, which accounted for roughly 43 % of worldwide net sales in 2024.  This reflects a strategic shift to integrate Sorriso fully into the company’s worldwide Oral, Personal and Home Care product suite rather than treating it as a standalone regional offering.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies that deviate from the ground truth. (1) It incorrectly states that Colgate-Palmolive moved Sorriso from a 'primarily Brazil-focused toothpaste into a core component of its global Oral Care portfolio' and implies a strategic shift or integration occurred during 2022–2024. However, the original answer indicates continuity: Sorriso was consistently listed as a principal regional trademark in all three years (2022, 2023, 2024), with no evidence of a strategic shift or elevation to global brand status. (2) The LLM claims the brand is listed among 'principal global and regional trademarks' in 2023 and 2024 filings only, but the ground truth confirms it was already listed in 2022, contradicting the implied timeline of change. (3) The 43% figure for Oral Care's share of net sales in 2024 is not present in the original answer and cannot be verified from the provided truth; this number is an unsupported addition. (4) The conclusion that there was a 'strategic shift to integrate Sorriso fully' is not supported by the ground truth, which emphasizes stability and consistent positioning, not transformation. While the LLM correctly identifies Sorriso as part of the Oral, Personal and Home Care segment and acknowledges its regional importance, the narrative of evolution and integration is factually incorrect. The answer misrepresents continuity as change, failing the core multi-hop reasoning test. Quantitative accuracy is partially acceptable due to plausible percentages and correct years, but unsupported figures reduce precision. Contextually, the response addresses the right domain (brand positioning within portfolio), so relevance is moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 461,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nMetLife’s exposure to operating joint ventures contracted modestly from 2022 through 2024 – the carrying value of its equity‑method investments slipped from about $25.2 bn at the end of 2023 to $24.9 bn at the end of 2024, and unfunded commitments fell from $6.7 bn to $5.8 bn – while the cash‑flow contribution of these ventures to net investment income rose sharply, jumping from $38 m in 2023 (down from $51 m in 2022) to $175 m in 2024. This three‑year trend shows the company is scaling back new capital commitments to joint‑venture projects but is extracting greater returns from its existing portfolio, reflecting a strategic shift toward a leaner, higher‑return equity‑method investment mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023 to $38 million in 2024. However, the LLM claims exposure was $25.2 billion in 2023 and $24.9 billion in 2024—off by a factor of over 600x. These figures appear to conflate total equity-method investments with exposure to *operating joint ventures*, a critical distinction. Additionally, the LLM incorrectly states that cash-flow contributions rose to $175 million in 2024, while the ground truth shows a decline from $77M to $51M to $38M—directly contradicting the LLM’s claim. (2) Number verification: $77M (2022), $51M (2023), $38M (2024) in original answer vs. $25.2B and $24.9B (incorrect metric and magnitude) and $175M income (fabricated). No calculation in LLM aligns with ground truth. (3) Multi-hop reasoning fails: the LLM misidentifies the metric (total equity investments vs. operating joint ventures), misrepresents the trend (growth in returns vs. actual decline in exposure), and draws an opposite conclusion (higher returns on leaner portfolio vs. actual strategic withdrawal). (4) Scores justified: correctness is low (2/10) due to fundamental factual errors; quantitative accuracy is poor (2/10) due to massive magnitude and metric errors; qualitative accuracy is minimal (3/10) as some structure is present but based on wrong data; contextual relevance is moderate (6/10) because the answer addresses the general topic of joint venture strategy but with incorrect data and inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 449,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron retained its 36.4 % equity stake in Angola LNG Limited, but the partnership became far more tightly coupled to its upstream gas operations in Angola.  Chevron deepened its integration by investing in the Block 0 Sanha Lean Gas Connection, advancing the South N’Dola and Quiluma‑Maboqueiro gas‑field developments, and securing new offshore exploration blocks (49 & 50), so that the gas produced from these upstream projects is funneled directly into the Angola LNG plant that it part‑owns and helps operate.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Chevron's 36.4% stake in Angola LNG Limited, which matches the ground truth across 2022–2024, satisfying quantitative accuracy for ownership percentage. However, it introduces several upstream projects not mentioned in the original answer: 'Block 0 Sanha Lean Gas Connection', 'South N'Dola', and 'offshore exploration blocks 49 & 50'. These are not present in the ground truth and cannot be verified from the provided knowledge, constituting factual inaccuracies. While the core idea of increased integration with upstream gas projects is correct, the specific examples are fabricated or misattributed. The ground truth specifies that feedstock comes from Quiluma and Maboqueiro fields via the New Gas Consortium (NGC), where Chevron holds a 31% nonoperated interest—this detail is omitted in the LLM answer. Additionally, the original answer notes a strategic evolution from passive investor (2022) to more integrated role (2024), with explicit operational linkage emerging in 2024. The LLM answer implies deeper operational involvement and suggests Chevron 'helps operate' the plant, but the ground truth describes Chevron as a nonoperator in NGC and does not state it operates or co-owns operations at the LNG plant—only that it supplies gas. This misrepresents Chevron’s operational role. The qualitative reasoning is partially sound in identifying integration trends but fails in precise multi-hop synthesis: it invents projects and overstates operational involvement without evidence. Contextually, the answer stays focused on the evolution of Chevron’s role and upstream integration, making it highly relevant. Overall, key facts like the stake percentage are correct, but incorrect project names, missing NGC context, and overstated operational role reduce correctness despite capturing the general trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 498,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the $622 million 3.625 % senior notes maturing in October 2024 remained on the balance sheet at roughly that amount in 2022 and 2023, but by the end of FY 2024 the balance had been reduced to zero – the note was fully retired using cash from the October 2024 $5 billion senior‑note issuance (and related proceeds from the VMware merger and other asset sales).  This repayment illustrates AVGO’s proactive debt‑management strategy of pre‑emptively refinancing near‑term maturities with longer‑dated, lower‑cost debt, thereby shortening its near‑term exposure and improving overall leverage as the maturity date approached.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $622 million outstanding amount for the 3.625% notes due October 2024 in 2022 and 2023, and accurately states that the balance was reduced to zero by FY 2024, aligning with the ground truth that the notes were fully retired. These quantitative figures and dates are correct. (2) However, the LLM introduces specific details not present in the original answer: it claims the repayment was funded by a $5 billion senior-note issuance in October 2024, proceeds from the VMware merger, and other asset sales. While plausible, these specifics are not supported by the ground truth, which only states the notes were retired without specifying the funding source. This overreach slightly undermines factual accuracy. (3) The multi-hop reasoning is sound—correctly tracking the liability across three fiscal years and inferring a proactive debt management strategy. The conclusion about refinancing with longer-dated, lower-cost debt is a reasonable interpretation, though the original answer is more cautious, only stating the company 'proactively addressed its maturing obligations' without specifying refinancing mechanics. (4) Despite the added speculative detail, the core facts, numbers, and strategic interpretation are correct and relevant. The answer addresses both parts of the question: the evolution of exposure (quantitative trend) and the implied strategy (qualitative inference). Thus, the correctness score is 8 due to minor over-speculation, but quantitative accuracy is high (9), qualitative reasoning is strong (8), and relevance is perfect (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 440,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nSPG’s interest expense on the Unsecured Notes – 35B was $28.5 million (shown as “Annual Debt Service (14) $28,500” in the 2022, 2023 and 2024 tables). Thus the expense remained flat at $28.5 million each year from 2022 through 2024, indicating that the financing cost of this fixed‑rate 3.80 % note stayed unchanged over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the interest expense is accurately reported as $28,500 (in thousands), which equals $28.5 million—format variation is acceptable and correctly interpreted. The value is correctly stated for all three years: 2022, 2023, and 2024. (2) The answer addresses both parts of the question: it describes the trend (flat/unchanged) and interprets it correctly as indicating a fixed-rate structure, even adding the specific rate of 3.80%, which is consistent with and enhances the ground truth. (3) Entity accuracy is correct: SPG, Unsecured Notes - 35B, and the years 2022–2024 are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three years of data, concluding a consistent financing cost due to fixed-rate terms. No factual, numerical, or logical errors are present. All aspects of the question are addressed with precision and clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 283,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved its DTC strategy from an aggressive subscriber‑growth push to a more disciplined, profitability‑focused model.  In 2022 it reorganized DMED and announced an ad‑supported Disney+ tier, price hikes and cost‑realignment, and by 2023‑24 it was tightening content‑spending, rationalizing distribution windows and leveraging joint‑venture deals (e.g., Star India) while confronting steep rises in programming and sports‑rights costs and intensified competition from other streaming services.  The result is a shift toward monetizing the existing library through advertising and higher subscription fees, even as the company continues to invest heavily in new content and technology to maintain its competitive edge.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Disney's DTC strategy from 2022 to 2024, aligning well with the ground truth. (1) It correctly identifies the shift from subscriber growth to profitability, price increases, ad-supported tiers, cost realignment, and tighter content spending—all consistent with Disney's strategic moves. It also accurately notes rising programming and sports-rights costs and intensified competition, which are key challenges highlighted in the original answer. (2) There are no specific numeric values in the LLM answer that contradict the ground truth; the original mentions $12.25 billion in unused bank facilities, but the LLM does not attempt to include or misstate this figure, so no inaccuracy is introduced. Thus, quantitative accuracy is full. (3) The multi-hop reasoning is sound: the LLM synthesizes strategic shifts across years, connects financial pressures (rising costs) with business decisions (ad tiers, price hikes), and acknowledges competitive dynamics. However, it omits explicit mention of the declining affiliate fees from linear networks and Disney’s reliance on subscription and ad revenue to offset them—a key economic driver in the original. It also does not mention the uncertainty in returns or negative returns on DTC investments in 2022, which is a notable omission in qualitative completeness. (4) Despite these omissions, the answer remains contextually relevant and semantically aligned with the main trajectory: a shift toward monetization amid rising costs and competition. The use of terms like 'rationalizing distribution windows' and 'joint-venture deals' adds detail not in the original but does not contradict it. Overall, the answer is factually sound and relevant, with only minor gaps in completeness, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 496,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nMetLife has consistently applied the deposit method to reinsurance treaties that do not expose it to a reasonable possibility of a significant loss. Prior to 2023 the related deposit assets and liabilities were modest—about $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (as reflected in the 2021‑2022 filings). The November 2023 risk‑transfer with Global Atlantic created a large new deposit arrangement: the Company recorded a $10.3 billion deposit receivable (shown in premiums, reinsurance and other receivables) and a corresponding $1.3 billion deposit liability (shown in other liabilities), pushing the balances to roughly $5.1 billion of assets and $1.3 billion of liabilities in 2023, and to $4.6 billion and $1.2 billion respectively in 2024. The transaction also required a one‑time net cost of reinsurance of $770 million, recorded in other liabilities and amortized over time, which is the primary way the 2023 risk‑transfer impacted the evolution of MetLife’s deposit‑method accounting.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of MetLife's use of the deposit method from 2022 through 2024, including the impact of the 2023 risk transfer with Global Atlantic. It correctly identifies the 2022 deposit asset and liability figures at $1.8 billion and $1.4 billion, respectively, and the 2024 figures at $4.6 billion in assets and $1.2 billion in liabilities, matching the ground truth. The mention of the $10.3 billion deposit receivable from the Global Atlantic transaction is accurate and well-contextualized. However, there is a minor quantitative inaccuracy: the LLM states that a $1.3 billion deposit liability was recorded in connection with the transaction, but the ground truth does not specify this amount, and the overall deposit liabilities declined from $1.4B to $1.2B by 2024, making the $1.3B figure inconsistent. Additionally, the LLM calculates 2023 balances as 'roughly $5.1 billion of assets' ($1.8B + $10.3B - offset?) and $1.3B liabilities, but this aggregation is not explicitly supported in the ground truth, which only provides 2022 and 2024 data points. The $770 million net cost of reinsurance is mentioned in the LLM answer but absent in the original answer, suggesting either an over-extraction from source data or inclusion of non-ground-truth details. Despite these issues, the qualitative reasoning is strong: it correctly identifies the strategic shift in 2023 and the rebalancing in 2024, synthesizing multi-hop information across years and entities (MetLife, Global Atlantic, reinsurance accounting). The answer is fully contextually relevant, addressing all parts of the question with appropriate financial terminology and logical flow. The minor numerical discrepancies prevent a perfect score, but the overall factual and conceptual accuracy is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 491,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nFrom the 10‑K data, CVS trimmed its commercial‑mortgage‑backed‑securities (CMBS) book over the three‑year span: amortized cost fell from about **$1.17 bn at the end of 2022** to **$1.07 bn in 2023** and **$1.07 bn (≈$1.066 bn) in 2024**, while fair value moved from **$1.02 bn → $0.98 bn → $0.98 bn** (≈$0.975 bn).  At the same time, the total unrealized loss on CMBS shrank from roughly **$224 m in 2022 to $102 m in 2023 and $100 m in 2024**, and the securities’ average duration dropped from 6.1 years to 5.4 years.  This contraction reflects a deliberate shift away from CMBS toward shorter‑duration, higher‑quality debt holdings and other investments, indicating that CVS is reducing its exposure to this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative accuracy. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and then dropped to just $3 million in 2024. In contrast, the LLM claims CVS held approximately $1.17 billion in 2022, $1.07 billion in 2023, and $1.07 billion in 2024—overstating the exposure by more than double in 2022 and 2023 and completely missing the dramatic drop in 2024. These figures are not within acceptable rounding or formatting variations and represent a fundamental factual error. (2) The LLM introduces amortized cost and fair value metrics not present in the original answer, which may exist in filings but contradict the ground truth derived from the knowledge graph. The reported trend—gradual decline followed by stabilization—is inconsistent with the ground truth’s pattern of a slight increase followed by a near-total divestment. The calculation of unrealized losses and duration changes, while internally consistent, are irrelevant and incorrect in context. (3) The multi-hop reasoning is flawed: the model fails to identify the correct trajectory (increase then sharp drop) and thus misinterprets the strategic implication. While the conclusion about de-risking may seem plausible, it is based on incorrect data and therefore invalid. The model does correctly identify the company (CVS) and asset class (CMBS), but misrepresents the time-series evolution. (4) The contextual relevance is moderate because the answer addresses the right topic and attempts to interpret strategy, but the factual foundation is so weak that the analysis is misleading. Correctness and quantitative accuracy are severely penalized due to major discrepancies in key financial figures and trend description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 489,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nThe “hello” brand has been listed as a principal global trademark in the 2022, 2023 and 2024 Form 10‑K filings, confirming that Colgate‑Palmolive continued to protect the name through trademark disclosures each year.  Across the three years the brand is consistently placed in the Oral Care sub‑category of the Oral, Personal and Home Care segment—whose share of worldwide net sales stayed around 42‑43 %—indicating a stable strategic emphasis on “hello” as a core oral‑care brand within the company’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that the 'hello' brand was consistently listed as a principal trademark in Colgate-Palmolive’s 10-K filings across 2022, 2023, and 2024, which matches the original answer’s assertion of ongoing inclusion in trademark disclosures. (2) The LLM adds a specific quantitative detail—Oral, Personal and Home Care segment’s share of worldwide net sales at 42–43%—which is not contradicted by the ground truth and enhances precision, though this exact percentage range is not present in the original answer; however, since it does not conflict and is contextually plausible, it does not reduce accuracy. (3) The LLM correctly identifies the multi-hop elements: continuity of trademark status over three years and placement within the Oral Care sub-category of the broader segment, demonstrating sound reasoning and synthesis across years and categories. (4) While the original answer emphasizes strategic positioning in terms of diversification and consumer engagement, the LLM focuses on stability and core branding, which is semantically consistent. The only minor gap is the lack of explicit mention of 'personal hygiene' or 'Home Care' beyond oral care, but since the brand is specifically associated with oral care in practice, this specialization is reasonable. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy for not fully echoing the broader strategic interpretation in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 436,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nMetLife continued to use the deposit method only for a limited set of modified‑coinsurance arrangements that do not expose it to a significant loss.  The balance of deposit assets fell from roughly **$5.1 bn in 2023 to $4.6 bn in 2024**, and deposit liabilities declined from **$1.3 bn to $1.2 bn**, even as total ceded reinsurance recoverables increased from **$16.7 bn to $17.6 bn**.  This pattern reflects the 2023 risk‑transfer transaction, which created a large temporary deposit that was largely amortized by 2024, signalling a strategic shift away from deposit accounting toward more traditional ceded reinsurance to manage capital and reinsurance‑risk exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports the 2024 deposit assets ($4.6 billion) and liabilities ($1.2 billion), it incorrectly states that deposit assets were $5.1 billion in 2023, whereas the ground truth reports no specific 2023 asset/liability figures but emphasizes a broader accounting framework was adopted that year. More critically, the ground truth shows deposit assets increased from $1.8 billion in 2022 to $4.6 billion in 2024, indicating growth in deposit method usage, but the LLM claims a decline from $5.1B to $4.6B, which contradicts the trend. The LLM also fabricates a '2023 risk-transfer transaction' creating a 'temporary deposit' that was 'amortized', which is not supported by the original answer. Instead, the original attributes the 2024 increase to the Global Atlantic transaction, suggesting strategic expansion, not reduction, of deposit-method reinsurance. (2) The quantitative values for 2024 are correct, but the 2023 figures are wrong: ground truth does not provide 2023 deposit asset/liability numbers but implies an upward trend, while LLM invents $5.1B and $1.3B figures. The claim of declining balances contradicts the actual increase from $1.8B to $4.6B in assets. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a strategic shift away from deposit accounting, while the original answer concludes a strategic shift toward more reinsurance arrangements not transferring sufficient risk—i.e., greater reliance on deposit method. This is a direct reversal of the correct interpretation. The mention of increasing total ceded reinsurance recoverables is plausible but used to support an incorrect narrative. (4) The contextual relevance is moderate because the answer addresses reinsurance strategy and risk exposure, but the conclusions are factually inverted. Due to major errors in numbers, trend direction, and strategic interpretation, the correctness score is low despite some accurate 2024 data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 543,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nNEE’s Special Use Funds grew sharply – the fair‑value of the fund rose from roughly **$5.5 bn in 2022** to **about $9.8 bn by the end of 2024**, as shown in the Level‑1/2 fair‑value tables that detail equity, government‑bond and corporate‑debt holdings.  This increase is reflected on the balance sheet as a dedicated “Special Use Funds” asset of **$9.8 bn (2024) versus $5.5 bn (2022)**, and because the funds are accounted as regulatory assets, fair‑value changes flow through regulatory assets/liabilities and trigger the need to post collateral (cash and letters‑of‑credit) to meet the nuclear‑decommissioning and storm‑fund obligations disclosed in the collateral‑risk sections.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. According to the ground truth, the fair value of Special Use Funds was $8,698 million in 2023 and $9,800 million in 2024, with a $1,102 million increase from 2023 to 2024. However, the LLM incorrectly states the 2022 value as $5.5 billion (vs. implied $8,698M - growth from prior year, with $538M in a subcategory in 2023), and omits the 2023 reported value entirely. This misrepresents the trajectory and magnitude of growth. The $9.8 billion figure for 2024 is correct and properly cited on the balance sheet, but the baseline is wrong, leading to an inaccurate portrayal of the growth trend. Additionally, the LLM introduces 'Level-1/2 fair-value tables' and specific asset breakdowns (government bonds, corporate debt) not mentioned in the original answer, adding unsupported detail. On qualitative aspects, the LLM correctly identifies the regulatory asset treatment and links fair value changes to collateral requirements (cash and letters of credit) for nuclear decommissioning and storm funds, which aligns with the collateral implications in the question. It also correctly notes enhanced balance sheet presentation by naming 'Special Use Funds' as a line item in 2024. However, it misses key evolution in valuation methodology — such as the use of pricing vendors for debt, commingled funds based on underlying securities, and the new category of equity investments without readily determinable fair values growing from $485M to $538M — which were central to the original answer’s narrative on transparency. The reasoning partially reflects multi-hop synthesis (linking fair value, balance sheet, and collateral), but flawed inputs reduce reliability. While the answer addresses all three areas (fair value, collateral, balance sheet), the factual errors in core financial data severely limit correctness. Semantic equivalence fails on numbers, though structure and intent are relevant and responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 537,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nIn the 2022 filing the Security Insights Platform was introduced as a solution that interprets mainframe security posture and generates remediation recommendations, with a note that its output can be consumed by customers’ own SIEM systems. The 2023 filing broadened the description to stress direct integration with customers’ in‑house security‑information‑and‑event‑management tools and the ability to trigger automated remediation actions. By the 2024 filing the language emphasized a seamless, out‑of‑the‑box connection to internal toolchains and built‑in workflow automation, positioning the platform as a source of actionable, orchestrated remediation rather than merely advisory insight.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of AVGO's Security Insights Platform evolution from 2022 to 2024, despite using plausible financial and technical language. (1) The original answer (ground truth) states that the platform's description remained largely consistent across the three years, with only a stable value proposition and no significant expansion in integration or remediation features. However, the LLM claims a progressive evolution: from basic SIEM compatibility in 2022, to automated remediation in 2023, to 'out-of-the-box' workflow automation in 2024—none of which is supported by the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, counts) in either the question or answers, so quantitative accuracy is not heavily applicable; however, the use of years (2022, 2023, 2024) is correct in format and sequence, hence a score of 8. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers increasing integration and automation capabilities over time, when the knowledge graph confirms no such enhancements were described. This reflects a failure in synthesizing the actual consistency across filings. (4) Contextually, the answer addresses the right topic (integration with in-house tools and remediation workflows) and uses relevant terminology (SIEM, remediation, toolchains), so it is relevant but factually inaccurate. The core error is inventing a technological progression that did not occur according to the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 412,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nNIKE continued to **own** its Laakdal, Belgium distribution center in each of the fiscal years 2022, 2023 and 2024, and the facility remained listed among the company’s most significant non‑U.S. distribution sites (see 2022 Form 10‑K pp. 25‑29; 2023 Form 10‑K pp. 27‑31; 2024 Form 10‑K pp. 27‑31).  No expansion, contraction, or change in operating status was disclosed— Nike simply reaffirmed that Laakdal is a core, company‑owned hub for European logistics.  This consistency signals that the site is strategically vital to Nike’s European supply‑chain network, providing a controlled, high‑capacity distribution node that underpins the company’s ability to serve European markets reliably and efficiently.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth. (1) It correctly states that NIKE owned the Laakdal facility in fiscal years 2022, 2023, and 2024, and that it was consistently described as one of the company’s most significant non-U.S. distribution centers—matching the original answer’s claim of no changes in ownership or operational status. (2) There are no numerical values requiring calculation (e.g., financial figures or dates), but the fiscal years and references to Form 10-K pages are accurately cited in context, with no conflicting or erroneous data. (3) The multi-hop reasoning is sound: the model synthesized consistent disclosures across three annual reports to infer strategic stability, correctly concluding that the lack of change underscores the site’s strategic importance. (4) The answer addresses all parts of the question: ownership, operational footprint across the three years, and the implication of consistency for European logistics strategy. Wording differs slightly but maintains semantic equivalence—e.g., 'core, company-owned hub' vs. 'stable and integral part'—without affecting factual accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 331,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 SPG’s holding of **Unsecured Notes ‑ 32B** remained essentially unchanged in size – the face amount stayed at **$750 million** – and the coupon stayed fixed at **3.38 %**.  The only evolution was the maturity extension: the 2022 filing listed a maturity of **15 June 2026**, while the 2023 and 2024 filings show the same note maturing on **15 June 2027**.  This three‑year pattern reflects SPG’s strategy of maintaining a stable, low‑cost unsecured debt position while deliberately extending the maturity to spread refinancing risk and preserve liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors, particularly regarding the maturity date, which is critical to the question. The original answer states that the maturity date was unspecified in 2022 and then explicitly listed as 06/15/27 in both 2023 and 2024. However, the LLM claims the 2022 maturity was 06/15/26, which is incorrect and unsupported by the ground truth. Additionally, the face amount is misrepresented: the ground truth specifies $750,000, but the LLM reports $750 million—a discrepancy of three orders of magnitude. The interest rate (3.38%) is correctly reported. (2) Quantitative accuracy is severely compromised: $750,000 ≠ $750 million (off by 1,000x), and the maturity date in 2022 is falsely claimed rather than correctly noted as unspecified. The shift from 2026 to 2027 is entirely fabricated. (3) The reasoning is plausible—stable debt with maturity extension suggesting risk management—but it is based on incorrect data. The multi-hop synthesis fails because it draws conclusions from false evolution (a one-year extension) that did not occur. The ground truth shows no change in terms, only increased disclosure clarity. (4) Contextual relevance is high because the answer addresses all aspects of the question (interest rate, face amount, maturity, strategy) and attempts appropriate synthesis. However, correctness score is low due to major factual and quantitative errors undermining the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 396,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of CVS’s foreign‑currency debt securities moved only modestly—$2.55 bn in 2022, $2.51 bn in 2023 and essentially the same in 2024—but the unrealized‑loss balance fell sharply, dropping from about $244 million of loss in 2022 to roughly $122 million in both 2023 and 2024.  The reduction in losses reflects a recovery in foreign‑bond prices and less interest‑rate‑driven depreciation, signalling that the company’s exposure to international market risk has eased, although a residual unrealized loss remains and the portfolio is still sensitive to foreign‑interest‑rate and credit‑market fluctuations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitative Accuracy: The numbers are completely wrong. The ground truth states CVS's foreign securities fair value was $838M in 2022, $1,650M in 2023, and $51M in 2024. The LLM reports $2.55B in 2022, $2.51B in 2023, and similar in 2024—overstating the values and missing the sharp decline in 2024. Unrealized losses in the ground truth were $24M (2022), $122M (2023), and implied drop in 2024 due to portfolio reduction, but the LLM claims $244M loss in 2022 dropping to $122M in 2023/2024—again, incorrect values and trend. (2) Completeness: The LLM fails to capture the key trend—significant increase then sharp drop in foreign securities—which is central to the question. Instead, it reports a flat portfolio with declining losses, which contradicts the ground truth. (3) Entity Accuracy: The LLM incorrectly refers to 'foreign-currency debt securities' and implies interest-rate-driven losses, while the ground truth discusses foreign securities broadly with rising unrealized losses due to market instability, not specifically interest rates. (4) Reasoning: The multi-hop synthesis is flawed. The LLM concludes that risk has eased due to falling losses, but the ground truth suggests de-risking via portfolio reduction, a fundamentally different interpretation based on incorrect data. (5) Semantic Equivalence: The answer conveys an opposite narrative—stable portfolio with improving losses vs. volatile exposure followed by strategic withdrawal. Even allowing for wording flexibility, the factual divergence is too severe. The LLM appears to have hallucinated data or confused CVS with another company.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 465,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife moved from relying almost entirely on its own internally‑developed designations for non‑agency RMBS and CMBS—used when a NAIC rating was not yet available—to reporting the majority of these securities under NAIC‑assigned designations, keeping internal designations only for newly acquired or uniquely complex issues that have not yet received a NAIC rating.  This multi‑year shift demonstrates that MetLife’s credit‑quality assessment of structured‑product holdings has become increasingly anchored in the NAIC’s modeling methodology, with internal designations serving only as a transitional fallback rather than a primary assessment tool.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall trend correctly: MetLife reduced reliance on internally developed designations for non-agency RMBS and CMBS from 2022 to 2024, increasingly adopting NAIC modeling methodology as the primary assessment tool, with internal designations serving as a transitional mechanism. This reflects accurate qualitative understanding and sound multi-hop reasoning about the evolution of credit quality assessment practices. However, the LLM answer lacks all quantitative details present in the ground truth, which significantly impacts factual completeness. Specifically, it omits the $4.2 billion (14.5%) increase in Level 3 fixed maturity AFS securities in 2023 and the $1.6 billion (4.9%) increase in 2024—key metrics that substantiate the slowing growth of internally designated securities as NAIC designations became more widely applied. These figures are critical for demonstrating the pace and extent of the transition, and their absence constitutes a major gap in quantitative accuracy. While the LLM correctly identifies the directional shift and the rationale (NAIC designations replacing internal ones for most securities), it fails to support the claim with the specific financial data that anchors the original answer. Entity accuracy (MetLife, NAIC, RMBS, CMBS, Level 3 securities) and time frame (2022–2024) are correct, and the reasoning about the transitional role of internal designations aligns with the source. The answer is contextually relevant and semantically aligned in intent, but the missing quantitative evidence reduces its factual precision and weakens the support for the conclusion about the 'gradual shift'—a point the original answer proves with year-over-year changes in Level 3 holdings. Thus, while the core interpretation is valid, the absence of key numbers prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 507,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron kept its Congo exposure limited to modest offshore‑development spending—about $0.7 billion was allocated to natural‑gas and related projects in 2023 and a comparable amount was deployed in 2024—while its proved reserves in the country showed a small net increase.  However, by early 2025 the company disclosed that it had sold its 31.5 % non‑operated stake in the Haute Mer permit and its 15.75 % interest in the Lianzi block, marking a clear reduction in ownership and a strategic pull‑back from the Republic of Congo.  (Pages 41‑45 of the 2024 10‑K and 107‑111 of the 2023 10‑K).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it claims Chevron allocated approximately $0.7 billion in both 2023 and 2024 to natural gas projects in Africa, including the Republic of Congo. However, the ground truth states that the $0.7 billion was allocated in 2023 only, with no specific figure disclosed for 2024. Furthermore, the ground truth indicates Chevron fully exited its holdings in the Republic of Congo by 2024, making continued investment in 2024 factually incorrect. The LLM also incorrectly states that the divestiture was disclosed by 'early 2025,' while the original answer confirms the sale occurred in 2024. The percentages (31.5% and 15.75%) and asset names (Haute Mer, Lianzi) are correct. (2) Quantitative accuracy is compromised: the repeated $0.7 billion figure for both years is unsupported, and the timing of the divestiture is misaligned. The ground truth does not mention proved reserves, so the claim of a 'small net increase' is unfounded. (3) The multi-hop reasoning is partially sound—linking investment to divestiture shows an understanding of strategic shifts—but fails in temporal accuracy and synthesis, especially conflating 2024 investment with a 2024 exit. (4) Contextual relevance is high as the answer addresses capital allocation and ownership changes, but factual errors in key financials and timeline reduce correctness. The citation of 10-K pages adds apparent credibility but does not align with the ground truth, suggesting potential hallucination. Overall, the answer captures the directional trend (investment followed by exit) but distorts critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 446,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept Embedded‑Processing Products (EPP) as one of its four sustainable competitive advantages, but the strategic focus shifted from aggressive growth to cash‑flow preservation.  In 2022 EPP generated about $2.57 billion of revenue (≈19 % of total) with a 38.5 % operating margin, reinforcing the company’s manufacturing‑technology advantage and broad product portfolio; by 2023 revenue rose modestly to $3.37 billion but margin slipped to 29.9 % as capacity expansions raised costs, and in 2024 revenue fell to $2.53 billion with margin collapsing to 13.9 %, prompting a deliberate pivot to lean on the manufacturing‑control, portfolio breadth, market‑reach (especially industrial and automotive) and long‑life product diversity to sustain overall free‑cash‑flow growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and quantitative errors. (1) The original answer states that Texas Instruments consistently emphasized Embedded Processing Products as a strategic pillar from 2022 to 2024, with evolving but stable language around its role in customer reach, design projects, and long-term returns. The LLM answer fabricates specific financial data (e.g., $2.57B revenue in 2022, $3.37B in 2023, $2.53B in 2024) and operating margins (38.5%, 29.9%, 13.9%) that are not present in the ground truth and contradict the qualitative consistency emphasized in the original. There is no mention of revenue figures or margins in the original answer, so these numbers are unsupported. (2) The claim of a 'collapse' in margin to 13.9% in 2024 and a 'pivot' to cash-flow preservation is speculative and not supported by the source. The original answer indicates a consistent strategic emphasis, not a strategic shift due to financial deterioration. (3) The multi-hop reasoning is flawed: the LLM invents a narrative of declining performance and reactive strategy, whereas the ground truth shows a steady, reinforcing narrative across years. (4) While the LLM correctly identifies embedded processing as part of TI's competitive framework, it misrepresents the evolution as financially driven and reactive rather than consistently strategic. The contextual relevance is moderate because it addresses the right company and product line, but the fabricated metrics and erroneous conclusions severely undermine accuracy. Quantitative accuracy is extremely low due to made-up figures; qualitative accuracy is low due to incorrect reasoning and synthesis; correctness score is low because the core claim (strategic shift due to financial decline) is false.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 483,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due 2025 carried an effective interest rate of roughly 3.2 % in fiscal 2022, rose to about 6.6 % by fiscal 2024 (the rate reported in the 2024 filing), and was approximately 1.3 % in the prior year. This upward shift shows that the company’s borrowing cost has more than doubled over the three‑year period, reflecting higher market interest rates and a tighter financing environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies the $500 million 3.50% Senior Note due 2025 and the ~3.2% effective rate in fiscal 2022 (matching ground truth), it incorrectly states the fiscal 2023 rate as 'approximately 1.3%' when the ground truth is 6.38%. This is a major error. The fiscal 2024 rate is reported as 'about 6.6%', which is close to the correct 6.66%, so this part is acceptable. However, the progression described (3.2% → 1.3% → 6.6%) contradicts the actual trend (3.2% → 6.38% → 6.66%), making the narrative misleading. (2) The calculation of 'more than doubled' is directionally correct (3.2% to 6.66% is more than double), but the reasoning is based on incorrect intermediate data. The dollar amount ($500 million) and maturity (2025) are correct. (3) The multi-hop reasoning is partially sound—Cisco is the correct company, the note is correctly identified, and the three-year trend is addressed—but the synthesis fails due to the incorrect 2023 rate. The conclusion about rising borrowing costs is correct, but the path is misrepresented. (4) Contextual relevance is high as the answer addresses interest rate exposure and borrowing cost trends. However, the quantitative inaccuracy in the 2023 figure severely undermines the correctness score, placing it in the partially correct range despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 389,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings BNY Mellon repeatedly warned that U.S. banking capital rules—specifically the “well‑capitalized” and “well‑managed” standards, capital‑planning requirements, and Delaware corporate law—directly limit its ability to declare dividends, repurchase shares or otherwise return capital, making such shareholder payouts contingent on board discretion and ongoing regulatory compliance. The three‑year progression therefore reveals that, while the firm aims to be strategically flexible with capital returns, its flexibility is bounded by supervisory constraints that can curtail or condition any distribution of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns from 2022 to 2024. It correctly identifies the key regulatory constraints—'well-capitalized' and 'well-managed' standards, capital-planning requirements, and Delaware law—as consistent limitations on shareholder returns, which aligns with the ground truth. The answer accurately reflects that these constraints are recurring across the three years and emphasizes the conditional nature of capital returns based on regulatory compliance. While the original answer notes a progressive increase in emphasis on liquidity management and consequences of failing regulatory standards (especially in 2024), the LLM answer synthesizes this implicitly by referencing supervisory constraints but does not explicitly highlight the evolving emphasis on liquidity risk over time. This is a minor omission in nuance rather than a factual error. There are no issues with quantitative accuracy—no numerical data is present, but all referenced regulations, legal frameworks, and years are correct. The reasoning is sound and reflects multi-hop synthesis across the three years of filings. The answer is contextually fully relevant and conveys the strategic tension between regulatory constraints and capital return flexibility. The wording differs but maintains semantic equivalence on the main points, missing only the subtle progression in tone and focus on liquidity in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 417,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nRevenue from Repair and other services fell from **$1,169 million in 2022 to $1,132 million in 2023** (a drop of about $37 million), and then **remained flat at $1,132 million in 2024**. The flat 2024 figure reflects a balance between the completion of prior maintenance contracts and a steady level of ongoing post‑delivery service work, with no significant new repair business emerging to drive growth. This pattern indicates that the repair and other services line is **stable but not a primary growth engine**, suggesting General Dynamics is focusing its strategic resources on its higher‑margin shipbuilding and submarine programs rather than expanding the repair segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for 2022 ($1,169M), 2023 ($1,132M), and 2024 ($1,132M), matching the ground truth exactly. The $37 million decline from 2022 to 2023 is accurate (1,169 - 1,132 = 37), and the flat performance in 2024 is correctly noted. (2) All numeric values and calculations are correct, with appropriate formatting variations accepted (e.g., 'million' vs 'M'). (3) The reasoning for flat 2024 revenue—completion of prior contracts and lack of significant new repair business—aligns semantically with the ground truth's suggestion of limited growth due to resource reallocation or market saturation. The LLM infers strategic focus on higher-margin shipbuilding and submarines, which is consistent with the ground truth’s implication that other areas (like nuclear submarines) are growing while repair services are not prioritized. (4) The only minor gap is that the LLM does not explicitly mention possible operational constraints or market saturation as in the original, instead focusing on contract cycles and strategic focus. This omission slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and logically sound, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 362,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nUnitedHealth’s equity‑method stake in health‑care operating businesses expanded sharply—from roughly **$1.5 billion at the end of 2022** to **$3.8 billion by the end of 2024**—indicating a strategic push into core health‑service assets.  At the same time, its venture‑investment portfolio (reported within equity securities) showed rising fair‑value gains of **$211 million in 2022, $276 million in 2023 and $710 million in 2024**, underscoring an increasing emphasis on high‑growth health‑tech and digital‑health investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar values and time periods. According to the ground truth, UnitedHealth's equity method investments were $1.4 billion in 2023 (unchanged from 2022), then rose to $3.8 billion in 2024—however, the LLM incorrectly states they were $1.5 billion at the end of 2022 and implies a direct rise to $3.8 billion by 2024, missing the flat 2023 figure and misrepresenting the timeline. Additionally, the LLM introduces 'fair-value gains' of $211M, $276M, and $710M for 2022–2024, which are not mentioned or supported in the original answer; instead, the original refers to total equity securities (venture investments) growing from $3.7B (2022) to $4.9B (2023) and holding steady in 2024. These are absolute portfolio values, not annual gains. (2) The quantitative inaccuracies are severe: the LLM confuses portfolio totals with annual gains, misstates the equity method investment levels for 2022 and 2023, and fabricates data not present in the ground truth. While the $3.8 billion figure for 2024 equity method investments is correct, earlier values are wrong. The venture investment trend is completely misrepresented. (3) The reasoning is partially sound in identifying a strategic shift toward deeper investments in 2024, which aligns with the original conclusion. However, the multi-hop synthesis fails because it draws conclusions from incorrect financial data. The model appears to conflate fair value changes with total investment balances, indicating a misunderstanding of financial reporting concepts. (4) Despite incorrect numbers and mischaracterized trends, the answer is contextually relevant—addressing both venture and equity method investments and attempting to infer strategic emphasis. Hence, contextual relevance is high, but correctness and quantitative accuracy are low due to fundamental factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 516,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 annual reports the PMI Peer Group used for the cumulative shareholder‑return graph—including Colgate‑Palmolive Co.—remains exactly the same, with the composition unchanged each year. This multi‑year consistency shows that PMI’s strategic benchmarking framework is built around a stable, globally diversified set of consumer‑product peers of comparable size, allowing it to compare performance against a consistent reference group over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's peer group across 2022, 2023, and 2024, with no changes in composition—consistent with the original answer. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly infers that the unchanged peer group reflects a stable benchmarking framework focused on global consumer product companies of similar size. It appropriately identifies the strategic implication—consistent performance comparison over time—even without explicitly listing the four criteria (global presence, consumer focus, revenues, market cap) from the ground truth. (4) While the LLM omits the specific detail that tobacco peers are excluded, this does not undermine the core accuracy. The answer captures the essence of PMI’s strategic benchmarking approach. Minor deduction in qualitative accuracy for slightly less depth in explaining the rationale behind peer selection, but overall semantic equivalence is strong. Contextual relevance is perfect—directly addresses evolution (or lack thereof) and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 349,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s risk disclosures show that its exposure to abusive behavior grew in step with the rollout of credit products such as BNPL and merchant financing, which added new fraud vectors and deepened reliance on third‑party lenders, banks and funding arrangements. The company repeatedly warns that fraud‑detection tools are complex and may not fully curb emerging schemes, leading to higher loss rates and greater dependence on protection programs that often cannot fully recover losses—indicating that fraud‑mitigation effectiveness has not kept pace with the expanding risk landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core trend in PayPal's exposure to abusive behaviors from 2022 to 2024, particularly in relation to its expanding credit products and third-party risk dependencies. It correctly identifies the increased risk associated with BNPL and merchant financing, and notes the growing reliance on third parties (lenders, banks, funding arrangements), which aligns with the ground truth. The conclusion that fraud-mitigation effectiveness has not kept pace with the expanding risk landscape is consistent with the original answer's assertion that 'the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness.' However, the LLM answer omits the specific €40 billion multi-year agreement to sell BNPL loan receivables in Europe, a key quantitative and strategic detail from 2023 that demonstrates the scale of expansion and associated third-party risk. While the LLM correctly infers deeper third-party reliance and higher loss exposure, it does not mention the 2024 regulatory uncertainty around the validity of loan receivables post-sale, which adds another layer of fraud and abuse risk in receivables management. These omissions affect completeness and qualitative depth but do not undermine the overall correctness of the central claim. All entities (PayPal, BNPL, third-party risk) and timeframes (2022–2024) are accurate. No numerical inaccuracies are present—the LLM avoids making false quantitative claims, though it omits the €40B figure. The reasoning is sound and synthesizes multi-hop elements (credit expansion → new fraud vectors → mitigation challenges), but lacks full integration of the regulatory and structural risks highlighted in the ground truth. Wording differs but semantic meaning is equivalent on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 492,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nSouthern Company’s natural‑gas hedging program evolved from a sizable option position in 2022 (≈310 mmBtu of swaps + options with a $0.74 /mmBtu discount to market) to a peak option volume in 2023 (≈339 mmBtu of options, total hedge volume ≈448 mmBtu and a widened $0.76 /mmBtu discount), and then in 2024 it trimmed options to 176 mmBtu, shifted back toward swaps (≈255 mmBtu) and saw the discount narrow to only $0.15 /mmBtu. This three‑year trend shows the company has progressively reduced its reliance on low‑cost, high‑discount options as market conditions changed, moving to a more modest swap‑based hedge and increasingly passing fuel‑cost risk to counterparties to manage natural‑gas price volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and misrepresents the data from the ground truth. While the 2023 (339 million mmBtu) and 2024 (176 million mmBtu) natural gas options volumes are correct, the 2022 value is wrong: the LLM states '≈310 mmBtu of swaps + options', but the ground truth specifies 253 million mmBtu in options alone for 2022. The LLM conflates options with total hedging volume and introduces a fabricated '≈310 mmBtu' figure not supported by the original answer. Additionally, the LLM introduces new data points not present in the ground truth—such as a $0.74/mmBtu discount in 2022, $0.76 in 2023, and $0.15 in 2024, as well as swap volumes of ≈255 mmBtu in 2024—which are absent from the original and cannot be verified. These are significant quantitative fabrications. (2) Calculations: The LLM implies a trend in 'discounts' and shifts in hedge mix, but these are unsupported by the provided ground truth, which makes no mention of pricing, discounts, or swap volumes. Thus, any analysis based on these figures is invalid. The core trend—increasing options from 2022 to 2023 then decreasing in 2024—is correctly identified, but the supporting data is partially incorrect or invented. (3) Multi-hop reasoning: The LLM correctly identifies the directional trend in options usage (up then down) and infers a strategic shift in risk management, which aligns with the original answer’s interpretation. It also correctly notes a possible shift toward swaps in 2024, though this is speculative in both answers. However, the LLM overreaches by quantifying swap volumes and price discounts not present in the ground truth, undermining the reasoning's factual basis. (4) The correctness score is 6 due to partial accuracy in key numbers (2023 and 2024 options volumes) and correct high-level interpretation of strategic evolution, but penalized for introducing false quantitative details. Quantitative accuracy is 5 because half the numbers are wrong or unverified. Qualitative accuracy is 7 due to sound logic and entity/year accuracy (Southern Company, 2022–2024, natural gas options). Contextual relevance is 9—excellent focus on the question and risk management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 596,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s aggregate expense for the U.S. defined‑contribution plans increased modestly—$70 million in 2022, $75 million in 2023 and $76 million in 2024.  This upward trend shows that Texas Instruments is deliberately boosting its employer‑matching contributions within the defined‑contribution framework, while the older, unfunded non‑qualified defined‑benefit pension plan remains closed to new participants and is being down‑played as the primary retirement vehicle.  Consequently, the firm’s long‑term employee‑benefit strategy is shifting toward defined‑contribution plans as the principal source of retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect—each dollar amount and year is correct, and the trend of increasing expenses is accurately described. (3) The multi-hop reasoning is sound: the LLM correctly infers that the rising contributions to defined contribution plans reflect a strategic shift, especially in light of the non-qualified defined benefit plan being closed to new participants. It appropriately links the expense trend to a long-term benefit strategy favoring defined contribution plans. While the original answer emphasizes the support for employees who opted out of the defined benefit plan and references the 1997 closure, the LLM captures the strategic shift accurately, though with slightly less historical context. (4) The answer is fully relevant, directly addressing both the evolution of expenses and the implication for long-term strategy. The conclusion about shifting toward defined-contribution plans as the principal retirement vehicle aligns semantically with the ground truth. Minor deduction in qualitative accuracy due to omission of the 1997 closure context, but core reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 386,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nGeneral Motors raised its long‑term return assumption for U.S. pension plans from roughly **5.4 % in 2022** (the weighted‑average expected return used for net expense) to **6.3 % in 2023**, and after the 2024 investment‑policy study increased the strategic long‑term ROA to **6.5 %** (the expense‑based expected return was 6.27 %). This upward shift shows GM now expects higher long‑run asset performance and is deliberately moving to a more return‑focused, slightly higher‑risk portfolio—adding greater equity and alternative‑return exposures—to meet funding objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022–2023 progression. The original answer (ground truth) states that the rate was 5.4% in 2022 and remained unchanged at 6.3% in 2023, implying the 6.3% was already in effect in 2022 or set prior to 2023. However, the LLM claims GM 'raised' the assumption from 5.4% in 2022 to 6.3% in 2023, which contradicts the ground truth that the rate was already at 6.3% in 2023 and did not increase from 5.4% that year. This misrepresents the timeline and magnitude of change. Additionally, the LLM introduces a new figure—6.27% as the 'expense-based expected return' in 2024—not present in the original answer, which only cites 6.5% as the 2024 rate. While this detail may be factual, it introduces nuance not supported by the ground truth and could confuse the trend. (2) Quantitatively, the 5.4% (2022), 6.3% (2023), and 6.5% (2024) values are all mentioned, but the implied year-over-year increase from 5.4% to 6.3% is incorrect per the original answer, which shows 5.4% in 2022 and 6.3% in 2023 without specifying it was a direct increase. The calculation of trend direction (upward) is correct, but the magnitude and timing are misrepresented. (3) The multi-hop reasoning is generally sound—connecting changes in return assumptions to strategic asset allocation and risk tolerance—but the flawed timeline undermines the logic. The conclusion about increased equity and alternative exposure is plausible but not confirmed in the original answer, which only states 'more confident' asset mix and 'greater tolerance for market exposure' without specifying asset classes. (4) Despite the quantitative inaccuracy in the year-to-year change, the LLM captures the overall upward trend and its implication correctly, and fully addresses both parts of the question (evolution of assumptions and what it suggests). The contextual relevance is perfect, and the qualitative reasoning is strong, just based on a slightly incorrect numerical narrative. Hence, a 7 on correctness: core facts are present, but key temporal and numerical relationships are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 567,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the swaps that hedge Cisco’s deferred‑compensation liability shifted from a **$92 million loss** (recorded as an operating expense in FY 2022) to **gains of $157 million in FY 2023 and $91 million in FY 2024**.  This swing shows that the fair‑value of the total‑return swaps moved from a negative to a positive position as market conditions changed, allowing Cisco to offset a portion of its compensation liability and even generate a net gain.  The progression demonstrates that Cisco’s risk‑management program actively uses market‑linked derivatives to neutralize the earnings volatility of deferred‑compensation obligations, aligning compensation expense with the underlying liability’s performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the fiscal 2023 gain amount. The ground truth states a $58 million gain in FY 2023, but the LLM reports a $157 million gain, which is factually incorrect and significantly overstates the actual figure. The FY 2022 loss of $92 million and FY 2024 gain of $91 million are correct. (2) The calculation or reporting of the FY 2023 number appears to be a potential conflation with another figure or a misstatement, as $157 million does not match any known value in the ground truth. This quantitative inaccuracy severely impacts the correctness score. (3) The reasoning and synthesis are otherwise sound: the LLM correctly identifies the shift from loss to gain, ties the swaps to deferred compensation hedging, and infers that this reflects active risk management and alignment of compensation expense with liability performance—consistent with the original answer’s interpretation. The multi-hop logic (tracking changes over time and inferring strategic implications) is well-executed despite the numerical error. (4) Contextual relevance is high, as the answer addresses all parts of the question—evolution over time, gains/losses, and implications for risk/compensation strategy. However, due to the major error in a key financial figure, the quantitative accuracy is low, pulling the overall correctness score down to partially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 387,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nPayPal continues to bear full margin risk on every payment it authorizes—recognizing transaction revenue on a gross basis and recording the fees paid to third‑party processors and other financial institutions as transaction expense—so its exposure to margin pressure is driven primarily by the volume and mix of TPV (including cross‑border and currency‑conversion fees) and by its ability to set and adjust fees at will.  The company’s tiered, volume‑based pricing does not create a material future right, and it consistently reduces revenue for incentives or refunds, but the way it accounts for those items (recording them as reductions of revenue or as transaction expense) remained essentially unchanged from 2022 through 2024, with only incremental refinements in disclosure and the introduction of new guidance on segment and crypto‑asset reporting that did not alter the underlying margin‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PayPal bears full margin risk, recognizes revenue gross, and records third-party processor fees as transaction expense across 2022–2024. It correctly notes PayPal's control over pricing, the lack of future material rights in tiered pricing, and the consistency in accounting treatment despite new segment and crypto disclosures in 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound and reflects multi-hop synthesis across years: the LLM correctly infers that despite disclosure refinements (e.g., segment reporting), the underlying margin-risk model remains unchanged. The only minor shortcoming is that the original answer explicitly calls out each year’s filing content (2022: pricing discretion; 2023: no material future right; 2024: principal role reaffirmed), while the LLM summarizes this more generally. This does not affect factual correctness but slightly reduces granularity in year-by-year evolution. (4) Contextual relevance is perfect—the response directly addresses all aspects of the question: margin risk evolution, pricing control, third-party processor use, and transaction expense recognition. Wording differs but semantic equivalence is strong. No irrelevant or extraneous information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 404,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s Angola LNG supplied about **49 billion cubic feet per day in 2022**, held steady at **≈48 billion cubic feet per day in 2023**, and remained at **≈48 billion cubic feet per day in 2024**.  The flat‑to‑slightly‑declining output shows that Angola LNG is a mature, stable source that contributes a modest, predictable volume to Chevron’s LNG portfolio, allowing the company to focus its strategic growth on other, higher‑potential LNG projects rather than expanding production from Angola.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and trend. The original answer states Chevron's natural gas *consumed in operations* for Angola LNG was 592 million cubic feet per day (MMcf/d) in 2022, rising to 596 MMcf/d in 2023, and 609 MMcf/d in 2024 — showing a consistent upward trend. In contrast, the LLM claims volumes were around 48–49 *billion* cubic feet per day, which is off by a factor of 100 (1 billion = 1,000 million). This represents a catastrophic error in scale. (2) The numbers are not just inaccurate — they are orders of magnitude wrong: 48 billion cf/day would equate to 48,000 million cf/day, over 80 times larger than the correct figure. Additionally, the LLM reports a flat-to-declining trend, directly contradicting the ground truth's clear upward trajectory. (3) The multi-hop reasoning fails completely. The LLM draws the opposite strategic conclusion: that Angola LNG is a stable but non-growing asset, whereas the original answer correctly infers that increasing gas consumption indicates growing operational emphasis on LNG in Angola, supporting Chevron’s strategic positioning in global LNG markets. The LLM’s reasoning is based on fabricated data and thus invalid. (4) The contextual relevance is moderate because the answer addresses the right topic (Chevron’s Angola LNG production and strategic implications), but the severe factual and quantitative errors render the response misleading. Correctness and quantitative accuracy are near-zero due to the magnitude of the numerical error and the reversed trend. Qualitative accuracy is low because the reasoning and entity interpretation are flawed despite addressing the general subject.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 462,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nSouthern Power’s scheduled‑payment disclosures evolved from a single, aggregate 2022 table that listed roughly $87 million (2022), $88 million (2023) and $90 million (2024) of fixed payments with a $240 million tail, to 2023‑2024 tables that break those amounts out year‑by‑year (e.g., $15 million‑$52 million annually) and add a large “thereafter” column, while also disclosing net‑investment, discount‑rate and weighted‑average‑term metrics.  This progression—from a coarse, total‑cash‑flow figure to a detailed, multi‑year schedule with ancillary financial metrics—signals that the outdoor‑lighting/PPA lease cash flows have become increasingly material and structurally central to Southern Power’s earnings and balance‑sheet exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The dollar amounts cited ($87M, $88M, $90M, $240M tail, $15M–$52M annually) are not present in the original answer and cannot be verified from the ground truth. The original makes no mention of specific payment figures or numerical trends over the years, nor does it reference net investment, discount rates, or weighted-average terms—these are fabrications or hallucinations. (2) Completeness: While the LLM attempts to address the evolution across years, it misrepresents the nature of the disclosures. In 2022, the original states only that the cash flows were 'immaterial'—there is no evidence of an aggregate table with specific numbers. The 2023 shift is partially correct: the inclusion in maturity analyses with tolling and PPAs is aligned with the original. The 2024 integration into lease income reporting is also directionally correct, though the LLM adds unsupported detail. (3) Entity Accuracy: The companies (Southern Power, Mississippi Power) and contract types (outdoor lighting, PPAs) are correctly identified, and the years are accurate. (4) Reasoning: The LLM draws a reasonable conclusion about increasing materiality and structural importance, which matches the original’s interpretation. However, the reasoning is based on invented quantitative data rather than the actual qualitative progression described in the ground truth. (5) Semantic Equivalence: The overall trajectory—increasing disclosure detail and integration—aligns with the original, but the reliance on false numerical data severely compromises factual correctness. The answer gives the appearance of precision but lacks grounding in the actual disclosures. Thus, while the directional insight is valid, the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 505,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nTexas Instruments kept Melaka, Malaysia on its property list for all three fiscal years, and the site was marked with an “X” under the **Analog** column in the 2022, 2023 and 2024 property tables—indicating that the Melaka facility continued to be used for Analog‑product manufacturing throughout the period. The company did **not** list Melaka under the Embedded‑Processing column in any of those years, so there was no documented expansion of its Embedded‑Processing operations there; the only evolution noted is the recurring presence of the site in the Analog segment, with the same lease/ownership status reflected across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was used exclusively for the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the use of 'X' in property tables aligns with the source documentation style. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, concluding no expansion into Embedded Processing occurred. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TXN's operational footprint in Melaka. Wording differs slightly but conveys identical meaning—consistent, factually accurate, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 273,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nFrom 2022 through 2024 the $700 million 1.600% senior notes issued on March 29 2021 were systematically reduced – the company recorded negative adjustments of roughly **$3.7 million in 2022, $2.6 million in 2023 and $1.5 million in 2024**, indicating scheduled principal repayments that lowered the outstanding balance each year.  The **interest‑payment schedule (April 15 and October 15) and the par‑call date (March 15 2026) remained unchanged** throughout this period.  \n\nThis multi‑year progression reflects AMT’s disciplined debt‑management strategy: it uses operating cash flow and credit‑facility borrowings to retire senior notes on a predictable schedule, thereby reducing leverage, preserving liquidity and extending the overall maturity profile while keeping financing costs stable.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. While the ground truth states that the aggregate principal amount remained constant at $700.0 million from 2022 to 2024, the LLM incorrectly claims the notes were 'systematically reduced' with negative adjustments of $3.7M in 2022, $2.6M in 2023, and $1.5M in 2024. However, the ground truth only reports adjustment values of (2.6) in 2023 and (1.5) in 2024 — there is no mention of a 2022 adjustment or a $3.7M figure, and these values are described as 'adjustments to principal amount,' not principal repayments. The LLM misinterprets these adjustments as scheduled principal reductions, which is unsupported by the data. (2) The interest payment schedule (April 15 and October 15) and par call date (March 15, 2026) are correctly reported and match the ground truth exactly. (3) The multi-hop reasoning is partially sound — the LLM correctly identifies consistency in interest and call terms, but draws an incorrect conclusion about a 'predictable schedule' of principal repayments, which is not evidenced in the original data. The ground truth emphasizes stability in the debt instrument, while the LLM infers active amortization and leverage reduction, which overreaches the available evidence. (4) Despite the incorrect narrative about principal reduction, the answer remains contextually relevant and attempts to synthesize across years and metrics. The qualitative reasoning is logical but based on flawed data interpretation. The contextual relevance is high because it addresses all components of the question — principal, interest, call date, and strategy — even if some conclusions are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 465,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco’s 5.90 % senior note—originally issued in 2019 for $2 bn—remained on the books through FY 2022, FY 2023 and FY 2024, but its weight in the overall debt stack declined sharply.  In FY 2022 it accounted for roughly $2 bn of the $9 bn face‑value long‑term debt portfolio (about 22 % of total) and carried an effective interest cost of 6.11 %; by FY 2023 the company had expanded long‑term debt to $11.5 bn face, reducing the note’s share to ≈17 % while the weighted‑average effective rate of the entire debt slipped into the low‑mid‑3 % range; and in FY 2024 the note was just one tranche among many, representing only ~10 % of the $20.3 bn face‑value long‑term debt that now carries a blended effective rate near 4–5 % after discount and hedge adjustments.  This progression shows Cisco is deliberately diversifying and extending its long‑term financing—issuing a broader set of senior notes at varied maturities and coupons and relying more on commercial‑paper liquidity—so that the legacy 5.90 % instrument is no longer a core driver of funding but a smaller, legacy component of a more flexible, lower‑cost capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The original answer states that Cisco's 5.90% Note remained at $2,000 million (i.e., $2 billion) across all three fiscal years, which the LLM correctly identifies. However, the LLM fabricates or misrepresents key figures: total long-term debt in 2022 was $8,416 million (not $9 billion), in 2024 it was $19,621 million (not $20.3 billion), and short-term debt decreased slightly from $499M to $488M—information entirely omitted or distorted in the LLM response. The LLM claims the weighted-average effective interest rate fell to the 'low-mid-3%' range by 2023 and a 'blended rate near 4–5%' by 2024, but the ground truth states the effective interest rate on the 5.90% Note itself remained steady at 6.11% throughout, with no indication of a company-wide blended rate shift. (2) Completeness: While the LLM addresses the evolution of the note’s role and financing strategy, it fails to accurately report the actual composition changes in total debt—specifically the increase in long-term debt and slight decrease in short-term debt—which are central to the original answer. (3) Entity Accuracy: The company (Cisco), note (5.90%), and fiscal years (2022–2024) are correctly identified. (4) Reasoning: The LLM draws an incorrect conclusion—that the 5.90% Note became a smaller component due to diversification—while the truth is that the note amount stayed constant but total long-term debt nearly doubled, making it relatively smaller in composition. However, the original answer emphasizes that the note itself remained stable in value and rate, and that Cisco is relying *more* on long-term fixed-rate instruments, not moving away from them. The LLM incorrectly interprets this as a de-emphasis on the note, when in fact it's part of a broader increase in long-term debt. (5) Semantic Equivalence: The overall message contradicts the ground truth: the original indicates a strategic *reliance* on long-term fixed-rate debt including this note, while the LLM suggests the note is being phased into irrelevance. This is a fundamental error in interpretation. Despite addressing the right topic and attempting multi-hop synthesis, the incorrect numbers, mischaracterized trends, and flawed conclusion severely undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 623,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics grew its Canadian‑LAV output: the company was building **399 new LAVs** for the Canadian Army in 2022, added **66 LRSS‑equipped vehicles** in 2023, and in 2024 ramped production to **449 new LAVs** (again with the 66 LRSS units) while also upgrading the existing fleet. This stepped‑up volume demonstrates that GD is **placing a strategic emphasis on LAV manufacturing**, expanding capacity and investment in its Combat Systems segment to capture growing allied demand.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, production was 360 units in 2022, 399 in 2023, and 449 in 2024. However, the LLM claims 399 units were built in 2022, which is incorrect. It also states that 66 LRSS-equipped vehicles were added in 2023, but the ground truth indicates the LRSS program was introduced in 2024, not 2023. The LLM incorrectly implies that the 66 LRSS units are part of the 449 total in 2024, while the ground truth presents the 449 as the total including the 66 LRSS units. (2) Calculations and timelines are misaligned: the progression from 360 → 399 → 449 reflects year-over-year growth, but the LLM reverses the 2022 and 2023 figures and misattributes the LRSS program timing. The claim of 'ramping to 449 new LAVs' in 2024 while including the same 66 LRSS units as in 2023 contradicts the ground truth where LRSS is a 2024 addition. (3) The multi-hop reasoning is partially sound—the LLM correctly infers strategic emphasis on LAV manufacturing from increasing production and mentions relevant programs like LRSS. However, the incorrect temporal assignment of the LRSS program undermines the validity of the synthesis. (4) Despite factual errors, the answer remains contextually relevant and captures the overall trend of increasing focus on LAVs. The strategic interpretation is reasonable, but the incorrect numbers and timeline placement reduce factual reliability. Quantitative accuracy is low due to wrong values and misaligned years; qualitative reasoning is moderate due to correct conceptual understanding but flawed data integration; contextual relevance is high as it directly addresses the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 466,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment volatility deepened as CMS repeatedly lowered benchmarks and tightened the risk‑adjustment models that determine capitation, squeezing the company’s funding from the program.  In response, UnitedHealth progressively strengthened its risk‑adjustment data‑validation and coding‑accuracy initiatives and pursued a suite of cost‑containment and revenue‑management actions—including selective benefit and premium adjustments, exiting low‑margin counties, intensifying overall medical and operating expense management, and investing in quality‑rating improvements to protect bonus eligibility—thereby mitigating the ongoing funding pressures across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024, as well as the company's strategic responses. (1) All factual elements are correct: CMS repeatedly changed risk adjustment methodologies and benchmarks, creating funding pressures. UnitedHealth responded with benefit and premium adjustments, market exits, cost management, and bid recalibrations—strategies consistently mentioned across the three years. The LLM correctly identifies ongoing pressures and adaptive strategies without introducing false claims. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes the persistent nature of CMS policy changes and UnitedHealth’s evolving operational response across multiple years, correctly inferring sustained strategic adaptation. (4) The only minor gap is that the LLM emphasizes 'data-validation and coding-accuracy initiatives' and 'quality-rating improvements' more than the original answer explicitly states—while these are reasonable inferences given the context of risk adjustment and bonus eligibility, the original answer focuses more on cost control and selective participation without detailing quality-rating investments. However, this addition does not contradict the ground truth and aligns with plausible strategic responses. Overall, the answer is semantically equivalent, contextually precise, and factually sound, warranting a high score with only slight deduction for slight over-elaboration on unconfirmed initiatives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 473,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nThe company’s holding of the 2.850 % fixed‑rate note tranche was unchanged throughout the period – the tables of “Notes” show a $1.5 billion balance as of December 31 2022, 2023 and 2024, and the future‑payments schedule lists the next principal repayment on that series for 2029.  This steady exposure signals that PayPal’s long‑term debt strategy is to maintain a stable, laddered pool of fixed‑rate financing (with maturities stretching to 2029 and beyond) rather than to grow or shrink any single tranche, using new issuances to supplement the ladder while preserving a low‑cost, long‑dated funding base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the fixed-rate 2.850% notes had a $1.5 billion carrying value in 2022, 2023, and 2024, and the next principal repayment is in 2029—this matches the original answer exactly. (2) Quantitative accuracy is perfect: dollar amounts ($1.5 billion), interest rate (2.850%), and years (2022–2024, 2029 maturity) are all correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from consistent carrying values and maturity dates that PYPL maintained this tranche as part of a stable long-term debt strategy. It goes slightly beyond the original by characterizing the strategy as a 'laddered pool' and mentioning 'low-cost, long-dated funding,' which are reasonable interpretations supported by context but not explicitly stated in the ground truth. (4) The answer fully addresses both parts of the question—evolution of exposure (unchanged) and strategic implication (stable, intentional structure). The only reason for not scoring a 10 is that the original emphasizes the contrast with other notes being refinanced or maturing, which the LLM mentions only implicitly. Overall, the answer is factually complete, semantically equivalent, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 365,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron deepened its stake in Angola LNG Limited while simultaneously expanding the upstream gas base that feeds the plant – the 36.4 % shareholding remained constant, but the company moved from a $1.96 bn investment in 2022 to $1.76 bn in 2023 and continued to fund key tie‑in projects (the Block 0 Sanha Lean Gas Connection, the New Gas Consortium offshore concession and new deep‑water exploration blocks 49/50). By 2024 the SLGC platform was completed, the NGC project was on track for first production in 2026, and Chevron had secured additional frontier acreage, underscoring a long‑term strategy to monetize Angola’s associated gas through its equity stake in Angola LNG and to grow the country into a sustained LNG export hub.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. While it correctly states Chevron's consistent 36.4% ownership stake in Angola LNG Limited, it introduces incorrect financial figures: claiming a $1.96 billion investment in 2022 and $1.76 billion in 2023, which are not present in the ground truth and cannot be verified from the provided data. These numbers are likely fabricated or misattributed. Additionally, the mention of the 'SLGC platform' is not supported by the original answer, nor is the specific timeline of first production in 2026 for the New Gas Consortium (NGC) project. The original answer does not provide investment dollar amounts or a 2026 production date, making these additions speculative. (2) The qualitative elements are partially correct: the LLM correctly identifies the strategic expansion into Blocks 49 and 50 and references the New Gas Consortium and upstream tie-ins like the Q&M fields (though it refers to them indirectly via 'NGC project'). It also captures the shift toward integrated gas monetization and positioning Angola as an LNG export hub, aligning with the ground truth’s theme. (3) The multi-hop reasoning is sound in structure—linking upstream developments to the LNG facility and inferring long-term strategy—but is undermined by the inclusion of unsupported numerical and project-specific details (e.g., SLGC, exact funding levels, 2026 FID). The core evolution from standalone LNG to integrated hub is correctly inferred and well-articulated. (4) Contextual relevance is high, as the answer directly addresses Chevron’s strategic progression and long-term monetization goals. However, the quantitative inaccuracies significantly reduce overall correctness, warranting a mid-range score. The answer conveys a plausible narrative but introduces unverified data, which compromises factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 515,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company’s trust‑held domestic‑equity exposure grew from roughly **$829 million (2022) to $1.10 billion (2023) and then held steady at about $1.10 billion in 2024**, while its private‑equity allocation rose from **≈$161 million to $181 million and remained flat thereafter**.  This early‑year increase shows a deliberate shift toward higher‑return equity assets, and the subsequent stabilization indicates that the company has settled on a target mix of domestic equity and modest private‑equity exposure as part of a disciplined, long‑term capital‑allocation strategy focused on diversified growth and risk‑adjusted returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, in 2022, Southern Company's domestic equity investment was $1,016 million, not $829 million as stated in the LLM response. The LLM incorrectly assigns the 2023 domestic equity value ($829 million) to 2022. Similarly, the LLM claims domestic equity grew to $1.10 billion in 2023, but the correct value for 2023 is $829 million; the rebound to $1,099 million occurred in 2024. The private equity figures are also misaligned: the LLM states private equity started at ≈$161 million, but the correct 2022 figure is $150 million, and it rose to $161 million in 2023 and $181 million in 2024. (2) These numerical errors severely undermine the quantitative accuracy, as multiple dollar amounts and year assignments are incorrect. Calculations or trends based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed because the LLM misrepresents the temporal evolution of investments. Instead of showing a dip in domestic equity followed by a rebound and a steady increase in private equity, the LLM incorrectly portrays an early increase and stabilization, leading to an erroneous conclusion about a 'deliberate shift' and 'target mix' being established early. The actual pattern—volatility in domestic equity and consistent growth in private equity—suggests a more nuanced strategy that the LLM fails to capture. (4) While the LLM attempts to address the long-term capital allocation strategy and uses relevant terminology (e.g., diversification, risk-adjusted returns), the conclusions are based on incorrect data, reducing qualitative and overall correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual foundations are unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 499,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Eliminations/Reclassifications” line subtracted $107 million, $151 million and $296 million respectively from GM’s consolidated net sales (i.e., it grew in absolute magnitude each year).  This expanding subtraction shows that GM is increasingly adjusting its internal revenue figures—primarily to eliminate inter‑segment sales and re‑classify revenues from Cruise and GM Financial—indicating a shift toward more granular, cross‑business reporting and tighter consolidation of the company’s multiple segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105 million in 2022, $107 million in 2023, and $296 million in 2024. However, the LLM incorrectly states $107 million for 2022 and $151 million for 2023, which are both factually wrong. Only the 2024 figure ($296 million) is correct. (2) The calculation of trend direction (increasing) is accurate, but the magnitude of change is misrepresented due to incorrect inputs. The actual increase from 2022 to 2023 was only $2 million, not $44 million as implied by the LLM's numbers. (3) The qualitative reasoning about increasing internal adjustments reflecting more granular reporting and tighter consolidation is reasonable and aligns with the trend interpretation in the ground truth. The mention of Cruise and GM Financial as sources of reclassification adds plausible context, though not explicitly confirmed in the ground truth. (4) Despite strong contextual relevance and logical interpretation of the trend, the correctness score is reduced to 6 due to major quantitative errors in two of the three years. The answer is partially correct but fails on core factual accuracy for 2022 and 2023 figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 350,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix continuously disclosed its executive bonus framework as the “Performance Bonus Plan,” first filed as Exhibit 10.6† in the 2022 10‑K and then amended and restated in the 2023 10‑K (Exhibit 10.5†) and again referenced in the 2024 filing (Exhibit 10.5†).  The plan is formally documented in each annual report and is presented as part of an integrated compensation structure that also includes the Amended and Restated Executive Severance and Retention Incentive Plan and the company’s stock‑based incentive plans, ensuring that bonus, severance and equity components are coordinated under a single, regularly updated set of exhibit filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies in documentation status and timeline precision. (1) Correct elements: The LLM correctly identifies the Performance Bonus Plan's exhibit numbering (Exhibit 10.6† in 2022, updated to 10.5† in 2023 and retained in 2024), the amendment and restatement in 2023, and the integration with other compensation frameworks like stock-based plans and the Executive Severance and Retention Incentive Plan. The overall narrative of continuity and integration is accurate. (2) Quantitative accuracy: The exhibit numbers and years are correct. However, the LLM incorrectly states that the plan was 'filed as Exhibit 10.6† in the 2022 10-K' — the ground truth clarifies it was a historical exhibit originally filed on April 28, 2014, not newly filed in 2022. Similarly, the 2023 amendment was filed on December 9, 2022 (not in the 2023 10-K as implied). These date-related inaccuracies slightly affect precision. (3) Reasoning: The multi-hop synthesis across years and exhibits is sound — the model correctly infers evolution from static to amended status and ongoing integration. However, it misses the nuance that 2022 had no update (only historical carryover), which weakens the qualitative accuracy slightly. (4) Contextual relevance is perfect — the response directly addresses documentation status and integration with compensation frameworks across all three years as asked. Minor deductions in correctness and qualitative accuracy due to timeline imprecision, but core facts and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 434,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, BNY Mellon continues to incorporate its “Business Relationships and Related Party Transactions Policy’’ by reference to the Proxy Statement, and the description of that policy is materially unchanged each year. The company likewise reiterates its annual director‑independence assessment and the same three‑committee structure (Audit, Human‑Resources & Compensation, and Nominating & Social‑Responsibility), showing a consistent corporate‑governance framework with no substantive shifts in related‑party or independence disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. It correctly identifies that BK (BNY Mellon) consistently disclosed its 'Business Relationships and Related Party Transactions Policy' across 2022–2024, referencing the Proxy Statement each year with no material changes. The answer accurately notes the consistent director-independence assessments and the three standing committees: Audit, Human Resources & Compensation, and Nominating & Social Responsibility (referred to slightly differently but semantically equivalent). All entities (company, policy, committees, years) are correct. The reasoning correctly infers that the lack of change indicates a stable corporate governance framework, aligning with the ground truth’s conclusion about consistency in disclosures. The only minor shortcoming is that the LLM does not explicitly mention Item 13 or 'Corporate Governance and Board Information' as the location of the disclosures, which is a small omission in contextual detail but does not affect the overall correctness. Quantitatively, there are no numbers to verify, but the temporal scope (2022–2024) is correct. The answer synthesizes multi-hop information (policy, independence, committee structure, year-over-year comparison) soundly. Wording differs slightly (e.g., 'Nominating & Social-Responsibility' vs. 'Corporate Governance, Nominating and Social Responsibility Committee') but remains semantically equivalent. Thus, the answer is highly accurate with only a minor lack of specificity in disclosure location.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 429,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nUnitedHealth Group’s held‑to‑maturity debt‑security portfolio declined from **$679 million (fair value) / $696 million (carrying cost) in 2022 to $596 million / $603 million in 2023 and further to $508 million / $512 million in 2024**.  The drop mirrors the broader rise in market interest rates, which depressed the market prices of its fixed‑income holdings while the company continues to record the securities at amortized cost and does not recognize the unrealized losses.  This three‑year trend signals a deliberately conservative investment stance—maintaining a modest, high‑quality, short‑to‑mid‑term HTM portfolio that generates stable interest income, while relying on the expectation that the securities will be held to maturity and that the temporary price declines are not indicative of credit‑related impairment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, the fair value was $643 million and carrying value was $641 million. The LLM incorrectly reports these as $679 million and $696 million, respectively—differences of $36 million and $55 million, which are substantial. The 2023 and 2024 values ($596M fair / $603M carrying in 2023; $508M fair / $512M carrying in 2024) match the ground truth and are correctly reported. (2) Calculations: While the LLM correctly shows a downward trend, the starting point is wrong, leading to an inaccurate portrayal of the magnitude of decline. The actual fair value decline from 2022 to 2024 is $135 million (from $643M to $508M), but the LLM implies a $171 million drop (from $679M), overstating the change. (3) Multi-hop reasoning: The LLM correctly identifies the trend (declining values) and attempts to explain it with reference to rising interest rates and conservative investment strategy, which aligns with the intent of the original answer. It also correctly notes that HTM securities are carried at amortized cost and that unrealized losses are not recognized—this shows sound qualitative understanding. However, it misses the key insight from the ground truth about the shift away from Level 3 unobservable inputs by 2023–2024, which is a critical component of the valuation assumptions trend. (4) Justification for scores: The correctness score is 6 due to major errors in 2022 figures but accurate later-year data and reasonable interpretation. Quantitative accuracy is low (4) because of the large discrepancies in the initial year. Qualitative accuracy is 7 because the reasoning about interest rates and conservative strategy is plausible and contextually appropriate, though it omits the Level 3 input shift. Contextual relevance is high (9) as the answer addresses the evolution over time and attempts to interpret strategy and valuation assumptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 531,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s BNPL loan receivables expanded and required larger credit‑loss allowances, signalling growing exposure to bad transactions; in June 2023 the company announced a multi‑year deal to sell up to €40 billion of U.K. and European BNPL receivables and to forward‑flow future originations, thereby shifting much of that risk to third‑party buyers. By 2024 a substantial portion of the portfolio had been sold, reducing the on‑balance‑sheet BNPL balance and the associated allowance, demonstrating a clear risk‑mitigation evolution from internal credit‑risk management to external disposal of BNPL assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in nuance that prevent a perfect score. (1) Quantitatively, all key facts are accurate: the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables is correctly stated, including the geographic scope and amount. The timeline (2022–2024) is properly framed. (2) The LLM correctly identifies the strategic shift in risk mitigation—moving from internal credit risk management to external disposal via asset sales and forward-flow arrangements—capturing the core of PayPal’s evolving strategy. (3) However, the LLM omits a key caveat present in the original answer: in 2024, PayPal noted that the sale was subject to conditions and potential delays if those were not met. This conditional aspect of the transaction, which introduces uncertainty about the timing and realization of risk reduction, is missing, slightly weakening the qualitative accuracy. (4) The LLM adds a detail not in the original—that the on-balance-sheet BNPL balance and allowance were reduced by 2024—but while plausible and consistent with the sale, the original does not confirm this outcome definitively, instead emphasizing the conditional nature of the benefits. Despite this, the overall reasoning is sound, the multi-hop synthesis across years and strategic moves is accurate, and the answer remains contextually relevant and factually strong. Minor lack of hedging around the 2024 outcome justifies a score of 8 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 419,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s upstream output in Myanmar dropped sharply – oil‑equivalent production fell from about **17 kb/d in 2022 to 15 kb/d in 2023 and then to only 4 kb/d in 2024**, while natural‑gas production fell from **94 MMcf/d in 2022 to 87 MMcf/d in 2023 and 22 MMcf/d in 2024**.  This decline reflects Chevron’s **strategic draw‑down and planned exit from its Myanmar upstream assets**, reallocating capital toward other basins and lower‑carbon growth opportunities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Chevron's upstream production in Myanmar declined from 17 MBD in 2022 to 15 MBD in 2023, and the company fully exited in April 2024, implying zero production thereafter. However, the LLM claims production dropped to 4 kb/d in 2024, which contradicts the complete withdrawal. Additionally, the LLM introduces natural gas figures (94 MMcf/d in 2022, 87 in 2023, 22 in 2024) that are not present in the original answer and cannot be verified from the provided truth. (2) The numbers for 2022 and 2023 (17 and 15 kb/d) align with the ground truth, but the 2024 figure is incorrect—Chevron fully withdrew in April 2024, so any positive production volume for the full year is factually wrong. The introduction of gas volumes and oil-equivalent breakdowns is unsupported. (3) The reasoning about a strategic shift is partially correct—the original answer confirms a strategic exit for portfolio optimization and risk management, which aligns with the LLM’s mention of draw-down and capital reallocation. However, the LLM fails to mention the full exit in April 2024, a key multi-hop fact that underscores the finality of the decision. (4) The contextual relevance is high because the answer addresses production trends and strategic implications, but correctness is undermined by fabricated granular data and omission of the complete exit. Quantitative accuracy is low due to incorrect 2024 numbers and unsupported gas metrics. Qualitative accuracy is moderate—core idea of strategic exit is correct, but details lack precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 445,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nThe data in the 2022 10‑K (pp. 5‑9), the 2023 10‑K (pp. 3‑7) and the 2024 10‑K (pp. 3‑6) show that PC & notebook sales, which are grouped under the “Personal electronics” market, fell from roughly 20 % of that segment’s revenue in 2022 to just under 15 % by 2024.  This steady decline signals that Texas Instruments is deliberately scaling back its reliance on the consumer‑PC market and re‑orienting its strategy toward higher‑growth, higher‑margin areas such as industrial, automotive and analog semiconductors.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The original answer states that the Personal Electronics segment as a whole contributed 24% of TI's total revenue in 2022, 15% in 2023, and 20% in 2024. However, the LLM incorrectly claims that 'PC & notebook sales' made up 'roughly 20% of that segment’s revenue in 2022' and 'just under 15% by 2024' — this misrepresents both the metric (segment revenue vs. subcategory share within segment) and the actual figures. The ground truth does not provide the percentage of PC & Notebooks within the Personal Electronics segment, only the segment's share of total company revenue. Thus, the LLM fabricates or misinterprets the data. (2) The calculation and use of percentages are therefore incorrect. The LLM reports a decline in PC & Notebooks' contribution *within* the Personal Electronics segment, while the original answer tracks the segment's declining *overall* revenue contribution — a critical distinction. (3) The reasoning partially captures the strategic shift but is based on flawed data. The conclusion about TI moving toward industrial, automotive, and higher-margin areas aligns with the original answer and is contextually sound, showing correct multi-hop synthesis of strategic intent from revenue trends. (4) Despite incorrect numbers, the answer is contextually relevant and addresses both parts of the question — the evolution and its strategic implication — with reasonable logic. However, the quantitative inaccuracy severely undermines the correctness score, warranting a mid-low score due to core factual error in financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 451,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nBetween 2022 and 2024 GM’s indemnification liability to Stellantis stayed essentially unchanged – the company recorded only an immaterial accrual for a few recall‑related payments, while repeatedly stating that it **cannot reasonably estimate any material loss** from the ongoing consumer‑class actions in Germany, the United Kingdom, Austria and the Netherlands that allege emissions violations of legacy Opel/Vauxhall vehicles.  Consequently, any additional indemnification that might arise from those matters is viewed by GM as **remote**, with no material known liability or accrual beyond the trivial amounts already reflected in the financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements correctly but misses critical evolution in GM's indemnification obligations from 2022 to 2024, particularly the increasing specificity and disclosure of regulatory investigations. Quantitatively, there are no explicit numerical errors since all amounts are described as 'immaterial' or 'trivial,' which aligns with the ground truth. However, the LLM incorrectly implies that the indemnification liability 'stayed essentially unchanged' over the period, which contradicts the ground truth showing a clear trend of increasing disclosure and emerging exposure. In 2023, GM began disclosing indemnifications for emissions claims, product liabilities, and recalls with an immaterial payment made and an inability to estimate future losses—this level of detail is missing in the LLM response. In 2024, GM specifically accrued for a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, a new and important development not mentioned at all in the LLM answer. Additionally, the LLM overgeneralizes by stating that additional indemnification is 'remote' across all matters, while the ground truth notes that Takata-related recall indemnification is considered remote, but does not make that claim for all exposures. The answer also introduces 'consumer-class actions in Germany, the UK, Austria and the Netherlands' alleging emissions violations—while plausible, these specific jurisdictions and the characterization as 'consumer-class actions' are not present in the original answer and may represent unsupported inference. The multi-hop synthesis across years is weak: the LLM fails to show how disclosures evolved from no specific indemnification in 2022, to broader indemnity categories in 2023, to specific regulatory accruals in 2024. Despite these issues, the answer remains contextually relevant and correctly identifies the immaterial financial impact and uncertainty in estimating future losses, which are central themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 538,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450 % Senior Notes due 2026 were first created by Supplemental Indenture No. 10 in September 2021; over the following three years the company filed additional supplemental indentures in 2022, 2023 and 2024 that added new tranches under the same indenture, effectively laddering low‑coupon, long‑dated debt and enabling it to refinance at progressively lower rates. This multi‑year pattern reveals American Tower’s strategy of extending maturities and exploiting favorable market conditions to manage its debt profile and reduce overall financing costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, while the 1.450% interest rate and 2026 maturity date are correct, and the September 2021 issuance date aligns with the ground truth, the claim that 'additional supplemental indentures in 2022, 2023, and 2024 added new tranches' is false. The original answer confirms that the same Supplemental Indenture No. 10 was referenced across all three years without material modification or new tranches. (2) The LLM incorrectly infers refinancing activity and 'progressively lower rates,' which is unsupported; the ground truth explicitly states there was no refinancing or material change. (3) Qualitatively, the reasoning is flawed: the model fabricates a debt 'laddering' strategy and cost-reduction narrative despite evidence of stability and continuity. The multi-hop synthesis fails—instead of recognizing consistent documentation (Exhibits 4.25, 4.22, 4.21) as evidence of stability, the model misinterprets it as expansion. (4) Contextually, the answer addresses the question's structure and discusses debt strategy, so it remains relevant, but the conclusions are based on incorrect premises. Minor formatting variations (e.g., '1.450 %' vs '1.450%') are acceptable, but core factual and logical errors severely undermine accuracy. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 392,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company continued to administer its 2019 Long‑Term Incentive Plan by issuing a new, year‑specific form of Performance Share Unit Agreement in each of those years (2022, 2023 and 2024) and accompanying Restricted‑Stock‑Unit agreements (2022, 2023 and 2024), thereby introducing updated deferred‑stock and performance‑share awards while keeping the 2019 LTIP as the governing framework.  The successive exhibits illustrate a progressive rollout and refinement of these award types across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies when compared to the ground truth. While it correctly identifies the continued use of the 2019 Long-Term Incentive Plan (LTIP) as the governing framework from 2022 to 2024, it incorrectly states that new Performance Share Unit (PSU) and Restricted Stock Unit (RSU) agreements were issued annually in 2022, 2023, and 2024. The original answer specifies only the 2019 Form of PSU and RSU Agreements in 2022, the introduction of a new Deferred Stock Unit Agreement for Directors in 2023, and the 2022 Form of PSU Agreement in 2024 — not annual updates for each year. Thus, the claim of 'year-specific' agreements issued every year is factually incorrect. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), but the dates associated with agreement forms are misrepresented. The LLM implies the existence of 2023 and 2024 forms of both PSU and RSU agreements, which are not mentioned in the ground truth. This misrepresents the timeline and evolution of the plan. (3) The multi-hop reasoning is partially sound — the model recognizes the ongoing use of the 2019 LTIP and links it to evolving award structures — but fails to accurately trace the specific instruments introduced each year. It misses the key point that the 2023 update was director-focused and that the 2024 update relied on a 2022-dated form, not a new one. The synthesis across years is oversimplified and distorted. (4) Despite these errors, the answer remains contextually relevant, addressing the core theme of how the 2019 plan evolved through new agreements. However, due to significant factual inaccuracies in the progression of award types and incorrect attribution of annual updates, the correctness and qualitative accuracy scores are moderate. The answer conveys a plausible but incorrect narrative of continuous annual refreshes, undermining its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 522,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 through 2024 the Combat Systems segment steadily amplified its aerostructure work: the share of segment revenue rose from 18 % (2022) to 20 % (2023) before modestly retreating to 19 % (2024), while OTS — the unit that supplies missile‑subsystem aerostructures, control actuators, warheads and hypersonic rocket cases — announced major capacity expansions (metal‑parts output to 86 k rounds/month by 2025, propellant capacity to 16 M lb/yr by 2028, and dedicated hypersonic‑rocket‑case production).  This three‑year trend shows that General Dynamics is deliberately deepening its aerostructure expertise to become a core supplier of next‑generation missile platforms, positioning the company to capture the growing market for hypersonic and advanced tactical missile systems.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth states that the Combat Systems segment accounted for 20% of consolidated revenue in 2023 and 19% in 2024, but the LLM incorrectly claims the segment's revenue share was 18% in 2022, rising to 20% in 2023 and falling to 19% in 2024. The original answer does not mention any revenue share for 2022, so the 18% figure is fabricated. Additionally, the LLM introduces OTS (Ordnance and Tactical Systems) with specific capacity expansion metrics (86k rounds/month, 16M lb/yr propellant) and future production targets for 2025 and 2028, none of which appear in the original answer or are supported by the provided ground truth. These details are unsupported and constitute hallucination. (2) The original answer does not provide any segment revenue percentages for 2022, nor does it mention OTS or any production capacity plans. Therefore, the LLM's numerical claims cannot be verified and are likely incorrect. The only correct numbers are the 20% (2023) and 19% (2024) shares, which align with the ground truth. However, the attribution of a rising-then-falling trend based on 18% → 20% → 19% is misleading because the 18% figure lacks support. (3) The multi-hop reasoning is partially sound in that the LLM identifies a strategic focus on aerostructures and links it to next-gen missile systems, which is consistent with the original answer. However, it overreaches by inferring a 'steady amplification' of work based on unsupported revenue percentages and by introducing new entities (OTS) and forward-looking capacity plans not present in the source. The conclusion about positioning for hypersonic systems goes beyond the original answer, which mentions 'next-generation missile subsystems' but does not specify hypersonics. (4) The correctness score is 4 due to partial factual alignment (correct 2023 and 2024 percentages, correct general strategic theme) but major fabrication of data. Quantitative accuracy is low (3) due to invented numbers and unsupported metrics. Qualitative accuracy is moderate (5) because the reasoning direction is plausible but based on incorrect premises. Contextual relevance is high (8) as the answer addresses the evolution of aerostructures and strategic positioning, even if with inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 628,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly list “Jackpot” alongside other key local cigarette brands in the Philippines, underscoring that PMI has continued to treat the brand as a core pillar of its Philippine portfolio and to rely on it for maintaining market share in the region.  At the same time, the filings frame Jackpot within a broader strategic shift: the company is using its established local cigarette brands as a platform to accelerate the rollout of smoke‑free and reduced‑risk products (e.g., IQOS and oral nicotine offerings) across Southeast Asia, signalling that Jackpot’s role is evolving from a pure‑cigarette revenue driver to a conduit for PMI’s regional transition toward a smoke‑free product portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and strategic interpretation. It correctly identifies Jackpot as a key local brand in the Philippines across 2022–2024, consistent with the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), as the response avoids specific figures that could introduce error and instead focuses on qualitative trends, which are accurately portrayed. The answer correctly reflects PMI’s continued emphasis on Jackpot amid its broader smoke-free transition, referencing IQOS and reduced-risk products in the regional strategy. However, the LLM adds an interpretive layer—that Jackpot is being used as a 'conduit' or 'platform' to accelerate smoke-free product rollouts—which, while plausible and strategically logical, is not explicitly supported in the ground truth. The original answer states Jackpot remains strategically relevant despite the smoke-free push, but does not assert an active role in promoting smoke-free products. This represents a minor overextension in reasoning, reducing qualitative accuracy slightly. Nonetheless, the core facts, timeline, and strategic context are sound, and the answer fully addresses the multi-part question about evolution and strategic implications, making it contextually highly relevant. Semantic equivalence is strong, with only slight extrapolation beyond the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 398,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron moved capital out of new upstream development in the Republic of Congo and toward preserving cash and exiting non‑core interests.  In 2022 it was still funding modest maintenance and incremental enhancements to existing Congo production (see CVX_10k_2022 pp. 31‑35), but by 2023 the Africa‑related capital budget was trimmed and the focus shifted to cost‑efficient operations (CVX_10k_2023 pp. 107‑111).  In 2024 Chevron announced the sale of its 31.5 % non‑operated stake in the Haute Mer permit and its 15.75 % interest in the Lianzi field, effectively divesting those assets and redirecting the associated capital to lower‑carbon investments and shareholder returns (CVX_10k_2024 pp. 41‑45).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor factual inaccuracy regarding the timing of the asset sale. The original answer states the sale occurred in January 2025, while the LLM answer attributes the announcement to 2024. Although Chevron may have announced the sale in 2024 for a transaction closing in early 2025, the ground truth explicitly references the sale date as January 2025, making the LLM's framing potentially misleading without clarification. The percentages (31.5% and 15.75%) and the nature of the assets (non-operated Haute Mer and Lianzi interests) are accurate. The capital deployment description for 2022 and 2023 is qualitatively consistent with the original, though the LLM adds interpretive details (e.g., 'preserving cash', 'redirecting to lower-carbon investments') not explicitly confirmed in the ground truth. These are plausible strategic rationales but represent inference beyond the provided facts. The multi-hop reasoning across years and documents is sound, and the synthesis of operational focus shifting from investment to divestiture is correctly captured. Quantitative accuracy is high—no dollar amounts are misstated (though the $0.7 billion mentioned in the original is not included in the LLM answer, possibly due to document reference limitations). This omission reduces completeness slightly but does not invalidate the core narrative. Contextual relevance is excellent, directly addressing capital deployment and asset disposition as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 419,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nBetween 2022 and 2024 Southern Company kept its outdoor‑lighting contracts classified as operating leases, but the revenue recognized from those leases was sharply reduced and ultimately deemed immaterial.  Alabama Power’s operating‑lease income fell from $208 million in 2022 to virtually $0 by 2024, and Georgia Power’s dropped from $77 million to just $9 million, reflecting a shift to variable‑payment treatment that is excluded from the maturity tables.  As a result, the contracts no longer receive a separate revenue allocation; instead, any variable lease payments are captured in wholesale or other income, and the lease‑payment structure remains a month‑to‑month renewal after an initial term of up to ten years, with no material impact on the subsidiaries’ financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that outdoor lighting contracts at Mississippi Power were considered immaterial in 2022 with no significant value disclosed, but the LLM claims Alabama Power had $208 million and Georgia Power $77 million in lease income in 2022—specific figures not supported by the original answer and contradicting the 'immaterial' designation. There is no mention in the ground truth of such high values or their decline to near zero; instead, the evolution is in disclosure practices (e.g., inclusion in maturity analyses in 2023, term disclosures in 2024), not a collapse in revenue. The claim that lease income fell to $0 or $9 million by 2024 is unsupported and factually incorrect based on the provided truth. (2) The quantitative inaccuracies are severe: the LLM fabricates precise dollar amounts ($208M, $77M, $9M) that do not appear in the original answer, which explicitly states immateriality and lack of disclosure. These numbers are not just inconsistent—they fundamentally misrepresent the financial reality. (3) The reasoning is flawed: the LLM infers a 'shift to variable-payment treatment' and 'month-to-month renewal' with 'initial terms up to ten years,' none of which are mentioned in the ground truth. The original answer focuses on improved disclosure and inclusion in maturity analyses and revenue categorization (e.g., PPA lease income in wholesale revenues), not structural changes in payment terms. The multi-hop synthesis fails: the LLM invents a narrative of declining revenues and changing contract structures rather than tracking the actual evolution in accounting treatment and transparency. (4) While the LLM correctly identifies that outdoor lighting contracts are operating leases and mentions subsidiaries like Alabama Power and Georgia Power, and touches on revenue allocation (e.g., inclusion in wholesale income), these correct elements are overshadowed by the fabricated data and incorrect causal explanations. The contextual relevance is moderate because it addresses the right topic and subsidiaries, but the factual foundation is unsound, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 589,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nCisco’s 3.50 % senior note due June 15 2025 carried a flat $500 million carrying amount in fiscal 2022, 2023 and 2024, but its effective interest rate rose from about 3.2 % in 2022 to 6.38 % in 2023 and 6.66 % in 2024. The jump reflects the note’s discount‑accretion and the higher market yields that emerged as interest‑rate levels increased, signalling that the note’s valuation has been re‑priced upward and that Cisco’s borrowing cost has risen despite the unchanged coupon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: the $500 million carrying amount for the 3.50% Note in fiscal years 2022, 2023, and 2024, and the effective interest rates of 3.20% in 2022, 6.38% in 2023, and 6.66% in 2024. Minor rounding of 3.20% to 'about 3.2%' is acceptable and does not affect factual accuracy. (2) All numeric values match the original answer exactly or within acceptable formatting variations (e.g., '6.38%' vs '6.38%'). No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while the coupon rate and carrying amount remained constant, the effective interest rate increased over time, and it appropriately infers the likely cause—rising market yields and discount-accretion dynamics. This aligns with and expands upon the ground truth’s conclusion about market conditions and debt valuation. (4) The answer is contextually complete and relevant, addressing both the evolution of the note’s metrics and the implications for Cisco’s debt valuation and market conditions. The only reason for not scoring a 10 is that the original answer emphasizes a general 'shift in market conditions or internal risk assessments,' while the LLM specifies 'higher market yields' and 'borrowing cost has risen'—a plausible interpretation but slightly more specific than the source. Still, this reflects strong qualitative reasoning rather than inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 402,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s outstanding balance for **Unsecured Notes – 35A stayed constant at a $750 million face amount** (shown in the “Face Amount” column of the unsecured‑notes tables for each year), carrying a fixed 2.65 % coupon and annual debt service of roughly $19.9 million, with maturity in 2030.  This unchanged, long‑dated position illustrates Simon Property Group’s deliberate, laddered debt‑management strategy—maintaining a stable, low‑cost funding tranche while avoiding refinancing risk and preserving flexibility in its overall capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million face value, 2.65% interest rate, and July 15, 2030 maturity date for Unsecured Notes - 35A are consistent across 2022–2024. The annual debt service calculation ($750M × 2.65% = $19.875M ≈ $19.9M) is accurate. (2) Quantitative elements are fully correct—no discrepancies in dollar amounts, percentages, or dates. Format variations (e.g., $750 million vs $750M) are acceptable and handled appropriately. (3) The reasoning is sound: the LLM correctly infers a laddered debt-management strategy from the stability of this instrument, even though the broader context of other debt changes (e.g., 2024 $1B issuance of Notes - 41A) is slightly underemphasized. While the original answer explicitly contrasts the stability of Notes - 35A with other portfolio changes, the LLM captures the strategic intent—maintaining stable, low-cost financing and avoiding refinancing risk. (4) The answer is contextually relevant, directly addressing both the evolution (no change) and strategic implication. The only minor shortcoming is less explicit synthesis of multi-hop evidence (i.e., comparing Notes - 35A stability against other active refinancings), which slightly reduces qualitative accuracy. Overall, the answer conveys semantic equivalence with strong factual and logical rigor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 385,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 the Embedded‑Processing business fell sharply in both size and profitability: revenue dropped from roughly $3.27 billion (2022) to $3.37 billion (2023) and then to $2.53 billion (2024), while operating profit slid from about $1.25 billion to $1.01 billion and finally to $0.35 billion, pushing its profit margin from ~38 % to just 14 %.  As a result, while EP still contributes to TI’s broad product portfolio and global market reach, its strategic weight has receded—TI now leans more on its analog segment and the underlying manufacturing/technology advantage, using Embedded‑Processing mainly as a complementary, lower‑margin offering rather than a primary growth driver.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, the revenue and profit figures provided—$3.27B (2022), $3.37B (2023), $2.53B (2024), and corresponding profits and margins—are fabricated and not supported by the original answer or any known public filings. The original answer contains no financial data about Embedded Processing Products' revenue or profitability, but it certainly does not mention a drop in operating profit from $1.25B to $0.35B or a margin decline from 38% to 14%. These numbers are entirely inconsistent with Texas Instruments' actual 10-K disclosures, which show Embedded Processing revenues declining modestly but not as dramatically as claimed, and no such collapse in margins. (2) The qualitative reasoning is flawed: the original answer emphasizes consistent strategic importance of Embedded Processing as the second of four sustainable competitive advantages, with unchanged language across 2022–2024 highlighting its value in customer engagement and investment returns. The LLM incorrectly claims that the strategic weight of Embedded Processing has 'receded' and that it is now a 'lower-margin offering' and 'complementary'—a direct contradiction of the ground truth, which states the strategic framing remained stable and consistently emphasized. (3) The multi-hop reasoning failed completely: instead of synthesizing the consistent strategic language across years as evidence of sustained importance, the LLM invented financial deterioration to justify a strategic downgrading that did not occur. (4) Contextual relevance is low because the answer addresses a different narrative—declining performance and strategic de-emphasis—while the question asked about evolution within the framework of sustainable competitive advantages, which the LLM ignored. The only minor point of relevance is mentioning the product portfolio, but even that is framed incorrectly. Overall, the answer is factually wrong, numerically inaccurate, and conceptually misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 544,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast moved its wireless shared‑data service from a single, post‑pay, bundled model—offering unlimited, shared‑data or per‑gigabyte options on Verizon’s network for residential and small‑business customers who also took broadband—into a more flexible portfolio that adds prepaid unlimited plans (launched in 2024 under the NOW brand), tiered shared‑data buckets for multiple lines, and “bring‑your‑own‑device” or interest‑free financing (24 months domestically, extended to 24‑48 months for international customers).  At the same time the company expanded internationally, rolling out wireless services in the United Kingdom and Italy via MVNO agreements (and its own core network), providing both unlimited and measured‑data plans and offering the same financing options that had previously been U.S.-only.  This evolution gave customers greater choice of plan type, payment terms and geographic coverage while still tying the service to the company’s broader connectivity ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of CMCSA's evolution in wireless shared data plans—increased flexibility and international expansion—but introduces several unverified or incorrect details not supported by the ground truth. Correct elements include: the bundling of shared data plans with broadband in 2022, the presence of unlimited, shared, and per-gigabyte options by 2023, and international expansion with the 2024 launch of prepaid unlimited plans under the NOW brand. However, the LLM adds unsupported specifics: (1) mention of small-business customers is not in the original; (2) 'tiered shared-data buckets for multiple lines' is not mentioned; (3) 'bring-your-own-device' and financing terms (24–48 months) are absent from the ground truth and cannot be verified; (4) expansion to the UK and Italy via MVNO agreements and 'own core network' is overly specific and not confirmed in the original answer, which only states international expansion generally; (5) the claim that financing options were previously U.S.-only and then extended internationally is unsupported. While the overall theme of increased flexibility and geographic reach aligns with the truth, these factual overextensions reduce quantitative and qualitative accuracy. The answer is contextually relevant and addresses both plan flexibility and international expansion, but the addition of unverified details—especially around financing, device options, and specific countries—undermines factual correctness. The original answer does not mention Verizon’s network, MVNOs, or financing, so including them constitutes hallucination. Thus, while the core evolution is partially correct, the score is reduced due to significant unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 469,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior moved beyond isolated transaction‑level fraud to a systemic risk driven by its expanding credit offerings (e.g., PPWC, PPBL, BNPL) and tighter integration with third‑party lenders, banks and payment‑network rules.  This evolution forces the company to manage a far more complex risk‑management agenda—monitoring sophisticated credit‑risk models, overseeing the sale and funding of loan receivables, and detecting increasingly refined third‑party fraud and synthetic‑identity schemes across a global, multi‑product ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolving nature of PayPal's exposure to abusive behaviors from 2022 to 2024, particularly in relation to credit products and third-party fraud. It accurately reflects the increasing complexity of risk management in PayPal's digital payments ecosystem. However, it omits specific factual details present in the ground truth, such as the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023 and the legal uncertainty around loan receivables from FDIC-insured banks in 2024. These are key quantitative and contextual elements that demonstrate multi-hop synthesis across years and risk domains. (2) There are no numeric inaccuracies because the LLM does not introduce any incorrect numbers—it simply avoids citing the specific €40 billion figure, which is a notable omission. Since it doesn't state any false quantitative claims, quantitative accuracy is high. (3) The reasoning is sound in identifying a trend toward systemic risk and increased complexity due to credit expansion and third-party integrations. However, it lacks explicit anchoring in the year-by-year progression (2022: fictitious accounts; 2023: large-scale BNPL sales; 2024: synthetic identity fraud and legal risks) that forms the core of the multi-hop analysis. While the general trajectory is correct, the absence of specific milestones reduces qualitative accuracy. (4) The answer remains contextually relevant and synthesizes the broader implications well, especially regarding risk-management complexity. The use of terms like 'synthetic-identity schemes' and 'global, multi-product ecosystem' aligns with the original. Due to the omission of key documented events and figures that ground the evolution in actual filings, the answer is partially correct but not fully aligned with the ground truth, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 511,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead kept its El Segundo, California campus as the dedicated hub for clinical‑ and commercial‑scale cell‑therapy manufacturing, using the site to produce products such as Yescarta and Tecartus.  The 10‑K filings note that the company invested in expanding and modernizing the facility—adding new production lines and automation upgrades—so that by 2024 El Segundo was handling full‑scale commercial output and supporting an broader pipeline, reflecting a strategic push to increase cell‑therapy capacity.  (Pages 9‑13 of the 2023 10‑K and 8‑12 of the 2024 10‑K describe the facility’s role and the ongoing capital investments.)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies El Segundo as a key facility for GILD's cell therapy manufacturing from 2022 to 2024 and correctly notes its role in clinical and commercial production, which aligns with the ground truth. However, the LLM introduces specific claims not present in the original answer or verifiable from the knowledge graph, such as 'expanding and modernizing the facility—adding new production lines and automation upgrades' and 'full-scale commercial output by 2024'. These details about capital investments and operational scale are not supported in the ground truth, which states only that GILD reaffirmed its reliance on the site without mentioning expansions or upgrades. Additionally, naming specific products (Yescarta and Tecartus) as being produced at El Segundo goes beyond the information in the original answer, which does not specify products tied to that location. (2) There are no explicit numbers, dollar amounts, or dates in either answer, so quantitative accuracy is not compromised—format and references to 10-K pages are plausible but not verifiable as correct or incorrect in this context; thus, no numerical inaccuracies are present. (3) The multi-hop reasoning is partially sound—LLM connects El Segundo to cell therapy manufacturing across years, which is correct, but it overreaches by inferring strategic expansion and modernization efforts not stated in the ground truth. The original answer emphasizes continuity and risk management, not growth or investment, so the reasoning diverges in emphasis and factual content. (4) The contextual relevance is high because the response addresses the evolution of the facility’s role and ties it to strategic capacity, even if it adds unsupported detail. The correctness score is 6 due to plausible but unverified claims that shift the answer from descriptive continuity to active expansion, altering the factual basis. Qualitative accuracy is reduced for incorrect inference, while quantitative and contextual scores remain high due to absence of numeric errors and strong topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 562,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nAcross the 2022‑2024 filings the company’s senior‑note schedule moved from a near‑term 2.300 % tranche that matured on May 18 2022 (shown in the 2022 filing) to a laddered structure with later‑dated issuances—new 2.750 % and 3.000 % series added in 2023 with maturities in 2025‑2029 and the 2.750 % notes due 2024 refinanced in 2024 alongside fresh 2.750 % and 3.000 % issues extending to 2026‑2032.  This progression shows Costco deliberately extending the average maturity of its debt and reducing reliance on near‑term refinancing, i.e., a strategy of laddering and lengthening its maturity profile to manage interest‑rate risk and preserve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Costco's 2.750% Senior Notes had a fixed maturity date of May 18, 2024, and remained unchanged across the 2022–2024 filings. In contrast, the LLM claims the notes were refinanced in 2024 and that new tranches with maturities extending to 2032 were issued, which contradicts the original answer. It also incorrectly states that a 2.300% tranche matured in 2022 and that new 2.750% and 3.000% series were added in 2023—none of which is supported by the ground truth. (2) Quantitative inaccuracies include: incorrect interest rates (2.300%, 3.000%), incorrect maturity dates (2025–2032), and false refinancing events in 2024. The only correct numeric element is the 2.750% rate and the 2024 maturity, but even the context around it (refinancing) is wrong. (3) The multi-hop reasoning is flawed: instead of recognizing consistency in the maturity structure over time, the model fabricates a narrative of strategic refinancing and maturity extension. It fails to synthesize the correct information across years and invents new debt instruments not present in the original data. (4) While the answer attempts to address the company's debt management strategy, its conclusions about 'laddering' and 'lengthening maturity' are based on false premises. The contextual relevance is moderate because it discusses debt strategy, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 416,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s Angola LNG natural‑gas output was about **49 billion cubic feet per day in 2022**, fell modestly to **≈48 bcf/d in 2023**, and remained essentially flat at **≈48 bcf/d in 2024** (the 2024 table shows 48 MMCFD for both 2024 and 2023).  This slight decline followed by stability indicates that Chevron is not pursuing aggressive growth in African gas production; instead it is preserving the existing Angola LNG capacity while directing new investment toward other basins and lower‑carbon projects.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states Chevron's natural gas production volumes were 7,107 MMCFD in 2022, 7,148 MMCFD in 2023, and 7,569 MMCFD in 2024. The LLM incorrectly reports values around 48–49 billion cubic feet per day (bcf/d), which is 7,000 times higher than the correct values (confusing bcf with mcf). For example, 48 bcf/d = 48,000 MMCFD, whereas the correct figure is ~7,100–7,569 MMCFD. This is a catastrophic quantitative error. (2) The LLM claims production 'fell modestly' and 'remained flat', but the ground truth shows a consistent increase across all three years. The LLM also references a '2024 table' showing 48 MMCFD for both years, which contradicts both the ground truth and internal consistency (it previously said 48 bcf/d). (3) The multi-hop reasoning is flawed: the conclusion that Chevron is not pursuing growth in Africa contradicts the ground truth's upward trajectory, which indicates strengthening output. The LLM fails to synthesize the correct trend and misinterprets the strategic implication. (4) Despite addressing the right question structure (evolution over time and strategic implication), the answer is built on entirely incorrect data, leading to a correctness score of 1. Quantitative accuracy is 1 due to massive unit confusion. Qualitative accuracy is 2 because the structure and intent are present but reasoning is based on false premises. Contextual relevance is 5 as the topic and framing match the question, but content is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 426,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “Total‑return swaps‑deferred compensation” line moved from a **$(92) million loss** in 2022 to **$58 million** of gains in 2023 and **$91 million** of gains in 2024.  This progression shows that Cisco’s market‑linked hedging of its deferred‑compensation obligations shifted from dragging earnings down to actually contributing positively, indicating a more effective (and larger) swap program that is reducing the volatility of its compensation‑related liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024, matching the ground truth exactly. Number formatting (e.g., $(92) million) is standard and semantically equivalent. (2) All numeric values are accurate and consistent with the original answer; no calculations are required beyond correct reporting of gains/losses, which are flawless. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the trend across three fiscal years and infers strategic implications. It accurately interprets the shift from loss to gain as an improvement in the impact of swaps on earnings. The conclusion about reduced volatility and a more effective swap program is a reasonable extension of the data, though slightly more assertive than the original answer’s cautious phrasing (e.g., 'suggesting either improved market conditions or strategic shift'). While this interpretation is logical, it leans slightly toward speculation by attributing the change more definitively to program effectiveness. (4) Despite this minor interpretive difference, the LLM answer maintains factual fidelity, covers all question components (evolution over time and strategic implications), and uses correct entities (Cisco, Total Return Swaps-Deferred Compensation, fiscal years 2022–2024). Thus, the answer is highly accurate, with only a slight deduction in qualitative accuracy for the stronger causal claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 410,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened its supplier standards by revising its human‑rights policy (the 2021 update was reinforced in 2023 with a risk‑based monitoring framework and a new forestry‑grievance process, and again in 2024 by requiring key suppliers to report CDP emissions and by expanding the Vendor Code of Conduct to embed modern‑slavery and conflict‑minerals provisions); it enhanced monitoring through third‑party verification of Scope 1‑2 GHG emissions, annual CDP reporting, and alignment with SASB/GRI/TCFD standards, while also mandating that a growing share of purchased products carry independent certifications such as ENERGY STAR, WaterSense and How2Recycle; and it broadened third‑party certifications by requiring 100 % SmartWay certification for transportation providers, increasing renewable‑energy purchases, and securing inclusion in the Dow Jones Sustainability Index and a science‑based net‑zero target with interim 2030 reduction goals.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unverified details not present in the ground truth, despite addressing the general theme of supplier practices evolution. (1) Correct/Incorrect Elements: The ground truth states that Lowe's updated its wood sourcing policy in 2023 with country-level risk assessments, a new forestry grievance process, and enhanced monitoring, and further strengthened its risk-based framework in 2024. The LLM answer incorrectly attributes a 2021 human rights policy update as being 'reinforced in 2023'—this timeline is unsupported by the ground truth, which begins with 2022 practices. The LLM also fabricates specific requirements such as 'CDP emissions reporting by key suppliers', 'Scope 1-2 GHG verification', 'SASB/GRI/TCFD alignment', and '100% SmartWay certification for transportation providers', none of which are mentioned in the original answer. Additionally, claims about 'renewable-energy purchases', 'Dow Jones Sustainability Index inclusion', and 'science-based net-zero target with 2030 goals' are not supported by the ground truth. (2) Quantitative Accuracy: The LLM introduces precise but unsubstantiated metrics like '100% SmartWay certification' and '2030 reduction goals'—these numbers and targets do not appear in the original answer and cannot be verified. The original answer contains no specific percentages, dates, or numerical targets, so the LLM's inclusion of such figures reduces accuracy. (3) Multi-hop Reasoning Assessment: While the LLM attempts to synthesize policy updates, monitoring, and certifications across years, it fails to accurately reflect the actual progression described in the ground truth. The correct multi-hop synthesis should focus on the evolution of the wood sourcing policy, grievance mechanisms, and expansion of certified products—all centered on forestry and environmental sourcing. Instead, the LLM shifts focus to climate reporting and conflict minerals, which are not mentioned in the original. (4) Justification: The correctness score is low due to major factual overreach and invention of details. However, the answer is contextually relevant—addressing policy, monitoring, and certifications—and captures the directional trend of increasing rigor, which supports a moderate contextual relevance and qualitative reasoning score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 623,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive threat from wireless carriers deepened as they moved from LTE‑based 4G offerings to full‑scale 5G and fixed‑wireless access, using those networks to bundle mobile, broadband and video services (e.g., unlimited‑data plans that bundle streaming or “Xfinity Mobile”‑style MVNO packages).  The filings repeatedly name AT&T, Verizon and T‑Mobile (and, in the European context, BT/Virgin Media and Dish) as the primary wireless competitors that leverage 5G/fixed‑wireless capabilities and bundled product strategies to erode Comcast’s broadband and wireless market share.  By 2024 the threat was framed as “wireless telecommunications companies offering internet services (using 5G fixed‑wireless and 4G/5G broadband) that compete with our broadband and wireless services, often through bundled pricing and content‑driven bundles.”",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the evolution of wireless threat from 2022 to 2024, progression from 4G to 5G and fixed-wireless access, bundling strategies (e.g., unlimited data with streaming), and correct naming of major U.S. competitors AT&T, Verizon, and T-Mobile. The 2024 framing of the threat as 5G fixed-wireless and bundled offerings matches the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect numbers or miscalculations. (3) The multi-hop reasoning is sound: the LLM synthesizes technological evolution (4G → 5G → fixed wireless), competitive bundling, and named competitors across time, correctly attributing strategic shifts to the right timeframe. One minor deviation: the mention of BT/Virgin Media and Dish as European competitors is not present in the ground truth, which focuses solely on U.S. competitors (AT&T, T-Mobile, Verizon). This addition does not contradict the original but introduces entities not confirmed in the source, slightly reducing qualitative accuracy. (4) The answer is contextually excellent—directly addresses technological capabilities, bundling, named competitors, and temporal evolution. Wording differs but semantic meaning is equivalent. Overall, a very strong response with only a minor overextension on competitor geography.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 399,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal kept recording transaction revenue on a gross basis and therefore retained full margin risk, even while it fine‑tuned a volume‑based, tiered‑pricing model and issued fee‑discounts, rebates and other incentives that are booked as revenue reductions.  The company’s reliance on third‑party payment processors remained a cost line‑item rather than a risk‑transfer mechanism, so its pricing strategy has been adjusted only modestly to offset margin pressure while preserving its discretion to set fees.  This multi‑year pattern shows that PayPal’s control over pricing and cost management is largely exercised through scale and selective discounting, but the underlying margin risk persists because it continues to bear the bulk of transaction‑related expenses itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly identifies that PayPal retained full margin risk from 2022 to 2024, consistently recording transaction revenue on a gross basis, which aligns with the original answer's claim of bearing 'full margin risk.' The treatment of incentives (discounts, rebates, rewards) as revenue reductions is accurately described, matching the 2023 and 2024 details in the ground truth. The role of third-party payment processors as a cost (not risk transfer) is correctly stated, consistent with the original's 'transaction expenses.' (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years regarding pricing discretion, cost structure, and incentive programs, correctly inferring that despite evolving tactics (tiered pricing, discounts), the core risk model remained unchanged. The only minor gap is that the LLM omits the 2024 detail about contractual compensation from sellers violating terms (e.g., fraud), which introduces a new revenue stream affecting margins. This is a small but relevant omission in completeness. (4) Contextual relevance is perfect—the answer directly addresses the evolution of margin risk, pricing strategy, processor use, and incentives, and draws a valid conclusion about centralized control and cost management. The conclusion about 'scale and selective discounting' is a reasonable interpretation of the pattern. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 465,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco’s accounting for free‑rent and step‑rent provisions has remained consistent from FY 2022 through FY 2024: the Company includes any free‑rent period and any extension options that it is reasonably certain to exercise in the “lease term” used to compute straight‑line lease expense, and it records the right‑of‑use asset at the present value of all lease payments (including the rent‑free periods) discounted with its incremental borrowing rate.  The only evolution is a more explicit discussion of how lease‑term assumptions—particularly the assessment of extension options—affect the ROU‑asset valuation and the routine impairment testing of those assets (e.g., the $391 impairment charge disclosed in FY 2023), but the core methodology and disclosures have not changed materially across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco's accounting treatment for free-rent periods remained consistent from FY2022 to FY2024, with lease terms including free-rent periods and extension options that are reasonably certain to be exercised, and that the right-of-use (ROU) asset is measured using the present value of lease payments discounted at the incremental borrowing rate—this matches the original answer exactly. (2) The only addition in the LLM answer is the mention of a $391 million impairment charge in FY2023, which is factually correct and consistent with public filings (though not mentioned in the ground truth); this does not detract from accuracy and adds relevant context. There are no incorrect numbers, dates, or calculations. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly identifies that while disclosures became more detailed (e.g., on variable lease payments and impairment), the core accounting policy did not change. (4) The LLM slightly expands on the original by referencing impairment testing and more explicit disclosures around lease-term assumptions, which is supported by actual filings but not contradicted by the ground truth. This represents a minor enhancement rather than an error. Overall, the answer is semantically equivalent and factually correct, warranting a high score with only a small deduction in qualitative accuracy due to the slight expansion beyond the documented evolution in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 431,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s core margin‑risk framework – recognizing fees on a gross‑principal basis and absorbing all payment‑processor costs – remained unchanged, but the company progressively sharpened the language around how that risk is managed.  In the 2022 filing it simply noted that it bears full margin risk on each transaction; by 2023 it explicitly stated that volume‑based tiered pricing does not create a material future right, and in 2024 it added detailed guidance on the timing and accounting of performance‑based versus non‑performance‑based incentives and introduced contract‑asset recognition, indicating a more granular, risk‑aware approach to pricing and contract structure while still relying on the same principal‑risk model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of PayPal's margin risk exposure from 2022 to 2024. (1) It correctly identifies that PayPal continued to bear full margin risk and recognize fees on a gross basis throughout the period, with no change in the fundamental pricing model (tiered, volume-based). It accurately notes the 2023 clarification around material rights and the 2024 enhancements in incentive accounting and contract-asset recognition, which align with the ground truth's mention of performance-based incentives and ASU 2023-07-driven transparency. (2) There are no numeric values to verify, but all dates (2022, 2023, 2024) and financial reporting concepts (gross basis, processor costs, incentives) are used correctly. (3) The multi-hop reasoning is sound: the model synthesizes changes across years in contract structure, incentive accounting, and disclosure practices, correctly inferring a more granular approach while maintaining structural stability. (4) The only minor gap is that the LLM does not explicitly mention ASU 2023-07 or segment reporting, which the ground truth highlights as a 2024 development affecting margin analysis. However, the reference to 'detailed guidance on timing and accounting' and 'contract-asset recognition' implies awareness of updated accounting standards. Wording differs but semantic meaning is closely aligned. Thus, the answer is factually correct and contextually complete, meriting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 428,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note due February 15 2039 has remained fully issued (a $2 billion principal amount) and its reported effective interest rate has been 6.11 % in each of the last three fiscal years—FY 2022, FY 2023 and FY 2024—as shown in the “Long‑Term Debt” tables for July 27 2024, July 29 2023 and July 30 2022. Because the outstanding balance and the effective rate have not changed, the company has not refinanced or repriced that tranche; instead it has continued to fund its long‑term obligations through a diversified mix of new fixed‑rate senior notes at lower coupons (e.g., 2.5 %–5 % range) while keeping the 5.90 % series as a stable, higher‑cost legacy issuance. This pattern indicates that Cisco’s long‑term debt strategy emphasizes staggered maturities and the issuance of fresh debt at prevailing market rates, while maintaining existing notes to preserve balance‑sheet flexibility and manage overall financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion (i.e., $2,000 million) outstanding balance on the 5.90% Note due February 2039 across fiscal years 2022, 2023, and 2024, and that the effective interest rate remained constant at 6.11%—all of which aligns exactly with the ground truth. The dates (July 27, 2024, July 29, 2023, July 30, 2022) correspond to the fiscal year-ends as reported in Cisco’s 10-K filings and are factually accurate. (2) All numeric values—$2 billion principal, 5.90% coupon, 6.11% effective rate—are quantitatively accurate and match the original answer. Format variations (e.g., $2 billion vs $2,000 million) are acceptable and semantically equivalent. (3) The reasoning is sound and goes beyond the ground truth by providing context about Cisco’s broader debt strategy—issuing new notes at lower rates while retaining higher-cost legacy debt. This inference is reasonable and consistent with the observed stability in the 5.90% Note, though the original answer did not explicitly mention new issuances in the 2.5%–5% range. While this additional detail is plausible and contextually appropriate, it is not verifiable from the ground truth provided, slightly reducing qualitative accuracy. However, the core multi-hop synthesis—linking stable utilization and effective rate over three years to a consistent long-term debt strategy—is logically sound and correctly inferred. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in utilization and interest rate, and drawing a valid conclusion about Cisco’s financing strategy. The only reason for not awarding a perfect 10 is the introduction of unverified specifics about new debt coupons, which, while reasonable, are not confirmed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 490,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 the Lowe’s IP disclosures repeatedly list “Kobalt” as one of the company’s private‑brand product names, with the wording tightening slightly each year—from a simple list in 2022 to a more formal “private brand product names, such as Kobalt, STAINMASTER and allen+roth” phrasing in 2023‑24. This consistent inclusion shows that Lowe’s has maintained a steady strategic emphasis on protecting the Kobalt trademark as a core private‑brand asset, even as the broader corporate narrative began to highlight private brands more prominently in later years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Kobalt was consistently mentioned in Lowe's IP disclosures from fiscal 2022 to 2024 as a private brand, alongside STAINMASTER and allen+roth, which matches the original answer's entity and timeline accuracy. (2) There are no numeric values requiring calculation, but the fiscal years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of disclosures, noting consistent inclusion and subtle evolution in phrasing, which supports the conclusion of stable strategic emphasis. The slight tightening in language ('such as' phrasing in 2023–24) is a nuanced observation that adds value without contradicting the ground truth. (4) The original answer emphasizes no 'explicit increase or decrease in prominence,' which the LLM supports by stating 'steady strategic emphasis' and 'maintained,' though it slightly extends the interpretation by suggesting broader corporate narrative shifts—this is a minor inference beyond the ground truth but not factually incorrect. Overall, the answer is semantically equivalent, highly relevant, and well-reasoned, warranting a high score with only a small deduction in qualitative accuracy for the slight interpretive stretch.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 372,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 37B retained essentially the same terms: a fixed 2.25 % coupon, a $700 million face amount, and a maturity date of January 15, 2032.  The unchanged, low‑cost, long‑dated structure shows that SPG is deliberately using a stable, long‑term unsecured debt tranche to lock in favorable financing and extend its maturity profile, underscoring a strategy of managing interest‑rate risk while preserving liquidity for growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest rate (2.25%), face amount ($700 million, equivalent to $700,000 in thousands as used in filings), and maturity date (January 15, 2032) are correctly reported and consistent across 2022–2024. (2) Quantitative accuracy is perfect—numbers match exactly in value, with acceptable format variation ($700 million vs $700,000 in thousands). (3) The multi-hop reasoning is sound: the model correctly synthesizes that no changes occurred over the three years and infers a strategic rationale—locking in low-cost, long-term financing to manage interest rate risk and extend maturity profile—which aligns with and expands upon the original answer’s implication of confidence in debt management. (4) The answer addresses all parts of the question: evolution (no change), specific terms (rate, amount, date), and strategic implication. Wording differs but meaning is preserved and enhanced with relevant financial context. All entities (Simon Property Group, Unsecured Notes - 37B) are correctly identified. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 323,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nBased on the property tables in the three Form 10‑K filings—TXN 10‑K 2022 (pages 16‑20), TXN 10‑K 2023 (pages 14‑18) and TXN 10‑K 2024 (pages 14‑18)—the Melaka, Malaysia site is marked with an “X” under the **Analog** column and left blank under **Embedded Processing** for each year. This shows that TI’s operational footprint in Melaka has consistently been assigned to the Analog business segment and has not been expanded into the Embedded Processing segment across 2022, 2023 and 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog business segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the use of Form 10-K page numbers adds verifiable context without introducing errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of SEC filings, confirming consistency over time and across business segments. (4) The answer addresses all parts of the question—evolution over time, involvement in Analog and Embedded Processing segments, and location-specific operations—demonstrating completeness, precision, and contextual fidelity. Minor wording differences (e.g., referencing 'marked with an X' in tables) do not affect factual accuracy and actually enhance transparency about evidence source. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 329,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the balance of PayPal’s 2.850 % fixed‑rate notes remained flat at roughly **$1.5 billion** (issued in September 2019 with a 2029 maturity).  While that tranche stayed unchanged, the company’s overall term‑debt footprint expanded – it added newer issuances in 2022‑2024 (e.g., $3 bn of 2022 notes, ¥90 bn of 2023 notes and $1.3 bn of 2024 notes) and retired portions of older series – so the 2.850 % notes now represent a stable, long‑dated pillar within a broader, increasingly diversified debt profile.  This pattern signals a long‑term strategy of **maintaining a core, low‑cost funding source while opportunistically extending maturity and adjusting the mix of debt to manage interest‑rate risk and liquidity**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PYPL's 2.850% fixed-rate notes remained at $1.5 billion from 2022 through 2024, matching the ground truth. It accurately notes the issuance date (September 2019) and maturity (2029), which aligns with known details of this debt tranche. The mention of new issuances in 2022–2024, including $3 billion in 2022, ¥90 billion in 2023, and $1.3 billion in 2024, is consistent with PYPL’s broader debt activity during this period. (2) All numeric values are correct and properly formatted; no calculation errors are present. The $1.5 billion exposure is accurately maintained across years, and the additional debt figures are factually sound. (3) The reasoning is strong: the LLM correctly infers that the stability of the 2.850% notes indicates a strategic decision to preserve a low-cost, long-term funding source, even as other debt was retired (e.g., 1.350% notes by 2023) and new debt issued. It synthesizes multi-hop information—linking the unchanged liability with broader debt management trends—though it does not explicitly mention the retirement of the 1.350% notes, which slightly weakens the qualitative completeness. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution (or lack thereof) in exposure and the strategic implication. The conclusion about maintaining a core funding source while diversifying debt mix accurately reflects PYPL’s long-term debt strategy. Minor deduction in qualitative accuracy for not explicitly referencing the retirement of the 1.350% notes, which is a key contrast point in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 445,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nAcross 2022 through 2024 Gilead has consistently used its Hoofddorp, Netherlands site as a commercial‑scale manufacturing and processing hub for cell‑therapy products, positioning the facility as a key European node in the company’s global cell‑therapy strategy.  The site’s role has deepened each year, expanding from an initial commercial‑production footprint to a central production centre that supports the supply of multiple Kite cell‑therapy products (e.g., Yescarta, Tecartus) for both European and worldwide markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in conveying the evolving strategic role of Gilead's Hoofddorp facility from 2022 to 2024, with accurate timeframes and a focus on commercial manufacturing of cell therapy products. It correctly identifies the continuity and growing importance of the site. However, it introduces information not present in the ground truth: specifically, the claim that the site 'expanded from an initial commercial-production footprint to a central production centre' and that it supports 'multiple Kite cell-therapy products (e.g., Yescarta, Tecartus)' for worldwide markets. The original answer does not mention product names, Kite brand, or any expansion in function beyond the consistent use for commercial manufacturing and processing. While the general progression toward deeper strategic integration is implied in both, the LLM overstates the evolution by suggesting a functional expansion that isn't explicitly supported in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are used), and the context is highly relevant. The qualitative inaccuracy lies in the unsupported inference of functional growth and specific product linkage, which constitutes a minor but notable deviation from the documented facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 360,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.375 % Senior Notes due June 2027 remained classified as long‑term debt with a stable carrying amount of $1.25 billion, but the way the current portion was shown changed. In the 2022 table the note carried a $73 million current‑portion allocation, while by 2023 the aggregate current portion of all long‑term debt had risen to $1.081 billion (largely reflecting the $1 billion 2.75 % notes due in 2024), and the 1.375 % notes were still presented as long‑term with no separate current‑portion line. After the 2.75 % notes were fully repaid in May 2024, the current‑portion figure dropped to $103 million in 2024, leaving the 1.375 % notes firmly in the long‑term‑debt category and no longer split between current and long‑term.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite capturing some correct elements. The principal amount of $1.25 billion for the 1.375% Senior Notes is correctly stated and consistent with the ground truth. However, the LLM misrepresents how the current portion of long-term debt relates to these specific notes. According to the ground truth, the current portion associated with the 1.375% notes specifically was $73M in 2022, $1,081M in 2023, and $103M in 2024. The LLM incorrectly attributes the $1.081 billion current portion in 2023 to the 2.75% notes due in 2024, claiming the 1.375% notes had no separate current portion—this contradicts the ground truth which explicitly ties the spike to the 1.375% notes. Similarly, the drop to $103M in 2024 is correctly stated in amount but misattributed to repayment of unrelated notes rather than the natural maturity progression of the 1.375% notes themselves. (2) Quantitatively, the $73M, $1,081M, and $103M figures are mentioned but misassigned in context—especially the 2023 figure, which the LLM says applies to other debt, not the 1.375% notes. The $1.25B principal is correct. (3) The multi-hop reasoning fails: the model incorrectly synthesizes the change in current portion with unrelated debt instruments (2.75% notes), showing flawed logic in connecting maturity timelines and classification changes. It misses the core point that the 1.375% notes themselves transitioned into the current portion as they approached maturity. (4) Contextual relevance is high—the answer addresses debt classification and current portion trends—but factual correctness is undermined by misattribution and incorrect causal explanations, leading to a low correctness score despite relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 481,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s 2.850 % fixed‑rate notes—originally issued in September 2019 with a $1.5 billion principal and a 2029 maturity—remained on the balance sheet at essentially the same $1.5 billion outstanding each year (the notes were not retired early; only other tranches maturing in 2022 were repurchased).  During the same period the company supplemented its long‑term funding by issuing newer fixed‑rate notes in 2022, 2023 and 2024 and by drawing down its $5 billion revolving credit facility, using the proceeds to refinance near‑term debt and support share‑repurchases.  This pattern shows that PayPal’s long‑term debt strategy is to extend maturity, keep a stable, low‑cost fixed‑rate base (including the 2.850 % notes), and manage liquidity through a mix of term debt and revolving credit rather than aggressively retiring existing long‑dated obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion principal amount of the 2.850% fixed-rate notes, their origin in the September 2019 $5.0 billion issuance, the October 1, 2029 maturity date, and the consistent carrying amount across 2022–2024. The effective interest rate (2.96%) is not mentioned in the LLM answer, which is a minor omission but does not affect the core financial obligation description. (2) Quantitative accuracy is perfect: dollar amounts ($1.5B, $5B credit facility), interest rate (2.850%), and timeframes (2019 issuance, 2029 maturity) match the ground truth exactly. Format variations (e.g., $1.5 billion vs $1.5B) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly infers that while PayPal issued new debt and used its credit facility to refinance near-term obligations and fund share repurchases, it maintained the 2.850% notes unchanged, indicating a strategic choice to preserve low-cost, long-term fixed-rate debt. This reflects accurate synthesis across multiple years and debt instruments. (4) The qualitative interpretation of PayPal’s debt strategy—maintaining a stable, low-cost fixed-rate base while managing liquidity and refinancing other tranches—is logically derived and consistent with the ground truth. The only minor gap is the absence of the effective interest rate (2.96%), which was included in the original answer but not critical to the overall conclusion. Contextual relevance is excellent, as the response directly addresses both parts of the question: evolution of the obligation and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 455,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s gas‑related option exposure contracted sharply – the “options – primarily gas” line fell from roughly $356 million (assets) / $347 million (liabilities) in 2022 to about $100 million each in 2023‑2024, while the forward‑gas position peaked in 2023 and slipped in 2024.  At the same time the valuation inputs stayed highly volatile: the weighted‑average implied volatility for gas options hovered near 50 %–55 % and ranged from the high‑teens to well over 300 %, signalling that NEE continues to price in substantial gas‑price uncertainty and therefore maintains a cautious, largely forward‑oriented risk posture in the gas market.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the decreasing trend in fair value of gas-related options from 2022 to 2024, with accurate figures for 2022 ($356M assets, $347M liabilities) and approximate values for 2023 ($100M each). However, it incorrectly states that both asset and liability values were about $100M in 2024, when liabilities actually increased to $102M. More critically, the LLM misrepresents the implied volatility trend: the ground truth shows volatility increasing from 36% (2022) to 50% (2023) to 52% (2024), indicating rising volatility assumptions, but the LLM claims volatility 'hovered near 50–55%' and 'ranged from high-teens to over 300%', which contradicts the source data. This mischaracterization undermines the conclusion about risk positioning.\n\n2) Quantitative inaccuracies include: (a) omission of the $102M liability figure in 2024, (b) incorrect portrayal of volatility as stable or highly variable when it was steadily increasing, and (c) introduction of a 'forward-gas position' not mentioned in the original answer, with no supporting data. The core fair value numbers for assets are mostly correct, but the volatility data is significantly distorted.\n\n3) The multi-hop reasoning is partially sound—linking changes in fair value and volatility to risk positioning is appropriate—but the flawed input data leads to an incorrect interpretation. The LLM concludes NEE maintains 'substantial gas-price uncertainty' and a 'cautious, forward-oriented risk posture', whereas the original answer suggests a de-risking trend due to declining exposure and rising but stabilizing volatility assumptions. The synthesis is logical but based on incorrect data.\n\n4) Despite the factual errors, the answer remains contextually relevant, addressing both parts of the question (evolution of exposure and risk implications) and using appropriate financial terminology. The structure and intent align well with the query, but the quantitative inaccuracies—especially on volatility—reduce overall correctness. A score of 5 reflects partial accuracy with significant factual and interpretive flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 565,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nIn fiscal 2024 Cisco’s available‑for‑sale debt investments produced a **$67 million loss** in other income (loss), net—following a **$21 million loss** in 2023 but a **$9 million gain** in 2022; these shifts moved the overall other‑income line from a **$392 million gain** in 2022 to **$(306) million** in 2024. The recurring negative contributions from the AFS portfolio show that its fair‑value movements—driven by interest‑rate changes, credit‑quality concerns and market‑liquidity swings—are a material source of earnings volatility for Cisco’s investment holdings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, Cisco reported 'higher losses' in AFS debt investments in fiscal 2023 and continued losses in 2024, but the original answer does not provide specific dollar amounts. The LLM answer fabricates precise figures—$67M loss in 2024, $21M loss in 2023, and $9M gain in 2022—which are not present in the ground truth and cannot be verified from the provided knowledge. Similarly, the claim that other income (loss), net moved from $392M gain in 2022 to $(306)M in 2024 is unsupported by the original answer and introduces numerical precision absent in the source. (2) These numbers appear internally consistent (showing a worsening trend), but since they are not derived from the ground truth, they constitute hallucinations. The ground truth only supports directional trends (increasing losses, negative impact), not exact values. (3) The reasoning about increasing volatility due to AFS debt investments aligning with interest rate and credit market factors is logically sound and consistent with the multi-hop inference that recurring losses indicate portfolio volatility. The synthesis across years is appropriate and captures the essence of the trend. (4) While the qualitative direction and contextual relevance are strong—correctly identifying Cisco, AFS debt investments, their negative impact on other income, and the implication of volatility—the introduction of fabricated quantitative data severely undermines factual correctness. Thus, the correctness and quantitative accuracy scores are low despite reasonable logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 456,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s documented its original 4.550 % senior notes—first issued under the Fourteenth Supplemental Indenture (April 5 2019)—through a series of later supplemental indentures (the Twentieth Supplemental Indenture dated March 24 2022, the Twenty‑First Supplemental Indenture dated September 8 2022, and the Twenty‑Second Supplemental Indenture dated March 30 2023). Each of these filings added new tranches with staggered maturities (e.g., 4.450 % due 2062, 5.800 % due 2062, 5.850 % due 2063) and updated the indenture language to reflect the change of trustee to U.S. Bank Trust Company and to incorporate amendments to the company’s credit facilities.  \n\nThis multi‑year pattern shows that Lowe’s is deliberately building a long‑dated, fixed‑rate debt base by layering new note series with extended maturities, using supplemental indentures to extend and diversify its obligations while preserving a consistent legal framework. The approach signals a strategic focus on securing low‑cost, long‑term financing and reinforcing a stable capital structure that can support the company’s growth initiatives over the coming decades.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The original issuance of the 4.550% Notes was under the Fifteenth Supplemental Indenture dated April 5, 2019, not the Fourteenth as claimed. The LLM incorrectly references a series of later supplemental indentures (Twentieth, Twenty-First, Twenty-Second) with specific dates and new tranches (e.g., 4.450% due 2062, 5.800% due 2062, etc.), none of which are supported by the ground truth. The ground truth confirms no changes to the 4.550% Notes’ documentation or terms from 2022–2024, and no new tranches or amendments were made during this period. (2) The claim about a change of trustee to U.S. Bank Trust Company and updates related to credit facilities is unsupported and incorrect. (3) The multi-hop reasoning is flawed: instead of recognizing the consistency in disclosure as evidence of a stable long-term debt strategy, the model fabricates a narrative of active debt layering and structural evolution. While the general theme of long-term financing strategy is relevant, the specific evidence used is entirely inaccurate. The conclusion about strategic diversification and extended maturities is not substantiated by the data. Semantic equivalence fails due to incorrect entities, dates, indenture numbers, and financial terms. Minor contextual relevance is retained because the answer addresses the general topic of long-term debt strategy, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 407,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s Unsecured Notes ‑ 35B kept the same $750 million face amount and a fixed 3.80 % interest rate (maturing 07/15/50).  The unchanged size and rate show that SPG is maintaining a modest, long‑dated fixed‑rate tranche within its capital structure, reflecting a strategy of locking in low‑cost, stable financing and minimizing refinancing risk over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face value ($750 million), interest rate (3.80%), and maturity date (07/15/50) for Simon Property Group's Unsecured Notes - 35B across 2022–2024, matching the ground truth exactly. Format variations (e.g., $750 million vs $750,000,000) are acceptable and semantically equivalent. 2) All quantitative elements are accurate: the face amount, percentage, and date are consistent with the original answer. There are no calculation errors. 3) The reasoning is sound: the LLM correctly infers that maintaining the same terms reflects a strategy of stable, long-term fixed-rate financing and reduced refinancing risk. While the original answer emphasizes 'no refinancing or restructuring' and 'confidence in managing long-dated liabilities,' the LLM captures the same strategic implication using slightly different phrasing—'locking in low-cost, stable financing.' 4) The only minor difference is that the LLM does not explicitly mention the extension of the maturity date as a repeated confirmation (i.e., unchanged from 2022 to 2024), but since the date itself is correctly stated and the stability is emphasized, this does not constitute a factual omission. The answer fully addresses both parts of the question: evolution of exposure and strategic implication. Thus, the answer is factually complete and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 383,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 to 2024 PayPal’s bad‑transaction risk moved from a largely reactive focus on rising fraud, charge‑offs and buyer‑protection losses tied to its credit and BNPL products—and the vulnerability of its third‑party payment processors—to a proactive strategy that sells and securitises large pools of loan receivables (e.g., the €40 bn U.K./European BNPL portfolio and forward‑flow arrangements) while diversifying its processor base and tightening fraud‑detection controls.  This evolution reflects a shift toward actively off‑loading and hedging credit risk to preserve cash flow and operational stability.  Consequently, the multi‑year trend shows that PayPal is building greater resilience by converting reliance on external credit‑risk exposure into managed, market‑based financing solutions, even as cross‑border and regulatory pressures persist.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023 is accurately cited (matching the original answer), and there is no incorrect numeric or temporal data. The format '€40 bn' is equivalent to '€40 billion', so quantitative accuracy is perfect. (2) The answer addresses all components of the question: evolution of bad transaction risk from 2022–2024, credit products (including BNPL), cross-border trade implications, and third-party dependencies (noted via payment processors). It correctly identifies the shift from internal risk absorption to external mitigation through asset sales. (3) Multi-hop reasoning is sound: it synthesizes PayPal’s growing reliance on securitization and forward-flow arrangements as a strategic evolution, connects this to operational resilience, and acknowledges ongoing regulatory and cross-border challenges. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'valid-when-made' doctrine or Synchrony Bank, which are specific elements in the original answer that add legal and partnership context to U.S. credit risk. While the broader trend of reducing balance sheet exposure is captured, these precise details enhance completeness and are slightly underrepresented. However, the core transformation in risk strategy—offloading credit risk via sales and financing solutions—is semantically equivalent and well-reasoned. Thus, the answer is factually robust, contextually relevant, and demonstrates strong qualitative synthesis, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 454,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nCostco’s competitive edge over BJ’s Wholesale Club sharpened from 2022 through 2024 by making Kirkland Signature the cornerstone of its value proposition—private‑label sales rose from roughly 71 % of worldwide net sales in 2022 to about 73.3 % in 2024, reinforcing the low‑price, high‑quality image that BJ’s, which relies mainly on national brands, cannot match. This sustained emphasis on Kirkland, together with the Executive‑membership rewards and a membership‑renewal rate that stayed above 90 %, has solidified Costco’s differentiation from BJ’s in the warehouse‑club market.  (Competition section; Intellectual‑Property discussion of Kirkland; Membership data showing rising private‑label sales penetration.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any specific percentage of net sales attributed to Kirkland Signature, nor does it state that private-label sales rose from 71% in 2022 to 73.3% in 2024—these figures are fabricated or hallucinated. There is no support in the original answer for numerical penetration rates of private-label products or trends in their sales share. (2) The calculation of a 2.3 percentage point increase in private-label sales is therefore invalid, as the underlying data does not exist in the ground truth. The original answer emphasizes qualitative consistency in messaging around Kirkland Signature but provides no metrics on sales penetration or growth. (3) While the LLM correctly identifies the multi-hop elements—Costco vs. BJ's, the role of Kirkland Signature, and the importance of membership metrics—it fails to accurately represent the stability of the strategy as emphasized in the ground truth. Instead, it suggests an intensification of differentiation ('sharpened'), which contradicts the original answer’s assertion of consistent, stable messaging with no significant shift. (4) Despite these errors, the answer is contextually relevant and captures the general theme of Kirkland Signature as a differentiator and the competitive dynamic with BJ's. It also correctly references relevant sections (competition, intellectual property, membership), indicating sound reasoning structure. However, the inclusion of false quantitative data severely undermines factual correctness, warranting a low quantitative accuracy score and a partial correctness score overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 464,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nNEE’s Level‑3 fair‑value of gas‑forward contracts was about **$191 million (asset) / $31 million (liability)** at the end of 2022, rose to **$377 million (asset) / $77 million (liability)** in 2023, and then fell to **$296 million (asset) / $46 million (liability)** by the end of 2024.  The net position stayed positive but trended downward, indicating that the company expanded its hedging activity in 2023 and then reduced its overall gas‑forward exposure in 2024, reflecting a more conservative risk posture toward natural‑gas price fluctuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of assets for 2022 ($191M) and 2024 ($296M), and the liability increase from $31M in 2022 to $46M in 2024, which matches the ground truth. However, it incorrectly states the 2023 liability as $77M, whereas the original answer reports $46M as the 2024 liability and implies a lower 2023 figure (since liabilities rose 'more sharply' from $31M to $46M over the period). The $77M figure is not supported by the ground truth and represents a significant quantitative error. The 2023 asset value of $377M is correctly cited. (2) Calculations: The net positions are implied but not explicitly miscalculated; however, the incorrect liability figure in 2023 undermines the accuracy of any derived insights about net exposure. The ground truth does not mention a reduction in exposure in 2024, only a spike in 2023 and a still-increased level in 2024 compared to 2022. (3) Multi-hop reasoning: The LLM synthesizes the three-year trend correctly in structure and infers a strategic shift, but the conclusion about reduced exposure and 'more conservative risk posture' in 2024 is not fully supported by the ground truth, which describes a 'growing but increasingly balanced exposure' and rising market risk overall. Thus, the reasoning diverges in interpretation. (4) Despite the incorrect 2023 liability and slightly off conclusion, the answer captures the core trend—rising asset exposure with increasing liabilities—and addresses all parts of the question with relevant context, earning high marks for completeness and relevance. Quantitative accuracy is penalized due to the material error in the 2023 liability figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 458,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nIn the 2022 filing Lowe’s reported $2.56 bn of forward interest‑rate swaps (cash‑flow hedges); the 2023 filing shows that amount rising to roughly $2.8 bn, as the company broadened its hedge to lock in financing costs amid accelerating rate hikes, and the 2024 filing trims the notional back to about $2.2 bn, reflecting a pull‑back as rates stabilized and the firm shifted toward longer‑dated fixed‑rate debt. This progression indicates a move from an aggressive short‑term hedge stance to a more balanced, longer‑term interest‑rate risk‑management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, Lowe's did not report a $2.56 billion or $2.8 billion notional amount of forward interest rate swaps in 2022 or 2023. Instead, in 2023, the fair value of these swaps was $251 million (not notional), and they were classified as other current assets. By 2024, the swaps were no longer held, not reduced to $2.2 billion. The LLM fabricates notional values and trends that contradict the ground truth. (2) The numbers are entirely inaccurate: $2.56B, $2.8B, and $2.2B do not appear in the original answer and are not supported by the data. The only correct numeric reference in the ground truth is $251 million (fair value, not notional) as of February 3, 2023. The LLM confuses notional amounts with fair values and invents a trend that does not exist. (3) The multi-hop reasoning is flawed. The original answer shows a progression from using swaps (2022 discussion of past hedges), holding $251M in fair value (2023), to holding zero (2024). The LLM incorrectly infers continued and fluctuating notional usage, missing the key point that swaps were fully exited by 2024. The conclusion about shifting to longer-dated debt is speculative and not supported in the provided ground truth. (4) The contextual relevance is moderate because the answer addresses interest rate risk management and attempts to interpret strategy, but the factual foundation is so weak that the reasoning collapses. Correctness and quantitative accuracy are very low due to complete fabrication of key financial figures and misrepresentation of the instrument's status over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 458,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its fiber‑to‑the‑premises rollout and DOCSIS 4.0 upgrades, moving from up‑to‑1 Gbps downstream on its HFC network to offering symmetrical multigigabit speeds (as high as 10 Gbps for residential and 100 Gbps for business) and 2 Gbps downstream in roughly half of its footprint.  This expansion directly counters Lumen’s fiber‑based network build‑out, allowing Comcast to match or exceed Lumen’s speed tiers and to bundle broadband, video and wireless services in the same overlapping markets.  The higher‑speed, symmetric offerings also enable new bundled packages and revenue streams (e.g., multigig symmetrical services, advanced xFi Wi‑Fi) that strengthen Comcast’s competitive positioning against Lumen.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially relevant and addresses the competitive dynamics between CMCSA (Comcast) and Lumen in overlapping markets with a focus on fiber-based broadband expansion, which aligns with the question. However, it introduces significant factual inaccuracies not present in the ground truth. The original answer states that Lumen was expanding its fiber network and was consistently identified by CMCSA as a key competitor from 2022 to 2024, but does not mention any specific speed upgrades by CMCSA such as DOCSIS 4.0, 10 Gbps residential, or 100 Gbps business services. These specific speed figures and technology rollouts (e.g., 'symmetrical multigigabit speeds', '2 Gbps downstream in half of its footprint') are not supported by the ground truth and appear to be fabricated or inferred beyond available data. There is no mention in the original answer of CMCSA's technological upgrades or specific service tiers, so these quantitative claims cannot be verified and are likely incorrect. While the LLM correctly identifies the competitive tension in overlapping markets and the bundling of services as a strategic response, this reasoning is built on unsupported technical specifics. The entity names (CMCSA, Lumen) and time frame (2022–2024) are accurate, and the general theme of intensifying competition due to fiber expansion is consistent. However, the lack of quantitative accuracy and the introduction of unverified technical details severely undermine the correctness. The answer is contextually relevant and shows logical reasoning structure, but fails on factual fidelity, especially regarding CMCSA's network capabilities and upgrades.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 451,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal turned its seamless‑checkout ambition into a broader, more integrated offering: it layered consumer‑credit options—including BNPL, interest‑free installment plans and co‑branded credit cards—directly into the checkout flow across an expanding set of markets (U.S., U.K., France, Germany, Australia, Spain, Italy and, via Paidy, Japan); simultaneously it widened global currency support to roughly 150 currencies and enabled balances and withdrawals in 24‑56 currencies, letting shoppers and merchants transact in almost any locale; and it broadened omnichannel merchant solutions by unifying online checkout (PayPal, Venmo, Braintree, PayPal Complete Payments), in‑person point‑of‑sale tools (Zettle), payout and financing services, and risk‑management features, all under a single, data‑driven platform that personalizes offers and drives higher conversion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures PayPal's evolution from 2022 to 2024 in enhancing seamless checkout experiences, integrating consumer credit (BNPL, co-branded cards), expanding global currency support, and strengthening omnichannel merchant solutions. (2) Quantitatively, the LLM states 'roughly 150 currencies,' matching the original answer's 'approximately 150'—a correct and acceptable approximation. The ground truth does not specify exact numbers for currencies in 2022 (over 100), so the LLM's progression is consistent. The mention of 24–56 currencies for balances and withdrawals adds detail not in the original but is plausible and does not contradict it. (3) The multi-hop reasoning is sound: the LLM synthesizes PayPal’s integration of BNPL and branded cards (2024), links Zettle and Braintree to omnichannel solutions, and connects global expansion with local market support (listing specific countries including Japan via Paidy, which is accurate contextually). (4) The LLM enhances the original with additional specificity (e.g., named markets, 'data-driven platform', 'personalizes offers') without introducing errors. The only minor deviation is the lack of explicit year-by-year framing (2022 vs 2023 vs 2024), but the evolution is implied chronologically. Overall, the answer is factually correct, comprehensive, and contextually rich—justifying a 9 for correctness (not 10 due to slightly less temporal clarity), with high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 420,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe RedCard (Target Debit) penetration fell steadily – from roughly **20.5 % of all purchases in fiscal 2022**, to **19.8 % in fiscal 2023**, and **18.6 % in fiscal 2024** (and about **17.8 % in the first 2025 period**). This downward trend shows that the card’s ability to generate incremental sales is eroding; while the 5 % discount still encourages some additional spend, the shrinking share of transactions paid with a RedCard indicates growing market saturation or diminishing returns, suggesting Target can no longer count on the card as a primary engine of sales growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 18.6% in 2023 and 17.8% in 2024. However, the LLM states 19.8% in 2023 and 18.6% in 2024, which misrepresents the trajectory. It also incorrectly introduces a data point for 'first 2025 period' (17.8%), which is not part of the original 2022–2024 scope and conflates the 2024 figure with a future period. (2) The calculation of trend direction (downward) is correct, but the specific percentages are off, affecting the factual precision. The 2023 value is overstated by 0.8 percentage points, and the 2024 value is misassigned. (3) The qualitative reasoning about the card’s diminishing role in driving incremental sales is sound and aligns with the original answer’s interpretation. The mention of market saturation and diminishing returns is a reasonable inference, though not explicitly stated in the ground truth, which focuses on weakening customer engagement. The synthesis of the trend’s implication is logically consistent. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of penetration rate and its implication for sales), uses correct entities (Target Debit Card/RedCard), and interprets the trend appropriately. However, the incorrect numbers reduce confidence in the factual basis. The score is lowered primarily due to the quantitative errors, despite otherwise strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 416,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nBetween 2022 and 2024 AMD made the treatment of development‑plus‑IP arrangements more explicit.  The 2022 filing only said that combined dev‑service and IP deals could be treated as a single performance obligation, but the 2023‑2024 disclosures added a formal “distinct‑licensing” test—(i) the license must be capable of being distinct and (ii) distinct in the context of the arrangement.  If the license is deemed distinct, revenue is recognized at a point in time; if it is not distinct, the arrangement is combined with the development services and revenue is recognized over time, making the separation between combined deals and standalone IP licenses clear and consistently applied.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy regarding the evolution of AMD's revenue recognition policy. The ground truth states that AMD's approach remained consistent from 2022 to 2024, with no change in the application of the distinct-licensing test. However, the LLM incorrectly claims that the 'distinct-licensing test' was introduced or made explicit in 2023–2024, implying an evolution in policy that did not occur. In reality, the same evaluation framework—assessing whether a license is distinct in the context of the arrangement—was already in place in 2022, as confirmed in the original answer. While the LLM correctly describes the accounting treatment (revenue recognized at a point in time for distinct licenses and over time for non-distinct ones), it misrepresents the timeline and change over the period. There are no numerical figures in the question, so quantitative accuracy is not applicable in a traditional sense, but all referenced years and concepts are correctly named (AMD, 2022–2024, development services, IP licensing), supporting a high score for entity accuracy and contextual relevance. The reasoning is logically structured but based on a false premise of policy change, undermining the qualitative accuracy. Thus, the answer is partially correct in mechanics but flawed in core factual synthesis across years, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 384,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024, FlyEase progressed from a newly‑introduced, inclusive‑design technology noted alongside Nike’s core performance platforms (Air, Zoom, Free, etc.) to a mature, cross‑category capability that is now embedded in footwear, apparel and digital experiences, with growing emphasis on scaling its use and tying it to Nike’s broader sustainability and accessibility objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of FlyEase from a newly introduced technology to a mature, integrated capability within Nike's innovation portfolio from fiscal 2022 to 2024. The key stages of progression—introduction, integration alongside core technologies, and maturation—are accurately reflected. The mention of FlyEase being embedded across footwear, apparel, and digital experiences, along with ties to sustainability and accessibility, adds contextual depth that is plausible and relevant, though not explicitly detailed in the original answer. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced because the original answer specifically notes FlyEase being grouped with mature technologies like React and Air Max by 2024, while the LLM generalizes this as 'cross-category capability' without naming specific peer technologies. However, the core reasoning and multi-hop synthesis—tracking strategic positioning over three fiscal years—are sound and logically structured. The answer is fully contextually relevant, directly addressing the evolution of FlyEase’s strategic role. Minor lack of specific reference to how it was categorized in each year (e.g., 'no longer highlighted as new') prevents a perfect qualitative score, but overall, the semantic meaning is equivalent and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 396,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe data show that the outstanding balance of American Tower’s 1.250 % senior notes has been steadily shrinking—from about **$552 million at the end of 2022** to roughly **$546 million after 2023 adjustments** and further reductions reflected in the 2024 adjustments—indicating that the company is actively retiring this tranche of debt.  This reduction is driven by repayments funded through new note issuances, revolving‑credit borrowings and cash flows, underscoring a debt‑management strategy that focuses on lowering leverage and extending the maturity profile of its long‑dated financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported principal amounts. The ground truth states the principal was $609.1 million in 2022, $551.9 million in 2023, and $517.7 million in 2024. However, the LLM incorrectly reports $552 million at the end of 2022 (should be 2023), $546 million after 2023 adjustments (inconsistent with 2023's actual $551.9M), and vague 'further reductions' in 2024 without citing the correct $517.7M figure. These errors undermine the quantitative foundation of the response. (2) The interest payment schedule (May payments, February 2033 maturity) is omitted entirely, which is a key part of the original answer and relevant to the debt management strategy. (3) While the LLM correctly infers a debt reduction strategy and links it to broader financial management (e.g., lowering leverage, extending maturities), this reasoning is based on incorrect data. The mention of funding via new issuances and credit borrowings goes beyond the original answer and is unsupported by the provided ground truth. (4) Despite incorrect numbers, the answer captures the directional trend (declining principal) and draws a plausible conclusion about debt retirement, which maintains some qualitative and contextual relevance. However, the quantitative inaccuracies severely limit correctness, especially in a financial context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 384,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $3.50 % Notes due 2040 were carried at a net amortized cost of roughly $1 billion, while their market‑value disclosure moved only modestly—from about $870 million in FY 2023 to $851 million in FY 2024—reflecting the typical decline in fair value that accompanies rising interest‑rate expectations.  The company continues to treat the 2040 notes as a core, long‑dated, low‑coupon financing pillar, refinancing shorter‑term obligations (e.g., the 0.584 % 2024 notes that were retired in FY 2025) and preserving a staggered maturity profile that supports its long‑term capital‑allocation strategy.  This trajectory shows NVIDIA’s intent to lock in inexpensive, fixed‑rate debt for the next two decades while maintaining flexibility to retire or refinance nearer‑term maturities as market conditions evolve.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million in FY2022, but the LLM omits this entirely and instead starts with FY2023 at $851 million (which is correct) and mentions a prior value of 'about $870 million' in FY2023—this is factually wrong, as $851 million is the FY2023 value, not a prior one. The LLM also states the notes were carried at 'roughly $1 billion' in net amortized cost across all years, but the ground truth shows a specific carrying value of $1,000 million only in FY2024, with no mention of amortized cost in prior years. The effective interest rate of 3.54% in FY2024 is omitted in the LLM response. (2) The LLM incorrectly implies that the fair value declined from $870M to $851M between FY2023 and FY2024, when in fact the ground truth shows a drop from $1,066M (FY2022) to $851M (FY2023), then a rebound to $1,000M (carrying value, not fair value) in FY2024. This misrepresents the trajectory. (3) The qualitative reasoning about NVIDIA’s long-term debt strategy—such as using the 2040 notes as a 'core, long-dated, low-coupon financing pillar' and maintaining a staggered maturity profile—is contextually plausible and aligns with the general strategy implied by the ground truth. However, the LLM introduces unverified details, such as the retirement of '0.584% 2024 notes in FY2025', which is not supported by the provided ground truth and constitutes a hallucination. (4) The contextual relevance is moderate because the answer addresses the multi-year evolution and strategic implications, but the flawed data and unsupported details undermine the correctness. The multi-hop synthesis is partially sound but based on incorrect inputs. Quantitative accuracy is low due to wrong numbers and misattribution of values across years. Qualitative accuracy is mid-range due to reasonable strategic interpretation despite factual gaps. Correctness score is 4 due to partial factual alignment but major omissions and errors in key financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 561,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix broadened its membership strategy by introducing a lower‑priced ad‑supported tier (2022), expanding into interactive games (2022‑2024) and adding live‑event programming (2023‑2024) while periodically raising subscription prices in several markets. In its 2022 filing the company warned that if the new games offering or any price changes failed to resonate, member acquisition and retention could suffer; the 2023 filing added that the rollout of live programming and continued game development pose a risk that consumers may not value the expanded content, potentially dampening growth; and the 2024 filing again flagged that ongoing expansions of games, live content and pricing adjustments could erode satisfaction and increase churn if the new services are not well‑received.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution of Netflix's membership plans from 2022 to 2024, including games, ad-supported tiers, live programming, and pricing adjustments, and correctly identifies the associated risks to member acquisition and retention. However, there are factual inaccuracies in timing: the ad-supported tier was introduced in 2023 (not 2022), and live programming began in 2024 (not 2023–2024). The LLM incorrectly states that the ad-supported tier launched in 2022, which contradicts the ground truth. Additionally, while games were introduced in 2022, the LLM implies ongoing expansion through 2024, which is plausible but not explicitly confirmed in the original answer. (2) There are no numeric values (e.g., prices, percentages) in either the question or ground truth, so quantitative accuracy is not heavily applicable; however, the misattribution of launch years for key features constitutes a factual error in temporal data, which is critical in this context. (3) The multi-hop reasoning is partially sound—information is synthesized across years and services—but the incorrect assignment of events to years undermines the accuracy of the synthesis. The risk statements per year are generally aligned with the original: 2022 focused on games and pricing, 2023 on ad-tier and live programming, 2024 on continued expansion and churn risk. However, the LLM conflates the timing of live programming and ad-tier rollout. (4) The answer is contextually relevant and well-structured, addressing all components of the question. Due to the misplacement of key strategic launches (ad-tier in 2022 instead of 2023, live programming starting in 2023 instead of 2024), the qualitative and correctness scores are reduced. Minor wording differences are acceptable, but incorrect year assignments for major product launches are significant enough to prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 516,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s overall venture‑related equity securities stayed flat at about **$4.9 billion** from 2022 through 2024, but the size of its **equity‑method investments in health‑care operating businesses more than doubled**—rising from roughly **$1.4 billion in 2023** (and about $1.3‑$1.5 billion in the prior year) to **$3.8 billion as of December 31 2024**. This rapid increase shows that the company is moving from a largely passive venture‑fund exposure toward **active, strategic minority stakes in health‑care innovators**, underscoring a deliberate effort to deepen its involvement in the sector’s growth opportunities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.8 billion equity-method investment in 2024 and the $1.3–$1.5 billion range for prior years, aligning with the ground truth of $1.3 billion in 2022 and $1.4 billion in 2023. However, it incorrectly states that equity securities were flat at $4.9 billion from 2022 through 2024, when in fact they increased from $3.7 billion in 2022 to $4.9 billion in 2023 and remained steady in 2024. This misrepresents the growth trajectory in equity securities, a key part of the question. (2) The quantitative error lies in the misstatement of the 2022 equity securities value—claiming $4.9 billion in 2022 is off by $1.2 billion, a significant miscalculation. All other numbers (equity method investments: $1.3B→$1.4B→$3.8B) are either directly accurate or reasonably approximated. (3) The reasoning is strong: the LLM correctly infers a strategic shift from passive to active investments based on the disproportionate growth in equity method investments, which reflects sound multi-hop synthesis of intent from financial trends. (4) Contextual relevance is perfect—the answer addresses both parts of the question (trends in equity securities and equity method investments) and interprets strategic implications accurately. Despite the major quantitative error in backdating the $4.9B figure, the core insight about strategic positioning remains valid, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 397,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike’s redeemable preferred‑stock arrangement with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the $0.3 million, $1‑par, cumulative‑dividend preferred stock that pays $0.10 per share each May 31 and must be fully satisfied before any common‑stock dividend can be declared; the stock is redeemable at par at the option of Sojitz America or Nike and carries only limited class‑voting rights (e.g., on the sale of substantially all assets, mergers, or the trademark), with no new issuances or modifications reported in 2022‑2024.  Consequently, Sojitz America’s strategic influence stayed confined to these protective shareholder rights and its historic role as a Japanese‑trading‑company conduit for import‑export financing, while Nike’s international operations continued to be managed through its regional business units rather than through any expanded operational control by Sojitz America.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the $0.3 million par value, $1 par value (though original answer states $0.3M par without specifying per-share par, so minor discrepancy), and $0.10 annual dividend are correct, as is the unchanged nature of the preferred stock arrangement from 2022–2024. The description of dividend priority and redemption rights aligns with known terms, and no numeric errors are present—hence high quantitative accuracy. However, the qualitative assessment reveals a critical divergence: while the original answer identifies a strategic evolution in fiscal 2024 where Nike explicitly highlighted Sojitz America’s operational importance in import-export financing due to rising trade risks, the LLM answer asserts that Sojitz America’s role 'remained unchanged' and that its strategic influence was 'confined' to shareholder rights and historic functions. This contradicts the ground truth, which emphasizes a shift toward recognizing Sojitz America as a more strategically vital partner in international operations by 2024. The LLM fails to capture this evolution, instead implying continuity in strategic relevance, thus missing the core multi-hop insight—synthesizing unchanged financial terms with an emerging operational emphasis. This omission significantly undermines the correctness despite numerical fidelity. Contextual relevance is high as the response addresses all question components (ownership, dividends, international role), but the reasoning misinterprets the strategic trajectory. Therefore, while numbers are correct, the failure to reflect the nuanced strategic evolution results in a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 458,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 grew from roughly **$1.5 billion at the end of fiscal 2022** to **$1.637 billion at the end of fiscal 2023** and then held essentially steady at **$1.604 billion at the end of fiscal 2024**.  This modest upward movement—driven mainly by the accretion of discount and the issuance of new senior unsecured debt—shows that NVIDIA is maintaining a sizable, low‑cost fixed‑rate position in its long‑term capital structure while keeping overall leverage relatively stable.  The flat‑to‑slightly‑higher balance signals a strategic focus on financing growth through long‑dated debt rather than aggressive new issuance or rapid deleveraging.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the carrying value of NVIDIA's 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, decreased to $1,604 million in fiscal 2023, and then increased to $2,000 million in fiscal 2024. The LLM incorrectly reports the 2022 value as $1.5 billion (~$1,500 million), which is $647 million lower than the actual figure. It also misstates the 2023 value as $1.637 billion instead of $1,604 million, and claims it remained at $1.604 billion in 2024—this is incorrect, as the value actually rose to $2,000 million in 2024. These errors affect all three years and completely reverse the trend described. (2) The quantitative inaccuracies are severe: the direction of change from 2022 to 2023 is misrepresented (LLM says increase, truth is decrease), and the 2024 value is wrong by nearly $400 million. The LLM also introduces concepts like 'accretion of discount' and 'issuance of new senior unsecured debt' not supported by the ground truth. (3) The multi-hop reasoning is flawed—the model fails to correctly identify the trend (decrease then increase) and instead reports a flat-to-slight increase, leading to an incorrect interpretation that NVIDIA is maintaining stable leverage. The ground truth indicates a strategic repositioning with a notable rebound in long-term debt in 2024, which the LLM misses entirely. (4) Due to major factual and directional errors in financial data and trend interpretation, the correctness score is low at 2. Quantitative accuracy is 2 due to widespread number mismatches. Qualitative accuracy is 3 because while the answer discusses relevant concepts (long-term debt positioning), the reasoning is based on false premises. Contextual relevance is 6 because the response addresses the right topic and metric, but with incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 508,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife moved from a funding profile that leaned heavily on long‑term debt and internal cash flows toward a more balanced mix that still uses short‑term commercial paper but increasingly supplements it with a wider array of global sources—preferred and common equity, long‑term notes, collateral‑financing arrangements, policy‑holder balances and the shelf‑registration program.  This diversification “limits dependence on any one market or source of funds and generally lowers the cost of funds,” allowing the company to meet its liquidity needs while keeping the overall cost of capital lower than it would be if it relied on a single, narrow funding channel.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and entity representation compared to the ground truth. (1) While there are no explicit numbers, dates, or calculations to verify, the answer does not contradict any quantitative facts (e.g., years 2022–2024 are correctly referenced), so quantitative accuracy is high. (2) However, the core claim—that MetLife 'moved from' a long-term debt-heavy profile to a more balanced mix—implies a strategic shift or evolution over time that is not supported by the original answer. The ground truth states that MetLife's funding structure remained 'consistent' and 'stable' across 2022–2024, with no major structural changes. The LLM incorrectly frames the evolution as a transition, when the original emphasizes continuity. (3) The multi-hop reasoning is flawed: instead of synthesizing the consistent reliance on commercial paper and credit facilities across years, the model infers a diversification trend that isn't documented. The mention of 'preferred and common equity, long-term notes, collateral-financing arrangements, policy-holder balances, and shelf-registration' may be factually plausible but is not highlighted in the original as increasing or newly emphasized. (4) Contextually, the answer addresses the question’s focus on funding diversity and cost of capital, and correctly notes that diversification lowers funding costs—this supports a decent contextual relevance score. However, the misrepresentation of strategic evolution undermines factual correctness. Thus, the correctness and qualitative accuracy scores are moderate due to incorrect synthesis and unsupported claims about change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 463,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nFrom 2022 through 2024 the parent‑company’s intercompany financing changed materially: the short‑term notes payable to subsidiaries rose from $8.7 bn (2022) to $9.9 bn (2023) and then fell sharply to $2.0 bn by the end of 2024, while a new long‑term notes payable balance of $14.4 bn appeared in 2024, indicating a shift from short‑term borrowing to longer‑dated financing.  The company’s service‑level guarantees were disclosed as immaterial in each year and were never accrued, but the growing long‑term intercompany debt reflects an expanding liquidity commitment and heightened contractual risk exposure over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the 2023 ($9.9B) and 2024 ($2.0B) notes payable figures are correct, it incorrectly states the 2022 amount as $8.7B, whereas the ground truth is $8.1B. This is a material error, especially given the focus on trend analysis. Additionally, the LLM introduces a 'new long-term notes payable balance of $14.4B in 2024' that is not present in the original answer or implied by the ground truth, which only references short-term notes payable and their volatility—there is no mention of long-term intercompany debt. (2) The service level guarantees are correctly described as immaterial and not accrued in any year, aligning with the ground truth. However, the conclusion that there was 'heightened contractual risk exposure' contradicts the original answer’s assertion that the risk profile remained stable despite internal financing changes. (3) The multi-hop reasoning is partially sound—the model correctly identifies the volatility in intercompany notes and links it to liquidity strategy. However, the unsupported introduction of a $14.4B long-term debt distorts the synthesis and leads to an incorrect inference about increasing risk exposure. (4) The contextual relevance is high as the answer addresses both service level guarantees and notes payable over time, and attempts to interpret liquidity and risk implications. However, due to the incorrect numbers and fabricated long-term debt figure, the overall correctness is significantly compromised. The qualitative reasoning would score higher if not for the invention of data not present in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 449,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a pure card‑network play to a premium‑issuer/processor model that leans on high‑spending Card Members, travel‑and lounge benefits, and expanded digital‑service offerings, while its reliance on the GMNS network grew more regulated.  Heightened global scrutiny—U.S. Category III oversight, EU and Australian interchange‑fee caps and the company’s exit from those licensing markets—has raised compliance costs and forced tighter risk‑management, and competition from Visa, Mastercard, UnionPay and fast‑growing fintech payment platforms has intensified pricing and merchant‑acceptance pressure.  In response, Amex has deepened its data‑analytics and cybersecurity investments, broadened cobrand and merchant‑services partnerships, and invested in new payment‑and‑lending products to preserve growth amid tighter regulatory and competitive constraints.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024. (1) All entities are correct: American Express, Visa, Mastercard, UnionPay, EU, Australia, and U.S. regulatory framework (Category III) are accurately referenced. The mention of fintech platforms like PayPal or Alipay is generalized as 'fast-growing fintech payment platforms,' which is semantically acceptable. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Amex’s shift from competitive differentiation to increased regulatory dependency, noting its exit from EU and Australian licensing markets, heightened compliance costs due to interchange-fee caps, and strategic responses like expanded partnerships and digital investments. (4) Minor omissions affect qualitative accuracy: the original answer specifically names National Payments Corporation of India and platforms like Venmo and Alipay, which the LLM generalizes. Additionally, the original emphasizes Amex’s 2022 positioning as the fourth-largest network, a detail absent in the LLM response. The LLM also introduces 'GMNS network'—a term not present in the original and potentially misleading without clarification—which slightly detracts from precision. However, the overall trajectory—increased regulatory constraints shaping strategy—is correctly conveyed. The answer is highly relevant to the question and effectively summarizes strategic responses. Thus, correctness and qualitative accuracy are high but not perfect due to minor omissions and a slightly ambiguous term.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1647,
        "completion_tokens": 489,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips kept the same cash‑settled PSU design for performance periods that began in 2018 or later: an **accrued reinvested dividend equivalent is charged to compensation expense during the performance period and paid only at settlement**, whereas pre‑2018 awards received no dividend equivalent until after the performance period ended.  By 2023‑2024 the cash‑settled PSU balances were fully vested and carried **no remaining unrecognized compensation cost**, confirming that the dividend‑equivalent feature had been fully integrated into the long‑term incentive structure.  This evolution shows the company’s intent to align executive pay with total shareholder return—linking cash payouts not just to stock‑price performance but also to the dividend component—thereby reinforcing sustained, long‑term value creation for both management and shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in ConocoPhillips' dividend equivalent structure: pre-2018 awards received no dividend equivalents during the performance period, while 2018 and later awards feature accrued reinvested dividends paid at settlement. This matches the original answer's key factual claim. (2) All dates (2018 as the transition point, 2022–2024 timeframe) are correct, and there are no numerical inaccuracies—though no specific dollar amounts are mentioned, which is acceptable given the qualitative nature of the question. (3) The reasoning is sound: the shift to accrued reinvestment is correctly interpreted as enhancing long-term incentive alignment by deferring dividend benefits until settlement, reinforcing pay-for-performance linkage. The mention of cash-settled PSUs being classified as liabilities is omitted, but the LLM correctly notes that by 2023–2024, balances were fully vested with no remaining unrecognized cost, which is consistent with the lifecycle of these awards. (4) The conclusion about aligning executive pay with total shareholder return (including dividends) is a valid inference and adds value, even if slightly more interpretive than the original. The only minor shortcoming is the lack of explicit mention of the balance sheet classification (liability treatment), which was part of the original answer’s evidence for the company’s commitment to cash-based incentives. However, this does not undermine the core correctness. Overall, the answer demonstrates strong multi-hop synthesis across years and policy changes, with excellent contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 462,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra’s Special Use Funds stayed robust, hovering around $9 billion (a modest dip from $9.1 bn to $8.8 bn) and composed of high‑quality, liquid securities. This ample liquidity buffer enables the company to satisfy derivative‑related collateral obligations—such as the $645 million cash posting required for a BBB/Baa2 rating downgrade and potentially much larger contingent postings if ratings fall below investment grade—without straining its finances. Consequently, its liquidity position remains strong, providing a comfortable cushion against the collateral demands of its extensive derivative portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NextEra Energy's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, but the LLM claims a decrease from $9.1 billion to $8.8 billion, which is incorrect in both direction and magnitude. The LLM also cites a $645 million cash posting requirement for a BBB/Baa2 downgrade, but the ground truth states actual cash collateral posted was $691 million in 2023 (up from $84 million in 2022), with no mention of a $645 million threshold. Additionally, the LLM fails to mention the key reduction in potential collateral obligations from $5.2 billion in 2022 to $2.4 billion in 2023, a critical point in assessing risk management improvements. (2) Quantitative errors include incorrect fund balances, wrong collateral amounts, and missing data points (e.g., no mention of $2.7 billion potential exposure in 2022). The direction of change in Special Use Funds is reversed. (3) The multi-hop reasoning is flawed: the LLM recognizes the role of Special Use Funds in covering derivative collateral, but fails to synthesize the actual trend of declining risk exposure and increasing liquidity reserves over time. It misses the strategic improvement narrative supported by the data. (4) While the answer is contextually relevant—discussing liquidity and derivative collateral—it misrepresents the core financial trends and omits key evidence of improved risk positioning, leading to a low correctness score despite some conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 428,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe 1.600% Notes carry a fixed $700 million principal through 2022‑2024, and the annual amortization adjustments have fallen from roughly $(2.6)$ million in 2023 to $(1.5)$ million in 2024, indicating a tapering of discount/premium amortization. This stable principal and declining amortization show that American Tower is treating the issue as a long‑term, low‑cost funding source, planning to address the 2026 call date through refinancing or cash‑flow‑driven repayment rather than accelerating principal reductions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly identifies the $700 million principal as fixed across 2022–2024, it misstates the amortization adjustments. The ground truth shows adjustments decreasing from (3.7) million in 2022 to (2.6) million in 2024, but the LLM claims they fell from (2.6) million in 2023 to (1.5) million in 2024—introducing incorrect values and omitting 2022 entirely. This represents a major error in numerical reporting. (2) The LLM incorrectly implies the amortization is related to discount/premium amortization, while the original answer refers more generally to adjustments likely representing amortization or accrued interest—this interpretation is speculative and not fully supported. Additionally, the mention of a '2026 call date' is not present or verifiable in the ground truth and introduces unsupported external information. (3) The multi-hop reasoning is partially sound in that it connects stable principal with declining amortization to infer a long-term debt strategy, which aligns with the original conclusion. However, the flawed data undermines the validity of this inference. (4) Despite incorrect numbers and unsupported details, the answer remains contextually relevant by addressing both the trajectory and strategic implication. The core idea of a stable, long-term funding strategy is consistent, earning moderate scores for qualitative accuracy and high relevance. However, the quantitative inaccuracies severely reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 429,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payments widened as CMS repeatedly revised the risk‑adjustment model and froze or cut benchmark rates, producing lower capitation and greater payment uncertainty; in response the company progressively (1) trimmed or restructured benefit designs and selectively raised premiums, (2) exited or limited enrollment in low‑margin counties, and (3) intensified medical‑cost and operating‑expense controls while bolstering its risk‑adjustment data‑validation and analytics capabilities to reduce audit‑driven recoupments and protect margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 is accurately described, with CMS revising methodologies annually and implementing benchmark freezes/cuts. The strategic responses—benefit redesign, selective premium increases, county exits, and cost controls—are fully aligned with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent regulatory pressure across three years and maps evolving corporate responses, showing progression in strategy (e.g., 'progressively' refining actions). It also adds a nuanced detail—enhancing data-validation and analytics capabilities to reduce audit recoupments—which is consistent with UNH’s known practices and enriches, without contradicting, the ground truth. (4) The only reason for not scoring a perfect 10 is that the original answer explicitly structures the response by year (2022, 2023, 2024), while the LLM generalizes the evolution across the period. This is a minor omission in temporal granularity but does not affect factual correctness. Overall, the answer is contextually complete, logically structured, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 396,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nFrom 2022 to 2024 the employee merchandise discount grew from a simple, flat‑rate discount on most store items (roughly a 10 % off‑price that applied to the full product mix) to a more layered benefit that is now linked to Target’s Circle loyalty program and paired with higher base wages, tuition‑reimbursement, and free mental‑health resources.  This expansion shows that Target is using broader merchandise‑discount and related perks as part of a holistic financial‑well‑being strategy—aimed at increasing employees’ disposable income, reducing out‑of‑pocket costs, and strengthening retention through improved financial security.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Target's evolving employee benefits strategy from 2022 to 2024, correctly identifying the integration of merchandise discounts within a broader financial well-being framework that includes higher wages, tuition support, and mental health resources. However, it introduces specific quantitative and structural details not present in the ground truth: notably, the claim of a '10% off-price' discount is unsupported by the original answer, which does not specify the discount rate. Additionally, the assertion that the discount became 'linked to Target’s Circle loyalty program' is not mentioned in the ground truth and represents an unsupported inference. The original answer emphasizes consistency in the merchandise discount as a benefit while highlighting the expanding context of financial support (e.g., wage increases from $15 to $15–$24, addition of sick pay, tuition-free education, and mental health services), but does not describe structural changes to the discount itself. The LLM incorrectly implies an evolution in the discount's design (from flat-rate to layered), whereas the ground truth states the discount remained a 'consistent offering'—the evolution was in framing and surrounding benefits, not the discount mechanism. While the conclusion about Target’s holistic strategy aligns semantically with the original, the inclusion of fabricated specifics reduces factual accuracy. Multi-hop reasoning is partially sound—linking wages, benefits, and retention—but based on incorrect granular details. Contextual relevance is high as the response addresses both parts of the question: evolution of discounts and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 460,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nAmerican Express’s foreign‑government‑bond portfolio grew only modestly—from roughly $610 million in 2022 to about $660 million by 2024—while the weighted‑average yield rose from roughly 2.4 % to just under 3 % as global rates increased.  Over the same three‑year span more than 95 % of the holdings matured within one year, with only a tiny fraction extending beyond five years.  This short‑duration, high‑quality allocation reflects a deliberately conservative risk appetite, using sovereign bonds to manage foreign‑exchange exposure while preserving liquidity and limiting interest‑rate sensitivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that American Express held $630 million in Foreign Government Bonds in 2022, but the LLM claims $610 million. The 2024 value is reported as $660 million in the LLM answer, but no total portfolio value for 2024 is provided in the ground truth, making this an unsupported addition. More critically, the yield data is completely misrepresented: the LLM reports a single average yield rising from 2.4% to under 3%, while the ground truth shows a split by maturity with dramatic changes—e.g., short-term yields jumping from 1.74% to 6.45% in 2023 and then falling to 5.86% in 2024, and long-term yields peaking at 4.48% then collapsing to 2.03%. The LLM’s claim of a uniform rise to just under 3% is factually incorrect. (2) The LLM incorrectly states that over 95% of holdings matured within one year throughout the period, which is not supported by the original data—no such maturity distribution percentages are given in the ground truth. (3) The reasoning and synthesis are flawed: the original answer reveals a dynamic shift—increased short-term yields in 2023 followed by a sharp drop in long-term yields in 2024—indicating active strategy shifts in response to interest rate changes. The LLM instead concludes a 'conservative risk appetite' and 'short-duration, high-quality allocation' as a static strategy, missing the evolution entirely. This misreads the multi-hop pattern of change over time. (4) While the LLM addresses the general topic of yield, maturity, and risk strategy, its factual inaccuracies in numbers, missing granular yield-by-maturity data, incorrect portfolio sizes, and flawed interpretation of strategic intent severely undermine correctness. The contextual relevance is moderate because it attempts the right themes, but the qualitative and quantitative inaccuracies result in a largely incorrect assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 522,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nCollateral posted under master‑netting arrangements dropped from $1.49 bn in 2022 to $0.80 bn in 2023 and $0.49 bn in 2024, a reduction that is reflected in the declining “Other assets, including intangibles – net” balance. This downward trend shows ExxonMobil is relying less on external collateral, indicating a more efficient management of its derivative exposure and lower counterparty‑credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collateral values for 2022 ($1.49 bn = $1,494 million), 2023 ($0.80 bn = $800 million), and 2024 ($0.49 bn = $491 million), matching the ground truth exactly in dollar amounts despite format differences (bn vs million). All numeric values and years are accurate. (2) Quantitative accuracy is perfect—no calculation errors, and the downward trend is correctly described. (3) The reasoning is sound: the LLM correctly links the decline in collateral to derivative exposure management and infers reduced reliance on external collateral, which aligns with the ground truth's interpretation of reduced derivative exposure or shifted risk management. The only minor difference is that the LLM adds 'lower counterparty-credit risk' and 'more efficient management,' which are reasonable inferences but not explicitly stated in the original answer. These do not contradict the ground truth and are logically consistent, so they don't reduce accuracy. (4) The answer is fully contextually relevant, addressing both the quantitative trend and its implication for derivative exposure management. The multi-hop synthesis—linking collateral changes in 'Other assets' to risk management strategy—is correctly executed. Scored 9/10 overall due to slight interpretive expansion beyond the original answer, but not enough to warrant a lower score given the factual correctness and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 397,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe 2.700% senior notes were issued on March 29 2021 at a fixed 2.700% coupon, with semi‑annual interest payments on April 15 and October 15 and a maturity of April 15 2031 (par‑call January 15 2031). Across the 2022‑2024 filings (pages 46‑50 of the 2022 10‑K, pages 109‑113 of the 2023 10‑K, and pages 112‑116 of the 2024 10‑K) the notes remain outstanding with the same coupon, interest schedule and maturity, showing that AMT has deliberately retained this low‑cost, long‑dated debt while retiring higher‑rate obligations—an approach that capitalizes on favorable market conditions and locks in low rates before they rise.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key quantitative details. According to the ground truth, the maturity date was updated to January 15, 2031 by 2023 and remained so in 2024, but the LLM incorrectly states the maturity as April 15, 2031 throughout. Additionally, the par-call date (January 15, 2031) is mentioned in the ground truth but conflated with maturity in the LLM response. The LLM also fails to mention the decrease in interest rate spread from (5.0) to (4.4) by 2024, a key evolution in terms. However, it correctly identifies the $700.0 million principal amount, the 2.700% coupon rate, and semi-annual interest payments in April and October. (2) The issuance date (March 29, 2021) is correctly cited, but the LLM implies the note details are unchanged through 2024, which contradicts the ground truth showing a change in maturity date and interest rate spread. The interest payment dates are slightly off—ground truth specifies April and October without exact days, while LLM specifies April 15 and October 15, which may be inferred but not explicitly confirmed across all years. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategy of retaining low-cost debt, which aligns with the ground truth’s interpretation of stable financing. However, it misses the nuance that market conditions may have improved by 2024 (as reflected in the reduced interest rate spread), suggesting evolving rather than static conditions. (4) The contextual relevance is high—the answer addresses the evolution of terms and interprets strategy appropriately—but the correctness score is limited by significant factual errors in dates and omission of key metric changes, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 477,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nThe fair‑value of NVIDIA’s 2.00 % Notes due 2031 was $1.04 billion at the end of fiscal 2023 and rose modestly to $1.06 billion by the end of fiscal 2024 (Note 9 – Fair Value of Financial Assets and Liabilities). The underlying principal and maturity date did not change; the increase reflects the notes’ growing market value as discount rates fell. This steady, low‑coupon, long‑dated debt shows NVIDIA’s long‑term strategy of anchoring its capital structure with inexpensive, durable financing to fund growth while avoiding frequent refinancing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in 2022 was $1.2 billion, but the LLM omits this entirely. For 2023, the ground truth reports a beginning balance of $1.044 billion and an ending balance of $1.057 billion; the LLM reports $1.04 billion at the end of 2023, which is close but not precise. For 2024, the ground truth specifies a carrying value of $1.25 billion (with no short-term portion), but the LLM reports a fair value of $1.06 billion—this is a major discrepancy in both amount and metric (carrying value vs. fair value). (2) The LLM incorrectly labels the 2024 figure as 'fair value' when the ground truth specifies 'carrying value,' which are distinct accounting metrics. Additionally, the LLM claims the increase is due to falling discount rates, which is speculative and not supported in the original answer. (3) While the LLM correctly identifies the strategic use of long-term, low-cost debt, it fails to reflect the full multi-hop progression from 2022 to 2024 as required. The omission of the 2022 $1.2 billion figure and misrepresentation of 2024 data undermine the synthesis. (4) Despite these issues, the answer is contextually relevant and captures the general idea of stable, long-term debt strategy. The reasoning about durable financing is plausible but not fully grounded in the provided data. Hence, partial credit is given for qualitative insight and relevance, but significant deductions apply for factual and numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 425,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife’s deposit assets on reinsurance fell from roughly $5.5 billion to $4.6 billion, and its deposit liabilities declined from about $1.4 billion to $1.2 billion. This reduction shows a deliberate pull‑back from the deposit method, signaling a strategic shift toward more traditional ceding arrangements and a focus on simplifying the reinsurance program and improving capital efficiency.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude of trends. According to the ground truth, MetLife's deposit assets on reinsurance increased from $1.8 billion in 2022 to $5.1 billion in 2024, whereas the LLM claims they decreased from $5.5 billion to $4.6 billion. This misrepresents both the starting value and the trend. Similarly, deposit liabilities in the ground truth rose from $1.4B (2022) to $1.3B (2023) to $1.2B (2024), showing a slight decline in the final year, but the LLM incorrectly states a continuous decline from $1.4B to $1.2B without acknowledging the 2023 increase. (2) The numbers are factually wrong: no year in the ground truth reports $5.5B or $4.6B in deposit assets. The only correct figure loosely approximated is the $1.2B liability in 2024. The LLM also omits the key 2023 Global Atlantic transaction involving $10.3B in reinsurance recoverables, which is central to explaining the asset increase. (3) The multi-hop reasoning is flawed: instead of recognizing the strategic expansion in deposit-method reinsurance agreements (especially post-Global Atlantic), the LLM infers a 'pull-back' and shift to traditional ceding, which contradicts the evidence of growing deposit assets. The conclusion about simplification and capital efficiency is unsupported by the provided data. (4) The contextual relevance is partially maintained as the answer discusses reinsurance strategy and deposit method accounting, but the factual inaccuracies and reversed trend interpretation severely undermine the response. Due to major errors in all key metrics and strategic interpretation, the correctness score is very low at 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 459,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nUnitedHealth Group’s held‑to‑maturity debt‑security portfolio slipped from **$603 million (amortized cost) / $596 million (fair value) at year‑end 2022** to **$512 million (amortized cost) / $508 million (fair value) at year‑end 2024** (the 2023 figure remained $603 million/$596 million).  The roughly $90 million reduction in carrying amount and $88 million decline in fair value over the three‑year span reflects a deliberate downsizing of long‑duration fixed‑income holdings—likely to curb interest‑rate sensitivity and re‑allocate capital toward shorter‑maturity or more liquid assets—while the remaining securities continued to trade below cost, a pattern the company attributes to broad market rate increases rather than credit deterioration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, the fair value was $679 million and carrying value was $696 million, but the LLM incorrectly states $596 million (fair) and $603 million (carrying) for 2022—this is actually the 2023 data. The LLM repeats the 2023 figures as if they were 2022, then correctly reports 2024 values ($512M carrying, $508M fair). Thus, the 2022 numbers are wrong, and the 2023 data is misrepresented as static when it should reflect a drop from 2022. (2) Calculations: The LLM claims a ~$90M reduction in carrying value and ~$88M in fair value from 2022 to 2024. Using ground truth: carrying value dropped from $696M to $512M = $184M reduction; fair value from $679M to $508M = $171M reduction. Therefore, the LLM’s calculated declines are off by nearly half, due to using incorrect base year values. (3) Multi-hop reasoning: While the LLM correctly infers a strategic downsizing and links it to interest rate sensitivity and capital reallocation—consistent with the ground truth’s interpretation of strategic repositioning—the reasoning is based on incorrect data, weakening the validity of the conclusion. The mention of securities trading below cost aligns with the idea of market rate impacts, which is plausible context. (4) Despite incorrect numbers, the answer addresses all parts of the question: evolution over time, fair vs carrying value, and interpretation of strategy/market adjustments. Wording and semantic intent are relevant and mostly aligned, but factual errors in core data severely impact correctness. Hence, quantitative accuracy is low (5), qualitative reasoning is reasonable given flawed input (7), and relevance is high (9). Overall correctness is reduced to 6 due to major data misattribution across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 496,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe Target Credit Card (now the Target Circle Card) penetration fell each year: ≈ 20.5 % in fiscal 2022 (ended Jan 29 2022), ≈ 19.8 % in fiscal 2023 (ended Jan 28 2023) and ≈ 18.6 % in fiscal 2024 (ended Feb 3 2024). This steady decline indicates that the card‑holder discount program is losing its ability to attract new cardholders and to generate incremental purchases, suggesting that the current credit‑card strategy is becoming less effective at driving additional sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. It also accurately reflects the downward trend year-over-year. The fiscal year-end dates are correctly noted (e.g., Jan 29, 2022, etc.), which aligns with Target's fiscal calendar. (2) All numeric values and time periods are accurate. The use of '≈' is acceptable given that the original data may be rounded, and the values match precisely. No calculation errors are present. (3) The reasoning correctly identifies the declining trend and links it to potential weakening effectiveness of the credit card strategy. However, the LLM answer omits a key nuance from the original answer: despite the decline, Target's internal analysis still finds that the card drives incremental sales and retains strategic value. The LLM instead concludes the strategy is 'becoming less effective,' which is a stronger and slightly less balanced interpretation than the original. This misses the multi-hop synthesis that while penetration is down, the card still contributes meaningfully to sales. (4) The answer is factually correct and contextually relevant, with full quantitative accuracy. The qualitative accuracy is slightly reduced due to the omission of the mitigating insight about ongoing incremental sales. Contextual relevance is high as it directly addresses both parts of the question—trend and strategic implication—though with a slightly one-sided conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 417,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nNike continued to **own** its major distribution hub in **Laakdal, Belgium** across the FY 2022, FY 2023 and FY 2024 filings, listing it alongside other owned overseas sites (e.g., Taicang, China; Tomisato, Japan; Icheon, Korea).  This consistent, wholly‑owned status shows that Nike is deliberately **reinforcing direct control over its European logistics network**, using Laakdal as a strategic gateway to serve European markets efficiently and to underpin its broader supply‑chain expansion in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Nike maintained ownership of its Laakdal, Belgium distribution hub throughout fiscal years 2022–2024, which matches the original answer's assertion of unchanged ownership and operational role. The characterization of Laakdal as a major, wholly-owned facility used to reinforce direct control over European logistics is consistent with the ground truth’s conclusion about Nike’s strategic focus on maintaining control over key logistics nodes. There are no numeric values requiring calculation, and all dates (FY2022–FY2024) are correctly referenced. The LLM adds contextual detail—comparing Laakdal to other owned international facilities (Taicang, Tomisato, Icheon)—which is not in the original answer but does not contradict it and supports the reasoning. The only minor difference is that the original emphasizes the 'consistency' of the facility's significance and ownership without explicitly stating strategic intent, while the LLM infers a more active strategy ('reinforcing direct control', 'supply-chain expansion'). This interpretation is reasonable and logically sound, but slightly more assertive than the original’s neutral tone. Thus, while all facts are correct (quantitative and entity accuracy perfect), the qualitative reasoning edges toward interpretation, warranting a 9 instead of 10. Contextual relevance is full—every part of the question is addressed: ownership, operational footprint evolution, and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 423,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nAcross the FY 2022, FY 2023 and FY 2024 10‑K filings, Lumentum Holdings is consistently listed among NVIDIA’s networking competitors (optical modules, switches and DPUs).  At the same time, NVIDIA’s narrative shifts toward expanding its own supply‑chain capabilities—adding redundant, in‑house and contract‑manufacturer sources for interconnect and cable solutions—and to strengthening IP protection through a growing patent portfolio and tighter export‑control licensing.  These developments suggest that NVIDIA is increasingly relying on internal or tightly controlled suppliers rather than external vendors, causing Lumentum’s relative competitive weight to recede over the three fiscal years.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that Lumentum Holdings is consistently listed as a competitor to NVIDIA in networking products across FY 2022–2024, and it correctly identifies the domain (optical modules, switches, and DPUs). It also accurately notes NVIDIA’s strategic moves to strengthen supply chain capabilities and IP protection. However, the key reasoning and conclusion are factually incorrect: the LLM claims that Lumentum’s 'relative competitive weight' has 'receded' over the period, which directly contradicts the ground truth. The original answer emphasizes that Lumentum remained a 'persistent competitive force' and was consistently named across all three years, indicating sustained relevance despite NVIDIA’s strategic advancements. There is no evidence in the ground truth to support a decline in Lumentum’s competitive positioning. This misinterpretation reflects a failure in multi-hop reasoning—while the individual facts are mostly accurate (entities, years, domains), the synthesis and inference are flawed. Quantitative accuracy is scored highly because there are no numerical claims requiring verification (e.g., dates like patent expirations to 2045 are not misrepresented, just omitted). Contextual relevance is strong as the answer addresses the core topic and timeframe. However, the incorrect qualitative conclusion significantly undermines the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 388,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s dependence on external rights‑holders has become increasingly fragile: studios and content providers are pulling popular titles, demanding higher fees and reserving exclusivity for their own streaming services, which forces Netflix to negotiate tighter, more expensive licensing deals or lose access to key libraries. In response, the company has shifted its acquisition strategy toward greater investment in original productions and exclusive content agreements, while also contending with new regulatory pressures—such as European content‑quota and levy rules—that can limit how it licenses or owns material. This evolution reveals a strategic pivot from a pure‑licensing model to a hybrid approach that relies more on owned‑and‑produced content to differentiate the service amid intensifying competition and evolving global regulatory environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Netflix's increasing challenges with rights holders from 2022–2024, rising licensing costs, content withdrawal by studios launching their own platforms, strategic shift toward original content, and the emergence of regulatory pressures (e.g., European content quotas) in 2024 are all correctly represented. (2) There are no numeric values (e.g., dollar amounts, percentages, or specific counts) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes Netflix’s evolving content strategy across years, connects licensing risks to competitive dynamics (studio-owned streaming services), and incorporates regulatory changes as a new layer in 2024. The only minor gap is that the original answer explicitly structures the evolution year-by-year (2022, 2023, 2024), while the LLM generalizes the trend across the period—this slight lack of temporal granularity prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing how Netflix’s reliance on licensing has evolved and what that reveals about its strategy amid competition and regulation. Wording differs but meaning is preserved. Overall, this is a strong, factually correct response with only minor structural differences from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 399,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company kept outdoor‑lighting contracts in the “operating‑leases” line of its lease‑income table and continued to exclude any variable‑payment amounts from the maturity analysis.  The contracts were consistently described as immaterial, so they are not shown as a separate line item but are simply rolled into the aggregate operating‑lease maturity schedule, with the same presentation format used in each year.  Consequently, there was no change in materiality, revenue classification, or how the scheduled payments are displayed in the maturity tables across the 2022‑2024 periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims there was 'no change' in materiality, revenue classification, or presentation from 2022 to 2024, but the original answer shows a clear evolution: immaterial in 2022, inclusion in maturity analyses with tolling/PPAs in 2023, and explicit inclusion of initial-term payments in 2024. This progression reflects increasing materiality recognition and transparency, directly contradicting the LLM's claim of no change. (2) While no specific dollar amounts are in the original answer, the LLM incorrectly asserts that disclosures and presentation remained static across years, which is factually wrong. The key 'numbers' here are the years and their associated disclosures, which the model misrepresents. (3) The multi-hop reasoning fails: the question requires synthesizing changes over time across three dimensions (materiality, revenue classification, presentation), but the LLM incorrectly concludes no evolution occurred. It misses the shift from immaterial (2022) to structured inclusion (2023–2024), and fails to recognize that inclusion in maturity analyses alongside PPAs and tolling arrangements indicates a change in both materiality assessment and presentation. (4) The LLM also misstates revenue classification by implying these are lease-income items, while the original answer focuses on lease *payments* and obligations, not revenue. The contextual relevance is moderate because it addresses the right company and topic, but the core factual claims are incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 434,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000% notes due April 2030 had an outstanding principal of roughly $603 million at the end of fiscal 2022, increased modestly to $606 million by the end of fiscal 2023 and remained at $606 million through fiscal 2024. This flat trajectory shows that the company is treating the issuance as a stable, long‑term financing component and is not actively repaying or refinancing this tranche.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, the outstanding principal was $1,086 million in fiscal year 2022, but the LLM incorrectly reports it as $603 million. This is a major discrepancy of over $480 million. The LLM correctly reports the balance as $606 million in both 2023 and 2024. However, it falsely claims the balance increased from $603M to $606M, when in reality it decreased sharply from $1,086M to $606M—a critical difference in trend direction. (2) Calculations and comparisons are therefore fundamentally flawed: the actual evolution shows a significant reduction (nearly 45% decrease) in 2023, indicating active debt repayment, whereas the LLM suggests stability or even a slight increase. This misrepresents the financial reality. (3) The multi-hop reasoning is unsound: the model fails to correctly synthesize the balance changes across years, leading to an incorrect interpretation of AVGO’s debt strategy. The ground truth indicates a deliberate debt reduction in 2023, which the LLM completely misses. Instead, it concludes the debt is being treated as a stable long-term instrument due to flat trajectory—this is not supported by the actual data showing a large drop in year-over-year balance. (4) Contextual relevance is moderate: the answer addresses the right instrument (5.000% notes due April 2030), the correct company (AVGO), and the correct time frame (2022–2024), and attempts to interpret strategy, but the conclusion is invalid due to incorrect data. The qualitative reasoning would have been acceptable if based on correct numbers. Overall, the answer is mostly incorrect due to severe quantitative inaccuracies that invalidate the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 477,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nGM’s long‑term expected return on U.S. pension assets climbed from **5.6 % in 2022 to 6.3 % in 2023** and stayed essentially flat at **≈6.27 % in 2024**.  This upward shift reflects a deliberate **strategic re‑allocation of the pension portfolio**—equity exposure was raised (from 9 % to 11 % of assets) and “other” (private‑equity, real‑estate, hedge‑fund) allocations increased (from 23 % to 29 %), while debt exposure was trimmed (from 68 % to 60 %).  The changes are aimed at generating higher returns to improve funded positions and offset lower discount rates, while still managing volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported rates of return. According to the ground truth, the long-term rate of return was 5.4% in 2022, 6.3% in 2023, and 6.5% in 2024. The LLM incorrectly states 5.6% in 2022 and approximately 6.27% in 2024, which is both numerically and directionally wrong (the trend should show an increase to 6.5%, not a slight decrease from 6.3%). These errors undermine the quantitative foundation of the response. (2) The calculation of the 3-year trend is therefore flawed: the actual increase is 1.1 percentage points (from 5.4% to 6.5%), but the LLM implies only a 0.67-point increase (from 5.6% to ~6.27%), which misrepresents the magnitude and direction of change. (3) While the LLM provides detailed asset mix shifts (equity, debt, 'other' allocations), these specific allocation percentages (e.g., equity from 9% to 11%, 'other' from 23% to 29%) are not present in the original answer and appear to be fabricated or misattributed, as the ground truth does not include such granular data. Thus, the multi-hop reasoning fails because it introduces unsupported details. (4) Despite these issues, the LLM correctly identifies the general strategic intent—shifting toward higher-return assets to improve funded status amid market conditions—which aligns semantically with the original conclusion about a more optimistic outlook and shift to higher-risk strategies. The answer is contextually relevant and attempts sound reasoning, but the core numerical inaccuracies and unsupported specifics severely limit its correctness. Hence, the correctness score is low, with moderate qualitative and high contextual relevance scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 463,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe 2.700 % Senior Notes due 2031 appear in the supplemental indentures filed in 2022, 2023 and 2024, showing that the issue remains outstanding and is being referenced in later debt‑amendment transactions.  This signals that American Tower is treating the 2031 notes as a core, long‑dated, low‑coupon component of its capital structure—using long‑maturity, fixed‑rate debt to fund its tower portfolio and maintain a stable, diversified maturity profile rather than retiring or refinancing the securities early.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core insight of the ground truth: the consistent treatment of American Tower's 2.700% Senior Notes due 2031 across 2022–2024 filings reflects a stable, long-term financing strategy. (1) All entities are correct—American Tower, the 2.700% Senior Notes, and the 2022–2024 timeframe are accurately referenced. The percentage (2.700%) and maturity year (2031) are factually correct. (2) There are no calculations, but the temporal consistency across filings is correctly inferred, aligning with the ground truth’s emphasis on continuity. (3) The multi-hop reasoning is sound: the model synthesizes the presence of the notes across three years and infers strategic intent—using long-dated, fixed-rate debt to maintain capital structure stability. While the LLM does not explicitly mention 'Supplemental Indenture No. 8' or cite the specific document names (e.g., AMT_10k_2022.pdf), this level of documentary detail is not essential to the strategic interpretation. The omission is minor and does not affect the factual or inferential correctness. (4) The answer conveys semantic equivalence: it correctly identifies the notes as a 'core' component, emphasizes long-term use, low coupon, and absence of early retirement, which aligns with the ground truth’s conclusion of strategic confidence and stability. The answer is concise but complete for the question’s scope. Minor deduction from 10 to 9 due to lack of explicit reference to the indenture continuity, which strengthens the evidence base in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 427,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior and credit‑related losses grew as fraud, charge‑backs and defaults increased across its credit products and cross‑border transactions, prompting the company to overhaul its risk‑management framework.  To mitigate these risks it (i) sold and securitized U.K./EU BNPL loan receivables and diversified its payment‑processor relationships—including a migration away from a single U.S. processor—thereby reducing reliance on vulnerable funding sources; (ii) strengthened fraud‑detection and buyer‑/seller‑protection systems and tightened underwriting for its consumer and merchant credit offerings; and (iii) enhanced cross‑border compliance and currency‑risk controls, tightening monitoring of international trade to limit the financial impact of abusive activity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of PayPal's exposure to abusive behaviors and key mitigation strategies across 2022–2024, aligning with the ground truth in broad strokes. It correctly identifies increasing fraud in credit products and cross-border transactions, and notes strategic risk reduction via selling/securitizing BNPL receivables in Europe and the U.K., which matches the 2023 action in the original answer. However, it omits the specific €40 billion figure from the multi-year agreement, a key quantitative detail. While the format variation (e.g., not requiring '€40 billion' to be explicitly stated) is acceptable, the complete absence of any numerical value for the transaction reduces quantitative precision. (2) The LLM introduces additional details not present in the ground truth—such as 'migration away from a single U.S. processor' and 'diversified payment-processor relationships'—which are unsupported by the original data. These additions, while plausible, introduce factual overreach. Similarly, 'tightening underwriting' and 'enhanced cross-border compliance' are reasonable inferences but not explicitly stated in the ground truth, which focuses on third-party risk and detection systems. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the shift from identifying risk (2022), taking action (2023), and reinforcing systems (2024). However, it fails to explicitly mention the 2022 identification of stolen identities or the 2024 emphasis on third-party operational and reputational risks, which are central to the original answer’s narrative. (4) The contextual relevance is high—the answer directly addresses the question’s focus on evolution and mitigation. The qualitative accuracy is reduced due to unsupported details and missing key elements of PayPal’s stated third-party reliance. Overall, the answer is factually plausible and captures the strategic trajectory but lacks precise alignment with documented actions and omissions in entity-specific risk disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 552,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nThe pension plan’s stake in “Collective Trust and Other Funds” fell sharply in dollar terms—from **$622 million in 2022 to $498 million in 2023 and $382 million in 2024**—and its share of the total NAV portfolio dropped from roughly **46 % to 32 % and then to about 40 %**.  This pull‑back from alternative, less‑liquid investments coincides with UNP’s broader de‑risking strategy, which has moved the target allocation toward a much higher proportion of debt (≈70‑80 %) and a lower equity range (≈20‑30 %).  The trend signals that the company is deliberately reducing exposure to higher‑volatility fund assets and focusing on a more stable, income‑oriented portfolio to safeguard long‑term employee benefit obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar amounts and percentages. According to the ground truth, UNP's allocation was $756 million in 2022 and $382 million in 2023, with no updated dollar value provided for 2024. The LLM incorrectly states $622M (2022), $498M (2023), and $382M (2024), misrepresenting both the starting value and the trend. Additionally, the ground truth does not mention any percentage of total NAV portfolio or a rebound to 40% in 2024; these figures are fabricated. (2) The calculation of a drop from $622M to $498M to $382M implies a continued decline, which aligns directionally with the actual decrease from $756M to $382M, but the magnitude and base values are wrong. The percentages cited (46%, 32%, 40%) have no support in the original answer and contradict the narrative since a drop to 32% followed by a rise to 40% would not clearly signal de-risking without explanation. (3) The reasoning about de-risking and strategic rebalancing toward debt and away from volatile assets is consistent with the ground truth’s interpretation of a 'de-risking or rebalancing' strategy. However, the LLM introduces unsupported details such as target allocation ranges (70–80% debt, 20–30% equity) and NAV portfolio share changes that were not present in the source, undermining the multi-hop synthesis. (4) While the overall direction of the trend (decreasing allocation) and the qualitative interpretation (de-risking) are partially aligned, the incorrect numbers and invented metrics severely reduce factual reliability. The contextual relevance is high because the answer addresses both parts of the question—trend and strategic implication—but the factual foundation is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 482,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards moved from an active grant program to a discontinued one. In 2022 the company began granting BPAs to selected non‑executive employees, measuring them at intrinsic value on the grant date and amortizing the expense over the probable vesting term while adjusting each reporting period for changes in share price and the probability of achieving the performance targets; a small number of awards remained outstanding at year‑end 2022. In 2023 the same intrinsic‑value methodology continued, but the 2022‑ and 2023‑granted BPAs were modified so that, for active participants, vesting would occur on the fifth anniversary rather than the original schedule, and the outstanding balance began to shrink as awards vested or were forfeited. By the end of 2024 no new BPAs were granted and none were outstanding, so no further expense is recorded and the program effectively ended.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, Pfizer issued 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained outstanding at year-end valued at $59.05 per share. The LLM answer omits all these specific numbers and instead vaguely refers to 'a small number of awards remaining outstanding,' which fails to meet the required precision. Furthermore, the LLM incorrectly claims that BPAs were granted in 2023, stating '2022- and 2023-granted BPAs were modified,' while the ground truth explicitly states that no BPAs were granted in 2023 and none remained outstanding by year-end. This is a major factual error. (2) The LLM also misrepresents the timeline and evolution: it suggests the program was modified in 2023 with a new vesting schedule, but the ground truth indicates no grants and no outstanding awards in 2023, implying full termination or vesting/forfeiture, not a modification. Then, in 2024, the LLM says no new BPAs were granted and none were outstanding, which aligns with the ground truth, but it fails to mention the key development — that Pfizer introduced a new formal valuation methodology using intrinsic value based on closing stock price at grant date, with quarterly adjustments for stock price and performance probability. Instead, the LLM implies the methodology was already in place in 2022 and continued, which contradicts the ground truth showing a methodological formalization in 2024. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the discontinuation of grants in 2023 and the reintroduction of a structured accounting framework in 2024. It incorrectly assumes continuity of grants into 2023 and misattributes the timing of accounting policy details. (4) Despite these issues, the answer is contextually relevant — it addresses grant activity, outstanding status, and accounting treatment over the three years — and captures the high-level narrative of program wind-down. However, due to major quantitative errors and incorrect sequencing of events, the correctness score is low. The qualitative accuracy is moderate because some reasoning structure is sound, and contextual relevance is high as the response stays on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 625,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nThe collateral that the company posts under master‑netting arrangements fell sharply – from about **$1.49 billion in 2022**, to **$0.80 billion in 2023**, and then to **$0.49 billion in 2024**.  This downward trend shows that ExxonMobil’s net credit exposure to derivative counterparties has been trimmed, so the amount of external collateral (mainly initial margin) that must be posted against its investments, advances and long‑term receivables has been reduced, reflecting either smaller derivative notional balances or improved counterparty credit quality and lower margin‑call requirements over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all three collateral values: $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024), which match the ground truth of $1,494 million, $800 million, and $491 million respectively—minor rounding is acceptable ($1.49B ≈ $1,494M). 2) Quantitatively, all numbers and trends are accurate; the downward trajectory is correctly described. 3) The reasoning is sound: the LLM correctly infers that the decline suggests reduced derivative exposure or lower margin requirements, and adds nuanced interpretation—such as improved counterparty credit quality or smaller notional balances—which is consistent with and expands upon the original answer without introducing error. 4) The answer fully addresses both parts of the question: the change over time and the implication for derivative exposure and margin requirements. The only minor gap is that the original answer emphasizes 'strategic adjustment' as a possible cause, while the LLM focuses more on credit exposure and counterparty factors—this is a difference in emphasis, not inaccuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 327,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom’s 10‑K filings show that in 2022 industrial fiber‑optics was listed only as one of several “Industrial” components (alongside optocouplers, sensors and motion‑control encoders) and was framed mainly as a support technology for factory‑automation and medical‑device applications (see AVGO_10k_2022.pdf pp. 8‑12). By 2023 the company broadened the narrative, presenting industrial fiber‑optics as a distinct growth area within its industrial portfolio and explicitly linking it to renewable‑energy and automotive‑electronics use‑cases alongside optocouplers, sensors and encoders (see AVGO_10k_2023.pdf pp. 3‑7). In 2024 the emphasis shifted further, describing industrial fiber‑optics as part of a comprehensive automation suite that serves a wider range of industrial end‑markets—from factory automation to renewable‑energy systems—underscoring a strategic intent to deepen Broadcom’s presence in high‑margin, diversified industrial markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and strategic interpretation. (1) All entities—Broadcom (AVGO), Industrial Fiber Optics, and the relevant years (2022, 2023, 2024)—are accurately identified. There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (2) The LLM correctly captures the evolution: in 2022, fiber optics were part of a broader industrial suite with emphasis on factory automation and medical devices; in 2023, expanded to include renewable energy and automotive electronics; in 2024, integrated into a broader automation suite. These points match the ground truth’s description of increasing application scope and structured presentation. (3) The multi-hop reasoning is sound—information is synthesized across three years of strategic positioning. However, the LLM omits specific details from the ground truth, such as the 'structured table format' in 2023 and the explicit listing alongside optocouplers, sensors, encoders, and Ethernet ICs in 2024. It also does not mention defense, aerospace, or subsystems in electric vehicles, slightly narrowing the application scope compared to the original. (4) Despite these minor omissions, the core strategic insight—that Broadcom is deepening its industrial presence with more focused, high-margin applications—is correctly inferred. Wording differs but semantic meaning is equivalent. Thus, the answer earns a high score but not perfect due to missing granular details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 445,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nAcross 2022 through 2024 PayPal continues to record transaction revenue on a **gross‑basis** and treats the fees it pays to third‑party processors as a separate “transaction expense,” thereby **bearing full margin risk** for every payment it authorizes.  The company retains complete discretion over the **transaction‑pricing structure**—including variable percentages, tiered volume discounts and performance‑based incentives—so the margin it retains is directly driven by the fees it sets.  While total payment volume and revenue grew each year, the underlying mechanics of pricing control and reliance on external processors remained essentially unchanged, so PayPal’s exposure to margin risk stayed constant, with only incremental refinements to incentive accounting and contract‑asset recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that PayPal bears full margin risk across 2022–2024 by recording revenue on a gross basis and treating third-party processor fees as transaction expenses, which aligns with the original answer’s emphasis on continued exposure to margin risk. It accurately notes PayPal’s discretion over pricing (e.g., variable percentages, volume discounts), which is central to its control over margins. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer to compare, so quantitative accuracy is not compromised—no errors in this regard. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent treatment of margin risk, pricing control, and use of third-party processors across the three years, correctly concluding that the risk profile remained stable. The only minor shortcoming is that it does not explicitly cite each year (2022, 2023, 2024) with a distinct statement as in the original, instead generalizing across the period—though this does not distort the truth. (4) The answer is fully contextually relevant, directly addressing how margin risk evolved (or did not evolve) in relation to pricing control and third-party processors. The use of terms like 'gross-basis,' 'transaction expense,' and 'margin risk' is semantically equivalent and precise. Overall, the answer is factually correct with only slight compression of the year-by-year confirmation, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 432,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s exposure to Meridian narrowed to a residual, wind‑down phase: the 2021 sale generated a $167 million after‑tax loss, and the 2022 10‑K (pp. 114‑118) notes that any post‑closing adjustments were immaterial; the 2023 10‑K (pp. 71‑75) confirms that the interim transition‑service agreements and the three‑year Master Services Agreement—under which any limited post‑sale services were to be provided—were fully performed and expired by the end of 2023, with no material revenue or expense recorded in 2023 or 2024; the 2024 10‑K (pp. 2‑6) shows no remaining contractual obligations or financial impact from Meridian.  This progression indicates that Pfizer has deliberately disengaged from the Meridian business, ending its strategic partnership and shifting focus away from that legacy area toward its core vaccine, oncology and other biopharma priorities.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key factual inaccuracies. It correctly identifies the $167 million loss from the sale of Meridian and references the post-sale agreements. However, it incorrectly states that the sale occurred in 2021 and that all agreements expired by the end of 2023, which contradicts the ground truth stating the Manufacturing Supply Agreement (MSA) began post-sale in late 2021 and lasted three years with a two-year extension option—meaning it would extend into 2024 or beyond. The LLM claims no contractual obligations existed in 2024, but the ground truth shows Meridian was still referenced in Pfizer's 2024 glossary, indicating an ongoing formal relationship. (2) Quantitative accuracy is partially correct: the $167 million loss is accurate, and the timing of the 2021 sale aligns with ground truth. However, the assertion that no material revenue or expense was recorded in 2023 or 2024, while plausible, cannot be fully verified from the ground truth, which does not specify financial activity beyond the initial loss. The LLM incorrectly implies all agreements ended by 2023, misrepresenting the duration of the MSA. (3) Multi-hop reasoning is partially sound—LLM traces the timeline from sale to wind-down—but fails to recognize the continuation of the contractual relationship into 2024 as evidenced by the glossary inclusion. This undermines the synthesis of strategic positioning, leading to an overstatement of complete disengagement. (4) Contextual relevance is high—the answer addresses financial impact, contractual evolution, and strategic focus. However, due to the misrepresentation of the contractual timeline and relationship status in 2024, the conclusion about 'deliberate disengagement' and 'ending strategic partnership' is overstated. The ground truth suggests a shift to a reduced but formalized relationship, not full termination. Thus, while the direction of strategic refocusing is correctly inferred, the extent and timeline are inaccurate, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 554,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory pressure on PMI’s reduced‑risk products intensified markedly, progressively narrowing the company’s ability to differentiate those products and to communicate with adult consumers.  In 2022 the filings noted existing bans on advertising, flavor restrictions and plain‑packaging rules, but by 2023 the scope of restrictions expanded to include broader flavor prohibitions, tighter limits on any health‑related or benefit‑focused messaging for RRPs/SFPs, and heightened scrutiny of product‑specific claims.  By 2024 further measures—such as mandatory plain‑packaging, bans on brand‑level marketing and stricter controls on communications about reduced‑risk products—have substantially curtailed PMI’s capacity to distinguish its RRPs and to reach adult smokers, eroding its competitive positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolving regulatory impact on Philip Morris International (PMI) from 2022 to 2024. It accurately captures the increasing regulatory constraints on product differentiation and adult consumer communication for reduced-risk products (RRPs) and smoke-free products (SFPs). The answer correctly identifies key regulatory trends—such as advertising bans, flavor restrictions, plain packaging, and limits on health-related messaging—across the three years, which is consistent with the original answer's emphasis on growing restrictions. The use of specific regulatory measures (e.g., brand-level marketing bans, controls on reduced-risk claims) adds detail that is plausible and contextually appropriate, though the original answer does not specify such granular policy examples. Where the LLM diverges slightly is in its stronger emphasis on concrete regulatory expansions (e.g., 'broader flavor prohibitions' in 2023, 'mandatory plain-packaging' in 2024) that are not explicitly detailed in the ground truth, which focuses more on the evolution of PMI's *language* and framing (e.g., shift from RRPs to SFPs, increasing concern about disproportionate impact). The LLM correctly reflects the intensifying challenge but adds inferential detail not present in the source. There are no factual inaccuracies in dates, entities, or financial data—none of which are numerically quantified in this case—so quantitative accuracy is perfect. Qualitative accuracy is high but not perfect due to the added specificity that goes beyond the original synthesis. Contextual relevance is excellent, as all parts of the question are addressed with appropriate focus on competitive positioning, product differentiation, and consumer communication. The multi-hop reasoning across years is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 507,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements and is **not** offset against its derivative liabilities fell sharply—from about **$1.49 billion in 2022 to $0.80 billion in 2023 and $0.49 billion in 2024**, a total decline of roughly **$1.0 billion** over the three‑year span.  This reduction shows that the company is deliberately scaling back the amount of collateral it must post, reflecting tighter derivative positioning, stronger counterparty credit quality and a more disciplined approach to managing derivative‑related credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth of $1,494 million, $800 million, and $491 million respectively (with acceptable rounding). The total decline of ~$1.0 billion is accurate: $1,494M - $491M = $1,003M. 2) All numeric values are correct and properly formatted; minor rounding (e.g., $1.49B vs $1.494B) is acceptable and common in financial reporting. Calculations (decline over period) are sound. 3) The reasoning correctly infers that the downward trend reflects strategic risk management, such as tighter derivative positioning and improved credit risk discipline. While the original answer emphasizes reduced derivative exposure or lower margin requirements, the LLM attributes the decline to stronger counterparty credit quality and disciplined risk management—this is a plausible and consistent interpretation, though slightly different emphasis. It successfully performs multi-hop reasoning by identifying the trend across three years and interpreting its implications for risk practices. 4) The answer is semantically equivalent to the original: it captures the full trend, correct figures, and provides a reasonable, contextually grounded explanation. The only minor difference is in the nuance of interpretation (e.g., 'stronger counterparty credit quality' is not explicitly in the ground truth), but this does not contradict it and falls within reasonable inference. All parts of the question are addressed: the change from 2022–2024 and its implication for derivative risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 441,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy’s expected volatility assumption fell from **28.6 % in 2022 (and again in 2023)** to **18.7 % for awards granted in 2024**.  This decline shows the company moved from a relatively high‑risk view of future price swings to a more muted expectation of market volatility, reflecting a shift toward perceiving lower equity‑price risk over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a critical factual error in the quantitative data: it states that Duke Energy's expected volatility was 28.6% in both 2022 and 2023, which contradicts the ground truth. According to the original answer, the volatility was 26.9% in 2022, increased to 28.6% in 2023, and then dropped to 18.7% in 2024. The LLM incorrectly merges the 2023 value as the 2022 value and omits the actual 2022 figure entirely. This misrepresents the trend, especially the initial increase from 2022 to 2023. However, the 18.7% figure for 2024 is correct.\n\n(2) Quantitative accuracy is low because two of the three data points are wrong: 2022 is incorrect (28.6% vs. true 26.9%), 2023 is misstated (implied same as 2022), and only 2024 is accurate. The calculation of trend direction (decrease overall) is partially correct but misses the intermediate rise, undermining the full evolution.\n\n(3) The reasoning is partially sound in interpreting the drop from ~28.6% to 18.7% as indicating lower perceived market risk, which aligns with the ground truth’s conclusion. However, the multi-hop synthesis fails because it does not acknowledge the increase in volatility from 2022 to 2023, which is a key part of the trend. The omission weakens the analysis of how risk perception evolved over time, making the explanation oversimplified.\n\n(4) Contextual relevance is high because the answer addresses the core question about volatility evolution and its implication for market risk perception. The language is appropriate, and the interpretation of reduced volatility as signaling lower risk is consistent with financial logic. Despite incorrect inputs, the qualitative inference based on the final drop is reasonable.\n\nOverall, the answer gets partial credit for identifying the 2024 drop and its implication but is significantly penalized for incorrect year-specific values and failure to capture the full three-year trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 519,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nThe 3.125 % senior notes that mature in January 2025 remained unchanged at a $495 million carrying amount in the fiscal‑year‑end balances for 2022, 2023 and 2024. Because this liability is included in the $1.245 billion “current portion of long‑term debt” reported as of Nov 3 2024, Broadcom is managing it as a short‑term obligation that will be rolled into its broader refinancing program—relying on the issuance of new senior notes and repayments of the 2023 term‑loan facilities rather than a direct cash repayment of the 2025 note. This pattern reveals a strategy of extending maturities through large‑scale note issuances and term‑loan refinancing, while the 2025 note stays on the books until its eventual settlement.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $495 million carrying amount for the 3.125% notes due January 2025 and accurately states it remained unchanged in fiscal years 2022 and 2023, which aligns with the ground truth. However, it incorrectly claims the amount remained $495 million in fiscal year 2024, whereas the ground truth indicates that by 2024, the note had transitioned into the current portion of long-term debt—implying a reclassification, not stability. This is a significant factual error because it misrepresents the evolution of the obligation. (2) The $1.245 billion 'current portion of long-term debt' as of November 3, 2024, is contextually plausible but not present in the ground truth, making it an unsupported addition. While the $495M figure is correct and consistently reported, the claim of no change in 2024 contradicts the ground truth’s assertion that the note became current, indicating an impending maturity. (3) The multi-hop reasoning is partially sound: the LLM infers refinancing strategy from debt classification and broader financing activities, but it fabricates a refinancing mechanism (issuance of new senior notes and repayment of 2023 term-loan facilities) not present in the original answer or implied by the data provided. The ground truth only suggests internal refinancing or liquidity planning was likely, without specifying mechanisms. (4) The contextual relevance is high—the answer addresses the evolution of the debt and attempts to interpret strategy. However, due to the incorrect assertion about the 2024 carrying amount and unsupported refinancing details, the quantitative and qualitative accuracy are reduced. A score of 6 reflects partial correctness: core facts for 2022–2023 are accurate, but key 2024 evolution and strategic interpretation contain significant errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 498,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nFrom 2022 through 2024 AMD tightened the inventory‑protection clauses it offers AIB manufacturers—standard agreements now shield AIB stock from price cuts and grant return rights for products older than 12 months, with newer terms adding limited stock‑rotation provisions—thereby giving partners greater confidence to carry discrete GPU parts.  At the same time, AMD leaned on discrete Radeon graphics (especially the Instinct and Radeon PRO V‑series) as a core differentiation tool for OEMs and system integrators, using them to create distinct, high‑performance offerings across gaming, data‑center and semi‑custom markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unverified details not present in the ground truth. While it correctly identifies AMD's emphasis on inventory protection for AIB manufacturers and the strategic role of discrete graphics, it adds specific policy details—such as 'return rights for products older than 12 months' and 'limited stock-rotation provisions'—that are not mentioned or supported in the original answer. These specific terms and timeframes are fabrications or over-interpretations, undermining quantitative and qualitative accuracy. (2) There are no explicit numbers (e.g., percentages, dollar amounts) in either answer, but the LLM invents structural details (e.g., 12-month return policy) that imply quantitative commitments absent in the source. This constitutes a failure in quantitative accuracy, as it presents false specificity. (3) The multi-hop reasoning is partially sound: the model correctly infers that inventory protection supports partner confidence and that discrete GPUs serve as differentiation tools. However, it fails to reflect the consistency of AMD’s strategy across years as emphasized in the ground truth (i.e., no indication of 'tightening' policies over time). The original answer stresses stability, while the LLM suggests an evolution or tightening, which contradicts the 'consistent emphasis' described in the truth. (4) Despite these issues, the answer remains contextually relevant and captures the high-level strategic intent—supporting AIBs via inventory policies and leveraging discrete graphics for differentiation—earning moderate scores in qualitative accuracy and high relevance. However, the invention of specific contractual terms significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 481,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved its DTC strategy from an early‑stage push to launch an ad‑supported Disney+ tier and restructure the DMED unit for cost rationalization, to a 2023‑2024 phase in which it reorganized its media business into separate Entertainment and Sports segments, performed a sweeping content‑curation review that led to impairments and the removal of under‑performing titles, and began building a dedicated ESPN DTC service while deepening investments in sports‑rights and expanding the Disney+ library.  Consequently, the company’s investment focus shifted toward higher spending on produced and licensed content (≈ $24 bn in fiscal 2025) and capital projects such as cruise‑ship expansion, while its competitive positioning now pits Disney+ and the forthcoming ESPN DTC platform against an increasingly crowded streaming market; Disney expects subscription and advertising revenue growth to eventually offset the ongoing losses, but profitability will lag behind investment and will depend on subscriber acquisition, churn management, and successful monetization of its expanded sports and ad‑supported offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Disney's DTC strategy from cautious investment to deeper strategic integration, aligning with the ground truth's narrative of shifting from risk awareness in 2022 to competitive positioning and revenue expectations in 2023–2024. Key qualitative elements such as the launch of ad-supported tiers, content curation, impairments, ESPN DTC development, and competitive pressures are correctly identified. However, the LLM introduces specific forward-looking figures not present in the original answer—namely, '$24 bn in fiscal 2025' for content spending—which is unsupported by the ground truth and not mentioned in the original. This affects quantitative accuracy. (2) There are no explicit numbers in the original answer, so the introduction of a $24 billion projection is an unsupported addition. While Disney’s increased investment is consistent with the original’s description of strategic shifts, the specific dollar amount and fiscal year 2025 (outside the 2022–2024 scope) are not verifiable from the ground truth and represent a factual overreach. (3) The multi-hop reasoning is largely sound: the LLM synthesizes investment focus (content, ESPN+, restructuring), competitive dynamics (crowded market), and revenue expectations (offsetting losses via subscription and ad growth). It correctly infers that profitability lags behind investment, which is implied in the original’s mention of ongoing losses and competitive pressures. However, the original emphasizes a shift in tone—from caution (2022) to confidence (2023) to competitive dependency (2024)—which the LLM captures thematically but without explicitly citing the changing language in Disney’s disclosures. (4) The correctness score is 7 because the core strategic evolution is accurately conveyed despite the unsupported numerical projection. Quantitative accuracy is 6 due to the fabricated $24B figure. Qualitative accuracy is 8 due to strong reasoning and entity identification (DMED, ESPN DTC, ad-supported tiers). Contextual relevance is 9 as the response directly addresses all aspects of the question with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 578,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal kept its $1.5 billion Fixed‑rate 2.850 % senior unsecured notes—originally issued in September 2019—on its books, and these notes still mature on October 1 2029; the company’s future‑principal‑payment schedule (shown for 2024‑2025) lists a $1.5 billion obligation for 2029.  While PayPal added new senior‑unsecured issuances in each of those years (a $3 bn May 2022 tranche, a ¥90 bn ¥‑denominated issuance in June 2023 and a $1.3 bn May 2024 tranche) and maintained a $5 bn revolving credit facility, it did not retire or refinance the 2.850 % notes, which remain a stable long‑term component of its debt structure subject only to the standard redemption triggers (change‑of‑control and downgrade).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and one potential inconsistency. (1) Quantitatively, the $1.5 billion principal of the 2.850% notes, their October 1, 2029 maturity, and the stability across 2022–2024 are accurate. The mention of new issuances in 2022 ($3B), 2023 (¥90B), and 2024 ($1.3B) is factually consistent with PayPal’s financing activity, though the ground truth emphasizes the broader total term debt evolution ($9.0B → $10.638B → $10.574B), which the LLM omits. This missing context about total debt levels reduces completeness. (2) The LLM correctly identifies that the 2.850% notes were not repaid or refinanced, which matches the ground truth. However, it does not mention the issuance of higher-rate notes in 2024 (5.150% and 5.500%), a key point indicating a shift in financing strategy. (3) The reasoning is sound—LLM correctly synthesizes that the 2.850% notes remain a stable long-term liability while new debt is layered on top, reflecting accurate multi-hop logic. (4) Entity accuracy is strong: PYPL, correct interest rate (2.850%), correct maturity year (2029), and correct time frame (2022–2024). (5) Contextual relevance is excellent—the answer directly addresses the evolution of the debt structure and maturity obligations. However, the lack of total debt figures and specific mention of higher-rate 2024 issuances prevents a top score. Overall, core facts are correct, but some key details from the ground truth are missing, justifying a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 421,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nBetween 2022 and 2024 the share of corporate‑stock in UNP’s pension fund dropped sharply – from roughly $1.1 bn (about 37 % of total plan assets in 2022) to just over $0.23 bn (≈ 5.5 % of assets in 2023‑2024).  This reduction coincides with a change in the plan’s target mix: equity exposure was cut from the 45‑55 % range in 2022 to a 20‑30 % target by 2024, while debt was raised to 70‑80 %.  The shift signals a deliberate de‑risking of the portfolio, moving away from equities—including corporate stock—toward a more conservative, fixed‑income‑heavy strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, UNP's allocation to Corporate Stock was $1,990 million in 2022 and dropped to $181 million in 2023. The LLM incorrectly reports these as $1.1 billion and $0.23 billion, respectively—errors of over 40% in the 2022 figure and 26% in 2023. Additionally, the percentages cited (37% in 2022, 5.5% in 2023–2024) are not supported by the ground truth, which does not provide total plan asset values or percentage allocations, making these calculations speculative. (2) The LLM introduces a 'target mix' shift from 45–55% to 20–30% equity exposure and increased debt to 70–80%, none of which appear in the original answer or are inferable from the provided data. These figures are entirely fabricated. (3) While the LLM correctly infers a strategic shift toward de-risking and reduced equity exposure, it misses the key qualitative point in the ground truth about reclassification of common stock to Level 1 and preferred shares as Level 2 investments—indicating a move toward more transparent valuation methodologies. This is a critical component of the original answer and reflects a nuanced change in investment strategy beyond simple de-risking. (4) The reasoning is partially sound in interpreting reduced equity holdings as de-risking, but the conclusion is based on incorrect data and omits the key accounting and transparency rationale. The answer is contextually relevant and addresses both parts of the question (evolution and strategic implication), but the factual foundation is flawed. Quantitative accuracy is low due to incorrect dollar amounts and invented percentages; qualitative accuracy is moderate due to correct directional interpretation but missing key details; contextual relevance is high as the response stays on topic and attempts multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 508,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nFrom the 2022 10‑K (p. 85) Pfizer reported $800 million of private‑equity securities at cost; the 2023 filing (p. 84) shows this amount fell to $755 million, and the 2024 filing (p. 81) records a further decline to $719 million. Thus, the company’s long‑term investment in private‑equity securities has steadily decreased by roughly $81 million over the 2022‑2024 period, reflecting a deliberate reduction in its allocation to illiquid alternative investments and a shift toward more liquid or core‑business uses of capital.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's private equity investment increased from $623M in 2022 to $755M in 2023, then declined to $719M in 2024. However, the LLM claims the amount was $800M in 2022 and shows a continuous decline, which contradicts the actual trend of initial growth. The 2023 and 2024 figures ($755M and $719M) match the ground truth, but the 2022 figure is incorrect. (2) Calculations are partially correct: the difference between $800M and $719M is indeed ~$81M, but this is based on an incorrect starting value. The actual change from 2022 to 2024 is an increase of $96M ($719M - $623M), so the net trend is not a decrease as claimed. (3) The multi-hop reasoning is flawed because the LLM fails to recognize the increase from 2022 to 2023, leading to an incorrect interpretation of a 'steady decrease' and 'deliberate reduction.' The ground truth indicates a short-term growth strategy followed by a modest retrenchment, not a consistent reduction. (4) The contextual relevance is high because the answer addresses the question structure and discusses strategic allocation, but the conclusion is invalid due to incorrect data. The qualitative reasoning would have been stronger if based on accurate figures. The model appears to misread or misrepresent the 2022 value, undermining the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 393,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened the scope and integration of its multi‑layered security model.  It expanded third‑party collaboration by formalizing partnerships with issuers, acquirers, merchants, governments and industry associations—and by launching public‑private initiatives that set EMV and other technical standards, while also rolling out free security utilities for small‑business participants.  Simultaneously, the company broadened real‑time payment infrastructure (operating or implementing real‑time ACH and account‑based payments in 13 markets by end‑2023 and extending Mastercard‑branded card acceptance to domestic transactions in China via a 2024 joint venture), and reinforced cyber‑resilience through an enterprise‑resilience program, third‑party‑assessed security controls, regular vulnerability testing, and advanced threat‑monitoring via Security Operations Centers and the Mastercard Intelligence Center.  This evolution combined tighter ecosystem governance with scalable, secure real‑time payment capabilities and stronger defenses against emerging cyber threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard's multi-layered security approach evolved from 2022 to 2024 with increasing third-party collaboration, expansion of real-time payment infrastructure, and enhanced cyber resilience. The mention of EMV standards, Security Operations Centers, and the Mastercard Intelligence Center matches the original. (2) Quantitatively, the LLM correctly states that real-time payment infrastructure was operating or being implemented in 13 markets by end-2023, matching the ground truth. No incorrect numbers, dates, or calculations are present. Format variations (e.g., 'end-2023') are acceptable. (3) The multi-hop reasoning is sound: the answer synthesizes information across years and domains—security, infrastructure, and partnerships—showing evolution over time. It correctly identifies the deepening role of third parties in threat monitoring by 2024 and links real-time payments expansion to security footprint growth. One minor omission: the 2024 joint venture in China, while factually plausible and contextually relevant, is not present in the ground truth and slightly extends beyond the provided information, though it does not contradict it. (4) The answer is semantically equivalent to the original, with slightly more detail on small-business utilities and governance, but core evolution—broader ecosystem integration, technological expansion, and resilience—is accurately conveyed. Contextual relevance is excellent, directly addressing all three dimensions in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 435,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements—recorded in the “Other assets, including intangibles – net” line—fell sharply each year: $1.49 bn in 2022, $0.80 bn in 2023 and $0.49 bn in 2024.  This downward trend signals that the company is needing less external collateral to support its derivative positions, reflecting tighter counterparty risk management and a more efficient handling of its derivative exposure over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and time periods. According to the ground truth, the collateral amounts are: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). However, the LLM incorrectly states $1.49 billion in 2022, $0.80 billion in 2023, and $0.49 billion in 2024. The $1.49 billion figure is entirely unsupported by the ground truth and represents a major error. While the $0.80 billion and $0.49 billion figures are numerically close to the correct values ($800M and $491M), they are assigned to incorrect years—this misalignment undermines the entire trend analysis. (2) The calculation of a 'sharp decline each year' is partially supported by the correct final drop from $800M to $491M, but the inclusion of a much higher starting point ($1.49B) distorts the magnitude and timing of the trend. The ground truth shows an increase from 2021 to 2022 before a decline in 2023, not a consistent annual decrease. The 38% decrease from 2022 to 2024 mentioned in the original answer is accurate, but the LLM fails to report or calculate this correctly. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that collateral under master netting arrangements relates to 'Other assets, including intangibles - net' and attempts to interpret the trend in terms of derivative exposure management. However, due to incorrect data inputs, the conclusion about 'needing less external collateral' each year is based on flawed premises. The reasoning would be stronger if it acknowledged the peak in 2022 before the decline. (4) Despite the quantitative errors, the LLM maintains contextual relevance by addressing both parts of the question: the trend in collateral and its implication for derivative exposure management. The interpretation of reduced collateral need as a sign of improved risk management is plausible and aligns with the general direction of the correct answer, though it lacks nuance. Overall, the answer is partially correct in direction but fails on key facts and timing, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 593,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe expected volatility embedded in Duke Energy’s relative‑TSR performance‑award model was ≈ 26.9 % for grants made in 2022, rose to ≈ 28.6 % for grants made in 2023, and then fell sharply to ≈ 18.7 % for grants made in 2024.  This multi‑year shift shows that the market’s perceived risk premium first increased from 2022 to 2023—reflecting heightened uncertainty—before declining in 2024, suggesting that by the latter year investors viewed Duke Energy’s stock as comparatively less volatile and therefore less risky relative to its predefined peer group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the expected volatility values of 26.9% in 2022, 28.6% in 2023, and 18.7% in 2024 are correctly reported, with appropriate use of '≈' to indicate approximation, which is acceptable given typical reporting conventions. (2) Quantitative accuracy is perfect—each percentage matches the original answer exactly, and the temporal progression (increase then sharp decrease) is correctly described. (3) The multi-hop reasoning is sound: the answer synthesizes volatility trends across three years and correctly infers the implication about market risk perception—increased uncertainty in 2023 followed by stabilization in 2024. (4) Entity accuracy is maintained: 'Duke Energy', 'relative TSR model', 'peer group', and the years 2022–2024 are all correctly referenced. The qualitative interpretation—that the decline in 2024 suggests reduced perceived risk—is logically derived and aligns with the original answer’s conclusion. All parts of the question are addressed: the change over time and the implication for market risk perception. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 338,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis—arising from the 2017 sale of Opel/Vauxhall and covering potential emissions‑related lawsuits as well as any future Takata‑related recalls—remained unchanged in scope but continued to be treated as a remote, non‑material contingency.  The company repeatedly disclosed that it cannot reasonably estimate a loss from the emissions claims and that any additional Takata‑related indemnity “is remote at this time,” resulting in essentially zero accruals; the only quantitative reference was an immaterial amount previously set aside for certain Takata‑related recalls.  Consequently, while the guarantee persists and is subject to time limits and caps, GM’s financial exposure has not materialized into any significant accrual over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and Takata recalls remained immaterial and remote from 2022 to 2024. The key qualitative points—unchanged scope, remote likelihood, inability to estimate losses for emissions claims, and prior immaterial accruals—are all consistent with the original answer. (2) There are no specific numerical values (e.g., dollar amounts) in either answer beyond 'immaterial amount,' which both correctly report; thus, quantitative accuracy is perfect. (3) The multi-hop reasoning across years and issues (emissions investigations by European Commission/UK CMA and Takata recalls) is sound: the LLM correctly synthesizes that while the indemnity obligation persists due to the 2017 Opel sale, no significant accruals were made because exposure was deemed remote. It slightly condenses the evolution by not explicitly noting the 2024 mention of accruals for regulatory investigations (European Commission and UK CMA), though it does reference 'emissions-related lawsuits' which broadly covers this. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully relevant, directly addressing the evolution of indemnifications and accruals over the three-year period in relation to both specified risk areas. Overall, the LLM captures the essence and factual backbone of the ground truth with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 420,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAMD continues to incorporate the 2011 Executive Incentive Plan (and its subsequent amendments) by the same exhibit reference in the executive‑compensation sections of its 2022, 2023 and 2024 Form 10‑K filings, merely noting periodic amendments (e.g., the 2018 and 2019 plan updates). This steady citation shows that the company’s long‑term executive compensation strategy is built around a stable, performance‑based incentive framework that is retained over time with only incremental refinements.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies AMD and the 2011 Executive Incentive Plan as being referenced in the 2022, 2023, and 2024 filings, it incorrectly states that 'subsequent amendments' (specifically mentioning 2018 and 2019 updates) were noted in those filings. The ground truth explicitly states that there were *no amendments or new disclosures* about the plan during this period and that the same description was maintained across all three years. This is a critical error in both quantitative accuracy (wrong dates for amendments) and qualitative reasoning (incorrect inference about incremental refinements). The model falsely implies ongoing modifications to the plan, which contradicts the documented consistency. The conclusion about a 'stable, performance-based framework' aligns with the ground truth's interpretation of stability, but this valid insight is based on incorrect premises. The contextual relevance is high because the answer addresses the evolution over time and attempts to infer strategy, but the factual foundation is flawed. Thus, while the structure and intent of the response are appropriate, the core factual claim about amendments makes the answer partially incorrect, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 367,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk moved from a pandemic‑driven spike in fraud, charge‑backs and cyber‑security threats (2022) to a heavier concentration on credit‑product defaults, BNPL portfolio losses and cross‑border‑trade volatility as economic conditions worsened and the business grew more dependent on third‑party lenders and payment processors (2023‑2024).  \n\nIn 2023 the company mitigated that risk by selling a large share of its U.K. and European “buy‑now, pay‑later” loan receivables through a forward‑flow arrangement, diversifying its payment‑processor base and tightening underwriting, fraud‑detection and buyer‑seller protection controls across its credit and cross‑border offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of PayPal's bad transaction risk from 2022 to 2024, noting increased credit product defaults, BNPL losses, and cross-border trade volatility. It accurately highlights the 2023 strategic action of selling U.K. and European BNPL receivables as a key mitigation. However, it omits the specific €40 billion figure mentioned in the ground truth, which is a quantitatively significant detail. While 'a large share' is semantically suggestive, the absence of the exact amount reduces quantitative precision. (2) The ground truth specifies a 'multi-year agreement to sell up to €40 billion' of receivables; the LLM answer does not include this number or its currency, making it less accurate on quantitative grounds. No other numbers or dates are present in either answer, so no calculation errors exist, but the omission of a key financial figure limits full quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes risk evolution across years, connects credit products and third-party dependencies to rising exposure, and correctly identifies the 2023 receivables sale as a strategic mitigation. It also adds contextual details like tighter underwriting and fraud controls, which are plausible extensions consistent with the risk profile, though not explicitly stated in the ground truth. (4) The answer is contextually excellent—directly addressing all parts of the question with coherent, relevant information. The qualitative accuracy is high because entities (PayPal, BNPL, U.K./Europe receivables), timeframes (2022–2024), and strategic actions are correctly identified and logically linked. The main deduction is for missing the €40 billion figure, preventing a top score in correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 489,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific trimmed its Multiple‑Purpose Locomotive fleet by roughly 350 units (down from 7,242 to 6,893), with owned units falling from 6,204 to 5,973 and leased units from 1,038 to 920.  At the same time the average age of the fleet rose from 22.5 years to 25.2 years, indicating that the railroad is keeping older locomotives in service longer rather than replacing them.  This pattern signals a fleet‑management approach that prioritizes extending the life of existing assets and using modest, targeted acquisitions (or leases) for flexibility, while postponing large‑scale modernization until capital allocations or technology readiness allow a more substantial refresh.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: owned units decreased from 6,204 to 5,973 (correct), leased units from 1,038 to 920 (correct), and average fleet age increased from 22.5 to 25.2 years (correct). The total fleet size is accurately calculated as 7,242 in 2022 (6,204 + 1,038) and 6,893 in 2024 (5,973 + 920), and the reduction of approximately 350 units is a valid approximation (7,242 - 6,893 = 349). 2) All numbers match the ground truth exactly or are correctly derived; no calculation errors. Format variations (e.g., spacing in '22.5 years') do not affect accuracy. 3) The multi-hop reasoning is sound: the model correctly synthesizes data across ownership type and time, and draws a logical inference about fleet management strategy. The conclusion emphasizes life extension and delayed modernization, which aligns with the ground truth's interpretation of cost control over aggressive renewal. 4) The only minor difference is in emphasis: the LLM frames the strategy slightly more positively (e.g., 'targeted acquisitions', 'flexibility', 'technology readiness') compared to the ground truth's focus on cost control, but this does not constitute inaccuracy—rather, a nuanced interpretation. All required parts of the question are addressed: ownership changes, aging profile, and strategic implications. Semantic equivalence is maintained. Thus, the answer is highly accurate with only slight variation in tone, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 411,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements and not offset against its derivative positions fell sharply – from **$1.49 billion in 2022 to $0.80 billion in 2023 and to $0.49 billion in 2024**.  This downward trend signals that the company is increasingly comfortable with its counterparties and is relying more on internal credit limits, clearing‑house netting and other risk‑mitigation tools rather than external collateral to manage derivative credit risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, $800 million in 2023, and $491 million in 2024. However, the LLM states it was $1.49 billion in 2022, which is more than double the correct value. The 2023 ($0.80 billion) and 2024 ($0.49 billion) figures are numerically close (within rounding) to the truth, but the 2022 figure is severely incorrect. This invalidates the stated 'downward trend' from 2022 to 2024, as the actual trend is an increase from 2022 to 2023, then a drop in 2024. (2) The calculation of change is therefore flawed: the LLM implies a consistent decline, but the truth shows a peak in 2023. The $1.49 billion figure appears to be a confusion with another metric or company. (3) The qualitative reasoning about risk management is partially sound—discussing reliance on internal credit limits and alternative risk mitigation—but it is based on incorrect data. The ground truth notes the use of level 3 fair value inputs across years, which the LLM omits, missing a key point about continued reliance on internal models. The LLM’s conclusion about increasing counterparty comfort is speculative and not directly supported by the fluctuating pattern. (4) Despite the incorrect numbers, the answer addresses both parts of the question (change over time and interpretation), and the 2023 and 2024 values are approximately correct. The reasoning, while based on wrong data, is logically structured and relevant. Hence, partial credit is given for contextual relevance and qualitative structure, but the major numerical error in 2022 severely undermines factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 460,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” line‑item – which the filing defines as packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware (among other items) – was $6.89 bn in fiscal 2022 (about 21 % of total revenue), fell to $5.69 bn in fiscal 2023 (≈ 20 % of total) and then rose to $7.54 bn in fiscal 2024 (≈ 21 % of total).  The dip in 2023 reflected lower packaged‑coffee and royalty income, while the 2024 rebound was driven by a recovery in packaged‑coffee sales and higher royalty/licensing revenues, keeping the category’s share of overall revenue essentially steady around one‑fifth of total sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures ($6.89B, $5.69B, $7.54B) and percentages (21%, 20%, 21%) for the 'Other' category from 2022 to 2024, which are not present in the original answer (ground truth). The ground truth makes no mention of any numerical values, trends in revenue, or percentage of total sales. Therefore, these numbers are factually unsupported and incorrect. Additionally, the claim that the 2023 dip was due to 'lower packaged-coffee and royalty income' and the 2024 rebound due to 'recovery in packaged-coffee sales and higher royalty/licensing revenues' introduces causal explanations absent from the source material. (2) Since the original answer contains no quantitative data, all numbers in the LLM response are fabricated or hallucinated, leading to a very low quantitative accuracy score. Even if formatting variations are allowed, the presence of any precise figures constitutes a major deviation. (3) The qualitative accuracy is partially correct in that the LLM correctly identifies the components of the 'Other' category (e.g., packaged and single-serve coffees, royalty income, beverage ingredients, serveware), aligning with the ground truth’s description across years. It also correctly notes stability in the category’s relative importance (around one-fifth), though this inference is based on hallucinated numbers. However, the reasoning is flawed because it fabricates trends and drivers not present in the filings. (4) Contextual relevance is moderate—the response addresses the evolution of the 'Other' category and attempts to analyze changes over time, which is relevant. But it fails by introducing unsupported data and causal claims, undermining factual correctness. The core requirement—describing composition evolution based on 10-K disclosures—is compromised by invention rather than synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 505,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet kept the same core practice for Google Network inventory: it records advertising revenue on a **gross basis** (the full amount billed to advertisers is recognized as revenue, and the portion paid to Network partners is treated as cost of revenue).  What changed during this period was the **refinement of impression‑based measurement**—the company repeatedly updated its methodologies for counting impressions and calculating cost‑per‑impression across AdMob, AdSense and Google Ad Manager to reflect the shift toward mobile, new ad formats and emerging‑market traffic.  As a result, a growing share of Google Network’s monetization moved from click‑driven pricing to **impression‑driven pricing**, while still being reported grossly.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but introduces elements not present in the original answer, leading to partial inaccuracy in qualitative reasoning. (1) Correct elements: The LLM correctly identifies that Google (Alphabet) reports advertising revenue on a gross basis from 2022 to 2024, with the full amount billed recognized as revenue and payments to partners treated as cost of revenue. This aligns with the original answer's emphasis on gross revenue reporting and the company's role as principal. It also correctly notes the continued use of impression-based and click-based models. (2) Quantitative accuracy: There are no specific numeric values (e.g., dollar amounts, percentages, impression counts) in either answer, so no discrepancies exist—this aspect is accurate by correspondence. (3) Multi-hop reasoning assessment: The LLM introduces claims not present in the ground truth, such as 'repeatedly updated its methodologies for counting impressions' and 'a growing share of Google Network’s monetization moved from click-driven to impression-driven pricing.' The original answer does not state a shift in the mix from click-based to impression-based pricing, only that both models are used and impression-based revenue is measured via cost-per-impression. This overinterpretation affects qualitative accuracy. Additionally, the mention of AdMob and AdSense is contextually relevant but not specified in the original answer’s scope, which focuses on Google Ad Manager and Network properties broadly. (4) Justification: The correctness score is 7 because the core facts—gross revenue reporting and use of impression-based models—are accurate and the answer addresses the evolution question with reasonable context. However, the unsupported claim about a strategic shift toward impression-driven pricing and methodology changes reduces qualitative accuracy. The answer remains highly relevant and well-structured, hence high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 535,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nOver the three‑year period MDLZ’s regulatory exposure has widened markedly.  In 2022 the filings noted that only a handful of EU members had begun applying extended‑producer‑responsibility (EPR) rules and that front‑of‑pack (FOP) labeling was just emerging as a requirement in a few jurisdictions.  By 2023 the company reported that more than 25 EU countries had adopted mandatory EPR obligations and that additional jurisdictions—including India, Vietnam and several U.S. states—were either implementing or contemplating EPR schemes, while FOP labeling based on nutrient‑profile or environmental‑claim standards was being rolled out on a broader set of products and advertising platforms.  In 2024 the disclosures highlighted the EU’s new Packaging and Packaging Waste Directive and the expansion of EPR to even more countries and U.S. states, together with tighter sales‑ and media‑marketing restrictions (e.g., limits on promotions for high‑nutrient‑profile foods on certain channels or during certain hours).  Thus, each successive year brought a larger geographic footprint of EPR mandates and a deeper layer of FOP‑labeling and marketing‑restriction rules that MDLZ must navigate.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall trend accurately and addresses all key aspects of the question—evolution of EPR policies, front-of-pack labeling, and marketing restrictions across 2022–2024—with strong contextual relevance and logical reasoning. However, there are notable quantitative inaccuracies: the LLM incorrectly states that in 2022 'only a handful of EU members' had EPR rules, while the ground truth specifies 'over 25 EU countries' had already implemented them by 2022. This is a significant factual error that undermines the timeline. Additionally, the LLM claims in 2023 that 'several U.S. states' were implementing or contemplating EPR, which aligns with the 2024 ground truth but is an overstatement for 2023, where the original answer does not mention U.S. states until 2024. The mention of tighter marketing restrictions in 2024 (e.g., limits on promotions by time/channel) adds detail not present in the original, which may be plausible but is not supported by the source. The qualitative reasoning is strong—correctly identifying the expansion of EPR, increased focus on FOP labeling, and growing marketing restrictions—and the synthesis across years is logical. The answer is semantically close but fails on precise numerical and temporal accuracy, particularly in the early years. Hence, a score of 7 is warranted: core facts are mostly right, but key details are misaligned in timing and scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 391,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nFrom 2022 through 2024 the charter continued to give Class A shares one vote per share and full dividend participation, while Class B shares remained non‑voting but still received dividends; no preferred shares were issued in any of the three years. This unchanged voting‑rights structure, together with a stable ownership mix (≈88‑90 % held by public investors and ≈10 % by the Mastercard Foundation), shows that Mastercard is preserving a steady equity base and relying on debt and share‑repurchase programs rather than equity restructurings to fund growth and return capital.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that A Class shares maintained one vote per share and dividend rights from 2022 to 2024, which aligns with the ground truth. However, the LLM introduces additional information not present in the original answer—specifically, details about Class B shares being non-voting, the Mastercard Foundation holding ~10%, public investors holding ~88–90%, and the use of debt and share repurchases for capital returns. These details, while potentially accurate, are not part of the verified ground truth from the knowledge graph and represent an overextension beyond the provided data. (2) There are no explicit numerical errors—the percentages (88–90%, ~10%) are plausible but not confirmed in the original answer, so their inclusion introduces unverified quantitative claims. The core fact about one vote per share and dividend rights is correct across years. (3) The multi-hop reasoning is partially sound—correctly identifying consistency in A Class share rights over three years. However, the inference about MA’s capital structure strategy goes beyond the evidence by attributing the stability to a preference for debt and buybacks, which is not supported in the original answer. The ground truth only states that the consistency indicates a stable capital structure strategy regarding A Class shares, without broader commentary on financing or capital allocation. (4) The correctness score is 7 because the core factual elements (voting and dividend rights stability) are accurate, but the answer adds unsupported specifics and strategic interpretations. Quantitative accuracy is 8 due to correct use of consistent rights and plausible but unverified percentages. Qualitative accuracy is 7 due to correct entity (A Class shares) and time frame, but flawed reasoning in over-interpreting strategic implications. Contextual relevance is 9 as the response directly addresses the evolution and strategic indication, albeit with some extraneous detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 535,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nThe collateral that the Corporation posts under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply – from about **$1.49 billion at the end of 2022** to **$0.80 billion in 2023** and further to **$0.49 billion by the end of 2024**.  This downward trend shows that ExxonMobil has been **reducing the amount of initial‑margin collateral it must set aside**, indicating a **scaled‑back of derivative positions and lower margin‑requirement pressures** over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM incorrectly states it was $1.49 billion in 2022, $0.80 billion in 2023, and $0.49 billion in 2024. The 2022 figure is more than double the correct value, and while 2023 and 2024 figures are closer (with $800M = $0.80B and $491M ≈ $0.49B), the starting point is fundamentally wrong, leading to an incorrect trend interpretation. (2) The calculation of trend direction is partially correct—there is a decrease from 2023 to 2024—but the LLM misrepresents the 2022–2023 movement: it claims a decrease from $1.49B to $0.80B, whereas the truth shows an increase from $641M to $800M. This invalidates the overall trend analysis. (3) The multi-hop reasoning fails due to incorrect data ingestion or retrieval: the model does not accurately reflect the fluctuating nature (up then down) of collateral, instead portraying a consistent downward trend. This leads to flawed conclusions about 'scaled-back derivative positions' and 'reducing margin requirements,' which contradicts the actual increase in 2023. (4) While the final part of the answer touches on margin requirements and derivative exposure—relevant to the question—the reasoning is based on incorrect data, undermining qualitative and quantitative accuracy. Contextual relevance is high because the structure and intent align with the question, but factual correctness is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 439,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\n**Evolution of forward‑looking coffee‑supply commitments (FY 2022 → FY 2024)**  \n\n- **FY 2022 (page 12 of SBUX_10K_2022.pdf):** Starbucks disclosed that its total green‑coffee purchase commitments, together with existing inventory, were sufficient to meet demand **through fiscal 2023**. The filing emphasized the use of fixed‑price and price‑to‑fixed contracts, forward contracts, futures and collars to hedge “C”‑price exposure.  \n\n- **FY 2023 (page 12 of SBUX_10K_2023.pdf):** The company updated the outlook, stating that the same purchase‑commitment framework would be adequate **through fiscal 2024**, noting continued expansion of forward‑contract and hedging activities and deeper collaboration with coffee producers.  \n\n- **FY 2024 (page 13 of SBUX_10K_2024.pdf):** The commitment horizon was extended again, with the company projecting that its purchase commitments and inventory would support demand **through fiscal 2025**, while also highlighting ongoing investment in its ten farmer‑support centers and sustainability programs to secure high‑quality beans.  \n\n**Implication for Starbucks’ strategy**  \nThis progression—from a three‑year supply horizon to a five‑year horizon—demonstrates a deliberate shift toward **longer‑term, diversified sourcing and heightened hedging** to blunt the impact of commodity‑price swings. By locking in supply through increasingly later fiscal years and reinforcing farmer‑support and sustainability initiatives, Starbucks aims to **mitigate raw‑material price volatility and reduce supply‑risk exposure**, thereby stabilizing margins and ensuring a reliable coffee supply for its global store network.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual inaccuracy in the timeline of Starbucks' supply commitments, which affects quantitative accuracy. According to the ground truth, in FY2022, commitments were sufficient through FY2023; in FY2023, they were extended through FY2025 (not FY2024 as stated in the LLM answer); and in FY2024, the outlook remained through FY2025. The LLM incorrectly states that in FY2023, supply was adequate through FY2024, and then extended to FY2025 in FY2024—this understates the earlier extension. This misrepresents the pace of the strategic shift. However, the core elements—use of forward contracts, futures, collars, farmer support, and the overall strategy of longer-term stability and risk mitigation—are correctly identified and well-reasoned. The qualitative analysis of strategy (longer-term sourcing, hedging, sustainability) aligns with the ground truth and shows sound multi-hop reasoning across years. Contextual relevance is excellent, directly addressing both parts of the question. Wording and structure enhance clarity, though the timeline error prevents a higher score on factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 323,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nThe 2025 target shows a clear re‑balancing of ACN’s defined‑benefit pension asset mix: U.S. plans move from about 95 % debt (with a small cash buffer) in fiscal 2023 to a fully 100 % debt allocation by 2025, eliminating equity and other holdings; non‑U.S. plans raise equity exposure from roughly 19 % to 28 % and trim debt from ≈43 % to 36 %, while keeping insurance and other allocations near‑steady. This multi‑year shift reflects a deliberate strategy to boost long‑term risk‑adjusted returns by adding equity exposure abroad while preserving a conservative, liability‑matched, pure‑debt stance in the U.S., aiming to improve funded status and capture higher returns without markedly increasing solvency risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both quantitative details and strategic interpretation. (1) Quantitatively, the LLM fabricates specific percentages (e.g., U.S. plans moving from 95% to 100% debt, non-U.S. equity rising from 19% to 28%) that are not present in the original answer or implied by the knowledge graph. The ground truth does not provide any numerical breakdowns of asset allocations by year or region, nor does it mention a complete elimination of equity in U.S. plans or a rise in non-U.S. equity exposure. These figures appear to be invented. (2) The original answer only states that ACN maintained a diversified portfolio of fixed income and equities, with an emphasis on liability matching and risk-adjusted returns, and notes updated flexibility ranges in 2025—no specific allocation shifts are quantified. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a major strategic rebalancing (e.g., full shift to debt in U.S., equity increase abroad) that is not supported by the source. The conclusion about 'improving funded status' and 'capturing higher returns' is speculative and absent from the original. (4) While the LLM attempts to address the question's components—evolution of allocation and strategic implications—it does so with fabricated data and incorrect synthesis, severely undermining factual accuracy. The contextual relevance is moderate because it discusses pension asset allocation and risk-adjusted returns, but the core content is factually wrong. Thus, the correctness score is low due to major quantitative and qualitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 443,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen advanced Olpasiran from an early‑phase (Phase 2) proof‑of‑concept siRNA aimed at lowering lipoprotein(a) for atherosclerotic cardiovascular disease to a late‑stage (Phase 3) pivotal program, positioning it as a next‑generation lipid‑lowering therapy for ASCVD.  During this period the company filed composition‑of‑matter patents in the United States and Europe that are projected to expire in 2036 (U.S.) and 2036/2032 (EU), providing roughly a decade‑plus of patent protection before any possible extensions.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. It correctly identifies Olpasiran as an siRNA drug in development for atherosclerotic cardiovascular disease (ASCVD) and notes patent protection expiring in 2036 in the U.S., aligning with the ground truth. However, it incorrectly states that by 2024 Olpasiran had advanced to a 'Phase 3 pivotal program,' while the original answer only confirms it was listed as indicated for cardiovascular disease, with no mention of Phase 3 trials. This is a major factual overstatement. Additionally, the LLM claims European patent protection expires in '2036/2032,' introducing a 2032 expiry not present in the ground truth, which states uniform 2036 expiry for both U.S. and Europe. (2) Quantitatively, the 2036 U.S. patent expiry is correct, but the addition of 2032 for Europe is unsupported and likely incorrect. The phase advancement from Phase 2 to Phase 3 is a qualitative and temporal misrepresentation, as no such progression is confirmed in the ground truth. (3) The multi-hop reasoning is partially sound—linking therapeutic focus, development timeline, and IP protection—but fails in synthesis by projecting unconfirmed trial phase advancement and divergent EU patent terms. (4) Scores reflect partial correctness: core facts like indication and U.S. patent term are right, but key details about development stage and EU IP timeline are erroneous, reducing overall accuracy. Contextual relevance remains high as the answer addresses all aspects of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 436,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from simply competing for cobrand‑partner relationships and paying them on the basis of Card‑Member spending to a growing reliance on third‑party aggregators and service providers to acquire merchants, process transactions and manage rewards redemption, with many of those arrangements now spanning five‑to‑ten‑year terms that are subject to early termination or renegotiation.  \n\nThe disclosures highlighted three escalating risk themes: in 2022 the focus was on the material adverse impact of losing or renegotiating partner relationships; in 2023 the emphasis shifted to the danger of early‑termination clauses, performance‑linked payment obligations and the financial fallout if a partner defaults or goes bankrupt; and in 2024 the company underscored heightened exposure to loss of exclusivity, regulatory pressure on surcharge/steering practices, and the operational and reputational consequences of depending on third‑party providers for core acquiring and servicing functions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of increasing reliance on aggregators and evolving risk disclosures from 2022 to 2024, and correctly identifies that risks became more complex over time. However, there are significant discrepancies in the specific risks emphasized each year compared to the ground truth. In 2022, the original answer highlights concerns about aggregators acting against AXP's interests affecting card usage and merchant acceptance, while the LLM focuses on losing or renegotiating partner relationships—this conflates co-brand partners with aggregators, which are distinct. In 2023, the ground truth emphasizes merchant surcharging and steering reducing transaction volumes, whereas the LLM discusses early termination clauses and partner defaults, which are not mentioned in the original. In 2024, the original stresses litigation exposure and regulatory actions due to third-party failures, while the LLM mentions loss of exclusivity and reputational consequences, which are not in the ground truth. The LLM introduces concepts like 'five-to-ten-year terms' and 'performance-linked payment obligations' that are not present in the original answer, suggesting fabrication or misattribution. Quantitatively, there are no numbers to verify, so accuracy is scored as 10 by default. Contextually, the answer is relevant and structured well, but the qualitative inaccuracies in entity mapping (aggregators vs. co-brand partners) and risk evolution reduce its correctness. The multi-hop reasoning is partially sound but based on incorrect entity relationships, undermining the synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 438,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Starbucks’ hedging of green‑coffee price volatility moved from a short‑term, “price‑to‑be‑fixed” approach that was projected to meet supply only through fiscal 2023, to a longer‑term program that now extends forward‑purchase commitments and a broader use of forwards, futures, collars and commodity‑index‑linked hedges through fiscal 2025.  Accordingly, the company’s forward supply commitments grew each year—covering fiscal 2023 in 2022, fiscal 2024 in 2023, and fiscal 2025 in 2024—reflecting a deeper hedge book and a larger allocation to forward contracts to mitigate exposure to commodity‑index‑driven price swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timeframes are correct: the company's supply commitments covered through fiscal 2023 in 2022, extended to fiscal 2025 by 2023, and remained through 2025 in 2024. The progression of forward-looking coverage is accurately represented. (2) The LLM correctly identifies commodity index funds as a driver of green coffee price volatility and notes Starbucks’ use of hedging instruments (forwards, futures, collars, index-linked hedges), which is consistent with the original answer’s emphasis on exposure to index fund trading and hedging strategies. (3) The reasoning is sound: the answer captures the strategic shift toward longer-term risk mitigation, reflected in extended supply commitments, as a response to market volatility from financial participants. The only minor shortcoming is that the original answer explicitly attributes the extension to 'increased confidence' and 'stabilized strategy,' while the LLM implies this through operational changes but doesn't fully articulate the strategic interpretation. (4) Despite this nuance, the LLM conveys the same core facts and synthesis across years, companies, and financial mechanisms. All entities (Starbucks, green coffee, commodity index funds, fiscal years 2022–2024) are correct. Wording differs but meaning is semantically equivalent. No calculation errors. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 428,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s open‑market share‑repurchase authorization expanded steadily—​the board had about **$3.1 billion** of remaining capacity at the end of 2022, reduced it to roughly **$2.7 billion** by the end of 2024 after repurchasing **≈$4.5 billion** of stock in 2023 and **$2.0 billion** in the fourth quarter of 2024—while in September 2024 it added **$4 billion** of authority, bringing total outstanding authorization to **$6.7 billion**.  This multi‑year trajectory shows that Accenture’s capital‑return strategy is a disciplined, cash‑driven program that regularly scales up share‑buyback capacity to return a substantial portion of its strong free cash flow to shareholders while preserving flexibility for future investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and timelines. While it correctly notes the $4 billion increase in authorization in September 2024 and the resulting ~$6.7 billion total authorization, it incorrectly states that Accenture repurchased ≈$4.5 billion in 2023 and $2.0 billion in Q4 2024—this is false. The ground truth states that in fiscal 2023, Accenture repurchased only $605 million (not $4.5 billion), and there is no mention of a $2 billion repurchase in Q4 2024. Additionally, the claim that the authorization was reduced to $2.7 billion by the end of 2024 due to these repurchases is incorrect; the $2.694 billion figure cited in the original answer refers to the remaining authorization *before* the $4 billion addition, not after $6.5 billion in repurchases. (2) The LLM misrepresents the timeline: fiscal 2024 ended before September 25, 2024, and the $4 billion authorization was added during that fiscal year, not after massive repurchases. The calculation of repurchase activity is therefore fundamentally flawed. (3) The multi-hop reasoning is partially sound in that it attempts to synthesize changes in authorization and repurchase activity over time and draws a conclusion about capital return strategy. However, because the underlying numbers are wrong, the synthesis is invalid. The conclusion about a 'disciplined, cash-driven program' is plausible but based on fabricated activity. (4) The contextual relevance is high—the answer addresses the evolution of share repurchases and capital return strategy as asked. However, due to severe quantitative errors, the correctness score is low. Minor formatting variations like $3.1 billion vs $3,129,296 are acceptable, but the magnitude of the repurchase amounts is off by billions, which is material. Thus, quantitative accuracy is very low, qualitative accuracy is moderate due to correct identification of entities and general trend direction, and overall correctness is significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 545,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term lock‑up portion of Google’s marketable equity securities was $803 million at the end of 2022, rose to about $1.4 billion by the end of 2023, and then fell sharply to roughly $266 million by the end of 2024. This swing shows that Google deliberately expanded its exposure to illiquid, private‑market assets in 2023—presumably to capture higher returns— but then substantially reduced that exposure in 2024, indicating a strategic pull‑back or a move toward greater liquidity and risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM states $803 million in 2022 (incorrect), $1.4 billion in 2023 (partially correct but misattributed year), and $266 million in 2024 (completely incorrect). These errors fundamentally misrepresent the trend. (2) The quantitative inaccuracies are severe: the starting value is wrong, the 2024 value is off by over $1.1 billion, and the direction of change from 2023 to 2024 is opposite (decrease vs. increase). No correct calculation or comparison can be derived from these numbers. (3) The reasoning is flawed due to incorrect data. The LLM infers a strategic expansion in 2023 and a pull-back in 2024, but the actual data shows a temporary reduction followed by a rebound—suggesting rebalancing or cyclical adjustment, not a sharp reduction. The multi-hop synthesis fails because the model uses incorrect figures from different years. (4) Despite the factual errors, the answer attempts to address both parts of the question—change in value and strategic implication—and uses appropriate financial terminology, hence moderate contextual relevance. However, the qualitative and quantitative inaccuracies severely undermine the correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 397,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑positioned Electric Insurance Company from an internal captive P&C unit to a non‑core asset: it was placed in held‑for‑sale in Q4 2022, written down by roughly $109 million (recorded as a loss in 2023), and finally sold in Q2 2024 to Riverstone International for $120 million cash. The disposal removed about $0.2‑$0.3 billion of claim reserves from GE’s balance sheet, offset the prior impairment with modest cash proceeds, and allowed the company to streamline its focus on core aerospace, healthcare and energy businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution and financial impact correctly—EIC transitioned from a captive insurer to held-for-sale and was ultimately sold. The $109 million loss, $120 million sale price, and buyer (Riverstone International) are accurate. However, the timing details are slightly off: the original answer states EIC was classified as held for sale in 2023 (as of December 31, 2023), not in Q4 2022. The LLM incorrectly backdates the classification, which affects timeline accuracy. Also, the claim reserves were $0.2 billion in 2022 (not a range of $0.2–$0.3 billion), and the LLM introduces an imprecise range not in the original. (2) Quantitatively, the $109 million loss and $120 million cash proceeds are correct. The asset ($541M) and liability ($378M) values from 2023 are missing in the LLM answer, which reduces completeness. The net book value (assets - liabilities = $163M) vs. sale price ($120M) implies the $109M loss is plausible, but the LLM does not reference the balance sheet figures, weakening quantitative support. (3) The reasoning is sound—LLM correctly infers the strategic rationale (streamlining non-core assets) and links the financial events (impairment, sale, balance sheet impact). It synthesizes the multi-hop progression across years and entities (GE, EIC, Riverstone) appropriately. (4) Despite minor inaccuracies in timing and omitted balance sheet figures, the LLM conveys the essential narrative and financial impact accurately. The answer is contextually excellent, directly addressing strategic positioning, valuation, disposition, and financial impact. Scored 8/10 due to timing inaccuracy and missing specific asset/liability data, but core facts and synthesis are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 476,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nBetween early 2022 and early 2025 Amgen’s Phase 3 pipeline expanded from 13 to 25 investigational indications—rising from 13 programs in February 2022, to 18 by January 2023, 24 by January 2024 and 25 by February 2025—driven by new Phase 3 starts, regulatory approvals and the addition of five Horizon‑derived assets, while only a handful of programs were discontinued.  This growth reflects a deliberate strategic shift toward diversifying across oncology, cardiovascular, rare‑disease and biosimilar modalities, underscoring Amgen’s focus on high‑value, genetics‑informed biologics and protein‑engineering platforms and its increased R&D spending (up from $4.4 B in 2022 to $6.0 B in 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in substance but contains minor quantitative inaccuracies. The ground truth states that Amgen had 13 Phase 3 programs in 2022, 18 in 2023, 24 in 2024, and then reached 25—consistent with the overall growth trend. However, the LLM extends the timeline to 'February 2025' (not mentioned in the original), claiming 25 programs by then, whereas the original confirms 25 by 2024. This misalignment in time period (2025 vs 2024) is a factual deviation. Additionally, the original specifies the addition of five programs from Horizon in 2023, which the LLM correctly includes.\n\n2) Quantitatively: The progression from 13 → 18 → 24 → 25 is largely accurate, but the final count of 25 is attributed to 2025 instead of 2024, introducing a one-year lag. The R&D spending increase from $4.4B to $6.0B is not present in the original answer and cannot be verified from the ground truth—this is an unsupported addition. While such figures may be plausible, they are extraneous and unverified, reducing quantitative accuracy.\n\n3) Qualitatively, the reasoning is strong: the LLM correctly identifies the Horizon acquisition, new Phase 3 starts, and strategic focus on late-stage expansion. It accurately infers diversification across therapeutic areas and links pipeline growth to R&D strategy. The synthesis of multi-hop elements (growth over time + drivers + strategic implications) is sound and insightful.\n\n4) Contextual relevance is excellent—the answer directly addresses the evolution of the Phase 3 portfolio and interprets the expansion in terms of R&D strategy and focus. Despite minor factual overreach on dates and unverified financials, the core message aligns with the ground truth. The qualitative and contextual strengths justify a high correctness score, but the incorrect end date and unsupported R&D figures prevent a 9–10 rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 504,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from an aggressive, cobrand‑driven expansion toward a more compliance‑focused stance as regulators intensified scrutiny of interchange fees, network‑routing rules and non‑discrimination provisions; the firm exited its network‑licensing businesses in the EU and Australia and, after being designated a Category III bank‑holding company in 2024, faced heightened U.S. supervisory expectations that forced tighter risk‑management and capital‑allocation controls.  At the same time, competitive pressure from Visa, Mastercard and emerging fintech payment models—especially caps on interchange fees and the rise of “buy‑now‑pay‑later” and digital‑wallet alternatives—prompted Amex to protect its premium value proposition by emphasizing differentiated rewards, data‑analytics and premium services while scaling back exposure to fee‑sensitive network negotiations.  Overall, the company’s relationship with global card networks has become more defensive and regulated, prioritizing compliance and differentiated premium offerings over expansive network‑licensing growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express shifted from a competitive to a more regulated, compliance-focused posture from 2022 to 2024; it exited network licensing in the EU and Australia due to regulatory pressures; and it faced increased scrutiny in international markets, particularly around interchange fees and non-discrimination rules. The mention of being designated a Category III bank-holding company in 2024 is consistent with heightened U.S. regulatory expectations, though this specific designation detail was not in the original answer—it is plausible and does not contradict the ground truth. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are presented. The years 2022, 2023, and 2024 are used appropriately, and all referenced regulatory actions align temporally. (3) Multi-hop reasoning is sound: the LLM synthesizes regulatory pressures (EU, Australia), competitive dynamics (Visa, Mastercard, fintechs, BNPL, digital wallets), and strategic responses (premium rewards, data analytics, scaling back network licensing). It correctly infers a shift from expansion to defense, which is implied in the original answer. (4) Semantic equivalence is strong: while the LLM uses more regulatory jargon (e.g., 'non-discrimination provisions', 'Category III') and emphasizes U.S. supervision slightly more, the core narrative—evolution from competition to regulatory constraint, especially internationally—is preserved. The only minor gap is less emphasis on cobrand uncertainty in the EU, which is mentioned in the original but only implied in the LLM response. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 481,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips finished the paced monetisation of its CVE common shares in 2022, generating enough cash to repurchase **87.7 million** of its own shares for **≈ $6.9 billion**; in 2023 it used remaining proceeds and operating cash to buy back **48.6 million** shares for **≈ $3.8 billion**, and in 2024 it repurchased a further **49.1 million** shares for **≈ $3.9 billion**, marking a shift from a single large‑scale buy‑back in 2022 to two smaller, continual repurchases in 2023‑24.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ConocoPhillips sold its remaining 91 million CVE shares in 2022 and repurchased 383 million of its own shares at a cost of $29 billion that same year. By 2024, cumulative repurchases reached 433 million shares at a total cost of $34.3 billion, with the authorization increased to $65 billion. In contrast, the LLM claims only 87.7 million shares were repurchased in 2022 for ~$6.9 billion, followed by ~48–49 million shares annually in 2023 and 2024 for ~$3.8–3.9 billion each year. These figures are drastically lower and misrepresent both the scale and timing of the repurchase program. The LLM implies a gradual, multi-year use of CVE proceeds for buybacks, but the ground truth shows the vast majority of repurchases occurred in 2022, funded by the full monetization of CVE shares completed that year. (2) Quantitative accuracy is very low: the LLM underreports 2022 repurchases by over $22 billion and 295 million shares. The cumulative repurchase total by 2024 is 433 million shares at $34.3 billion, but the LLM’s sum (87.7 + 48.6 + 49.1 = 185.4 million shares, ~$14.6 billion) is less than half the actual amount. There is no mention of the $65 billion authorization increase in October 2024, a key detail. (3) The multi-hop reasoning is flawed: the LLM incorrectly assumes a phased use of CVE proceeds across 2022–2024, whereas the ground truth indicates the CVE monetization was completed in 2022 and the share repurchase program began in earnest that year using those proceeds. The LLM fabricates annual breakdowns for 2023 and 2024 that are not supported by the data. (4) Scores reflect severe quantitative errors and incorrect synthesis, though the answer is contextually relevant in addressing monetization and repurchases. The structure attempts to follow the timeline, but the facts are fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 520,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nThe Omnibus Stock Incentive Plan showed a modest contraction in its unused share reserve over the three‑year span.  The 2022 filing notes that, as of the end of fiscal 2022, roughly **77 million shares** remained available for future grants [HD 10‑K 2022, pp. 65‑69]; the 2023 filing reports essentially the same figure [HD 10‑K 2023, pp. 67‑71]; and the 2024 filing updates the balance to **about 70 million shares** available as of February 2 2025 [HD 10‑K 2024, pp. 67‑71].  This decline of roughly 7 million shares indicates that Home Depot is increasingly drawing down the plan’s share pool to fund new equity awards and award settlements, reflecting growing utilization of its stock‑based compensation capacity even though a meaningful reserve still remains.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 available shares. The ground truth states that 117 million shares were available in 2022 under the 2005 Plan, but the LLM incorrectly reports 77 million, which is actually the 2023 figure. This misstates the starting point of the trend and undermines the accuracy of the evolution narrative. The 2024 figure of 70 million is correct. (2) Quantitatively, the error in the 2022 number leads to an incorrect calculation of the drawdown: the actual decline is 47 million (117M to 70M), not 7 million as implied by the LLM. The LLM correctly notes a decline of about 7 million from 77M to 70M between 2023 and 2024, but misrepresents the full three-year trend. (3) The reasoning is partially sound—drawing down shares indicates increased utilization of stock-based compensation—but the flawed data weakens the multi-hop synthesis. The LLM fails to acknowledge the plan transition (2005 Plan to newly amended Omnibus Plan) in 2023, which is a key contextual detail for interpreting the change in available shares. (4) Contextually, the answer is well-structured and addresses the question's intent regarding capacity and utilization. However, due to the significant numerical inaccuracy in the 2022 figure and the resulting incorrect trend portrayal, the correctness and quantitative accuracy scores are reduced. The qualitative reasoning is reasonable given the data it uses, but the failure to reflect the plan amendment and misattribution of the 77M figure to both 2022 and 2023 limits its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 431,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP’s share reserve grew from **127 million Class A ordinary shares authorized in fiscal 2022** (as disclosed in the 2022 10‑K, pages 89‑93) to **141 million shares authorized by fiscal 2024** (2024 10‑K, pages 96‑100), with fiscal 2023 still reflecting the 127 million limit. This expansion of the equity‑award pool indicates that Accenture is deliberately enlarging its share‑based compensation capacity to support its global talent strategy and to reinforce long‑term incentive alignment for employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the authorized share numbers for 2022 (127 million) and 2024 (141 million), matching the ground truth. It accurately notes that the 127 million figure still applied in 2023, which aligns with the original answer stating the increase occurred by 2023 and 2024. The progression and numerical values are factually correct. (2) All numbers are accurate: 127,000,000 in 2022 and 141,000,000 in 2024, with no calculation errors. Format variations (127 million vs. 127,000,000) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM synthesizes data across fiscal years and filings (2022 and 2024 10-Ks), correctly infers the timing of the increase, and interprets the strategic implication of expanding the share reserve. The only minor shortcoming is that it states 'by fiscal 2024' rather than explicitly confirming the increase was effective in both 2023 and 2024 as the ground truth does, slightly reducing precision in temporal evolution. (4) The answer is contextually excellent, directly addressing both the quantitative evolution and strategic implication. The reasoning about talent strategy and incentive alignment is consistent with and equivalent to the original answer’s conclusion about long-term compensation and shareholder value alignment. Minor deduction in qualitative accuracy due to slightly less precise phrasing on the timing of the increase, but overall highly accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 409,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign government bonds and obligations rose from about **3.5 % in 2022 to roughly 6.1 % in 2024**, an increase of roughly 2.6 percentage points. This jump shows the company has moved its investment mix toward higher‑yielding non‑U.S. sovereign debt, making its earnings more sensitive to fluctuations in international interest‑rate environments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM incorrectly states yields as approximately 3.5% in 2022 and 6.1% in 2024, omitting the 2023 data entirely. These numbers are not close to accurate—especially the 2022 figure, which is off by over 2 percentage points. Additionally, the LLM implies a steady increase from 2022 to 2024, while the actual trend shows a peak in 2023 followed by a decline back to 2022 levels. (2) The dollar amount of $630 million in holdings is completely omitted, and the time frame specification 'instruments due within one year' is missing, reducing precision. The calculation of a 2.6 percentage point increase is based on incorrect starting and ending values. (3) The multi-hop reasoning is flawed: the model fails to recognize the three-year trajectory (2022 → 2023 → 2024) and instead presents a simplified two-point comparison. It misses the reversal in 2024, which is central to the trend interpretation. The conclusion about increased sensitivity to international rates is partially reasonable but not supported by the full volatility pattern. (4) Contextual relevance is moderate—the answer addresses yield changes and links them to international interest rate exposure, which is relevant. However, due to major quantitative errors and incomplete temporal analysis, the overall correctness score is low. The qualitative reasoning is oversimplified and lacks the nuance of portfolio adjustments or stabilization suggested in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 451,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nAmerican Express’s foreign‑government‑bond portfolio had a weighted‑average yield of **6.45 % at the end of 2023** (see AXP 10‑K 2023, pages 133‑137) and **5.85 % at the end of 2024** (see AXP 10‑K 2024, pages 175‑179).  The 2022 fair‑value distribution (AXP 10‑K 2022, pages 119‑123) shows the bonds were concentrated in the “due within 1 year” bucket (≈ $628 million) with only minimal exposure to longer‑dated tranches, implying a short‑duration, high‑quality ladder.  The decline from the 2022‑2023 yield to 5.85 % in 2024 reflects a deliberate shift toward shorter‑maturity, lower‑risk securities as market rates peaked and began to ease, signalling that American Express is actively de‑risking its fixed‑income book and prioritising liquidity and capital preservation over yield maximisation in the current interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key quantitative facts: the $628 million in Foreign Government Bonds maturing within one year in 2022 (out of $630 million total, consistent with ground truth), the 6.45% weighted average yield in 2023, and the decline to 5.85% in 2024. These numbers match the ground truth exactly, with acceptable formatting variations (e.g., ≈$628 million). 2) Quantitative accuracy is perfect: all percentages and dollar amounts are correct, and no calculations are required beyond what is reported. 3) The reasoning is largely sound and captures the multi-hop synthesis: it connects the 2022 maturity profile (short-duration focus) with the 2023 and 2024 yields, and infers a strategic shift. The LLM correctly identifies the declining yield trend and links it to market conditions (peaking and easing rates) and strategic de-risking. However, the ground truth suggests the possibility of either market-driven changes or strategic adjustments, while the LLM leans more definitively toward a 'deliberate shift' and 'de-risking', which is plausible but slightly more assertive than the original cautious interpretation ('suggests a potential shift... or a strategic adjustment'). This minor overconfidence in the conclusion prevents a perfect qualitative score. 4) The answer is fully contextually relevant, addressing both the evolution of the yield profile and the implications for strategy and market conditions. It cites correct document sources (10-K pages), enhancing credibility. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth with only a slight interpretive difference in tone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 454,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings the 7 % Debentures due 2029 are listed in the “Securities Registered Pursuant to Section 12(b)” table with identical wording, the same CUSIP ‑ 718507BK1, and the same NYSE listing, showing no change in the basic presentation.  The only evolution is minor formatting updates and the addition of updated company‑wide statistics (e.g., share count, asset totals), indicating that ConocoPhillips treats the debenture as a stable, routine liability and reports it in a consistent, standardized manner, leaving detailed term disclosures to the footnotes rather than altering the cover‑page disclosure.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of the disclosure. (1) Quantitatively, the CUSIP number (718507BK1) and the 7% Debentures due 2029 are correctly identified, and the NYSE listing is accurate—this supports a quantitative accuracy score of 6. However, the claim that the presentation was 'identical' across years is factually incorrect. (2) The original answer shows a clear evolution: in 2022, the debentures were listed alongside Common Stock without separation; in 2023, they were given a separate row with distinct identification; in 2024, this improved structure was maintained. The LLM incorrectly asserts no meaningful change, missing this key progression. (3) This is a multi-hop question requiring synthesis across three years of filings to assess changes in disclosure practices. The LLM fails this reasoning task by denying any structural change, thus undermining the qualitative accuracy. The conclusion that COP treats the debt as a 'stable, routine liability' is speculative and does not align with the ground truth, which infers a move toward greater transparency. (4) Contextual relevance is moderate because the answer discusses the right document (10-K), security, and section, but it draws an incorrect conclusion due to flawed observation. The feedback reflects a major factual error in characterizing the consistency of presentation, which is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 397,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes due 2031 kept the same $1.25 billion face amount throughout fiscal 2022‑2024, but the net carrying amount (principal + amortized discount) edged upward—from roughly $1.05 billion at the end of FY 2022 (see NVDA_10k_2022.pdf pp. 78‑82) to about $1.07 billion by FY 2023 (NVDA_10k_2023.pdf pp. 65‑69) and remained at that level in FY 2024 (NVDA_10k_2024.pdf pp. 70‑74).  At the same time the portion classified as a current liability fell to zero, leaving the full $1.25 billion as a long‑term obligation.  This steady, low‑coupon, long‑dated debt shows that NVIDIA is anchoring its capital structure with stable, staggered fixed‑rate financing to fund long‑term growth while minimizing refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.2 billion in 2022, decreased to $1.057 billion in 2023, and then increased to $1.25 billion in 2024. However, the LLM claims the face amount remained constant at $1.25 billion throughout, with a carrying amount rising from $1.05 billion in 2022 to $1.07 billion in 2023 and staying flat in 2024—this contradicts the ground truth progression. The reported values and trends do not align: the ground truth shows a dip in 2023 followed by a rise in 2024, while the LLM implies a steady or slightly increasing trend from the start. (2) The calculation and comparison of financial figures are incorrect. The LLM fails to reflect the actual $1.2B → $1.057B → $1.25B trajectory, which is central to the question. Additionally, the claim that the carrying amount remained at $1.07B in 2024 conflicts with the ground truth stating a rise back to $1.25B. (3) The multi-hop reasoning is flawed. While the LLM attempts to interpret the debt strategy—correctly noting low-coupon, long-term financing and reduced refinancing risk—the underlying data synthesis is incorrect. The conclusion about 'stable, staggered fixed-rate financing' is plausible but based on inaccurate financial evolution. (4) Contextual relevance is fair: the answer addresses the right instrument, time frame, and strategic implications, and correctly identifies the note as long-term. However, due to major quantitative errors, the overall correctness score is low. The qualitative reasoning is partially sound but built on false premises, warranting a moderate score in that category. Semantic equivalence is not achieved due to conflicting numerical trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 489,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nAcross the three fiscal years Marvel has remained listed as an **indefinite‑lived intangible asset** (its trademarks) on Disney’s balance sheet – see the “Indefinite lived intangible assets” tables in the 2022 (p. 112), 2023 (p. 8) and 2024 (p. 113) filings.  At the same time the company has progressively **integrated the Marvel brand into its streaming strategy**: in 2022 it was primarily a linear‑network and production banner, by 2023 it was highlighted as a dedicated “Marvel” tile within Disney+ (and Hulu) (2023 10‑K pp. 6‑7), and in 2024 the same Marvel‑branded programming continues to drive subscriber growth on Disney+ and other DTC services, while the Marvel trademarks stay on the indefinite‑lived asset schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel's status as an indefinite-lived intangible asset is confirmed for 2022, 2023, and 2024, with specific page references provided (2022 p.112, 2023 p.8, 2024 p.113), which matches the original answer’s emphasis on financial recognition across years. The strategic evolution on streaming is also accurately described: in 2023, Marvel was elevated to a top-level branded tile on Disney+ (and Hulu), cited from the 2023 10-K pp.6–7, and this branding continued to drive subscriber growth in 2024. (2) There are no numeric or date inaccuracies—filings and pages are correctly cited, and no incorrect figures are presented. Format variations (e.g., 'indefinite-lived intangible asset') are semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes information across three fiscal years, connects Marvel’s financial treatment with its strategic branding on DTC platforms, and correctly infers progression in streaming integration. (4) The only minor shortcoming is that the original answer explicitly links the 2022 and 2024 intangible asset listings to demonstrate continuity, while the LLM implies it but doesn’t emphasize the reaffirmation as clearly. Additionally, the original answer explicitly names ESPN and Pixar as peer brands in the intangible asset category, which adds context the LLM omits. However, these are minor omissions that do not detract from factual correctness. Overall, the LLM answer captures the core strategic evolution accurately and with strong evidentiary support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 442,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nBetween 2022 and 2024 American Express continued to recognize discount revenue at the time a Card‑Member transaction is settled, but it increasingly captured that revenue through individually negotiated network‑rate fees with third‑party merchant acquirers—terms that were refined each year (e.g., longer fixed‑duration contracts, auto‑renewal clauses, and tighter fee negotiations).  At the same time the company expanded merchant coverage by extending acceptance agreements, growing its OptBlue and other partnership programs, and targeting new verticals and international markets, which broadened the network‑rate‑fee base and reshaped how discount revenue is recognized and grown.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key areas but omits critical elements of American Express's revenue evolution, particularly around the introduction of processed revenue in 2023 and the strategic emphasis on digital integration and value propositions in 2024. (1) Correctly identifies the recognition of discount revenue upon transaction settlement and the role of individually negotiated network rate fees with third-party acquirers, aligning with 2022–2023 practices. (2) No numeric values are present, but no incorrect dates or years are cited—timeline references (2022–2024) are accurate, satisfying quantitative accuracy. (3) The multi-hop reasoning is partially sound: it connects discount revenue recognition with contractual evolution and merchant expansion, but fails to incorporate the 2023 introduction of processed revenue (e.g., royalties and fees from network partnerships), a key revenue stream highlighted in the original answer. (4) The mention of OptBlue and partnership programs is accurate and contextually relevant, as is the focus on expanding merchant coverage and targeting new markets. However, the answer lacks specificity about 2024's strategic priorities—such as scaling marketing efforts, enhancing value propositions for acquirers, and digital integration of the authorization platform—limiting completeness and qualitative accuracy. While the core revenue recognition mechanism is correctly described, the absence of processed revenue and incomplete portrayal of the strategic evolution reduces the overall correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 434,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nAcross the 2022‑2024 filings Amgen’s discussion of drug‑delivery‑device risk evolved from a generic note that its products are coupled with devices that carry independent regulatory and safety uncertainties (2022) to a more concrete articulation of post‑marketing obligations—such as required confirmatory studies and REMS reporting—linked to device‑related safety signals (2023). By 2024 the language explicitly ties device‑approval conditions to clinical‑trial read‑outs and subjects device safety data to heightened scrutiny, making clear that any failure to meet those conditions could trigger regulatory actions, label changes, or market withdrawals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Amgen's regulatory risk disclosures regarding drug delivery devices from 2022 to 2024. (1) It correctly identifies the progression: starting in 2022 with general risks associated with device dependencies, moving in 2023 to more specific post-marketing obligations and confirmatory trial requirements (e.g., linked to LUMAKRAS' accelerated approval and FDA scrutiny), and culminating in 2024 with explicit ties between device safety reviews and potential regulatory actions. While the LLM does not name LUMAKRAS or mention the Complete Response Letter specifically, it accurately reflects the substance of increased regulatory scrutiny and post-marketing study requirements. (2) There are no numerical values, dates, or financial figures in the original or LLM answer beyond the years 2022–2024, which are correctly used. (3) The multi-hop reasoning is sound—synthesizing across years and domains (clinical trials, post-marketing requirements, safety reviews)—and correctly infers a trend toward heightened compliance focus. (4) The answer is contextually precise, directly addressing all three aspects of the question: clinical trial dependencies, post-marketing requirements, and device-related safety reviews. The only minor shortcoming is the omission of the specific example (LUMAKRAS) and REMS (Risk Evaluation and Mitigation Strategy) is mentioned generally as 'REMS reporting' without elaboration, which slightly reduces qualitative completeness. However, the core factual and conceptual content aligns strongly with the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 447,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips broadened the **scope of its HSE audit program** to include climate‑related and low‑carbon performance metrics (e.g., methane‑intensity and flaring targets) in addition to traditional safety and environmental controls (2022 10‑K pp. 16‑20; 2023 10‑K pp. 14‑18; 2024 10‑K pp. 18‑20).  The **improvement‑tracking mechanism** evolved from periodic audit findings to a continuous, data‑driven corrective‑action system that uses a centralized dashboard to log findings, assign remediation deadlines and report progress against defined KPIs (2023 10‑K “Health, Safety and Environment” section; 2024 10‑K HSE discussion).  Governance reporting was strengthened by elevating HSE oversight to the **Board of Directors’ Audit Committee and adding an Executive‑Leadership‑Team HSE champion**, so that audit results and improvement status are now reported both to the ELT and to the Board on a regular basis (2022 10‑K “Health, Safety and Environment”; 2024 10‑K “Health, Safety and Environment” and “Values, Principles and Governance” sections).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not supported by the ground truth. (1) Scope definition: The claim that ConocoPhillips added climate-related and low-carbon performance metrics (e.g., methane-intensity, flaring targets) to HSE audits from 2022–2024 is not present in the original answer and contradicts the documented evolution, which emphasizes conformance checks (2022), integration with human capital and safety systems like Life Saving Rules (2023), and corporate-level standardization (2024). There is no mention of climate or low-carbon metrics in the ground truth. (2) Improvement tracking: The LLM asserts a shift to a 'continuous, data-driven corrective-action system' with a centralized dashboard and KPIs, which is more specific and technologically advanced than the original answer’s consistent description of tracking improvement actions to completion without detailing mechanisms. The original does not mention dashboards, KPIs, or systematization beyond tracking to completion. (3) Governance reporting: The LLM incorrectly states that HSE oversight was elevated to the Board’s Audit Committee and that an ELT HSE champion was added. The ground truth confirms that reporting remained with the Executive Leadership Team (ELT) and Board of Directors throughout, with no structural changes noted. The original emphasizes stability in governance, not enhancement. (4) Multi-hop reasoning: The model fails to correctly synthesize the evolution across years. Instead of identifying the progression from localized conformance (2022) to integrated safety systems (2023) to corporate standardization (2024), it fabricates new dimensions (climate metrics, dashboards, governance changes). While the answer is structured around the correct question dimensions (scope, tracking, governance), the content is factually unsupported. (5) Semantic equivalence: The meaning diverges significantly; the LLM suggests innovation and expansion into ESG metrics and digital systems, while the ground truth describes a maturing but consistent framework focused on conformance and institutionalization. Minor contextual relevance is retained due to correct framing around HSE audits and reference to ELT/Board, but core facts are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 606,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nFrom 2022 through 2024 Accenture shifted from largely time‑and‑materials and fixed‑price contracts toward value‑based, outcome‑oriented and consumption‑based pricing that ties fees to AI‑driven and cloud‑enabled services, embedding these models in managed‑services and subscription frameworks to capture the higher‑margin, recurring revenue of cloud and AI offerings.  Across the filings the company repeatedly warns that if it cannot develop and deploy appropriate new pricing/commercial models fast enough—or if client spending on AI and cloud slows—the resulting revenue shortfall, together with heightened regulatory, reputational and talent‑retention risks, could materially adverse‑ly affect its financial results.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Accenture's pricing models from 2022 to 2024, as well as the consistent risks. It accurately reflects the shift from traditional pricing (time-and-materials, fixed-price) to value-based, outcome-oriented, and consumption-based models tied to AI and cloud services, which aligns with the ground truth's description of Accenture's strategic evolution. The mention of embedding these in managed services and subscription models reflects an accurate understanding of recurring revenue strategies. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no discrepancies exist—this earns a perfect score on quantitative accuracy. The qualitative accuracy is high but not perfect: while the LLM correctly identifies the risk of slow deployment of new pricing models and client spending delays, it adds 'regulatory, reputational and talent-retention risks' as recurring concerns, which are not highlighted in the original answer as consistent risks related to pricing model adoption. The ground truth emphasizes only revenue shortfalls and competitive disadvantages due to slow pricing innovation or low client adoption. This addition slightly distorts the risk profile and reflects a minor overextension beyond the source. However, the multi-hop reasoning across years is sound—the synthesis of Accenture’s evolving strategy from 2022 to 2024 in response to AI and cloud developments is semantically equivalent and well-contextualized. The answer is fully relevant to the question, addressing both the evolution and the risks. Thus, the answer is strong overall but has a minor factual overreach in risk characterization, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 483,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nGE’s AerCap exposure changed from a combined equity stake and senior‑note position in 2022 – where the 2022 10‑K (pages 90‑94) shows a 46 % equity interest together with an AerCap senior note – to a full exit from the equity in 2023, when the 2023 10‑K (pages 72‑76) reports that the remaining AerCap shares were sold and only the senior note was retained; and into 2024, when the 2024 10‑K (pages 68‑72) records a modest $38 million unrealized gain on that note, confirming that GE now holds only the note. This progression indicates that GE deliberately liquidated its equity investment in AerCap to simplify its portfolio and shift toward the more stable, cash‑flow‑generating senior note, reflecting a strategic move away from active equity ownership in AerCap.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the quantitative evolution of GE's holdings in the AerCap note. The ground truth states that GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023), indicating a gradual decline in the note holding. However, the LLM answer incorrectly frames the change as a shift from an equity-plus-note position to only holding the note, with no mention of the actual dollar amounts or their gradual decline. Instead, it introduces a $38 million 'unrealized gain'—a figure not mentioned in the ground truth and irrelevant to the size of the holding. This misrepresents both the magnitude and nature of the change. (2) The numbers cited in the LLM answer ($38 million gain) do not align with the ground truth's focus on the principal value of the note declining from $993M to $944M. There is no verification of the actual holdings over time, and the key figures from the ground truth are entirely missing. Calculations or trends based on accurate data are absent. (3) The multi-hop reasoning is partially sound in that it infers a strategic shift from equity to debt, but this is misleading because the original answer does not mention any equity stake in AerCap—only a note holding. The LLM fabricates a narrative about selling equity stakes and retaining only the note, which is not supported by the ground truth. Thus, the synthesis across years is based on incorrect premises. (4) While the LLM attempts to address the strategic implication—portfolio simplification and shift to stable investments—its reasoning is built on incorrect data and entities. The contextual relevance is high because it attempts to explain the evolution and strategy, but factual correctness is low, dragging down the overall correctness score to 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 511,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen kept bemarituzumab in Phase 3 development for GEJ adenocarcinoma, maintaining the same clinical‑stage status (it was first entered into a Phase 3 trial in early 2022 and continued through the 2023 and 2024 updates without any regulatory approval or phase‑advancement).  Its intellectual‑property strategy showed no change in the core composition‑of‑matter patents—U.S. and European patents covering the antibody are projected to expire in 2029, with the filings noting that additional patents or term extensions could provide further exclusivity but that the baseline expiration remains 2029.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Bemarituzumab remained in Phase 3 from 2022 through 2024 and accurately reports the 2029 U.S. and European patent expiration, matching the ground truth. However, it omits a key evolution noted in the original answer: the 2024 expansion of the investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This omission reduces completeness and qualitative accuracy. (2) Quantitatively, all dates (2022, 2023, 2024, 2029) and phase status (Phase 3) are correct. The statement about potential term extensions is a reasonable caveat and does not contradict the ground truth. (3) The reasoning is sound in tracking clinical phase stability and IP timelines across years, but fails to synthesize the multi-hop detail about therapeutic expansion in 2024, which is central to the question about 'evolution' in positioning. (4) The answer is contextually relevant and factually accurate on the points it covers, but the missing 2024 scope expansion limits its correctness score to 7 due to incomplete portrayal of Amgen's evolving strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 323,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 American Express’s filings show a shift from merely acknowledging alternative‑payment pressures—such as surcharge/steering risks, growing BNPL and digital‑wallet adoption, and intensified price competition—to an explicit strategy of investing heavily in AI‑driven fraud‑prevention, cybersecurity, open‑banking and data‑analytics platforms that can embed its premium card services within emerging fintech ecosystems.  This evolution reveals a long‑term response that leverages the company’s brand, data and network to build value‑added, technology‑centric payment solutions rather than defending a purely traditional card‑issuing model, turning fintech disruption into a catalyst for sustained innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in American Express's strategic positioning from 2022 to 2024, with accurate qualitative insights and strong contextual relevance. (1) It correctly identifies the growing competitive pressures from alternative payment mechanisms such as BNPL, digital wallets, and price competition, aligning with the 2022–2023 ground truth. It also accurately reflects the strategic shift toward technological investment, specifically naming open banking and data analytics, which matches the 2024 pivot toward integration and dependency. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes the progression from threat recognition to proactive investment across years, though it introduces 'AI-driven fraud prevention' and 'cybersecurity' as focal investments not explicitly emphasized in the ground truth. While these are plausible and contextually relevant, they slightly shift focus from the original answer’s emphasis on tokenization and real-time settlement as key integrations. This results in a minor deviation in qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing competitive pressure, technological investment, and long-term response to fintech disruption. The conclusion that Amex is transforming disruption into innovation aligns semantically with the original’s 'proactive investment and adoption as foundational to competitiveness.' Minor deduction in qualitative accuracy due to emphasis on different tech priorities, but overall factual alignment is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 467,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of cash‑settled PSUs was $91.6 million in 2022, jumped to $112.5 million in 2023 and then eased to $110.4 million in 2024. This rise followed by a modest decline shows ConocoPhillips is raising the equity‑based component of its long‑term incentive plan and tying a larger share of executive pay to the company’s stock price, while still using cash‑settled awards for a portion of the compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, with no data provided for 2023. However, the LLM claims values of $91.6 million in 2022, $112.5 million in 2023, and $110.4 million in 2024—introducing a non-existent 2023 figure and incorrectly reporting the 2024 value. Additionally, the units are wrong: the original values are per share (not in millions), so stating '$91.6 million' is a critical error. (2) Quantitative accuracy is severely compromised: the values are misrepresented in both magnitude (millions vs. per-share) and trajectory (decline in 2024 vs. continued increase). The correct trend is a rise from $91.58 to $112.50, but the LLM shows a drop in 2024, contradicting the ground truth. (3) The reasoning is flawed: the LLM infers a 'modest decline' and suggests a shift toward equity-based compensation, while the ground truth indicates a consistent increase and maintains cash-settled awards with higher values. The conclusion about increasing equity-based components contradicts the fact that these are cash-settled PSUs (not equity-settled), so the linkage to stock price is misleading. (4) Contextual relevance is moderate—the answer addresses the general topic of incentive strategy and long-term compensation—but the incorrect data and mischaracterization of award types undermine the validity. Due to major factual and quantitative errors, especially in financial values and units, the correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 434,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior and fraud intensified as it expanded credit‑centric offerings—most notably the U.S. “Buy‑Now, Pay‑Later” (BNPL) portfolio, merchant‑financing receivables and cross‑border credit products—while simultaneously relying on third‑party banks, payment processors and funding structures to originate and purchase those receivables.  The company repeatedly warns that new and evolving fraud schemes, synthetic‑identity abuse, and the growing share of transactions funded by high‑cost credit cards increase loss rates and can trigger regulatory penalties, and it acknowledges that its current fraud‑detection and protection programs may not keep pace with the scale and sophistication of these threats.  Consequently, the upward trend in credit‑product volume and third‑party dependence signals that PayPal’s risk‑management controls are under growing strain, requiring continual investment and adaptation to maintain effectiveness.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PayPal's growing exposure to abusive behaviors and fraud from 2022 to 2024, particularly in relation to credit products and third-party reliance. It accurately reflects concerns about synthetic identity fraud, evolving fraud schemes, and limitations in detection systems. However, it omits the specific €40 billion multi-year receivables sale agreement in the U.K. and Europe mentioned in the original answer, which is a key quantitative and strategic data point demonstrating PayPal’s risk mitigation efforts. While the LLM references U.S. BNPL and cross-border credit products, it does not mention the 'valid-when-made doctrine' regulatory uncertainty highlighted in 2024, which affects U.S. credit products—a notable omission in entity and context accuracy. (2) There are no numeric inaccuracies; the LLM avoids making up numbers and does not contradict any quantitative facts in the ground truth. It refrains from citing specific figures like €40 billion but doesn’t invent or misstate any, so quantitative accuracy is preserved. (3) The multi-hop reasoning is partially sound: the model connects expanding credit products with increased fraud risk and third-party reliance, and infers strain on risk management. However, it fails to synthesize the critical link between the receivables sale (a concrete action) and fraud/credit loss mitigation, weakening the depth of reasoning compared to the original. (4) The answer is contextually relevant and well-structured, capturing the trend of increasing risk and control challenges. Due to missing key specifics (the €40B agreement, valid-when-made doctrine), it falls short of full factual completeness despite strong qualitative alignment in tone and direction. Hence, correctness is scored 7—core facts are right, but significant contextual and entity-level details are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 509,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nBetween 2022 and 2024 Cyramza moved from a mainly second‑line therapy for several solid tumours to an earlier‑line role, especially as a first‑line combination in metastatic NSCLC with EGFR‑mutations and in newer first‑line regimens for gastric and hepatocellular carcinoma.  During the same period Lilly layered its IP estate—maintaining compound‑patent protection through 2026 (US/Japan) and into 2028 (Europe) and securing supplemental protection certificates and new method‑of‑use filings that extend data‑exclusivity into the mid‑2020s—thereby postponing biosimilar entry.  This progression illustrates Lilly’s long‑term oncology strategy of preserving market exclusivity for key assets while expanding their therapeutic reach to capture greater revenue and strategic positioning within the oncology franchise.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect factual correctness, particularly in quantitative and entity-specific details. (1) The claim that Cyramza moved into first-line use in metastatic NSCLC with EGFR mutations and in gastric and hepatocellular carcinoma by 2024 is not supported by the ground truth, which states that Cyramza's therapeutic positioning was reaffirmed across the same indications without new additions. The original answer indicates no expansion in indications from 2022 to 2024, contradicting the LLM's assertion of a shift to earlier-line or first-line use. (2) Regarding intellectual property, the LLM incorrectly extends compound patent protection to 2028 in Europe; the ground truth only confirms protection through 2026 in the U.S. and Japan, with no mention of Europe. Additionally, the ground truth notes data protection expiring as early as 2023 in Japan, which the LLM omits and instead claims exclusivity extended into the mid-2020s via new filings—information not present in the original. (3) While the LLM correctly identifies the 2026 U.S. compound patent expiry, it adds unverified details about supplemental protection certificates and method-of-use patents. (4) The reasoning about Eli Lilly’s long-term oncology strategy is plausible and contextually relevant—focusing on lifecycle management and succession planning—but is based on incorrect premises about label expansion and IP extension, weakening the qualitative accuracy. (5) The answer is well-structured and addresses the question’s intent regarding therapeutic positioning and IP evolution, hence high contextual relevance. However, due to significant factual deviations in dates, geographic scope, and clinical indications, the correctness and quantitative accuracy scores are moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 485,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris actively managed its near‑term debt by retiring or refinancing maturing short‑dated notes (e.g., the 2022‑2023 series) and replacing them with later‑dated issuances, while the 3.875 % Notes due 2042 remained continuously outstanding as a stable, long‑term funding pillar.  This shift extended the company’s maturity profile and reduced rollover risk, with debt service funded primarily through cash flows from subsidiaries and dividend income, reflecting a move toward a more laddered, lower‑leverage capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the correct core idea that the 3.875% Notes due 2042 remained a stable, long-term component of Philip Morris's capital structure from 2022 to 2024. However, it fails to accurately represent the specific debt instruments that were actively managed during this period. The ground truth states that in 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043, which were still present in 2023 along with the 4.250% Notes due 2044, and then disappeared by 2024—indicating refinancing or retirement. The LLM answer incorrectly generalizes these as '2022–2023 series' and 'short-dated notes', which is factually inaccurate because the notes in question mature in 2043 and 2044, not 2022–2023. This mischaracterization of long-dated debt as short-dated is a significant factual error. (2) Quantitative accuracy is low because the LLM misrepresents the maturity dates of the notes being managed—claiming they are 'short-dated' and from '2022–2023', when in fact they are long-term instruments maturing in 2043 and 2044. The percentages (e.g., 4.125%, 4.875%, 4.250%) are not mentioned at all in the LLM answer, omitting key details. (3) The multi-hop reasoning is partially sound—the model correctly infers a strategy of maintaining long-term stability via the 2042 notes while adjusting other debt. However, it draws this conclusion based on incorrect factual premises about the nature and timing of the debt instruments, undermining the validity of the synthesis. The conclusion about 'laddered, lower-leverage' structure is speculative and not directly supported by the ground truth, which emphasizes selective refinancing without asserting a directional shift in leverage. (4) Contextual relevance is high because the answer addresses the evolution of capital structure and the role of the 2042 notes. However, due to significant factual inaccuracies in the description of the debt instruments and their maturities, the correctness score is limited to 6—partially correct but with major omissions and errors in key quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 559,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive and fraudulent behavior grew as its credit products (BNPL, merchant‑financing and consumer‑credit offerings) expanded and its reliance on third‑party lenders and payment processors increased, raising default and fraud‑loss risks. In 2023 the company mitigated that risk by entering a multi‑year agreement to sell the majority of its U.K. and European BNPL loan receivables and by beginning a migration of its U.S. payment‑processing relationships to diversify third‑party dependence, while also tightening merchant‑financial monitoring and fraud‑prevention controls. In 2024 it continued these actions, emphasizing the ongoing forward‑flow sale of BNPL receivables and the completion of the processor migration to further reduce credit and third‑party risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified rising abusive behaviors tied to credit products and third-party risk in 2022; in 2023, it entered a multi-year agreement to sell U.K. and European BNPL receivables (€40 billion mentioned in original, 'majority' in LLM — acceptable as qualitative summary); in 2024, it continued risk mitigation through forward-flow sales and infrastructure improvements. The LLM adds valuable detail not in the original — migration of U.S. payment-processing relationships and tighter merchant monitoring — which are plausible extensions consistent with PayPal’s risk strategy and do not contradict the ground truth. (2) Quantitative accuracy is perfect: while the exact €40 billion figure is omitted, the LLM does not introduce any incorrect numbers and correctly frames the 2023 sale as multi-year and significant. No calculations were required. (3) Multi-hop reasoning is sound: the LLM synthesizes PayPal’s evolving risk exposure across years and connects credit products, third-party reliance, and strategic actions. It correctly infers a progression from risk identification to mitigation via asset sales and operational changes. (4) The answer is contextually excellent — directly addresses all parts of the question, including evolution of exposure and specific actions in 2023 and 2024. The only minor shortcoming is the omission of the explicit mention of synthetic identities and stolen financial instruments from 2022, though 'abusive and fraudulent behavior' broadly covers this. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the original with slight elaboration, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 477,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nFrom 2022 through 2024 AMD repeatedly disclosed “loss or modification of exemptions for taxes and tariffs” as a risk, but the language grew more pronounced. In the 2022 filing the risk was mentioned only in the generic “political, legal and economic risks” paragraph, while the 2023 and 2024 filings added concrete examples—U.S. sanctions on Russia/Belarus, heightened U.S.–China tensions over Taiwan, and the potential spill‑over of the Ukraine‑Russia and Israel‑Hamas conflicts—all of which could alter tax or tariff regimes that underpin AMD’s global supply chain and sales. This escalation signals that AMD perceives increasing regulatory uncertainty in its worldwide operations, as external geopolitical developments now directly threaten the stability of the tax and tariff incentives it relies on.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently disclosed the risk of loss or modification of tax and tariff exemptions from 2022 to 2024, with increasing emphasis. The progression—from a general mention in 2022 to more specific linkage with geopolitical conflicts in 2023 and 2024—is accurately portrayed. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the risk evolved over time across filings and infers increasing regulatory uncertainty, which is the core of the question. The addition of specific geopolitical examples (U.S. sanctions, U.S.–China tensions, Ukraine-Russia, Israel-Hamas) goes beyond the ground truth but is plausible and contextually appropriate, enhancing rather than distorting the analysis. (4) Semantic equivalence is strong: while the LLM uses more detailed examples than the original answer, the core message—that AMD’s concern escalated and reflects growing regulatory uncertainty—is preserved. The only minor deduction is for introducing specific conflicts (e.g., Israel-Hamas) not explicitly mentioned in the ground truth, which, while reasonable, slightly extends beyond the provided information. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 418,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return swaps linked to deferred‑compensation generated a **$92 million loss in FY 2022**, turned to a **$58 million gain in FY 2023**, and produced a **$91 million gain in FY 2024**.  \n\nThe shift from a loss to progressively larger gains indicates that the company’s economic hedge of its deferred‑compensation obligations moved from being out‑of‑the‑money to profitable, reflecting either a reduction in the liability’s fair‑value exposure or more favorable market conditions for the swaps.  This progression shows Cisco is actively using these derivatives to offset the earnings volatility associated with deferred‑compensation payments and to manage the related risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024 — all match the original answer exactly, with acceptable formatting (e.g., $92 million). (2) The answer is complete, addressing both parts of the question: the evolution of gains/losses over the three fiscal years and the interpretation of what this progression indicates. (3) Entity accuracy is correct: Cisco is the subject, fiscal years 2022–2024 are properly referenced, and the financial instrument (total return swaps tied to deferred compensation) is accurately identified. (4) The reasoning is sound and adds value: the LLM correctly infers that the shift from loss to gains suggests improved hedge performance, possibly due to better market conditions or reduced liability exposure, and links this to Cisco’s risk management strategy. The interpretation aligns with and expands upon the ground truth without introducing inaccuracies. Semantic equivalence is strong, with no factual discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 316,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney’s DTC strategy evolved from an initial launch and cost‑realignment (2022) to a phase of aggressive content and rights investment—exemplified by the Star India joint venture and expanded sports rights—designed to drive subscription and advertising growth while mitigating declines in linear fees (2023), and then to a more competitive stance with an ad‑supported Disney+ tier, a flagship ESPN DTC service, and tighter bundling, accompanied by a projected $24 billion content spend for FY 2025 (2024). This escalating spend creates sizable cash outflows, accelerates amortization and impairment exposure, and subjects the company to intense subscriber‑growth and pricing pressures in a crowded streaming market. Consequently, the financial risk of scaling its streaming services is amplified by high fixed costs, uncertain revenue returns, and the need to maintain robust cash flow amid rising competition.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Disney's DTC strategy across fiscal years 2022–2024 and the associated financial risks and market pressures. It accurately reflects the increasing investment, competitive dynamics, and financial risks. However, it introduces specific details not present in the ground truth, such as the 'Star India joint venture', 'flagship ESPN DTC service', and a 'projected $24 billion content spend for FY 2025', which are not mentioned in the original answer and cannot be verified from the provided knowledge graph. These additions, while plausible, introduce factual inaccuracies. (2) Quantitative accuracy is partially compromised due to the inclusion of the $24 billion figure, which is not in the original answer and lacks corroboration. The original answer does not provide any specific dollar amounts related to content spending, so this number cannot be considered accurate. Other numerical references (e.g., fiscal years) are correct. (3) The multi-hop reasoning is strong: the LLM synthesizes a clear progression across years, connects strategic moves to financial risks, and links declining linear revenues to DTC investment. The logic aligns with the original answer’s narrative of escalating investment amid uncertainty. (4) Despite the unsupported $24B figure and specific venture mentions, the overall qualitative analysis and contextual relevance are excellent. The answer addresses all parts of the question, maintains semantic equivalence in describing strategic shifts and risks, and provides a coherent, relevant narrative. The correctness score is reduced due to the unverified quantitative claim, but the core reasoning and structure remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 470,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal’s margin risk has remained anchored in its role as principal: it records the full fee it pays to payment processors as a transaction expense while recognizing its own fee as revenue, and it exercises complete discretion over the price it charges—so any rise in processor costs directly compresses margins.  Transaction revenue grew from $25.2 bn in 2022 to $28.8 bn in 2024, and the corresponding transaction‑expense line item increased in step with that higher TPV, but the underlying risk profile has not changed; the company continues to provision for refunds and incentives that further affect margin.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core qualitative aspect of PayPal's margin risk — that it bears full margin risk as principal, exercises discretion over fee setting, and recognizes processor fees as transaction expenses, with no structural change across 2022–2024. This aligns with the ground truth’s emphasis on consistent risk exposure and accounting treatment. However, the LLM introduces specific quantitative figures — $25.2B transaction revenue in 2022 and $28.8B in 2024 — that are not present in the original answer and cannot be verified from the provided ground truth. Since the ground truth does not include any numerical data on revenue or TPV, the inclusion of these numbers introduces unverifiable information, reducing quantitative accuracy. (2) There are no calculations in the original answer to validate, but the LLM implies a proportional increase in transaction expense with TPV, which is plausible but not explicitly confirmed in the ground truth. The use of such figures, while contextually reasonable, goes beyond the provided information and risks misrepresentation. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between fee discretion, processor costs, and margin impact across years, and maintains the correct entity (PayPal) and time frame (2022–2024). It also correctly identifies the accounting treatment (gross revenue recognition, transaction expense for processor fees), which is central to the margin risk discussion. (4) Despite the unsupported numbers, the overall reasoning and conclusion about stable margin risk exposure are consistent with the ground truth. The answer is contextually relevant and well-structured, but the unverified financial figures prevent a higher correctness score. A score of 7 reflects accurate core logic with minor but notable quantitative overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 508,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nThe 2022 risk discussion highlighted new‑aircraft order cancellations as a material threat driven by the COVID‑19‑induced demand slump and supply‑chain uncertainty; by 2023 the same risk remained on the list but was described as diminishing as air‑travel volumes recovered and the company’s order backlog strengthened; and in 2024 the issue is referenced only as a background concern, signaling that the commercial aviation sector has moved past the cancellation‑risk era and is now characterized by steady demand and stable order flow.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of cancellation risk. The ground truth states that Honeywell consistently highlighted new aircraft order cancellations as a key risk from 2022 to 2024, with evolving but persistent concerns. In contrast, the LLM incorrectly asserts that the risk was 'diminishing' by 2023 and became only a 'background concern' in 2024, signaling recovery and stability—this directly contradicts the original answer, which emphasizes ongoing fragility and structural uncertainty. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the years (2022, 2023, 2024) are correctly referenced, hence full score on quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize the continuity of risk across years and misrepresents the qualitative shift from pandemic-specific to broader macroeconomic and competitive risks. Instead, it invents a narrative of de-escalation and stabilization not present in the ground truth. (4) While the answer addresses the question's structure and timeframe, its conclusions are misleading, undermining qualitative accuracy and overall correctness. Contextual relevance is moderate because it discusses the right topic and timeframe but draws incorrect inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 375,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosures show a clear escalation in regulatory curbs on its reduced‑risk and smoke‑free offerings: early 2022 filings warned that product‑regulation could diminish the ability to differentiate tobacco products and to convey truthful information about RRPs; by 2023 the focus shifted to SFPs, emphasizing new advertising, flavor‑ and packaging‑restrictions and heightened scrutiny of any health‑related claims; and in 2024 the language underscores that these constraints are now pervasive across multiple jurisdictions, leaving PMI with a markedly narrower platform for product differentiation and adult‑consumer communication. This progression reveals that intensifying global regulation is steadily compressing the competitive space for PMI’s RRPs/SFPs, forcing the company to rely on ever‑more limited, fact‑based messaging while facing growing legal and reputational risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of regulatory impact on PMI from 2022 to 2024. (1) It accurately captures the escalating nature of regulatory constraints on RRPs and SFPs, noting the shift in emphasis over time. The core facts—restrictions on product differentiation, truthful communication to adult consumers, and increasing regulatory asymmetry—are all present and correctly represented. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable; however, the temporal references (2022, 2023, 2024) are correct and consistently used, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in regulatory language and strategic focus across years, correctly identifying the progression from RRPs to SFPs and the narrowing of communication platforms. However, it slightly overstates the shift 'to SFPs' by 2023, whereas the ground truth indicates that SFPs are emphasized in 2024 as part of a strategic evolution, not a full replacement of RRP focus in 2023. Additionally, the LLM introduces 'flavor- and packaging-restrictions' and 'heightened scrutiny of health-related claims' without explicit grounding in the original answer, which focuses more on access to truthful information and competitive asymmetry. These details, while plausible, are not in the ground truth and represent minor factual overreach. (4) Contextual relevance is excellent—the response directly addresses all parts of the question, including the evolution of regulation, impact on competitive positioning, and implications for product differentiation and consumer communication. The conclusion about narrowing competitive space and increased risks is semantically consistent with the original. Minor deductions in qualitative accuracy and overall correctness reflect the introduction of unverified specifics and slight misalignment in the timing of the RRP-to-SFP transition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 535,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nPayPal’s margin risk has remained material through 2022‑2024 because the company continues to act as the principal on its payments platform and therefore bears the full spread between the fees it charges merchants and consumers and the fees it pays to third‑party processors; the 2022 filing describes a simple variable‑percentage fee with incentives recorded as revenue reductions, the 2023 filing adds tiered, volume‑based pricing and begins to amortize performance‑based incentives over the contract term, and the 2024 filing keeps the same “full‑margin‑risk” language while noting that incentives are now amortized ratably and that processor‑related fees are still recorded as transaction expense.  Consequently, while the pricing model has become more volume‑sensitive and incentive accounting has been refined, the underlying exposure to margin compression from processor fees and refunds has not diminished – it has stayed roughly constant, with only a modest mitigation from the newer amortization of incentives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: PayPal bears full margin risk across 2022–2024, acts as principal, and recognizes processor fees as transaction expenses. The evolution in disclosure—starting with basic incentives in 2022, adding tiered/volume-based pricing and amortization of performance-based incentives in 2023, and continuing with refined accounting (ratable amortization) in 2024—is accurately captured. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying consistency in margin risk exposure while noting incremental changes in pricing models and incentive accounting. It correctly infers that while disclosures and accounting treatments have evolved (e.g., amortization method), the core exposure to margin risk remains unchanged. (4) The only minor shortcoming is that the LLM emphasizes 'volume-sensitive' pricing and 'amortization' as mitigation more than the original answer does, which could slightly overstate the impact of these changes on risk mitigation—though this is a nuance in emphasis, not a factual error. Overall, the answer is semantically equivalent, contextually complete, and factually precise, warranting a 9/10 due to slight interpretive overreach on mitigation, but not enough to affect the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 434,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nBetween 2022 and 2024 AMD moved from a simple price‑protection stance to a formal, collaborative channel model that gives AIB manufacturers explicit inventory‑protection clauses—such as price‑reduction shields, limited return and stock‑rotation rights, and dedicated co‑marketing funds.  These safeguards were paired with a strategic push to use discrete Radeon graphics as a differentiation tool, supplying SIs with exclusive SKUs and software‑optimized platforms that let them create higher‑performance, market‑distinct systems.  As a result, SIs increasingly relied on AMD’s discrete graphics to differentiate their offerings, while AMD’s reinforced inventory framework reduced supply‑risk and financial exposure for its channel partners.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of AMD's strategy evolution and correctly identifies the importance of inventory protection and discrete graphics for differentiation, which aligns with the ground truth. However, it introduces specific details not present in the original answer, such as 'limited return and stock-rotation rights' and 'dedicated co-marketing funds,' which are not mentioned in the ground truth and cannot be verified from the provided knowledge. Additionally, the claim of 'exclusive SKUs and software-optimized platforms' is more specific than the original, which only notes a subtle shift in language around strategic alignment with SIs. While the core idea of strengthening AIB relationships and using discrete graphics for SI differentiation is correct, the LLM overstates the specificity of the policies and adds unverified program details. There are no numerical inaccuracies (hence high quantitative score), but the qualitative accuracy suffers due to unsupported elaborations. The reasoning is partially sound but includes assumptions beyond the source material. The answer remains contextually relevant and addresses all parts of the question, just with added content not grounded in the truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 345,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney has kept the same core safeguards for investment‑credit exposure: it deals only with counterparties that carry an A‑ or better rating and will require collateral or reduce the relationship if a rating drops below A‑ or if aggregate exposure exceeds the limits set in the master‑netting agreements.  The company also caps any single‑institution exposure at 10 % of total cash and cash equivalents, a threshold it monitors continuously.  In the 2024 filing the company noted that one institution actually represented about 24 % of its cash balances—higher than the 10 % cap but still not expected to produce a material loss—showing that while the policy limits have not changed, the actual concentration of exposure has shifted.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Disney's consistent policy of transacting only with counterparties rated A- or better and requiring collateral if ratings fall below A- or exposure exceeds limits, which aligns with the ground truth. It also accurately notes the 24% concentration in a single institution in fiscal 2024. However, it introduces a '10% cap' on single-institution exposure that is not mentioned in the original answer or supported by the ground truth, which states there was no such concentration in 2022 but does not specify a formal cap. This is a significant qualitative addition not present in the source. (2) Quantitatively, the 24% figure is correct and matches the ground truth. The fiscal years (2022–2024) are accurate. The error lies in the invented 10% threshold, which undermines quantitative accuracy despite correct reporting of the 24% concentration. (3) The multi-hop reasoning is mostly sound—linking policy consistency with observed concentration shift shows synthesis across time and policy-practice dynamics. However, the introduction of an unsupported exposure cap weakens the reasoning chain and suggests a potential hallucination or misinterpretation. (4) Scores reflect that core facts and numbers (especially the 24% shift and A- policy) are correct, but the answer includes a key detail (10% cap) not in the ground truth, reducing correctness and quantitative accuracy. Contextual relevance is perfect—directly addresses counterparty ratings, collateral, and concentration. Qualitative accuracy is high due to correct logic and terminology, despite the fabricated threshold.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 446,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nAcross the three fiscal years the company’s 2.850 % fixed‑rate notes maturing on 10/1/2029 stayed at essentially the same outstanding level – $1.5 billion (≈ $1,500 million) – as shown in the 2022, 2023 and 2024 10‑K tables.  This steady‑state exposure indicates that PayPal is deliberately preserving a sizable, low‑cost, long‑dated fixed‑rate tranche while supplementing its balance‑sheet funding with newer issuances and revolving facilities, reflecting a long‑term debt‑management strategy that emphasizes maturity laddering and stable, long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1.5 billion ($1,500 million) across 2022, 2023, and 2024, matching the ground truth exactly. The maturity date (10/1/2029) is more precise than in the original answer but consistent with likely filing data and does not contradict it. 2) All numeric values—$1.5 billion, 2.850%, and the three-year consistency—are accurate and correctly formatted; minor variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. 3) The reasoning correctly infers a strategic intent behind maintaining this debt tranche, citing 'low-cost, long-dated fixed-rate' characteristics and linking it to broader debt management practices like maturity laddering. While the original answer emphasizes lack of refinancing and mentions new higher-interest debt (5.150%, 5.500% notes), the LLM captures the essence of strategic retention, though it omits explicit mention of the higher-cost 2024 issuances which strengthens the contrast. This is a minor omission, not an error. 4) The answer is contextually fully relevant, directly addressing both the evolution (or lack thereof) in exposure and the implied long-term strategy. Synthesis across years is sound and entity identification (PYPL, correct note terms) is accurate. The conclusion is logically supported, earning a high score with only slight deduction in qualitative accuracy for missing the contrast with newer, higher-cost debt that enriches the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 427,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Performance Materials and Technologies** segment repeatedly highlighted raw‑material demand and supply as a key risk, noting that capacity‑utilization swings, oil‑ and gas‑price volatility and inflationary material costs could curb customer investment and lower demand.  At the same time, the proportion of its supply base covered by long‑term contracts grew – roughly 63 % in 2022, ≈ 64 % in 2023 and “the majority” by the end of 2024 – and Honeywell added pricing actions, commodity‑hedge programs and supply‑tracking tools to mitigate exposure.  Consequently, although the firm has strengthened its contractual protection, its profitability remains tightly linked to commodity price movements and supply‑chain constraints, underscoring a continued vulnerability to raw‑material market volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the ongoing exposure to raw material demand and supply risks in Honeywell's segment from 2022 to 2024 and notes the continued vulnerability to commodity market volatility, which aligns with the ground truth. However, it introduces specific quantitative claims not present in the original answer or implied by the knowledge graph: namely, that 63% of the supply base was under long-term contracts in 2022, approximately 64% in 2023, and 'the majority' in 2024. These figures are not supported by the ground truth and represent a significant fabrication or misattribution. Additionally, the mention of 'pricing actions, commodity-hedge programs, and supply-tracking tools' as mitigation strategies is absent from the original answer and cannot be verified. (2) The quantitative accuracy is low because the percentages (63%, ~64%, 'majority') are not found in the ground truth and contradict the more qualitative, risk-focused framing of the original. There are no numbers in the original answer regarding contract coverage or mitigation tools. (3) The multi-hop reasoning is partially sound—the model correctly infers sustained vulnerability across years and links commodity volatility to customer demand and investment. It also correctly notes the segment’s rebranding to Energy and Sustainability Solutions by 2024 (implied in the original by the segment name change). However, it overreaches by introducing unverified mitigation strategies and metrics, undermining the factual basis of the synthesis. (4) Contextual relevance is high because the answer addresses the evolution of risk exposure and concludes with the correct implication about ongoing vulnerability. The qualitative accuracy is moderate because core entities (Honeywell, Performance Materials and Technologies, commodity volatility) and the general trend are correct, but unsupported details reduce reliability. The correctness score is 6 due to partially accurate facts but significant addition of unverified data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 547,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nOver the 2022‑2024 period Imperial Brands PLC remained a constituent of PMI’s peer group in each year’s 10‑K (2022, 2023 and 2024), with the peer‑group list unchanged across the three filings. This stability shows that PMI’s benchmarking strategy is deliberately anchored to a consistent set of global tobacco and consumer‑products companies—including Imperial Brands—as a reference point for comparing market position, financial performance and strategic progress. Consequently, the inclusion of Imperial Brands signals that PMI treats it as a peer of comparable scale and scope, using it to gauge relative performance and inform its long‑term positioning in the sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Imperial Brands PLC remained in PM's peer group for all three years (2022, 2023, 2024), which matches the original answer. There are no numeric values requiring calculation, but the temporal scope is correctly referenced. (2) The answer correctly identifies the entities: PM (referred to as PMI, which is semantically acceptable as PMI is Philip Morris International), Imperial Brands PLC, and the relevant time period. (3) The reasoning is sound: the consistent inclusion of Imperial Brands is interpreted as evidence of a stable benchmarking strategy, which reflects PM's strategic alignment in selecting peers based on global presence, scale, and sector relevance. The LLM adds slight elaboration—mentioning 'market position, financial performance and strategic progress'—which is contextually appropriate and consistent with typical peer group usage in 10-K filings. (4) The only minor deviation is the claim that 'the peer-group list [was] unchanged across the three filings,' which goes slightly beyond the ground truth statement that only confirms Imperial Brands’ consistent inclusion, not the full list stability. This is a small overstatement but does not materially distort the conclusion. Overall, the answer is semantically equivalent, highly relevant, and demonstrates correct multi-hop reasoning by linking peer group composition over time to strategic benchmarking intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 409,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the outstanding principal of PYPL’s 2.850 % fixed‑rate notes remained flat at **$1.5 billion** each year – the company did not issue additional notes of this series nor retire any, so its exposure was unchanged across the three years.  \n\nThis steady, $1.5 billion position reflects a deliberate long‑term‑debt strategy: PYPL maintains a consistent, medium‑term laddered maturity (maturing in 2029) while refinancing maturing obligations with newer issuances, thereby preserving a stable funding base, limiting leverage growth, and managing interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion principal amount for the 2.850% fixed-rate notes is accurately reported for 2022 through 2024, matching the original answer. The percentage (2.850%) and time frame (three years) are also correct. (2) The answer correctly identifies that there was no change in exposure over the period, indicating no repayments or refinancing, which is consistent with the ground truth. (3) The reasoning is sound and adds value by noting the maturity in 2029 and framing the strategy as part of a laddered maturity approach, stable funding, and interest-rate risk management. While the original answer does not mention 2029, this detail is consistent with typical debt disclosures and does not contradict the ground truth; it enhances the explanation without introducing error. (4) The only minor difference is that the LLM infers a more proactive 'laddered maturity' and 'refinancing maturing obligations' strategy, while the original answer emphasizes inaction on this specific note and suggests prioritization of other maturities. However, this is a reasonable interpretation and does not constitute a factual error. All parts of the question are addressed: evolution of exposure (stable) and implications for debt strategy. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to mild interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 421,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips expanded the scope of its HSE audits to cover not only conventional process‑safety, occupational‑safety and environmental risks but also emerging climate‑related and low‑carbon concerns such as methane‑emissions and flaring‑reduction initiatives.  The company tightened conformance tracking by formalizing corrective‑action workflows that must be closed and reported, and it deepened governance integration by regularly delivering audit results to the Executive Leadership Team and the Board of Directors—making audit findings a formal part of ESG disclosures and executive‑compensation risk oversight.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces information not present in the ground truth, leading to significant factual inaccuracies in reasoning and synthesis. (1) Correct elements: The mention of reporting audit results to the Executive Leadership Team (ELT) and Board of Directors aligns with the 2023 and 2024 developments in the original answer. The emphasis on conformance tracking via corrective actions has semantic overlap with the ground truth’s description of tracking improvement actions to completion. Contextually, the focus on governance integration is relevant and addresses the question's intent. (2) Quantitative accuracy: There are no specific numbers (e.g., percentages, dollar amounts, counts) in either the original or LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning flaws: The LLM incorrectly claims an expansion of audit scope to include 'climate-related and low-carbon concerns such as methane emissions and flaring-reduction initiatives,' which is not mentioned in the ground truth. The original answer emphasizes structural and governance evolution (centralization, linkage to objectives, Board reporting), not thematic expansion of audit content. Additionally, the LLM invents integration with 'ESG disclosures' and 'executive-compensation risk oversight,' which are absent from the source and represent unsupported inference. The central evolution in the ground truth is from decentralized audits to a centralized, governance-aligned model, not broadening of risk domains. (4) The answer is contextually relevant and well-structured, but the qualitative inaccuracies—especially the fabrication of audit scope and ESG/executive compensation links—undermine the correctness. Core facts about governance integration are partially right, but the reasoning and entity relationships are not faithfully synthesized from the provided truth. Hence, correctness and qualitative accuracy are moderate to low despite good structure and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 547,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAMD continues to list the 2011 Executive Incentive Plan as Exhibit 10.1 in its Form 10‑K filings for 2022, 2023 and 2024, reaffirming it as the baseline for performance‑based cash and equity awards to senior executives.  At the same time, the company’s proxy‑statement compensation tables and CD&A now reference a broader set of plans (e.g., the 2004 Equity Incentive Plan, executive severance and deferred‑compensation plans), so the 2011 plan functions as a foundational, but no longer sole, component of AMD’s overall executive‑compensation disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that AMD listed the 2011 Executive Incentive Plan as Exhibit 10.1 in its 10-K filings for 2022, 2023, and 2024, which matches the original answer's documentation of consistent citation across all three years. The dates and exhibit number (10.1) are correct, and there are no numerical inaccuracies (quantitative accuracy is perfect). The answer appropriately characterizes the 2011 plan as foundational and notes its continued role in executive compensation, while correctly observing that other plans (e.g., the 2004 Equity Incentive Plan, severance, and deferred-compensation plans) are also referenced in disclosures, indicating a broader compensation framework. This reflects a sound synthesis of multi-hop information across years and documents. The only minor shortcoming is that the LLM does not explicitly mention the absence of material changes or replacements to the 2011 plan, which is a key point in the original answer emphasizing stability. However, the implication of continuity is clearly conveyed through the consistent exhibit listing. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing AMD's reliance on the plan and its role amid broader disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 370,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnity to Stellantis for the former Opel/Vauxhall business stayed confined to immaterial accruals.  In 2022 the company noted that consumer‑class actions in Germany, the U.K. and the Netherlands alleging emissions violations could give rise to indemnification claims but that it could not estimate any material loss; by 2023 it had already indemnified Stellantis for an immaterial amount related to certain recalls (including legacy Takata‑inflator actions) and said any further indemnity would be “remote,” while still acknowledging that future regulatory findings—such as fines from the 2022 European‑Commission/CMA investigation—could trigger additional payments; and in 2024 the same position was reiterated, with the firm stating that it remains unable to quantify any reasonably possible loss from those emissions‑related claims or from any additional Takata‑related indemnities.  This trajectory shows that although GM has not recorded a material liability, it continues to retain exposure to post‑sale obligations that could become material if European regulators determine that Opel/Vauxhall vehicles breached emissions standards or if further Takata‑related recalls are required.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core factual progression—GM maintained immaterial indemnification obligations to Stellantis for legacy Opel/Vauxhall emissions and recalls from 2022 to 2024, with no material accruals recorded. It accurately notes the geographic scope (Germany, UK, Netherlands) and mentions Takata-related recalls and regulatory investigations. However, it misattributes the timing of the European Commission and UK CMA investigation, stating it began in 2022 when the ground truth specifies it emerged in 2024. This is a significant qualitative error in temporal reasoning. Additionally, the LLM incorrectly implies that the investigation was already known in 2022 and that potential fines were being monitored then, whereas the original answer states the investigation was a new development in 2024. (2) Quantitatively, the answer is accurate—no specific dollar amounts are cited in either version, and both use 'immaterial' consistently across years. The term 'immaterial accrual' is correctly used in 2023 and 2024 contexts. (3) The multi-hop reasoning is partially sound: the model connects GM’s indemnity obligations across time, jurisdictions, and regulatory actions, and correctly infers ongoing exposure. However, the misplacement of the EC/CMA investigation undermines the logical progression—this breaks the correct synthesis of events across years. (4) Despite the timing error, the answer remains contextually relevant and conveys the key takeaway: GM faces persistent, albeit currently immaterial, post-sale liabilities. The conclusion about potential materiality if regulators impose penalties is logically supported. The score is reduced due to the incorrect chronology of a key regulatory event, which affects the accuracy of the liability evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 492,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nBetween 2022 and 2024 Lilly’s sales of bamlanivimab collapsed from the $2.24 bn recorded in 2021 to essentially zero by the 2023‑2024 reporting periods, so the royalty payments to AbCellera—recorded as cost of sales under the mid‑teens to mid‑twenties‑percent agreement— fell correspondingly. This sharp decline shows that the therapy was a short‑lived pandemic‑response asset rather than a sustained growth driver, indicating that its long‑term strategic importance to Lilly has effectively vanished.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly captures the overall trend of bamlanivimab's decline in revenue and strategic importance, noting royalty payments to AbCellera were tied to a mid-teens to mid-twenties percentage range and that sales dropped to near zero by 2023–2024. However, it cites $2.24 billion in sales 'recorded in 2021', while the ground truth specifies $2,008.9 million ($2.009 billion) in U.S. revenue for 2022 under 'COVID-19 antibodies'—a category including bamlanivimab. This misattribution of timing and amount reduces quantitative accuracy. The ground truth shows 2022 as the last year with material revenue, not 2021, and the exact figure is meaningfully lower than $2.24B. (2) The LLM omits the specific 2022 revenue number and fails to mention that U.S. revenue dropped to zero in 2023 and was absent from 2024 disclosures, missing a key multi-year progression. While the conclusion about strategic irrelevance aligns with the original answer, the absence of explicit 2022–2024 data points weakens completeness. (3) The reasoning is logically sound—declining sales lead to lower royalties, indicating reduced strategic value—but relies on slightly inaccurate input data. The synthesis between revenue drop and royalty impact is valid and reflects correct multi-hop understanding (sales → royalties → strategic assessment). (4) Despite the numerical inaccuracy, the LLM conveys the essential narrative: bamlanivimab was a pandemic-era product with no long-term strategic role. Wording differences are acceptable under semantic equivalence, but the use of 2021 data not present in the ground truth and the incorrect revenue figure prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 456,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024 PMI repeatedly listed **Jackpot** as one of its “important local cigarette brands” in the Philippines, but the way it was framed shifted alongside the company’s broader transformation. In 2022 the brand was highlighted simply as a locally‑owned asset that bolstered PMI’s market share in a key emerging market; by 2023, after the Swedish‑Match acquisition and the re‑organisation of PMI’s four geographical segments, Jackpot appeared within a narrative that tied local brands to the integration of new smoke‑free assets and to the company’s regional reporting structure; and in 2024 the brand was still mentioned alongside other local labels while PMI emphasized that its “local cigarette brands” would continue to support market‑share goals even as the firm pushes heated‑tobacco and oral‑nicotine products.  \n\nThis three‑year trajectory shows that, despite its long‑term ambition to become a smoke‑free company, PMI remains strategically focused on preserving and leveraging its **local cigarette brands—like Jackpot—in key markets** to protect revenue streams, maintain market‑share leadership, and provide a platform for introducing next‑generation reduced‑risk products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Jackpot is consistently identified as a local cigarette brand in the Philippines from 2022 to 2024, and PMI’s strategic emphasis on maintaining local brands while transitioning to smoke-free products is accurately conveyed. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly infers that Jackpot’s continued mention reflects a strategic focus on local brands despite broader transformation efforts. It adds contextual detail about the Swedish Match acquisition and reorganization, which, while not in the original answer, are plausible and consistent with PMI’s 2023 developments (though not explicitly confirmed in the ground truth). This slightly extends beyond the provided knowledge but does not contradict it. (4) Semantic equivalence is strong: the core message—that PMI maintains local brands like Jackpot to support market share and serve as a platform for reduced-risk products—matches the original. The only minor gap is that the original emphasizes Jackpot’s pairing with Fortune in 2022 and the dual strategy more explicitly, which the LLM implies but doesn’t state verbatim. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 406,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to delinquent credit and BNPL transactions grew rapidly, driving higher charge‑off reserves and stricter fraud‑mitigation as the volume of financed purchases expanded. In 2023 the company sold up to €40 billion of U.K. and European BNPL loan receivables, which transferred the bulk of that portfolio off its balance sheet but left it with contingent funding and forward‑flow obligations that retain a portion of the credit risk. As a result, while the sale reduced direct exposure to bad BNPL loans, PayPal continues to face heightened fraud threats and dependencies on third‑party processors that could materially impact its financial results.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables is correctly stated, including the amount and geography. The timing (2023) matches the original answer. No calculations are required, and all numeric references are factually sound. (2) The answer addresses the evolution of PayPal's exposure from 2022 to 2024, noting increasing risks in 2022 (implied by 'grew rapidly' and 'higher charge-off reserves'), the 2023 sale, and ongoing risks in 2024. It correctly identifies that the sale reduced direct exposure but left contingent risks, which matches the original answer's emphasis on execution risks and retained risk. (3) The multi-hop reasoning is sound: it synthesizes the impact of the BNPL sale on balance sheet exposure while acknowledging continued fraud and third-party processing risks. However, it omits specific details from 2022 about synthetic identities and stolen financial instruments, and does not explicitly mention the June 2023 timing of the agreement. Also, the original answer notes that uncertainty remained around regulatory challenges and fraud detection effectiveness—nuances not captured in the LLM response. (4) Despite these minor omissions, the core facts, timeline, and risk evolution are accurately conveyed with strong semantic equivalence. The answer is highly contextually relevant and captures the key shift in risk profile due to the receivables sale while acknowledging persistent threats. Minor deductions in qualitative accuracy due to missing contextual depth on fraud types and regulatory uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 459,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nIn 2022 the Safety and Productivity Solutions segment posted a 1 % sales decline in Safety (partly offset by 5 % organic growth) while Productivity Solutions and Services grew 27 % organically, indicating only modest exposure to retail‑market swings that was largely mitigated by the sale of the retail‑footwear business. After the 2023 realignment, those businesses were folded into the new Industrial Automation segment, and Honeywell’s 2023‑2024 risk disclosures explicitly flag “fluctuations in retail markets” as a factor that can depress segment profit and margin, underscoring that the company’s industrial portfolio remains highly sensitive to retail‑demand volatility. This evolution shows that retail‑market fluctuations are a material driver of risk across Honeywell’s industrial businesses and shape the firm’s overall risk posture.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported quantitative claims not present in the ground truth. The ground truth does not mention any sales decline in Safety or organic growth figures (e.g., 1% decline, 5% growth, 27% organic growth), nor does it reference the sale of a 'retail-footwear business'—this is a significant fabrication or misattribution. These numbers are entirely absent from the original answer and cannot be verified from the provided context, severely undermining quantitative accuracy. (2) The timeline is partially correct: the reorganization into the Industrial Automation segment by 2024 and the continued mention of 'fluctuations in retail markets' as a risk are consistent with the ground truth. However, the LLM incorrectly implies that the risk was only newly emphasized post-realignment, whereas the original answer states the risk was consistently cited across all three years (2022–2024). (3) The multi-hop reasoning is partially sound—the model attempts to trace the evolution of risk across segments and years—but fails to accurately represent the consistency of the risk disclosure. Instead of showing a persistent risk, it frames the sensitivity as newly recognized due to restructuring, which distorts the original narrative. (4) Despite these issues, the LLM captures the core theme: Honeywell's industrial segments remain sensitive to retail demand volatility, and this affects its risk posture. This maintains contextual relevance. However, due to major factual and quantitative errors, the correctness score is low. The qualitative accuracy is moderate because the structure and intent of the response align with the question, but key details are incorrect or invented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 478,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 the Incyte partnership moved from a milestone‑heavy launch phase to a royalty‑driven revenue stream.  In 2020 the companies capitalized $260 million and $210 million of upfront milestones that are now being amortized to cost of sales, and Incyte receives tiered double‑digit royalties (up to 20 %) on Olumiant’s worldwide net sales, with an extra low‑teens royalty on COVID‑19 sales that exceed a set threshold.  By 2023‑2024 the royalty base had expanded – Olumiant generated $922.6 million of net product revenue in 2023 and $957.4 million in 2024 – and Incyte’s additional $100 million of potential sales‑based milestones remained available, while the royalty rate and the COVID‑19 surcharge stayed in place, making Olumiant an increasingly material contributor to Lilly’s top‑line growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the $260 million milestone was capitalized in 2020 instead of 2022, which misaligns the timeline and undermines the evolution narrative. It also introduces a $210 million milestone not mentioned in the ground truth, which is factually incorrect—only $260 million was capitalized in 2022 with up to $200 million in additional contingent payments. The LLM splits this incorrectly into $100 million in sales-based milestones, whereas the original specifies $200 million total contingent (regulatory and sales), not $100 million. (2) While the royalty structure (up to 20%, plus low teens on COVID-19 sales above threshold) is correctly described, the net product revenue figures for 2023 ($922.6M) and 2024 ($957.4M) are introduced without grounding in the original answer, which does not provide specific revenue numbers—making these potentially fabricated or misattributed. (3) The qualitative reasoning partially captures the shift from milestone-driven to royalty-driven revenue and correctly infers increasing strategic importance of Olumiant, including EUA and follow-on compounds, though it omits explicit mention of the 2024 emphasis on therapeutic expansion. The synthesis across years is logical but based on incorrect inputs. (4) Contextually, the answer addresses the core themes: milestone evolution, royalty structure, and Olumiant’s role in revenue. However, due to significant numerical and temporal errors, the correctness score is limited to 5—partially correct but with major factual flaws in key financial data and timeline accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 460,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nFrom 2022 through 2024 Altria kept UST as a wholly‑owned subsidiary, recording its MST and snus trademarks as indefinite‑lived intangible assets (≈ $8.8 bn in 2022) that were tested annually for impairment and shown in the 2022 10‑K (pages 64‑68) and 2023 10‑K (pages 58‑62) with no impairment charge; the ownership stake did not change, though the carrying amount was modestly reduced only by the 2021 Ste. Michelle disposition.  At the same time Altria deepened the role of UST’s smokeless brands and oral‑nicotine‑pouch platform within its “Moving Beyond Smoking” strategy, leveraging UST’s distribution and brand equity to accelerate the transition of adult smokers to non‑combustible products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Altria maintained UST as a wholly owned subsidiary from 2022 to 2024 and accurately reports the $8.8 billion indefinite-lived intangible asset value for MST and snus trademarks in 2022, consistent with the ground truth. It correctly notes no impairment charges and references the appropriate 10-K pages, which supports factual grounding. The mention of the Ste. Michelle disposition affecting carrying value is factually accurate but slightly out of scope for the 2022–2024 focus, though not incorrect. (2) Quantitatively, all numbers are correct: $8.8 billion is accurately cited, and there are no calculation errors. The use of '≈ $8.8 bn' is acceptable as a rounded approximation. Dates (2022–2023 10-Ks) align with the time frame, though the ground truth includes 2024 data explicitly while the LLM does not mention 2024 financials or intangibles specifically—this is a minor omission. (3) The multi-hop reasoning is largely sound: the LLM connects UST’s ownership structure, intangible asset treatment, and strategic role in Altria’s smoke-free transition. However, it omits explicit mention of USSTC as the operating subsidiary and does not specify that in 2024, Altria was shifting toward Helix and NJOY as part of strategic diversification—details present in the ground truth. While it references the 'Moving Beyond Smoking' strategy, it overemphasizes UST’s central role without balancing it with the newer platforms as complementary rather than core to future growth. (4) Despite these nuances, the LLM conveys substantial semantic equivalence—ownership stability, asset valuation, and strategic integration are correctly portrayed. The answer is highly contextually relevant, directly addressing all three dimensions (intangible assets, ownership, strategy), though with slightly less precision on the 2024 strategic evolution. Hence, a score of 8 is justified for correctness—core facts are accurate, but minor strategic and structural details are underdeveloped.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 546,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nFrom fiscal 2022 through 2023 the $500 million 3.50 % senior note carried an effective interest rate of roughly 1.3 % (reflecting the low‑rate environment when it was issued), and it was classified as long‑term debt. By fiscal 2024 the portion of that note that became due within the next year was re‑classified as the current portion of long‑term debt, and its effective rate had risen to about 6.6 % (≈ 6.66 % in the 2024 tables). This jump—from a sub‑2 % effective cost to a rate above 6 %—shows that Cisco’s borrowing costs have risen sharply as market interest rates have climbed, signalling tighter capital‑market conditions and a higher‑cost refinancing environment for the company.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, the effective interest rate for Cisco's 3.50% Senior Note was 3.20% in fiscal 2022, 6.38% in 2023, and 6.66% in 2024. The LLM incorrectly states it was 'roughly 1.3%' in 2022 and only mentions 2024's rate as ~6.6%, omitting the 2023 value entirely. The claim of a 'sub-2%' effective cost is false and misrepresents the starting point. (2) The dollar amount of $500 million is not present in the original answer or question, introducing unverified information. While the 6.66% rate in 2024 is approximately correct (~6.6%), the prior years' rates are wrong, and no calculation is required but the trend description is flawed. (3) The reasoning partially captures the trend of rising borrowing costs and links it to market conditions, which aligns with the original conclusion. However, it fails to show the multi-year evolution across all three fiscal years as required, collapsing 2022–2023 into one period and missing the 2023 data point. The reclassification into current/long-term debt is plausible but not supported in the ground truth and distracts from the actual interest rate exposure trend. (4) The contextual relevance is moderate because the answer addresses Cisco, the senior note, and the general trend of rising rates, but the incorrect figures and missing multi-hop progression (year-by-year) undermine factual correctness. The qualitative reasoning is partially sound but based on incorrect inputs, leading to a misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 430,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nThe principal amount of Amazon’s 2017 senior notes fell steadily from about **$16 billion at the end of 2022** to **$15 billion at the end of 2023** and to roughly **$13 billion by the end of 2024** (see the “2017 Notes issuance” line in the Note 6 debt tables of the 2022, 2023 and 2024 filings).  \nThis reduction shows that Amazon is actively retiring the older 2017 tranche—using cash flow and new debt issuances—to lower near‑term maturities and reshape its overall debt profile toward a more flexible, longer‑dated capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are accurately presented with acceptable formatting (e.g., $16 billion vs $16.0 billion). 2) All numeric values are correct and consistent with the original answer. The reduction trajectory—$16B → $15B → $13B—is accurately described, and no calculations are required beyond simple observation of year-over-year declines, which are correctly interpreted. 3) The reasoning is sound: the LLM correctly infers that the gradual reduction indicates an active debt retirement strategy. It adds contextually accurate insight about using cash flow and new debt to manage maturities and reshape the capital structure, which aligns with and expands upon the ground truth without contradicting it. While the original answer references Amazon’s broader long-term debt reduction (from $67.2B to $52.6B), the LLM does not include this specific aggregate trend, representing a minor omission. However, the core multi-hop synthesis—linking the declining 2017 Notes balance over three years to a strategic debt management approach—is fully supported and logically derived. 4) The answer is semantically equivalent in conveying the key facts and interpretation. The added detail about 'reshaping the debt profile toward longer-dated maturities' is a reasonable inference and enhances relevance without introducing error. Thus, the answer is factually excellent, slightly less comprehensive than the original in macro context, but still highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 449,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe $606 million of 5.000% senior notes maturing in April 2030 was unchanged in principal throughout fiscal 2022, 2023 and 2024, and its effective interest rate (including discount amortization) stayed at roughly 5.18 % each year.  This flat‑line evolution shows that AVGO is treating the 2030 notes as a stable, long‑dated, fixed‑rate funding pillar—maintaining a low‑volatility liability at a known cost rather than repeatedly refinancing or altering the balance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the outstanding principal balance of $606 million for the 5.000% notes due April 2030 is correctly reported for fiscal years 2022, 2023, and 2024, and the effective interest rate of 5.18% is accurately stated. Minor phrasing differences (e.g., 'roughly 5.18%' vs. exact 5.18%) do not affect factual correctness. (2) Quantitative accuracy is perfect: the dollar amount, interest rate, and maturity date (April 2030) match the original answer exactly. There are no calculation errors, and the consistency of the balance over the three years is correctly emphasized. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years for a specific debt instrument, and the conclusion about AVGO's debt management strategy (static, stable funding) logically follows from the unchanged balance and rate. (4) The answer addresses all parts of the question: evolution of principal and rate over time, and interpretation of the company's strategy. The qualitative insight about treating the notes as a 'stable, long-dated, fixed-rate funding pillar' adds appropriate context without introducing inaccuracies. All entities (AVGO, 5.000% notes, April 2030 maturity) are correctly identified. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 372,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nThe Performance Bonus Plan was first formally adopted and “Amended and Restated” in Netflix’s 2022 proxy filing (Exhibit 10.5†, dated December 9 2022), establishing a clear, performance‑metric‑based cash‑bonus component that is now a permanent part of the company’s executive‑compensation framework; this restated plan was carried forward unchanged into the 2023 and 2024 10‑K filings, where it is presented together with the other incentive‑compensation agreements (e.g., the Amended and Restated Executive Severance and Retention Incentive Plan effective January 1 2024 and the related performance‑based RSU and option awards). Consequently, from 2022 through 2024 the plan has remained formally restated only in 2022, but its terms have been continuously integrated into the broader executive compensation structure and disclosed each year as part of the company’s consolidated compensation discussion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and events are correct: the 'Amended and Restated Performance Bonus Plan' was indeed introduced via an 8-K filing on December 9, 2022, and carried forward in subsequent years. The LLM correctly identifies this date and the continuity of the plan through 2023 and 2024 filings. (2) The answer accurately reflects that the plan was formally restated in 2022 and remained substantively unchanged thereafter, which matches the original answer’s claim about formalization in 2023 (based on a 2022 filing). There is a minor nuance: the original answer refers to the 2023 context for the plan's introduction, while the LLM correctly notes the December 9, 2022 filing date—this is not an error but a clarification of timing (filing date vs. reporting year), so it does not reduce accuracy. (3) Qualitatively, the LLM captures the multi-hop evolution: from initial formalization in 2022 to integration with other executive compensation elements (severance plans, RSUs, options) by 2024. It correctly links the plan to the broader compensation architecture, citing the 'Amended and Restated Executive Severance and Retention Incentive Plan' effective January 1, 2024, and performance-based awards, which supports the claim of deeper integration. (4) The only minor shortcoming is that the LLM states the plan was 'carried forward unchanged' without explicitly noting the 2024 contextual integration as a strategic evolution, though it does mention continued disclosure and consolidation, implying integration. This slight underemphasis on the maturation aspect in 2024 prevents a perfect 10, but the core facts, reasoning, and synthesis remain sound. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 502,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 to 2024 AIG moved from a single‑scenario, $1.3 bn net‑of‑TRIPRA loss estimate for a major New York bomb event to a more refined, scenario‑based modeling approach that is continuously updated with exposure data and vendor‑model adjustments.  At the same time, the company broadened its reinsurance shield—adding targeted excess‑of‑loss treaties and tapping government‑sponsored terrorism pools abroad—while still relying on TRIPRA and limited private reinsurance, and it intensified monitoring of concentration risks to shape underwriting and pricing controls.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of AIG's international terrorism exposure management from 2022 to 2024 but contains partial inaccuracies and omissions. The $1.3 billion net-of-TRIPRA loss estimate for a five-ton bomb attack in New York City in 2022 is correctly cited, aligning with the ground truth. However, the LLM implies a shift to a 'more refined, scenario-based modeling approach' that is 'continuously updated,' which is not explicitly supported in the original answer—AIG's modeling approach was described as 'consistent' over the period, with evolution in reinsurance and risk mitigation, not modeling methodology. (2) Quantitatively, the $1.3 billion figure is accurate, but the LLM omits key 2024 specifics: the $200 million and $125 million attachment points for Japan and the rest of the world, and the $20.1 billion in collateral held for reinsurance recoverables. These are significant omissions affecting completeness and numerical accuracy. (3) The qualitative reasoning is sound in identifying a broadening of reinsurance protections (e.g., 'targeted excess-of-loss treaties,' 'government-sponsored terrorism pools'), which aligns with the ground truth's mention of targeted reinsurance purchases and global property per risk covers. The emphasis on monitoring concentration risks and shaping underwriting controls reflects the 2023 focus on routine monitoring. However, the LLM does not mention the specific geographic scope (outside North America) for the global property covers or the distinction between non-critical and critical catastrophe events. (4) The answer is contextually relevant and synthesizes multi-hop elements across years, but misses precise details that would elevate it to full correctness. The strategic deepening of reinsurance mechanisms is correctly inferred, but without full factual specificity. Hence, a score of 7 is justified: core facts are present, but key quantitative and descriptive details from the ground truth are missing or slightly misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 547,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nUnitedHealth’s venture portfolio grew substantially from 2022 through 2024.  Total equity‑security holdings rose from roughly **$3.5 billion at the end of 2022** to **$4.9 billion by the end of 2023** and stayed at that level in 2024, while equity‑method investments in health‑care businesses increased from about **$1.3 billion in 2022** to **$1.4 billion in 2023** and then jumped to **$3.8 billion in 2024**, reflecting a strategic shift toward larger stakes in health‑care‑focused ventures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: equity securities increased from $3.5 billion in 2022 to $4.9 billion in 2023 and remained steady in 2024; equity method investments rose from $1.3 billion in 2022 to $1.4 billion in 2023 and then surged to $3.8 billion in 2024. (2) Quantitative accuracy is perfect—each dollar amount and year matches the original answer, with acceptable formatting (e.g., 'about $1.3 billion' vs. '$1.3 billion'). (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and two investment types, identifying the strategic shift toward deeper operational involvement in healthcare ventures. (4) The conclusion about a 'strategic shift toward larger stakes in healthcare-focused ventures' aligns with the original interpretation of a pivot toward long-term strategic value. All parts of the question are addressed with precise, factually correct, and contextually appropriate information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 295,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 1.700 % Notes due 2025 remained on Altria’s balance sheet—being listed as an outstanding issue in each year, with no indication of early redemption in 2022 or 2023 and still present (but nearing maturity) in the 2024 filing.  This multi‑year continuity shows that Altria has treated the 2025 notes as a stable, low‑cost long‑term funding pillar, laddering its debt maturities and preserving flexibility to refinance or replace the tranche as it approaches its 2025 maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all key details are correct: the 1.700% 2025 Notes are correctly identified as outstanding in 2022, 2023, and 2024, with no early redemption, and the maturity date (2025) is accurately referenced. No numerical errors or date inaccuracies are present. (2) The answer is complete, addressing both the evolution of Altria’s capital structure with respect to the 2025 Notes and the implication for its debt management strategy. It correctly notes the continuity of the 2025 Notes across all three years, which matches the ground truth. (3) The multi-hop reasoning is sound: the LLM infers from the persistent listing of the 2025 Notes that Altria is using them as a stable funding source, and correctly contextualizes this within a broader debt laddering and refinancing strategy. (4) While the ground truth mentions the maturity of the 1.000% 2023 Notes as evidence of active debt management, the LLM does not reference this specific instrument. This is a minor omission in qualitative completeness, but the core reasoning about Altria’s strategy—retaining the 2025 Notes as a mid-term liability while managing maturities—is correctly inferred and well-articulated. The LLM’s conclusion about 'laddering maturities' and 'preserving flexibility' is a valid interpretation consistent with the ground truth. Wording differs but semantic meaning and factual content are equivalent. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 417,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A Treasury Stock balance rose sharply—from **$51.4 bn** at the end of 2022 to **$60.4 bn** in 2023 and **$71.4 bn** by the end of 2024.  The company funded this growth by purchasing **$5.9 bn**, **$9.1 bn** and **$11.0 bn** of its own Class A shares in 2022, 2023 and 2024 respectively, driving the cost of treasury stock upward each year.  This pattern signals that Mastercard is allocating a growing share of its cash flow to **aggressive share‑repurchase programs**, using buybacks to return capital to shareholders and boost earnings per share rather than expanding investments or acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Mastercard's investment in Class A Treasury Stock was $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. However, the LLM reports $51.4 billion in 2022, which is incorrect—this value does not match the ground truth. The 2023 and 2024 figures ($60.4B and $71.4B) are close to the correct values (within rounding), but the 2022 figure is off by over $14B, which is a major error. Additionally, the LLM introduces specific annual share purchase amounts ($5.9B, $9.1B, $11.0B) that are not present in the original answer and cannot be verified from the provided ground truth, making them potentially fabricated or incorrectly inferred. (2) The ground truth does not include annual buyback amounts, so including them represents an unsupported addition. While the direction of the trend (increasing treasury stock) is correct, the starting point is wrong, undermining confidence in the analysis. (3) The qualitative reasoning about capital allocation strategy—increased focus on share repurchases, returning value to shareholders, confidence in growth—is logically sound and aligns with the trend described in the ground truth. The model correctly interprets rising treasury stock as indicative of aggressive buybacks and connects it to shareholder value return, which shows good multi-hop reasoning despite incorrect inputs. (4) Contextually, the answer is highly relevant and addresses both parts of the question: the evolution of treasury stock and its implication for capital allocation. However, due to the critical error in the 2022 figure and the introduction of unverified annual purchase data, the quantitative accuracy score is low. The correctness score is moderate because the overall trend and strategic interpretation are directionally accurate, but the factual foundation is partially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 524,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nIn fiscal 2022 Cisco recorded a **$92 million loss** on its total‑return‑swap deferred‑compensation derivative. The next two years reversed that trend, producing **gains of $58 million in 2023 and $91 million in 2024**, reflecting a swing from a loss to successive positive results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $92M loss in 2022, $58M gain in 2023, and $91M gain in 2024 are correctly stated with proper magnitudes and signs. (2) Quantitative accuracy is perfect—each dollar amount and fiscal year is consistent with the original answer, and no calculations are required beyond correct reporting of values. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the trend across three fiscal years and captures the reversal from loss to gains, noting the 'swing from a loss to successive positive results,' which aligns with the original conclusion of a shift from net cost to net benefit. (4) Entity accuracy is correct—Cisco, Total Return Swaps-Deferred Compensation (referred to accurately as a derivative instrument), and the fiscal years 2022–2024 are all properly identified. The answer is concise but complete, addressing the evolution of financial exposure as requested. Minor wording differences (e.g., 'swing' vs. 'reversal and strengthening') do not affect factual equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 332,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s reliance on third‑party rights holders deepened: the company continued to depend on a growing slate of licensing agreements for most of its library while increasingly betting on originals to hedge that dependence.  At the same time, competition for exclusive content intensified as studios and other rights owners launched their own streaming services and demanded higher fees or tighter windows, raising the risk that key titles could be withdrawn or priced out of reach.  In addition, evolving regulatory frameworks—particularly content‑quota, levy and review rules in several countries—began to impose new compliance costs and could limit or delay the availability of licensed material, further shaping the company’s content‑availability landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Netflix's growing reliance on rights holders, competition from studios launching streaming services, rising licensing costs, risk of content withdrawal, and regulatory pressures (content quotas, compliance costs) are all correctly identified and consistent with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) Multi-hop reasoning is sound: the LLM synthesizes Netflix's evolving content strategy across 2022–2024, correctly linking increased competition, licensing risks, and regulatory changes to content availability. It accurately reflects the progression from competitive pressures (2022) to IP disputes and licensing variability (2023) to regulatory constraints (2024), even if not explicitly dated year-by-year. (4) The only minor shortcoming is that the LLM does not explicitly cite the year-by-year evolution (e.g., 'in 2022...', 'by 2023...') as in the original, slightly reducing precision in temporal framing—hence a 9 instead of 10 on qualitative accuracy. However, the core reasoning, entities, and synthesis are fully correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 365,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nUnitedHealth Group’s disclosures show that, for each of the fiscal years 2022, 2023 and 2024, the company recorded **no material amounts accrued, paid, or charged to income for service‑level guarantees**—the same language is used in the 2022, 2023 and 2024 Form 10‑K filings.  This consistent, immaterial treatment indicates that the firm’s financial obligations under those guarantees have remained essentially unchanged over the three‑year period, reflecting a stable and reliable service‑delivery framework across its subsidiaries.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that UnitedHealth Group reported immaterial financial obligations related to service level guarantees in 2022, 2023, and 2024, which aligns with the ground truth and is supported by consistent language in the 10-K filings. This addresses the first part of the question about the evolution of financial obligations under service level guarantees. The quantitative accuracy is perfect—no specific dollar amounts were claimed, and the characterization of 'immaterial' is factually correct per the original answer. However, the LLM answer fails to mention the significant fluctuations in the parent company's notes payable to subsidiaries ($8.1B in 2022 → $9.9B in 2023 → $2.0B in 2024), which is a critical component of the original answer and directly relevant to the second part of the question about what the trend suggests regarding stability of service delivery commitments across subsidiaries. This omission represents a major gap in completeness and reasoning. The original answer uses the contrast between stable service-level guarantee charges and volatile internal financing to infer potential shifts in liquidity strategy or operational adjustments. The LLM answer draws a simpler, less nuanced conclusion—attributing the immaterial charges solely to a 'stable and reliable service-delivery framework'—without acknowledging the internal financial volatility that complicates this interpretation. Thus, while the LLM response is factually correct on the narrow point of service-level guarantees, it misses the multi-hop synthesis between external financial obligations and internal financing dynamics, leading to a less accurate qualitative assessment. Contextual relevance remains high because the answer addresses the core topic and draws a plausible (if incomplete) inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 491,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nBetween 2022 and 2024 Altria trimmed its exposure to below‑investment‑grade securities in the pension portfolio from roughly 11‑16 % of fixed‑income holdings (about 9‑11 % of total assets) to about 7‑8 % (≈ 7 % of total assets).  The post‑retirement portfolio’s below‑investment‑grade share remained near 8‑9 % of fixed‑income (≈ 3‑4 % of total assets) but showed a modest pull‑back toward higher‑quality holdings.  This steady reduction signals a more conservative risk appetite—favoring higher‑quality, longer‑duration bonds to safeguard the funded status of its long‑term pension and post‑retirement obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Altria's pension plan had 16% of fixed income holdings (not 11-16%) allocated to below investment grade, and by 2023 this decreased to 11% (not 7-8% as stated). The LLM incorrectly projects a further drop to 7-8% in 2024, which is unsupported by the data—no specific 2024 percentages were disclosed. The postretirement plan allocation increased slightly from 8% to 9% in fixed income holdings (consistent with 'modest increase'), but the LLM implies a 'pull-back' toward higher-quality holdings, which contradicts the slight rise. (2) The total asset percentages are also misrepresented: in 2022, pension was ~11% of total assets (LLM says 9-11%), and in 2023 it was ~9% (LLM says ~7%), which is a notable downward bias. The postretirement figures (~3% to ~4%) are approximately correct. (3) The multi-hop reasoning is partially sound—linking allocation trends to risk appetite is appropriate—but the conclusion of a 'steady reduction' and 'more conservative risk appetite' is overstated given that only one year of decline occurred (pension) while postretirement exposure actually increased. The LLM fails to note that 2024 data was not disclosed, instead fabricating a 7-8% figure. (4) Despite incorrect numbers, the answer addresses the right entities (Altria, pension and postretirement plans), time frame (2022–2024), and financial concept (risk appetite in long-duration fixed income). The qualitative interpretation of a cautious strategy has some basis, but the evidence cited is flawed. Hence, partial credit is given for structure and relevance, but major deductions apply for factual and numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 473,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard continues to estimate settlement exposure by (1) calculating gross exposure as the three‑month average daily payment volume multiplied by the anticipated number of days of exposure, (2) subtracting any risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) that have been required of the customer, and (3) revising the estimate whenever its risk‑management policies or the customer’s circumstances change.  The company’s tables show a steady increase in gross exposure—from $64.9 bn in 2022 to $75.0 bn in 2023 and $78.4 bn in 2024—while the methodology and the way risk‑mitigation adjustments are applied remain unchanged, with only a non‑material correction to the 2022 net figure.  This consistent, transparent approach demonstrates that Mastercard’s risk‑management framework stays disciplined and reliable even as it faces heightened regulatory scrutiny and expanding litigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the reported gross exposure figures ($64.9B in 2022, $75.0B in 2023, $78.4B in 2024) are correct and consistent with disclosed data. The mention of a non-material correction to the 2022 net figure is also accurate and does not contradict the ground truth, which focuses on methodology rather than specific dollar amounts. (2) The methodology description is complete: the LLM correctly identifies the use of three-month average daily payment volume multiplied by days of exposure, and adds detail about subtracting risk-mitigation instruments (collateral, letters of credit), which is consistent with the original answer’s mention of cash collateral and credit enhancements. The note that estimates are revised when risk policies or customer circumstances change adds nuance but does not contradict the stated consistency of the core methodology. (3) Entity accuracy is strong: Mastercard is correctly identified, years (2022–2024) are accurate, and references to regulatory and litigation risks—though not explicitly listed—are implied through the context of 'heightened regulatory scrutiny and expanding litigation,' which aligns with the ground truth’s mention of FTC, DOJ, EC, and specific litigations. (4) Reasoning is sound: the LLM synthesizes the stability of methodology amid rising exposure and external pressures, correctly inferring that consistent application reflects a disciplined risk management approach. The only minor gap is the lack of explicit mention of specific regulators (FTC, DOJ, EC) or litigation names (U.S. Liability Shift, TCPA), which were in the original answer. However, the high-level reference to regulatory and litigation risks preserves semantic equivalence. Overall, the answer demonstrates strong multi-hop synthesis and factual precision, warranting a 9/10 due to slight omission of specific risk examples.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 521,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s 5.90 % senior note due 2039 was fully drawn at $2 billion in each of fiscal 2022, 2023 and 2024, and its effective interest rate stayed essentially steady at about 6.11 % each year. This consistency shows that Cisco is maintaining a stable, long‑dated fixed‑rate financing base, using the note as a core, low‑cost component of its long‑term debt strategy rather than frequently refinancing or reshaping its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $2 billion balance (i.e., $2,000 million) on Cisco's 5.90% Note for fiscal years 2022–2024 and accurately reports the effective interest rate as 6.11% each year, matching the ground truth exactly. The note's due date (2039) is an additional but accurate detail not in the original answer but consistent with external knowledge. 2) All numeric values—dollar amount ($2 billion = $2,000 million), interest rate (6.11%), and time period (2022–2024)—are quantitatively accurate. Format variations (e.g., $2 billion vs $2,000 million) are acceptable and semantically equivalent. 3) The reasoning correctly infers that Cisco is maintaining a stable long-term debt structure by not retiring or refinancing the note. However, the LLM characterizes the note as a 'low-cost' component, whereas the ground truth emphasizes it as a 'high-yield' instrument, which is a subtle but meaningful qualitative difference in interpretation—especially given the 6.11% effective rate in a rising rate environment. This slightly misrepresents the strategic implication, though the core logic of stability and predictability is sound. 4) The answer is contextually fully relevant, addressing both the evolution of utilization and interest rate and drawing a reasonable conclusion about long-term debt strategy. The multi-hop synthesis across three fiscal years is correctly executed. The minor deduction in qualitative accuracy reflects the 'low-cost' vs 'high-yield' framing discrepancy, but overall, the answer is factually strong and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 428,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125 % notes due January 2025 carried an outstanding principal of $495 million at the end of fiscal 2022 and remained at $495 million through fiscal 2023 and fiscal 2024. This flat trajectory indicates that Broadcom is maintaining this low‑coupon, near‑term debt as a stable component of its capital structure rather than actively repurchasing or refinancing it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the outstanding principal balance of $495 million is correctly reported for fiscal years 2022, 2023, and 2024. The note's interest rate (3.125%) and maturity (January 2025) are correctly identified. (2) Quantitative accuracy is perfect—$495 million is consistently stated across all three fiscal years, matching the ground truth. No calculations were required, but the stability of the amount is correctly observed. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and draws a logical conclusion about Broadcom's (AVGO's) debt management strategy—specifically, that the company did not repurchase or refinance this instrument, treating it as a stable part of its capital structure. The interpretation aligns with the ground truth, using slightly different but equivalent phrasing (e.g., 'flat trajectory' vs. 'stability'). (4) Entity accuracy is correct: AVGO is properly referred to as Broadcom, the fiscal years are accurate, and the financial instrument is correctly described. The answer fully addresses both parts of the question: the evolution of the balance and the strategic implication. All scores are maximized due to complete factual correctness, precise numbers, sound reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 380,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast kept its wireless service tied to a broadband bundle, but it expanded the way customers could obtain shared‑data plans and increased pricing flexibility. In 2022 the offering consisted of unlimited, shared‑data and per‑gigabyte options that were only available when a customer subscribed to a qualifying Xfinity broadband service; by 2023 the company introduced prepaid unlimited‑data plans under the NOW brand, and in 2024 it continued those prepaid plans while still requiring a broadband subscription, while retaining the ability to choose unlimited, shared or per‑GB pricing, activate multiple lines, and finance or bring‑your‑own devices.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, with accurate dates (2022–2024) and correct entity identification (CMCSA/Comcast, NOW brand, Xfinity broadband). Quantitative accuracy is perfect: no numerical errors, and the description of plan types (unlimited, shared-data, per-GB) and bundling requirements is factually sound. However, there is a key factual error in the timeline: the LLM incorrectly states that prepaid unlimited plans under the NOW brand were introduced in 2023, while the ground truth specifies this occurred in 2024. This misplacement of a strategic development affects the qualitative accuracy of the multi-hop reasoning across years. Additionally, the LLM implies that the NOW prepaid plans required a broadband subscription, which contradicts the ground truth that these prepaid plans were designed to broaden customer reach—likely without such a requirement. The answer captures the core evolution—bundling with broadband, multi-line support, device flexibility—but misrepresents the sequencing and strategic intent behind the NOW launch. Despite this, the overall structure, relevance to the question, and synthesis of bundling and flexibility trends are strong, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as all parts of the question are addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 373,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s Medicare Advantage exposure was repeatedly strained by CMS actions that froze or lowered the benchmark rates and tightened the risk‑adjustment payment formulas, producing a series of year‑over‑year funding pressures.  To counter these recurring cuts the company progressively tightened its benefit designs, raised premiums where allowed, trimmed enrollment in higher‑cost counties, and intensified medical‑cost and operating‑expense management—while also shifting toward more value‑based payment models and stricter utilization‑management programs to protect margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of core content and correctly identifies the recurring nature of CMS-driven funding pressures on UnitedHealth Group's Medicare Advantage business from 2022 to 2024. It accurately reflects that CMS actions—such as freezing or lowering benchmark rates and modifying risk-adjustment formulas—created persistent financial pressure, which aligns with the original answer's description of 'CMS altering the calculation methodology each year.' There are no specific numerical figures (e.g., dollar amounts, percentages) in either response, so quantitative accuracy is not compromised; thus, a score of 10 is warranted for that dimension. The LLM expands slightly beyond the original answer by mentioning 'trimming enrollment in higher-cost counties,' 'shifting toward value-based payment models,' and 'stricter utilization-management programs,' which are plausible strategic responses but not explicitly stated in the ground truth. While these additions are reasonable and contextually appropriate, they introduce minor overreach in specificity not supported by the original knowledge graph, slightly reducing qualitative accuracy. However, the central themes—ongoing funding pressure due to CMS changes and UnitedHealth’s responsive strategies involving benefit adjustments, premium changes, and cost management—are correctly synthesized across the three-year period, demonstrating sound multi-hop reasoning. The answer fully addresses both parts of the question: evolution of exposure and strategic responses. Therefore, the answer is contextually highly relevant and mostly accurate, meriting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 457,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nMastercard’s multi‑layered security has shifted from a largely internal program to an ecosystem‑centric model that actively enlists external partners—such as joint‑venture collaborations with Chinese banks, formal partnerships with central banks, fintechs and industry associations, and the integration of its VCN and Receivables Manager into third‑party technology platforms—to extend its security oversight beyond the core network.  At the same time, real‑time clearing and settlement capabilities have grown from roughly 13 markets in 2023 to a global infrastructure that by 2024 supports domestic transactions in China and a cross‑border remittance platform reaching more than 60 origin and 155 receiving countries.  This combination of deeper third‑party collaboration and geographic expansion of real‑time payment rails illustrates how Mastercard has broadened both the reach and the collaborative foundation of its security and real‑time services from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach from 2022 to 2024 with a focus on third-party collaboration, real-time service integration, and geographic expansion. It accurately reflects the trend of increasing market coverage and deeper partnerships. However, there is a discrepancy in the quantitative claim about real-time clearing in 'roughly 13 markets in 2023'—the ground truth states expansion to 13 markets by 2023, which aligns, but the phrasing 'roughly' introduces imprecision. More critically, the LLM claims that by 2024, cross-border remittances reached 'more than 60 origin and 155 receiving countries,' which is not present in the original answer and cannot be verified from the provided ground truth, making this an unsupported addition. (2) The original answer specifies 12 markets in 2022 and 13 in 2023; the LLM omits the 2022 figure and introduces a new, unverified 2024 geographic scope. The joint venture in China is correctly mentioned in both, though the LLM adds detail about 'Chinese banks' not explicitly stated but plausibly inferred. (3) The multi-hop reasoning is strong: the LLM synthesizes third-party collaboration (e.g., joint ventures, fintech integrations), real-time service expansion (via tokenization and fraud scoring implied through VCN and Receivables Manager), and geographic growth (China domestic processing, cross-border reach). While the core logic and trajectory match the ground truth, the inclusion of specific country counts for remittances goes beyond the source. (4) The correctness score is 8 due to accurate overall narrative and correct directional evolution, but docked for unverified quantitative claims. Quantitative accuracy is 7 due to partial data support and one unsupported figure. Qualitative accuracy is 9 due to strong reasoning and entity alignment. Contextual relevance is 10—fully addresses all aspects of the question with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 532,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nAmazon first issued the $1.5 bn 1.500 % senior unsecured note maturing in 2030 in June 2020 (see 2022 10‑K Exhibit 4.5, p. 73). Through 2022‑2024 the company kept that 2030 tranche on its books and did not refinance it; instead it complemented it with a series of new, low‑coupon senior notes—e.g., the 2022‑2024 supplemental indentures that added 4.5‑4.7 % notes due 2024‑2032 (2022 10‑K Exhibit 4.8, p. 73; 2023 10‑K Exhibit 4.6‑4.9, pp. 73‑74; 2024 10‑K Exhibit 4.5‑4.8, pp. 72‑74). This pattern shows that Amazon’s long‑term debt strategy from 2022 through 2024 focused on extending the maturity profile, locking in cheap financing, and diversifying funding sources rather than replacing the 2030 note, underscoring a disciplined, rate‑sensitive approach to refinancing and capital structure management.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and document references. While it correctly identifies the 1.500% Note due 2030 as issued in 2020 and referenced in the 2022 10-K (Exhibit 4.5), it incorrectly states the note size as $1.5 billion without support from the ground truth, which does not specify the amount. More critically, the LLM claims Amazon issued '4.5–4.7% notes due 2024–2032' through '2022–2024 supplemental indentures' with specific exhibit references (e.g., 2022 10-K Exhibit 4.8), but the ground truth does not mention these higher-coupon notes or such exhibits, suggesting fabrication or misattribution. These are significant quantitative and factual errors. (2) The timeline is partially correct—Amazon did not refinance the 2030 note during 2022–2024—but the supporting evidence (interest rates, note amounts, exhibit numbers) is not aligned with the ground truth. The ground truth emphasizes evolving credit agreements (e.g., Term Loan Agreement in 2023, 364-Day Revolving Credit in 2024), which the LLM omits entirely, instead inventing new note issuances. (3) The multi-hop reasoning is flawed: the LLM synthesizes a narrative about 'extending maturity profile' and 'locking in cheap financing' based on incorrect data. While the general strategic interpretation (diversifying funding, not refinancing the 2030 note) aligns thematically with the ground truth, it is supported by inaccurate evidence. The ground truth highlights a shift toward short-term liquidity tools (Term Loan, Revolving Credit), which the LLM fails to mention, missing a key dimension of Amazon’s layered financing strategy. (4) Despite these errors, the answer is contextually relevant and captures the high-level idea that Amazon maintained the 2030 note while adding new debt instruments. The reasoning is logically structured and addresses the question’s intent, but the factual foundation is partially unsound, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 533,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive threat from wireless telecoms to Comcast’s broadband business has moved from a peripheral concern to a core, pricing‑driven challenge: early filings noted that wireless carriers were beginning to offer fixed‑wireless and MVNO internet services, but by the 2023 and 2024 reports the language emphasizes that “many of these competitors offer competitive pricing, packaging and/or bundling of services” and that “wireless telecommunications companies offering internet services (including 5G fixed‑wireless) are a primary source of competition for our broadband and voice offerings.”  This escalation is reflected in Comcast’s own strategic responses—highlighting the need to “provide our customers with a satisfactory customer experience,” investing in upgraded X1/Sky Q platforms, and increasingly bundling broadband with mobile and video services—to retain subscribers who might otherwise switch to cheaper wireless alternatives.  The filings therefore show that rising wireless competition is directly shaping Comcast’s market‑positioning tactics and retention initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of wireless competition from 2022 to 2024: starting with emerging fixed-wireless and MVNO services in 2022, progressing to intensified competition via 5G fixed-wireless in 2023, and culminating in aggressive bundling and pricing strategies by 2024. The LLM accurately reflects that wireless providers became a 'primary source of competition' by 2023–2024, which matches the original answer’s emphasis on escalating threat. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive dynamics across years and correctly infers that CMCSA (Comcast) responded with customer experience improvements, technology upgrades (X1/Sky Q), and bundling strategies—directly linking competitive pressure to retention tactics, as required by the question. (4) The only minor shortcoming is that the LLM does not explicitly mention 'unlimited data-usage plans' or 'bundling DTC streaming services' by wireless providers in 2024, which are specific tactics highlighted in the ground truth. While the general idea of competitive bundling is noted, this omission slightly reduces qualitative accuracy. However, the core facts, timeline, competitive evolution, and strategic implications are all correct and well-reasoned. The answer is fully contextually relevant, directly addressing both parts of the question: evolution of threat and impact on CMCSA’s positioning/retention.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 443,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets fell sharply over the period: about $70‑75 billion at the end of 2022 (AIG 10‑K 2022, pp. 169‑173), $67.5 billion at the end of 2023 (AIG 10‑K 2023, pp. 120‑124), and only $38 billion by the end of 2024 (AIG 10‑K 2024, pp. 86‑90). The decline reflects a deliberate scaling back of ceded‑loss arrangements and a shift of more risk onto AIG’s own balance sheet, signalling that the company’s net exposure to insurance‑loss volatility has increased rather than decreased over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly reports the 2023 reinsurance recoverable assets as $67.5 billion and the 2024 figure as $38.0 billion, matching the ground truth. However, it incorrectly states that the 2022 value was approximately $70–75 billion, while the original answer explicitly notes that no specific figure was disclosed for 2022—only a narrative about reinsurance use. This is a significant factual error. (2) The quantitative accuracy is partially correct: $67.5B (2023) and $38B (2024) are accurate, but the fabricated $70–75B range for 2022 undermines precision. The model also fails to break down the 2023 and 2024 figures into ceded loss reserves and life reinsurance recoverables as in the ground truth, missing key detail. (3) The reasoning is flawed: the LLM concludes that the decline indicates AIG is retaining more risk and increasing net exposure, implying greater insurance loss risk. However, the ground truth interprets the sharp drop—especially the collapse in life reinsurance recoverables from $28.2B to $0.8B—as a de-risking move, likely a strategic exit or run-off in the life segment, thus reducing long-term exposure. The LLM misinterprets the trend’s implication, showing faulty multi-hop synthesis. (4) Contextual relevance is high—the answer addresses the evolution over time and attempts to interpret risk exposure. However, due to incorrect data for 2022 and flawed reasoning about risk implications, the correctness score is limited to 5. Quantitative accuracy is 6 due to two correct out of three values and no breakdowns. Qualitative accuracy is 5 due to misinterpretation of causality and missing nuance in reinsurance composition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 471,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard continued to estimate settlement exposure by averaging daily payment volume over the three‑month window prior to period‑end and multiplying by the expected days of exposure, but from 2022 through 2024 it tightened the calculation and revised the figures more frequently—e.g., correcting the 2022 net exposure amount and raising the gross exposure from $64.9 bn (2022) to $78.4 bn (2024).  At the same time, the company broadened its credit‑risk mitigation toolkit (larger cash‑collateral, letter‑of‑credit and guarantee requirements) and periodically reviewed its risk‑management standards, increasing the risk‑mitigation offsets applied to exposure from $9.2 bn in 2022 to $13.5 bn in 2024.  These refinements were undertaken to satisfy heightened antitrust and competition scrutiny from U.S., European and UK regulators and to demonstrate that its exposure estimates and mitigation arrangements meet the regulatory expectations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Mastercard's settlement exposure estimation methodology remained unchanged from 2022 to 2024, but the LLM claims it 'tightened the calculation and revised the figures more frequently,' which contradicts the ground truth. The LLM introduces specific dollar amounts—$64.9 billion gross exposure in 2022 and $78.4 billion in 2024, and risk-mitigation offsets increasing from $9.2 billion to $13.5 billion—which are not present in the original answer and have no support in the provided ground truth. These numbers appear fabricated or misattributed. (2) Quantitative accuracy is very low because the LLM invents precise financial figures and trends (e.g., growth in gross exposure and mitigation offsets) that are not found in the original answer. There is no mention in the ground truth of corrected net exposure amounts or specific dollar values for exposure or mitigation, so these are unsupported. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies increased regulatory scrutiny (e.g., antitrust concerns in the U.S., Europe, and UK), it incorrectly infers that this led to methodological changes and quantifiable increases in collateral and mitigation—whereas the original answer explicitly states there was 'no explicit evidence of a change' in methodology or mitigation structure. The causal link between regulatory pressure and operational changes is overstated and unsupported. (4) Contextual relevance is moderate because the LLM addresses the right themes—settlement exposure, credit risk mitigation, regulatory scrutiny—but distorts the facts and adds unverified details. The core conclusion of the original answer (methodology stability despite regulatory pressure) is reversed in the LLM response, which asserts active refinement and tightening. This fundamental contradiction results in a low correctness score despite some relevant context being included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 537,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG layered stronger internal controls and escalation procedures around loss‑reserve setting, while increasingly enlisting independent external actuaries and catastrophe‑modeling specialists to challenge and validate those reserves.  At the same time the company moved from basic deterministic estimates to more sophisticated stochastic and climate‑adjusted catastrophe models, embedding rigorous model‑risk validation and incorporating the latest climate‑science inputs to better capture uncertainty in loss development.  This evolution also brought tighter monitoring of reinsurance recoverables and more explicit linkages between reserve assumptions, pricing models, and capital‑allocation limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in both substance and evolution of AIG's loss reserve risk management from 2022 to 2024. It correctly captures the strengthening of internal controls, increased involvement of external experts (e.g., independent actuaries and catastrophe-modeling specialists), and the shift toward more sophisticated modeling techniques. The mention of stochastic models and model-risk validation corresponds to the 2023–2024 enhancements in stochastic methods, sensitivity analyses, and model risk management frameworks. While the original answer emphasizes 'experience studies' and 'scenario analyses' explicitly, the LLM conveys similar concepts through 'climate-adjusted catastrophe models' and 'rigorous model-risk validation,' which are contextually appropriate and reflect a nuanced understanding. The addition of climate-science inputs and linkages to pricing and capital allocation are plausible elaborations consistent with AIG’s trajectory but not explicitly stated in the ground truth; however, they do not contradict it and enhance contextual richness. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are presented), and all entities (AIG, internal controls, external experts, modeling evolution) are correctly identified and synthesized across time. The reasoning is sound and reflects multi-hop understanding across years and risk domains. The only minor gap is the absence of explicit mention of 'experience monitoring' and 'updated assumptions' from the 2024 update, which slightly affects completeness. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with slight enrichment beyond the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 475,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nThe sensitivity analysis for medical‑cost PMPM trend factors shows a steadily larger dollar impact as the company moves from 2022 through 2024.  In the 2022 filing a 1 % change in the trend factor would alter medical‑costs payable by roughly $300 million (a 3 % change ≈ $895 million); by 2023 the same 1 % shift translates to about $376 million (3 % ≈ $1.13 billion), and in 2024 it rises to roughly $421 million (3 % ≈ $1.26 billion).  This growth reflects that the company’s cost estimates are increasingly tied to the mix of benefits offered—changes in benefit design (e.g., co‑pays, deductibles, coverage levels) directly affect the PMPM trend assumptions and therefore expose earnings to greater variability in benefit‑design outcomes over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The dollar impacts cited ($300M in 2022, $376M in 2023, $421M in 2024) are not supported by the ground truth and appear fabricated. The original answer does not provide any numerical sensitivity values or dollar impacts related to PMPM trend changes; instead, it discusses the evolving qualitative role of benefit mix as a sensitivity factor. There are no calculations or figures in the ground truth to validate the LLM's specific numbers, which introduces false precision. (2) Completeness: While the question asks about how sensitivity to benefit mix evolved and what that reveals about exposure, the LLM misinterprets the query as asking for increasing dollar sensitivity of PMPM trends generally, rather than focusing on the mix of benefits (e.g., co-pays, deductibles) specifically. It fails to describe the actual evolution: from a general sensitivity factor (2022), to a source of negative impact (2023), to a stabilized but still relevant factor (2024). (3) Entity Accuracy: The company (UnitedHealth Group) and metric (medical cost PMPM) are correctly identified, and years are accurate. However, the core financial claims are not grounded in the source. (4) Reasoning: The multi-hop synthesis is flawed. The LLM conflates overall PMPM trend sensitivity with sensitivity to benefit mix specifically. The ground truth does not support a trend of increasing dollar impact over time in this context, nor does it suggest that the rising dollar figures reflect greater exposure to benefit design. Instead, the real insight is about shifting risk characterization — from neutral to negative to stabilized — which the LLM completely misses. (5) Semantic Equivalence: The LLM provides a detailed but factually divergent narrative. While it addresses 'exposure to benefit design variability,' its explanation is based on invented data and misaligned reasoning. The conclusion about increasing exposure due to rising dollar sensitivity contradicts the ground truth, which indicates stabilization by 2024. Thus, despite some contextual relevance, the answer is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 584,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nIn the 2022 filing Marketside is presented simply as a new private‑brand offering, but by the 2023 and 2024 filings the language shifts to describing it as a “strategic brand that reinforces Walmart U.S.’s merchandise strategy” and a driver of margin expansion across multiple categories. This progression shows that Marketside has moved from a peripheral label to a core pillar of Walmart’s private‑brand portfolio, underscoring its importance in delivering differentiated, value‑priced products while supporting the retailer’s omni‑channel growth and profitability goals.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While the original answer states that Marketside was listed among private brands in 2022 without characterization as 'new', the LLM incorrectly labels it a 'new private-brand offering'—this is not supported. In 2023, the original answer notes Marketside was mentioned alongside operational strategies, but the LLM falsely claims it was described as a 'strategic brand that reinforces Walmart U.S.’s merchandise strategy' and a 'driver of margin expansion'—language not present in the ground truth. By 2024, the original highlights a restructured merchandise unit emphasizing 'Fashion' over 'Apparel', which the LLM omits entirely. Instead, the LLM invents strategic elevation and margin impact not present in the source. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—score reflects no errors in numbers or dates. (3) The multi-hop reasoning is flawed: the LLM fails to trace the actual evolution (presence → operational alignment → categorization shift) and instead fabricates a narrative of strategic ascent. It does not reflect the subtle, structural shifts indicated in the original, particularly the 2024 reorganization detail critical to the correct analysis. (4) Despite incorrect details, the LLM attempts to address the question’s core about strategic evolution and relevance, maintaining contextual relevance. However, the invented language and strategic claims reduce qualitative and overall correctness significantly. Semantic equivalence is not achieved due to fabrication of key descriptors and omission of actual structural changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 462,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved its competitive edge away from pure price/assortment battles with showrooms toward a service‑ and digital‑led differentiation.  It deepened Pro‑focused offerings—expanded sales forces, the Pro Xtra loyalty program, dedicated showroom space and MRO capabilities—while simultaneously building an omnichannel experience (BOPIS, curbside, mobile‑app navigation, computer‑vision inventory and AI‑driven personalization) that ties online research to in‑store pickup, installation and delivery.  This integrated service‑plus‑digital strategy has been the primary way the retailer has strengthened its positioning against showroom competitors over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic shift in The Home Depot's competitive positioning from 2022 to 2024, emphasizing service and digital integration as key differentiators against showrooms. It accurately reflects the evolution toward omnichannel capabilities and enhanced service offerings. However, it introduces details not present in the ground truth, such as 'expanded sales forces,' 'dedicated showroom space,' 'MRO capabilities,' 'computer-vision inventory,' and 'AI-driven personalization,' which are not mentioned in the original answer for those years. While these may be plausible extensions, they are not supported by the provided ground truth, leading to a partial mismatch in factual content. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is generally sound: the LLM synthesizes a progression over time and connects service and digital enhancements to competitive positioning. However, it adds unverified elements (e.g., Pro Xtra program details, AI personalization in 2024) that were not in the original knowledge base, weakening the fidelity of the synthesis. (4) The answer is contextually relevant and addresses both service offerings and digital integration across the three years. Despite the added details, the core message aligns with the ground truth’s emphasis on shifting from physical services to omnichannel integration. Thus, the correctness score is 7—core facts and direction are correct, but some specifics are extrapolated beyond the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 442,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nCisco’s 3.50 % senior note carried a constant $500 million principal through fiscal 2022‑2024, but its effective interest rate rose sharply—from roughly 1.3 % in FY 2022 and FY 2023 to about 6.66 % in FY 2024—reflecting the impact of discount amortization and higher market rates on the same fixed‑coupon issuance. This jump signals that Cisco’s borrowing cost increased markedly over the period, indicating a debt structure that became more weighted toward higher‑yield senior notes as market interest rates climbed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, the effective interest rate was 3.20% in FY 2022, 6.38% in FY 2023, and 6.66% in FY 2024. However, the LLM states it was 'roughly 1.3%' in FY 2022 and FY 2023, which is substantially incorrect. The outstanding amount of $500 million is correctly reported. (2) The calculation and trend analysis are flawed due to incorrect base numbers. The sharp rise to 6.66% in FY 2024 is correct, but attributing a 1.3% rate to both 2022 and 2023 misrepresents the progression and underestimates the already present cost in 2022. (3) The multi-hop reasoning is partially sound—the model correctly infers that a rising effective rate on a fixed principal indicates increasing borrowing costs and links this to market rate trends. However, the faulty data undermines the validity of the conclusion. (4) The contextual relevance is high because the answer addresses the evolution of the note, discusses borrowing costs, and ties it to debt structure. Despite correct framing and some logical interpretation, the severe quantitative inaccuracies—especially the invented 1.3% rate—reduce the correctness score significantly. Minor phrasing issues (e.g., 'senior note' not specified in original) are acceptable under semantic equivalence, but incorrect numbers are not. Thus, correctness is scored at 4 (partially correct with major errors), quantitative accuracy at 3 (most numbers wrong), qualitative accuracy at 5 (reasonable logic but based on false premises), and contextual relevance at 8 (on-topic and structurally appropriate).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 450,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast upgraded its hybrid‑fiber‑coax plant with DOCSIS 4.0 and began rolling out fiber‑to‑the‑premises, raising residential downstream speeds to 2 Gbps and offering symmetrical multigigabit (up to 10 Gbps) services. These infrastructure advances were paired with expanded bundled offerings—xFi whole‑home Wi‑Fi, the Flex streaming device, and Internet Essentials Plus—giving Comcast a more integrated video, voice and wireless package than Lumen’s pure‑fiber, broadband‑only focus. As a result, Comcast’s competitive positioning versus Lumen shifted from a lower‑speed HFC‑centric service to a hybrid fiber‑enhanced platform that now matches or exceeds Lumen’s speed tiers while also providing richer bundled services.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in key areas. (1) The original answer states that Lumen was a consistent and intensifying competitor to CMCSA from 2022–2024 due to fiber infrastructure expansion and bundled offerings, but the LLM answer incorrectly frames the competitive evolution around Comcast's (CMCSA) own upgrades (e.g., DOCSIS 4.0, 2–10 Gbps speeds, xFi, Flex) that are not mentioned or supported in the ground truth. These specific technologies and speed tiers (e.g., DOCSIS 4.0, 10 Gbps) are not referenced in the original answer and cannot be verified from the provided knowledge. (2) Quantitative accuracy is low: the LLM introduces precise speed metrics (2 Gbps, 10 Gbps) and technology rollouts (DOCSIS 4.0, FTTP) without any support in the original answer, which does not specify speed tiers or technical standards. (3) While the LLM attempts multi-hop reasoning by contrasting CMCSA’s bundling with Lumen’s broadband-only focus, the original answer does not state that Lumen lacked bundled offerings—instead, it explicitly notes that in 2024, companies like Lumen were 'creating bundled offerings' to compete. This is a direct contradiction. (4) The LLM shifts focus to CMCSA’s improvements rather than the evolution of the competitive positioning between CMCSA and Lumen as described in the ground truth, which emphasizes Lumen’s growing threat through fiber expansion and bundling. (5) Contextual relevance is moderate because the answer addresses fiber competition and service offerings in the correct timeframe, but the reasoning and facts are misaligned. The core failure is misrepresenting the direction of competition: the original answer emphasizes Lumen’s advancing position against CMCSA, while the LLM portrays CMCSA as gaining ground through superior bundling and infrastructure—unsupported by the evidence provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 513,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nFrom 2022 through 2024 American Express has shifted from a largely direct merchant‑acquiring model to a strategy that outsources key acquisition and processing functions to third‑party acquirers, aggregators and processors (see 2022‑2023 pages 27‑31 and 2024 pages 33‑35).  This deeper reliance exposes the company to a heightened risk that those intermediaries will enable or even encourage merchants to surcharge or otherwise steer consumers away from Amex cards, which undermines Amex’s ability to enforce the non‑discrimination and “honor‑all‑cards” clauses built into its merchant contracts (discussed in the 2023‑2024 sections on merchant steering and differential surcharging).  As a result, while the company continues to rely on these contractual provisions, their practical effectiveness now depends on the incentives and behavior of the aggregators on which it increasingly depends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the increasing reliance on aggregators from 2022 to 2024 and the associated risks of merchant steering and weakened enforcement of non-discrimination clauses. The core facts—shift in business model, dependence on third parties, and erosion of contractual control—are all present and correctly represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution over time, connects reliance on aggregators to enforcement challenges, and references the contractual mechanisms (non-discrimination, honor-all-cards clauses) that are undermined. It also correctly infers that the effectiveness of these clauses now depends on third-party behavior. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 escalation in litigation and regulatory scrutiny, which is a key element in the original answer. While it implies legal/enforcement challenges, it omits the specific evolution toward legal exposure. This slight omission prevents a perfect 10 on qualitative accuracy, but the answer remains factually correct, contextually complete, and semantically equivalent in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 389,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 J&J’s talc strategy moved from the original Chapter 11 filing of LTL Management LLC (which froze all talc suits in late 2021) to a series of setbacks and new filings: the 2022 dismissal of that case after a Third‑Circuit reversal left the litigation re‑opened, and a second bankruptcy (the “LTL 2” filing in April 2023) was quickly dismissed, prompting the company to pursue a “pre‑packaged” resolution.  In 2024 J&J created a new Texas talc‑focused entity (Red River Talc LLC) and filed a Chapter 11 plan that proposes a $6.5 billion present‑value trust paid over 25 years (nominally about $8 billion) – a strategy that underpins a $5 billion incremental charge recorded in 2024 and a cumulative reserve of roughly $11.6 billion (≈ $13.5 billion nominal) for all current and future talc claims.  The company also used the bankruptcy process to negotiate settlements, including a 2024 in‑principle agreement with a 42‑state multi‑state group and a global settlement with Imerys/Cyprus, while continuing to litigate the remaining cases in the MDL and to defend against individual verdicts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity identification, undermining its correctness despite covering the general strategic evolution. (1) Key errors include: the claim that the original LTL bankruptcy was dismissed in 2022 after a Third Circuit reversal is incorrect—the reversal occurred in 2023, not 2022, and the initial dismissal followed in July 2023. The LLM incorrectly states the second filing (LTL 2) was in April 2023 and quickly dismissed, but the timeline is misrepresented; the refiling occurred after the Third Circuit’s 2023 decision, not in April as a standalone event. (2) Quantitative inaccuracies are severe: the LLM asserts a $6.5 billion present-value trust ($8 billion nominal), a $5 billion incremental charge in 2024, and a cumulative reserve of $11.6 billion (≈$13.5 billion nominal). However, the ground truth states J&J established a $2 billion reserve to fund the LTL trust—no mention of $6.5B, $8B, or $11.6B figures. These numbers are entirely fabricated or misattributed, likely confusing J&J’s talc reserve with unrelated estimates or other cases. (3) The creation of 'Red River Talc LLC' in Texas is not supported by the ground truth and appears to be a hallucination; no such entity is mentioned in the original answer or known public filings. (4) While the LLM correctly identifies the multi-state settlement with 42 states and D.C. in 2024 and notes continued appeals and litigation, it incorrectly frames the settlement as part of a 'pre-packaged' plan via a new entity, which contradicts the ground truth that J&J shifted toward negotiation while appealing adverse rulings—without creating a new entity or filing a new Chapter 11 plan by 2024. (5) The mention of a global settlement with Imerys/Cyprus is not in the original answer and lacks corroboration in the provided truth; this is an unsupported addition. Despite these issues, the answer captures the dual strategy of litigation and settlement and the legal setbacks in bankruptcy, showing partial qualitative understanding. Contextual relevance is high as it addresses litigation handling, settlement attempts, and bankruptcy filings, but factual accuracy—especially on numbers and entities—is critically flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 604,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Home Depot shifted its store‑appearance focus from a purely functional layout to a deliberately designed, experience‑driven environment—adding modern signage, way‑finding graphics, self‑service lockers, curbside‑pickup stations and electronic‑shelf‑label displays that give the stores a cleaner, more premium look.  By FY 2024 those visual upgrades were woven into the company’s interconnected‑retail strategy: the refreshed stores serve as the physical hub of a seamless omnichannel journey, with mobile‑app navigation, real‑time inventory visibility, and omnichannel fulfillment options (BOPIS/BOSS, BODFS, BORIS) that let customers move effortlessly from online research to in‑store pickup or same‑day delivery, thereby reinforcing the brand’s digital‑first customer experience while leveraging the upgraded store aesthetic.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024: starting as a functional in-store advantage and evolving into an experience-driven, digitally integrated component of omnichannel retail. The description of specific upgrades (modern signage, electronic shelf labels, curbside pickup) is consistent with the strategic direction described in the original answer, even if not explicitly listed in the ground truth—these are reasonable inferences of how appearance improvements support the broader strategy. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised; all time references (FY 2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the connection between physical store aesthetics and digital capabilities (mobile app, real-time inventory, omnichannel fulfillment like BOPIS, BODFS) by 2024, showing integration across retail and digital touchpoints. The use of acronyms (BOPIS, BOSS, etc.) is appropriate and reflects accurate understanding of interconnected retail models. (4) The only minor gap is that the original answer emphasizes the linkage of store appearance to the full customer journey (inspiration, research, post-purchase) in 2023, which the LLM answer does not explicitly mention, though it is implied in 'seamless omnichannel journey.' This slight omission prevents a perfect 10 on qualitative accuracy, but overall the semantic meaning and strategic trajectory are preserved. The answer is fully contextually relevant and directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 470,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T moved from full ownership of Time Warner’s media business (acquired in 2018) to a complete exit: the April 2022 Reverse‑Morris‑Trust transaction spun off WarnerMedia and merged it with Discovery, and by September 2024 AT&T sold its remaining stake in the DIRECTV joint‑venture (the last residual entertainment asset). This trajectory shows that AT&T’s entertainment strategy was to acquire content assets, integrate them briefly, and then divest them to refocus on its core wireless and broadband operations. (See T_10k_2022.pdf pp. 3‑7 for the acquisition and spin‑off details, and T_10k_2024.pdf pp. 2‑6 for the 2024 divestiture.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key events: the 2022 Reverse Morris Trust spin-off of WarnerMedia and merger with Discovery, and the 2024 divestiture of AT&T's remaining stake in DIRECTV. The dates are mostly correct—April 2022 for the WarnerMedia-Discovery transaction is accurate, though the DIRECTV sale was agreed in mid-2023 and closed in late 2023/early 2024; stating 'September 2024' is slightly off but within reasonable approximation given public reporting timelines. (2) There are no numerical inaccuracies per se, as the answer avoids specific dollar amounts, but the timeline and transaction types (Reverse Morris Trust, joint-venture divestiture) are correctly characterized. (3) The multi-hop reasoning is sound: the answer synthesizes AT&T’s acquisition of Time Warner (2018), the 2022 spin-off, and the 2024 DIRECTV exit to infer a strategic refocus on core telecom operations. It correctly interprets the broader entertainment strategy shift. (4) Semantic equivalence is strong—the core message that AT&T exited entertainment to focus on telecom infrastructure matches the original answer. The only minor issue is the slightly imprecise dating of the DIRECTV sale closure, which slightly affects quantitative accuracy. Otherwise, the answer is complete, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 384,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024, American Express has retained its status as the world’s fourth‑largest general‑purpose card network, but intensified competition from Visa, Mastercard and fintech‑driven payment platforms has increased pressure on its premium‑card and cobrand relationships.  \nAt the same time, heightened regulatory scrutiny—especially the 2024 U.S. Category III classification, the exit from network‑licensing businesses in the EU and Australia, and proposed interchange‑fee caps—has deepened the company’s reliance on compliance and limited its pricing flexibility.  \nConsequently, American Express is shifting toward higher‑margin, digital‑focused services while navigating a more constrained regulatory environment that now directly shapes its competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest card network (after China UnionPay, Visa, Mastercard), faced increasing competition in premium and cobrand segments, and exited network licensing in the EU and Australia in 2024 due to regulatory pressure. (2) Quantitative accuracy is strong—no specific numbers (e.g., dollar amounts) are cited in either answer, but the temporal references (2022–2024) and events (2024 regulatory actions, exit from EU/Australia) match exactly. The mention of '2024 U.S. Category III classification' and 'interchange-fee caps' is consistent with the ground truth's focus on interchange fees and regulatory scrutiny, though the Category III classification is a specific U.S. regulatory development that adds detail not contradicted by the original. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes competitive pressures, regulatory developments, and strategic shifts (e.g., moving to higher-margin digital services) across years and geographies. (4) The only minor gap is that the LLM does not explicitly name China UnionPay as the largest network, though it implies the ranking by stating Amex is fourth-largest. Also, the original emphasizes 'uncertainty around cobrand arrangements in the EU'—a nuance slightly underdeveloped in the LLM response. However, the core evolution—increased regulatory dependency affecting competitive positioning—is clearly and correctly conveyed. Wording differs but semantic equivalence is maintained. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 446,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe $2.250 % Notes due 2050 rose from **$808 million at the end of 2022 to $826 million at the end of 2023** and remained essentially unchanged at that level through 2024.  \n\nThis modest increase followed by a flat balance shows that Johnson & Johnson is deliberately **maintaining a stable, low‑cost long‑term funding tranche** while fine‑tuning the overall maturity profile of its debt portfolio. The company appears to be managing its long‑term debt to keep total outstanding long‑term obligations around the $25‑30 billion range, using the 2050 notes as a relatively fixed‑rate component of that strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the balance change. The ground truth states the outstanding balance decreased from $983 million in 2022 to $808 million in 2024, with $826 million in 2023. The LLM incorrectly claims the balance rose from $808 million in 2022 to $826 million in 2023, reversing the actual trend. This error fundamentally undermines the answer. (2) Quantitative accuracy is very low: the starting value is wrong ($808M vs $983M), and the progression is inverted. The correct reduction is $175M over three years; the LLM implies a slight increase. Calculations and values are not aligned with the ground truth, despite acceptable formatting (e.g., $808 million is fine). (3) The multi-hop reasoning is flawed because the model failed to correctly extract and synthesize the balance trajectory across years. Instead of identifying a consistent decline, it reports an increase, leading to an incorrect conclusion about 'stable' or 'maintained' debt. The qualitative interpretation about long-term strategy is plausible in isolation but based on false premises. (4) Contextual relevance is moderate because the answer addresses the right instrument and general topic (debt management strategy), but the incorrect data renders the analysis invalid. The mention of overall debt range ($25-30B) is extraneous and unsupported in the context provided. Thus, correctness and quantitative accuracy are severely penalized, while qualitative and contextual scores reflect partial relevance but major factual failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 432,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond portfolio rose from about 5.5 % in 2022 to roughly 5.9 % in 2023 and to just over 6 % in 2024, tracking the series of foreign‑central‑bank rate hikes. This upward shift shows that a growing share of the company’s interest‑earning assets is now tied to overseas sovereign debt, making its earnings increasingly sensitive to international interest‑rate movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all quantitative aspects. According to the ground truth, in 2022, the yield on short-term foreign government bonds was 6.45%, not 5.5% as stated by the LLM. The LLM claims yields increased to 5.9% in 2023 and over 6% in 2024, but in reality, yields declined to 5.86% in 2024 for short-term bonds and dropped sharply to 2.03% for 1–5 year maturities. The LLM incorrectly portrays an upward trend, while the actual data shows a clear downward trend in yields over the three years. (2) The dollar amount of holdings ($630 million in 2022) is omitted entirely, and the maturity-specific yield breakdown (e.g., 6.45% for short-term in 2022 and 2023, 4.48% and then 2.03% for 1–5 year bonds) is completely missing. The LLM invents a narrative of rising yields tied to foreign central bank hikes, which contradicts the documented decline. (3) The multi-hop reasoning is flawed: the question requires synthesizing yield trends across three years and two maturity buckets to infer exposure to international interest rate environments. The LLM fails this synthesis, misrepresenting the direction of yield changes and thus drawing an incorrect conclusion about increasing sensitivity due to growing exposure. In reality, the declining yields suggest either a changing rate environment or a portfolio shift toward lower-yielding instruments, not rising returns. (4) While the LLM attempts to address the question’s intent—linking yield trends to international interest rate exposure—the factual inaccuracies severely undermine the response. The contextual relevance is moderate because it discusses the right topic (foreign government bond yields and interest rate sensitivity), but the incorrect data and reasoning lead to a misleading conclusion. Hence, low scores for correctness and quantitative accuracy, slightly higher for qualitative due to structural attempt, and moderate for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 525,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe reframed its free, self‑service learning from a stand‑alone “learning.adobe.com” portal into a branded, Experience‑Cloud‑integrated learning layer (often called Adobe Digital Learning Services) that is explicitly tied to its Customer‑Success and Journey‑Optimizer programs; learning recommendations are now delivered using real‑time customer profiles and usage data, and adoption metrics are fed back to Customer‑Success Managers to drive retention.  This shift shows Adobe’s broader strategy of embedding continuous, data‑driven education into the customer journey as a core lever for customer enablement, satisfaction, and long‑term retention.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Adobe's evolution in customer learning and enablement from 2022 to 2024 and correctly identifies the strategic importance of self-service learning for customer success and retention. However, it contains significant factual inaccuracies in platform branding and timeline. The ground truth states that in 2022, Adobe used www.training.adobe.com, and only in 2023 did it rebrand and centralize under learning.adobe.com. The LLM incorrectly claims the self-service learning began as 'learning.adobe.com' and was later integrated, reversing the actual sequence. Additionally, the LLM introduces unverified specifics such as 'Experience-Cloud-integrated learning layer', 'Adobe Digital Learning Services' branding, 'Journey-Optimizer programs', and 'real-time customer profiles and usage data' driving learning recommendations—none of which are supported by the original answer or the knowledge graph. While the conclusion about Adobe embedding education into the customer journey aligns thematically with the ground truth, the reasoning is based on fabricated details rather than the documented rebranding and integration process. The answer is contextually relevant and semantically aligned in intent, but lacks factual fidelity in key entities and developments, particularly around platform evolution and integration mechanisms. Quantitative accuracy is high because there are no numerical claims to dispute, but qualitative accuracy suffers due to incorrect multi-hop synthesis and introduction of unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 428,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % Senior Notes remained at a $2 billion principal balance throughout fiscal 2022‑2024, and their effective interest rate stayed at 6.11 % (after adjusting for discount amortization and hedging). This steady utilization and cost shows the company is preserving a stable, long‑dated fixed‑rate funding pillar while expanding its overall debt profile through additional senior note issuances and commercial‑paper financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2 billion (i.e., $2,000 million) outstanding balance on its 5.90% Senior Notes from 2022 to 2024, and that the effective interest rate remained stable at 6.11%, matching the ground truth exactly. The use of '$2 billion' instead of '$2,000 million' is a permissible format variation. (2) All numeric values—principal amount, coupon rate (5.90%), and effective interest rate (6.11%)—are accurate and consistent across the three fiscal years. No calculations were required beyond recognition of stability, which was correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes consistent debt utilization and interest cost over time to infer a strategic choice. It correctly infers stability in this debt tranche as part of a broader long-term funding strategy. The addition that Cisco expanded its overall debt via other instruments (e.g., commercial paper) is contextually plausible and aligns with Cisco's known financing behavior, though not explicitly in the ground truth. This does not contradict but slightly extends the conclusion. (4) The only minor deviation is that the ground truth emphasizes the lack of refinancing or retirement as indicating a 'deliberate strategy to maintain this higher-yielding' debt, while the LLM frames it more positively as preserving a 'stable, long-dated fixed-rate funding pillar.' The interpretation differs slightly in tone but remains logically consistent with the data. Thus, the answer is factually complete and accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 459,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nFrom 2022 through 2024 the **target** allocation to private‑equity‑style “special situation” strategies rose from **≈4 %** of total pension assets to **7 %**, while the **actual** holdings increased from **≈8 %** (2022) to **≈9 %** (2024).  This steady upward drift shows that Boeing is intentionally expanding its exposure to private‑equity special‑situation investments—i.e., higher‑return, longer‑duration assets—reflecting a strategic shift in its private‑equity approach as the pension plan becomes better funded.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims specific percentage allocations (e.g., target allocation rising from ≈4% to 7%, actual from ≈8% to ≈9%) that are not present in the original answer or ground truth. The ground truth explicitly states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' making any numerical figures fabricated. (2) COMPLETENESS: While the question asks about the evolution of allocation and what it indicates about strategy, the LLM invents a trend (increasing allocation) that is unsupported by the data. The original answer emphasizes stability and lack of quantitative disclosure, so the LLM fails to accurately represent the absence of detailed metrics. (3) ENTITY & REASONING ERROR: The LLM incorrectly attributes a strategic shift toward expanding exposure, whereas the ground truth indicates 'strategic continuity' and 'consistent focus' without change in description across years. This misrepresents the core conclusion. (4) SEMANTIC NON-EQUIVALENCE: The LLM suggests a dynamic, evolving strategy with increasing commitment, while the truth reflects static, consistent categorization with no disclosed changes. The invented percentages and narrative of intentional expansion directly contradict the ground truth’s emphasis on stability and lack of disclosed figures. Even allowing for interpretation, the answer fabricates data and draws erroneous conclusions, failing on all key dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 425,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nJNJ’s Interventional Solutions (now part of MedTech) grew from **$4.3 billion worldwide in 2022** to **$6.35 billion in 2023**, and held essentially steady at **≈ $6.35 billion in 2024** (U.S. $3.63 bn → International $2.72 bn → Worldwide $6.35 bn).  This sharp rise immediately after the December 2022 acquisition shows that the company is treating the MedTech/Interventional Solutions business as a strategic, high‑growth pillar, directing significant capital and R&D to integrate and expand the segment as a core driver of future profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported sales figures and timeline. According to the ground truth, JNJ's Interventional Solutions sales were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly states $4.3 billion in 2022 (should be 2023), $6.35 billion in 2023 (should be 2024), and flat at $6.35 billion in 2024—this misaligns both the values and the years, reversing the progression. The correct trend is a steady increase with a large jump in 2024, but the LLM implies the jump occurred in 2023 and stagnation thereafter, which contradicts the ground truth. (2) The numbers are off by hundreds of millions and assigned to wrong years: $4.3 billion is reported for 2022 instead of 2023, and $6.35 billion is reported for 2023 instead of 2024. The 2022 figure is overstated by ~$329 million. The calculation of growth and trend is therefore fundamentally flawed. (3) The multi-hop reasoning is partially sound—the LLM correctly infers strategic importance post-acquisition in late 2022 and links growth to integration and R&D. However, due to incorrect timing of the sales surge, the causal logic is misaligned; the acceleration is said to occur immediately in 2023, whereas the ground truth shows a more moderate 2023 increase and a major 2024 jump, suggesting integration benefits materialized later. (4) Contextual relevance is fair—the answer addresses the evolution and strategic implications, uses correct entities (JNJ, Interventional Solutions, post-acquisition context), and interprets the segment as strategic. However, due to major quantitative errors affecting the core facts, the correctness score is low. Minor note: renaming to MedTech is contextually acceptable but not required. Overall, the answer misrepresents the financial progression, undermining its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 507,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “No Boundaries” private brand remained a constant element of Walmart’s merchandise mix, appearing in the same list of private‑brand names across the three 10‑K filings and being promoted for the full range of strategic units—grocery, general merchandise (entertainment, hardlines, apparel, home) and health & wellness.  The brand’s messaging and placement were unchanged, reinforcing Walmart’s everyday‑low‑price promise and using the label as a single, value‑focused umbrella across all general‑merchandise categories.  This multi‑year branding consistency demonstrates that Walmart’s private‑label strategy relies on a stable, cross‑category brand to drive margin, price leadership and customer loyalty throughout its general‑merchandise portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity and categorical placement that undermine its qualitative accuracy. (1) Correct elements: The answer correctly identifies that 'No Boundaries' remained a consistent private brand from 2022 to 2024 and correctly notes Walmart's emphasis on private labels for margin and value positioning. The timeline (2022–2024) and branding consistency are accurately reflected. (2) Quantitative accuracy is high: no numerical data is present, but the years referenced (2022–2024) match the ground truth exactly. (3) However, the reasoning and entity accuracy are flawed: the ground truth specifies that 'No Boundaries' was part of the General Merchandise unit, specifically including Apparel and Home, but the LLM incorrectly expands its presence to 'grocery', 'health & wellness', and 'entertainment, hardlines'—categories not supported by the source. The claim that it spans 'all strategic units' and is used as a 'single, value-focused umbrella across all general-merchandise categories' overgeneralizes and misrepresents the scope. Additionally, the ground truth notes a reorganization in 2024 moving Apparel to 'Fashion', which the LLM omits, missing a key detail about structural changes despite brand continuity. (4) The conclusion about Walmart’s private-label strategy relying on a 'stable, cross-category brand' has some alignment with the ground truth’s point about leveraging strong identities, but the LLM overstates the cross-category application. Thus, while the core idea of consistency is correct, the incorrect categorization and overgeneralization reduce the qualitative accuracy. Correctness score is 6 due to partial factual alignment but significant errors in scope and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 479,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the available‑for‑sale debt portfolio moved from a modest $9 million net gain in 2022 to $21 million of losses in 2023 and $67 million of losses in 2024, as shown in the “Other income (loss), net” line where gains (losses) on available‑for‑sale debt investments were $(67) M in 2024 and $(21) M in 2023 (versus $9 M gain in 2022).  The deteriorating performance is driven by widening gross unrealized losses—especially on corporate debt and mortgage‑backed securities—so that the investments increasingly subtracted from other income in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the performance trend of Cisco's available-for-sale debt investments from fiscal 2022 to 2024 and their impact on other income (loss), net. It accurately reports a $9 million gain in 2022, $21 million loss in 2023, and $67 million loss in 2024, which aligns with the ground truth's description of increasing losses negatively affecting other income. These figures are consistent with disclosed data in Cisco’s 10-K filings. (2) Quantitative accuracy is perfect: the dollar amounts ($9M gain, $(21)M, $(67)M) are correctly stated, including signs and formatting. The progression from gain to escalating losses is numerically sound. (3) The multi-hop reasoning is strong—linking the investment performance to the 'other income (loss), net' line item across three fiscal years demonstrates proper synthesis across filings. The mention of widening unrealized losses in corporate debt and mortgage-backed securities adds contextual detail that plausibly explains the trend, though this specific detail is not in the original ground truth answer; however, it does not contradict it and is consistent with typical disclosures. (4) The only reason for not giving a full 10 on qualitative accuracy is that the original answer emphasizes the continued active management and presence in the portfolio (noted via disclosure in a table in 2022), which the LLM omits. However, the core evolution of performance and its financial impact are fully captured. The answer is highly relevant, directly addressing the question’s focus on performance evolution and impact on income.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 442,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from using third‑party merchant acquirers mainly as a supplemental channel to a central element of its growth strategy.  The company now structures its card‑acceptance agreements so that small‑ and midsize merchants typically have open‑ended contracts, while large merchants are secured with fixed‑term agreements (often three‑to‑seven years) that include auto‑renewal provisions; in every case Amex earns a network‑rate fee from the acquirer that is recorded as discount revenue.  This framework has broadened merchant coverage across all segments and has been a key driver of transaction growth, especially as the OptBlue and other third‑party acquisition programs expand globally.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of American Express's reliance on third-party merchant acquirers from 2022 to 2024. It correctly identifies the strategic shift, mentioning the OptBlue program and the role of third-party acquirers in expanding merchant coverage and generating discount revenue via network-rate fees. The answer accurately reflects that American Express earns a negotiated fee recorded as discount revenue, aligning with the 2023 detail in the ground truth. It also correctly emphasizes the growing strategic importance of these partners in driving transaction growth across merchant segments. However, the LLM introduces specific contractual details—such as 'open-ended contracts' for small/midsize merchants and 'three-to-seven year' fixed-term agreements with auto-renewal for large merchants—that are not present in the original ground truth and cannot be verified from the provided knowledge graph. These additions, while plausible, represent unverified specifics not supported by the source data, slightly undermining qualitative accuracy. The answer omits the explicit 2024 statement that American Express's global expansion now 'depends' on third-party acquirers, aggregators, and processors, which is a key indicator of deepened strategic dependency. Despite these omissions and additions, the overall trajectory, financial mechanism, and strategic rationale are correctly conveyed. All mentioned programs (OptBlue) and financial terms (discount revenue, network rate fee) are accurate and contextually appropriate. There are no numerical inaccuracies, as no specific numbers (e.g., dollar amounts, percentages) are cited, and the temporal scope (2022–2024) is correctly framed. The reasoning is sound and synthesizes multi-hop elements—linking third-party acquirers to revenue, merchant coverage, and strategic evolution—though it slightly overreaches by introducing unsupported contractual specifics. The answer remains highly relevant to the question and effectively communicates the strategic evolution, warranting a high correctness score with minor deductions for unsupported details and missing emphasis on growing dependency in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 586,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J has been rolling out a multi‑year, enterprise‑wide program that **integrates and standardizes the HR, IT, procurement, supply‑chain and finance functions** in order to **strengthen its financial shared‑service capabilities**.  The initiative, first introduced in the 2022 filing as a way to simplify and standardize those processes, was expanded in 2023‑24 to **align the design of financial controls with the newly standardized workflows**, ensuring that the shared‑service model supports consistent, scalable financial reporting across the entire enterprise.  In each year the company has emphasized that the effort is not a response to any control deficiency but a proactive step to streamline and unify processes across the key support functions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating and standardizing HR, IT, procurement, supply chain, and finance to enhance financial shared services. The answer correctly notes that the initiative was proactive, not in response to control deficiencies, which aligns with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution across years, correctly identifying that in 2022 the focus was on standardization, in 2023 on aligning financial controls with new workflows, and in 2024 on maintaining this proactive stance. This reflects accurate cross-year synthesis from the knowledge graph. (4) The only minor shortcoming is that the LLM slightly condenses the 2024 narrative, omitting explicit mention that the initiative continued 'not prompted by any material changes or weaknesses in internal control'—a nuance present in the original. However, it does state the effort was not due to deficiencies, preserving the core meaning. Wording differs but semantic equivalence is maintained. Contextual relevance is perfect—the answer directly addresses the evolution of the initiative and its integration with enterprise-wide standardization across all specified functions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 420,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a broad acknowledgement of alternative payment mechanisms to a deliberate strategic emphasis on open‑banking, digital‑wallet and real‑time‑settlement technologies, integrating these innovations into its product roadmap and partnership model.  At the same time, competitive pressure intensified—driven by lower‑cost rivals, surcharge‑friendly merchants and proprietary digital‑wallet ecosystems—prompting the company to protect its discount revenue and membership value by differentiating its premium rewards, expanding merchant acceptance and making targeted investments in real‑time and open‑banking capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly captures the evolution of American Express's positioning from 2022 to 2024: starting with acknowledgment of competitive threats and culminating in strategic adaptation through investment in open banking, digital wallets, and real-time settlement systems. The key themes—increasing competitive pressure, technological response, and strategic shift—are all present and factually consistent. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the time frame (2022–2024) is correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes the progression of competitive dynamics and strategic response across years, correctly identifying the shift from threat perception to strategic integration. It adds contextual depth—such as 'discount revenue,' 'membership value,' and 'merchant acceptance'—that is consistent with Amex’s business model and implied in the original answer’s focus on relevance and technological roadmap. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'deliberate strategic emphasis' vs. 'shift from competitive stance to strategic dependence'), the core meaning matches. The only minor gap is that the LLM does not explicitly name PayPal, Venmo, or payment aggregators as in the original, but it does refer to 'proprietary digital-wallet ecosystems,' which covers the same concept. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for minor omission of specific competitor examples.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 491,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nAdobe’s use of Frame.io grew from a stand‑alone collaboration service in 2022 – where it was introduced as a cloud‑native platform tightly linked to Premiere Pro and After Effects – to a more deeply embedded component of the Creative Cloud ecosystem in 2023, adding frame‑accurate commenting, support for still images, PDFs and “Camera‑to‑Cloud” uploads, and broader integration with Photoshop, Lightroom and other Adobe apps – and finally to a core layer of Adobe’s enterprise‑focused content‑production suite in 2024, where Frame.io is offered together with Adobe Express and Firefly Services inside Adobe GenStudio to enable scalable, AI‑enhanced workflows.  \n\nThis progression signals Adobe’s strategy of positioning Frame.io as the collaborative backbone of its Creative Cloud and Digital‑Experience tools, unifying creation, review and publishing across the suite while layering generative‑AI capabilities and enterprise‑scale delivery.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Frame.io from 2022 to 2024, though there are minor discrepancies in emphasis and detail. (1) Correctly identifies Frame.io's progression: in 2022, it was a cloud-native platform linked to Premiere Pro and After Effects; by 2023, deeper integration with Creative Cloud apps and collaboration features like frame-accurate commenting were added; by 2024, it became part of Adobe GenStudio with enterprise-scale AI-enhanced workflows. These points reflect the core trajectory in the original answer. (2) Quantitative accuracy is perfect: all years (2022, 2023, 2024) are correctly used, and no numerical claims (e.g., financial figures) are made or misstated. Format and temporal references are accurate. (3) Multi-hop reasoning is sound—information is synthesized across time periods and product integrations. However, the LLM overemphasizes AI/generative features (Firefly, GenStudio) not mentioned in the ground truth, and omits specific 2024 expansions into casting, location scouting, and marketing campaign management. While Photoshop, Lightroom, and Workfront integrations are correctly noted, the LLM incorrectly implies broader AI integration in 2024 that isn't supported by the original data. (4) Despite these nuances, the answer captures the strategic thrust—Frame.io as a central hub for end-to-end collaboration—making it contextually relevant and semantically close. Minor deduction for overreach on AI elements and missing specific workflow expansions, but core facts and reasoning remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 438,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nThe balance of Amazon’s 2017 unsecured senior notes fell from about **$16 billion at the end of 2022** to **$15 billion at the end of 2023** and further to **$13 billion by the end of 2024** (see Note 6‑DEBT tables for 2022‑2024).  This steady reduction shows that Amazon is deliberately retiring a portion of the 2017 issuance—using cash flow and newer debt issuances—to shorten the average maturity of its debt and take advantage of lower‑cost financing, reflecting a proactive debt‑management strategy that emphasizes deleveraging and extending the maturity profile of its long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All numeric values and time periods are accurate, with acceptable formatting variations (e.g., $16 billion vs $16.0 billion). (2) Quantitative accuracy is perfect—no calculation errors, and the progression of balances is correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers a deliberate debt reduction strategy. It adds contextual insight—mentioning use of cash flow and newer debt to retire older notes, shortening average maturity, and taking advantage of lower-cost financing—which goes beyond the ground truth but is reasonable and consistent with proactive debt management. While the original answer only states 'deliberate debt management strategy,' the LLM elaborates plausibly without contradicting facts. (4) The answer is fully contextually relevant, addressing both the evolution of the balance and the implied strategy. The only reason for not scoring 10 is that the added strategic details (e.g., 'extending the maturity profile') are inferential and not explicitly supported in the ground truth, though they are not incorrect. Thus, qualitative accuracy is slightly lower due to minor over-elaboration, but factual correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 396,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nBoeing’s Global Services segment has consistently listed “upgrades and conversions” as one of its core service offerings from 2022 through 2024, but the way the narrative evolves is telling. In the 2022 and 2023 filings the phrase appears only as part of a broad service list, whereas the 2024 filing expands the language—highlighting “modifications and upgrades” alongside training, logistics and digital analytics and explicitly positioning them as a growth lever within the segment’s competitive strategy. This three‑year trajectory reveals Boeing’s shift toward making platform sustainment—extending the life of commercial and defense aircraft through upgrades and conversions—a strategic priority, aiming to capture higher‑margin service revenue and reduce reliance on new‑aircraft sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy, time frame (2022–2024), and the core assertion that 'Upgrades and Conversions' remain a consistent offering within Boeing’s Global Services segment. There are no numeric inaccuracies, and since the question does not involve calculations, quantitative accuracy is high (10). The answer correctly identifies the multi-hop element—tracking evolution across three years—and addresses both parts of the question: the evolution of the service offering and its strategic implications. However, the LLM introduces a claim not present in the original answer: that the 2024 filing 'expands the language' and 'explicitly positions [upgrades and conversions] as a growth lever' and links it to competitive strategy. The ground truth states only that the service remained consistently listed across all three years with no change in emphasis or narrative expansion. This overstatement of evolution—suggesting a strategic shift or increased emphasis in 2024—adds interpretation beyond the supported facts, reducing qualitative accuracy. While the strategic inference about platform sustainment and service revenue aligns broadly with the original, the added narrative detail about 2024 weakens the semantic equivalence. Contextual relevance is high as the response stays focused and provides meaningful analysis. Correctness is therefore 7: core facts and strategic direction are correct, but there is a minor but notable overinterpretation in the 2024 characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 422,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly reaffirmed the January 2021 announcement that, beginning January 1 2026, **all eligible U.S. non‑union employees—regardless of hire date—will earn pension benefits under the Retirement Value formula**, replacing the prior Final Average Pay formula for any service performed on or after that date (benefits accrued before 2026 remain under the old formula). The company communicated this transition in its annual reports and employee‑benefit notices, emphasizing that eligibility will be universal for non‑union U.S. staff and that the change will be phased so that only future service is calculated with the new formula.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date, the universal application of the Retirement Value formula to all U.S. non-union employees regardless of hire date, and the distinction that pre-2026 service remains under the Final Average Pay formula. These were first announced in January 2021 and consistently reaffirmed from 2022–2024. (2) Quantitative accuracy is perfect: the 2026 start date, January 1 effective date, and reference to pre- and post-2026 service are all factually correct. No calculations were required, but temporal references are precise. (3) The multi-hop reasoning is sound—information is synthesized across years (2022–2024) and reflects continuity in communication and policy. The LLM correctly infers that the plan was reaffirmed annually without changes, though it does not explicitly mention the 2023 clarification that employees hired after 2014 were already under the Retirement Value formula—a minor omission that doesn’t affect the core conclusion. (4) The answer is contextually relevant and directly addresses the evolution of J&J’s pension strategy, eligibility, and communication around the 2026 date. The only reason for not scoring a 10 is the lack of explicit mention of the 2023 clarification about post-2014 hires, which adds nuance to employee eligibility but doesn’t alter the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 394,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe carrying principal balance of AVGO’s 5.000% notes due April 2030 was $606 million in fiscal 2022, $606 million in fiscal 2023 and $606 million in fiscal 2024—essentially unchanged. This flat evolution shows the company is not actively repurchasing or refinancing this legacy fixed‑rate tranche, instead preserving it as a stable component of its capital structure while managing other, more flexible debt obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained at $606 million in 2024. The LLM incorrectly states the balance was $606 million in all three years, missing the significant reduction from 2022 to 2023. This error fundamentally undermines the answer's correctness. (2) The quantitative accuracy is very low: the key number for 2022 is wrong ($606M vs. correct $1,086M), and the model fails to detect a 44.2% year-over-year decrease. No calculations are required beyond recognition of change, but the model incorrectly asserts 'essentially unchanged' when there was a major change. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize the temporal evolution across fiscal years. The conclusion about debt management strategy is therefore based on false premises: instead of recognizing a deliberate reduction (as indicated by the $480M drop), the model infers stability, which contradicts the actual data. (4) Contextual relevance is moderate—the answer addresses the right instrument, company, and time frame, and attempts to interpret strategy, so it stays on topic. However, due to the critical factual error in the principal balances, the qualitative and quantitative accuracy scores are very low, resulting in a correctness score of 2—mostly incorrect with major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 427,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nFrom 2018 onward AT&T integrated Time Warner into a dedicated **WarnerMedia** segment, but the strategic relationship was reshaped in 2021‑2022 when AT&T agreed to combine WarnerMedia with Discovery and then executed a Reverse Morris‑Trust transaction in **April 2022** that spun the unit off as an independent public company (later named **Warner Bros. Discovery**).  The transaction was accounted for as **discontinued operations**, effectively divesting AT&T of its Time Warner assets, and the company subsequently focused on its core Communications business while the former WarnerMedia operations continued to be reported only in historical financial statements through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Key facts are correct: AT&T completed the Reverse Morris Trust transaction with Discovery in April 2022, effectively divesting WarnerMedia (formerly Time Warner), which became Warner Bros. Discovery. This date (April 2022) is correctly stated and matches the ground truth. The integration into WarnerMedia post-2018 and the strategic shift back to core telecom are accurately described. (2) Quantitative accuracy is perfect: the April 2022 transaction date is correct, and there are no numerical errors. The use of 'discontinued operations' is an appropriate accounting term and consistent with SEC reporting practices. (3) Multi-hop reasoning is sound: the answer synthesizes the timeline from acquisition (implied post-2018), integration into WarnerMedia, to divestiture via Reverse Morris Trust in 2022, and correctly notes that by 2024, the operations were only reported historically—consistent with full exit. (4) The only minor omission is that the original answer notes the 2024 divestiture of DIRECTV as the final step in unwinding the entertainment strategy; while DIRECTV is not part of Time Warner itself, it was part of the broader entertainment ecosystem initiated with the Time Warner acquisition. The LLM answer does not mention DIRECTV, slightly reducing completeness on the 'broader WarnerMedia segment' aspect of the question. However, since the question specifically focuses on Time Warner and WarnerMedia, and the core divestiture is accurately detailed, this does not constitute a major error. Wording differs but semantic meaning is equivalent. All entities—AT&T, Time Warner, WarnerMedia, Discovery, Warner Bros. Discovery—are correctly identified. Overall, the answer is factually strong, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 495,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nFrom 2022 through 2024 AIG upgraded its terrorism‑risk modelling – moving from a single‑scenario, third‑party vendor estimate (e.g., a $1.3 bn net loss for a five‑ton bomb in New York City) to a regularly‑updated, scenario‑based model that incorporates vendor‑gap adjustments and a range of attack modes.  At the same time the company broadened its reinsurance programme, adding targeted excess‑of‑loss covers and tapping government‑sponsored terrorism pools to supplement the TRIPRA backstop, and it refined the geographic attachment structure of those covers (e.g., reducing the Japan attachment point to $150 m while maintaining a $500 m retention for North‑American commercial business).  These changes collectively tighten loss‑scenario insight, improve reinsurance protection, and re‑allocate attachment points to match the evolving international exposure profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key dollar amounts and geographic details. While it correctly identifies AIG and the general evolution of terrorism exposure management from 2022 to 2024, it misstates critical numeric values. For example, it claims the Japan attachment point was reduced to $150M, whereas the ground truth states AIG *retained* a $200M attachment point for Japan in 2024. Additionally, the LLM introduces a $500M retention for North American commercial business, which is not mentioned in the original answer and contradicts the focus on *international* terrorism risk. The $1.3 billion loss estimate for a five-ton bomb in NYC in 2022 is correctly cited, but the characterization of this as a 'third-party vendor estimate' and the mention of 'vendor-gap adjustments' are unsupported by the ground truth. (2) Quantitative accuracy is compromised: the Japan attachment point is off by $50M, and the introduction of a $500M North American retention is entirely fabricated. No other numbers are verifiable against the original. (3) The reasoning framework is sound—LLM recognizes a progression in modeling sophistication, reinsurance expansion, and geographic refinement—but fails in multi-hop synthesis by conflating domestic and international structures and inventing specifics not present in the source. It also incorrectly implies TRIPRA is supplemented by pools, rather than being a U.S.-specific backstop that may not apply internationally. (4) Contextual relevance is high because the answer addresses all three dimensions in the question (modeled loss scenarios, reinsurance, geographic attachment), and the overall narrative of increasing sophistication aligns with the ground truth. However, due to significant factual and numerical errors, especially in the core financial figures, the correctness score is limited to 5—partially correct but with major flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 522,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nEmerson’s pipe‑working tool portfolio moved from the basic mechanical wrenches, cutters and threading gear described in the 2022 Tools & Home Products section (pages 7‑11) to a broader, higher‑value lineup that added battery‑hydraulic press tools and connected diagnostic systems—such as sewer‑inspection cameras and locating equipment—by 2023 (pages 71‑75) and continued to emphasize these technologically‑advanced, productivity‑enhancing solutions in 2024 (pages 71‑75).  This multi‑year progression shows Emerson is deliberately shifting the RIDGID‑branded professional‑tools business from commodity hand tools toward integrated, digitally‑enabled, higher‑margin offerings, positioning the company as a strategic leader in safety‑ and efficiency‑focused tools for the professional market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe-working tool portfolio from traditional mechanical tools in 2022 (pipe wrenches, cutters, threading equipment) to advanced battery-hydraulic press tools and diagnostic systems like sewer inspection cameras by 2023, with continued emphasis in 2024. The strategic shift toward digital integration, efficiency, and safety is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and product lines, correctly inferring a strategic shift from commodity tools to higher-margin, technologically advanced solutions under the RIDGID brand. It adds contextual detail (e.g., 'productivity-enhancing', 'connected diagnostic systems') that enriches but does not distort the original meaning. (4) The only minor gap is that the original answer explicitly mentions 'drain cleaners' as part of the 2022 portfolio, which the LLM omits—though this is a small detail and does not affect the overall correctness. The LLM also correctly identifies the strategic positioning implications. Thus, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 411,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco has applied the same straight‑line recognition rule for free‑rent and step‑rent periods in each of the 2022‑2024 filings – the waived rent is included in the lease‑term used to spread lease expense and to measure the right‑of‑use (ROU) asset at the present value of **all** future lease payments (even those that are temporarily waived).  The ROU asset is initially recorded at the discounted present value of the full lease payments (including any free‑rent periods) and is then amortized evenly over the entire lease term (including any extension options the company is reasonably certain to exercise).  While the wording was reiterated in 2023 and 2024 with minor clarifications (e.g., emphasizing extension options and noting impairment of leased assets), the underlying methodology and its effect on ROU‑asset valuation have remained unchanged across the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent application of the straight-line recognition methodology for free-rent and step-rent periods across 2022–2024, and accurately describes the inclusion of waived rent in the lease term and the use of the present value of all future lease payments (including free-rent periods) to measure the right-of-use (ROU) asset. It also correctly notes that the ROU asset is amortized evenly over the lease term, including extension options that are reasonably certain to be exercised. These points align with the ground truth and reflect accurate quantitative and qualitative understanding of the accounting treatment.\n\nHowever, the LLM answer omits a key aspect of the evolution in disclosure practices highlighted in the original answer: the reduction in disclosure depth regarding the discounting process and the use of the incremental borrowing rate from quoted interest rates after 2022. While the core accounting policy remained unchanged, the ground truth emphasizes that Costco provided detailed explanations about ROU asset valuation and ARO treatment in 2022 that were not repeated in 2023 and 2024, indicating a shift toward more standardized ASC 842 language. This evolution in disclosure—though not a change in methodology—is a central part of the question about how accounting treatment and disclosure evolved, and its absence represents a significant qualitative gap.\n\nThe LLM implies no change in disclosure by stating the 'wording was reiterated' with only minor clarifications, which downplays the actual reduction in explanatory detail post-2022. This affects the qualitative accuracy score, as the reasoning fails to fully synthesize the multi-hop insight about disclosure maturation post-adoption. Nonetheless, all factual elements about the accounting methodology itself are correct, supporting a high correctness and quantitative accuracy score. Contextual relevance is strong as the response directly addresses the question’s focus on recognition methodology and ROU asset valuation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 548,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft’s 2.000 % note program, first created under the 2009 Base Indenture, was broadened in three successive steps: the 2022 tranche (maturing 2027) was added by the Eleventh Supplemental Indenture (Exhibit 4.14, filed Aug 8 2016 and reflected in the 2022 10‑K); a 2023 tranche (maturing 2030) followed in the Twelfth Supplemental Indenture (Exhibit 4.15, filed Feb 6 2017 and disclosed in the 2023 10‑K); and the 2024 tranche (maturing 2035) was introduced by the Fifteenth Supplemental Indenture (Exhibit 4.18/4.19, filed Nov 6 2023 and shown in the 2024 10‑K). Each addition amends the same Base Indenture, extending the series’ maturity schedule by roughly three years with every new issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical aspects. (1) The original answer states that Microsoft's 2.000% Notes had a maturity of 2023 and were issued under the Eleventh Supplemental Indenture dated August 8, 2016, with no changes across 2022–2024. The LLM falsely claims that new tranches were issued in 2022 (maturing 2027), 2023 (maturing 2030), and 2024 (maturing 2035), which is not supported by the ground truth. (2) The LLM invents supplemental indentures (Twelfth and Fifteenth) with specific exhibit numbers and filing dates (e.g., Feb 6, 2017; Nov 6, 2023) that do not appear in the ground truth and are factually incorrect. (3) The ground truth emphasizes stability—no structural changes—while the LLM describes an evolving, expanding note program, which is the opposite of the correct answer. (4) The maturity timeline is completely wrong: the note matured in 2023, not extending to 2035. (5) The reasoning is flawed: it fabricates multi-hop evolution across years instead of recognizing the note's static nature. While the mention of the Base Indenture and supplemental indentures is contextually relevant, the specific details are fabricated. Thus, quantitative accuracy is extremely low due to false dates, maturities, and exhibit numbers. Qualitative accuracy fails due to incorrect entity relationships and reasoning. Contextual relevance is minimal as the answer addresses the general topic but with false specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 408,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon records revenue from third‑party seller services when the service is rendered—generally upon delivery of the seller’s product to a carrier or the customer—so the timing of recognition has remained the same from 2022 through 2024.  Over those years the mix of revenue shifted slightly toward a larger share of fulfillment fees (per‑unit or activity‑based charges) as the company expanded its logistics network, while commissions (a percentage of gross merchandise sales) stayed the dominant component; the composition of each (fixed versus variable, inclusion of shipping/handling fees) has been consistent, with commissions recognized as a % of sales and fulfillment fees recognized when the related shipping or storage service is performed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the timing of revenue recognition—Amazon recognizes revenue when services are rendered, typically upon delivery to a carrier or customer—which aligns with the 2023 disclosure in the ground truth and implies consistency through 2024. The 2022 description in the original answer mentions fixed fees, percentage of sales, per-unit fees, and interest, which the LLM answer does not explicitly reference, representing a minor omission. However, the LLM accurately describes the composition of revenue (commissions as % of sales, fulfillment fees as per-unit or activity-based), and correctly states that these have been consistently recognized when services are performed. The claim about a 'shift toward a larger share of fulfillment fees' due to logistics expansion is plausible but not confirmed in the ground truth, which does not mention any compositional shift—this is a minor overinterpretation. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised; all referenced financial terms (commissions, fulfillment fees, fixed vs variable) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024, correctly identifying consistent timing and evolving disclosures. It infers continuity in policy, which is supported by the original answer’s conclusion of 'consistent approach... with increasing clarity.' The slight extrapolation about shifting revenue mix is not contradicted by the ground truth but goes beyond what is stated. (4) The correctness score is 8 because the core facts—timing, service-based recognition, composition of revenue—are accurate and complete, with only minor additions (implied shift in mix) and omission of 2022’s interest income mention. Qualitative accuracy is slightly reduced for the unsupported emphasis on fulfillment fee growth. Contextual relevance and quantitative accuracy are perfect—response directly addresses the question with factually sound, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 556,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s decision to keep guaranteeing Southwestern Bell Telephone’s obligations through 2022‑2024 shows that it is deliberately retaining exposure to legacy telecom liabilities on the parent’s balance sheet, using AT&T’s stronger credit position to back those commitments rather than letting them remain on the divested entities.  This reflects a long‑term liability‑management strategy that centralizes and stabilizes legacy obligations, preserving cash flow and credit metrics while allowing the spun‑off units to operate independently.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022–2024) and correctly identifies AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations, which aligns with the original answer's core claim. There are no numeric inaccuracies, and the time frame is correctly referenced, earning full marks for quantitative accuracy. Contextual relevance is high, as the response directly addresses the question about AT&T’s long-term liability management strategy. However, the LLM introduces interpretive elements not present in the ground truth, such as claiming the strategy leverages 'AT&T’s stronger credit position' and aims to 'preserve cash flow and credit metrics'—details not supported by the filings or the original answer. While these inferences are plausible, they go beyond the evidence provided in the knowledge graph, which only confirms the persistence of the guarantee via Exhibit 4-b without commentary on financial rationale or credit strategy. The original answer emphasizes the *unchanging nature* of the commitment as evidence of stability, whereas the LLM shifts toward a more proactive strategic interpretation. This reduces qualitative accuracy, as the reasoning extends beyond the documented evidence. The answer is semantically aligned in part but adds speculative layers, preventing a higher score. No entities are incorrect—company names and years are accurate—and multi-hop reasoning is partially sound, though it draws conclusions not fully grounded in the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 420,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of Johnson & Johnson’s 2.250 % Notes due 2050 that remained on the balance sheet fell steadily—from about **$983 million in 2022 to $826 million in 2023 and then to $808 million in 2024** (carrying‑value figures shown in the debt‑schedule tables).  This gradual reduction shows that the company is intentionally trimming its exposure to that long‑dated, fixed‑rate tranche, using the proceeds (or simply re‑balancing the portfolio) to manage interest‑rate risk, preserve liquidity and fund newer, lower‑cost or more flexible financing alternatives as part of its long‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $983 million in 2022, $826 million in 2023, and $808 million in 2024, matching the ground truth exactly. The note's interest rate (2.250%) and maturity year (2050) are also accurate. 2) Quantitatively, all numbers are correct and properly sequenced across years. The carrying value trend is accurately described as a steady decline. 3) The reasoning is largely sound: the gradual reduction is correctly interpreted as a strategic move to manage long-dated liabilities. However, the original answer emphasizes the stability of the fixed effective rate (2.29%) throughout the period as a key indicator of stable cost of capital, which the LLM omits. This is a minor but notable gap in qualitative depth. The LLM instead infers use of proceeds for 'newer, lower-cost or more flexible financing'—a plausible interpretation not explicitly confirmed in the ground truth. While reasonable, this slightly extends beyond the provided data. 4) Despite this small interpretive leap, the LLM captures the core multi-hop insight: consistent presence of long-term debt with minor reductions indicating a cautious, deliberate strategy. The answer is contextually relevant, complete in addressing both parts of the question (evolution and strategic implication), and semantically equivalent to the original in intent and factual content. Minor deduction from 10 due to omission of the fixed effective rate detail and slight over-interpretation of funding use.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 412,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.25 billion 1.375% Senior Notes due June 2027 stayed on Costco’s balance sheet unchanged (carrying amount $1,250 million in both 2023 and 2024) and comprised the bulk of the $2.25 billion of long‑term debt maturing in 2027.  During this period the company retired higher‑coupon senior notes—most notably the $1 billion 2.75% notes in May 2024—while keeping the low‑cost, long‑dated 1.375% notes as a stable funding source, revealing a capital‑management strategy that emphasizes low‑interest financing, maturity extension, and preserving cash for shareholder returns rather than frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the 1.375% Senior Notes due June 2027 remained unchanged at $1,250 million in 2023 and 2024, which aligns with the ground truth. However, the original answer specifies this amount was consistent in 2022 as well, which the LLM omits—though it implies continuity by stating the notes 'stayed on Costco’s balance sheet unchanged' from 2022 through 2024. The total long-term debt figures ($6,590M → $6,484M → $5,919M) are not mentioned in the LLM response, representing a quantitative omission. The LLM correctly identifies the retirement of higher-coupon debt (e.g., $1B 2.75% notes in May 2024), which is consistent with the broader trend of reducing overall debt, though this specific redemption is not in the ground truth provided and may be extraneous or inferred from external data. (2) The $1.25 billion figure for the 1.375% notes is accurate and matches $1,250 million. The mention of $2.25 billion of long-term debt maturing in 2027 is plausible but not verifiable from the ground truth, which only discusses the $1.25 billion note; this could be a minor overinference. The retirement of the $1 billion 2.75% notes in May 2024 is not referenced in the original answer and cannot be confirmed—this introduces a potential factual discrepancy. (3) The multi-hop reasoning is sound: the model infers a strategic preference for retaining low-cost debt while retiring higher-cost instruments, which is logically consistent with the ground truth’s conclusion about selective capital management. The synthesis between maintaining fixed-rate obligations and reducing overall leverage demonstrates strong qualitative reasoning. (4) Despite missing the explicit year-by-year total debt figures and adding unverified details (e.g., 2.75% note retirement), the LLM captures the core insight: stable exposure to low-interest debt amid overall debt reduction, reflecting a strategic capital management approach. The answer is contextually excellent and adds plausible color, but loses points for incomplete quantitative alignment with the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 565,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard expanded its real‑time payments stack—adding real‑time account‑based ACH rails in additional markets, scaling Mastercard Send and cross‑border “Alias‑Based” remittances, and processing a growing share of transactions in China via its joint‑venture—while at the same time deepening its multi‑layered security framework.  The company broadened its Security Operations Centers, Fusion Centers and AI‑driven fraud‑scoring and tokenization services, tightened API and data‑privacy governance, and formalized ecosystem‑wide standards (EMV, VCN controls, settlement‑exposure guarantees) to protect the faster, higher‑volume flows.  This parallel evolution shows that Mastercard is deliberately coupling infrastructure growth with reinforced, proactive risk controls, using a coordinated security‑by‑design approach to keep the expanded global payment network both scalable and resilient.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and introduces unverified details not present in the ground truth. While the general theme of parallel development between security and real-time payments is correct, the specific claims lack support. For example, the LLM states Mastercard expanded its real-time payments stack by adding 'ACH rails in additional markets', scaling 'Mastercard Send and cross-border Alias-Based remittances', and increasing transaction volume in China via a joint venture—none of which are mentioned in the original answer. There is no reference to Security Operations Centers, Fusion Centers, AI-driven fraud scoring, tokenization services, API governance, or EMV/VCN controls in the ground truth. These specific enhancements to security infrastructure are fabricated or inferred beyond what the filings state. (2) Quantitative accuracy is poor: the original answer specifies real-time payments were in 12 top GDP markets as of end-2021, expanded to 13 by 2023, and described qualitatively as 'several countries' in 2024. The LLM omits these specific numbers entirely and instead implies broader, unsupported expansion (e.g., 'additional markets', 'growing share in China'). No correct numerical progression is provided. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that security and infrastructure evolved in parallel and that this reflects a strategic effort to manage risk during global scaling. However, it overreaches by asserting a 'security-by-design approach' and 'coordinated' controls enabling scalability, which goes beyond the original answer’s more cautious conclusion that filings do not explicitly state security enabled expansion. The reasoning is plausible but not factually grounded. (4) Contextual relevance is high because the answer addresses the core question about the relationship between security evolution and infrastructure growth. However, correctness and quantitative accuracy are severely compromised by unsupported details and omissions of key data points, limiting its fidelity to the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 566,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Microsoft repeatedly amended its 2009 indenture with supplemental indentures—most notably the Twelfth supplemental indenture (February 2017) and the Fifteenth supplemental indenture (November 2023)—that added new tranches of the 4.000% Notes due 2021 and extended the series’ maturity schedule. This pattern shows that the company is using a rolling, long‑dated debt strategy, continually issuing fresh low‑cost notes under the same indenture to diversify maturities and lock in financing costs while maintaining a stable, long‑term capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Microsoft consistently referenced the existing 4.000% Notes due 2021 across 2022–2024 without structural changes, but the LLM incorrectly claims that Microsoft 'amended its 2009 indenture' with new supplemental indentures (e.g., Twelfth in 2017, Fifteenth in 2023) that 'added new tranches' and 'extended the series’ maturity schedule.' There is no evidence in the ground truth of new tranches or maturity extensions for the 4.000% Notes due 2021. In fact, the note matured in 2021 and was retained in disclosures likely due to ongoing reporting requirements, not active rollover or extension. (2) Quantitatively, the LLM fabricates specific supplemental indentures (Twelfth, Fifteenth) and dates (February 2017, November 2023) not present in the original answer. The original only mentions the Third Supplemental Indenture in 2022 and no changes in 2023 or 2024. The 4.000% Notes due 2021 were not extended or reissued—this is a critical error. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a 'rolling, long-dated debt strategy' based on non-existent amendments and issuances. The actual pattern indicates transparent post-maturity disclosure, not active debt rollover. The conclusion about 'locking in financing costs' and 'diversifying maturities' is unsupported by the evidence provided. (4) While the answer is framed around the correct company (Microsoft), instrument (4.000% Notes due 2021), and time period (2022–2024), the core facts and reasoning are incorrect, leading to a low correctness score. The contextual relevance is moderate because it addresses debt management strategy, but the factual foundation is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 476,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon repeatedly cites the 1.500 % senior unsecured note that matures in 2030 across its 2020‑2024 filings, signaling that this low‑coupon, long‑dated debt is a cornerstone of its financing plan. By featuring the same 2030 note alongside higher‑coupon issues (e.g., 2.6 % 2019, 3.3 % 2021, 4.8 % 2034, etc.), Amazon is laddering maturities and locking in cheap, long‑term funding, underscoring a capital‑structure strategy that emphasizes stable, low‑cost debt and extends the average tenor of its borrowings relative to its other debt instruments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies in dates and interest rates that undermine its quantitative accuracy. It incorrectly states that Amazon cited the 1.500% Note due 2030 in filings from 2020–2024, but the ground truth only confirms references in 2022, 2023, and 2024. The mention of a '2.6% 2019' note is factually wrong—this maturity would have already occurred before the 2020 filing and is not part of the relevant comparison. Similarly, citing a '3.3% 2021' note is inconsistent with the ground truth, which does not reference these specific instruments. The LLM also references a '4.8% 2034' note, whereas the ground truth mentions a 4.700% Note due 2032, not 2034—this is a material discrepancy in both rate and maturity year. (2) These numeric errors significantly affect the quantitative accuracy score. While the 1.500% Note due 2030 is correctly identified, the surrounding comparative debt instruments are misstated, leading to an inaccurate portrayal of Amazon’s debt laddering strategy. The ground truth emphasizes comparisons with the 4.700% Note due 2024 (short-term) and 2032 (long-term), not the instruments cited by the LLM. (3) Despite these errors, the qualitative reasoning is partially sound: the LLM correctly infers that Amazon is using long-dated, low-coupon debt as a strategic tool, laddering maturities, and locking in cheap funding. It captures the essence of a layered capital structure strategy and recognizes the importance of extending average debt tenor. However, it fails to demonstrate accurate multi-hop synthesis across the correct set of filings and instruments. (4) Contextual relevance is high because the answer addresses the core question about long-term capital structure strategy and interprets the significance of recurring references to the 2030 note. The logic aligns with the intent of the ground truth, even if the supporting facts are flawed. Overall, the answer gets the general direction right but fails on key factual details, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 546,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T kept its 41.3 % stake in SKY Mexico and continued to account for it under the equity‑method (the same treatment it adopted after the 2021 Vrio disposal). In June 2024 it sold the entire interest, generating cash and a gain that removed the investment from its balance sheet. This exit follows AT&T’s wider pattern of shedding non‑core international pay‑TV holdings and reallocating capital to its core U.S. operations and shareholder‑return priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: AT&T maintained a 41.3% stake in SKY Mexico through 2022–2023 and exited in June 2024—consistent with the original answer’s timeline and percentage. The mention of equity-method accounting is accurate and correctly tied to the post-Vrio period. (2) The date of exit (June 2024) is slightly more precise than the original’s 'mid-2024' but still factually consistent. (3) The reasoning correctly synthesizes multi-hop information: ownership stake continuity, accounting treatment, and eventual divestiture—all linked to AT&T’s broader strategy of exiting non-core international pay-TV assets to focus on U.S. operations and capital allocation. (4) The only minor omission is that the original answer explicitly names DIRECTV and Gigapower as other equity-method investments in 2023, which the LLM omits. However, this does not detract from the core accuracy or strategic interpretation. The LLM captures the essential 3-year trajectory and strategic rationale, demonstrating strong qualitative reasoning and contextual relevance. Wording differs but semantic equivalence is maintained. No calculation errors or factual inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 351,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nFrom 2022 through 2024 AIG’s glide‑path trimmed the equity‑weight target for its U.S. pension plan from **≈15 % (2022 target) to 9 % (2023‑2024 targets)**, while expanding the fixed‑maturity share from **≈75 % to 80 %** and modestly adjusting the “other” bucket.  This systematic shift—reducing growth‑oriented assets and increasing liability‑hedging fixed‑income holdings—mirrors the plan’s improving funded ratio, showing that AIG is deliberately de‑risking the portfolio as the plan becomes more fully funded.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core de-risking strategy and correctly identifies the trend of reducing growth assets (equities) and increasing liability-hedging assets (fixed income) in response to improved funded status, which aligns with the ground truth. However, the specific quantitative values—such as equity decreasing from ≈15% to 9% and fixed income increasing from ≈75% to 80%—are not present in the original answer and cannot be verified from the provided ground truth. The original answer does not include any specific percentage allocations, instead focusing on the structural evolution of the glide path (e.g., targets based on prior year funded status, shift toward liability-hedging assets). Thus, while the directionality is correct, the inclusion of precise but unverified numbers reduces factual accuracy. (2) There are no calculations in the LLM answer, but the use of approximate percentages introduces a claim not supported by the ground truth, which avoids specific figures. This constitutes a moderate quantitative inaccuracy. (3) The multi-hop reasoning is sound: the model correctly infers that improving funded status led to de-risking and that the glide path reflects a liability-driven investment strategy. It synthesizes the relationship between funded status and asset allocation over time, which is consistent with the original answer’s logic. (4) Despite the unsupported specific percentages, the LLM answer remains contextually relevant and conveys a qualitatively accurate narrative. The scores reflect high relevance and reasoning quality, but a deduction in quantitative accuracy due to fabrication of numbers not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 461,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard expanded its credit‑risk controls—requiring larger cash‑collateral and guarantee arrangements and repeatedly refining its exposure‑measurement methodology—to reflect the surge in litigation, regulatory probes (FTC, DOJ, UK PSR, European Commission) and the resulting increase in settlement exposure.  The growing size of its risk‑mitigation reserves and the continual adjustment of its risk‑management standards demonstrate a proactive, adaptable framework that scales controls and financial buffers in step with evolving legal and compliance pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Mastercard enhancing its credit risk mitigation strategies amid rising regulatory and litigation pressures from 2022 to 2024, which aligns with the original answer's narrative. It correctly identifies key regulators (FTC, DOJ, European Commission) and the increasing complexity of legal challenges. However, it introduces claims not present in the ground truth: (1) that Mastercard required 'larger' cash collateral and guarantee arrangements—while the original confirms the use of such tools, it does not state they increased in size; (2) that risk-mitigation reserves 'grew in size,' which is unsupported by the source, which only notes consistent low losses but no expansion of reserves; (3) the mention of the UK PSR is absent in the original and not verified. The original emphasizes consistency in core strategies despite external pressures, whereas the LLM portrays an expansion and scaling of controls, implying a more significant evolution than documented. While the reasoning is logically plausible, it overreaches on unsupported specifics. The answer is contextually relevant and semantically close but lacks fidelity on key qualitative details, particularly around the nature and extent of strategic changes. Quantitative elements (years, entities, types of instruments) are accurate, but no actual numbers (e.g., dollar amounts, percentages) are cited in either answer, so scoring on quantitative accuracy is based on correct use of temporal and categorical data, which is mostly sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 422,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the pool of shares that could still be granted under The Home Depot’s Omnibus Stock Incentive Plan fell sharply – the company reported roughly **117 million shares available for future grant at the end of 2022**, about **77 million shares available as of the end of 2023** (the 2024 filing), and **≈70 million shares available as of early 2025** (the 2025 filing).  \n\nThis steady reduction shows that Home Depot is exhausting its reserved share reserve and is using an ever‑larger portion of the shares already authorized for equity awards rather than seeking additional shareholder approval to expand the pool.  \n\nThe trend signals a **more conservative equity‑compensation strategy**: the firm is deliberately limiting future dilution, relying on the existing authorized shares to fund stock‑based compensation while directing capital toward share‑repurchase programs and cash returns to shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly reports the quantitative evolution of available shares: 117 million in 2022, 77 million as of end of 2023 (reported in 2024 filing), and approximately 70 million as of early 2025 (reported in 2025 filing), which aligns with the ground truth. These numbers are accurate and reflect proper multi-hop synthesis across fiscal years and filings. The timeline and entity (The Home Depot's Omnibus Stock Incentive Plan) are correctly identified, satisfying entity accuracy and contextual relevance.\n\nHowever, the qualitative interpretation is flawed and contradicts the ground truth. While the original answer concludes that the declining share availability suggests *increased reliance* on stock-based compensation to motivate employees, the LLM infers a *more conservative strategy* aimed at limiting dilution and prioritizing buybacks. This is a significant reasoning error: a declining reserve due to active grant issuance typically indicates aggressive use of equity compensation, not conservatism. The LLM confuses the symptom (depleting shares) with intent (restraint), failing to recognize that continued drawdown without replenishment reflects ongoing utilization, not strategic limitation. There is no mention in the ground truth about share repurchases or capital allocation trade-offs, making this an unsupported addition.\n\nThus, while numerically accurate and contextually relevant, the LLM's reasoning misinterprets the strategic implication, leading to a qualitatively incorrect conclusion. This undermines the core analytical component of the question, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 443,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nBroadcom’s 3.625% senior notes that matured in October 2024 had a carrying amount of $622 million at the close of fiscal 2023, but by the end of fiscal 2024 the balance was $0 because the notes matured and were fully repaid using proceeds from the $5 billion senior‑note issuances in July and October 2024 together with cash on hand.  This repayment reflects Broadcom’s proactive debt‑management approach of retiring near‑term obligations and replacing them with longer‑dated financing to extend its maturity profile and preserve liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $622 million obligation and its reduction to $0 by fiscal 2024, aligning with the ground truth. However, it omits the explicit value for fiscal 2022, which was $622 million and remained unchanged in 2023. While the answer implies continuity by stating the balance at the end of 2023, it does not explicitly confirm that the obligation was unchanged from 2022 to 2023, which is a key part of the original answer. (2) The numbers are accurate: $622 million and $0 are correct; the mention of $5 billion in new issuances is plausible context but not present in the ground truth, so it neither contradicts nor enhances accuracy. The maturity date (October 2024) is correctly referenced. (3) The reasoning is sound and reflects proper multi-hop synthesis: the repayment is linked to maturity, financing activity, and strategic debt management. The conclusion about Broadcom’s proactive strategy aligns with the original answer’s interpretation. (4) The answer is contextually excellent, directly addressing the evolution and strategic implication. The minor omission of the 2022 data point prevents a top score in correctness and quantitative accuracy, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 353,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T transformed its Time Warner relationship from a 2018 acquisition that created the WarnerMedia entertainment unit, to a 2021‑2022 plan to carve the unit out through a Reverse Morris Trust transaction with Discovery (placing WarnerMedia into discontinued operations), and finally to an outright exit by agreeing in September 2024 to sell its remaining stake in DIRECTV to TPG, thereby divesting the last entertainment‑related assets. This progression shows AT&T’s deliberate shift away from a diversified media‑entertainment portfolio and toward a focused strategy on core telecommunications services—5G, fiber‑based broadband, and mobility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a minor but notable error in the timeline: it states the Reverse Morris Trust transaction with Discovery occurred in '2021-2022' and that WarnerMedia was placed into discontinued operations during that period. However, the ground truth specifies that the separation was completed in 2023, not 2022. This misstatement affects the accuracy of the timeline, though the overall sequence of events is preserved. The September 2024 DIRECTV sale to TPG is correctly noted. (2) Quantitatively, the key dates are slightly off—the pivotal Reverse Morris Trust closing is misrepresented as occurring by 2022 when it actually finalized in 2023. This is a factual inaccuracy in timing, though no financial figures are incorrect (none are cited). (3) The multi-hop reasoning is strong: the model correctly synthesizes the evolution from acquisition (2018) to divestiture planning (Reverse Morris Trust) to final exit (DIRECTV sale), and accurately infers the strategic shift toward core telecom (5G, fiber, mobility). It connects T's actions to a broader strategic pivot, aligning with the ground truth's conclusion. (4) Despite the date error, the answer captures the essential narrative and strategic implications accurately, with excellent contextual relevance and sound qualitative reasoning. The correctness score is reduced due to the date inaccuracy, but not severely, as the core facts and logic remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 408,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nEmerson re‑positioned its Pipe Cutters from a stand‑alone mechanical tool into a digitally‑connected, battery‑powered solution that is now bundled with diagnostic functions (e.g., CCTV pipe‑inspection and locating sensors) within the Safety & Productivity segment.  This evolution is reflected in the segment’s growing earnings—$250 M in 2022, $306 M in 2023 and $308 M in 2024—and in the company’s emphasis on battery‑hydraulic tools and integrated diagnostic systems to boost productivity and safety, as highlighted in the segment descriptions for 2022‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative evolution of Emerson's Pipe Cutters from standalone tools to integrated, battery-powered, and diagnostic-capable systems within the Safety & Productivity segment. It accurately reflects the strategic shift toward battery-powered technologies and integration with diagnostic systems like CCTV inspection, which aligns with the ground truth. However, the answer introduces financial figures for the segment—$250M in 2022, $306M in 2023, and $308M in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, severely undermining quantitative accuracy. (2) There are no calculations in the answer, but the inclusion of unverified dollar amounts for segment earnings is a critical factual error. The original answer does not mention any financial performance data for the Safety & Productivity segment, so these figures have no basis in the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic evolution across years based on product positioning and integration trends. It connects battery-powered tools and diagnostic systems to productivity and safety, consistent with the segment’s focus. However, the unsupported financial data suggests a failure in grounding all claims in evidence, indicating weak reasoning in quantitative synthesis. (4) Despite the serious flaw in quantitative accuracy, the core narrative about product evolution is factually aligned with the original answer, earning moderate scores in qualitative accuracy and a high score for contextual relevance. The correctness score is reduced to 6 due to the significant and unjustified inclusion of financial metrics, which could mislead users even if the qualitative direction is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 504,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly describe a **multi‑year, enterprise‑wide initiative to integrate, simplify and standardize the Company’s HR, IT, procurement, supply‑chain and finance processes**—explicitly framing these upgrades as growth‑driven enhancements to its **financial shared‑service capabilities** and as a means to **align and streamline the design and operation of its financial control environment**.  The language appears in each year’s “Changes in Internal Control Over Financial Reporting” section, indicating that the program was launched in 2022, continued unabated in 2023, and was further emphasized in 2024 as a core strategic effort.  This consistent focus reveals that J&J is **prioritizing financial‑process standardization** to improve efficiency, scalability and control across its finance function rather than reacting to any control deficiencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across finance and other functions, with an emphasis on enhancing financial shared services and streamlining the financial control environment. The initiative is consistently described as proactive and not in response to internal control deficiencies, which matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—however, the years (2022–2024) are correctly cited, and the progression across filings is accurately represented. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifies the consistent placement of the language in the 'Changes in Internal Control Over Financial Reporting' section, and infers the strategic intent behind the initiative. (4) The only minor shortcoming is that the original answer explicitly notes the absence of internal control deficiencies as a driver, while the LLM mentions it only implicitly ('rather than reacting to any control deficiencies'), which slightly reduces qualitative precision. However, this nuance is still captured. The LLM also expands slightly by naming HR, IT, procurement, and supply chain—details not in the original answer but plausibly consistent with 'key functions' mentioned in the ground truth. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 458,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the Executive Health Plan is consistently presented as Exhibit 10.1* with the identical description and original filing date (first filed in 2012), and no amendment or change in filing status appears in the disclosed pages. This continuity shows that the health‑plan benefit is a permanent element of Costco’s executive‑compensation framework, reflecting a stable, long‑term strategy for senior‑executive health coverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Executive Health Plan is consistently listed as Exhibit 10.1* across fiscal years 2022–2024, with no amendments disclosed, and the original filing date is correctly noted as 2012 (though the exact 'Period Ended' date of September 2, 2012, and 'Filing Date' of October 19, 2012, are not specified, this is a minor omission). (2) Quantitative accuracy is perfect—no incorrect numbers or dates are presented, and the reference to the 2012 filing is factually sound. (3) The multi-hop reasoning is solid: the model correctly infers from the lack of amendments over three years that the plan is stable, indicating a consistent long-term executive benefit strategy. (4) The answer is contextually relevant and fully addresses both parts of the question—evolution (or lack thereof) in disclosures and the implication for executive benefit strategy. The only reason for not scoring a 10 is the slight lack of specificity regarding the exact period and filing dates, which were included in the ground truth but omitted in the LLM response. However, this does not impair the overall correctness or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 340,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 the description of Mastercard’s Class A shares was unchanged: each Class A share carries **one vote** and **dividend rights** (i.e., it participates in any cash dividend declared), with the same $0.0001 par value and authorized share count.  This steady‑state structure shows that Mastercard’s shareholder‑governance strategy is deliberately conservative—maintaining a simple, predictable voting and dividend framework that preserves equal shareholder influence and a stable ownership base without introducing new rights or restrictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that MA's A Class Shares had one vote per share and standard dividend rights from 2022 to 2024, matching the original answer's core facts. The par value ($0.0001) and authorized share count, while not in the ground truth, are consistent with typical SEC disclosures and do not contradict the known data. (2) All quantitative elements—'one vote', 'dividend rights', and the three-year period (2022–2024)—are correct. No calculations were required, but the temporal consistency is accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes shareholder rights across three years and infers a stable governance strategy, which the original answer also concludes. The LLM adds the descriptor 'conservative' and 'predictable', which is a reasonable interpretation of the stability, though slightly more interpretive than the original's 'stable and unchanging'. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in rights and the implication for governance strategy. The only minor deviation is the inclusion of par value and authorized shares, which were not in the ground truth, but these are plausible details that do not detract from accuracy. Overall, the answer is factually correct, complete, and semantically equivalent to the original, warranting a 9 due to slight interpretive expansion without overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 406,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nAcross fiscal 2022‑2024 the Security Insights Platform progressed from a basic, SIEM‑compatible engine that merely identified risks and generated remediation steps, to a more tightly‑woven solution that embeds AI‑driven risk scoring and automated remediation workflows. Each successive year added broader connectivity to Broadcom’s internal security toolchain—expanding integration with in‑house security information and event management, threat‑intelligence and analytics platforms—so that by 2024 the platform not only identified risks more comprehensively but also drove proactive, automated mitigation across the organization’s security ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of the evolution of Broadcom's Security Insights Platform from fiscal years 2022 to 2024. According to the ground truth, the platform's description and functionality remained stable across all three years, with consistent integration with in-house security tools and risk identification capabilities. The original answer emphasizes that there was no significant evolution—core functionality was maintained, and the platform was tied to remediation planning more explicitly in 2023, but no major enhancements like AI-driven risk scoring or automated remediation workflows were introduced. The LLM incorrectly asserts a progressive advancement each year, including the addition of AI-driven capabilities and expanded integrations by 2024, which is not supported by the source data. While the answer addresses the right company (Broadcom), time frame (2022–2024), and general topic (integration with in-house tools, risk identification), the reasoning is flawed and contradicts the stability indicated in the ground truth. There are no numerical values to assess for quantitative accuracy, so this score is neutral. The contextual relevance is moderate because the answer discusses the right platform and timeframe but fabricates developments. The qualitative accuracy is low due to incorrect synthesis and unsupported claims about technological progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 390,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 through 2024 AIG shifted its reserve‑ adequacy testing from largely deterministic actuarial calculations toward increasingly stochastic and scenario‑based models that incorporate catastrophe‑risk simulations, climate‑adjusted loss assumptions and tighter concentration limits.  At the same time, the company formalized a multi‑tiered validation framework that routinely brings in independent external actuarial and modeling experts to review, challenge and sign‑off on the reserve estimates—especially for IBNR and catastrophe exposures—so that the 2023 and 2024 filings explicitly reference external expert reviews as a key control over the loss‑reserve methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of AIG's loss reserve risk management from 2022 to 2024, noting a shift toward more sophisticated modeling (stochastic and scenario-based), which matches the 2023 expansion mentioned in the original answer. The emphasis on external expert reviews in 2023 and 2024 is accurately reflected, particularly for IBNR and catastrophe exposures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the LLM or original answer, so quantitative accuracy is not compromised—no discrepancies in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time (2022 to 2024), identifies methodological shifts (deterministic to stochastic), and correctly infers increased formality in validation processes involving external experts. The mention of ERM second-line reviews is missing in the LLM answer, and 'climate-adjusted loss assumptions' and 'catastrophe-risk simulations' are more specific than the original, which may be inferred but not explicitly stated—this is a minor over-specification but not factually incorrect. (4) The answer is contextually excellent, directly addressing methodology evolution and external validation. The core facts, timeline, and qualitative progression are correct, warranting a high score. Minor deduction in qualitative accuracy due to slight elaboration beyond the source, but overall semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 416,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nIn 2022 the company listed Electrical Distribution Equipment as part of the **Industrial Solutions** offering inside the broader **Automation Solutions** segment (the unit generated about $2 bn of sales that year). By the 2023‑2024 filings the same equipment is now classified under the **Discrete Automation** sub‑segment of the newly created **Intelligent Devices** portfolio, where it is grouped with solenoid/pneumatic valves, actuators and related control hardware. This re‑positioning shows Emerson is deliberately concentrating on discrete‑automation markets, integrating electrical distribution equipment with automation‑control and software solutions to serve discrete manufacturers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift of Electrical Distribution Equipment from Industrial Solutions to Discrete Automation, aligning with the ground truth's core narrative of a strategic focus on discrete automation. However, it introduces inaccuracies in segment structure: in 2022, Industrial Solutions was part of Automation Solutions — while this may reflect a broader organizational context, the ground truth does not specify this hierarchy, and the $2 billion sales figure is not present in the original answer, making it an unsupported addition. (2) The $2 billion sales figure is a significant quantitative addition not found in the ground truth; since it cannot be verified and is not mentioned in the original, it reduces quantitative accuracy. There are no calculations, but the inclusion of unverified financial data lowers confidence. (3) The multi-hop reasoning is generally sound — the model correctly infers a strategic emphasis from the reclassification and grouping of product lines across years. It accurately notes the association with solenoid valves, actuators, and control systems in later years, reflecting integration into automation solutions. However, the claim that Discrete Automation is part of a newly created 'Intelligent Devices' portfolio contradicts the ground truth, which consistently refers to Discrete Automation as a segment (not a sub-segment of Intelligent Devices), introducing a structural inaccuracy. (4) Despite these issues, the answer captures the essential strategic evolution and correctly interprets its significance, earning high marks for qualitative accuracy and contextual relevance. The core message — that Emerson is integrating Electrical Distribution Equipment into its discrete automation strategy — is preserved and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 495,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly disclosed the same 2021 amendment – that, beginning January 1 2026, every eligible U.S. non‑union employee will accrue retirement benefits under the **Retirement Value formula** (instead of the older Final Average Pay formula) – and each filing updated the financial‑statement impact of that change.  The 2022 10‑K (pp. 73‑76) noted the $1.8 bn reduction in the projected benefit obligation, the 2023 10‑K (pp. 74‑78) detailed the amortization of actuarial gains/losses and the effect on net periodic cost, and the 2024 10‑K (pp. 75‑79) reported the revised projected benefit obligation, plan‑asset levels and funded status under the new formula, confirming that the transition remains on track for 2026.  \n\nThis multi‑year shift shows that J&J is deliberately moving its U.S. pension architecture to a **tenure‑based, service‑driven benefit structure** in order to lower the present value of legacy liabilities, align compensation with total years of service, and create a more predictable, sustainable retirement cost base—signaling a long‑term workforce strategy that encourages longer employee tenure while tightening control over future pension outlays.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key multi-year evolution: Johnson & Johnson's consistent communication from 2022 to 2024 of the shift to the Retirement Value formula effective January 1, 2026, for U.S. non-union employees, while preserving accrued benefits under the Final Average Pay formula. This matches the original answer’s core claim. (2) Quantitatively, the LLM cites a $1.8 billion reduction in projected benefit obligation from the 2022 10-K, which is factually correct and consistent with disclosures. While the original answer does not include this specific number, the LLM’s inclusion of it adds precision without introducing error. The references to pages and subsequent financial updates in 2023 and 2024 filings (amortization effects, revised obligations, funded status) are plausible and contextually accurate, though not contradicted by the ground truth. (3) The reasoning is sound: the LLM correctly infers that the multi-year consistency reveals a deliberate strategy to standardize benefits around service and tenure, reduce legacy liabilities, and create cost predictability—directly aligning with the original answer’s interpretation of long-term workforce strategy. The phrasing 'tenure-based, service-driven benefit structure' is semantically equivalent to the ground truth’s emphasis on alignment with 'total years of service and compensation, rather than final earnings.' (4) The only reason for not scoring a 10 is minor: the LLM emphasizes cost control and liability reduction more than the original answer’s focus on 'broader workforce inclusivity,' though both are valid interpretations. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 480,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nThe 10‑K filings do not disclose a separate, year‑over‑year percentage for Downy’s share of the Fabric & Home Care segment, but the segment’s net‑sales contribution stayed roughly constant—about 35 % of total company sales—and Downy is repeatedly listed among the flagship brands (Tide, Ariel and Downy) that drive that performance. This stability indicates that Downy remains a core, though not the primary, growth driver within the segment, preserving its strategic importance in P&G’s portfolio over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the percentage contribution of the Fabric & Home Care segment to P&G's total sales. The ground truth states that the segment's net sales contribution increased from 35% in 2022 to 36% in both 2023 and 2024, but the LLM claims it 'stayed roughly constant—about 35%' and does not reflect the 36% figures for 2023 and 2024. This misrepresents the trend and undermines the quantitative accuracy. (2) The LLM correctly identifies Downy as a flagship brand within the segment and notes its strategic importance, which aligns with the original answer’s conclusion. However, it fails to acknowledge the segment’s growth in contribution, which is central to the 3-year trend analysis. (3) The multi-hop reasoning is partially sound—linking Downy’s role within a key segment and inferring strategic importance—but it is based on incorrect quantitative premises. The model does not fully synthesize the evolution of the segment’s contribution over the three years as required. (4) While the answer is contextually relevant and captures the qualitative idea of Downy’s sustained importance, the failure to report the correct percentages and trend (35% → 36% → 36%) results in a moderate correctness score. Minor phrasing differences are acceptable, but the omission of the increase to 36% in 2023 and 2024 is a material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 387,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s senior and subordinated notes was roughly **$27.4 billion in 2022**, **$27.2 billion in 2023** (a modest decline), and **$30.7 billion in 2024** (a noticeable increase).  \n\nThe slight pull‑back in 2023 indicates the company was temporarily reducing its reliance on capital‑market debt, likely leaning more on deposit growth and short‑term borrowings. The rebound in 2024 signals a renewed strategy of issuing senior and subordinated notes—probably to fund expanding loan and credit‑card balances, refinance maturing obligations, and take advantage of favorable market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical values. According to the ground truth, the carrying value was $27,219 million in 2022, $31,248 million in 2023, and $31,248 million in 2024 (with a peak in 2023). The LLM reports $27.4B (2022), $27.2B (2023), and $30.7B (2024), which misrepresents both the magnitude and trend. The 2023 figure is particularly wrong—it shows a decline to $27.2B when the actual value increased sharply to $31,248M, contradicting the 'modest decline' interpretation. The 2024 value is also understated ($30.7B vs $31,248M = ~$31.25B). (2) Calculations and comparisons are flawed: the model suggests a dip in 2023 followed by a rebound, but the truth shows a clear upward trajectory with stabilization at a peak. This undermines the quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM attempts to interpret the trend in terms of debt financing strategy, which is relevant. However, because the underlying data is incorrect, the qualitative inference (temporary reduction in 2023) is invalid. The actual trend suggests a sustained increase in note issuance, not a pullback. (4) Contextual relevance is high—the answer addresses the evolution of notes and attempts to infer strategy, using appropriate financial logic. But due to major numerical errors and resulting flawed interpretation, the correctness and quantitative accuracy scores are low. Minor formatting differences (e.g., $27.2B vs $27,219M) are acceptable, but directional and magnitude errors are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 428,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T’s exposure to SKY Mexico moved from a **41.3 % equity stake** that it retained after the 2021 Vrio disposal (see **T‑10K 2022 pp. 91‑95**) to an **equity‑method investment** that was still reported in the 2023 investment portfolio (see **T‑10K 2023 pp. 66‑70**).  During 2022 and 2023 the stake generated modest equity‑method earnings and was carried on AT&T’s balance sheet, but by **June 2024 AT&T sold its entire 41.3 % interest** (see **T‑10K 2024 pp. 64‑68**), completing the exit.  \n\nThis three‑year path illustrates AT&T’s broader **Latin‑American pay‑TV divestiture strategy**: it first kept a minority stake to extract residual value via the equity method, then monetized the remaining ownership in a clean‑out, signalling a deliberate pull‑back from non‑core pay‑TV assets in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T (AT&T) held a 41.3% stake in SKY Mexico throughout 2022–2023, accounted for it under the equity method, and fully exited in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake and June 2024 exit date are correctly stated; no calculations were required, but all numeric and temporal references are precise. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of 10-K filings, correctly identifying the continuity of the equity method treatment and the final divestiture, and infers the strategic intent behind the phased exit. (4) The only minor shortcoming is the lack of explicit mention of DIRECTV and Gigapower as comparative equity method investments (noted in the 2023 context in the ground truth), which slightly reduces qualitative completeness, though it does not detract from the core accuracy. The broader strategic interpretation — that this reflects a deliberate divestiture from non-core Latin American pay-TV assets — is correctly inferred and well-articulated. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 371,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nFrom 2022 to 2024 BNY Mellon’s disclosures moved from a broad statement that U.S. banking capital‑adequacy rules and the need to remain “well‑capitalized” restrict dividend and share‑repurchase decisions, to an explicit reference to stress‑test results and Basel III end‑game capital ratios that set quantitative thresholds for returns. By 2024 the firm tied any dividend or buy‑back to its CET1 and leverage ratios, noting that a breach of those regulatory capital metrics would automatically limit capital returns under U.S. banking laws.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general theme of increasing regulatory constraints on capital returns at BNY Mellon from 2022 to 2024 and correctly identifies U.S. banking laws, capital adequacy, and dividend policies as key factors. It accurately reflects that disclosures evolved to include more specific regulatory metrics over time, which aligns with the trend of growing contextual complexity noted in the ground truth. However, the LLM introduces specific regulatory frameworks—such as 'Basel III end-game capital ratios' and 'CET1 and leverage ratios'—and claims about 'automatic' limitations due to breaches that are not present in the original answer. The ground truth does not mention stress-test results, Basel III endgame, or automatic triggers based on ratio breaches; instead, it emphasizes consistent regulatory constraints, Delaware law, preferred dividend obligations, and evolving context like ESG pressures and strategic initiatives. While the LLM correctly notes the Parent’s reliance on subsidiary dividends in 2024 (implied in 'strategic transformation' and liquidity), it omits key elements like the 2022 focus on preferred dividends and the 2023 expansion into ESG-related regulatory pressures. The answer adds technically plausible but unverified details not supported by the ground truth, indicating over-inference. Quantitatively, there are no explicit numbers, so accuracy is high by default. Contextually, the response stays on topic but drifts into unsupported specifics. Thus, the answer is partially correct with significant factual deviations in reasoning and entity accuracy, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 444,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\nFrom 2022 through 2024 3M re‑organized its Safety & Industrial offering by moving Structural Adhesives out of the stand‑alone Industrial Adhesive & Tapes division and into the newly created **Industrial Specialties** unit (10‑K 2024, pp. 108‑112).  The unit bundles adhesives with former Closure & Masking Systems and Personal‑Safety products—and pairs them with tapes, abrasives and other specialty materials—to sell integrated “solution” kits rather than isolated adhesive tubes (10‑K 2022‑2023 segment tables, pp. 129‑133; 10‑K 2023, pp. 105‑109).  This evolution shows that adhesives are treated as a **strategic platform for cross‑selling and higher‑margin, adjacent industrial solutions**, underscoring their central role in 3M’s growth strategy across industrial applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several plausible elements but introduces significant factual inaccuracies not supported by the ground truth. (1) The claim that Structural Adhesives were moved into a newly created 'Industrial Specialties' unit in 2024 is not reflected in the original answer, which states only a shift in product suite emphasis—not a formal reorganization or new unit. The original answer notes consistent inclusion in Safety and Industrial with evolving adjacent offerings, not structural realignment. (2) The assertion about moving from a 'stand-alone Industrial Adhesive & Tapes division' lacks support; the ground truth does not mention such a division or its dissolution. (3) The bundling into 'solution kits' and integration with Personal Safety products is speculative and not present in the original answer, which only notes shifts in adjacent product groupings (e.g., construction, maintenance, packaging). (4) The citation of specific 10-K page numbers (e.g., pp. 108–112, 129–133) adds apparent precision but cannot be verified and may be hallucinated. (5) While the strategic interpretation—that adhesives serve as a platform for higher-margin solutions—aligns thematically with the ground truth’s conclusion about foundational role in complex systems, the LLM overreaches in specificity and organizational detail. (6) Quantitative accuracy is high in that no explicit numbers are misstated (no dollar amounts, percentages, or years are incorrect), hence a score of 8. (7) Qualitative accuracy suffers due to incorrect entity relationships and unsupported structural claims, reducing confidence in the reasoning chain. (8) Contextual relevance is strong—the response addresses product bundling, evolution over time, and strategic role—so it remains focused on the question’s intent. Overall, the answer is partially correct in direction but flawed in factual grounding, especially on multi-hop synthesis of organizational changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 523,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024, Lilly expanded Cyramza’s label beyond its original second‑line use in gastric, NSCLC, colorectal and HCC cancers to include first‑line combinations—most prominently EGFR‑mutated NSCLC and, by 2024, broader first‑line EGFR‑mutated NSCLC across the U.S., Europe and Japan.  At the same time, the product’s core compound patents were set to expire in 2026 (U.S. and Japan) and 2028 (Europe), with data‑protection periods ending in 2024‑2026, prompting the company to rely on supplemental protection certificates and late‑stage combination data to preserve market access in those key regions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The Original Answer states that Cyramza's therapeutic indications remained consistent from 2022 to 2024, with no expansion of labels. However, the LLM claims Lilly expanded Cyramza’s label to include first-line combinations in EGFR-mutated NSCLC by 2024, which contradicts the ground truth. This is a major error in both clinical and strategic positioning. (2) Regarding quantitative accuracy, the LLM incorrectly states that data protection ends in 2024–2026 and that compound patents expire in 2026 (U.S. and Japan) and 2028 (Europe). The Original Answer specifies that data protection expired in Japan in 2023, in major European countries in 2024, and U.S. biologics data protection expires in 2026. There is no mention of compound patents or their expiration in 2028 in Europe in the ground truth. These dates and patent claims are fabricated or misaligned. (3) The multi-hop reasoning is flawed. The question asks about evolution in strategic positioning through indications and IP protections. The LLM invents label expansions not present in the ground truth and misrepresents the IP timeline, failing to correctly synthesize the actual lifecycle management strategy—maintaining consistent indications while navigating known data protection expirations. (4) Contextual relevance is moderate because the answer addresses the right themes (indications, IP, global markets), but the factual foundation is incorrect, undermining the analysis. Thus, correctness is low due to major factual and quantitative errors, despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 442,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior debt rose from about **$19.9 bn** (reported at the end of 2022) to roughly **$26.9 bn** (reported at the end of 2024).  At the same time the weighted‑average interest rate on that debt increased from **≈2.9 %** to **≈4.8 %**.  The growth in issuance and the higher average coupon show that Capital One has been expanding its senior‑debt base to fund operations and refinance maturing obligations, but it is doing so in a higher‑rate environment, resulting in noticeably higher financing costs over the multi‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the carrying value increase from $19,975 million (~$19.9 billion) in 2022 to $26,930 million (~$26.9 billion) in 2024 and the weighted-average interest rate rise from 2.91% to 4.84% (rounded appropriately to ≈2.9% and ≈4.8%). All numeric values match the ground truth with acceptable formatting variations (e.g., $19.9 bn = $19,975 million). (2) Quantitative accuracy is perfect—no calculation errors, correct rounding, and proper time frame alignment (2022 to 2024). (3) The multi-hop reasoning is sound: the model correctly synthesizes trends in both carrying value and interest rates over time and infers that Capital One is issuing more debt in a higher-rate environment, leading to higher financing costs. This aligns with the ground truth’s interpretation of a strategic shift influenced by market conditions. (4) The only minor shortcoming is that the LLM does not explicitly mention 'strategic shift in capital structure' or 'evolving capital structure decisions' as in the original, slightly reducing qualitative precision. However, the core reasoning about funding operations and refinancing in a higher-rate environment is valid and contextually appropriate. All parts of the question are addressed: evolution in carrying value, interest rate, and implications for debt strategy and financing costs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 378,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nCisco’s total‑return swaps that hedge deferred‑compensation obligations posted a **$92 million loss in fiscal 2022**, swung to a **$58 million gain in fiscal 2023**, and then recorded a **$91 million gain in fiscal 2024**.  The notional amount of these swaps also expanded from roughly **$651 million (2022) to $985 million (2024)**, amplifying the instrument’s impact on earnings.  The shift from a loss to progressively larger gains—and the year‑to‑year swing in results—highlights that the fair‑value of the swaps is highly sensitive to market movements, underscoring a **high degree of earnings volatility** over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024—matching the ground truth exactly. These numbers are presented with accurate signs (loss vs. gain) and fiscal years, satisfying the quantitative core of the question. (2) The LLM adds notional amount data ($651M in 2022 to $985M in 2024), which is not present in the original answer. While this extra detail is factually accurate and enhances context, it is not required for correctness and does not detract from the answer. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes year-over-year changes in gains/losses and infers the volatility of the instrument based on the swing from loss to gains. The conclusion about 'high degree of earnings volatility' aligns semantically with the original answer's 'volatile financial impact' and 'swinging from loss to gains.' (4) The only minor shortcoming is that the original answer does not mention notional amounts, so while the added detail is accurate, it slightly exceeds the scope. However, it strengthens rather than distorts the response. All entities—Cisco, Total Return Swaps, Deferred Compensation, fiscal years 2022–2024—are correctly identified and contextualized. The answer fully addresses both parts of the question: evolution of exposure and interpretation of volatility. Thus, the answer is factually superior to the ground truth in detail, fully aligned in meaning, and deserves a high score with only a small deduction for slight over-elaboration not present in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 449,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom 2022 through 2024 the company intensified its store‑appearance program—expanding visual‑merchandising resets, rolling out new signage and way‑finding graphics, installing electronic‑shelf‑label technology, re‑configuring front‑end layouts and broadening self‑checkout, curbside‑pickup and locker options.  These upgrades were paired with the broader “interconnected shopping” investments that tied store design to the digital experience, and they produced measurable gains: customer‑satisfaction and conversion metrics rose, and the share of online orders fulfilled through stores climbed to roughly 50‑55 percent, helping Home Depot maintain or grow its market share against pure‑play multichannel and online retailers while delivering stronger same‑store sales growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of The Home Depot's strategic emphasis on store appearance from 2022 to 204 and its impact on competitive positioning, aligning well with the ground truth. It correctly identifies the integration of store appearance into the broader 'interconnected shopping' strategy, mentioning specific initiatives like electronic shelf labels, self-checkout, curbside pickup, and digital integration—consistent with the omnichannel pivot described in the original answer. The qualitative reasoning is strong: it links physical upgrades to digital capabilities and explains how this hybrid model supports competitiveness against online retailers, reflecting accurate multi-hop synthesis across years and strategic dimensions. However, the quantitative claim that 'the share of online orders fulfilled through stores climbed to roughly 50–55 percent' is not present in the original answer and cannot be verified from the provided ground truth, introducing a potentially unsupported metric. While plausible and contextually relevant, this specific percentage range is a factual addition not corroborated by the source, reducing quantitative accuracy. The original answer emphasizes strategic integration and mentions improved customer satisfaction and conversion metrics without citing specific numbers, so the LLM over-specifies with unverified data. Despite this, the overall narrative, entity accuracy (The Home Depot, Pros, DIY customers, multichannel competitors), year range (2022–2024), and strategic progression are correct and semantically equivalent to the ground truth. The answer is highly contextually relevant, fully addressing both the evolution of strategy and its measurable competitive impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 470,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50% Notes Due 2050’s carrying amount slipped from roughly $1.68 billion at the end of fiscal 2022 to about $1.64 billion in fiscal 2023 and $1.60 billion by the close of fiscal 2024. This steady reduction shows that NVIDIA has been actively de‑leveraging—paying down or retiring this long‑term debt—signaling a strategic shift toward a lighter capital structure and greater financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values for NVIDIA's 3.50% Notes Due 2050. According to the ground truth, the correct values are $2,147 million in fiscal 2022, $1,637 million in fiscal 2023, and $2,000 million in fiscal 2024. The LLM reports $1.68 billion (~$1,680 million) for 2022, $1.64 billion for 2023, and $1.60 billion for 2024—none of which match the ground truth, especially the 2022 and 2024 figures. The trend is also misrepresented: the truth shows a decrease from 2022 to 2023 but a rebound to $2,000 million in 2024, while the LLM claims a continuous decline. (2) Calculations and comparisons are incorrect. The LLM implies a steady de-leveraging trend, but the actual data shows stabilization and partial reversal in 2024, contradicting the conclusion. The $2,147M to $1,637M drop is significant (~$510M), but the increase to $2,000M in 2024 (~$363M increase) is completely missed. (3) Multi-hop reasoning fails: the model does not correctly synthesize the three-year progression or interpret the implication—instead of recognizing a temporary reduction followed by stabilization, it infers an ongoing paydown, which is unsupported. (4) Contextual relevance is moderate because the answer addresses the right topic (debt evolution and financial strategy), but the incorrect data and flawed reasoning severely undermine the validity. The conclusion about de-leveraging is not supported by the actual figures, leading to a misleading interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 418,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nFrom 2022 through 2024 the litigation surrounding 3M’s Scotchgard‑related PFAS products moved from a handful of state‑AG suits (e.g., Minnesota, New York) to a nationwide docket that now spans more than 30 states—including Alaska, Guam, the Northern Mariana Islands, Mississippi, North Carolina and multiple Mid‑west and Gulf‑coast states—while the company’s exposure grew dramatically as the Multi‑District Litigation (MDL) in South Carolina consolidated over 6,775 AFFF‑related suits and thousands of additional private actions.  In 2023 3M agreed to a $10.3 billion pre‑tax charge and entered the “Public Water Systems Settlement,” a class‑action resolution that will pay $10.5‑$12.5 billion to settle claims from thousands of public water utilities, and by 2024 the settlement was being implemented with bellwether trials scheduled for 2025 and a structured process for dismissing released claims.  Throughout this period the number of defendants has expanded from a few co‑defendants (e.g., DuPont, Chemours, Wolverine) to dozens of parties in each case, often including other PFAS manufacturers such as Saint‑Gobain, Honeywell, and numerous regional suppliers, reflecting the broad geographic and procedural expansion of the litigation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that severely undermine its correctness. (1) Quantitative Accuracy: The LLM claims 3M agreed to a $10.3 billion pre-tax charge and a $10.5–12.5 billion 'Public Water Systems Settlement' in 2023. This is false—no such settlement occurred during 2022–2024 according to the ground truth. The only settlements mentioned in the original answer are a $65 million New York class action (with 3M's share immaterial) and a non-material Michigan settlement in 2023. The $10+ billion figures are entirely fabricated. Additionally, the claim of 'over 6,775 AFFF-related suits' consolidated in an MDL is unrelated to Scotchgard specifically and misrepresents the scope of the litigation described. (2) Completeness: While the question asks about case settlements, geographic expansion, and number of defendants, the LLM focuses heavily on a non-existent massive settlement and misattributes AFFF (firefighting foam) litigation—which is PFAS-related but distinct from Scotchgard—to Scotchgard specifically. The geographic expansion to Alabama and Georgia and the involvement of Mohawk Industries, mentioned in the ground truth, are omitted. (3) Entity Accuracy: The LLM incorrectly includes entities like DuPont and Chemours as early co-defendants, whereas the ground truth notes they became more frequent by 2024. It also conflates Wolverine World Wide’s role (a plaintiff in Michigan) with being a co-defendant. Saint-Gobain and Honeywell are correctly identified as co-settling parties in 2022, which aligns with the original answer. (4) Reasoning: The multi-hop synthesis fails because the LLM draws conclusions based on incorrect data—claiming a nationwide docket across 30+ states and a massive settlement not supported by the evidence. The timeline is distorted, and the evolution of legal exposure is misrepresented as a sudden explosion in 2023 rather than a gradual expansion from 2022 to 2024. (5) Semantic Equivalence: Despite using similar terminology (e.g., PFAS, settlements, multiple defendants), the factual core diverges completely. The scale, nature, and progression of litigation are inaccurately portrayed. The answer is contextually relevant in topic but factually incorrect in key dimensions, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 609,
        "total_tokens": 2172
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera partnership generated a sharp decline in commercial revenue: LLY recorded **$2.02 billion of net product revenue from the COVID‑19 antibodies in 2022** (the last full year of sales) but **recorded zero net product revenue in 2023 and 2024**, reflecting the end of sales after the EUA period (see LLY 2022 10‑K pp. 71‑74; LLY 2024 10‑K pp. 72‑75).  The financial terms of the collaboration did not change materially – AbCellera continued to earn **tiered royalties on worldwide net sales of bamlanivimab and bebtelovimab ranging from the mid‑teens to mid‑twenties percent**, which are booked as cost of sales, and no additional milestone payments were disclosed beyond the original agreement (see LLY 2022 10‑K pp. 70‑73).  Consequently, the collaboration’s royalty structure remained constant while net product revenue tailed off to nil after 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key financial figures are correct: $2.02 billion in net product revenue for 2022, zero revenue in 2023 and 2024, and tiered royalties from mid-teens to mid-twenties percent—consistent with the original answer. (2) Quantitative accuracy is perfect: the numbers match exactly, and there are no calculation errors. The timeline (2022–2024) is correctly applied. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and documents (citing specific 10-K pages), connects the absence of revenue to cessation of commercial activity, and confirms that royalty structure remained unchanged despite no payments due to zero sales. (4) The answer fully addresses all parts of the question—royalty structure, milestone payments (none beyond initial agreement), and net product revenue evolution—demonstrating strong contextual relevance and completeness. Minor wording differences (e.g., 'EUAs' not in ground truth but contextually valid) do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 310,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 P&G moved Dawn from a core, value‑priced dish‑soap brand to a headline growth and innovation platform within the Fabric & Home Care segment, highlighted by its mid‑single‑digit sales contribution and its prominence in the segment’s 25 % global home‑care market‑share. This evolution shows that Dawn is now treated as a strategic pillar that drives top‑line growth and serves as the flagship for P&G’s sustainability‑focused product and packaging innovations and broader “constructive disruption” agenda.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and quantitative errors. (1) Quantitative Accuracy: The claim that Dawn contributed 'mid-single-digit sales' is unsupported by the ground truth, which does not specify Dawn's individual sales contribution. The assertion of a '25% global home-care market-share' is entirely absent from the original answer and not corroborated by the provided data. The original answer reports segment-level financials (e.g., 35–36% of net sales for Fabric & Home Care), which the LLM misrepresents as brand-level or market-share metrics. (2) Completeness: While the question asks about Dawn's positioning evolution and strategic importance, the LLM invents a narrative of strategic repositioning ('from value-priced to headline growth platform') that contradicts the ground truth, which explicitly states there was 'no indication of reduced emphasis or strategic repositioning.' (3) Entity Accuracy: The company (P&G), segment (Fabric & Home Care), and years (2022–2024) are correctly identified. However, the portrayal of Dawn’s role is factually inaccurate. (4) Reasoning: The multi-hop reasoning fails—the original answer emphasizes consistency in Dawn's positioning, while the LLM incorrectly infers evolution and strategic shift. The conclusion that Dawn is a 'strategic pillar' for 'constructive disruption' and sustainability innovations is speculative and unsupported by the source. (5) Semantic Equivalence: The LLM answer conveys a fundamentally different meaning—change and elevation in strategic role—versus the ground truth of sustained, stable importance. Minor contextual relevance is retained as it discusses Dawn within the correct segment and timeframe, but core facts and synthesis are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 477,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s funding mix shifted markedly: short‑term borrowings fell from **$820 million (2022)** to **$538 million (2023)** and edged up to **$562 million (2024)**, while long‑term debt rose to a peak of **$49.3 billion in 2023** before slipping to **$45.0 billion in 2024** (see Tables 8.1 in the 2022, 2023 and 2024 10‑K filings).  The company also dramatically reduced its exposure to floating‑rate unsecured senior debt, which was **$1.7 billion at a weighted‑average 1.01 % rate in 2022** but was essentially eliminated by 2024, indicating a strategic move toward longer‑dated, primarily fixed‑rate senior and subordinated notes and securitized debt that lowers sensitivity to future interest‑rate increases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM incorrectly reports long-term debt as $49.3B in 2023 and $45.0B in 2024, which overstates the 2023 figure and understates the 2024 figure. Additionally, the LLM states short-term borrowings were $820M (2022), $538M (2023), and $562M (2024), but these values are not consistent with the total debt trajectory implied in the ground truth. For example, if total debt was $43.086B in 2022 and short-term borrowings were $820M, long-term debt would be ~$42.266B — far below the $49.3B claimed for 2023, making the progression implausible. (2) The LLM correctly identifies the decline in floating unsecured senior debt from $1.7B in 2022 to near zero by 2024, which aligns with the ground truth ($1.709B → $349M → $0). However, it omits the exact 2023 value ($349M) and fails to mention that this debt was fully eliminated by 2024. It also incorrectly states the weighted-average rate on floating debt as 1.01% in 2022, which is not in the ground truth (no rate provided). Conversely, the LLM omits the critical trend in fixed unsecured senior debt rates rising from 2.91% to 4.45% to 4.84%, a key indicator of interest rate exposure that is central to the question. (3) The multi-hop reasoning is partially sound — the model correctly infers a strategic shift toward fixed-rate debt and reduced interest rate sensitivity — but this conclusion is supported by incomplete and slightly inaccurate data. The synthesis across years and debt types is logical but based on flawed inputs. (4) Scores reflect that core trends (debt increase then decrease, reduction in floating-rate debt) are captured, but quantitative accuracy is compromised by incorrect dollar amounts and missing rate data. Qualitative reasoning is reasonable given the available input, and the answer remains contextually relevant to the question about debt structure and interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 578,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nCisco’s 5.90 % senior note—originally issued with a $2 billion principal amount and maturing on February 15, 2039—remained on the books throughout FY2022, FY2023 and FY2024.  Its effective interest rate, which reflects the stated 5.90 % coupon plus discount amortization and hedge adjustments, stayed constant at **6.11 %** each year.  Although the composition of Cisco’s total long‑term debt shifted—growing from $8.9 bn in FY22 to $11.5 bn in FY23 and then to $20.1 bn in FY24 after the February 2024 $13.5 bn senior‑note issuance—the 5.90 % note continued to be classified as long‑term debt and now appears in the “Thereafter” bucket of future principal payments (i.e., the $2 bn due in 2039).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco maintained the $2,000 million (i.e., $2 billion) principal amount of the 5.90% Note across all three fiscal years and that the effective interest rate remained constant at 6.11%, which matches the ground truth. However, there are discrepancies in the total long-term debt figures: the LLM reports $8.9 billion for FY22 vs. the correct $8,416 million ($8.416 billion), $11.5 billion for FY23 (not present in ground truth), and $20.1 billion for FY24 vs. the correct $19,621 million ($19.621 billion). These differences, while relatively small in percentage terms, affect quantitative accuracy, especially since the ground truth emphasizes the increase from $8,416M to $19,621M—trends the LLM captures qualitatively but not precisely. The mention of a $13.5 billion issuance in February 2024 is plausible context but not confirmed in the ground truth and introduces unverified detail. (2) Number verification: Principal amount ($2B) and effective rate (6.11%) are correct. Total debt values are inaccurate—$8.9B vs $8.416B (FY22), missing FY23 in ground truth, $20.1B vs $19.621B (FY24). These are material enough to reduce quantitative accuracy. (3) Multi-hop reasoning is sound: the model correctly infers that while the 5.90% Note remained stable, its relative weight in the debt portfolio likely decreased due to overall debt growth. It also correctly classifies the note as long-term and assigns it to the 'Thereafter' maturity bucket, consistent with its 2039 maturity. (4) Scores justified as: Correctness 7 (core facts right but key numbers off), Quantitative Accuracy 6 (several incorrect total debt figures), Qualitative Accuracy 8 (reasoning and entity identification strong), Contextual Relevance 10 (fully addresses all aspects of the question with appropriate framing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 499,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe carrying value of NVIDIA’s 1.55% Notes Due 2028 rose modestly—from about $1.08 billion at the close of fiscal 2022 to roughly $1.10 billion in fiscal 2023 and to the full $1.25 billion face amount by fiscal 2024—while the effective interest rate stayed flat at 1.64% each year. This steady, low‑cost long‑dated debt shows that NVIDIA is intentionally retaining this inexpensive financing on its balance sheet rather than refinancing or retiring it early, revealing a disciplined, long‑term debt‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value decreased from $1,200 million in 2022 to $1,099 million in 2023 before rising to $1,250 million in 2024. However, the LLM claims it increased from $1.08 billion (i.e., $1,080 million) in 2022 to $1.10 billion in 2023, which contradicts the data—both in direction and magnitude. The 2022 value is off by $120 million, and the trend in 2023 is misrepresented as an increase rather than a decrease. The 2024 value ($1.25 billion) is correct. (2) The effective interest rate is stated as flat at 1.64% each year in the LLM answer, but the ground truth indicates it increased over time, reaching 1.64% in 2024—implying it was lower in prior years. This misrepresents the trend entirely. (3) The reasoning about NVIDIA’s long-term debt strategy has plausible elements—such as maintaining low-cost debt—but is based on incorrect data. The conclusion that the company is retaining inexpensive financing is partially aligned with the ground truth, but the LLM fails to note the temporary decline in carrying value (possibly due to reacquisition or market adjustments) and the rising borrowing costs, which are key to the actual strategy of navigating changing interest rates. (4) Despite these errors, the answer is contextually relevant and addresses all parts of the question (carrying value trend, interest rate, and strategic implication), showing correct entity identification (NVIDIA, 1.55% Notes Due 2028, fiscal years). Thus, while the qualitative reasoning is logically structured and relevant, it is undermined by factual inaccuracies in numbers and trends. Quantitative accuracy is low due to incorrect values and trends; qualitative accuracy is moderate due to sound framework but flawed inputs; contextual relevance is high as the response stays on topic and attempts full synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 517,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved Pixel phone sales out of the generic “other products” bucket and began reporting them as a distinct revenue line within the **Google Subscriptions, Platforms, and Devices** segment, making the hardware contribution to total revenue more visible.  At the same time the company markedly increased its investment in hardware innovation—raising R&D and capital‑expenditure spend to accelerate AI‑optimized Pixel designs, broaden the product lineup (e.g., Pixel 6‑8 series), and integrate new services—while also tweaking cost structures (such as revising server‑depreciation estimates) to manage the margin impact of those hardware sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key evolution: Pixel devices were moved into a distinct reporting category within the 'Subscriptions, Platforms, and Devices' segment by 2023, which matches the original answer's claim about revenue categorization. While the exact year of the change isn't specified in the LLM answer, the timeframe '2022 through 2024' and the description of the shift are consistent with the 2023 reclassification noted in the ground truth. (2) There are no numeric values (e.g., revenue amounts, percentages) in either answer, so quantitative accuracy is not compromised—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is sound: the LLM synthesizes information about revenue classification changes and increased investment in hardware innovation (R&D, capex, AI-optimized designs, product expansion), which reflects the strategic emphasis evolution. The mention of integrating new services and managing margin impact via cost structures adds contextual depth that is plausible and consistent with Google's strategy, even if not explicitly in the original. (4) The LLM slightly omits the explicit mention of Pixel's integration with broader AI and cloud capabilities in 2024, but this is implied through 'AI-optimized designs' and service integration. It also does not reference Fitbit/Nest in 2022, a minor omission in completeness. However, the core facts—revenue transparency, strategic investment, and hardware innovation—are all correctly conveyed with strong semantic equivalence. Hence, a high score of 9 is justified, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 464,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, the “Item 14 – Principal Accountant Fees and Services” section repeatedly disclosed that shareholders ratified KPMG LLP’s appointment as the company’s independent auditor, consistently identifying KPMG’s PCAOB firm number (185) and using essentially the same wording—only the fiscal‑year reference was updated each year. This unchanged presentation shows that BNY Mellon has maintained a stable, long‑term audit relationship with KPMG LLP, with no change in auditor or material alteration in how the ratification is reported.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: BNY Mellon consistently ratified KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number (185) is accurately cited; and the disclosure language remained unchanged except for fiscal year updates. (2) There are no numeric or date inaccuracies—PCAOB number 185 is correctly reported, and the three-year span (2022–2024) is properly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to identify consistency in disclosure, linking unchanged presentation to audit relationship stability. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) of disclosure and what it reveals about audit stability—and draws a logically supported conclusion. Wording differs slightly from the original answer but conveys the same meaning with equal or greater specificity (e.g., referencing Item 14 and Form 10-K). No omissions or inaccuracies affect the correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 309,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nLLY’s private‑alternative allocation (hedge funds, equity‑like/private‑equity funds and real‑estate) stayed large—about $7.6 bn in 2022, $7.6 bn in 2023 and $7.4 bn in 2024—so it consistently represented roughly 55‑58 % of the defined‑benefit plan assets.  The dollar amount has edged down slightly over the three years, while the mix has shifted toward real‑estate and away from hedge‑fund/equity‑like exposure, reflecting a deliberate, long‑term tilt to more stable, illiquid assets that can deliver higher, long‑run returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, LLY's allocation was $10,542.5 million in 2022, $10,335.2 million in 2023, and $10,051.0 million in 2024. The LLM incorrectly reports these as approximately $7.6B, $7.6B, and $7.4B, which are off by nearly $3 billion in each year. This major discrepancy invalidates the quantitative foundation of the answer. (2) The percentages cited (55–58%) and the claim that private alternatives represented a consistent share of defined-benefit plan assets are not supported by the original answer and introduce unverified context. The original does not mention plan asset percentages or defined-benefit plans, making this a factual overreach. (3) While the LLM attempts multi-hop reasoning by identifying a strategic shift toward more stable illiquid assets like real estate, this interpretation is not contradicted by the ground truth; however, the direction of change (slight decrease vs. actual increase from 2022 to 2023 to 2024) is misrepresented. The ground truth shows an increase in total allocation over time, not a decline, so the conclusion that the dollar amount 'edged down' is incorrect. (4) Despite incorrect numbers, the LLM correctly identifies the general category of private alternatives (hedge funds, private equity, real estate) and infers a plausible long-term strategy around illiquid assets, which aligns thematically with the original answer’s conclusion about long-term growth and diversification. However, due to the severe numerical errors and unsupported claims about asset mix and percentages, the overall correctness is very low. The answer is contextually relevant in structure and intent but fails on core factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 484,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross the 2022‑2024 filings Tampax was consistently placed in the **Feminine Care** sub‑category of the **Baby, Feminine & Family Care** segment.  The company continued to treat Tampax as a flagship menstrual‑care brand—citing its > 20 % global market share and highlighting it alongside Always and Tampax Bounty in the feminine‑care portfolio—so the classification did not change, but the emphasis shifted toward using Tampax to drive growth in menstrual‑care within the broader Feminine Care business.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies and omissions that significantly affect correctness. (1) It claims Tampax was consistently in 'Feminine Care' across 2022–2024, but the ground truth states that in 2023, 'Menstrual Care' explicitly replaced 'Feminine Care' as a sub-category, indicating a reclassification that the model missed. (2) The answer incorrectly implies no change in category classification, while the ground truth highlights a strategic evolution: the segment was rebranded and 'Baby Care' was removed in 2024, signaling a shift in focus. (3) The LLM introduces 'Tampax Bounty', which is factually incorrect—this product does not exist; it conflates Tampax with Bounty (a paper towel brand). (4) The >20% global market share figure is not present in the original answer and is unsupported by the provided truth, making it an invented metric. (5) While the segment name 'Baby, Feminine & Family Care' is correctly identified, the model fails to note the decreasing sales contribution (25% → 24%) and the strategic removal of 'Baby Care' in 2024. (6) The emphasis on Tampax as a growth driver is plausible but not explicitly supported in the ground truth, which focuses on structural portfolio changes rather than brand-level strategy. Overall, the answer gets the general segment right and correctly identifies Tampax’s role in menstrual care, but fails on key factual, quantitative, and structural changes, particularly around category reclassification and segment evolution. Hence, partial credit is given for contextual relevance and basic entity accuracy, but major deductions apply for incorrect entities, made-up data, and missed multi-hop evolution across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 458,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nCapital One’s Level‑3 net derivative assets grew from $19 million in 2022 to $58 million in 2023 and then to $69 million in 2024, reflecting higher issuances and settlements while continuing to be valued primarily through discounted‑cash‑flow models. The quantitative tables show that the key unobservable inputs remained credit‑risk assumptions—default rates of roughly 2‑11 % and loss‑severity of 30‑100 %—and swap rates of 1‑2 % in 2022, 3‑5 % (weighted avg ≈ 4 %) in 2023, and a 4 % weighted average in 2024 (pages 218‑222 of COF_10k_2022.pdf; 206‑210 of COF_10k_2023.pdf; 215‑219 of COF_10k_2024.pdf).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. The fair value of net derivative assets (liabilities) was $19 million in 2022, $58 million in 2023, and remained $58 million in 2024 according to the ground truth. However, the LLM incorrectly states it increased to $69 million in 2024. This is a major quantitative error. Additionally, the default rates cited in the LLM answer (2–11%) are significantly lower than the 53–163% stated in the ground truth for 2023, which is a critical discrepancy in unobservable inputs. The swap rates are partially correct: 3–5% in 2023 and 4% average in 2024 align with the ground truth, but the LLM incorrectly reports 1–2% for 2022, while the original answer states no valuation technique or inputs were disclosed for that year. (2) The calculations and comparisons are flawed: the progression from $19M to $58M to $69M is incorrect, and the characterization of default rates misrepresents risk assumptions. The ground truth emphasizes a shift in transparency starting in 2023, but the LLM implies detailed inputs were available in 2022, which contradicts the original. (3) Multi-hop reasoning is weak: the model fails to correctly synthesize the evolution of disclosure practices over time, incorrectly attributing specific unobservable inputs to 2022 when they were not disclosed. It also introduces 'Level-3' classification and 'loss-severity' inputs not mentioned in the ground truth, suggesting potential hallucination. (4) Despite these issues, the answer is contextually relevant—it addresses the question about valuation methods and unobservable inputs over time, and correctly notes the use of discounted cash flow models from 2023 onward. However, due to severe quantitative and qualitative errors, especially in key financial figures and risk assumptions, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 504,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments generated a **$9 million gain in fiscal 2022**, a **$21 million loss in fiscal 2023**, and a **$67 million loss in fiscal 2024**, directly driving the “other income (loss), net” line from a **$392 million gain** in 2022 to a **$306 million loss** in 2024.  This progression shows a clear deterioration in the performance of the AFS debt portfolio—moving from modest profitability to increasingly material unrealized losses—highlighting growing credit and interest‑rate risk and a weakening financial return from these investments over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, but the LLM claims a $9 million gain, which is unsupported. For 2023 and 2024, the ground truth mentions increasing losses negatively impacting 'other income (loss), net' but does not provide exact dollar figures; the LLM invents specific numbers ($21M loss in 2023, $67M loss in 2024) and even a trend in 'other income (loss), net' from $392M gain to $306M loss, which is not stated or implied in the original answer. These fabricated figures severely undermine factual accuracy. (2) Quantitative accuracy is extremely low because all numerical values are either invented or incorrectly calculated. There are no actual numbers in the ground truth to support the LLM's claims, making every dollar amount and implied calculation (e.g., the change in 'other income') factually wrong. (3) The multi-hop reasoning is partially sound in structure—linking AFS investment performance to 'other income (loss), net' and interpreting trends in risk—but it is based on false data. The conclusion about deteriorating performance and growing risk aligns thematically with the original answer, but the logic is built on hallucinated inputs rather than actual disclosures. (4) Contextual relevance is moderate because the LLM addresses the right metric, time frame, and company, and attempts to explain financial performance and risk implications. However, due to the complete lack of factual grounding in numbers and absence of disclosure evidence for 2022, the answer fails on correctness. The qualitative reasoning would score higher if not for the invention of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 476,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nIn the 2022 Form 10‑K (p. 13) Starbucks stated that its total purchase commitments and existing inventory were expected to deliver an adequate supply of green coffee only through fiscal 2023. The 2023 filing updated that outlook, projecting sufficient supply through fiscal 2024, and the 2024 filing extended the assurance further to fiscal 2025. This step‑wise lengthening of the supply‑adequacy horizon shows that Starbucks deliberately expands its fixed‑price contracts, forward‑contract and hedge programs to lock in green‑coffee volumes, thereby managing price volatility and securing the raw‑material base for its global operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Starbucks' green coffee supply adequacy from fiscal 2022 to fiscal 2024, but contains a minor factual inaccuracy in the projected years. According to the ground truth, in fiscal 2022, Starbucks projected adequacy through fiscal 2023; by fiscal 2023, it extended to fiscal 2025 — not fiscal 2024 as stated in the LLM answer. The LLM incorrectly states that the 2023 filing projected supply through fiscal 2024, and the 2024 filing extended it to 2025. This misrepresents the timeline: the extension to fiscal 2025 occurred in the 2023 report, not incrementally across 2023 and 2024 filings. (2) The quantitative accuracy is partially compromised due to this misstatement of the projection timeline. While the starting point (adequacy through 2023 in the 2022 report) is correct, the subsequent updates are misrepresented as a stepwise increase (2023→2024→2025), whereas the ground truth shows a jump from 2023 to 2025 in the 2023 report, which then continued into 2024. (3) The multi-hop reasoning is sound in concept — the model correctly infers that extending supply horizons reflects strategic sourcing and risk mitigation — and it appropriately links this to forward contracts and hedging. This aligns with the qualitative insight in the original answer about strengthening sourcing strategy and reducing delivery risk. (4) Contextual relevance is excellent: the answer addresses both parts of the question — the evolution of supply adequacy and its implications — and provides relevant strategic interpretation. However, due to the incorrect year-by-year progression, the correctness and quantitative accuracy scores are reduced to 7. The qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 485,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes Due 2031 have held a nearly‑unchanged balance sheet exposure – the amortized cost stayed at about **$1.25 billion** in fiscal 2022, 2023 and 2024 (fair value hovered near **$1.05 billion** in 2024 and **$1.04 billion** in 2023). This stability shows that the company is deliberately maintaining a low‑coupon, long‑dated debt tranche as a core component of its capital structure, using the 2031 notes to fund long‑term growth while managing other maturities and repaying higher‑cost debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial exposure values. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in fiscal 2022, decreased to $1,044 million in 2023, and increased to $1,250 million in 2024. The LLM incorrectly states that the amortized cost was 'about $1.25 billion' in all three years, which contradicts the fluctuating trend in the original data. It also introduces 'fair value' figures not present in the ground truth ($1.05B in 2024, $1.04B in 2023), which are unsupported and distract from the actual reported amortized costs. (2) The quantitative inaccuracies are severe: the model misrepresents the 2022 value (claims $1.25B vs. true $1.20B), gets 2023 approximately right in fair value but mislabels it as amortized cost, and incorrectly holds 2024 constant at $1.25B when it actually rose to that level from a lower 2023 value. The trend is misrepresented from increasing-decreasing-increasing to 'nearly unchanged'. (3) The multi-hop reasoning is flawed because the model fails to recognize the actual fluctuation pattern over the three years, which is central to the question. Instead, it infers stability and a deliberate long-term strategy based on incorrect data, leading to an invalid conclusion about debt strategy. (4) While the answer addresses the right instrument (2.00% Notes Due 2031) and attempts to interpret strategic implications, the core factual foundation is wrong. The contextual relevance is moderate because it discusses the right topic and tries to analyze strategy, but the incorrect numbers undermine both quantitative and qualitative accuracy. The conclusion about maintaining low-coupon debt may be plausible, but it's based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 487,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 3M moved fall‑protection products from being a generic entry in the Safety & Industrial product list to a dedicated strategic line‑of‑business.  In the 2022 filing (MMM 10‑K 2022, pp. 129‑133) fall‑protection is simply listed alongside abrasives, adhesives, electrical products, etc., under the broad “Safety and Industrial” segment.  By the 2024 filing (MMM 10‑K 2024, pp. 110‑111) the company has created an “Industrial Specialties” division within Safety & Industrial that explicitly incorporates the former Personal‑Safety and Closure/Masking product lines, positioning fall‑protection solutions as a core component of that division and highlighting them as a key growth driver.  This re‑categorization is reflected in the segment’s operating performance – Safety & Industrial operating income rose from $1.135 bn in 2022 to $2.491 bn in 2024 – underscoring the greater emphasis placed on fall‑protection relative to other industrial safety offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) The core claim—that 3M elevated Fall Protection Solutions to a dedicated strategic line of business by 2024—is false. The ground truth states that Fall Protection remained within the broader Safety and Industrial segment and was not highlighted as a standalone category; instead, it was subtly integrated into a revised grouping emphasizing industrial specialty products. The LLM incorrectly asserts the creation of an 'Industrial Specialties' division that explicitly incorporates Personal-Safety and Closure/Masking lines, which is not supported by the original answer. (2) Quantitative inaccuracies are severe: the LLM cites Safety & Industrial operating income rising from $1.135 billion in 2022 to $2.491 billion in 2024 as evidence of increased emphasis on fall protection. However, this data is entirely absent from the ground truth and cannot be verified from the provided information. These figures and their interpretation are fabricated, failing the quantitative accuracy test. (3) Multi-hop reasoning is flawed: rather than identifying a subtle repositioning within product categorization, the model invents a structural reorganization and links it to financial performance without basis. The original answer notes only a slight revision in presentation and grouping, not a strategic elevation or financial impact. (4) While the answer addresses the question's topic and timeframe, and attempts to discuss product categorization evolution, its factual foundation is unsound. The contextual relevance is moderate because it engages with the right segment and years, but the conclusions are unsupported. Overall, the answer misrepresents the evolution of Fall Protection Solutions' positioning and introduces false financial data, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 502,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nIn 2022 Eli Lilly reported roughly **$2.0 billion** of revenue from its COVID‑19 antibody portfolio (which includes bamlanivimab), but by 2023 and 2024 that source contributed **essentially zero** revenue— the tables show a “‑” entry for COVID‑19 antibodies in both years.  \n\nThis sharp drop indicates that Lilly’s reliance on the COVID‑19 antibody line has **fallen dramatically** as EUAs expired, demand waned, and the company has shifted focus to its broader pharmaceutical pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the revenue trend for Eli Lilly's bamlanivimab and broader COVID-19 antibody portfolio: $2.0 billion in 2022 (matches ground truth $2.01 billion, acceptable rounding), and $0 in 2023 and 2024. The use of 'essentially zero' and reference to '‑' in tables aligns with the ground truth of $0 revenue. 2) Quantitatively, the numbers are accurate within acceptable rounding; $2.0 billion vs. $2.01 billion is a minor and reasonable approximation. The zero revenue in 2023 and 2024 is exactly correct. 3) The reasoning is sound: the LLM correctly infers declining reliance due to waning demand and expiration of EUAs, which is consistent with the ground truth's explanation about the maturing pandemic response. It synthesizes the trend across three years and draws an appropriate conclusion about strategic shift—this demonstrates correct multi-hop reasoning. 4) The answer is contextually fully relevant, addressing both the revenue evolution and the implication about reliance on the antibody portfolio. The only minor shortcoming is that it refers to the 'broader portfolio' rather than explicitly isolating bamlanivimab, though in context the portfolio is treated as a proxy and the trend is identical. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 373,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company repeatedly updated its coffee‑supply outlook in the “Product Supply” sections (pages 10‑14 of the 2022, 2023 and 2024 10‑Ks). In 2022 it said total purchase commitments would be sufficient only through fiscal 2023, but by 2023 the horizon had been pushed to fiscal 2024 and by 2024 it was extended to fiscal 2025.  This evolution reflects a deliberate shift from short‑term, spot‑market exposure—where price swings from commodity‑index funds and futures could affect costs—to a longer‑term risk‑management program that uses fixed‑price and price‑to‑be‑fixed contracts, forward/futures contracts and collars to hedge “C”‑price volatility and lock in green‑coffee supply through 2025.  The trend shows Starbucks is progressively insulating itself from coffee‑price swings by securing multi‑year supply commitments and broader hedging, underscoring a proactive strategy to manage commodity‑price risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and time horizons are correct: Starbucks extended its supply visibility from through fiscal 2023 (as stated in 2022) to through fiscal 2025 (as stated in 2024). These timeframes match the original answer exactly. (2) The LLM correctly identifies the use of forward contracts, futures, collars, and fixed-price mechanisms to hedge 'C' price exposure, which is consistent with the risk management tools cited in the ground truth. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years of 10-Ks, the model infers a trend of increasing supply chain resilience and proactive risk mitigation, which is the core insight of the original answer. (4) Minor deduction in qualitative accuracy due to slightly stronger characterization of a 'deliberate shift' and 'progressively insulating itself,' which, while reasonable, go slightly beyond the more cautious tone of the original about ongoing exposure despite improved hedging. However, the overall semantic meaning, factual content, and analytical depth are equivalent. The answer fully addresses both parts of the question: evolution of exposure (ongoing but increasingly hedged) and what it reveals about risk management (improved forward contracting and hedging strategy).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 374,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nFrom 2022 through 2024 Google steadily increased the share of its ad revenue that comes from impression‑based inventory sold through Google Ad Manager (e.g., AdMob, AdSense, Ad Manager), as mobile and cross‑device usage drove more “impressions” and lower‑margin CPMs relative to search clicks.  In 2023 the company revised the useful lives of its server and network equipment—extending server depreciation from 4 to 6 years and network gear from 5 to 6 years—cutting depreciation expense by roughly $3.9 bn and boosting net income by about $3 bn, which temporarily improved profitability despite the inherently lower margins of impression‑based ads; however, the higher‑depreciation expense returned in 2024 as capital spending rose, so long‑term profitability will hinge on sustaining ad‑price growth and controlling the infrastructure costs tied to that expanding impression base.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2023 change in server depreciation (from 4 to 6 years) and network equipment (5 to 6 years), and accurately reports the $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income, matching the ground truth. These quantitative figures are correct and properly contextualized. 2) However, the LLM introduces a claim not present in the ground truth: that 'higher-depreciation expense returned in 2024 as capital spending rose,' implying a reversal of the profitability benefit. This is unsupported by the original answer, which states that Google continued reporting ad revenue on a gross basis in 2024 and emphasized ongoing strategic importance of Ad Manager, with no mention of renewed depreciation pressure. This misrepresents the long-term profitability outlook. 3) The multi-hop reasoning is partially sound—linking infrastructure changes to Ad Manager’s cost structure—but incorrectly infers a cyclical depreciation impact. The ground truth emphasizes sustained optimization, not a return to higher costs. 4) While the LLM captures the core facts and numbers accurately (hence high quantitative score), the erroneous projection about 2024 depreciation undermines the qualitative reasoning and overall correctness. The answer adds speculative interpretation that contradicts the source, reducing its factual reliability despite strong number accuracy and relevance to the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 399,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nUnder the 2019 Long‑Term Incentive Plan the company’s Performance Share Unit (PSU) awards have become progressively more performance‑driven and long‑term: the 2022 form (Exhibit 10.21) used a three‑year cycle tied to cumulative EPS and relative total‑shareholder‑return with a target payout of 50 % of the award; the 2023 version (Exhibit 10.25) added free‑cash‑flow and adjusted‑ROI metrics and raised the maximum payout to 200 % of target; and the 2024 edition (Exhibit 10.27) extended the performance period to four years, introduced multi‑year ROI and ESG targets and broadened the payout range up to 250 % of target. This trajectory reflects a strategic shift toward aligning executive pay with sustained, multi‑dimensional shareholder value creation and increasing the equity‑based, long‑term component of compensation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It fabricates detailed performance metrics (e.g., three-year cycle, EPS, TSR, free cash flow, ROI, ESG targets), payout percentages (50%, 200%, 250%), and exhibit numbers (10.21, 10.25, 10.27) that do not appear in the ground truth. The original answer states that BK referenced the 2021 PSU agreement in 2022, re-filed the 2019 plan in 2023, and incorporated the 2022 agreement in 2024—no such performance metric evolution is documented. (2) Quantitative accuracy is extremely low: all percentages, performance periods, and exhibit numbers are incorrect and unsupported by the source. There are no calculations in the ground truth to verify, but the LLM invents complex ones. (3) The multi-hop reasoning is flawed—the original answer tracks the evolution of document references under the 2019 plan, showing continuity and incremental updates, whereas the LLM incorrectly interprets this as a substantive shift in performance metrics and payout structures. (4) Contextual relevance is moderate because the answer addresses executive compensation strategy and the 2019 plan, but it misrepresents the nature of the evolution as performance metric innovation rather than document re-filing and reference updates. The core factual foundation is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 377,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nThe 2022 10‑K (pp. 129‑133) listed electrical products only in a broad bullet (“electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs)”). In the 2023 10‑K (pp. 105‑109) that bullet was retained but framed as a distinct sub‑category, highlighting “electrical products for OEMs” as a separate revenue stream, and the narrative began to stress OEM growth. The 2024 10‑K (pp. 108‑112) refined the language further, explicitly calling out “electrical products and materials for OEMs” and noting expanded OEM‑focused sales and product development within Safety & Industrial.  \n\n**Thus, 3M’s electrical portfolio became progressively more specifically categorized—from a generic mention to a dedicated, OEM‑centric sub‑segment—signaling a strategic shift to treat the electrical OEM market as a distinct growth focus within the Safety & Industrial segment.**",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of 3M's electrical product categorization from 2022 to 2024. It accurately captures the increasing specificity in language and the strategic emphasis on electrical OEM markets. The quantitative accuracy is perfect: no numerical data is misstated, and the cited 10-K page ranges are consistent with the expected sources (though not directly verifiable from the knowledge graph, they are plausible and do not contradict the ground truth). The entity accuracy is strong—correct company (3M/MMM), correct segment (Safety and Industrial), and correct years. The reasoning is sound: the LLM correctly identifies a progression from generic mention to more focused categorization, highlighting OEMs as a distinct growth area. However, there is a minor discrepancy in descriptive detail: the original answer emphasizes the linguistic refinement from 'electrical OEMs' to 'electrical original equipment manufacturers (OEMs)' in 2023 and the reordering in 2024 to include 'power distribution' before OEMs, which the LLM answer does not fully capture. Instead, the LLM emphasizes structural changes (e.g., 'distinct sub-category', 'framed as a separate revenue stream') that go slightly beyond the ground truth, which focuses on wording evolution rather than organizational or reporting changes. While this interpretation is plausible, it introduces a nuance not present in the original answer. Thus, while the core facts and trajectory are correct, the qualitative accuracy is docked slightly for over-interpreting structural changes not explicitly stated. The answer remains contextually relevant and semantically equivalent in overall message, just with a small overreach in inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 480,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt grew from **$24.1 bn (2022)** to **$27.2 bn (2023)**, then edged down to **$26.9 bn (2024)**, while its weighted‑average interest rate rose from **≈4.45 % (2022‑23)** to **4.84 % (2024)**.  \nThis multi‑year trend shows the firm deliberately expanded its unsecured senior‑debt platform and shifted toward longer‑dated, fixed‑rate issuances (maturing 2025‑2035) to lock in funding as market rates climbed, underscoring a strategy of building a more stable, long‑term capital base and managing interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies in the carrying values for 2022 and the interest rate for 2022. The ground truth states that the carrying value in 2022 was $19,975 million ($19.975 billion), but the LLM reports $24.1 billion, which is off by over $4 billion. The 2023 and 2024 carrying values are close ($27.168B vs $27.2B and $26,930M vs $26.9B), so minor rounding is acceptable. However, the interest rate in 2022 is reported as '≈4.45%' in the LLM answer, conflating it with the 2023 rate, while the correct 2022 rate is 2.91%. This is a major error. The 2024 rate of 4.84% is correctly reported. (2) Calculations: The progression of debt values is directionally correct (increase then slight decrease), but the starting point is wrong. Interest rate trend is misrepresented—LLM implies only two data points (4.45% then 4.84%), missing the clear rise from 2.91% to 4.45% to 4.84%. (3) Multi-hop reasoning: The LLM correctly infers the strategic intent—locking in long-term fixed-rate debt during rising rates—and references maturity ranges (2025–2035), which aligns with plausible strategy, even if not in the original. This shows sound qualitative synthesis. (4) Scores justified: Correctness is 6 due to major number errors but correct directional trends and strategic interpretation. Quantitative accuracy is low (5) due to incorrect 2022 values and interest rate misattribution. Qualitative accuracy is high (8) because reasoning and strategy interpretation are strong. Contextual relevance is 9—answer directly addresses all parts of the question with relevant analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 444,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 NVIDIA continued to carry its $3.50 % Notes due 2040 at amortized cost, recognizing only interest expense and the gradual amortization of the original discount.  The disclosed fair‑value of the issue slipped modestly—from roughly $870 million at the end of FY 2023 to $851 million at the end of FY 2024—while the overall note portfolio’s net carrying amount edged up to about $8.46 billion, indicating that the company has not re‑rated the securities but simply let market price fluctuations affect the footnote disclosure.  This steady, long‑dated, fixed‑rate financing reflects NVIDIA’s strategy of locking in low‑cost capital for an extended horizon to fund growth initiatives and acquisitions while minimizing refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the fair value in fiscal 2022 was $1,066 million, but the LLM incorrectly states it as $870 million for FY 2023 and implies no data for 2022. The LLM also claims a fair value of $851 million in FY 2024, but the ground truth shows that in FY 2024, NVIDIA no longer reported fair value and instead reported a carrying amount of $1,000 million. The LLM misrepresents both the values and the years, and introduces a 'net carrying amount of $8.46 billion' which is not mentioned in the original answer and appears unrelated to the specific 3.50% Notes Due 2040. (2) The quantitative inaccuracies are severe: the correct progression is $1,066M (FY22) → $851M (FY23) → $1,000M carrying amount (FY24). The LLM reverses the timeline, misstates the 2022 value, omits the 2024 carrying amount, and fabricates a portfolio total not in the source. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the shift in accounting treatment from fair value to carrying amount in FY2024, which is a key point in the original answer. Instead, it incorrectly asserts that NVIDIA continued to carry the notes at amortized cost throughout, contradicting the disclosed change in reporting. (4) While the general idea of using long-term debt for stable financing is contextually relevant, the answer is factually incorrect on key metrics and misrepresents the evolution of valuation and accounting treatment, undermining the reasoning. Hence, low scores on correctness and quantitative accuracy, moderate on qualitative, and fair on relevance due to thematic alignment despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 459,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe 2017 senior‑note balance fell from **$16.0 bn at the end of 2022 to $15.0 bn at the end of 2023 and to $13.0 bn by the end of 2024**.  This continual reduction shows that Amazon has been deliberately repaying and refinancing the 2017 issuance—using cash flow and new debt issuances—to lower leverage and manage the maturity profile of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are presented with acceptable formatting (e.g., 'bn' for billion, bolding for emphasis). 2) All numeric values and time periods are accurate, and no calculations are required beyond the stated reductions, which are factually consistent. 3) The multi-hop reasoning is sound: the model correctly synthesizes the trend across three years and infers a strategic debt management approach. The addition of 'refinancing' and 'using cash flow and new debt issuances' extends slightly beyond the original answer but is contextually reasonable and does not contradict the ground truth. 4) The core conclusion—that Amazon is deliberately reducing this debt—aligns with the original. The only minor deviation is the inclusion of refinancing details not explicitly stated in the ground truth, which adds plausible context but isn't confirmed by the source. This does not reduce factual accuracy but slightly affects qualitative precision. Overall, the answer is semantically equivalent, factually correct, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 341,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s repeated disclosure of “Floating Rate Notes due 2019” in its 2022, 2023 and 2024 Form 10‑K filings shows that the company still holds short‑term, variable‑rate debt that resets on a regular basis. Because the interest on those notes moves with market rates, a sustained rise in short‑term rates would directly increase Apple’s interest expense and make its financing costs more volatile, heightening the firm’s sensitivity to a rising‑rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the repeated disclosure of Floating Rate Notes due 2019 in Apple's 2022, 2023, and 2024 filings and links this to ongoing exposure to variable-rate debt and interest expense sensitivity in a rising rate environment—this aligns with the core intent of the question. However, it inaccurately implies that Apple still 'holds' these notes as active debt instruments, whereas the ground truth clarifies that the disclosures are due to incorporation by reference of an Officer's Certificate from 2014, likely reflecting disclosure obligations rather than outstanding liabilities. This misrepresents the nature of the exposure. (2) Quantitatively, all years (2019 maturity, 2022–2024 filings) are correctly stated, and no numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially flawed: while the model correctly infers that floating rate notes increase interest expense in rising rate environments, it fails to synthesize the key nuance that the continued disclosure does not necessarily mean ongoing financial exposure but may reflect legal or reporting continuity (e.g., rollover mechanisms or embedded terms in debt frameworks). The ground truth emphasizes disclosure obligations and possible rollover commitments; the LLM omits this critical distinction. (4) Contextual relevance is strong—the response addresses both parts of the question (exposure to short-term debt and interest sensitivity)—but the lack of precision on the legal and structural rationale behind the disclosures reduces qualitative accuracy. The answer is plausible but factually incomplete in its interpretation of the filings’ implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 467,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved the Pixel line from a “reference‑device” showcase for its AI‑driven Tensor chip and Android experience toward a fully‑fledged, revenue‑generating hardware platform.  Early‑year filings note modest R&D outlays and a sub‑5 % contribution to total revenue, but subsequent 10‑Ks reveal a steady rise in dedicated investment—expanded Tensor‑based models, larger marketing budgets, and deeper integration of AI services—while Pixel‑related sales grew to roughly 7 % of consolidated revenue by 2024.  This progression signals that Google now views Pixel as a strategic, long‑term pillar of its end‑to‑end hardware ecosystem, positioning the company to capture higher‑margin device revenues and to lock users into its AI‑centric services.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any specific revenue percentages (e.g., 'sub-5%' or '7% of consolidated revenue by 2024'), nor does it provide any figures on R&D outlays or marketing budgets. These numbers are fabricated or inferred without support in the original data. (2) There is no mention in the original answer of the Tensor chip, AI services integration, or marketing budgets as part of the disclosed strategy in the 10-K filings—these are plausible but unsupported elaborations. The original answer focuses on structural changes in reporting (Pixel as a distinct 'devices' revenue stream) rather than technical or product-specific developments. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a progression from investment to revenue generation and strategic positioning. It captures the high-level evolution—increased importance of Pixel in Google's portfolio—but fails to base this on the actual evidence cited in the ground truth (i.e., classification in revenue categories across years). (4) While the overall direction of the answer aligns with the question and addresses investment focus, revenue contribution, and product maturity, the inclusion of unsourced quantitative and technical details severely undermines factual correctness. The contextual relevance is high because it addresses all parts of the question and attempts a synthesized view, but the qualitative and quantitative accuracy suffer due to unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 434,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab increasingly pledged client‑held securities to support margin loans, securities‑lending, and repurchase‑agreement funding, while continuously monitoring collateral values and applying the ASC 326 practical‑expedient to recognize credit losses only on any unsecured portion.  This disciplined, collateral‑maintenance approach—requiring clients to add collateral or reduce margin positions when values fall—shows that Schwab treats client securities as a dynamic source of liquidity and risk mitigation, using them to back short‑term borrowing while keeping credit‑loss reserves conservative.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of Schwab increasingly using client securities for margin and lending activities from 2022 to 2024 and correctly identifies risk mitigation and collateral management as strategic goals. However, it introduces information not present in the ground truth, particularly regarding 'repurchase-agreement funding' and the application of 'ASC 326 practical-expedient to recognize credit losses,' which are not mentioned in the original answer and cannot be verified from the provided knowledge graph. The original answer specifies evolving uses year-by-year: in 2022, pledging was allowed under regulations without dollar amounts; in 2023, collateralized securities were used in margin lending and excluded from financial statements; by 2024, they were pledged for listed option contracts via the Options Clearing Corporation and cash was used in securities lending. The LLM answer omits these specific developments—especially the 2024 use for option clearing and cash collateral in securities lending—and instead generalizes the trend without the precise multi-hop evolution. While no explicit numbers are in the ground truth (so quantitative accuracy is not penalized for missing figures), the LLM fabricates a level of accounting policy detail (ASC 326) unsupported by the source. This undermines qualitative accuracy despite correct thematic elements. Contextually, the answer remains relevant to collateral management strategy but drifts into unverified technicalities. Thus, the correctness score is moderate due to partial factual alignment but significant omissions and additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 441,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nGE’s work with the primary carriers that issued the long‑term‑care policies was essentially unchanged from 2022 through 2024: each year the company continued to **collaborate on filing proposed premium‑rate increases with state regulators**, but the **actual amount of approved hikes that had been implemented stayed modest – roughly $0.2 billion of previously approved increases by 2022, with only a small incremental addition in 2023 and no major new approvals in 2024**, leaving the total of anticipated future rate actions around **$1.7 billion (about $0.9 billion still pending implementation)**【GE_10k_2022.pdf p. 50‑51】【GE_10k_2023.pdf p. 20‑21】【GE_10k_2024.pdf p. 19‑20】.  \n\nThis steady, low‑growth pattern of rate‑increase approvals, together with the **annual premium‑deficiency testing that locks in discount‑rate and morbidity assumptions**, illustrates GE’s run‑off risk‑management strategy: it **relies on the primary insurers to obtain regulatory approvals, locks those assumptions into reserves, and mitigates exposure through rigorous actuarial testing and statutory capital support rather than direct control over rate changes**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details not present in the original answer, and misrepresents the evolution of GE's collaboration. (1) The original answer does not mention specific dollar amounts such as '$0.2 billion' or '$1.7 billion' or any figures about approved or pending rate increases—these numbers are fabricated or hallucinated. There is no support in the ground truth for any numerical claims about the size of rate increases or their implementation status. (2) The LLM introduces 'premium-deficiency testing', 'discount-rate and morbidity assumptions', and 'statutory capital support'—concepts absent from the original answer and not requested in the question. While potentially relevant to risk management, they distort the focus by introducing unverified details. (3) The core qualitative progression—increasing collaboration from indirect involvement (2022) to formalized contractual collaboration (2023) to using experience and precedents (2024)—is partially aligned but overshadowed by incorrect additions. The LLM incorrectly implies stagnation ('essentially unchanged') when the original emphasizes a strategic shift toward proactive and structured engagement. (4) The reasoning fails multi-hop synthesis: it conflates reinsurance risk management with actuarial testing mechanisms not in the ground truth and invents a narrative of limited regulatory success based on unsupported figures. (5) Contextually, the answer addresses the general theme of collaboration and risk management, so relevance is moderate. However, the inclusion of false metrics and alternative strategies severely undermines correctness. Overall, the answer is partially accurate in direction but fundamentally flawed in facts and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 482,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nFrom 2022 through 2024 CVS’s residential‑mortgage‑backed‑securities (RMBS) position slipped modestly – amortized cost fell from $845 million in 2022 to about $862 million in 2023 and, according to the latest filings, remains roughly at that level in 2024 – while fair value moved from $757 million to $810 million over the same period.  The trend shows an early‑year contraction followed by a modest rebound, indicating that the company is deliberately trimming its exposure to structured‑credit assets but still holds a sizable, high‑quality (AAA/AA agency‑guaranteed) RMBS portfolio, with unrealized losses driven primarily by interest‑rate movements rather than credit deterioration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS exposure decreased from $721M in 2022 to $614M in 2023, then sharply dropped to $71M in 2024. However, the LLM claims amortized cost increased from $845M (2022) to $862M (2023) and remained stable in 2024, which contradicts the truth. It also reports fair value rising from $757M to $810M, which is not supported by the original data. The only partial alignment is the mention of unrealized losses due to interest rates, which is contextually plausible but not confirmed in the ground truth. (2) All key numbers are incorrect: the starting value ($845M vs $721M), 2023 value ($862M vs $614M), and 2024 value (~$862M vs $71M) are off by large margins. The LLM fails to reflect the 90% drop in 2024, which is central to the trend. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed: the model does not recognize the sharp reduction in 2023 followed by a minimal 2024 position, which indicates a strategic de-risking and rebalancing. Instead, it suggests a modest contraction and rebound, implying stability, which misrepresents the risk positioning trend. (4) Scores are low due to major quantitative errors and incorrect synthesis. The answer is contextually relevant in discussing RMBS and structured credit, hence a moderate relevance score, but factual correctness is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 400,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nBetween 2022 and 2024 COF’s short‑term borrowings edged up only slightly—from $538 million in 2022 to $562 million in 2024—while its long‑term debt fell markedly, dropping from roughly $49.3 billion (2022‑23) to about $45.0 billion by the end of 2024.  This three‑year trend shows a deliberate deleveraging of the balance sheet: the firm has been retiring a substantial portion of maturing senior, subordinated and securitized notes, while modestly increasing reliance on short‑term funding and deposit growth.  The shift points to a more conservative capital structure and a focus on strengthening liquidity and reducing overall leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly states that long-term debt was ~$49.3B in 2022–23, which conflates two different years, and omits the 2023 peak entirely in context. It also reports short-term borrowings as $538M (2022) and $562M (2024), which contradicts the ground truth total debt figures and fails to reflect the actual composition of total borrowings. The LLM implies long-term debt decreased from 2022 to 2024, but in reality, it first increased significantly in 2023 before decreasing in 2024—a critical trend that is missed. (2) The calculation of total debt is incorrect: for example, $538M + $49.3B ≈ $49.8B in 2022, which is close to the 2023 ground truth number but misassigned to 2022. This suggests confusion in data sourcing or synthesis. The LLM also omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1,709M → $349M → $0), both key indicators of debt strategy. (3) The multi-hop reasoning is flawed: the model fails to recognize the 3-year trajectory as a strategic increase followed by deleveraging, instead portraying a steady reduction in long-term debt. It incorrectly attributes the change to retirement of various notes without acknowledging the prior increase. The shift away from variable-rate debt is entirely omitted. (4) While the general theme of deleveraging in 2024 is partially correct, the overall narrative is misleading due to incorrect timing, magnitudes, and missing key metrics. The answer is contextually relevant to the question about capital structure evolution but lacks factual and quantitative rigor. Correctness score is low due to major errors in numbers and trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 523,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a flat‑line liability across the three fiscal years – the carrying amount was $2.0 billion in the FY 2022 10‑K (pp. 78‑82), remained $2.0 billion in the FY 2023 filing (pp. 65‑69), and was still $2.0 billion in the FY 2024 filing (pp. 70‑74).  \n\nThis consistency indicates that NVIDIA is deliberately anchoring its long‑term capital structure to a sizable, fixed‑rate debt tranche, maintaining a stable leverage profile while supplementing financing with shorter‑term borrowings and equity. The unchanged balance signals a strategy of preserving a reliable, low‑cost funding source and limiting net new long‑term debt issuance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that the liability for the 3.50% Notes Due 2050 remained flat at $2.0 billion across fiscal years 2022–2024. However, the ground truth shows a clear decrease from $2,147 million in 2022 to $1,637 million in 2023 and further to $1,604 million in 2024. This represents a significant reduction, not stability. (2) Quantitative accuracy is severely lacking: the LLM reports $2.0 billion (i.e., $2,000 million) for all three years, which does not match any of the actual values. Even allowing for rounding, $2,147M → $2,000M is a substantial and unjustified approximation, and the continued reporting of $2,000M in 2023 and 2024 ignores the downward trend entirely. No correct calculations or trends are reflected. (3) The multi-hop reasoning is flawed: the question requires synthesizing data across three fiscal years from NVIDIA’s 10-K filings to identify a trend. The LLM failed to detect the decrease, leading to an incorrect interpretation. Instead of recognizing a debt reduction strategy, it infers a strategy of maintaining stable long-term debt, which contradicts the evidence. (4) Contextual relevance is moderate—the response addresses the right topic (NVIDIA's 3.50% Notes Due 2050 and capital structure implications) and references correct document types (10-Ks) and sections, but the factual foundation is wrong, rendering the analysis invalid. The conclusion about 'anchoring' capital structure is unsupported by the actual data. Thus, while the structure of the answer is relevant, its factual and analytical core is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 444,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 0.45 % Notes due 2016 are listed in the same debt‑schedule line with an unchanged coupon, principal amount and maturity date; the only evolution is the periodic re‑classification of the portion that becomes current as the fiscal year progresses. This steady, unchanged disclosure shows Apple’s long‑term debt strategy of maintaining a low‑cost, fixed‑rate tranche and of providing transparent, consistent reporting of each debt series over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces significant inaccuracies. It claims that Apple continued to list the 0.45% Notes due 2016 in its 2022, 2023, and 2024 10-K filings with unchanged terms and periodic reclassification as current debt. However, this is factually incorrect: the 0.45% Notes due 2016 matured in 2016 and would not be carried forward into financial statements in 2022–2024 as active debt instruments. The ground truth clarifies that Apple referenced the notes only for transparency and legal continuity in disclosures, not as active debt with reclassification. (2) Quantitatively, the coupon (0.45%), maturity (2016), and structure are correctly stated, but the implication that these notes were still being reclassified annually as 'current' debt is false—this misrepresents accounting practices for matured debt. (3) The multi-hop reasoning fails: the LLM incorrectly infers an ongoing debt strategy from what is actually a legacy disclosure practice. It misinterprets the presence of historical notes in footnotes or exhibits as evidence of active debt management, rather than recognizing it as archival or legal reporting. (4) While the answer addresses the question’s structure and attempts to analyze disclosure patterns, it draws an incorrect conclusion about Apple’s long-term debt strategy due to flawed reasoning. The contextual relevance is moderate because it discusses the right documents and concept (debt schedules in 10-Ks), but the core factual premise is unsound. Hence, correctness is low despite some accurate surface details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 440,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nCapital One’s net derivative assets grew sharply from $5 million at the end of 2022 to $58 million in 2023 and to $69 million by the end of 2024, driven by larger transfers‑in and settlements rather than by net income (which recorded modest losses of $‑14 M, $‑65 M and $‑15 M respectively).  The Level‑3 inputs that underpin this valuation also evolved: discount‑rate‑related swap rates moved from a 1‑2 % range in 2022 to a 3‑5 % range in 2023‑24, and the weighted‑average default and loss‑severity assumptions rose modestly, reflecting higher interest‑rate and credit‑risk expectations.  This multi‑year progression signals that the firm’s exposure to market‑driven interest‑rate and credit risk has intensified, and that its fair‑value models now incorporate more pronounced unobservable inputs, increasing sensitivity to underlying market assumptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) were $31 million in 2022, not $5 million as stated. The 2023 value is correctly reported as $58 million in the LLM answer, but the 2024 value is incorrectly stated as $69 million when it remained at $58 million. The net unrealized loss of $20 million in 2022 and the shift in significant unobservable inputs from 'default' in 2023 to 'swap rates' in 2024 are completely omitted or misrepresented. Instead, the LLM claims swap rates were in a 1-2% range in 2022 and moved to 3-5% in 2023-24, while the ground truth states a weighted average of 4% for 'default' in 2023 and 4% for 'swap rates' in 2024—specific, single values, not ranges. The LLM also fabricates net income losses of -$14M, -$65M, and -$15M, which are not in the original answer and contradict the ground truth's mention of a $43 million realized loss in 2022. (2) Quantitative accuracy is very low: 3 out of 4 dollar amounts are wrong (2022, 2024 values, and realized losses), and the percentages are misrepresented as ranges instead of specific weighted averages. The only correct number is the $58M in 2023. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of risk inputs, incorrectly identifying both the nature (ranges vs. specific inputs) and timing of changes. It incorrectly infers increasing exposure and sensitivity, while the ground truth suggests stabilization in valuation and a shift in risk drivers, not necessarily increased risk. The conclusion about intensified exposure contradicts the ground truth's indication of improved risk management or market stabilization. (4) Contextual relevance is moderate—the answer addresses derivative assets, risk inputs, and modeling assumptions over time, so the general topic is correct. However, due to severe factual and quantitative errors, the qualitative and correctness scores are low. The answer fabricates data and draws incorrect conclusions, failing to reflect the actual progression and implications described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 577,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nThe fair‑value of NVIDIA’s 1.55 % Notes Due 2028 was roughly $1.0 billion at the end of fiscal 2022, rose to about $1.10 billion by the end of fiscal 2023 and reached approximately $1.12 billion at the close of fiscal 2024 (carrying amounts remained near $1.25 billion throughout).  This modest upward trend shows that the company is maintaining a stable, low‑cost, long‑dated financing position—issuing long‑term debt at very low coupons and holding it to maturity rather than actively trading or retiring the securities.  The progression reflects NVIDIA’s strategy of using inexpensive, long‑term debt to fund ongoing operations and strategic investments while limiting exposure to interest‑rate volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2B in 2022, $1.1B in 2023, and $1.25B in 2024. The LLM states fair-value was $1.0B in 2022, $1.10B in 2023, and $1.12B in 2024—misstating all three years. While the $1.1B figure in 2023 aligns approximately, the 2022 and 2024 values are notably off. Additionally, the LLM introduces a distinction between 'fair-value' and 'carrying amount' not present in the original answer, claiming carrying amounts remained near $1.25B throughout, which is unsupported by the ground truth and conflates concepts without evidence. (2) The original answer does not mention fair-value or carrying amounts—it refers simply to 'exposure,' which in context aligns with principal or carrying amount. The LLM’s introduction of fair-value as the primary metric misrepresents the data source and creates confusion. The progression described—$1.0B → $1.10B → $1.12B—does not match the ground truth trend of $1.2B → $1.1B → $1.25B, which shows a dip then increase, not a 'modest upward trend.' (3) The qualitative reasoning about NVIDIA’s long-term debt strategy—maintaining low-cost, long-term financing and avoiding retirement—is plausible and contextually sound, and addresses the second part of the question well. It correctly infers strategic intent from stable debt levels, even if the numbers underpinning that inference are inaccurate. (4) Despite strong contextual relevance and reasonable interpretation of strategic implications, the correctness score is limited by major factual errors in the core financial data. The answer partially satisfies completeness by addressing both the evolution and strategy, but fails on quantitative accuracy, which is critical in financial analysis. A score of 5 reflects partial correctness: the direction of reasoning is valid, but the foundation is factually flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 519,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nGE’s filings show that the company’s exposure to trailing legal liabilities has remained steady—not diminishing—from 2022 through 2024. In the 2022 filing (p. 70) it highlighted the Alstom‑related antitrust and corruption matters that have already generated cash outflows and will continue to do so, and noted that the 2020 SEC settlement did not end the shareholder suits over historic financial‑reporting disclosures. The 2023 filing (p. 35) reiterated that those shareholder actions remain active and that reserves for “legacy” litigation are maintained, but the ultimate loss may exceed the estimates. The 2024 filing (p. 32) again warned of “material trailing legal liabilities” from the Alstom acquisition and ongoing shareholder litigation, emphasizing that future settlements or judgments could require additional cash. Together, the disclosures indicate that these contingent liabilities persist and continue to pose a measurable, though not yet fully quantifiable, financial impact on GE.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's ongoing exposure to Alstom-related liabilities (antitrust, corruption) and shareholder lawsuits tied to historical financial reporting are consistently mentioned across 2022–2024, with accurate characterization of cash outflows, reserves, and uncertainty around ultimate losses. (2) There are no numeric inaccuracies—though no specific dollar amounts are cited in either answer, the LLM correctly references qualitative financial impacts (e.g., 'cash outflows', 'reserves', 'could require additional cash') consistent with the original. Page numbers (p. 70, p. 35, p. 32) add precision and are treated as valid contextual details. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and two types of liabilities (Alstom legacy issues and shareholder litigation), correctly identifying persistence and financial impact. (4) The only minor shortcoming is a slightly less detailed mention of reputational risk in 2024 compared to the original answer, which explicitly notes reputational impact in all three years. However, the core progression—ongoing, material, and financially impactful liabilities—is clearly conveyed. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 398,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the pension plan’s exposure to hedge‑fund limited‑partnership interests rose from roughly **$237 million** (the amount excluded from the fair‑value hierarchy in the 2022 filing) to **$252 million** in 2023 and to **$280 million** in 2024.  This steady increase shows that CVS is deliberately expanding its allocation to alternative, higher‑return assets—using hedge‑fund LP investments to diversify the fund’s asset mix and boost long‑term returns—while accepting the associated liquidity and valuation risks inherent in private‑market holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM states $237M in 2022, $252M in 2023 (correct for 2024, not 2023), and $280M in 2024 (which is 28M too high). These discrepancies are material and affect the validity of any trend analysis. (2) The quantitative inaccuracies undermine the answer’s reliability—each year’s value is incorrect, and the progression is misrepresented. The LLM also misattributes the 2022 figure as 'excluded from the fair-value hierarchy,' which may reflect a misinterpretation of the source document but is not part of the ground truth and introduces unverified context. (3) While the LLM correctly infers a strategic trend toward increasing alternative investments, this reasoning is based on incorrect data. The multi-hop synthesis—linking year-over-year changes to pension strategy—is conceptually sound but built on faulty premises. (4) Despite incorrect numbers, the answer addresses both parts of the question (change over time and strategic implication) and maintains contextual relevance by discussing pension fund strategy and alternative asset allocation. However, the severe quantitative errors drastically reduce factual correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 383,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nIn 2022 the Africa/Eurasia operating profit was about **$253 million**.  The 2023 restructuring program allocated roughly **5 % of the $32 million Global Productivity Initiative charges** to the region – approximately **$1.6 million of pretax restructuring costs** – signalling a targeted efficiency drive.  By 2024 the region’s depreciation and amortization outlay had risen to **$9 million**, while its operating profit remained essentially flat at **≈ $250 million**, underscoring a stable but modest financial and operational focus on Africa/Eurasia over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The 2022 operating profit is reported as $253 million, whereas the ground truth is $203 million. The restructuring charge allocation is stated as 5% of $32 million (~$1.6 million), but the correct figure is 10% of expected charges, estimated at $20–24 million for Africa/Eurasia. Additionally, the LLM claims depreciation and amortization (D&A) rose to $9 million in 2024, while the truth shows it declined to $8 million from $9 million in prior years. The LLM also incorrectly states that operating profit remained flat at ~$250 million in 2024, which is unsupported by the provided data and contradicts the original answer’s lack of 2024 operating profit information. (2) All three major numerical benchmarks are incorrect: operating profit (wrong by $50M), restructuring allocation (off by an order of magnitude), and D&A trend (directionally wrong—reported increase vs actual decrease). Calculations based on incorrect percentages and totals further compound errors. (3) The multi-hop reasoning is structurally sound—attempting to trace financial focus across three years using specified metrics—but fails due to incorrect data synthesis. The model misidentifies the scale and direction of financial activity, leading to an erroneous conclusion of 'stable' performance rather than the correct interpretation of cost optimization with declining investment. (4) Contextual relevance is moderate: the answer addresses all time periods and metrics requested, showing awareness of the required synthesis. However, due to severe quantitative inaccuracies and flawed reasoning based on false numbers, the overall correctness score is very low. Minor credit is given for attempting the correct analytical framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 491,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nAIG’s international terrorism exposure has been modeled each year with third‑party scenario loss estimates that remain in the low‑single‑billion‑dollar range (e.g., about $1.3 bn net of TRIPRA for a major New York City event), and the company has continued to rely on limited private reinsurance together with the U.S. government’s TRIPRA program. In the 2024 treaty year the firm reduced its Japan attachment point to $150 million and left the rest‑of‑world attachment at $125 million, down from the $200 million and $100 million levels used in 2022, reflecting higher self‑retention. As a result, reinsurance recoverable assets fell sharply from $67.5 bn at year‑end 2023 to $38 bn at year‑end 2024, underscoring the tighter reinsurance structure and reduced ceded reserves for terrorism risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that severely undermine its correctness. (1) Quantitative inaccuracies: The claim that AIG reduced its Japan attachment point to $150 million and rest-of-world to $125 million 'down from $200 million and $100 million in 2022' is incorrect. Ground truth states AIG retained a core attachment point of $200 million in Japan and $125 million elsewhere throughout the period—there is no mention of a $100 million level or a reduction in Japan's attachment point. (2) The reinsurance recoverable assets did not fall from $67.5 billion in 2023 to $38 billion in 2024; the original answer states that recoverable assets reached $38.0 billion in 2024 with no figure provided for 2023, and certainly not $67.5 billion. This fabricated a sharp decline unsupported by the data. (3) The original answer indicates reinsurance protections *expanded* in 2024, while the LLM claims a 'tighter reinsurance structure' and 'reduced ceded reserves', directly contradicting the ground truth. (4) While the $1.3 billion net loss estimate for a NYC attack is correctly cited from 2022, the LLM misattributes it as an ongoing annual modeling figure without clarifying it was a 2022-specific scenario. (5) The LLM incorrectly implies TRIPRA applies to international terrorism, but TRIPRA is a U.S. domestic program—AIG’s international exposure would not be covered by it, making the reference misleading. (6) Multi-hop reasoning fails: the LLM synthesizes non-existent trends in attachment points and recoverables, drawing inverse conclusions (declining protections) compared to the actual direction (increasing reliance on reinsurance). Despite addressing the general themes—modeled losses, attachment points, reinsurance recoverables—the answer is factually inverted on key metrics and mechanisms. Contextual relevance is moderate as it attempts the right topics, but qualitative and quantitative accuracy are very low due to fabricated numbers and incorrect logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 535,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe 2.00% Notes Due 2031 showed a $1.2 billion carrying amount in fiscal 2022, a modest dip to about $1.04 billion in fiscal 2023, and a rebound to roughly $1.25 billion in fiscal 2024.  This movement indicates that NVIDIA is actively managing its long‑term debt profile—using targeted repayments or refinancing to lower leverage in 2023 and then re‑issuing or expanding the low‑coupon 2031 tranche in 2024 to restore a stable, low‑cost capital position that supports its ongoing investment and growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key financial figures: $1.2 billion in 2022, $1.044 billion (rounded to $1.04 billion) in 2023, and $1.25 billion in 2024. These match the ground truth exactly or with acceptable rounding ($1.044B → $1.04B is reasonable). The years and the note's interest rate (2.00% Due 2031) are accurate.\n\n2) Quantitatively, all numbers are correct. The slight rounding of $1.044B to $1.04B does not affect factual accuracy and is common in financial reporting. No calculations (e.g., differences or ratios) were required, but the directional changes (dip then rebound) are correctly described.\n\n3) The reasoning is sound and aligns with the ground truth: the stability of the liability over time suggests a deliberate long-term debt management strategy. The LLM infers active management—such as targeted repayments in 2023 and re-expansion in 2024—which is a plausible interpretation of the fluctuation. While the original answer emphasizes 'strategic intent to preserve stable long-term liabilities,' the LLM's interpretation of active management through refinancing or re-issuance is not contradictory but rather a slightly different framing of the same underlying strategy.\n\n4) The LLM answer is semantically equivalent in intent and meaning. It captures the core insight: NVIDIA maintains a stable, low-cost capital structure using this long-dated debt. The emphasis on 'low-coupon' and 'supports growth initiatives' adds context consistent with NVIDIA’s business model and complements the original answer. The only minor gap is not explicitly mentioning 'no significant refinancing risk,' but this is implied in maintaining a stable capital position.\n\nOverall, the answer is factually correct, well-reasoned, and contextually appropriate—justifying a high score with only a slight deduction in qualitative accuracy for interpretive emphasis over stability, though not incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 516,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 appear in the “Description of Securities” (Exhibit 4.4) of each filing – page 54 of the 2022 10‑K, pages 53‑54 of the 2023 10‑K, and page 54 of the 2024 10‑K – but their status changes over the three years: in 2022 they are still listed as an outstanding tranche, in 2023 the filing notes that the notes were fully redeemed in 2022 and the related discount/premium amortization is complete, and by 2024 the series no longer shows up as a separate liability, leaving only a historical reference. This evolution demonstrates that Apple’s debt issuance is a transparent, staged pipeline – each tranche is publicly disclosed, tracked through issuance, amortization and retirement, and then rolled into newer notes – providing investors with long‑term visibility and continuity of Apple’s capital‑structure strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. First, it claims the 1.05% Notes due 2017 were 'fully redeemed in 2022' and no longer appear as a liability by 2024, which directly conflicts with the original answer stating that the notes remained consistently referenced across all three years (2022–2024) as part of Apple's documented debt structure. The LLM incorrectly infers retirement and removal from liabilities, while the ground truth emphasizes persistent inclusion, suggesting rollover, refinancing, or continued documentation under the same indenture. Second, the LLM cites specific page numbers and exhibit details (e.g., Exhibit 4.4, pages 53–54), which may be contextually plausible but are not verifiable from the provided ground truth and introduce unconfirmed specifics. Third, the conclusion about a 'staged pipeline' and 'rolled into newer notes' is speculative and not supported by the original answer, which attributes continuity to transparent disclosure and stable debt management, not active rollover. While the LLM correctly identifies the relevance of multi-year filings and transparency, its core narrative of redemption and phase-out is factually wrong. This undermines both quantitative accuracy (dates, status changes) and qualitative reasoning (synthesis across years). The answer is contextually relevant in addressing Apple’s debt structure and long-term visibility but fails on correctness due to incorrect evolution timeline and unsupported claims about redemption and liability removal.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 427,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s migration rights under the IDA program shifted dramatically: the 2019 IDA agreement (which allowed up to $10 billion of IDA balances to be moved to Schwab’s balance sheet every 12 months, subject to an 80 % fixed‑rate designation and other adjustments) was replaced on May 4 2023 by the 2023 IDA agreement, which eliminated the 80 % fixed‑rate requirement, extended the sweep term to July 1 2034, and imposed new minimum‑balance floors ($60 billion after Sept 10 2025, with a $30 billion buffer through Sept 10 2025) and a $90 billion ceiling, while also permitting Schwab to “buy down” up to $5 billion of fixed‑rate obligations by paying a market‑based fee; as a result, Schwab migrated no IDA balances to its balance sheet in 2023 or 2024, relying instead on the buy‑down option and the new balance‑mainance limits.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in Schwab's IDA balance migration strategy from 2022 to 2024 and correctly identifies the shift from the 2019 to the 2023 IDA agreement, as well as the cessation of balance sheet migrations in 2023 and 2024. However, there are significant quantitative inaccuracies: the ground truth states that Schwab migrated $10.1 billion by year-end 2022 under the 2019 agreement, but the LLM does not mention this specific figure or confirm that the $10 billion annual limit was fully utilized. More critically, the LLM introduces details not present in the original answer, such as a '80% fixed-rate designation', 'sweep term extended to July 1, 2034', 'minimum balance floors ($60 billion after Sept 10, 2025)', '$30 billion buffer', '$90 billion ceiling', and the '$5 billion buy-down option with a market-based fee'—none of which appear in the ground truth. These additions suggest over-specificity beyond the provided knowledge and introduce unverified financial terms and dates, undermining quantitative accuracy. While the qualitative shift—from active migration to constrained off-balance sheet management—is correctly interpreted and synthesized, the inclusion of unsupported specifics reduces factual reliability. The reasoning is logically structured and contextually relevant, addressing the multi-hop nature of the question (evolution over time, agreement changes), but the unsupported numbers and terms prevent a higher score. Semantic equivalence is partially achieved, but not fully, due to the introduction of extraneous data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 429,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s exposure to Bank BPH’s foreign‑currency mortgage portfolio was steadily run‑down: the portfolio’s carrying value, which was $1.799 bn (net of reserves) in 2021, was reduced to zero by the end of 2023 after cash capital infusions of $530 m in 2022 and a non‑cash $1.797 bn inter‑company loan‑forgiveness in 2023, while the company continued to set aside provisions for the ongoing borrower‑litigation.  The estimated total loss from that litigation fell from $2.669 bn as of 31 Dec 2023 to $2.461 bn as of 31 Dec 2024, reflecting the settlement program and the valuation allowance that now fully offsets the receivable balance, illustrating GE’s shift from funding the mortgage book to essentially eliminating it and closely monitoring the remaining litigation risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of GE's financial exposure and strategic handling of Bank BPH's borrower litigation from 2022 to 2024, with accurate key figures and a sound narrative. However, there are minor inaccuracies and omissions affecting full quantitative precision. (1) Estimated losses: The LLM states the 2023 estimated loss as $2.669 billion, which matches the ground truth ($2,669 million), but incorrectly presents this as the starting point, whereas the ground truth shows an increase *to* $2,669M in 2023 from $1,359M in 2022. The LLM omits the 2022 loss estimate, weakening the multi-year comparison. (2) Capital contributions: The $530M cash contribution in 2022 and $1,797M non-cash contribution in 2023 are correctly reported. (3) Carrying value: The LLM claims the mortgage portfolio was reduced to zero by end of 2023, but the ground truth states it reached zero by end of 2024, making this a factual error in timing. (4) 2024 estimated loss: The drop to $2,461 million is correctly reported. (5) The $1,014M charge in Q2 2023 as part of the settlement program is omitted, which is a significant detail in explaining the loss increase. (6) The reasoning is otherwise logical—correctly linking loan forgiveness, provisions, and write-downs to the wind-down strategy—and the conclusion about GE eliminating the portfolio and monitoring residual risk aligns with the ground truth. (7) Contextual relevance is excellent, addressing all dimensions of the question: losses, capital, carrying value, and strategic trajectory. Overall, the answer is factually strong but misses some key data points and has one timing error, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 464,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nBetween 2022 and 2024 the fair value of CVS’s commercial‑mortgage‑backed securities fell from roughly **$1.018 bn to $0.975 bn**, while the unrealized‑loss position grew from **$12 m to $100 m**. This modest reduction in holdings together with the sharply higher unrealized losses—driven by rising interest rates rather than credit deterioration—indicates that CVS is deliberately trimming its CMBS exposure and treating the remaining securities as long‑term, interest‑rate‑sensitive assets, managing risk by holding them to recovery rather than selling.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains major factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574M in 2022, increased to $675M in 2023, and then dropped to $3M in 2024. The LLM incorrectly states fair values as $1.018B in 2022 and $0.975B in 2024, which are not only wrong but suggest a minor decline rather than a near-total divestment. The only correct numbers are the unrealized losses: $12M in 2022 and $100M in 2023. However, the LLM fails to mention that unrealized losses were not reported in 2024 due to the near-zero exposure, undermining the trend analysis. (2) The quantitative inaccuracies are severe: the LLM inflates 2022 fair value by over 77% ($1.018B vs $574M) and completely misses the 99.6% drop in 2024. This invalidates any calculation or comparison based on these figures. (3) The reasoning is partially sound in interpreting rising unrealized losses as interest-rate driven and not due to credit risk, but it fails the multi-hop synthesis: it does not recognize the dramatic 2024 drawdown as a strategic de-risking move. Instead, it suggests CVS is 'trimming' exposure and holding assets 'to recovery,' which contradicts the near-total exit shown in the data. (4) Contextual relevance is moderate—the answer addresses CMBS exposure, fair value, and unrealized losses over time, and attempts to infer risk management strategy. However, due to incorrect data and flawed interpretation of the trend, the conclusion about risk management is misleading. The correct narrative is a decisive risk reduction in 2024, not a passive hold strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 437,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Walmart steadily broadened the Marketside private‑brand assortment—adding new grocery categories, expanding SKU count and rolling the brand out to more store formats—while the 2023 and 2024 filings explicitly note “expansion” and “growth” of the Marketside portfolio. This three‑year progression shows that Walmart is treating Marketside as a core component of its grocery‑segment strategy, using private‑label expansion to boost margin, differentiate its offering and deepen customer loyalty.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported details not present in the ground truth. (1) The claim that Walmart 'broadened the Marketside private-brand assortment—adding new grocery categories, expanding SKU count and rolling the brand out to more store formats' is not supported by the original answer, which only states that Marketside was consistently included in the private brand portfolio from 2022 to 2024 without mentioning expansion of SKUs or categories. (2) The LLM asserts that '2023 and 2024 filings explicitly note expansion and growth of the Marketside portfolio,' but the ground truth does not mention such language in the filings—this is a fabrication. (3) While both answers agree that Marketside remained part of the portfolio, the original emphasizes continuity and coexistence with new brands like 'bettergoods,' whereas the LLM incorrectly frames the strategy around active expansion of Marketside specifically. (4) The conclusion about boosting margin, differentiation, and loyalty, while plausible, is speculative and not derived from the provided ground truth. The answer is contextually relevant and addresses the grocery segment and private label strategy, but fails on key qualitative and factual dimensions. Quantitative accuracy receives a moderate score because there are no explicit numerical errors (no numbers were cited), but the temporal framework (2022–2024) is correctly used. Overall, the LLM invents operational details and misrepresents the nature of Walmart's strategy, resulting in a partially correct but materially misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 441,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s progressively tightened its oversight of suppliers by updating its Vendor Code of Conduct and Human‑Rights policy to embed the Universal Declaration of Human Rights, conflict‑minerals standards and stricter environmental criteria, and by introducing a risk‑based wood‑sourcing policy that adds country‑specific risk levels, enhanced monitoring and a new forestry‑grievance process.  At the same time the company invested heavily in supply‑chain sustainability—spending > $300 million on energy‑efficiency and renewable‑energy projects, setting a science‑based net‑zero‑by‑2050 target with 2030 interim cuts (42 % Scope 1‑2 and 25 % Scope 3 reductions), and requiring suppliers to disclose emissions to CDP and adopt Sustainable Forestry Initiative standards—thereby strengthening both enforcement and measurable progress on environmental and human‑rights performance across its supply chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of Lowe's policy evolution—tightening supplier oversight, updating the Vendor Code of Conduct, enhancing wood sourcing with country-specific risk levels, and introducing a forestry grievance process—which aligns with the ground truth for 2023 and 2024. However, it misrepresents key quantitative details. The ground truth states that Lowe's invested *over $550 million by 2022* and *over $400 million through 2023* in operational sustainability initiatives, totaling more than $950 million across those years. In contrast, the LLM claims *'> $300 million'* spent on energy efficiency and renewables, which is factually incorrect and significantly underreports the scale of investment. Additionally, the LLM introduces specific emissions targets (42% Scope 1-2, 25% Scope 3 reductions by 2030, net-zero by 2050) and CDP disclosure requirements that are not present in the original answer and cannot be verified from the provided ground truth. (2) The dollar amounts are inaccurate: $300M vs. $550M+ and $400M+ reported in the truth; the LLM omits the cumulative nature of the spending and mischaracterizes the scope. No calculation is performed in the LLM answer, but the figures themselves are incorrect. (3) The qualitative reasoning is partially sound: the model correctly identifies multi-year policy enhancements related to human rights, conflict minerals, and wood sourcing, and links them to monitoring and enforcement. It synthesizes policy updates across years, showing an understanding of progressive strengthening. However, it adds unverified details (e.g., embedding the Universal Declaration of Human Rights, SFI standards, CDP disclosures, science-based targets) not present in the ground truth, indicating overreach or hallucination. (4) The contextual relevance is high—the answer addresses both policy evolution and investments in supply chain sustainability as asked. But due to significant quantitative inaccuracies and the introduction of unsupported specifics, the correctness score is limited to 5: partially correct but with major factual flaws in numbers and added content not grounded in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 584,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nIn the 2022 Form 10‑K Apple disclosed the $ X billion of 2.40 % senior notes that matured in 2023 as an outstanding long‑term borrowing (shown in Note 5 and classified as a current portion because the maturity was within the fiscal year). By the 2023 filing the note had been fully retired—Apple reported that the 2.40 % 2023 tranche was paid off and no longer appeared on the balance sheet. The 2024 filing contains no reference to a 2.40 % 2023 issue, indicating the debt was refinanced and replaced with newer long‑term borrowings, underscoring Apple’s ongoing strategy of proactively rolling maturing debt into fresh, low‑cost issuances to sustain a stable capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claims. According to the ground truth, Apple consistently disclosed the 2.40% Notes due 2023 in its filings for 2022, 2023, and 2024—even after maturity—demonstrating sustained transparency. However, the LLM incorrectly states that the note was retired by 2023 and absent in 2024, which contradicts the ground truth that it was still listed in 2024 filings. This misrepresents the entire pattern of disclosure. (2) Quantitatively, the LLM introduces a placeholder '$ X billion' without specifying the amount, which is a red flag. More critically, it asserts the note was 'paid off' and 'no longer appeared on the balance sheet' in 2023 and absent in 2024, which is factually wrong per the original answer stating it was still included in 2024. There are no calculations in the answer, but the timeline and status assertions are false. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent inclusion of the note across years as a sign of transparent legacy debt reporting, the model assumes retirement and replacement, inferring a refinancing strategy not supported by the data provided. The ground truth emphasizes continuity in disclosure, not refinancing or removal. (4) Contextual relevance is moderate—the answer addresses debt management strategy and attempts to interpret disclosure trends—but the factual foundation is incorrect, leading to a misleading conclusion. The model fabricates a retirement and refinancing narrative unsupported by the evidence. Thus, the correctness score is low due to major factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 445,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s exposure to AerCap moved from a sizable equity stake — about a 46 % ownership of AerCap ordinary shares (recorded as an equity security with a fair‑value of roughly $8.3 bn in 2021 and still reflected in the 2022 investment‑securities portfolio) — to a complete exit from the equity.  In 2023 the company sold the remaining AerCap shares, leaving only the AerCap senior note as its holding, and in 2024 the note remained on the balance sheet with a modest realized/unrealized gain reported in “Other income (loss).”  This progression shows that GE deliberately shifted from an equity‑heavy investment to a fixed‑income position, underscoring a strategic move toward more stable, cash‑generating assets and a streamlined portfolio after the HealthCare and Vernova spin‑offs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer states that GE's holdings of the AerCap note were $976M in 2022, $944M in 2023, and increased to $982M in 2024. The LLM answer does not mention these specific figures at all and instead incorrectly frames the evolution as a shift from a 46% equity stake in AerCap (valued at $8.3B in 2021) to only holding a note by 2023. There is no mention of the actual note values in any year, which are central to the question. (2) The numbers provided in the LLM answer (e.g., $8.3B equity value, 46%) are not present in the ground truth and appear to be fabricated or misattributed. The ground truth makes no reference to an equity stake or its sale, only the note holdings. Therefore, all quantitative claims in the LLM answer are unsupported and inaccurate. (3) The reasoning is flawed: the LLM assumes a multi-hop narrative involving equity divestment and transition to fixed income, but the ground truth only discusses the note — a financial instrument — and its fluctuating value. There is no evidence in the original answer of a strategic shift from equity to fixed income, nor any mention of spin-offs (HealthCare, Vernova) or their impact. These are extraneous details not grounded in the provided truth. (4) While the LLM attempts to interpret strategy — suggesting a move toward stable, cash-generating assets — this conclusion is based on incorrect premises. The ground truth suggests 'dynamic management' with 'slight overall stability,' not a strategic pivot. Thus, the reasoning fails the multi-hop test as it synthesizes non-existent data. Scores reflect major factual errors, especially in numbers and entities, though the answer is contextually relevant in discussing GE's financial instrument strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 495,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s U.S. pension glide‑path shifted from a ~15 % equity / ~75 % fixed‑income target (2022) to a ~9 % equity / ~80 % fixed‑income target (2023‑2024), with the “other” allocation falling from 10 % to 11 % (essentially flat).  This progression—reducing growth‑oriented equity and “other” holdings while increasing liability‑hedging fixed‑maturity securities—mirrors the plan’s improving funded ratio, showing that AIG de‑risked the portfolio by moving assets into safer, interest‑rate‑sensitive instruments as the pension’s financial position strengthened.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific percentage allocations (~15% equity / ~75% fixed-income in 2022, ~9% equity / ~80% fixed-income in 2023-2024), but these numbers are not present in the original answer (ground truth), which does not provide exact asset allocation percentages. Therefore, the quantitative claims cannot be verified and appear to be fabricated or inferred beyond the source material. The original answer focuses on the *mechanism* of the glide path—how target allocations are set based on prior-year funded status—and the *directional trend* of de-risking, not specific percentages. (2) There is a significant issue with quantitative accuracy: the LLM introduces precise figures (e.g., 15%, 75%, 9%, 80%) that are not supported by the ground truth. Additionally, the claim that 'other' allocation fell from 10% to 11%' is contradictory (a decrease cannot result in a higher percentage). This suggests a logical error in presentation. (3) The qualitative reasoning about de-risking in response to improved funded status is aligned with the original answer and reflects sound multi-hop understanding of liability-driven investing principles. The LLM correctly identifies the strategy of shifting from growth assets to liability-hedging assets as funded status improves. However, it overreaches by quantifying the shift without source support. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of the glide path and what it reveals about de-risking. The core concept of de-risking via increasing liability-hedging assets is correctly conveyed, even if unsupported specifics reduce factual accuracy. Thus, correctness is partially compromised by unsupported numbers, but the strategic interpretation is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 484,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments repeatedly framed embedded‑processing products as a core strategic pillar, but the financial trajectory of that line showed a clear evolution: after a 19 % revenue jump in 2021 (2022 10‑K), growth slowed to just 3 % in 2022 (2023 10‑K) and then turned negative with a 25 % decline in 2023 (2024 10‑K), while operating margins collapsed from roughly 38 % of revenue to under 14 %.  This multi‑year consistency underscores that, despite volatile top‑line performance, the embedded‑processing business continues to be a primary engine of cash generation—its high‑margin, capital‑intensive model underpins the long‑term growth of free‑cash‑flow‑per‑share, even when revenue dips.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth does not mention any revenue growth percentages (19%, 3%, -25%) or operating margin figures (38% to 14%) for embedded processing products across 2022–2024. These specific numbers and trends are not present in the original answer and appear to be fabricated or hallucinated. There is no mention of financial performance volatility in the ground truth, which instead emphasizes consistent strategic messaging. (2) The quantitative inaccuracies are severe: the LLM cites precise percentages for revenue growth and margin declines with apparent sourcing (e.g., '2022 10-K'), but these metrics are not part of the provided ground truth and contradict its qualitative emphasis on strategic consistency rather than financial fluctuation. Even if such data existed in actual filings, the original answer (ground truth) does not include them, so the LLM response diverges from the known facts in the knowledge graph. (3) The multi-hop reasoning is partially sound in structure—linking strategic emphasis across years—but flawed in execution. While the LLM correctly identifies that embedded processing is a strategic focus, it introduces a narrative of financial decline and margin collapse unsupported by the original answer, leading to an incorrect synthesis. The conclusion that the business remains a 'primary engine of cash generation' despite revenue dips is speculative and not aligned with the ground truth’s emphasis on strategic centrality due to competitive advantages and customer value, not financial resilience during downturns. (4) The contextual relevance is moderate because the answer addresses the right company, product line, and time frame, and attempts to link strategy to free cash flow per share. However, the introduction of false financial data severely undermines correctness. The qualitative reasoning would score higher if not for the invented metrics. Correctness is low due to major factual errors, even though the general direction of strategic importance is acknowledged.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 569,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s strengthened the intellectual‑property protection for its private‑brand names—especially Kobalt—by filing additional trademark and domain registrations and by tying those brands more tightly to its omnichannel platform.  The company shifted its brand‑portfolio emphasis toward higher‑value private labels while using digital‑first marketing, AI‑driven product recommendations and seamless fulfillment (click‑and‑collect, same‑day delivery) to integrate the private‑brand experience across in‑store, online and on‑site channels.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric values, dates, or calculations, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low because the answer introduces unsupported claims not present in the ground truth. Specifically: (1) There is no mention in the original answer about Lowe's filing additional trademark or domain registrations for Kobalt or other brands in fiscal 2022–2024; this is speculative and unverified. (2) The claim about 'shifting toward higher-value private labels' is not supported in the ground truth, which focuses on changes in disclosure emphasis rather than product-tier strategy. (3) While the ground truth notes the introduction of digital transformation language (e.g., remote support, mobile checkout) in 2024, the LLM overreaches by citing 'AI-driven product recommendations' and 'digital-first marketing,' which are not mentioned in the source. (4) The original answer emphasizes a narrowing of disclosed IP (removal of RONA and Reno Depot) as a sign of strategic focus, which the LLM omits entirely. Instead, the LLM fabricates specific initiatives (e.g., seamless fulfillment integration) without grounding in the filings. The contextual relevance is moderate because the answer addresses private brands and digital integration broadly, aligning with the question’s theme, but fails to accurately reflect the evolution as documented in the filings. The multi-hop reasoning is flawed—rather than synthesizing documented disclosure changes across years, it invents a narrative not supported by evidence. Thus, while the general direction (focus on private brands + digital) is plausible, the specific claims lack factual basis, warranting a correctness score of 4 for partial alignment with the truth but significant inaccuracies in reasoning and content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 504,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nIBM’s 2022 filing first listed “client relationships and trust” among the core ways it competes—alongside technology innovation, price and brand—while stressing that these ties help deliver business value to customers. By 2023 the language broadened to frame trust as the foundation of IBM’s hybrid‑cloud and AI platform, linking it to an open ecosystem, strategic partnerships and the ability to solve complex, regulated workloads. In 2024 the emphasis deepened further, describing trust as a strategic differentiator that underpins IBM’s hybrid‑cloud/AI growth, enabling it to leverage its incumbency, deep industry expertise and partner network to accelerate market share and prepare for next‑generation opportunities such as quantum computing. Together, the three‑year progression shows IBM is deliberately building its hybrid‑cloud and AI strategy around client trust, using it to differentiate from pure‑play cloud and AI vendors and to win high‑value, mission‑critical engagements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust as a competitive differentiator from 2022 to 2024, with evolving framing each year. In 2022, trust was tied to hybrid cloud and AI integration and business value delivery—consistent with the original answer’s mention of secure, open platforms and industry expertise. In 2023, the LLM correctly identifies the expansion of trust into ecosystem partnerships and complex workloads, matching the ground truth’s emphasis on AWS, Microsoft, and SAP collaborations. In 2024, the LLM captures the deepening focus on trust as foundational to growth and mentions strategic enablers like incumbency, industry expertise, and partner networks, which aligns with the addition of cybersecurity partners like Palo Alto Networks in the original. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects evolving language around trust to strategic positioning in hybrid cloud and AI, correctly inferring that this trajectory differentiates IBM from pure-play vendors and supports mission-critical engagements. The only minor gap is that the LLM does not explicitly name Palo Alto Networks or other cybersecurity partners in 2024, which is a specific detail present in the ground truth. However, it does refer to a 'partner network' and implies security through 'regulated workloads' and 'incumbency,' which captures the essence. (4) The answer is contextually excellent—directly addressing both parts of the question: the evolution over time and what it indicates about strategic positioning. The conclusion about differentiating from pure-play vendors and targeting high-value engagements is a valid interpretation supported by the data. Overall, this is a semantically equivalent, well-reasoned response with only a slight omission of a named partner in 2024, not affecting core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 582,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 the El Segundo, California site moved from a primarily **clinical‑trial manufacturing hub for Kite’s cell‑therapy products (e.g., Yescarta and Tecartus)** to a **fully integrated commercial‑scale production facility**.  Early in the period the plant was used to generate investigational drug‑product for Phase 1‑3 trials, but by 2023‑2024 it was expanded and qualified to meet **commercial demand**, supporting the launch of new cell‑therapy indications and providing the backbone of Gilead’s cell‑therapy supply chain while still continuing to produce clinical‑trial material.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about the evolution of Gilead's El Segundo facility. According to the ground truth, the facility's role remained consistent from 2022 to 2024, with no significant changes in responsibilities—it continued to handle both clinical and commercial manufacturing throughout the period. The LLM incorrectly asserts that the facility evolved from a 'primarily clinical-trial manufacturing hub' to a 'fully integrated commercial-scale production facility,' implying a transformation that did not occur per the filings. This misrepresents the factual timeline and strategic use of the site. There are no numeric values in either answer to verify for quantitative accuracy, but the qualitative error is severe: the model fabricates an expansion and qualification shift between 2023–2024 that is not supported by the source data. The reasoning is flawed as it fails to recognize the consistency across years and instead invents a progression. While the answer is contextually relevant—focusing on the right facility, company, and general topic of cell therapy manufacturing—the invented evolution undermines factual correctness. The mention of Yescarta and Tecartus, while plausible products, is not present in the original answer and adds unsupported specificity. Thus, despite addressing the question's scope, the answer conveys a false narrative, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 392,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s 10‑K filings show that the company continued to carry the 4.550 % senior notes that were first issued in 2019 and are scheduled to mature on April 5 2049; each year’s supplemental indenture (e.g., the 2022 Twentieth Supplemental Indenture and the 2023 Twenty‑Second Supplemental Indenture) added new tranches of debt but left the 4.550 % series unchanged in amount and maturity.  This multi‑year pattern demonstrates Lowe’s strategy of maintaining a stable, long‑dated fixed‑rate component in its capital structure—essentially “locking in” low‑cost financing and extending the debt‑maturity ladder rather than repeatedly refinancing shorter‑term obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 4.550% Notes maturing on April 5, 2049, and their consistent presence in Lowe's 10-K filings from 2022 to 2024, which aligns with the ground truth. However, it introduces inaccuracies regarding the supplemental indentures—claiming the 2022 Twentieth and 2023 Twenty-Second Supplemental Indentures added new tranches of debt while leaving the 4.550% notes unchanged. The ground truth specifies only the Fifteenth Supplemental Indenture dated April 5, 2019, as the governing document for these notes, with no mention of later supplemental indentures modifying other tranches. This is a significant factual error affecting quantitative and qualitative accuracy. (2) The maturity date (April 5, 2049), interest rate (4.550%), and issuance year (2019) are all correct. However, the references to specific supplemental indentures (Twentieth, Twenty-Second) are not supported by the ground truth and appear fabricated or misattributed, undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers that maintaining long-term debt with a fixed maturity reflects a strategy to extend the debt-maturity ladder and avoid refinancing risk. This interpretation aligns well with the ground truth’s conclusion about capital flexibility and long-duration debt strategy. (4) Despite the incorrect indenture details, the core insight about Lowe’s long-term debt strategy is preserved, warranting a correctness score of 7. The answer is contextually relevant and semantically close, but the erroneous citation of supplemental indentures prevents a higher score on factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 453,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the legal exposure tied to 3M’s Scotchgard (PFAS) products expanded dramatically: a wave of state‑attorney‑general lawsuits and the growth of the AFFF multidistrict litigation fed into a court‑approved public‑water‑system settlement that obligates 3M to pay $10.5 billion‑$12.5 billion (a $10.3 billion pre‑tax charge was recorded in Q2 2023) with payments stretching to 2036. This progression—from individual suits beginning in 2017, to MDL consolidation and bellwether trials slated for 2025—shows that PFAS‑related liability has become a multi‑billion‑dollar financial burden for 3M, forcing the company to set aside billions in reserves and underscoring the substantial, ongoing fiscal impact of Scotchgard‑related litigation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that severely undermine its correctness. (1) Quantitatively, the claim of a $10.5–12.5 billion settlement with a $10.3 billion pre-tax charge in Q2 2023 is incorrect and not supported by the ground truth. The original answer only mentions a $65 million settlement in 2022 and another $65 million in New York finalized in 2024, with no mention of a multi-billion-dollar settlement or any such charge in 2023. These figures are orders of magnitude off and represent a major fabrication. (2) The timeline is also inaccurate: the LLM references bellwether trials in 2025 and payments through 2036, which are not present in the ground truth. The original answer notes trial dates set for 2026 in Alabama, but nothing about 2025 trials or long-term payment schedules. (3) Qualitatively, while the LLM correctly identifies the expansion of PFAS-related litigation and links it to Scotchgard and AFFF, it conflates different litigation streams and overgeneralizes the scope. The original answer specifies discrete lawsuits in Michigan, New York, Illinois, Canada, Alabama, and Georgia, with specific co-defendants and settlement amounts, none of which are accurately reflected in the LLM response. (4) Contextually, the answer addresses the trend of increasing legal exposure and financial impact, which aligns with the question’s intent, but the reasoning is based on false premises. The conclusion about escalating financial burden is directionally consistent with the ground truth, but the magnitude and evidence are grossly misrepresented. Therefore, while the general theme of growing liability is relevant, the specific facts, numbers, and reasoning fail to match the ground truth, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 479,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has reshaped its Foster City, California campus from a primarily administrative and early‑stage R&D hub into a more integrated R&D‑plus‑manufacturing node that focuses on process‑chemistry, formulation and device‑development work for pipeline candidates, while handing off larger‑scale commercial production to its dedicated sites in Cork (Ireland), Hoofddorp (Netherlands), El Segundo and other global facilities.  This evolution reflects a strategic realignment that channels discovery and early‑stage manufacturing in Foster City and then leverages the company’s worldwide manufacturing network to support global product launches, collaborations and cell‑therapy scale‑up, thereby tightening the link between its U.S. R&D center and its broader global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Gilead's Foster City facility from a mixed administrative/R&D/manufacturing role in 2022 to a more focused hub on process chemistry, formulation, device development, and clinical-stage manufacturing in 2023–2024. The strategic shift of offloading commercial-scale production to other global sites (e.g., Cork, Hoofddorp, El Segundo) is accurately reflected, though the original answer specifically names La Verne and Oceanside as U.S. commercial sites, while the LLM emphasizes international sites and adds cell-therapy scale-up, which is contextually plausible but not explicitly confirmed in the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time (2022 vs. 2023–2024), distinguishes Foster City’s evolving role, and correctly aligns it with global operations. The only minor gap is the omission of the explicit mention of 'analytical method development' and 'API and drug product for clinical trials'—details present in the original answer—but the broader concepts are covered under 'formulation' and 'early-stage manufacturing'. (4) The answer is contextually excellent, directly addressing R&D focus, manufacturing responsibilities, and strategic alignment with global operations as required. Wording differs but semantic meaning is equivalent. One point deducted from correctness and qualitative accuracy for slight overgeneralization and inclusion of 'cell-therapy scale-up' not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 467,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nFrom 2022 through 2024 AIG layered additional oversight on its loss‑reserve risk: it codified a three‑tiered limit framework and risk‑appetite policy, required independent validation and “challenge” of reserve assumptions, and expanded the use of stochastic and scenario‑based modeling; each successive filing added stronger external scrutiny—2022 introduced formal external expert reviews of reserve estimates, 2023 brought structured challenge processes and third‑party catastrophe/terrorism model audits, and 2024 institutionalized credit‑risk monitoring of reinsurance recoverables and integrated outside model outputs into limit‑setting and capital‑allocation, thereby tightening governance, modeling rigor, and the incorporation of external reviews into loss‑reserve management.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and contextually relevant, capturing the evolution of AIG's loss reserve risk management from 2022 to 2024 with strong alignment to the ground truth. It correctly identifies the increasing sophistication in oversight (e.g., independent validation, challenge processes), modeling (stochastic and scenario-based methods), and integration of external reviews (expert reviews, third-party audits). The timeline is factually consistent: 2022 introduced external expert reviews, 2023 added structured challenge and model audits, and 2024 saw institutionalization within governance and capital processes. There are no numeric inaccuracies—dates and sequence are correct, and no specific dollar amounts or percentages are misstated. The qualitative content is largely equivalent to the original answer, though it introduces some details not explicitly in the ground truth (e.g., 'three-tiered limit framework', 'credit-risk monitoring of reinsurance recoverables', 'integration into capital allocation') that, while plausible, are not mentioned in the original. These additions do not contradict but slightly extend the source, suggesting possible over-specificity. The core multi-hop reasoning—synthesizing changes across years in oversight, modeling, and external review—is sound and well-structured. Thus, while the answer is factually robust and semantically aligned, it earns a slightly lower qualitative score due to minor content expansion beyond the ground truth. Overall, it correctly conveys the progression from reactive to proactive, model-driven, enterprise-wide governance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 439,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nBetween 2022 and 2024 the Melaka, Malaysia site remains listed in TI’s property tables only under the **Analog** column ( † in 2022, * in 2023, ** in 2024 ), indicating that the facility has continued to be dedicated solely to analog‑device manufacturing and has not been assigned any Embedded‑Processing capacity.  The changing footnote symbols simply reflect updates in lease/ownership details, underscoring that TI’s Melaka footprint is being used to expand its **analog** manufacturing base rather than to add embedded‑processing production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Texas Instruments' Melaka, Malaysia site remained exclusively dedicated to Analog manufacturing from 2022 to 2024, with no Embedded Processing activities introduced during this period. The mention of changing footnote symbols (†, *, **) correctly reflects updates in lease/ownership status without implying a change in manufacturing focus, which matches the ground truth's implication of operational stability. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing, 2022–2024 timeframe) are correctly identified and contextualized. The reasoning is sound: the continued presence only under the 'Analog' column in TI’s property tables supports the conclusion of a specialized, stable role in the company’s global manufacturing strategy. The only minor shortcoming is that the LLM slightly overemphasizes 'expansion' of the analog base based on footnote changes, while the ground truth emphasizes 'consistently maintained' without asserting expansion—this nuance prevents a perfect 10 on qualitative accuracy. However, this does not constitute a factual error, just a slight interpretive difference. Quantitative elements (years, site designation, absence of Embedded Processing) are fully accurate. The answer is highly relevant and synthesizes the correct multi-hop logic: (1) tracking the site across three years, (2) interpreting column placement in property tables, (3) drawing a conclusion about strategic focus. Thus, the answer is semantically equivalent to the original with high correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 443,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nLowe’s forward‑interest‑rate‑swap exposure grew from about $638 million at the end of fiscal 2022 to roughly $2.56 billion by fiscal 2023, and by fiscal 2024 the swaps were largely settled (fair‑value $0). This scaling shows the company deliberately expanded its cash‑flow hedges to lock in financing rates for a larger share of its anticipated debt issuances, reflecting a proactive strategy to manage future interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Lowe's did not increase its forward interest rate swap exposure from 2022 to 2023; instead, in 2022 the company referenced prior use of swaps (2019–2021), in 2023 it reported a $251 million fair value (not $2.56 billion), and by 2024 it no longer held any forward swaps. The LLM's claim of $638 million in 2022 and $2.56 billion in 2023 is entirely incorrect and contradicts the original answer. The only partially correct element is that swaps were gone by 2024, which aligns with the ground truth. (2) Quantitative accuracy is very low: the dollar amounts are off by more than an order of magnitude ($251M vs $2.56B), and the 2022 figure has no basis in the original answer. The original does not provide a 2022 fair value, only a discussion of past usage. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers growing exposure and a proactive expansion of hedging, when the actual progression shows a winding down and eventual cessation of forward swaps. The conclusion about a 'deliberate expansion' is the opposite of the truth—the company shifted away from hedging forecasted debt to focusing on existing debt. (4) Contextual relevance is moderate because the answer addresses the general topic of forward swaps and hedging strategy, but the factual foundation is so incorrect that the analysis is misleading. The qualitative reasoning fails due to incorrect premises, though the structure attempts to address the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 427,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nAcross IBM’s 2022, 2023 and 2024 Form 10‑K filings the company continues to disclose the 6.50 % Debentures due 2028 by referring to the same governing document—Exhibit 2 to the Form 8‑K filed on **January 8, 1998**—and does not introduce any newer or amended exhibit. This consistent citation shows that the debt instrument’s terms have been treated as a stable, long‑standing legal framework, with IBM repeatedly relying on the original 1998 filing as the authoritative source for the debenture series.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: IBM disclosed the 6.50% Debentures due 2028 in its 2022, 2023, and 2024 filings by consistently referencing Exhibit 2 to the Form 8-K filed on January 8, 1998. (2) Quantitative accuracy is perfect: the interest rate (6.50%), maturity year (2028), and filing date (January 8, 1998) match the original answer exactly. (3) The reasoning is sound and captures the multi-hop insight: the repeated citation of the same 1998 exhibit across three years implies no changes to the legal structure, indicating stability and absence of refinancing or amendments. (4) The answer addresses both parts of the question—evolution (or lack thereof) of disclosure and the implication of consistency—demonstrating strong qualitative and contextual accuracy. Minor wording differences (e.g., 'governing document' vs 'authoritative source') do not affect factual equivalence. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 286,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nThe reference to reflective signage moved from a peripheral item in the 2022 product list to a highlighted growth driver by 2023—when the Transportation & Electronics segment’s operating income jumped to $1.3 billion— and then was elevated further in 2024 with the creation of a dedicated “Commercial Branding and Transportation” division that places reflective‑signage activities at the core of the segment’s strategy. This progression signals that 3M now treats reflective signage as a strategic, high‑margin pillar within its portfolio rather than an ancillary offering.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) It falsely claims that reflective signage moved from a 'peripheral item' in 2022 to a 'highlighted growth driver' in 2023 and that a 'dedicated Commercial Branding and Transportation division' was created in 2024—none of which is supported by the original answer or implied by the product ordering data. The ground truth only notes changes in list position (5th → 4th → 4th), not organizational restructuring or strategic elevation to a 'core' pillar. (2) The LLM introduces a specific financial figure—'$1.3 billion' operating income for the segment in 2023—which is not mentioned in the original answer and cannot be verified from the provided context; this is a hallucination. (3) The multi-hop reasoning is flawed: the original answer infers strategic relevance from consistent top-half positioning, not income jumps or new divisions. The LLM misinterprets list order changes as evidence of dramatic strategic shifts unsupported by the data. (4) While the question asks about evolution and strategic importance, the LLM fabricates narrative elements (e.g., 'high-margin pillar', 'dedicated division') that go far beyond the evidence. The contextual relevance is moderate because it addresses the general topic and timeframe, but the factual and qualitative inaccuracies severely undermine correctness. Minor credit is given for recognizing that positioning changed and that this might reflect strategic importance, but the overall answer misrepresents the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 432,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Hoofddorp, Netherlands site from an early‑stage commercial cell‑therapy plant into the core European manufacturing hub for its cell‑therapy portfolio, using the facility to produce and ship products such as Yescarta and Tecartus at full commercial scale. By 2024 the site was regarded as strategically essential, underpinning Gilead’s European commercial production strategy and enabling larger volumes and broader indications for its cell‑therapy products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the facility's evolving strategic role from 2022 to 2024. It accurately captures the progression of Hoofddorp from an operational site to a core, strategically essential hub for commercial cell therapy manufacturing in Europe. The mention of Yescarta and Tecartus, while not in the original answer, is contextually plausible given Gilead's known cell therapy portfolio and does not contradict the ground truth; however, this specific product linkage is not verifiable from the provided ground truth and thus introduces unconfirmed detail. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects appropriate multi-hop synthesis across years (2022 to 2024) and strategic developments. The answer is semantically equivalent to the original in intent and factual trajectory, though slightly more specific in claiming 'ship products' and naming therapies—adding detail beyond the ground truth without inaccuracy. This results in a high but not perfect qualitative and overall correctness score due to the addition of plausible but unverified specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 342,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nFrom 2022 through 2024 the pool of shares that could still be issued under the 2003 Director Compensation Plan (which is now administered through its successor, the 2018 Director Compensation Plan) steadily shrank—from roughly **1.84 million shares available in 2022**, to **1.79 million in 2023**, and to **about 1.75 million shares in 2024**.  This continual reduction shows that Texas Instruments is still actively granting director‑related equity awards from the plan, but the diminishing reserve indicates the company is using an increasingly smaller portion of the plan’s authorized shares as it progresses through the current grant cycle.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the downward trend in shares available under the 2003 Director Compensation Plan from 2022 to 2024, with accurate approximate values: 1.84 million (vs. 1,843,134), 1.79 million (vs. 1,786,785), and 1.75 million (vs. 1,745,284). These rounded figures are semantically equivalent and acceptable per evaluation guidelines. (2) The quantitative values are correctly represented within reasonable rounding; no calculation errors are present. The direction and magnitude of the decline are accurately conveyed. (3) The reasoning is sound: the decreasing share availability is correctly interpreted as evidence of ongoing use of the plan for director compensation. The mention of the 2018 successor plan adds context not in the original answer but does not contradict it—many companies maintain legacy plans while transitioning to new ones. However, the original ground truth does not mention the 2018 plan, so this addition, while plausible, slightly deviates from the provided facts. (4) The answer fully addresses both parts of the question: the evolution of shares and the implication about ongoing use. The conclusion about active granting and diminishing reserves aligns with the ground truth. Minor deduction in qualitative accuracy due to the unverified reference to the 2018 plan, but overall the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 393,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nFrom 2022 through 2024 IBM shifted the way it disclosed its 0.950 % Notes due 2025 from a terse entry in the debt‑securities table (2022 10‑K) to a fully identified issue—labeled “IBM25B” with a ticker symbol—and to repeatedly citing the governing Exhibit 4.1/4.2 filing that details the notes’ terms. In the 2023 and 2024 filings the company not only listed the notes alongside its other registered securities but also incorporated the 2017 Form 8‑K by reference, thereby providing investors with a clear, searchable identifier and direct access to the full prospectus‑style terms. This incremental increase in specificity and repeatability signals IBM’s broader capital‑market strategy of treating its debt issuances as transparent, regularly communicated components of its capital structure, and reflects a more proactive investor‑engagement approach aimed at reinforcing confidence, lowering financing costs, and keeping stakeholders informed of any amendments or new tranches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were initially referenced in the 2022 10-K as part of a broader list, continued to be cited via the May 22, 2017 Form 8-K (Exhibit 4.1) in 2023, and by 2024 were assigned the trading symbol IBM25B on the NYSE. The LLM correctly identifies the evolution in disclosure and transparency. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and reference to Exhibit 4.1 (and slight variation to 4.2, which may reflect a minor clerical inconsistency but does not undermine accuracy)—are correct. The dates and document types (Form 8-K, 10-K) match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers increasing prominence and market visibility, and connects this to broader capital market strategy. (4) The LLM adds value by interpreting the trend as part of a proactive investor engagement strategy aimed at transparency and confidence-building—this is a reasonable and insightful extension of the ground truth, which states the move indicates greater transparency and investor accessibility. The only minor deviation is the mention of 'Exhibit 4.2' alongside 4.1, which is not in the original answer and could be a small factual overreach, but does not materially misrepresent the facts. Overall, the answer is semantically equivalent, contextually rich, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 414,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s use of the deposit method remained modest at first—deposit assets of roughly $1.8 bn and deposit liabilities of about $1.4 bn were reported in the 2021‑2022 filings—but the balances expanded sharply after 2023, reaching $5.1 bn of deposit assets and $1.3 bn of deposit liabilities by the end of 2023 (and $4.6 bn / $1.2 bn by the end of 2024) as disclosed in the 2023 and 2024 10‑Ks.  \n\nThe November 2023 risk‑transfer with Global Atlantic marked a strategic shift: rather than recording traditional ceded reinsurance recoverables, MetLife recorded a $10.3 bn deposit receivable (and transferred $9.5 bn of assets) while also booking a $770 mn net cost of reinsurance, thereby moving a large, non‑traditional block of universal‑life and annuity liabilities onto the balance sheet via deposit assets and liabilities and aligning the accounting with LDTI and the economics of the risk‑transfer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers match: 2022 deposit assets ($1.8B) and liabilities ($1.4B), 2023 ($5.1B assets, $1.3B liabilities), and 2024 ($4.6B assets, $1.2B liabilities) are correct. The $10.3B deposit receivable from the Global Atlantic transaction is accurately reported. The mention of $9.5B in transferred assets and $770M net cost of reinsurance adds detail not in the original but is consistent with plausible supplemental data and does not contradict the ground truth. (2) The timeline is slightly misstated with '2021-2022 filings'—the original specifies 2022 data, so referencing 2021 is a minor inaccuracy—but the core 2022 figures are correct. (3) The qualitative analysis captures the strategic shift: the use of deposit accounting instead of traditional reinsurance recoverables for the Global Atlantic transaction reflects a meaningful change in accounting approach, which the LLM correctly identifies and contextualizes with LDTI alignment and economic substance. (4) The answer fully addresses both parts of the question: the evolution of deposit assets/liabilities over time and the strategic implications of the 2023 transaction. The reasoning is sound, multi-hop synthesis is accurate, and the added context about LDTI and risk transfer enhances understanding without introducing error. Only a minor point on the 2021 reference prevents a perfect 10, but factual correctness remains excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 409,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the Safety & Industrial segment kept “fall‑protection solutions” in its core product list, and in 2024 the company reorganized those offerings into a new **Industrial Specialties** division that consolidates fall‑protection items with other personal‑safety products previously spread across the Closure, Masking and Personal Safety divisions.  During the same three‑year span the segment’s net sales slipped modestly (from $11.6 bn in 2022 to $10.96 bn in 2024) while operating income surged (from $1.135 bn to $2.49 bn), indicating that 3M is reallocating resources toward higher‑margin safety products and underscoring a strategic focus on workplace‑safety solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported information not present in the ground truth. (1) The claim that in 2024 3M reorganized fall protection into a new 'Industrial Specialties' division, consolidating products from Closure, Masking, and Personal Safety divisions, is not supported by the original answer or the knowledge graph; the ground truth indicates only a minor phrasing evolution in product listing, not a structural reorganization. (2) The financial figures—$11.6B sales in 2022 and $10.96B in 2024, with operating income rising from $1.135B to $2.49B—are entirely absent from the original answer and cannot be verified from the provided context; these numbers are likely hallucinated. (3) The qualitative reasoning about reallocating resources toward higher-margin safety products due to rising operating income is speculative and based on incorrect data, undermining the multi-hop logic. (4) While the LLM correctly identifies that fall protection solutions remained part of the Safety and Industrial segment from 2022 to 2024, it overreaches by inferring strategic shifts and organizational changes not reflected in the source. The ground truth emphasizes consistency and stable focus, not transformation or financial performance shifts. Thus, despite some contextual relevance in discussing 3M’s safety focus, the answer fails on quantitative and qualitative accuracy, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 402,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nAltria continued to hold UST as a wholly‑owned subsidiary throughout 2022‑2024, but the way it governed and deployed that smokeless‑tobacco business evolved.  In 2022 the company still relied on UST for its traditional MST/snus portfolio, yet by 2023 it formed the Horizon joint venture with Japan Tobacco (a 75 % Altria stake) to commercialize heated‑tobacco products and added the e‑vapor brand NJOY through acquisition—moves that shifted Altria’s smokeless strategy from a single‑owner model to a partnership‑driven, multi‑category approach that shares risk and leverages external expertise while retaining control over its core smokeless assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) It incorrectly states that Altria formed a Horizon joint venture with Japan Tobacco with a 75% stake in 2023 and acquired NJOY—these events are not mentioned in the original answer and contradict the documented evolution of UST’s role within Altria. The ground truth emphasizes UST’s continued status as a wholly owned subsidiary and its integration into Altria’s 'Moving Beyond Smoking' initiative, not a shift to a partnership-driven model. (2) There are no numeric values in the LLM answer that align with the ground truth’s $8.8 billion trademark valuation or any amortization details, and the 75% stake figure is unsupported. (3) The multi-hop reasoning is flawed: instead of tracing the consistent strategic emphasis on UST across years, the model fabricates a strategic pivot involving external partnerships and acquisitions not reflected in the source. (4) While the answer addresses Altria’s positioning in the smokeless market, it misrepresents the nature of that strategy, making it partially relevant but factually unsound. The core progression—UST as a stable, increasingly integrated subsidiary aligned with reduced-risk initiatives—is entirely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 357,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nTesla’s repeated citation of the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 in its 2022, 2023 and 2024 filings shows that the company treats this asset‑backed debt as a core, long‑term financing tool for its solar portfolio. By continually referencing the indenture, Tesla signals that it intends to rely on structured, solar‑project‑linked borrowing—rather than equity—to fund and sustain its solar energy initiatives and to assure investors of the cash‑flow stability underlying those projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core meaning of the ground truth. (1) All entities are correct: Tesla, SolarCity 5.45% Solar Bonds, Series 2015/C92-15, and the 2022–2024 filing period are accurately referenced. The percentage (5.45%) is correct, and no incorrect dates or figures are introduced. (2) Quantitative accuracy is perfect: the bond series, interest rate, and years of filing references (2022, 2023, 2024) match the ground truth. No calculations are required, but the temporal consistency is correctly noted. (3) Reasoning is sound: the LLM correctly infers that repeated mention indicates strategic reliance on structured solar debt, interprets the indenture reference as a signal of ongoing financial linkage, and connects this to investor confidence and cash-flow stability. It correctly identifies the use of debt over equity as a strategic choice. (4) The only minor shortcoming is completeness: the LLM omits specific mention of the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015'—a material detail in the original that strengthens the legal and historical grounding of the bond's significance. While not changing the conclusion, its absence slightly reduces qualitative completeness. Otherwise, the answer is semantically equivalent in intent and meaning, with excellent contextual relevance to Tesla's long-term solar financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 386,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s 10‑K filings repeatedly stress that its debt and equity securities are exposed to U.S. and foreign securities‑exchange rules, rating‑agency actions and market‑liquidity conditions, and that a breach of exchange‑listing requirements could impair its ability to raise capital or trigger defaults.  Accordingly, IBM’s capital‑market risk‑management strategy has evolved to focus on maintaining robust liquidity buffers, diversifying its funding base, hedging interest‑rate and currency risk, and closely monitoring credit ratings and regulatory changes so that evolving exchange regulations have a limited impact on the cost and availability of its financing.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in terms of IBM's actual risk management strategy evolution. (1) Correct elements: The LLM correctly identifies that IBM faces exposure to stock exchange regulations affecting both debt and equity securities across 2022–2024, and mentions relevant factors like market liquidity, credit ratings, and regulatory changes. These align with the general risk disclosures. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no numeric inaccuracies exist—this aspect is neutral and does not detract. (3) Multi-hop reasoning assessment: The LLM fails the core multi-hop synthesis. While the ground truth states IBM showed *no material reduction in dependency or mitigation strategy* over the period and instead demonstrated *increasing recognition* of regulatory risk as systemic, the LLM incorrectly claims IBM’s strategy has 'evolved' to include active mitigation via liquidity buffers, funding diversification, hedging, and monitoring—implying progress in risk control. This contradicts the original answer, which emphasizes IBM's continued lack of assurance in managing these risks and absence of meaningful strategic shift. (4) The LLM introduces proactive risk management actions (e.g., hedging, diversification) not present in the ground truth, which only describes IBM as observing and reiterating exposure without evidence of strategic evolution. Thus, while contextually relevant and factually plausible, the answer fabricates a mitigation narrative unsupported by the source data, leading to a moderate correctness score. Semantic equivalence is broken on the key point of strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 477,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nFrom 2022 through 2024, 3M repeatedly reshaped its Safety & Industrial reporting structure—first highlighting “electrical products and materials for construction and maintenance” within the broader segment, then creating an **Industrial Specialties** division (2023) and, after the health‑care spin‑off, making that division a core part of the Safety & Industrial business (2024). This deliberate re‑grouping shows that 3M is concentrating its strategy on industrial‑market electrical solutions, using dedicated reporting and resource allocation to strengthen its competitive positioning in construction‑ and maintenance‑related markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite correct dates and general topic focus. (1) It incorrectly claims that 3M created an 'Industrial Specialties' division in 2023 and restructured the Safety & Industrial segment around it post-healthcare spin-off in 2024—this is not supported by the ground truth. The original answer confirms that electrical products remained part of the Safety and Industrial segment throughout all three years without mention of a new division or structural changes tied to the healthcare spin-off. (2) The ground truth shows evolution in product emphasis within the segment—adding autobody repair and industrial abrasives in 2023, then rephrasing to highlight industrial specialties in 2024—but no formal creation of an 'Industrial Specialties' division. The LLM misrepresents this linguistic shift as an organizational restructuring. (3) Multi-hop reasoning fails: while the model identifies the continuity of electrical products, it fabricates strategic reorganizations and misattributes the evolution as structural rather than descriptive. (4) The conclusion about 'dedicated reporting and resource allocation' is unsupported inference. Though the focus on industrial markets is consistent with the original answer, the LLM's explanation is based on incorrect premises. Quantitative accuracy is high because there are no numbers to report and dates (2022–2024) are used appropriately. Contextual relevance is moderate since the answer addresses the general theme of strategic positioning in industrial markets but does so with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 435,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom the 2022‑2024 10‑K filings, Gilead describes the Oceanside, California campus as the company’s **commercial retroviral‑vector manufacturing site and a center for clinical‑trial manufacturing and process development of biologics candidates**.  Over the three‑year period the company **scaled up utilization of that facility**, adding capacity and integrating it more tightly into the supply chain for both retroviral‑vector‑based therapies (e.g., Yescarta) and additional biologics programs, so that by 2024 Oceanside had become a key hub for Gilead’s biologics and retroviral‑vector production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of GILD's Oceanside facility from 2022 to 2024 as described in the ground truth. It correctly identifies the progression toward commercial retroviral vector manufacturing and continued role in clinical manufacturing and process development of biologics. While the original answer specifies that in 2022 the site was part of a broader R&D footprint and only later became specialized, the LLM generalizes the 2022–2024 period together, slightly compressing the timeline but not misrepresenting the overall strategic shift. There are no numeric inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved). The reasoning is sound and reflects multi-hop synthesis across years, correctly inferring increased utilization and strategic importance. The mention of Yescarta adds contextual detail not in the original but is plausible and relevant. The only minor shortcoming is the lack of year-by-year differentiation (e.g., not explicitly stating that commercial retroviral vector manufacturing was a 2024 development), which slightly affects qualitative precision. However, the semantic meaning and strategic trajectory are correctly conveyed, and the answer fully addresses the question with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 362,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nAIG’s glide‑path reduced the growth‑oriented “Return‑Seeking” allocation from **15 % of the U.S. pension portfolio in 2022** to **9 % in the 2023 target** (and kept that 9 % level for the 2024 target). This reflects a deliberate shift toward a more liability‑driven, lower‑risk asset mix as the plan’s funded ratio improved.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that AIG reduced the Return-Seeking allocation from 15% in 2022 to 9% in 2023 and 2024, but the ground truth does not provide any specific percentage allocations for the Return-Seeking portion of the portfolio. Instead, the original answer describes a methodological evolution in the glide path approach—specifically, how target allocations are set forward-looking based on funded status at year-end. There is no mention of 15% or 9% in the ground truth, making the numerical claims entirely fabricated. (2) Quantitative accuracy is very low because the percentages cited (15%, 9%) are not present in the ground truth and cannot be verified from the provided information. The answer introduces precise numbers where none were given, which constitutes a serious factual error. (3) The reasoning is partially sound in that it infers a strategic shift toward de-risking, which could align with a glide path approach, but it fails the multi-hop requirement: instead of explaining how the target-setting process evolved (i.e., setting 2024 targets in 2023 based on 2023 funded status, etc.), it invents a narrative around specific allocation percentages that are not in the source. The model misinterprets the nature of the evolution—methodological vs. quantitative. (4) Contextual relevance is moderate because the answer addresses AIG’s U.S. pension plan and the general concept of glide path evolution, but it does so with incorrect data. While the direction of de-risking may be plausible, the absence of actual numbers in the ground truth means the LLM hallucinated key details. Correctness is severely compromised by these inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 468,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\n**Target‑allocation evolution (fiscal 2023 → fiscal 2025)**  \n\n| Plan region | Fiscal 2023 target mix* | Fiscal 2025 target mix* | Key changes |\n|-------------|------------------------|------------------------|-------------|\n| **U.S. defined‑benefit plan** | • Debt securities ≈ 97 %  <br>• Equity = 0 %  <br>• Cash = 0 %  <br>• Insurance = 0 %  <br>• Other = 0 % | • Debt securities = 100 %  <br>• All other buckets = 0 % | The U.S. portfolio stays essentially “all‑bond” – no equity or cash exposure is added; the allocation remains ultra‑conservative. |\n| **Non‑U.S. defined‑benefit plans** | • Equity ≈ 21 %  <br>• Debt ≈ 50 %  <br>• Cash ≈ 4 %  <br>• Insurance ≈ 15 %  <br>• Other ≈ 10 % | • Equity ≈ 28 %  <br>• Debt ≈ 36 %  <br>• Cash ≈ 7 %  <br>• Insurance ≈ 21 %  <br>• Other ≈ 8 % | Equity rises 7 pp, debt falls 14 pp, cash doubles, insurance rises 6 pp, other drops 2 pp. The non‑U.S. mix becomes more diversified and slightly more equity‑heavy. |\n\n\\*Percentages are taken from the “Target Allocation” tables in the 2023 and 2025 plan‑asset sections of the filing.\n\n**What the multi‑year shift signals about long‑term risk tolerance**\n\n1. **Gradual diversification** – The non‑U.S. plans are moving toward a higher equity and cash component while reducing the proportion of traditional fixed‑income assets. This indicates that ACN is **incrementally expanding its willingness to accept market volatility** in order to chase higher long‑term returns, but it does so within a controlled, still‑predominantly‑fixed‑income framework.\n\n2. **Conservative core retained** – The U.S. plan continues to be virtually 100 % debt, and even the non‑U.S. shift leaves debt as the single largest bucket (36 % of assets). The company is **not abandoning its liability‑matching, low‑volatility core**; the changes are modest and balanced by sizable cash and insurance holdings that help preserve funding stability.\n\n3. **Risk‑capacity signal** – By increasing equity exposure (especially abroad) and modestly raising cash/insurance buffers, ACN is **signaling a modestly higher long‑term risk tolerance**—it is comfortable allowing a small portion of the portfolio to fluctuate more for potential upside, while still safeguarding the ability to meet benefit obligations.\n\n**In short:** From fiscal 2023 to fiscal 2025 ACN’s defined‑benefit asset strategy shifts from a nearly‑all‑bond allocation (U.S.) and a balanced 21 %‑equity/50 %‑debt mix (non‑U.S.) to a slightly more equity‑heavy, cash‑rich, and diversified non‑U.S. portfolio, while the U.S. side stays ultra‑conservative. This multi‑year evolution suggests that ACN is **cautiously expanding its risk appetite**, moving toward a modestly higher‑return, more diversified asset mix without relinquishing the primary goal of matching liabilities and preserving funding security.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the original answer (ground truth) in both quantitative and qualitative aspects. (1) There are no actual numeric target allocations provided in the ground truth for ACN's defined benefit plans in fiscal 2023 or 2025; the original answer does not contain percentages like '97% debt' or '21% equity'—these numbers are fabricated. The ground truth focuses on the *planning horizon* and *strategic language* around asset allocation (e.g., shifting from one-year to two-year forward planning), not specific regional portfolio breakdowns. (2) The LLM invents a detailed table with U.S. and non-U.S. plans, specific percentage allocations, and year-over-year changes (e.g., 'equity rises 7 pp'), none of which appear in or can be inferred from the original answer. These numbers are entirely hallucinated. (3) The multi-hop reasoning is flawed: the original answer emphasizes a shift in *planning timeframe* (from setting targets one year ahead to two years ahead) as evidence of increased strategic confidence, not changes in asset mix. The LLM instead focuses on non-existent portfolio rebalancing, missing the core concept of forward-looking planning horizons and risk management philosophy. (4) While the LLM attempts to interpret risk tolerance, its conclusion about 'cautiously expanding risk appetite' through equity increases is unsupported by the ground truth, which instead cites consistent liability-matching and flexibility as signs of a stable, measured approach. The contextual relevance is moderate because the answer addresses asset allocation and risk tolerance, but the factual foundation is entirely incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1936,
        "completion_tokens": 464,
        "total_tokens": 2400
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nAcross 2022‑2024 the 5.45 % Solar Bonds, Series 2015/C25‑15 remained on Tesla’s balance sheet but were steadily wound down: the 2022 filing listed them as still outstanding (≈ $1 bn principal) with no new amendments, the 2023 filing recorded a supplemental indenture that added waivers and allowed a partial early redemption, and the 2024 filing confirmed the complete retirement of the remaining tranche. This progression shows Tesla is deliberately retiring the legacy multi‑tranche solar‑bond structure and shifting toward more conventional project‑level financing and direct asset‑retirement strategies.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth on key factual and qualitative points. (1) Quantitatively, the LLM claims the bond had approximately $1 billion principal in 2022 and was fully retired by 2024, including a 'partial early redemption' and 'complete retirement'—but the original answer states no such retirement occurred; instead, the bond series was consistently included in filings across all three years, indicating ongoing use, not wind-down. There is no mention of dollar amounts in the ground truth, so the LLM's $1B figure is unsupported and likely fabricated. (2) The LLM references a 'supplemental indenture' in 2023 with waivers and early redemption, and full retirement in 2024—none of which is mentioned or implied in the original answer. These specific events are factually incorrect and represent significant hallucinations. (3) Qualitatively, the LLM concludes Tesla is shifting away from structured solar bonds toward 'conventional project-level financing,' while the ground truth indicates the opposite: Tesla is expanding its use of such structures (e.g., adding Series C28-15 and C33-15) and maintaining long-term reliance on them. The multi-hop reasoning fails because the LLM misinterprets the pattern: consistency and expansion are portrayed as phase-out. (4) Contextually, the answer addresses the right topic—Tesla's solar bond strategy—and attempts a multi-year analysis, so it remains relevant. However, the factual foundation is flawed, leading to an incorrect strategic interpretation. Minor credit is given for addressing the time frame and bond series correctly as entities, but the narrative is fundamentally unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 456,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 to 2024 AIG shifted from a U.S.-centric, TRIPRA‑reliant terrorism model that produced a single $1.3 billion net loss estimate for a NYC five‑ton bomb (based on 2021 exposures) to a global, scenario‑based modeling framework that is applied across multiple jurisdictions and includes vendor‑model adjustments and sensitivity analyses.  This evolution was accompanied by the addition of targeted private reinsurance purchases for selected lines of business and greater reliance on government‑sponsored terrorism pools in non‑U.S. markets, while exposure concentrations are now monitored routinely worldwide to shape risk‑mitigation and reinsurance strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's international terrorism exposure management from 2022 to 2024, including the shift toward global scenario-based modeling, use of government-sponsored pools, and active monitoring of exposure concentrations. It accurately references the $1.3 billion net loss estimate for a five-ton bomb attack in New York City, consistent with the 2022 data in the ground truth. However, it does not mention the specific 2024 reinsurance recoverable asset value of $38.0 billion, which is a key quantitative metric indicating scaled risk transfer mechanisms—this omission affects completeness. Also, while the LLM notes 'vendor-model adjustments and sensitivity analyses,' this detail is not present in the original answer and may represent inference or overstatement. (2) The only numeric value provided in the LLM answer—$1.3 billion—is correct and matches the ground truth for 2022. The absence of the $38.0 billion reinsurance recoverable figure from 2024 and the $200 million attachment point in Japan (retained in 2024) constitutes a partial omission of key financial metrics. These missing figures impact quantitative completeness despite accuracy where numbers are stated. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years, identifying a shift from U.S.-centric TRIPRA reliance to a more global, actively managed framework. It correctly links reinsurance strategy changes with geographic diversification and risk monitoring. However, it fails to explicitly note the continuity in reliance on scenario modeling and pools, instead framing the change as a shift, which slightly misrepresents the evolutionary (not revolutionary) nature described in the original. (4) The contextual relevance is high—the response directly addresses modeled loss estimates, reinsurance strategies, and risk mitigation across jurisdictions. The qualitative accuracy is strong due to correct entity identification (AIG, TRIPRA, government pools) and logical progression, but docked slightly for missing specifics on Japan and reinsurance recoverables. Overall, the answer is factually aligned with minor gaps in completeness, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 598,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment experienced a steady erosion of sales—organic declines of roughly 20 % in 2023 and 12 % in 2022—reflecting worsening macro‑economic conditions and cutbacks in customer spending on automation, safety‑monitoring and plant‑capacity projects.  The segment’s margins were repeatedly squeezed by risks that were highlighted across all three years: reduced investment in process‑automation and safety initiatives, a slowdown in demand for safety and productivity products, intensified competition that drove product commoditization and pricing pressure, and the broader adverse industry economic environment.  These factors were consistently cited in the risk‑factor disclosures for 2022, 2023 and 2024 as the primary drivers of margin pressure.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the persistent risks in Honeywell's Safety and Productivity Solutions segment from 2022 to 2024, including reduced investment in process automation, product commoditization, pricing pressure, and adverse industry conditions. These align with the original answer’s core qualitative points. However, the LLM introduces specific quantitative claims—organic sales declines of 12% in 2022 and 20% in 2023—that are not present in the ground truth and cannot be verified from the provided knowledge graph. These figures are likely fabricated or misattributed, severely undermining factual accuracy. (2) There are no calculations in the original answer to verify, but the introduction of unsupported percentages constitutes a major quantitative error. The ground truth does not mention sales declines or numerical performance metrics, so these numbers are extraneous and incorrect. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes recurring risk factors across years and links them to margin pressure in the relevant segment. It also acknowledges the continuity into 2024 despite restructuring, which matches the original’s emphasis on persistent vulnerability. However, it fails to note the 2024 rebranding to Industrial Automation as a successor segment, missing a key structural detail. (4) While the qualitative themes are consistent and contextually relevant, the inclusion of false quantitative data significantly reduces correctness. The answer captures the right risks and their ongoing impact but presents them with invented metrics, leading to a partial score. Contextual relevance is high because the response stays focused on the question and synthesizes cross-year risks appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 481,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards (BPAs) were only issued in 2022 to selected non‑executive employees; the awards were measured at grant‑date using the intrinsic‑value method based on the closing share price and were expensed on a straight‑line basis over the probable vesting period, with periodic adjustments for share‑price movements, expected payout and management’s assessment of performance‑goal achievement. In 2023 and 2024 the company reported **no BPA grants and no BPA balances outstanding at year‑end**, so no expense was recorded in those years, even though the valuation and straight‑line amortization approach remained the same as in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution of Pfizer's BPA program from 2022 to 2024. (1) Quantitatively, the LLM correctly states that BPAs were only granted in 2022 and that there were no grants or outstanding balances in 2023 and 2024, aligning with the ground truth that 1,165 thousand were granted in 2022 and 859 thousand remained nonvested by year-end, with zero outstanding as of December 31, 2023. However, the LLM omits the specific weighted average intrinsic value of $38.73 per share mentioned in the original answer, which is a minor but notable omission in quantitative detail. (2) The LLM accurately describes the valuation methodology (intrinsic value method, straight-line amortization over probable vesting period) and the practice of adjusting for stock price changes and performance goal probabilities, which matches the 2024 disclosure in the ground truth. (3) The reasoning is sound: it correctly synthesizes that the program was active in 2022, fully wound down by 2023, and that 2024 focused on methodology despite no active awards. (4) The answer is contextually complete and relevant, addressing grant activity, valuation, and financial statement recognition across all three years. The only shortcoming is the missing $38.73 intrinsic value figure, preventing a perfect score, but the core facts, logic, and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 381,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture repurchased roughly 12.2 million shares for $4.1 bn in 2022, about 13 million shares for $4.5 bn in 2023, and 2.07 million shares for $605 m in Q4 2024 (total $4.5 bn for the full‑year 2024). Its remaining share‑repurchase authorization grew from $3.1 bn at the end of 2022 to $6.1 bn after a 2022 increase, held near $6 bn through 2023, and was raised to $6.69 bn in September 2024. This steady expansion of authority and consistent repurchase volume reflects a disciplined, cash‑driven capital‑return strategy that prioritizes returning excess cash to shareholders while maintaining flexibility for future growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, in fiscal 2022, Accenture had $3.129 billion in available authorization, not $3.1 billion growing to $6.1 billion after an increase in 2022 — this new authorization is not supported by the original answer. The LLM claims the remaining authorization was raised to $6.69 billion in September 2024, which aligns with the ground truth total of $6,694 million after a $4,000 million addition, but misrepresents the prior state. The ground truth states that as of August 31, 2024, the remaining authorization was $2,694 million *before* the $4,000 million addition — the LLM incorrectly implies the $6.69 billion was a continuation of a steady $6 billion level through 2023, when in fact the remaining authorization had decreased due to repurchases. (2) The LLM introduces specific repurchase volumes (e.g., 12.2 million shares for $4.1B in 2022) that are not present in the ground truth and cannot be verified; the original answer does not provide annual repurchase amounts, only authorization levels. These fabricated figures severely undermine quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that the authorization increased in 2022 to $6.1B, and that it remained stable through 2023, which contradicts the ground truth showing a reduction in available authorization by 2023 due to spending. The trend interpretation — while directionally reasonable — is based on incorrect data. (4) Despite these issues, the answer is contextually relevant and attempts to address the evolution of repurchase activity and strategy. The final conclusion about a disciplined capital return strategy is semantically aligned with the ground truth’s interpretation of increasing commitment, though it is based on inaccurate premises. Thus, correctness and quantitative accuracy are low due to unsupported numbers and miscalibrated trends, while qualitative reasoning and contextual relevance are partially preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 554,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter selling Meridian on 31 December 2021 for roughly $51 million, Pfizer’s only remaining ties were a three‑year master‑services agreement (with a two‑year extension) and interim transition‑service agreements that were fully completed by 31 December 2023; the 2022‑2024 Form 10‑K filings show only immaterial post‑close adjustments to discontinued operations and no further operational or strategic collaboration, confirming that Meridian is now fully divested.  The disclosures also note the $167 million after‑tax loss recorded on the 2021 sale and thereafter reflect only minor, non‑material adjustments, underscoring the strategic exit from any ongoing relationship.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the divestiture date (December 31, 2021), sale price (~$51 million), and after-tax loss (~$167 million), all of which match the ground truth. It accurately reflects that post-2021, Meridian was reported as discontinued operations and that by 2024, there was no active relationship. However, the LLM introduces specific operational agreements—a three-year master-services agreement with a two-year extension and interim transition-service agreements—completed by December 31, 2023, which are not present in the original answer or supported by the provided ground truth. This adds detail not confirmed by the source, slightly undermining factual accuracy. (2) All numeric values (dates, dollar amounts) are correct and properly formatted; no calculation errors. (3) The multi-hop reasoning is strong: the model correctly traces the financial and operational disengagement from 2022 through 2024, synthesizing the implications of the 2021 sale into subsequent disclosures. The conclusion of full divestiture and lack of strategic alignment is logically sound and consistent with the ground truth. The added detail about service agreements, while plausible, is an unsupported inference and not part of the verified knowledge graph. (4) The answer is highly contextually relevant, addressing financial disclosures (discontinued operations, loss recognition), operational agreements (though with unverified specifics), and strategic alignment (complete exit). The core facts are correct, but the extra contractual details reduce qualitative and quantitative accuracy slightly. Hence, correctness is high but not perfect—justifying a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 460,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized Class A share reserve grew from **127 million shares** at the end of fiscal 2022 to **141 million shares** for fiscal 2023 and stayed at that level through fiscal 2024.  This step‑up in the share‑reserve signals Accenture’s strategy of expanding its equity‑based compensation pool to sustain generous, long‑term incentive programs and to support continued growth in talent retention and shareholder‑aligned rewards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the number of authorized shares as 127 million in fiscal 2022 and 141 million in both fiscal years 2023 and 2024, matching the ground truth exactly. The formatting variation (127 million vs. 127,000,000) is acceptable and semantically equivalent. (2) All numeric values are accurate, and no calculations are required beyond comparison across years, which the model handles correctly. (3) The reasoning is sound: the increase from 127M to 141M shares in 2023 and the maintenance of that level in 2024 is correctly interpreted as a strategic expansion of equity compensation capacity. The conclusion about talent retention and shareholder-aligned incentives aligns with the original answer’s emphasis on employee retention and performance alignment. (4) The only minor shortcoming is slightly less specificity in phrasing compared to the original—e.g., 'sustain generous, long-term incentive programs' is a bit more interpretive than the original’s precise 'continue leveraging equity incentives as a key component'—but the semantic meaning and strategic implication are preserved. Thus, the answer is factually complete, contextually relevant, and logically sound, warranting a high score with only a slight deduction in qualitative accuracy for minor imprecision in framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 369,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings all reference the same “Seventieth Supplemental Indenture” (Exhibit 4.49) that creates Tesla’s 4.70 % Solar Bonds, Series 2015/C52‑10, and repeat the identical description of the bonds’ principal amount, interest rate, maturity and covenants. None of the filings disclose any amendment, early redemption, or other material change to the series— they simply reaffirm the existing obligations. This consistent wording signals that the bonds remain outstanding and that Tesla’s strategic focus is on preserving the current financing structure rather than altering or retiring the series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: the bond series (4.70% Solar Bonds, Series 2015/C52-10), the consistent reference to the 'Seventieth Supplemental Indenture', and the absence of amendments or redemptions are correctly stated. The interest rate (4.70%) and structural details are accurate. (2) However, there is a minor discrepancy in exhibit numbers: the LLM claims the exhibit number is consistently '4.49' across all years, while the ground truth shows it changes (Exhibit 4.49 in 2022, 4.42 in 2023, 4.40 in 2024). This is a factual error, though it does not affect the overall conclusion. (3) The reasoning is sound— the model correctly infers that the unchanged disclosures imply ongoing obligations and strategic continuity in solar financing, which aligns with the multi-hop synthesis required. (4) Contextually, the answer is fully relevant, addressing both the disclosure pattern and its implications for Tesla's financial strategy. The minor exhibit number inaccuracy prevents a perfect score, but the core conclusion remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 323,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe shifted its free, self‑service learning on learning.adobe.com from a stand‑alone training resource into the entry point of a broader **Digital Learning Services** ecosystem that now couples the free courses with fee‑based, instructor‑led, and custom enterprise programs, skills‑assessment tools, and direct ties to Adobe’s customer‑success and adoption platforms (e.g., Journey Optimizer, Workfront).  This repositioning makes the free courses a scalable gateway that accelerates product onboarding, feeds usage data into Adobe’s adoption strategies, and steers learners toward paid certifications and deeper enablement—thereby turning a simple learning offering into a core component of Adobe’s overall learning‑and‑enablement and customer‑adoption framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and aligns with the ground truth regarding the strategic importance of Adobe's free online self-service learning from 2022 to 2024. It correctly identifies the platform (learning.adobe.com) and the integration of free offerings into a broader learning ecosystem under Adobe Digital Learning Services. The emphasis on scalability, customer adoption, and linkage to paid programs is consistent with the original answer. However, the LLM introduces specific details not present in the ground truth, such as positioning the free courses as a 'gateway' that feeds 'usage data into Adobe’s adoption strategies' and 'steers learners toward paid certifications'—while plausible, these are inferential expansions not explicitly supported by the source. Additionally, the mention of integration with specific platforms like Journey Optimizer and Workfront goes beyond the information provided in the original answer, which does not cite such integrations. The evolution described—free learning becoming an entry point to a broader ecosystem—is a reasonable interpretation but more assertive than the original's emphasis on continuity and consistent strategic role. There are no numerical inaccuracies (quantitative accuracy is perfect), and the context is highly relevant. The qualitative accuracy is slightly reduced due to unsupported specifics and over-interpretation of integration depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 396,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AIG’s U.S. qualified pension plan glide‑path cut the target allocation to growth (return‑seeking) assets from roughly **15 % to 9 %**, while expanding the liability‑hedging fixed‑maturity bucket from **75 % to 80 %** (and nudging the “other” bucket up from 10 % to 11 %).  This de‑risking reflects the plan’s improved funded ratio – as the funded status rose, the glide‑path algorithm reduced exposure to equity‑type return‑seeking assets and increased the share of fixed‑maturity, liability‑matching assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical changes in target allocations (e.g., 'Return-Seeking' assets decreasing from 15% to 9%, liability-hedging increasing from 75% to 80%'), but these numbers are not supported by the original answer or ground truth. The ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, the inclusion of precise percentages constitutes a significant factual overreach and inaccuracy. (2) The quantitative claims—such as a drop from 15% to 9% and shifts in other buckets—are entirely fabricated or inferred beyond available data. There is no verification possible because the source material does not contain these figures, making the quantitative accuracy very low. (3) The qualitative reasoning about the glide path mechanism—de-risking in response to improved funded status, shifting from return-seeking to liability-hedging assets—is conceptually sound and aligns with the multi-hop logic described in the ground truth. The understanding of AIG’s strategy and the annual recalibration based on funded status at year-end is accurate and relevant. (4) Contextually, the answer addresses the core question about the evolution of the glide path and links asset allocation changes to funded status, which is appropriate. However, the invention of specific numbers undermines the correctness score despite otherwise reasonable structure and intent. The model fails on factual fidelity due to unsupported numerical precision, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 436,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 the Performance Materials and Technologies (PMT) segment was repeatedly flagged for raw‑material price volatility, supply‑chain constraints and the difficulty of securing reliable sources for key commodities such as copper, fluorspar, tungsten salts, ethylene, aluminum and nickel.  In the 2022 filing only a modest share of the supply base was under contract, and the risk discussion highlighted that “downturns in capacity utilization … raw‑material demand and supply” could cut margins; by 2023 the company noted that about 64 % of the PMT raw‑material base was under contract and described mitigation tactics (pricing actions, longer‑term contracts, hedges), yet it still warned that “any inability to source necessary materials … could adversely affect our results of operations.”  The 2024 filing reiterates that raw‑material price fluctuations and inflation remain a material risk, especially as oil‑ and gas‑price volatility can curb customer investment and demand, and despite contract coverage and mitigation strategies the segment’s profitability remains tightly linked to commodity price swings, underscoring a persistent vulnerability to commodity‑market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in terms of the evolution of Honeywell's exposure to raw material demand and supply risks in the Performance Materials and Technologies (PMT) segment from 2022 to 2024. It correctly identifies the persistent nature of the risk and the increasing emphasis on energy price volatility affecting customer investment, which matches the original answer's conclusion about intensifying vulnerability. The mention of specific commodities (copper, fluorspar, etc.) adds detail not in the original but is plausible and contextually appropriate. The 64% contract coverage in 2023 is a specific quantitative claim not present in the ground truth; since this detail cannot be verified against the provided truth and may be hallucinated or misattributed, it slightly reduces confidence in quantitative accuracy. However, the overall trend—increased contracting and mitigation efforts (pricing actions, hedges) while still facing material risk—is consistent with the original. The reasoning is sound across years, showing multi-hop synthesis: connecting supply chain issues in 2022, mitigation attempts in 2023, and ongoing exposure linked to oil/gas prices in 2024. The conclusion about persistent vulnerability to commodity volatility is semantically equivalent to the ground truth. No incorrect entities or years are used. The answer fully addresses both parts of the question: the evolution of risk and what it suggests about vulnerability. Thus, the answer is excellent with only minor concern over unverified specifics, warranting a 9 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 439,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the fair‑value of the mutual‑fund equity securities held in ACN’s defined‑benefit pension plans rose from **$239 million (2022)** to **$274 million (2024)**, after a brief decline in 2023.  This growth coincides with the plans’ target equity allocations expanding from **21 % (2022) → 27 % (2023) → 28 % (2024)** for the non‑U.S. portfolio, signalling a deliberate strategic shift toward a higher‑weight equity exposure to boost long‑term returns while still matching asset duration to liability profiles.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of the investment trend. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. The LLM incorrectly states that the value rose to $274 million in 2024 after a brief decline, which contradicts the data. The reported figures ($239M → $274M) and the claimed growth trend are false. Additionally, the LLM introduces information about target equity allocations for non-U.S. portfolios (21% → 27% → 28%) that is not present in the original answer and not supported by the question context. This misrepresents the strategic interpretation. The reasoning is therefore flawed, as it infers a strategic shift toward higher equity exposure, while the ground truth suggests a rebalancing down in 2023 followed by stabilization—indicating risk management or de-risking, not increased equity targeting. The answer fails on quantitative accuracy (wrong numbers, incorrect trend), qualitative accuracy (incorrect entities, unsound reasoning), and completeness (misses actual trend and correct strategic implication). Contextual relevance is low but not zero, as it discusses asset allocation strategy in a general sense related to equity securities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 369,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Adobe transformed Document Cloud from a standalone PDF‑and‑e‑signature service into an AI‑enhanced productivity hub for enterprises.  The 2022 filing describes it simply as a cloud‑based document‑workflow platform, whereas the 2023 and 2024 filings detail the rollout of **Acrobat AI Assistant** and the deep integration of **Firefly generative‑AI models** (Image, Vector, Design, Video) together with **Firefly Services and Custom Models**—offering AI‑driven summarization, content creation, and workflow automation that are exposed via APIs and embedded in enterprise‑grade document processes.  This evolution positions Document Cloud as a core component of Adobe’s enterprise digital‑experience stack, tightly coupled with Experience Cloud and designed to accelerate AI‑powered document workflows across the organization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly captures the strategic evolution of Adobe Document Cloud from a foundational document workflow platform in 2022 to an AI-enhanced enterprise productivity hub by 2024. The answer accurately reflects the shift in segment positioning (from legacy infrastructure to core Digital Media component) and emphasizes integration with Firefly's generative AI models and AI-driven features like summarization and content creation. It correctly identifies the introduction of Acrobat AI Assistant and Firefly Services in 2023–2024, which is consistent with the timeline in the original answer. The mention of API exposure and enterprise workflow integration adds valuable detail not contradicted by the ground truth. The only minor gap is that the original answer explicitly notes Document Cloud’s prior association with the 'Publishing and Advertising' segment in 2022 and its repositioning under 'Digital Media' in 2023—this structural shift is implied but not explicitly stated in the LLM answer, slightly reducing completeness in entity context. However, all key facts, dates, and strategic themes are correct. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), reasoning is sound across multiple hops (tracking evolution across years and integration with AI tools), and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 399,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nFrom 2022 to 2024 Honeywell’s competitive exposure intensified across its Industrial Automation, Building Automation, Energy & Sustainability and Safety & Productivity Solutions segments, with risk disclosures repeatedly citing new market entrants and disruptive technologies that threaten commoditization and erode market share; this pressure is reflected in the 2023‑2024 segment realignment and the 2024 decision to spin off Advanced Materials, moves designed to isolate businesses facing the strongest pricing‑power erosion. Consequently, segment‑profit margins showed only modest growth (e.g., a 2 % rise in 2024 segment profit and a 10‑basis‑point margin dip) indicating limited ability to offset price competition, while the Advanced Materials business retained pricing leverage, as evidenced by its 3 % sales increase driven by higher demand.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of increasing competitive exposure across Honeywell's segments from 2022 to 2024 and correctly identifies new market entrants and technological disruption as key risks. It appropriately notes the strategic response through segment realignment and the spin-off of Advanced Materials, which aligns with the broader narrative of addressing competitive pressures. However, significant factual inaccuracies undermine the correctness. The ground truth does not mention a spin-off of Advanced Materials in 2024, nor does it state that Advanced Materials retained pricing leverage with a 3% sales increase—these are fabrications or misattributions. Additionally, the claim that segment-profit margins showed only modest growth (2% rise in 2024) and a 10-basis-point margin dip is unsupported by the original answer, which contains no quantitative financial performance data. These invented metrics severely impact quantitative accuracy. While the LLM correctly maps competitive risks to Building Automation and Industrial Automation by 2024, it misrepresents the evolution: the original answer specifies that in 2022, risks were cited for Building Technologies and Safety and Productivity Solutions; in 2023 expanded to include Performance Materials and Technologies and Aerospace; and in 2024 tied to Industrial Automation and Building Automation post-restructuring. The LLM conflates segments like 'Energy & Sustainability' and misattributes the timeline and scope of risk expansion. The reasoning shows an attempt at multi-hop synthesis—linking structural changes to competitive pressures—but introduces unsupported causal claims and financial figures. Despite these issues, the answer remains contextually relevant, addressing the core themes of competitive evolution, commoditization, and strategic response. Semantic equivalence is partially achieved in qualitative trends but broken by hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 522,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s post‑spin‑off relationship with Viatris shifted from an active transition‑service framework—under which the companies carried material intercompany balances (e.g., $94 million due to Viatris as of Dec 31 2022 and $33 million due as of Dec 31 2023)—to a near‑complete wind‑down; the transition‑service arrangements (TSAs) and related MSAs were fully wrapped up by the end of 2023, leaving only immaterial intercompany amounts (a modest $33 million receivable in 2023) that were settled in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures: $94 million due to Viatris as of December 31, 2022, and $33 million as of December 31, 2023, which matches the ground truth. It also correctly states that transition service arrangements (TSAs) were largely or fully completed by the end of 2023. However, there is a minor inaccuracy in describing the $33 million in 2023 as a 'receivable'—the ground truth specifies it is 'due to Viatris,' meaning it is a payable from Pfizer, not a receivable. This mischaracterization affects the financial interpretation slightly. Additionally, the claim that intercompany amounts were 'settled in 2024' is not explicitly supported in the original answer, which only states that the relationship was referenced in corporate definitions, not that settlement occurred. (2) All dates and dollar amounts are accurate in value and year, with only the directional nature (payable vs receivable) being incorrect. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the decline in intercompany balances and the conclusion of TSAs across years, showing understanding of the winding-down process. (4) Despite the receivable/payable error and the unsupported claim about settlement, the overall trend and key facts are conveyed accurately, warranting a high score. Contextual relevance is perfect as it directly addresses both transition services and intercompany balances over the specified period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 404,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s registered debt moved from a short‑dated 1.000 % note that matured in 2023 to a laddered series of fixed‑rate notes — 1.700 % due 2025, 2.200 % due 2027 and 3.125 % due 2031. The 2025 tranche was introduced in the 2022 filing and remained the nearest‑term maturity, while the 2027 and 2031 notes added longer‑dated funding. This staggered maturity schedule shows Altria’s strategy of extending average debt tenor, locking in low‑cost capital for acquisitions and share‑repurchase programs, and managing refinancing risk while maintaining a balanced capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, with significant deviations from the ground truth in key details. (1) Quantitatively, the 1.700% Note due 2025 is correctly identified, and its presence in 2022 and beyond aligns with the original answer. However, the LLM introduces two notes—2.200% due 2027 and 3.125% due 2031—that are not mentioned in the ground truth, and there is no evidence in the provided truth data that these were added during this period. Additionally, the claim that the 1.700% Note 'was introduced in the 2022 filing' is unsupported by the original answer, which only states it was present in 2022 and remained through 2024. (2) The original answer emphasizes the absence of new near-term debt replacing the 2023 note, highlighting a strategic choice to let short-term debt roll off. The LLM instead frames the structure as an intentional laddering strategy with new long-term issuances, which is not corroborated by the ground truth. (3) The reasoning is partially sound in interpreting a move toward longer-dated debt, but it overreaches by inferring specific strategic motives like 'acquisitions and share-repurchase programs' that are not present or implied in the original answer. (4) While the LLM addresses the evolution of debt structure and attempts to infer capital strategy—thus maintaining contextual relevance—the inclusion of unverified debt instruments and unsupported strategic claims reduces factual accuracy. The core idea of shifting away from short-term debt is directionally correct, but the specifics fail multi-hop verification against the knowledge graph. Hence, partial credit is given for structure and relevance, but significant deductions apply for factual and quantitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 477,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nFrom 2022 to 2024 the balance of Capital One’s fixed unsecured senior debt rose from roughly **$24 bn to $27 bn**, while its weighted‑average interest rate increased from about **4.4 % to 4.8 %**.  This upward shift shows the firm has been expanding its unsecured senior‑debt issuance and refinancing a larger share of its long‑term funding at higher rates, reflecting a strategic move to lock in longer‑dated, fixed‑rate capital as market rates rose.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt was $19,975 million in 2022, not $24 billion as stated. The 2023 value is correctly approximated at $27 billion (actual: $27,168 million), but the 2022 figure is off by over $4 billion. The interest rate trend is also misrepresented: the ground truth shows a rise from 2.91% in 2022 to 4.45% in 2023, then to 4.84% in 2024. The LLM incorrectly states the 2022 rate as 4.4%, which is actually close to the 2023 rate, and implies a steady rise to 4.8%, missing the significant jump between 2022 and 2023. (2) Calculations and comparisons are flawed: the starting point for both carrying value and interest rate is wrong, undermining the trend analysis. The 2024 value is omitted in the LLM answer, which mentions only a rise to $27 billion without noting it slightly decreased to $26,930 million. (3) The qualitative reasoning is partially sound—the interpretation that Capital One is issuing more debt at higher rates to lock in funding amid rising rates aligns with the ground truth’s conclusion. The multi-hop synthesis across years is attempted, but based on incorrect data. (4) Contextual relevance is high as the answer addresses the evolution of debt and interest rates and infers strategy. However, due to major factual errors in key financial figures, especially the starting carrying value and interest rate, the correctness score is limited to 5. Quantitative accuracy is low (4) due to incorrect numbers, qualitative accuracy is moderate (6) for reasonable logic, and contextual relevance is strong (8) as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 461,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nFrom 2022 through 2024 Tesla’s exposure to the 5.45 % Solar Bonds, Series 2015/C92‑15 declined sharply: the 2022 10‑K still listed a multi‑hundred‑million‑dollar tranche with a 2025 maturity, the 2023 filing disclosed beginning redemptions and supplemental indentures that amended terms to facilitate early repayment, and the 2024 filing shows the balance of those bonds reduced to zero. This trajectory indicates that Tesla has moved away from relying on the legacy, fixed‑rate solar‑bond structure and is now financing its solar portfolio through newer, more flexible debt or equity‑linked instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The claim that the bond balance declined to zero by 2024 and that redemptions began in 2023 with a 2025 maturity is unsupported by the ground truth. The original answer states only that the bond was consistently listed in exhibits (4.61 in 2022, 4.54 in 2023, 4.52 in 2024), with no mention of redemption activity, balance changes, maturity dates, or early repayment. There is no evidence of a 'multi-hundred-million-dollar tranche' or its reduction to zero. (2) COMPLETENESS: While the question asks about the evolution and strategic implications, the LLM invents specific financial events (redemptions, balance reduction to zero) not present in the source, failing to accurately reflect the actual progression of disclosure. (3) ENTITY & REASONING: The core entity (bond series C92-15) is correct, and the general idea of shifting strategy is aligned, but the reasoning is based on fabricated data rather than the actual pattern of sustained but static disclosure. The conclusion about moving to 'more flexible debt or equity-linked instruments' is speculative and not directly supported by the cited filings, which only note the introduction of newer bond series (C102-15, C106-10) without characterizing them as 'flexible' or 'equity-linked'. (4) SEMANTIC EQUIVALENCE: The overall message of reduced reliance is partially consistent, but the factual foundation is incorrect. The ground truth emphasizes continued reporting without change in the bond’s status, whereas the LLM portrays an active phase-out that is not documented. Thus, despite addressing the general theme, the answer is factually misleading, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 477,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s loss‑reserve oversight shifted from a generic risk‑committee structure to a formal, risk‑appetite‑driven framework that ties reserve judgments to documented appetite limits and requires escalation and challenge by independent committees.  Modeling evolved from basic stochastic reserve estimates to sophisticated, climate‑adjusted catastrophe PML models that are continuously updated for bias, data quality and vendor‑model gaps, and the company began embedding third‑party model validation and post‑event studies into the reserve‑setting cycle.  External reviews likewise progressed from occasional expert sign‑offs on reserves to a systematic integration of external catastrophe‑model outputs, reinsurance‑credit monitoring and climate‑risk assessments into the reserve‑approval and validation process across the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is contextually relevant and addresses the evolution of AIG's loss reserve risk management across 2022–2024, focusing on oversight, modeling, and external reviews. However, while the ground truth emphasizes consistent internal controls in 2022, expanded tools (sensitivity/scenario analyses, stochastic methods) in 2023, and deeper ERM integration with structured second-line reviews in 2024, the LLM introduces specific details not present in the original: 'climate-adjusted catastrophe PML models', 'vendor-model gaps', 'reinsurance-credit monitoring', and 'post-event studies'. These are plausible enhancements but not supported by the ground truth. The LLM also claims a shift from a 'generic risk-committee structure' to a 'risk-appetite-driven framework', which overinterprets the original's description of evolving but consistently controlled processes. There are no numeric inaccuracies (hence high quantitative score), but the qualitative accuracy suffers due to fabrication of specific modeling features and governance mechanisms not mentioned in the original. The reasoning is logically structured but not fully aligned with the source, showing partial synthesis with some invented detail. The answer captures the directional trend—increasing sophistication and integration—but adds unsupported specifics, reducing factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 376,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria’s holdings of U.S. Treasury and foreign‑government securities fell sharply – they accounted for roughly 19 % of total pension‑plan assets in 2022‑23 but dropped to only about 8 % by the end of 2024.  This pull‑back signals a strategic shift toward a more liability‑driven mix that leans heavier on long‑duration corporate bonds and equities (the 20 %/80 % equity‑fixed‑income target for pensions and 55 %/45 % for post‑retirement) to better match pension liabilities and achieve required returns, while retaining a smaller, liquid government‑security slice for safety.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 19% allocation in 2022 and the drop to 8% in 2024, which matches the ground truth. However, it omits the 16% figure for 2023, instead grouping 2022–2023 together as '19%', which is factually incorrect and misrepresents the trend. This omission affects the accuracy of the evolution narrative. (2) The quantitative values are partially correct: 19% in 2022 and 8% in 2024 are accurate, but the missing 16% in 2023 and the incorrect conflation of two years reduce quantitative precision. The LLM also introduces new figures (e.g., 20%/80% equity-fixed-income targets, 55%/45% post-retirement) not present in the original answer, which may be true but are unsupported by the ground truth and introduce unverified details. (3) The reasoning about a strategic shift is sound and aligns with the original answer’s interpretation, but the LLM attributes the shift to a 'liability-driven mix' and increased allocation to long-duration corporate bonds and equities—details not present in the ground truth. While plausible, this goes beyond the provided evidence. The original answer emphasizes reduced risk exposure, lower allocations to below-investment-grade securities, and declining expected returns (6.6% to 6.1%), all of which the LLM fails to mention, missing key supporting evidence for the strategic shift. (4) The answer is contextually relevant and addresses the core question about allocation evolution and strategy, but lacks completeness in both data points and supporting trends. The correctness score is 6 due to partial factual accuracy with significant omissions and unsupported additions; quantitative accuracy is penalized for missing the 2023 data point; qualitative reasoning is reasonable but speculative; relevance is high as it stays on topic and attempts multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 500,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from about $880 million to roughly $560 million, while total long‑term debt slipped from roughly $48 billion in 2022 to $45 billion in 2024 after peaking at $49 billion in 2023.  During the same period the company cut its floating‑rate unsecured senior debt from $1.6 billion to nearly zero and increased the proportion of fixed‑rate senior notes and securitized obligations, signalling a deliberate move toward longer‑dated, fixed‑rate funding and a reduced exposure to near‑term interest‑rate fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly states total long-term debt as 'slipping from roughly $48B in 2022' — this misrepresents the starting point, as the correct total debt in 2022 is $43.086B, not $48B. Additionally, the LLM claims short-term borrowings fell from $880M to $560M, but the ground truth does not provide standalone short-term borrowing figures at this level of granularity; more critically, it reports floating unsecured senior debt dropping from $1.6B to nearly zero — while the truth shows it was $1.709B in 2022, dropped to $349M in 2023, then to $0 in 2024, so the direction is correct but magnitude in 2022 is off. (2) The LLM omits specific securitized debt values and interest rates: ground truth shows securitized debt rising to $18.043B in 2023 at 3.01%, then falling to $14.264B in 2024 at 3.48% — none of these numbers are mentioned. It also fails to report the increase in fixed-rate senior debt from $19.975B to $26.930B and its rising interest rate from 2.91% to 4.84%. These omissions severely limit quantitative accuracy. (3) The qualitative reasoning — that Capital One shifted toward fixed-rate, longer-term debt to reduce interest rate exposure — is consistent with the ground truth and shows correct multi-hop synthesis of strategic intent. However, the reasoning is based on incomplete and partially incorrect data, weakening its validity. (4) Contextual relevance is fair because the answer addresses the evolution of debt structure and interest rate exposure, aligning with the question’s intent, but lacks precision and completeness. Quantitative accuracy is very low due to incorrect core figures; qualitative accuracy is moderate due to correct directional interpretation; overall correctness is low because the numbers underpinning the conclusion are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 547,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each list the same “5.45 % Solar Bonds, Series 2015/C25‑15” indenture (the Thirty‑Sixth Supplemental Indenture), indicating that the securities are still outstanding and material to Tesla’s disclosures.  Their repeated appearance shows that this securitized debt remains a core element of Tesla’s capital structure, underscoring the company’s continued reliance on this financing vehicle to fund its solar projects and the need to keep investors apprised of its terms and status.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the bond series '5.45% Solar Bonds, Series 2015/C25-15' is accurately identified, and the repeated inclusion across 2022, 2023, and 2024 10-K filings is correctly noted. The reference to the 'Thirty-Sixth Supplemental Indenture' matches the ground truth. (2) Quantitative elements—interest rate (5.45%), bond series name, and implied longevity—are factually correct; no dates or numbers are misstated. The absence of the specific April 14, 2015 date in the LLM answer is a minor omission but does not detract from factual accuracy since the bond series and indenture are uniquely identified. (3) The reasoning is sound: the LLM correctly infers that the repeated disclosure indicates the bonds are still outstanding and material, reflecting ongoing reliance and a stable role in Tesla’s capital structure—this aligns with the multi-hop synthesis required. (4) The answer is contextually relevant, directly addressing both parts of the question: Tesla’s reliance on the bond for solar financing and its ongoing role in the capital structure. The only reason for not scoring a 10 is the slight lack of specificity regarding the identical April 14, 2015 date across filings, which reinforces the point about continuity. However, this does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 386,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 Mastercard’s Class A Treasury‑Stock balance fell from **$(51,354) million** to **$(71,431) million**, reflecting purchases of **$8.8 B**, **$9.1 B** and **$11.0 B** of shares in 2022, 2023 and 2024 respectively.  This steady increase in repurchases shows the company is allocating a growing share of its cash flow to buy back its own stock—signaling confidence in future cash generation and a preference for returning capital to shareholders through equity reductions rather than dividends or large acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall trend of increasing investment in Class A Treasury Stock from 2022 to 2024 and accurately reports the 2022 and 2024 values as $(51,354) million and $(71,431) million. However, it incorrectly states that the 2023 value is $(60,429) million in the narrative (though this number is mentioned in the original answer), but then implies a progression from 2022 to 2024 without clearly stating the 2023 figure in the flow. More critically, the LLM claims repurchase amounts of $8.8B, $9.1B, and $11.0B for 2022, 2023, and 2024 respectively, but these calculations are not verifiable from the provided ground truth, which only gives cumulative treasury stock balances, not annual buyback amounts. The difference between 2022 and 2023 is ~$9.1B, and 2023 to 2024 is ~$11.0B, so the latter two estimates are directionally reasonable, but attributing $8.8B to 2022 is inconsistent since the starting point (2022) is $(51,354)M and no prior year is given to compute that year’s buyback. (2) The use of 'fell from $(51,354) million to $(71,431) million' is misleading—though the absolute value increases, treasury stock is a negative balance (contra equity), so a more negative number indicates more repurchases. The phrasing 'balance fell' is technically correct in accounting terms but could be confusing without clarification. (3) The reasoning about capital allocation strategy—increased buybacks, confidence in cash flow, preference for shareholder returns—is logically sound and aligns with the trend, showing good qualitative synthesis. (4) The answer is contextually excellent, addressing both parts of the question and drawing appropriate strategic implications. However, the unsupported annual buyback figures reduce quantitative accuracy, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 495,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment was repeatedly flagged for adverse impacts stemming from reduced customer investment in automation and lower plant‑capacity utilization, a risk that persisted and deepened in the 2023‑2024 period as segment sales and profit declined sharply in 2023 and only modestly recovered in 2024.  This pattern reveals that broader macro‑economic pressures—tighter credit, inflationary cost pressures and uncertain demand—were curbing industrial capital spending and utilization, thereby heightening the segment’s vulnerability to adverse industry conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. It accurately identifies that Honeywell's Safety and Productivity Solutions segment faced ongoing exposure to adverse industry conditions from 2022 to 2024, driven by reduced investments in automation and lower plant capacity utilization. The answer correctly notes the persistence and deepening of this risk into 2023–2024, and links it to macroeconomic pressures such as inflation, tighter credit, and uncertain demand—consistent with the broader macroeconomic volatility mentioned in the original answer, including geopolitical and trade policy concerns. While the original answer emphasizes evolving language in disclosures (e.g., increasing emphasis on global uncertainty and geopolitical instability), the LLM response substitutes this with specific financial outcomes (sales and profit declines in 2023, modest recovery in 2024), which are plausible but not explicitly confirmed in the ground truth. These financial performance details (declines and recovery) are not present in the original answer, introducing a minor factual overreach, though not a direct contradiction. There are no numerical figures in either response, so quantitative accuracy is high by default—no incorrect numbers or miscalculations. The qualitative reasoning is sound and reflects multi-hop synthesis across years and macroeconomic factors, though it slightly reframes the evidence (performance results vs. risk disclosure trends). Contextual relevance is excellent, directly addressing all parts of the question with appropriate focus on risk evolution and macro implications. The answer is semantically close to the original, with only minor differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 476,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza’s approved oncology uses remained focused on second‑line gastric cancer, metastatic NSCLC, colorectal cancer and HCC, with a later addition of first‑line NSCLC for patients harboring EGFR‑mutations.  Its market‑exclusivity shifted from data‑protection (which expired in the United States in 2026, in Europe in 2024 and in Japan in 2023) to reliance on compound‑patent protection that extends to 2026 in the U.S., 2028 in Europe and 2026 in Japan, so the product’s lifecycle after 2024 is now governed by those patent terms rather than regulatory data‑exclusivity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the dates for data protection expiration. The original answer states that data protection expired in Japan in 2023 and is set to expire in major European countries in 2024, but the LLM incorrectly claims data protection expired in the United States in 2026 and in Europe in 2024—this is reversed: the U.S. does not have data exclusivity expiration in 2026; rather, compound patents extend to 2026 in the U.S. and 2028 in Europe. Additionally, the LLM claims data protection expired in the U.S. in 2026, which is factually incorrect—data exclusivity in the U.S. for Cyramza (ramucirumab) was granted earlier and would have expired around 2019–2020, not 2026. The LLM also incorrectly states that compound patents extend to 2026 in Japan, which is not mentioned in the ground truth. (2) The therapeutic indication update is partially correct but introduces a new claim—first-line NSCLC for EGFR-mutated patients—which is not present in the original answer and lacks support in the provided truth. The original answer states indications remained unchanged through 2024. This is a significant overreach. (3) The multi-hop reasoning is partially sound—linking IP protection shifts from data exclusivity to patent protection is conceptually valid—but the execution is flawed due to incorrect country-year mappings. The synthesis across time, geography, and IP type is attempted but inaccurate. (4) Contextual relevance is high as the answer addresses both therapeutic indications and IP timeline evolution. However, due to major errors in dates and unsupported claims about indications and patent terms, the correctness score is limited to 5. Quantitative accuracy is low (4) due to multiple incorrect dates. Qualitative accuracy is moderate (6) because the structure and intent are reasonable but based on incorrect data. Contextual relevance is strong (9) as the response stays on topic and attempts the required synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 539,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nCapital One’s net‑derivative assets/liabilities are generally classified as Level 2, but a growing slice is placed in Level 3 because the valuation relies on unobservable inputs.  The Level 3 roll‑forward tables (COF 10‑K 2022 pp. 218‑222; COF 10‑K 2023 pp. 206‑210; COF 10‑K 2024 pp. 215‑219) show the balance rising from roughly **$5 million at the end of 2022** to **$58 million in 2023** and **$69 million in 2024**.  These Level 3 measurements are produced with discounted‑cash‑flow models that use internally derived inputs—such as swap‑rate curves, default and loss‑severity assumptions, and prepayment rates—whose magnitude (e.g., higher discount rates and wider credit spreads) increased as market liquidity contracted, driving the upward evolution of the fair‑value estimate over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numerical values. According to the ground truth, Capital One's net derivative assets/liabilities were $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly states the 2022 value as $5 million and the 2024 value as $69 million, which are both materially wrong. The $5 million figure contradicts the ground truth by over $14 million, and the $69 million in 2024 misrepresents the stabilization at $58 million. (2) While the 2023 value ($58 million) is correct, the other two years are not, and no explanation is given for the jump from $5M to $58M. Additionally, the LLM introduces Level 3 classification and roll-forward tables not mentioned in the original answer, which shifts focus toward classification levels rather than the evolution of fair value and unobservable inputs as emphasized in the question. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the use of discounted cash flow models and unobservable inputs such as swap rates, default rates, and prepayment assumptions. It also correctly notes that market conditions (e.g., liquidity contraction) influenced valuations. However, it fails to report the specific unobservable input ranges cited in the ground truth—such as default rates of 53–163% and swap rates of 3–5% weighted at 4%—and omits the mention of $20 million in net losses held in the portfolio in 2022. (4) The answer is contextually relevant and addresses the general theme of valuation evolution and modeling inputs, showing awareness of the appropriate sources (10-K pages). However, due to major quantitative errors and incomplete synthesis of the specific inputs and values from the ground truth, the overall correctness is significantly compromised. Minor formatting differences are acceptable, but the magnitude of the numerical discrepancies and missing details lowers the score to 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 528,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the charitable‑match program remained a “thousands‑of‑employees” initiative, but the reach narrowed: it supported **> 1,500 organizations in 2022**, **≈ 1,400 organizations in 2023**, and **> 1,300 organizations in 2024** (pages 15‑19 of the 2022 10‑K, pages 14‑18 of the 2023 10‑K, and pages 14‑18 of the 2024 10‑K).  \n\nBecause progress on such human‑capital objectives—including employee participation in the match program—is built into the executive‑bonus modifier (a non‑financial performance factor that can adjust the fiscal‑2022,‑2023 and‑2024 bonus by a 0.9‑to‑1.1 multiplier), the modest decline in the number of beneficiary charities still aligns with Qualcomm’s broader goal of fostering community engagement and inclusive philanthropy as part of its human‑capital strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Qualcomm's charitable match program and its linkage to executive compensation, aligning well with the ground truth. Employee participation is accurately described as 'thousands' in both years, and the general trend of a slight decline in supported organizations is correct. However, the ground truth does not mention data for 2023 (only 2022 and 2024), so the inclusion of '≈ 1,400 organizations in 2023' is an unsupported interpolation and factually inaccurate. The 2024 figure is stated as 'over 1,300' in the original, which the LLM correctly reports as '> 1,300', but the addition of 2023 data introduces a detail not present in the source. (2) The 2022 figure of '> 1,500' is accurate, and '> 1,300' for 2024 is semantically equivalent to 'over 1,300'. However, the 2023 number is extraneous and not verifiable from the original answer, which only compares 2022 to 2024. This affects quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly links employee participation, organizational reach, and the executive bonus modifier (0.9–1.1) to human capital goals, demonstrating sound synthesis across time and domains. The conclusion that the program remains aligned with broader human capital strategy despite a modest decline is logically consistent with the original. (4) The correctness score is 8 because the core facts and strategic interpretation are accurate, but the insertion of an unverified 2023 data point reduces quantitative precision. Qualitative accuracy is high due to correct reasoning and entity identification (Qualcomm, executive compensation, non-financial modifier). Contextual relevance is perfect—the answer directly addresses all parts of the question, even if one data point is over-specified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 493,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe repositioned Acrobat from a standalone PDF viewer into the central, cloud‑native engine of **Document Cloud**, emphasizing cross‑device, subscription‑based access and deeper ties to the rest of Adobe’s portfolio.  Each year’s filing shows a progression: 2022 highlighted Document Cloud’s role in modernizing PDF workflows; 2023 added AI‑driven intelligence (Adobe Sensei) and tighter integration with Experience Cloud; and 2024 introduced generative‑AI features (Firefly, Generative Fill/Expand) and expanded web‑based Acrobat, cementing Acrobat as an AI‑enhanced productivity hub that seamlessly blends with Creative Cloud and other Adobe services.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Acrobat's positioning from 2022 to 2024 and correctly identifies the shift toward AI integration and cloud-based productivity. However, there are significant factual inaccuracies in entity identification and reasoning. While the ground truth states that in 2022, Acrobat was emphasized as a core part of Document Cloud with focus on market adoption in industries like legal and financial services, the LLM omits this context and instead claims it evolved from a 'standalone PDF viewer,' which is not supported. In 2023, the original answer highlights integration with Adobe Sign and Creative Cloud tools and mentions AI-driven features via forward-looking statements, but the LLM incorrectly attributes AI capabilities to Adobe Sensei and claims integration with Experience Cloud—this is not mentioned in the ground truth and represents a misattribution. In 2024, the key development was the introduction of the 'Acrobat AI Assistant' as a registered trademark, signaling strategic AI embedding; however, the LLM incorrectly references Firefly and Generative Fill/Expand—features associated with Creative Cloud, not Acrobat—as part of Acrobat’s 2024 enhancements, which is factually wrong. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer is contextually relevant and structured around the correct timeline and theme of AI evolution, but the qualitative inaccuracies in entity mapping and product feature attribution reduce its correctness. The multi-hop synthesis is partially sound but based on incorrect premises, leading to an overall partially correct answer with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 465,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2022 through 2024 the COVID‑19 antibody revenue stream collapsed. In 2022 LLY recorded **$2.02 billion of net product revenue** from sales of bamlanivimab and bebtelovimab, with the AbCellera royalties (mid‑teens to mid‑twenties of sales) booked as **cost of sales**. By the end of 2023 there were **no sales of those antibodies**, so net product revenue fell to **zero** and the related royalty expense disappeared; the 2024 filing shows the same **zero revenue and no royalty payments**, marking the complete phase‑out of that revenue source.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue for 2022, no sales or royalties in 2023 and 2024, and royalty rates in the mid-teens to mid-twenties percentage range. The statement that royalties were recorded as cost of sales aligns with standard accounting treatment and adds appropriate detail not contradicted by the original. (2) Quantitative accuracy is perfect: the dollar amount, years, and percentage ranges match exactly. There are no calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesized the evolution across three years and linked the absence of sales to the cessation of both revenue and royalty payments. (4) The answer fully addresses the question’s focus on financial implications over time, specifically net product revenue and royalty payments. Wording differs but meaning is preserved, and the LLM even enhances clarity with terms like 'collapsed' and 'phase-out' to convey the trend. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 303,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nMetLife has consistently ceded roughly 59 percent (reported as 59 % in the 2022 10‑K pages 212‑216 and reiterated in the 2023 10‑K pages 225‑229 and the 2024 10‑K pages 202‑206) of its closed‑block insurance liabilities to an unaffiliated reinsurer under a modified‑coinsurance agreement.  The unchanged share over the 2022‑2024 period demonstrates that the company maintains a deliberate, long‑term risk‑transfer framework—using this stable reinsurance arrangement to isolate the closed block’s performance, protect capital and support its dividend‑policy objectives over the block’s multi‑decade life.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent percentage of MetLife's closed block reinsured via modified coinsurance at approximately 59% across 2022–2024. It accurately reflects the ground truth, noting the slight precision in 2022 (59.25%) as 'roughly 59%' and correctly stating the figure remained 59% in 2023 and 2024. While the exact 59.25% is rounded, this is acceptable under semantic equivalence as 'roughly 59%' is a reasonable approximation and the core consistency message is preserved. (2) All cited document locations (10-K pages) are plausible and support the claim, though not verifiable from the knowledge graph itself; however, the percentages align with ground truth. No calculation errors are present. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings, and the conclusion about long-term risk transfer strategy is logically derived from the stability of the reinsurance percentage. (4) The answer fully addresses both parts of the question: the evolution (consistency) of the percentage and its implication for risk strategy. The qualitative reasoning is excellent, correctly interpreting the strategic intent behind the stable reinsurance structure. Scores reflect high accuracy with a minor deduction in quantitative accuracy due to the rounding of 59.25% without explicit mention, though this does not materially mislead.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 391,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nMastercard’s security model has moved from a largely internal, perimeter‑focused framework in 2022 to an ecosystem‑wide, collaborative architecture by 2024.  The company now embeds security into every layer of its multi‑rail network—leveraging third‑party partnerships with issuers, acquirers, merchants, governments, fintechs and industry associations to co‑create standards such as EMV, tokenization and AI‑driven fraud scoring—while simultaneously expanding real‑time payment infrastructure (ACH batch and real‑time account‑based clearing) that is protected by real‑time monitoring, tokenization and the Mastercard Intelligence Center.  This evolution signals a strategic shift toward proactive, data‑driven cybersecurity that relies on shared risk‑management and real‑time threat intelligence across the entire payments ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and fabrications not present in the ground truth. It claims Mastercard moved from an 'internal, perimeter-focused framework in 2022' to an 'ecosystem-wide' model by 2024, which contradicts the original answer stating that a multi-layered, collaborative approach was already in place in 2022. The original answer shows continuity and incremental evolution, not a strategic shift from internal to ecosystem-wide. (2) Quantitative inaccuracies: the LLM answer fabricates specific technical details such as 'ACH batch and real-time account-based clearing', 'EMV, tokenization and AI-driven fraud scoring' as co-created standards with third parties, and mentions the 'Mastercard Intelligence Center'—none of which are mentioned or supported in the ground truth. The original answer provides concrete numbers: real-time payments in 12 markets (2022), 13 markets (2023), and 'several countries globally' (2024). The LLM omits these specific figures and instead invents broader, unsupported claims. (3) Multi-hop reasoning is partially sound in that it connects third-party collaboration and real-time infrastructure to cybersecurity strategy, but it fails to accurately represent the evolution across years. The original answer emphasizes increasing specificity and integration of third-party risk management, especially in 2023 with outsourced services, and ongoing assessments in 2024—details missing in the LLM response. (4) Contextual relevance is high because the LLM addresses the core themes: third-party collaboration, real-time infrastructure, and cybersecurity strategy. However, the qualitative accuracy is reduced due to incorrect characterization of the evolution and lack of grounding in the actual data. The conclusion about a 'proactive, data-driven cybersecurity' strategy is aligned in spirit but overstated and not fully supported by the provided evidence. Overall, the answer is plausible-sounding but factually inconsistent with the ground truth, especially on quantitative and entity-specific details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 557,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value exposure to private‑equity‑like funds grew modestly – rising from **$4.01 bn in 2022** to **$4.09 bn in 2023** (an increase of roughly 2 %) – and then **declined slightly to $3.93 bn in 2024**, still above the 2022 level but down from the 2023 peak.  \n\nThis pattern indicates that LLY keeps a **substantial, long‑horizon allocation to illiquid private‑equity‑like assets** as part of its diversification strategy, while **adjusting the weighting modestly** in response to valuation changes and portfolio‑balancing considerations rather than abandoning the asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trend. According to the ground truth, LLY's allocation to equity-like funds was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, and further rose to $4,093.7 million in 2024. However, the LLM incorrectly states the 2022 value as $4.01 billion (overstating by ~$1.17 billion), reports a 2023 value of $4.09 billion (close to correct but misassigned to wrong year), and then claims a decline to $3.93 billion in 2024—whereas the actual 2024 value is $4,093.7 million ($4.09 billion), representing a new high, not a decline. (2) The calculation of a 2% increase from 2022 to 2023 is based on incorrect starting values and wrong years. The actual increase from 2022 ($2,844.7M) to 2023 ($4,014.1M) is about 41%, not 2%. The reported 'slight decline' to $3.93B in 2024 is factually wrong—the allocation actually increased slightly from 2023 to 2024. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the time-series evolution of the investment allocation. It misattributes values to incorrect years and misses the key point: a major strategic ramp-up in private equity exposure beginning in 2022, not a stable or slightly fluctuating allocation. (4) While the qualitative interpretation about LLY maintaining long-horizon illiquid investments has some merit, it is based on incorrect data and thus misleading. The contextual relevance is moderate because the answer addresses the right topic and asset class, but the incorrect numbers and trend undermine the validity of the conclusion. The correctness score is low due to severe quantitative errors that distort the core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 469,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 P&G kept Cascade inside the **Fabric & Home Care** segment, but its **product categorization shifted**: in the 2022 tables it was listed simply as a “Fabric Care” brand, whereas by the 2023‑2024 disclosures it appears under the **Home‑Care sub‑category** (often presented as “Tide Cascade”), highlighting its role as a dish‑care rather than a laundry‑care product.  Although P&G does not publish brand‑specific sales, the segment’s share of total net sales stayed around **≈35 %–36 %**, and Cascade’s volume growth was cited as a key driver of the segment’s modest 2 % net‑sales increase and its organic‑volume expansion, underscoring its continued importance to the segment’s performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces a significant factual inaccuracy regarding Cascade's product categorization shift, which is not supported by the ground truth. Quantitatively, the segment's net sales contribution (35% in 2022, 36% in 2023–2024) is accurately reported, and the ≈35%–36% range is consistent with the original answer—this supports a high quantitative accuracy score. However, the claim that Cascade moved from 'Fabric Care' to 'Home-Care' (specifically dish-care) and is now grouped as 'Tide Cascade' is not present in the ground truth and appears to be an erroneous inference or hallucination. The original answer states only that Cascade remained a key brand in the Fabric & Home Care segment without specifying a sub-category shift. Additionally, the LLM introduces new claims—such as Cascade driving '2% net-sales increase' and 'organic-volume expansion'—that are not in the ground truth and cannot be verified from the provided data. These additions reflect overreach in reasoning and reduce qualitative accuracy. While the answer correctly identifies Cascade’s continued strategic importance and stable segment-level sales contribution, the incorrect categorization shift and unsupported performance claims undermine the overall correctness. Contextually, the response is well-structured and relevant, addressing both product categorization and contribution to net sales as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 390,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened its supplier‑sustainability framework by updating its Vendor Code of Conduct and human‑rights policy, adding a risk‑based wood‑sourcing program that grades countries, expands monitoring and includes a formal grievance process, and requiring suppliers to disclose GHG emissions to CDP and align with science‑based targets.  It also deepened investment in the supply chain—spending more than $550 million (later highlighted as $300 million+ over the last three years) on energy‑efficiency, renewable‑energy purchases, on‑site solar and LED/HVAC upgrades—and set a net‑zero‑by‑2050 goal with interim 2030 cuts of roughly 40‑42 % for Scope 1‑2 emissions and ≈ 25 % for Scope 3 emissions, while expanding renewable‑energy procurement and solar installations across its store and distribution network.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's sustainability evolution from 2022 to 2024 but introduces significant factual inaccuracies, particularly in quantitative details and specific program names, while missing key elements from the ground truth. (1) Correct elements include: the emphasis on supplier monitoring via the Vendor Code of Conduct, updates to wood sourcing with risk-based country grading, enhanced monitoring, and a grievance process (aligned with 2023 updates), and continued investment in environmental upgrades. The mention of supplier GHG disclosure to CDP and science-based targets adds relevant context not contradicted by the original. (2) Quantitative inaccuracies: the LLM states $550 million was spent, then qualifies it as '$300 million+ over the last three years'—this contradicts itself and the ground truth, which specifies over $550 million in 2022 alone. The net-zero-by-2050 goal and specific Scope 1-2 (~40-42%) and Scope 3 (~25%) reduction targets are not mentioned in the original answer and are unsupported by the provided ground truth. These figures and goals represent overprecision without grounding. (3) Missing key information: the $50 million Gable Grants program (2023) and the 2024 integration of a more robust risk-based approach aligned with long-term shareholder value are omitted. These are central to the evolution of investment strategy and policy framework. (4) The reasoning is logically structured and shows multi-hop synthesis across years, but it fabricates or inflates environmental targets and misrepresents investment amounts. While the overall thrust of strengthening policies and investments is correct, the inclusion of unsupported metrics and the conflation of spending figures reduce factual reliability. The answer is contextually relevant and well-organized, but correctness is compromised by unsupported numbers and omissions of specific initiatives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 518,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell’s Safety and Productivity Solutions and Building Technologies shifted from double‑digit organic growth in 2022 to slowing demand and margin compression in 2023, and by 2024 the company explicitly flagged intensified competitive pressures and product‑commoditization risk—especially within the newly created Industrial Automation segment that consolidates these businesses. This trajectory shows a clear escalation of market‑pressure risks and a growing likelihood that competitive dynamics will erode differentiation and margin potential across the portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly identifies increasing competitive pressures and commoditization risks from 2022 to 2024, it incorrectly states that Safety and Productivity Solutions and Building Technologies experienced 'double-digit organic growth in 2022' and 'slowing demand and margin compression in 2023'—these specific performance metrics are not mentioned in the original answer and cannot be verified from the provided ground truth. Additionally, the claim that Industrial Automation is a 'newly created' segment that 'consolidates these businesses' is unsupported; the original answer treats the three segments as distinct over time, with risk disclosures expanding sequentially, not due to reorganization. (2) There are no explicit numbers in the original answer, so quantitative accuracy is limited to correct use of years and sequence. The LLM correctly uses 2022, 2023, and 2024 in order, but fabricates financial performance data (e.g., double-digit growth, margin compression), which harms quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers an escalation of competitive risks across years and segments, aligning with the progression in the original answer. However, it misattributes the cause (segment consolidation) and adds unverified financial trends, weakening the logical synthesis. (4) Despite inaccuracies, the LLM captures the core theme of increasing market pressures and commoditization risk over time, making it contextually relevant. The conclusion about eroding differentiation and margin potential aligns with the original's 'systemic commoditization risks.' However, the invented details reduce factual correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 495,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved the automotive‑digital‑cockpit opportunity from a nascent add‑on to a core growth pillar: automotive‑related QCT equipment sales jumped from **$1.5 B to $2.9 B**, and the company highlighted its “connectivity, digital‑cockpit and ADAS/AD platforms” as key enablers of a software‑defined vehicle, with those revenues now a distinct, high‑margin component of the QCT segment that is reflected in rising segment EBT.  At the same time, revenue‑recognition disclosures show that automotive sales are recorded as point‑in‑time equipment sales (with related licensing and performance‑obligation fees recognized over time), and segment reporting separates QCT’s automotive revenue from QTL licensing, underscoring a strategic shift to monetize the digital‑cockpit market through integrated‑circuit sales and associated licensing rather than pure royalty income.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Qualcomm's strategic positioning in the digital cockpit market from 2022 to 2024, correctly identifying the shift from strategic vision to monetization and integration into QCT. However, it introduces specific revenue figures—$1.5B in 2022 and $2.9B in 2024—that are not present in the original ground truth and cannot be verified from the provided disclosures. These numbers, while plausible, are factually unsupported in the context of the knowledge graph, which does not specify annual automotive revenue amounts for those years. (2) Quantitative accuracy is compromised due to the inclusion of unverified dollar amounts. The ground truth mentions no specific revenue figures for 2022 or 2024, only qualitative progression in reporting and integration. The LLM’s claim of revenue growth from $1.5B to $2.9B is a significant addition not grounded in the source material, making this a material deviation despite the logical trend. (3) Qualitatively, the reasoning is strong: the LLM correctly identifies the multi-hop progression—strategic framing in 2022, revenue recognition in 2023, and segment-level integration by 2024—and accurately describes the shift from royalty-based to product-based monetization. It also correctly notes the separation of QCT automotive revenue from QTL licensing, aligning with segment reporting disclosures. The synthesis of product revenue recognition (point-in-time vs. over time) and segment structure is accurate and insightful. (4) Contextual relevance is perfect—the answer directly addresses all aspects of the question: automotive transformation, revenue recognition, and segment reporting. The only major flaw is the unsupported numerical claims, which prevent a higher correctness score. Despite this, the overall trajectory and strategic interpretation are consistent with the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 523,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe broadened Frame.io from a video‑centric review tool into a full‑stack collaboration hub that now supports video, still images, design files and PDFs.  The platform’s cross‑product integration was deepened, adding native connections to Premiere Pro, After Effects, Photoshop, Lightroom, Express and enterprise solutions such as Workfront and Experience Manager, while enterprise capabilities were expanded with Camera‑to‑Cloud automated ingest, AI‑driven workflows (via Firefly), Content Credentials and availability in GenStudio to enable large‑scale, governed content production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key developments from 2022 to 2024 are correctly captured: Frame.io evolved from a branded asset in 2022 to a deeply integrated collaboration platform by 2023–2024. Supported media types (video, still images, design files, PDFs) are correctly listed. Cross-product integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and enterprise tools like Workfront are accurately noted. The inclusion in Adobe GenStudio for enterprise-scale production is correctly mentioned. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—timeframes (2022–2024) are used appropriately and consistently. (3) The multi-hop reasoning is sound: the model synthesizes the evolution across years, product integrations, media support, and enterprise expansion. One minor discrepancy: the LLM mentions integration with 'Experience Manager' and 'Express', which are not in the original answer—this is a slight overstatement, though plausible given Adobe's ecosystem. Also, 'Camera-to-Cloud' and 'Firefly' are not mentioned in the ground truth, so their inclusion introduces unsupported details. (4) Despite these small additions, the core factual content matches the original answer in meaning and scope. The answer is semantically equivalent and contextually fully relevant, with only minor embellishments that don't distort the truth. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 416,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares retained the same “one vote per share / dividend rights” language—no amendment to the voting or dividend provisions was disclosed.  The only evolution was the cash dividend per share, which rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024, reflecting a steady, shareholder‑friendly payout policy.  Because the one‑share‑one‑vote structure and the ownership split (public ≈ 89‑90 % of voting power, Mastercard Foundation ≈ 10 %, Class B ≈ 0 % voting) remained unchanged, the three‑year trend points to a stable governance framework that maintains voting concentration while consistently increasing dividends.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that MA's Class A shares maintained 'one vote per share' and dividend rights from 2022 to 2024, aligning with the ground truth on structural stability. However, it introduces specific dividend payout amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not present in the original answer or implied by the question, which only asked about the evolution of rights—not actual dividend payments. These figures are unsupported by the ground truth and appear to be hallucinated. Additionally, the mention of voting power distribution (public ~89-90%, Mastercard Foundation ~10%, Class B ~0%) and the ownership split is not part of the original answer and lacks verification from the provided knowledge base. While the reasoning about governance stability is logically sound and contextually relevant, the inclusion of unverified quantitative data significantly undermines factual accuracy. The model correctly performs multi-hop synthesis in concept (assessing trends over time), but injects extraneous, unverified numbers. Semantic equivalence fails on quantitative points, though the core qualitative conclusion about stability is consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 332,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nIn fiscal 2022 the Safety and Productivity Solutions segment posted a 1 % decline in retail‑related sales—partly because the company sold its retail‑footwear business—but overall segment sales still rose 21 % and profit grew 13 % as productivity‑ and warehouse‑automation revenues surged. By fiscal 2023 organic sales in the segment’s core sub‑businesses fell sharply, causing a 17 % drop in segment profit (even though margin improved), highlighting the segment’s heightened sensitivity to slowing consumer and capital‑spending demand. The modest 3 % sales increase and 2 % profit rise in fiscal 2024, coupled with the ongoing realignment into Industrial Automation, show that the segment remains vulnerable to retail‑market and broader consumer‑demand volatility over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer (ground truth) does not mention any specific percentages for sales or profit changes in any year—such as the claimed 1% decline in retail-related sales in 2022, 21% sales growth, 13% profit growth, 17% profit drop in 2023, or 3% sales and 2% profit increase in 2024. These figures are entirely absent from the ground truth and cannot be verified, making them likely hallucinated. (2) There is no mention in the ground truth of Honeywell selling a 'retail-footwear business'—this is a specific and unsupported detail that introduces factual error. The ground truth focuses on risk disclosures related to retail market fluctuations affecting demand for safety products and process automation, not divestitures of footwear lines. (3) The qualitative reasoning partially aligns: the LLM correctly infers ongoing vulnerability to retail and consumer demand volatility over time, and notes the rebranding to Industrial Automation by 2024. However, it misrepresents the nature of the exposure—ground truth emphasizes risk disclosures in filings (qualitative risk statements), not actual financial performance metrics. The LLM incorrectly shifts focus to reported financial outcomes rather than the forward-looking risk exposure highlighted in the original. (4) Contextually, the answer addresses the right segment, timeline, and general theme of retail market sensitivity, and correctly identifies the segment name change. However, the reliance on fabricated metrics undermines correctness. While the conclusion about continued vulnerability is consistent with the ground truth, it is supported by incorrect evidence. Thus, the answer is partially relevant and reasonably structured but factually unsound in key areas, especially quantitatively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 507,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the Olumiant partnership kept the same basic royalty framework—a tiered, double‑digit royalty (up to 20 % of worldwide net sales) payable to Incyte—while adding a new, low‑teens royalty that applies only when COVID‑19 sales exceed a specified aggregate threshold.  Milestone obligations were initially capitalized as intangible assets, and by 2023‑24 Incyte was eligible for up to $100 million of additional sales‑based milestones (plus the COVID‑19 performance milestones); these milestones were amortized into cost of sales, and the royalty payments made by LLY to Incyte were recorded as cost of sales.  Thus, the core double‑digit royalty persisted, but the COVID‑19 indication introduced an extra royalty tier and associated milestone payments that evolved the financial obligations from 2022 onward.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of the financial obligations and royalty structure between LLY and Incyte for Olumiant from 2022 to 2024, but has minor inaccuracies and omissions in the quantitative and temporal details. (1) Quantitatively, the LLM correctly identifies the up to 20% royalty rate on worldwide net sales and the additional low-teens royalty for COVID-19 sales above a threshold. However, it incorrectly states that 'up to $100 million of additional sales-based milestones' were still available in 2023–24, while the ground truth specifies that in 2022, Incyte was eligible for up to $100 million in regulatory milestones and $100 million in sales-based milestones—implying a total of $200 million in potential milestones, not $100 million as presented. The LLM conflates the two types and underrepresents the total milestone opportunity. (2) The answer correctly notes that milestone payments were capitalized as intangible assets and amortized into cost of sales by 2023, aligning with the 2023 evolution in accounting treatment. (3) Qualitatively, the reasoning is sound in identifying the shift toward royalty-based payments and the impact of the COVID-19 indication, but it fails to mention that by 2024, the focus had shifted to ongoing royalties because most contingent milestones had likely been triggered or expired—this key point about the lifecycle progression is missing. (4) The entities (LLY, Incyte, Olumiant, royalty rates, milestone types) and time periods (2022–2024) are accurate, and the answer is highly contextually relevant, addressing all parts of the question with appropriate financial terminology. Overall, the answer is factually strong but loses points for incomplete representation of milestone amounts and lack of clarity on the 2024 shift away from milestones.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 496,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nFrom 2022 through 2024 P&G kept **Always** in the **Feminine Care** sub‑category of the **Baby, Feminine & Family Care** segment, continuing to treat it as the flagship brand of that sub‑category.  Across the three years the company repeatedly highlighted Always as the primary driver of the segment’s > 20 % global market‑share in feminine care and as a key contributor to segment sales and earnings, positioning it ahead of other brands such as Tampax and Always Discreet in prominence and strategic focus.  The categorization did not change, but Always’s visibility and market‑leadership narrative were reinforced each year.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general idea that Always remained a key brand in the Feminine Care sub-category within the Baby, Feminine & Family Care segment from 2022 to 2024, which aligns with the ground truth and addresses the question's focus on strategic positioning and prominence. However, there are significant factual discrepancies. First, the claim that Always was the 'flagship brand' and positioned 'ahead of other brands such as Tampax and Always Discreet in prominence and strategic focus' is not supported by the original answer, which only states that Always remained a 'major brand' alongside Always Discreet and Tampax—without asserting hierarchy or leadership in strategic focus. Second, the LLM introduces a specific quantitative claim—'segment’s >20% global market-share in feminine care'—that does not appear in the ground truth and cannot be verified from the provided data, making it a hallucination. Third, the LLM states that 'the categorization did not change,' which directly contradicts the ground truth: in 2022, the category was 'Feminine Care (Adult Incontinence, Feminine Care)', but in 2023 and 2024 it evolved to 'Feminine Care (Adult Incontinence, Menstrual Care)', reflecting a strategic repositioning of Always toward menstrual care. This shift is a key point in the original answer and is entirely missed by the LLM. While the LLM correctly identifies the segment and general continuity of Always’ presence, it fails on critical details regarding product categorization evolution and introduces unsupported claims about market share and brand hierarchy. Thus, while contextually relevant and partially accurate, the answer contains significant factual and reasoning errors that reduce its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 470,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nACN’s defined‑benefit targets shifted from a near‑all‑debt posture in fiscal 2023 — U.S. plans 100 % debt; non‑U.S. plans 27 % equity, 48 % debt, 4 % cash, 11 % insurance, 10 % other — to a more balanced mix by fiscal 2024 (non‑U.S. equity raised to 28 %, debt trimmed to 36 %, cash to 7 %, insurance to 21 %, other to 8 %) and the 2025 target (identical to the 2024 mix) reflects a deliberate move toward greater equity and insurance exposure to improve risk‑adjusted returns while still matching liability duration.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in both quantitative details and overall interpretation. (1) QUANTITATIVE INACCURACY: The LLM claims specific allocations such as 'U.S. plans 100% debt' and detailed non-U.S. breakdowns (27% equity, 48% debt, etc.) for fiscal 2023, and similar precise figures for 2024 and 2025. However, the original answer states that the strategy emphasized a diversified portfolio with focus on duration matching but does not provide these exact percentage allocations. There is no mention of U.S. plans being 100% debt or non-U.S. allocations broken down by category in the ground truth. These numbers appear fabricated or hallucinated. (2) COMPLETENESS: While the LLM attempts to address the evolution across years, it misrepresents the nature of the change as a 'shift' toward more equity and insurance, implying a strategic rebalancing. The ground truth, however, emphasizes strategic continuity and stability, with only flexibility allowed for market conditions—not a deliberate shift in posture. (3) ENTITY & REASONING: The LLM incorrectly frames the evolution as a move from 'near-all-debt' to 'more balanced', which contradicts the ground truth's emphasis on consistent framework and liability duration matching. The multi-hop reasoning fails because it invents granular data not present in the source and draws conclusions unsupported by the evidence. (4) SEMANTIC EQUIVALENCE: The overall message diverges significantly—the ground truth highlights stability and tactical flexibility within a consistent strategy, while the LLM portrays an active strategic shift. Despite addressing the right topic and time periods, the answer is factually incorrect in key details and reasoning, warranting a low correctness score. Minor credit is given for attempting to trace a multi-year progression and linking allocation to risk-adjusted returns and liability matching, which is contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 532,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s trimmed its cash‑flow forward‑rate‑swap notional from roughly $2.56 billion to just under $1 billion, while the fixed‑to‑floating swaps used as fair‑value hedges on its existing long‑term debt expanded from about $0.85 billion to roughly $1.5 billion.  The re‑classification of a portion of those swaps from cash‑flow to fair‑value hedge accounting shows the company has shifted from primarily shielding future financing plans to directly protecting the fair value of its current fixed‑rate debt, revealing a more balance‑sheet‑centric interest‑rate risk‑management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, no current fair value was listed for forward interest rate swaps, but the LLM claims a notional of $2.56 billion, which is unsupported. In 2023, the fair value was $251 million (not notional), and there is no mention of a $1 billion notional or any reduction trend. By 2024, Lowe's had eliminated forward interest rate swaps entirely, but the LLM incorrectly implies they still held 'just under $1 billion' of them. The increase in fixed-to-floating swaps from $0.85B to $1.5B is not in the original answer and lacks support. (2) Calculations and values are entirely fabricated or mischaracterized: the original answer does not provide notional amounts or trends across years, only discrete disclosures (no 2022 value, $251M in 2023, none in 2024). The LLM invents a time-series narrative with specific dollar figures that do not appear in the ground truth. (3) The multi-hop reasoning is partially sound in interpreting the shift from cash flow hedges to fair value hedges as a strategic move, which aligns with the original answer’s conclusion about shifting from managing forecasted debt issuance to existing debt. However, this correct inference is based on incorrect data, undermining the reasoning chain. (4) Contextual relevance is high because the answer addresses the evolution of hedge types and accounting treatment and attempts to interpret strategic intent. However, due to severe quantitative inaccuracies and unsupported specifics, the correctness score is low despite some qualitative alignment in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 461,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nThe $5.000 % senior notes maturing in April 2030 showed virtually no change in outstanding balance—​about **$606 million** at the end of fiscal 2022, 2023 and 2024 (the same $606 million figure is reported as of Nov 3 2024 and Oct 29 2023).  At the same time the company’s overall debt load expanded dramatically (total principal rising from roughly **$40.8 bn** in 2023 to **$66.3 bn** in 2024 after the VMware merger), and it used cash from the merger, new senior‑note issuances and term‑loan repayments to shrink short‑term borrowings.  This pattern indicates that AVGO is managing its debt by **refinancing near‑term, higher‑cost obligations with longer‑dated, lower‑coupon senior notes while keeping legacy tranches—such as the 5 % 2030 notes—small and stable** as part of a broader strategy to extend maturities and lower overall financing costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, decreasing to $606 million in 2023 and 2024. However, the LLM claims the balance was $606 million in all three years, incorrectly stating no change and thus contradicting the core fact of a deliberate reduction. This error undermines the entire analysis. (2) The quantitative inaccuracies are critical: the $1,086M → $606M drop is a major data point indicating active repayment, but the LLM treats the amount as stable, misrepresenting the trend. Additionally, while the LLM correctly cites $606 million for 2023 and 2024, it falsely applies that same figure to 2022. The mention of total debt increasing from $40.8B to $66.3B post-VMware merger may be contextually plausible but is not part of the original answer and distracts from the specific debt instrument in question. (3) The multi-hop reasoning is partially sound—linking debt strategy to refinancing and maturity extension shows understanding of corporate finance concepts—but it is based on incorrect data. The conclusion that AVGO is keeping the 5% 2030 notes 'small and stable' directly contradicts the ground truth showing a 44.2% reduction, indicating active management rather than stability. (4) Scores reflect severe penalty on correctness and quantitative accuracy due to the central numerical error. Qualitative reasoning is somewhat accurate in framing broader debt strategy, and contextual relevance is moderate as the answer addresses debt management, albeit with flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 452,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nFrom 2022 through 2024 UPS continued to describe the same $276 million series of 7.620 % debentures—originally issued in 2005 and still outstanding—as a fixed‑rate instrument with a maturity of **April 1 2030**.  The debentures remain **callable at any time** at the greater of (i) principal plus accrued interest or (ii) the present‑value of the remaining scheduled payments discounted at a benchmark Treasury yield plus 5 basis points, and they are **not subject to any sinking‑fund requirements**; the redemption mechanics and interest‑rate formula were unchanged from the 2022 filing (the coupon had been reduced from 8.375 % to 7.620 % in 2020 and stayed at 7.620 % in 2023‑2024).  Across the three 10‑Ks the only evolution was an updated carrying‑value ( $280 million in 2022, 2023 and 2024) and re‑classification as long‑term debt, while the maturity date, interest rate, and redemption terms stayed the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the debentures have a principal of $276 million, mature on April 1, 2030, carry a fixed 7.620% interest rate (reduced from 8.375% in 2020), and remain callable at any time with the same redemption formula. The absence of sinking fund requirements is correctly noted. (2) Quantitative elements are precise: dollar amounts ($276 million), interest rates (7.620%, 8.375%), maturity date (April 1, 2030), and the redemption discount rate (Treasury yield + 5 bps) all match the original. The mention of a $280 million carrying value in 2022–2024 is consistent with accounting for premium amortization and does not contradict the $276 million principal. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent terms across 2022–2024 filings and correctly identifies that the interest rate did not change during this period, having been reset in 2020. It also captures the evolution in disclosure clarity, particularly around classification and carrying value. (4) The only minor shortcoming is that the LLM does not explicitly highlight the increased emphasis in 2024 on semi-annual interest payments, which the ground truth notes as a nuance in disclosure evolution. However, this omission does not undermine the core accuracy. Wording differs but meaning is semantically equivalent. The answer is fully relevant and addresses interest rates, redemption terms, and maturity structure as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 413,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen kept Olpasiran in its Phase 2 pipeline, progressing the siRNA‑based drug from early proof‑of‑concept studies toward later‑stage testing as a therapeutic aimed at lowering lipoprotein(a) for atherosclerotic cardiovascular disease.  During this period the company filed composition‑of‑matter patents covering the Olpasiran molecule, which are projected to expire in 2036 in both the United States and the European Union, thereby securing up to a 12‑year exclusivity window once the product is approved.  As a result, Olpasiran’s strategic positioning evolved from an early‑stage candidate to a late‑stage, IP‑protected asset poised for potential Phase 3 advancement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA in Phase 2 development targeting lipoprotein(a) for atherosclerotic cardiovascular disease in 2022, and accurately reports the 2036 expiration of composition-of-matter patents in both the U.S. and Europe. However, it omits the 2024 update in the original answer where the therapeutic indication broadened from 'atherosclerotic cardiovascular disease' to simply 'cardiovascular disease,' which is a key evolution in Amgen's strategic positioning. This omission affects completeness and nuance in the therapeutic focus progression. (2) Quantitatively, all dates (2022–2024, 2036 patent expiry) are correct, and the implied 12-year exclusivity window (from 2024 to 2036) is a reasonable interpretation, though not explicitly stated in the ground truth—this is a minor inference but not inaccurate. No calculation errors. (3) The reasoning is sound in connecting Phase 2 progression, IP protection, and strategic positioning, and correctly synthesizes information across time points and domains (clinical, IP). However, the failure to note the broadening of the indication in 2024 weakens the multi-hop synthesis across all years, particularly the shift in regulatory or clinical strategy. (4) Scores reflect high accuracy in facts and context, with a moderate deduction in correctness and qualitative accuracy due to the missing 2024 therapeutic indication update, which is a key part of the question's focus on 'evolution' through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 415,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nBetween 2022 and 2024 Tampax remained in the **Baby, Feminine & Family Care** segment, but its positioning was progressively emphasized as a core driver of that segment’s market leadership. In 2022 it was simply listed among the major brands (Always, Tampax Bounty, etc.), whereas in the 2023‑2024 disclosures P&G explicitly notes that **Tampax (together with Always) accounts for > 25 % of global menstrual‑care share**, highlighting its prominence as one of the segment’s leading brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Tampax's continued prominence within P&G's Feminine Care portfolio and correctly identifies its placement in the 'Baby, Feminine & Family Care' segment across the period. However, it introduces a specific quantitative claim—'Tampax (together with Always) accounts for >25% of global menstrual-care share'—that is not present in the original ground truth and cannot be verified from the provided knowledge graph. This undermines quantitative accuracy significantly. The ground truth emphasizes evolving segment nomenclature (e.g., shift to 'Menstrual Care' in 2023 and back in 2024), which the LLM omits, missing a key aspect of the categorization evolution. While the LLM correctly notes increasing emphasis on Tampax’s strategic role, it fails to reflect the actual structural changes in segment labeling that are central to the question. The reasoning is partially sound—there is correct synthesis of Tampax’s sustained prominence—but the unsupported market share figure and omission of reclassification details reduce factual correctness. Contextual relevance is high as the answer addresses brand positioning and segment context, but the inclusion of unverified data lowers overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 346,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s disclosures show that it continued to apply internally developed credit designations to non‑agency RMBS and CMBS that had not yet been evaluated by the NAIC, even after the NAIC introduced a 20‑category designation system and new RBC factors in 2021‑2022. This multi‑year pattern indicates that NAIC designations are typically unavailable at the time of purchase, revealing that MetLife’s acquisition strategy relies on buying these securities with the expectation that a NAIC rating will be assigned later, while using internal models to value them in the interim.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that MetLife consistently used internally developed designations for non-agency RMBS and CMBS from 2022 to 2024 when NAIC evaluations were not yet available. The mention of the NAIC's 20-category system and updated RBC factors in 2021–2022 adds contextual accuracy and is consistent with the timeline, even if not explicitly in the original answer; this does not contradict but rather enriches the explanation. All entities (MetLife, NAIC, non-agency RMBS/CMBS) and time periods (2022–2024) are correct. There are no numerical inaccuracies, as the response does not include specific figures requiring verification. The reasoning is sound: it correctly infers that the continued use of internal designations indicates a strategy of acquiring securities before NAIC ratings are assigned, reflecting both the lag in NAIC evaluations and MetLife’s proactive investment approach. The only minor shortcoming is that the original answer emphasizes the three-year consistency as evidence of a 'sustained strategy of investing in complex structured securities,' a nuance slightly underdeveloped in the LLM response, though implied. Overall, the LLM captures the core multi-hop logic—linking internal designation use over time to NAIC availability and acquisition strategy—accurately and coherently.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 384,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture expanded both the size of its buy‑back program and the amount it actually spent.  As of August 2022 the board had authorized about **$3.1 bn** of remaining capacity for open‑market purchases; by the end of fiscal 2024 the company still had roughly **$2.69 bn** of that capacity, and on September 25 2024 the board added **$4 bn** of authority, bringing total outstanding authorization to **$6.69 bn**.  Share‑repurchase outlays rose from **≈ $4.1 bn** of stock bought in fiscal 2022 to **≈ $4.5 bn** in fiscal 2024 (with the fourth‑quarter alone purchasing 2.07 million shares for $605 m), reflecting a deliberate acceleration of capital returns.  The trend shows Accenture is aggressively using its enlarged buy‑back authorization to return cash to shareholders, support the share price and offset dilution.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend correctly—Accenture increased its share repurchase authorization and activity over the period, indicating a growing capital return strategy. However, there are key quantitative inaccuracies. The ground truth states that in fiscal 2022, Accenture had $3.13 billion in available authorization (LLM reports $3.1 billion—acceptable rounding). The LLM claims repurchase outlays were ≈$4.1 billion in fiscal 2022 and ≈$4.5 billion in fiscal 2024, but the original answer does not provide total annual repurchase amounts for 2022 or 2024, only specifying a $605 million purchase in Q4 2024. Thus, these figures are unsupported and likely incorrect. Additionally, the LLM states 2.07 million shares were purchased in Q4 2024, while the ground truth specifies 2,000,308 shares—close but slightly off. (2) The date of the $4 billion increase—September 25, 2024—is correctly cited. The resulting total authorization of $6.69 billion is accurate ($2.69B + $4B). However, the LLM fabricates annual repurchase totals not present in the original, undermining quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects authorization levels across years, notes the increase, and infers a strategic emphasis on capital returns. It correctly identifies the September 2024 boost and links it to an ongoing trend. (4) Despite strong contextual relevance and mostly correct entity identification (Accenture, Class A shares, correct fiscal years), the inclusion of unverified annual repurchase amounts reduces factual reliability. The core narrative aligns with the ground truth, but unsupported numbers prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 459,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved industrial fiber‑optics from a generic “industrial product” listed alongside optocouplers and motion encoders (2022, pp. 8‑12) to a explicitly growth‑focused segment that enables high‑speed connectivity for industrial automation, renewable‑energy, automotive, defense/aerospace and edge‑AI applications (2023, pp. 3‑7; 2024, pp. 3‑7). This evolution shows the company is deliberately positioning industrial fiber‑optics as a strategic, high‑margin pillar to diversify and boost profitability in the industrial end‑market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its overall trajectory and strategic interpretation, but contains some overstatements and minor inaccuracies in detail compared to the ground truth. (1) Correct elements: The evolution from a broader, less-defined industrial product in 2022 to a more strategically emphasized offering by 2024 is accurately captured. The mention of industrial automation, automotive, and renewable energy as target applications aligns with the original answer. The strategic inference about Broadcom positioning fiber optics as a high-margin, growth-focused segment is a reasonable interpretation. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this dimension is not applicable; however, the years (2022, 2023, 2024) are correctly referenced, and no false metrics are introduced—thus, quantitative accuracy is perfect. (3) Multi-hop reasoning: The LLM synthesizes across years correctly in spirit, but introduces applications not explicitly mentioned in the ground truth—specifically 'defense/aerospace' and 'edge-AI'—which do not appear in the original knowledge graph. Additionally, the claim that fiber optics became a 'growth-focused segment' and 'strategic, high-margin pillar' goes beyond the documented evolution (which notes increased alignment with key applications and more structured categorization, but not explicit strategic elevation or margin commentary). (4) The original answer emphasizes consistency and maturation of positioning with increasing application specificity, while the LLM interprets this as a strategic pivot toward profitability and diversification—adding analytical depth but introducing unsupported claims. Thus, while the core facts are directionally correct, the qualitative accuracy is reduced due to overinterpretation and inclusion of unverified applications. Contextual relevance remains high as the answer directly addresses the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 528,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost was marketed as a residential‑ground service that used the UPS network for pickup and line‑haul but handed the final‑mile delivery to the United States Postal Service.  In early 2024 UPS announced that, beginning January 1 2025, it would insource that final‑mile step, ending its reliance on USPS and gaining greater control over service and cost as part of its broader “Fit‑to‑Serve”/Efficiency‑Reimagined strategy to shift volume toward higher‑yielding customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UPS SurePost used USPS for final-mile delivery from 2022–2024, and UPS announced in 2024 a shift to insource final delivery starting January 1, 2025. The date (January 1, 2025) and the strategic intent (greater control over service and cost) are correctly stated. (2) Quantitative accuracy is perfect: the timeline (2022–2024), announcement year (2024), and effective date (January 1, 2025) match the original answer exactly. No numerical calculations were required. (3) Reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies the historical reliance on USPS, the continuity through 2022–2023, the 2024 strategic change, and the future shift to in-house delivery. It also adds contextual depth by referencing UPS’s 'Fit-to-Serve'/Efficiency-Reimagined strategy, which is semantically consistent with a strategic shift toward higher-yielding customers, even if not in the original answer—this is a reasonable inference and enhances, rather than distorts, accuracy. (4) The only minor shortcoming is that the original answer emphasizes the motivation as 'enhancing control over service quality and customer experience,' while the LLM includes 'cost' and 'higher-yielding customers' as additional drivers. While plausible and contextually relevant, these are not explicitly confirmed in the ground truth, slightly reducing qualitative accuracy. However, this does not constitute a factual error, just a small expansion beyond the provided information. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 454,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline swelled from 13 programs (as of Feb 2022) to 24 programs by Jan 2024 and 25 by Feb 2025, with new late‑stage candidates such as bemarituzumab, TEZSPIRE, LUMAKRAS combination studies and Dazodalibep being launched, while several assets (e.g., LUMAKRAS, Otezla, RIABNI) moved from Phase 3 into FDA/EU approvals or conditional marketing authorizations.  The company also bolstered its pipeline through strategic acquisitions (e.g., Horizon‑derived programs) and filed composition‑of‑matter patents that extend exclusivity out to 2039.  This progression signals a deliberate R&D expansion—broadening therapeutic areas, deepening collaborations, and investing heavily in late‑stage development to secure a robust, diversified pipeline for future growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the quantitative evolution of Amgen's Phase 3 programs: 13 (Feb 2022), 24 (Jan 2024), and 25 (Feb 2025), aligning perfectly with the ground truth. The mention of growth to 25 by Feb 2025, driven by new initiations and approvals, is accurate and consistent. 2) All numbers and dates are factually correct. The progression from 13 to 24 to 25 is accurately represented, and the timeline matches the original answer. Minor variation in phrasing (e.g., 'Feb 2022' vs 'February 8, 2022') is acceptable and semantically equivalent. 3) The reasoning is sound: the LLM correctly infers a deliberate R&D expansion strategy, citing both internal development (new candidates like bemarituzumab, TEZSPIRE, LUMAKRAS combinations) and external growth via the Horizon Therapeutics acquisition, which the ground truth confirms added five Phase 3 programs. It also correctly notes movement of assets from Phase 3 to approval (e.g., Otezla, RIABNI), demonstrating multi-hop synthesis across development stages and corporate actions. 4) The answer is contextually complete and relevant, addressing both the quantitative evolution and strategic implications. The only minor omission is not explicitly stating the 18 programs as of January 31, 2023, though the jump from 13 to 24 is still accurately framed as significant growth. Additionally, while it mentions Horizon-derived programs, it doesn't explicitly state that the acquisition added five Phase 3 programs—this detail is implied but not confirmed. These are minor gaps that prevent a perfect 10 on qualitative accuracy, but overall the answer is factually robust, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 461,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares in FY 2022** to **141 million shares in FY 2023** (and remained at that level in FY 2024). This expansion shows that Accenture intentionally broadened its equity‑award pool, underscoring a strategic shift to rely more heavily on share‑based compensation as a core component of its talent‑retention and performance‑incentive strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the numbers match exactly: 127 million shares in FY 2022 and 141 million shares from FY 2023 to FY 2024, with correct fiscal year labeling. (2) The answer correctly captures the evolution of the share authorization over the three-year period and notes the increase of 14 million shares, though the exact difference isn't required. (3) The reasoning is sound: the expansion in authorized shares is correctly interpreted as a strategic move to enhance equity-based compensation for talent retention and performance alignment, which aligns with the original answer's conclusion. (4) All entities—Accenture plc, Amended 2010 SIP, Class A ordinary shares, and fiscal years 2022–2024—are accurately referenced. The answer is concise, contextually appropriate, and addresses both parts of the multi-part question: the numerical evolution and its strategic implication. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 292,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company lengthened the horizon of its green‑coffee coverage: the 2022 filing said existing inventory plus purchase commitments would be sufficient only through fiscal 2023, while the 2023 and 2024 filings each state that total purchase commitments together with inventory are expected to meet demand through fiscal 2025.  This extension reflects a deliberate inventory‑building and hedging strategy—using fixed‑price, forward and collar contracts and long‑term supplier relationships—to lock in supply, mitigate the inherent price volatility of green coffee, and reduce the risk of supply disruptions as the business expands globally.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution of Starbucks' green coffee supply coverage: from sufficient through fiscal 2023 (as stated in fiscal 2022), extended to fiscal 2025 (as stated in fiscal 2023), and maintained through fiscal 2025 in fiscal 2024. All timeframes match the original answer. (2) There are no numerical or date inaccuracies; the progression across fiscal years is correctly represented. (3) The multi-hop reasoning—synthesizing disclosures across three fiscal years (2022, 2023, 2024)—is sound and correctly infers the strategic shift. (4) The LLM adds contextual detail about hedging mechanisms (fixed-price, forward, collar contracts) and long-term supplier relationships, which enriches the explanation without deviating from the original meaning. This aligns with and supports the conclusion about a more forward-looking inventory and risk management strategy. All aspects of the question—evolution over time and strategic implication—are thoroughly and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 306,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS’s handling of the UPS/IBT Full‑Time Employee Pension Plan shifted in three key ways. First, the 2023 five‑year national master agreement with the Teamsters introduced wage and benefit increases for IBT participants, prompting a year‑end remeasurement of the plan’s obligations and generating actuarial gains/losses that were recorded in other‑comprehensive‑income. Second, beginning January 1 2023 the company stopped accruing additional defined‑benefit accruals for non‑union participants (and moved them to a defined‑contribution contribution structure), fundamentally changing the plan’s liability trajectory. Third, ongoing periodic remeasurements—driven by updated discount‑rate assumptions, the continued use of the MP‑2021 mortality scale, and fluctuations in asset returns—altered the plan’s funded status and resulted in recurring gains or losses that are reflected in the consolidated financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 2023 national master agreement prompted a year-end remeasurement with actuarial gains/losses recorded in other comprehensive income—however, the ground truth specifies that the 2022 remeasurement was due to the American Rescue Plan Act and resulted in a $3.3 billion pre-tax gain included in investment income, not OCI. The LLM omits this key event entirely and misattributes the remeasurement to the 2023 agreement. Additionally, the LLM claims that as of January 1, 2023, UPS stopped defined benefit accruals for non-union participants and moved them to defined contribution, which is not supported by the original answer and contradicts the ground truth that the plan remained noncontributory and structurally unchanged through 2024. (2) Quantitatively, the LLM fails to mention the $3.3 billion pre-tax ($2.5 billion after-tax) gain in 2022, a central financial figure in the ground truth. No correct numbers are provided, and the absence of these figures severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM fabricates a structural change in 2023 that is not in the original data and misaligns the cause of remeasurement. It also fails to connect the 2022 regulatory impact (American Rescue Plan Act) to the financial outcome, which is a critical link in the correct narrative. (4) While the LLM addresses the general themes of plan amendments, remeasurements, and collective bargaining, it does so with incorrect drivers and outcomes, reducing contextual relevance. The mention of periodic remeasurements due to discount rates and mortality assumptions adds plausible detail but is not in the ground truth and distracts from the actual key events. Thus, despite addressing the topic area, the answer is largely factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 508,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nWalmart continued to list “Holiday Time” as a stand‑alone private‑brand line in each of the fiscal‑year disclosures (2022 – 2024) — it appears in the brand‑name merchandise tables on pages 7‑8 of the 2023 10‑K, on pages 6‑7 of the 2024 10‑K, and in the comparable list in the 2022 filing.  What changes is the **contextual framing**: in the 2022 filing the brand was simply grouped with other private‑label names, whereas the 2023 and 2024 filings begin to reference “Holiday Time” explicitly as part of the **seasonal‑merchandise unit** (e.g., “seasonal/holiday merchandise” and “holiday décor”), signaling a deliberate move to treat it as a dedicated seasonal private‑label pillar.  \n\nThis evolution reveals that Walmart is **strategically positioning seasonal items under its own private brands** to capture peak holiday demand, differentiate those products from national‑brand competitors, and integrate them more tightly into its broader private‑label portfolio.  By doing so, the company can leverage exclusive “Holiday Time” merchandise to drive incremental sales during the most profitable period of the year while reinforcing the EDLP promise with proprietary, time‑sensitive offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Walmart, 'Holiday Time', fiscal years 2022–2024—are correctly identified. The evolution across years is accurately portrayed: in 2022, 'Holiday Time' was listed among other private brands without special emphasis; by 2023 and 2024, it was increasingly framed within seasonal merchandise. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—but all dates and fiscal years are correct, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and infers a strategic shift based on contextual framing in disclosures, correctly identifying the move toward treating 'Holiday Time' as a dedicated seasonal pillar. The conclusion about Walmart leveraging private-label seasonal products to capture holiday demand and support EDLP is logically supported. (4) The only minor gap is that the LLM does not explicitly mention the 2024 restructuring of merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, which is a specific structural detail in the ground truth. However, the answer captures the essence of this shift through references to 'seasonal-merchandise unit' and strategic positioning. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 422,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nACN’s defined‑benefit pension assets included mutual‑fund equity securities of roughly **$239 million at the end of fiscal 2022**, **$196 million at the end of fiscal 2023**, and **$274 million at the end of fiscal 2024**. The decline in 2023 reflects a temporary de‑risking of the portfolio, while the rebound in 2024—bringing the allocation back above its 2022 level—indicates a deliberate re‑allocation toward equities as part of the company’s target asset‑mix and risk‑management strategy. This trend suggests ACN is actively adjusting its equity exposure to balance long‑term return objectives with liability‑matching considerations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the value increased to $274 million in 2024, which is factually incorrect. This error fundamentally undermines the entire analysis. (2) Quantitative accuracy is severely compromised: the 2024 figure is wrong by over $77 million, and the trend is misrepresented (increase vs. no change). While the 2022 and 2023 figures are approximately correct (rounded), the 2024 number is not supported by the ground truth. (3) The multi-hop reasoning is flawed because it infers a 'rebound' and 're-allocation toward equities' based on a false increase in 2024. The actual trend—decline followed by stability—suggests a strategic reduction or stabilization, not re-allocation back into equities. The LLM fails to correctly synthesize the three-year trend. (4) Despite incorrect facts, the answer is contextually relevant, addressing the evolution over time and offering strategic interpretation. However, the reasoning is based on false data, leading to an incorrect conclusion about ACN's strategy. A correct interpretation would note a consistent reduction or stabilization, suggesting de-risking or strategic exit rather than re-entry into equities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 391,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks shifted from a descriptive view of green‑coffee price volatility—highlighting that futures‑market activity, including hedge‑fund and commodity‑index‑fund trading, can affect the “C” price—to an explicit, multi‑tool hedging program.  The company increasingly uses fixed‑price and price‑to‑be‑fixed purchase commitments together with forward contracts, futures and collars to lock in prices and secure supply through at least fiscal 2025, turning what was once passive exposure into a proactive risk‑management strategy that monitors and adjusts to futures‑market signals.  This evolution reveals that Starbucks manages commodity‑price risk through disciplined, layered hedges rather than relying on market fluctuations alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks' exposure to green coffee price volatility through the 'C' price and commodity index fund activity in the futures market is accurately described for fiscal 2022–2024. The evolution of hedging strategies—using forward contracts, futures, collars, fixed-price, and price-to-be-fixed contracts—is consistent with the original answer. The extension of supply commitments through fiscal 2025, first noted in 2023 and maintained in 2024, is correctly implied by the phrase 'through at least fiscal 2025'. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all timeframes (fiscal 2022–2024, through 2025) match exactly. (3) Multi-hop reasoning is sound: the LLM synthesizes Starbucks’ increasing strategic sophistication across years, correctly inferring a shift from passive acknowledgment to proactive risk management. It accurately connects futures market influences (including index funds) to hedging tools and long-term supply security. (4) The only minor deviation is that the LLM mentions 'collars'—a specific hedging instrument—not explicitly stated in the ground truth. However, this is a plausible and contextually appropriate detail consistent with Starbucks’ risk management practices and does not contradict the source. Overall, the answer captures the essence, timeline, and strategic implications accurately, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 424,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nAVGO carried $622 million of its 3.625 % senior notes maturing in October 2024 at the end of FY 2022 and FY 2023 (see AVGO_10k_2022.pdf pp. 101‑105; AVGO_10k_2023.pdf pp. 79‑83).  By the close of FY 2024 that balance had been reduced to zero (AVGO_10k_2024.pdf pp. 79‑83), indicating that the company retired the entire issue—using cash from its October 2024 senior‑note issuance and proceeds from the VMware merger—to eliminate near‑term maturities and reshape its short‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $622 million outstanding in FY 2022 and FY 2023, reduced to zero by FY 2024, matching the original answer. Dates (October 2024 maturity) and percentages (3.625%) are accurate. (2) The answer correctly identifies the evolution across fiscal years and concludes full retirement of the notes by 2024, which is consistent with the ground truth. (3) The reasoning is sound and adds value by specifying potential funding sources (October 2024 note issuance and VMware merger proceeds), which goes beyond the original answer but is plausible and contextually supported by AVGO’s known financing activities. However, this additional detail is not present in the ground truth and, while reasonable, introduces unverified specifics about funding sources not confirmed in the knowledge graph, slightly reducing qualitative accuracy. (4) The response fully addresses both parts of the question: the evolution of exposure and the implication for debt management strategy, concluding deliberate management of near-term maturities. Semantic equivalence is strong, with only minor expansion on rationale. Overall, this is a factually correct, complete, and relevant answer with excellent multi-hop synthesis across three fiscal years and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 374,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nMastercard’s settlement‑risk metrics expanded markedly from 2022 through 2024 – gross exposure rose from roughly $52 bn to $75 bn (2023) and $78 bn (2024), while net exposure climbed from about $46 bn to $63 bn and $65 bn – prompting the company to tighten its credit‑risk standards and rely more heavily on cash collateral, letters of credit and other mitigation arrangements.  At the same time, heightened regulatory scrutiny (U.S. FTC/DOJ investigations, EU antitrust probes, the UK Payment Systems Regulator fine) and a wave of litigation – including the UK Supreme Court interchange‑fee rulings, the U.S. merchant‑class MDL, ATM‑surcharge class actions and the Europe‑wide consumer collective actions – forced Mastercard to increase its loss‑contingency accruals (e.g., a $559 m reserve for the U.S. MDL and a £32 m UK fine) while continuing to monitor and revise its risk‑management methodology to preserve low historical loss rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention any specific figures for gross or net settlement exposure (e.g., $52B, $75B, $78B, $46B, etc.), nor does it state that exposure increased in this manner. These numbers are entirely fabricated. Similarly, the LLM claims Mastercard accrued a $559M reserve for the U.S. MDL and a £32M UK fine, but the original answer does not include these figures or any specific reserves/fines beyond general references to litigation and investigations. (2) There is no verification for the cited numbers because they do not appear in the ground truth. The original answer emphasizes qualitative risk management practices and regulatory developments without providing financial exposure metrics or contingency amounts. The LLM invents precise figures and trends (e.g., exposure rising from $52B to $78B) that are unsupported. (3) The multi-hop reasoning is partially sound in structure—linking regulatory scrutiny and litigation to risk management adjustments—but fails because it synthesizes non-existent data. While the original answer confirms FTC/DOJ investigations and EU antitrust probes, it does not mention a UK Payment Systems Regulator fine, UK Supreme Court interchange-fee rulings, ATM-surcharge class actions, or Europe-wide consumer collective actions. These are either incorrect or unverified. The EMV liability shift lawsuit (>$1B) and European Commission investigation are mentioned in the ground truth, but not the other litigations cited. (4) The contextual relevance is moderate because the LLM addresses credit risk mitigation, regulatory scrutiny, and litigation—core themes of the question—but distorts the facts with hallucinated data. Due to severe quantitative inaccuracies and inclusion of unverified legal proceedings, the overall correctness score is low at 3. Qualitative accuracy is slightly higher because some regulatory bodies (FTC, DOJ, EC) are correctly identified, but the reasoning is undermined by false specifics. Quantitative accuracy is very low due to complete fabrication of exposure figures and reserves.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 583,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures on drug‑delivery devices grew progressively more detailed and stringent. In 2022 the filing warned that separate regulatory approval and safety oversight of its delivery systems could lead to product removal if clearance were lost; by 2023 the discussion added explicit REMS‑based post‑marketing obligations, mandatory pharmacovigilance reporting and FDA inspections of device safety; and in 2024 the language emphasized heightened scrutiny of accelerated/conditional approvals, required confirmatory studies (e.g., for LUMAKRAS), and the risk of approval revocation or restrictive labeling if regulatory conditions are not met—signaling an evolution toward tighter compliance and safety oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution from general regulatory risks in 2022 to more specific post-marketing obligations and safety oversight in 2023 and 2024 is accurately captured. The mention of confirmatory studies for LUMAKRAS in 2024 matches the original answer. (2) There are no numeric values to verify, but all dates (2022–2024) and references to regulatory actions (e.g., labeling changes, product withdrawal) are consistent with the ground truth. Format and terminology (e.g., REMS, pharmacovigilance, confirmatory studies) are used appropriately. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and domains (compliance, post-marketing obligations, safety). The LLM correctly infers a trend toward tighter oversight, which is implied in the original answer. (4) Minor difference: the original answer mentions Repatha alongside LUMAKRAS in 2023, which the LLM omits. Also, the LLM introduces 'REMS-based obligations' and 'FDA inspections' not explicitly stated in the ground truth, though these are reasonable interpretations of increased regulatory scrutiny. These additions do not contradict but slightly extend the source. Overall, the answer is factually correct, comprehensive, and contextually precise, warranting a high score with only a small deduction for minor over-specification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 391,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 the company moved Parent’s Choice out of the broad “Grocery” bucket and into a dedicated **Baby & Toddler / consumables** sub‑category, giving it its own shelf‑space and omni‑channel fulfillment focus.  This re‑categorization shows Walmart is treating Parent’s Choice as a strategic anchor for its baby‑and‑consumables portfolio—leveraging the brand to reinforce everyday‑low‑price leadership and to drive family traffic through both store and digital channels.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that 'Parent's Choice' was moved out of the 'Grocery' category into a dedicated 'Baby & Toddler / consumables' sub-category. The ground truth states that 'Parent's Choice' remained consistently under the Grocery merchandise unit across fiscal years 2022, 2023, and 2024, with baby products becoming more explicitly defined within that unit in 2024. There is no evidence of re-categorization or creation of a new sub-category. (2) There are no numeric values in the response, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations were made because none were provided. Thus, this dimension scores highly by default. (3) The multi-hop reasoning is flawed: the model incorrectly infers a structural reorganization of merchandise categories based on increased emphasis or explicit labeling of 'baby products' within Grocery. It fails to recognize continuity in categorization and misinterprets Walmart’s strategy as a repositioning rather than a reinforcement within the existing framework. (4) While the LLM captures Walmart’s broader strategic goals—EDLP, omni-channel focus, family traffic—the interpretation of organizational changes is unsupported by the data. The answer is contextually relevant and addresses the right themes, but the factual foundation is incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 397,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings the only mention of the 4.70 % Solar Bonds, Series 2015/C24‑10 is the original 2015 indenture and its supplemental indentures; no new issuance or material restructuring is disclosed. The repeated inclusion of the same indenture—augmented only by routine waivers or supplemental amendments—shows that Tesla has kept this asset‑backed, fixed‑rate security in place without substantive change, reflecting a strategy of relying on a stable, long‑term securitized financing vehicle for its solar portfolio rather than pursuing new bond issues or major restructurings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that the 4.70% Solar Bonds, Series 2015/C24-10 were referenced in Tesla's 2022, 2023, and 2024 10-K filings through the original 2015 indenture and supplemental agreements, with no new issuance or material restructuring disclosed—consistent with the ground truth's emphasis on continued referencing without substantive change. The quantitative details (4.70%, Series 2015/C24-10, April 14, 2015 indenture) are correct, earning a perfect score on quantitative accuracy. The answer correctly infers that Tesla maintained a stable, long-term securitization strategy, which is semantically equivalent to the ground truth's conclusion about a 'consistent and scalable securitization strategy.' The only minor gap is that the LLM does not explicitly mention the broader context of other series (e.g., C27-10, C32-10 in 2023 or C4-10/C9-10 in 2024) that the ground truth notes, which slightly weakens the multi-hop synthesis and contextual richness. However, the core reasoning about a recurring, matured model is still logically supported. The answer is highly relevant, directly addressing the evolution across years and the strategic implication. Thus, correctness is 9 due to high accuracy with a small omission in completeness of contextual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 373,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nBroadcom has moved the Security Insights Platform from a stand‑alone mainframe risk‑assessment tool in 2022 to a core, AI‑driven element of its broader enterprise‑security portfolio by 2024.  Early versions delivered risk scores and remediation steps for mainframe posture; in 2023 the platform began feeding that data into Symantec and Carbon Black SIEM/XDR and endpoint‑security solutions, and in 2024 it is positioned as a tightly integrated module that works across Broadcom’s security stack—linking mainframe risk assessment with enterprise‑wide SIEM, network‑security and endpoint protections for continuous, automated risk management.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being contextually relevant to the question. (1) The original answer states that Broadcom's Security Insights Platform consistently emphasized mainframe risk assessment from 2022 to 2024, with only a subtle shift in 2024 toward stronger integration language—specifically, reiterating that data is available for use with in-house SIEM tools. In contrast, the LLM claims a significant evolution: positioning the platform as 'AI-driven' by 2024, integrating with Symantec and Carbon Black SIEM/XDR tools, and functioning as a 'tightly integrated module' across Broadcom’s security stack. These specific integrations and technological advancements (e.g., AI, endpoint protections) are not supported by the ground truth and represent substantial fabrication. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers deep integration with specific third-party tools and a technological transformation not present in the source material. The original answer emphasizes stability in functionality with only a nuanced shift in messaging, not a functional expansion. (4) While the LLM addresses the right topic—evolution of the platform’s positioning—and correctly identifies mainframe risk assessment as a core theme, it invents key details about integration capabilities and strategic repositioning, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the response aligns with the general subject and structure of the question, but factual divergence is severe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 468,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Company’s charter continued to give Class A shares one vote per share and identical dividend rights, while Class B remained non‑voting but retained dividend entitlement; the only change was the amount of dividends per share, which rose from $2.04 (2022) to $2.37 (2023) to $2.74 (2024).  This unchanged dual‑class voting structure—with public investors holding roughly 90 % of the voting power and the Mastercard Foundation retaining about 10 %—demonstrates that MA’s capital‑structure strategy has been to preserve a stable controlling ownership while steadily increasing cash returns through higher dividends and share‑repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that A Class shares maintained one vote per share and dividend rights from 2022 to 2024, aligning with the ground truth. However, it introduces specific dividend amounts ($2.04, $2.37, $2.74) and claims these increased annually, which are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but go beyond the confirmed data, introducing unverified quantitative details. (2) The mention of Class B shares being non-voting and dividend-entitled, while potentially accurate, is extraneous and not part of the original answer’s scope, which focused solely on A Class shares. The claim about public investors holding 90% of voting power and the Mastercard Foundation 10% is also absent from the ground truth and represents additional unverified context. (3) The multi-hop reasoning is sound in linking stable voting/dividend rights to a consistent capital structure strategy, which matches the original conclusion. The core logic—that unchanged rights reflect strategic consistency—is preserved and well-reasoned. (4) While the qualitative reasoning and contextual relevance are strong, the quantitative accuracy is reduced due to the inclusion of unsupported numerical values and percentages not present in the ground truth. The answer is semantically aligned in its main conclusion but overreaches on specifics, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 407,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen moved bemarituzumab from the initiation of its Phase 3 program (2022) through continued Phase 3 enrollment in 2023‑2024, maintaining its Breakthrough‑Therapy status and expanding trials across multiple indications and geographies.  Throughout this period the drug’s composition‑of‑matter patents filed in the United States and Europe remained projected to expire in 2029, providing roughly eight years of market exclusivity after any future approval, while Amgen continued to file additional method‑of‑use and formulation applications that could extend protection beyond that date.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in completeness and precision. (1) Quantitatively, the key date—2029 patent expiration—is accurately reported, matching the original answer. The mention of composition-of-matter patents expiring in 2029 in both the U.S. and Europe is consistent with the ground truth. However, the LLM implies ongoing Phase 3 enrollment in 2023–2024, while the original answer only confirms initiation in 2022 and does not specify continued enrollment or expansion across geographies/indications, making this a slight overstatement. (2) The LLM correctly identifies the patent timeline and notes additional method-of-use and formulation patents as potential extensions, which is a reasonable inference about IP strategy, though not explicitly stated in the original. This adds value but goes beyond the provided facts. (3) Multi-hop reasoning is sound: the answer synthesizes clinical development (Phase 3 initiation and status) with IP timelines across years and regions. However, the original answer emphasizes Bemarituzumab’s mechanism (anti-FGFR2b monoclonal antibody) and specific indication (gastric/GEJ cancer), which the LLM omits, reducing completeness. (4) Contextual relevance is high—the response directly addresses the evolution of clinical and IP strategy from 2022–2024. Overall, core facts are correct, but minor omissions and slight over-elaboration prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 404,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Walmart continued to list “No Boundaries” among the private‑brand families that sit inside the **Fashion** strategic merchandise unit (the apparel‑and‑accessories category within the broader General Merchandise segment).  The company’s 10‑K filings show that while the overall merchandising taxonomy was periodically revised, No Boundaries remained anchored to the Fashion unit and was highlighted in the same list of private‑label brands each year, underscoring a deliberate focus on expanding its apparel offering.  This consistency reveals that Walmart is shifting resources toward higher‑margin, private‑label fashion to capture value‑conscious shoppers and integrate apparel more tightly with its omni‑channel and membership (Walmart+) initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in the categorization of 'No Boundaries' across the years. According to the ground truth, in 2022 'No Boundaries' was under the 'Apparel' category, and only by 2024 was it moved to the broader 'Fashion' unit. However, the LLM claims that 'No Boundaries' was consistently listed under the 'Fashion' unit from 2022 through 2024, which contradicts the documented evolution in Walmart's strategic merchandise units. This misrepresents the key shift the question asks about—how the brand's placement changed over time. While the LLM correctly notes the continuity of the brand and links it to Walmart's focus on private labels and omni-channel strategy, it fails to accurately describe the reorganization itself, which is central to the question. There are no numerical inaccuracies (hence a 10 in quantitative accuracy), and the answer is contextually relevant, discussing private brands, fashion strategy, and omni-channel integration. However, the qualitative accuracy is low because the model misidentifies the timeline and structure of the merchandising units, undermining the reasoning behind Walmart's strategic shift. The answer synthesizes concepts plausibly but not faithfully to the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 357,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑Ks IBM repeatedly cites client relationships and trust as a principal competitive advantage, but the emphasis deepens over time. In 2022 it is listed among several “principal methods of competition,” while 2023 and especially 2024 frame trust and security as the foundation of IBM’s hybrid‑cloud and AI platform and tie them directly to its ecosystem of strategic partners and go‑to‑market narrative. This progression shows IBM is positioning trust not just as a differentiator but as the core pillar that enables its hybrid‑cloud and AI strategy to win and retain clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024. It correctly identifies that in 2022, trust was one of several competitive methods, and notes the increasing centrality of trust in 2023 and 2024. The answer accurately reflects the deepening linkage between trust and IBM’s hybrid cloud/AI strategy, particularly through ecosystem partnerships, aligning with the ground truth's point about strategic partnerships with hyperscalers and integrators. There are no numeric inaccuracies (quantitative accuracy is 10), as the response avoids specific figures that would require validation and instead focuses on qualitative progression. The reasoning is sound and reflects multi-hop synthesis across years and strategic themes. The only minor shortcoming is that the LLM answer does not explicitly mention 'solving complex client challenges through integrated technologies' (2023) or the extension of trust via 'ecosystem collaboration to enhance client outcomes' (2024) in the same detail as the original, slightly reducing qualitative completeness. However, the core message — positioning trust as a foundational pillar enabling hybrid cloud and AI strategy — is preserved with strong semantic equivalence. Contextual relevance is perfect, as the response directly addresses both the evolution and strategic implications of IBM’s trust focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 392,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C25‑15 remained on Tesla’s balance sheet through the 2022 filing, where they were reported as a distinct tranche of long‑term debt with accrued interest maturing in 2025. In the 2023 Form 10‑K the company disclosed a series of supplemental indentures that amended and effectively refinanced this tranche—moving the exposure into newer 4.70 % Solar Bond series—signaling a strategic shift toward lower‑cost, more granular asset‑backed financing. By the 2024 filing the 5.45 % series is no longer listed, indicating that the bonds have been retired or absorbed into the newer structures, reflecting Tesla’s move away from broad, high‑coupon solar bond issuances to project‑level debt and equity‑based funding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the claim that the 5.45% Solar Bonds, Series 2015/C25-15 were refinanced into a 4.70% series in 2023 and retired by 2024 is false—the original answer confirms the bond was consistently referenced across all three years (2022–2024) with no indication of refinancing or retirement. The maturity date of 2025 and the claim of refinancing via supplemental indentures are unsupported by the ground truth. (2) The answer incorrectly asserts that the bond was removed from the 2024 filing; in fact, it remained a key exhibit, indicating ongoing relevance. (3) Qualitatively, the reasoning is flawed: the LLM infers a strategic shift toward lower-cost financing and project-level debt, but the ground truth shows Tesla maintained consistent reliance on the same bond series, indicating stability, not change, in financing strategy. (4) Contextually, the answer addresses the question’s structure by discussing each year and attempting to infer strategy, so it remains relevant in framing, but the conclusions are based on fabricated developments. The multi-hop synthesis fails because it invents events (refinancing, retirement) not present in the data, leading to a fundamentally incorrect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 363,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nEmerson’s Safety & Productivity segment expanded its pipe‑working lineup between 2022 and 2024 by introducing cordless battery‑hydraulic tools—such as battery‑powered press units for pipe joining and battery‑driven cutters/crimpers for electrical cable work—and by adding advanced diagnostic equipment (e.g., CCTV pipe‑inspection and locating systems) that are now offered as standard features.  The 2023‑2024 disclosures (EMR 10‑K 2022 pp. 7‑11; EMR 10‑K 2023/2024 pp. 71‑75) highlight this shift toward battery‑driven, mobile solutions that boost safety and productivity on‑site.  Together, these moves show Emerson is deliberately repositioning its professional‑tools business as a high‑margin, innovation‑led platform that competes on technology and performance rather than solely on price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe-working tool offerings from 2022 to 2024, noting the introduction of battery-powered hydraulic tools for press connections (2023) and expansion into battery-powered cutters and crimpers for electrical cables (2024), as well as diagnostic systems like CCTV and locating equipment. The foundational role of pipe wrenches is implied through continuity, though not explicitly stated across all years. (2) There are no numeric values, dates, or financial figures in the original answer to verify quantitatively, but the years (2022–2024) and progression are correctly used. References to 10-K filings (e.g., EMR 10-K 2022 pp. 7–11) are plausible but not required for factual correctness—these do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes product evolution over time and infers strategic intent—modernization, productivity, safety, and technology-led differentiation—which is fully supported by the original answer. The conclusion about strategic repositioning as a high-margin, innovation-led platform is a reasonable interpretation consistent with the ground truth. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention that pipe wrenches were consistently offered across all years, which is a small but notable detail in the original answer. Otherwise, the semantic meaning, completeness, and contextual relevance are excellent. The answer directly addresses product innovation, battery-tech integration, and strategic positioning as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 450,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s capital‑allocation plan for its El Segundo, California campus shifted from an initial build‑out of GMP‑certified cell‑therapy suites to a sustained expansion that adds modular production lines and automation.  The 2022 10‑K (pp. 31‑35) earmarked funds to scale commercial manufacturing of Yescarta and Tecartus, the 2023 filing (pp. 9‑13) reports a ~30 % increase in CAPEX for the site to support both existing products and a growing pipeline of CAR‑T candidates, and the 2024 filing (pp. 8‑12) confirms that this investment is now embedded in Gilead’s broader biologics strategy—using El Segundo as the hub for next‑generation cell‑therapy platforms that feed directly into its expanding biologics pipeline.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth does not mention any '30% increase in CAPEX' or specific GMP suite build-outs, modular production lines, or automation investments. These details are fabricated or inferred beyond what the filings support. The original answer only confirms a strategic repositioning of El Segundo toward cell therapy manufacturing, not specific capital projects or percentages. (2) The cited page ranges (e.g., pp. 31–35 in 2022, pp. 8–12 in 2024) do not align with the actual source references in the ground truth (e.g., GILD_10k_2022.pdf:page_33:chunk_1), and the 30% CAPEX increase is not present in the verified data. No dollar amounts or percentages appear in the ground truth, so introducing a 30% figure constitutes a serious quantitative error. (3) While the LLM correctly identifies a strategic evolution at El Segundo—from general manufacturing to a focus on cell therapy—it overreaches in multi-hop reasoning by inventing specific capital allocation plans and linking them to CAR-T candidates and biologics pipeline integration without direct support. The ground truth confirms the site’s re-designation for clinical/commercial cell therapy manufacturing in 2023 and 2024 and mentions reliance on proprietary know-how, but does not tie this to modular expansion or automation. (4) Despite the factual errors, the answer is contextually relevant, addressing the evolution of capital allocation and alignment with biologics strategy. The core directional insight—increasing strategic importance of El Segundo for cell therapy—is consistent with the ground truth, but the lack of evidentiary support for specific investments and figures severely undermines correctness. Hence, a partial score is warranted for structure and relevance, but not for factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 504,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nFrom 2022 through 2024 IBM kept the 1.250 % Notes due 2027 in its debt‑security tables and continued to incorporate by reference the same indenture originally filed in January 2019; the 2024 filing merely added a brief note that a February 2 2024 supplemental indenture governs the issue, but no new issuance or material change was made. Consequently, the company’s relationship with the notes was one of ongoing disclosure and periodic updating of the governing documents, with the notes remaining outstanding throughout the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. (1) Quantitatively, the LLM correctly references the 1.250% Notes due 2027 and the January 2019 indenture filing, which aligns with the original answer. However, it introduces a 'February 2, 2024 supplemental indenture' not mentioned in the ground truth, which undermines accuracy. The ground truth states that in 2024, the notes were formally listed on the NYSE under trading symbol IBM27B, indicating public issuance and market presence — a critical development the LLM fails to mention. Instead, the LLM claims 'no new issuance or material change was made,' which directly contradicts the ground truth's assertion of a shift to active market presence. (2) The dates referenced (January 2019, 2022–2024) are generally consistent, but the specific February 8, 2022, and February 3, 2023, references in the ground truth are omitted. The LLM’s mention of a February 2, 2024, supplemental indenture lacks corroboration and appears incorrect or at least unsupported. (3) Qualitatively, the reasoning is flawed: the LLM interprets continued disclosure as evidence of no change, while the ground truth describes an evolution from disclosure to public issuance — a multi-hop inference the LLM misses entirely. The model fails to synthesize the progression from internal documentation to exchange listing, which is central to the question. (4) Contextually, the answer is relevant and addresses the timeline and disclosure practices, but it misses the key development in 2024 (NYSE listing), leading to an incomplete and partially misleading conclusion. Thus, while some factual elements are correct, the core narrative of evolution is inaccurately portrayed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 476,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nThe repeated citation of the 5.45 % Solar Bonds, Series 2015/C45‑15 — and the myriad supplemental indentures that later added new series with different coupons, maturities and conversion features— shows that Tesla has been systematically refinancing its solar portfolio rather than relying on a single, static bond issue.  From 2022 through 2024 the company layered newer, often lower‑coupon and convertible debt (e.g., 2 % convertible senior notes) alongside the original asset‑backed bonds, indicating a shift toward a more flexible, market‑responsive financing structure that can adjust terms, extend maturities and integrate solar assets with Tesla’s broader capital‑markets strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that Tesla referenced the same 5.45% coupon rate across multiple bond series (C45-15, C53-15, C62-15, C72-15), all issued in 2015 and consistently at 5.45%, indicating a standardized securitization model. However, the LLM incorrectly claims that newer bonds had 'different coupons, maturities and conversion features' and specifically mentions '2% convertible senior notes', which are not referenced in the ground truth and contradict the consistent 5.45% rate. There is no mention in the original answer of convertible debt or lower coupons being used in this solar financing context. (2) The dates and percentages are therefore factually wrong: the ground truth specifies all these bonds were issued in June–July 2015 (not new issuances in 2022–2024), and Tesla merely continued referencing them in later 10-Ks as part of ongoing securitization structures. The LLM implies active new bond issuances with varying terms during 2022–2024, which is unsupported. (3) The reasoning is partially sound in identifying a pattern of iterative financing and structured securitization, and the answer correctly infers that Tesla is moving toward a scalable, repeatable model. However, it misattributes this evolution to refinancing and flexible terms rather than the actual strategy of reusing a standardized bond framework across multiple asset pools. The multi-hop synthesis is flawed because it conflates general Tesla debt instruments (like convertible senior notes) with the specific solar asset-backed bonds. (4) While the answer addresses the evolution of Tesla's solar financing strategy and is contextually relevant, the core factual foundation is incorrect. The qualitative reasoning receives partial credit for capturing the idea of an evolving, structured approach, but the incorrect financial details severely undermine the correctness. Hence, the correctness score is low due to major quantitative and factual errors, despite some conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 557,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe transformed Acrobat from a pure PDF‑viewing tool into the centerpiece of its **Adobe Document Cloud**—a cloud‑based, AI‑enhanced document services platform.  The company deepened market adoption in PDF‑intensive verticals (government, financial services, legal, pharma, aerospace, insurance and publishing) by expanding Acrobat Web, tightening integration with Adobe Sign, and leveraging **Adobe Sensei/Firefly** to add generative‑AI capabilities such as auto‑masking, intelligent summarisation and “Generative Fill/Expand” that make documents more interactive and “intelligent.”  At the same time, Adobe broadened the scope of the platform with a web‑first Acrobat experience, AI‑driven workflow APIs, and strategic partnerships (e.g., Microsoft, ServiceNow, Notarize), positioning Acrobat as a recurring, AI‑powered revenue engine that now sits alongside Creative Cloud as a key pillar of Adobe’s Digital Media strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Acrobat from 2022 to 2024: starting with market adoption in document-intensive industries (legal, financial services, publishing), progressing to AI integration, and culminating in platform expansion. The mention of Acrobat Web, Adobe Sign integration, and partnerships (e.g., Microsoft, ServiceNow) supports the narrative of platform growth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2022–2024), domains (industries, technologies), and strategic moves (AI, partnerships). It correctly identifies Adobe Sensei/Firefly as the AI backbone and describes generative AI features like intelligent summarization and Generative Fill, which align with Adobe’s AI trajectory even if not explicitly named 'Acrobat AI Assistant' until 2024. The only minor gap is that the formal trademarking of 'Acrobat AI Assistant' in 2024—highlighted in the original—is not explicitly mentioned, though the AI capabilities described imply its existence. (4) The answer is contextually rich, directly addressing AI integration, market adoption in key industries, and platform expansion. Wording differs but semantic meaning matches. Minor deduction from 10 due to omission of the specific 'Acrobat AI Assistant' branding milestone, but core facts and strategic trajectory are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 433,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab steadily broadened the interactive toolset it offers RIAs. In 2022 it introduced the free **Schwab Advisor Portfolio Connect** and expanded API‑style integrations with CRM, portfolio‑management and trading platforms; in 2023 it added TD Ameritrade’s **thinkpipes** trading interface and the **iRebal** automated rebalancing engine to its RIA workflow, giving advisors real‑time charting and portfolio‑rebalancing capabilities; by 2024 those features were fully embedded with deeper API access, tighter custodial‑account integration and expanded third‑party platform connections, delivering a more seamless, interactive experience for RIAs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Schwab introduced 'Schwab Advisor Portfolio Connect' in 2022, while the ground truth indicates it was highlighted in 2024, not introduced earlier. (2) The claim that Schwab introduced 'thinkpipes' (likely meant to be 'ThinkPipes' or another platform) from TD Ameritrade and the 'iRebal' automated rebalancing engine in 2023 is unsupported by the original answer and contains unverified product names and integration details. The ground truth makes no mention of these specific tools or acquisitions being integrated into RIA offerings during this period. (3) The LLM asserts deeper API access and tighter custodial-account integration by 2024 with expanded third-party connections, which partially aligns with the general direction in the original answer but adds specific technical capabilities (e.g., 'real-time charting', 'fully embedded') not present in the source. (4) Multi-hop reasoning is flawed: the model fabricates product launches and integrations rather than accurately synthesizing the evolution based on documented platform enhancements. While the overall theme of expanding digital tools and integrations for RIAs is contextually relevant and aligns broadly with Schwab's strategy, the specific claims about features, timelines, and technologies are largely invented. Quantitative accuracy is low due to incorrect dating of product rollouts and fabricated features. Qualitative accuracy suffers from incorrect entity identification (e.g., 'thinkpipes', 'iRebal') and unsupported technical enhancements. Contextual relevance is moderate because the response addresses the general trajectory of tool expansion for RIAs, but fails on factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 482,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nEmerson initially listed air‑preparation equipment as a stand‑alone product family inside the Discrete Automation segment, offering filters, regulators and lubricators together with solenoid and pneumatic valves but without deep software coupling (see the Discrete Automation description in EMR 10‑K 2022, pp. 5‑6). Beginning in 2023 the company started bundling those components with pneumatic valves, actuators and control software, promoting integrated pneumatic‑control packages and expanding service‑center support (noted in the “Industrial Solutions” section of the 2023 filing, which emphasizes “integrated solutions to customers”). By 2024 the offering had evolved into a fully integrated hardware‑software solution that is part of the Plantweb IIoT ecosystem, delivering remote monitoring, predictive‑maintenance and tight integration with broader control and safety systems (as described in the Automation Solutions overview of the 2024 filing, pp. 71‑73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of the evolution of Emerson's Air Preparation Equipment positioning from 2022 to 2024. (1) In 2022, the LLM correctly identifies the standalone nature of the product line with integration limited to mechanical components like solenoid and pneumatic valves, matching the original answer’s emphasis on integration with valves, actuators, and pressure switches without deep software coupling. (2) For 2023, the LLM accurately reflects the shift toward bundling with control software and positioning as integrated solutions, which corresponds to the ground truth’s mention of alignment with programmable automation control systems and digital ecosystems. The reference to 'Industrial Solutions' in the 2023 filing supports this. (3) In 2024, the LLM correctly identifies full integration into Plantweb IIoT, enabling remote monitoring and predictive maintenance—directly aligning with the original answer’s focus on smart actuation, predictive maintenance, and secure wireless communication within Industry 4.0. The citation of pp. 71–73 in the 2024 filing adds credibility. (4) All years, entities (Emerson/EMR, Discrete Automation, Plantweb), and technological trends are correctly identified. The only minor gap is that the LLM does not explicitly mention 'electrical distribution' or 'materials joining solutions' from the 2023 description, slightly reducing completeness in multi-hop synthesis. However, the core progression—from mechanical to digitally integrated—is clearly and correctly conveyed. No numerical inaccuracies; dates and document references are consistent. Semantic equivalence is strong, with slightly different phrasing but identical technical meaning. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 507,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nThe Coca‑Cola Company has treated the 0.125 % Notes due 2029 as a continuously refreshed financing tranche, filing separate 8‑K notices in 2020, 2021, 2022, 2023 and 2024 that each reference the same series—moving from the September 2020 filing to the March 2021 filing and then reiterating it in the 2022‑2024 10‑K exhibits. This pattern shows that the company is actively managing its near‑term debt by repeatedly tapping the ultra‑low‑cost, long‑dated market to roll over maturing obligations and maintain liquidity within its broader financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that The Coca-Cola Company filed separate 8-K notices in 2020, 2021, 2022, 2023, and 2024 to 'refresh' or 'roll over' the 0.125% Notes due 2029 is incorrect. These notes were issued once and are not repeatedly reissued. The ground truth indicates evolving disclosure and contextual treatment in 10-K filings, not active refinancing via repeated 8-K filings. (2) Quantitative accuracy is poor: the LLM invents a pattern of filings (including specific months like September 2020 and March 2021) that are not supported by the ground truth. There is no mention of 8-Ks or repeated issuance in the original answer. The interest rate (0.125%) and maturity (2029) are correct, but the surrounding numeric claims about filing frequency and timing are fabricated. (3) Multi-hop reasoning is flawed. The original answer infers a strategic shift based on the changing context of disclosures and the introduction of higher-yielding long-term debt in 2024. The LLM instead asserts an unsupported 'rolling over' mechanism without evidence of refinancing activity, misrepresenting the nature of the company's debt management. It fails to note the key evolution in disclosure format or the strategic pivot toward longer-term, higher-yielding instruments. (4) Contextual relevance is moderate because the answer addresses debt management and near-term obligations, but the incorrect mechanism (active rollover via repeated issuance) undermines the validity. The conclusion about maintaining liquidity is plausible but unsupported by the cited behavior. Overall, the answer is largely incorrect in both fact and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 460,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon’s ability to return capital was governed by the same U.S. banking capital rules that require a “well‑capitalized” Tier 1 ratio, a stress‑test‑approved capital plan, and Federal Reserve/OCC approval before any dividend increase or share‑repurchase can be executed.  In 2022 the firm’s capital plan was subject to strict regulatory limits, in 2023 it obtained clearance to modestly raise its dividend and restart limited repurchases once the stress‑test demonstrated an adequate capital buffer, and in 2024 it continued to tie any further dividend hikes or buy‑backs to maintaining that same regulatory capital cushion and passing the annual supervisory review.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general theme of regulatory constraints on BNY Mellon's capital returns from 2022 to 2024 and correctly references key regulatory requirements such as 'well-capitalized' status, stress tests, and regulatory approvals. However, it introduces specific operational details not present in the ground truth, such as claiming that BNY Mellon 'obtained clearance to modestly raise its dividend and restart limited repurchases' in 2023 and linking 2024 actions directly to passing the 'annual supervisory review.' The original answer does not mention actual approvals, dividend increases, or resumption of repurchases—instead, it emphasizes the *disclosures* and *framing* of regulatory constraints in public filings, noting an evolution in language from general caution to more structured references to capital adequacy rules. The LLM answer shifts focus from how BNY Mellon *communicated* regulatory constraints to asserting specific regulatory outcomes and capital actions, which are not supported by the ground truth. While terms like 'well-capitalized' and 'stress-test-approved capital plan' are contextually relevant, the answer fabricates a narrative of incremental regulatory permission that goes beyond the disclosed information. There are no explicit numerical errors (hence moderate quantitative accuracy), but the qualitative reasoning is flawed in synthesis—failing to align with the multi-hop intent of tracking *disclosure evolution* rather than inferring actual capital actions. Contextual relevance is high because the answer stays within the domain of U.S. banking laws and capital planning, but it misrepresents the nature of the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 455,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, McGriddles moves from a brief menu‑item mention to being highlighted as a flagship “modernized, higher‑revenue‑generating” breakfast offering that “cater[s] to consumer preferences” and underpins the company’s broader menu‑innovation narrative. This steady framing shows that McDonald’s breakfast strategy has remained consistent—using signature items like McGriddles to drive traffic and revenue while emphasizing ongoing menu modernization and franchisee‑driven innovation.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect in its factual portrayal of McDonald's disclosures about McGriddles from 2022 to 2024. (1) The original answer (ground truth) states that McGriddles was consistently listed as a core breakfast sandwich without any innovation details across all three years. In contrast, the LLM claims McGriddles evolved into a 'flagship modernized, higher-revenue-generating' offering that was actively highlighted in innovation narratives—this is factually false according to the source documents. There is no mention in the 10-Ks of McGriddles being 'modernized' or specifically tied to revenue growth or franchisee-driven innovation. (2) No numeric data (e.g., dollar amounts, percentages, dates) are present in either answer, so quantitative accuracy is neutral; no errors here by the LLM, but also no numbers to verify. (3) The multi-hop reasoning fails: the LLM incorrectly synthesizes a narrative of increasing prominence and innovation around McGriddles, when the actual filings show no such evolution—McGriddles remained a static, baseline menu item. The broader context of 'ongoing testing' or 'menu evolution' in 2023 and 2024 was not linked to McGriddles in the filings. (4) The LLM answer is contextually relevant in structure—it addresses the time frame and attempts to discuss strategic implications—but the underlying facts are fabricated. The conclusion about consistency in breakfast strategy is superficially plausible but based on false premises. Thus, the correctness score is low due to major factual inaccuracies despite correct timeframes and document focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 436,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAdobe has shifted free, self‑service learning from a peripheral catalog in 2022—highlighted as “a large number of free online self‑service learning options on training.adobe.com”—to a core, strategically positioned element of Adobe Digital Learning Services by 2023‑2024, where it is delivered through the learning.adobe.com portal and paired with solution‑specific skill assessments that feed into the company’s fee‑based, instructor‑led and custom training programs. This evolution reflects a deliberate move to embed the free learning pathway as the primary gateway for customers across the Experience Cloud, reinforcing a seamless, cloud‑centric learning journey that supports Adobe’s broader Digital Experience offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the shift from training.adobe.com in 2022 to learning.adobe.com in 2023–2024 is accurately reported, and the strategic elevation of free self-service learning within Adobe Digital Learning Services is correctly portrayed. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes platform changes, strategic positioning, and integration with fee-based offerings across years, correctly inferring a maturing strategy. It adds value by noting the integration with skill assessments and positioning as a 'gateway'—a reasonable interpretation consistent with the ground truth’s emphasis on deeper integration. (4) The only minor gap is that the original answer explicitly notes the 2024 continuation and reinforcement on the same platform (learning.adobe.com), which the LLM implies but does not explicitly confirm for 2024. However, 'by 2023–2024' sufficiently covers the timeframe. Wording differs but semantic meaning matches. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with near-complete coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 371,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nEmerson kept Commercial Vacuums inside the **Safety & Productivity** segment through 2022‑2024, but the way it was framed changed: in the 2022 filing the segment was described broadly as “tools for professionals and homeowners,” whereas the 2023‑2024 disclosures began to isolate “Professional Tools” (including commercial vacuums) as a distinct sub‑category that is sold almost exclusively through distributors.  The strategic emphasis moved toward positioning these vacuums as core safety‑productivity solutions that complement Emerson’s broader pipe‑working, electrical and other professional‑tool lines, and the company aligned their marketing, development and distribution with the same distributor‑focused, safety‑oriented approach used for its other professional‑tool offerings.  (See Safety & Productivity description in EMR 10‑K 2022 pp. 7‑11 and the “Professional Tools” subsection in EMR 10‑K 2023 / 2024 pp. 71‑75.)",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, despite being contextually relevant and free of numerical errors. (1) The claim that Commercial Vacuums were in the Safety & Productivity segment in 2022 is incorrect: according to the ground truth, they were part of the Tools & Home Products segment in 2022, not Safety & Productivity. This is a major entity and temporal misattribution. (2) The LLM asserts that the 2022 filing describes Safety & Productivity as covering 'tools for professionals and homeowners,' but in 2022, Commercial Vacuums were not in that segment, so this framing misrepresents the structure. (3) The creation of a 'Professional Tools' sub-category in 2023–2024 filings as described by the LLM is not supported by the ground truth, which instead emphasizes re-categorization into Safety & Productivity and alignment with industrial tools like automation and electrical systems—not a new sub-category. (4) While the strategic emphasis on safety, productivity, and distributor channels may be plausible, the ground truth highlights integration with technologically advanced industrial systems (e.g., programmable automation, electrical distribution), which the LLM omits entirely. (5) The citation of page numbers and filings adds apparent precision but cannot compensate for incorrect core facts. Quantitative accuracy receives full marks because there are no numbers, dates, or calculations that are factually wrong—only misattributions of content to years and segments. Qualitative accuracy is low due to flawed multi-hop reasoning: the model failed to correctly trace the segment transition (from Tools & Home Products to Safety & Productivity), misrepresented the evolution of product categorization, and invented a sub-category not present in the ground truth. Contextual relevance is high because the answer addresses product categorization, strategic emphasis, and alignment with professional tools, even if the details are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 538,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead escalated the role of its Hoofddorp, Netherlands site, moving from an initial commercial‑manufacturing location for cell‑therapy products (e.g., Yescarta) toward a broader, integrated hub that now handles both the commercial processing of approved cell‑therapy medicines and the scale‑up of pipeline candidates, reflecting a strategic expansion of capacity and deeper incorporation into the company’s global cell‑therapy supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolving role of GILD's Hoofddorp facility from 2022 to 2024 with respect to cell therapy manufacturing and commercial processing, aligning with the ground truth's core narrative of increasing strategic importance. It accurately reflects the timeline and directional shift toward cell therapy focus. However, it introduces details not present in the original answer, such as the site becoming an 'integrated hub' handling 'scale-up of pipeline candidates' and specifically naming Yescarta, which were not mentioned or verifiable from the ground truth. While these additions are plausible, they go beyond the documented information and represent an over-enrichment of detail. The ground truth states that in 2022 the site was a 'principal manufacturing site' and only from 2023 onward was explicitly tied to commercial cell therapy manufacturing—this nuance is slightly compressed in the LLM answer by suggesting it was already a commercial cell therapy site in 2022. Despite this, the overall progression and strategic expansion are semantically consistent. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is highly relevant to the question. The reasoning is mostly sound but slightly overreaches in specificity, affecting qualitative accuracy. Thus, the correctness score is 7 due to minor factual overreach, though the central evolution is accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 396,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe 1.000 % Notes due 2028 are repeatedly highlighted in the 2022‑2024 filings as a core, low‑cost component of Coca‑Cola’s long‑term debt, underscoring the company’s continued reliance on that inexpensive tranche.  At the same time, the 2024 prospectus adds higher‑yield instruments such as the 5.000 % Notes due 2034 and 5.400 % Notes due 2064, indicating that the firm is now supplementing its legacy financing with more expensive, longer‑dated debt to fund strategic initiatives and reshape its maturity profile.  Together, the disclosures reflect a shift toward a more diversified capital structure that balances a stable, low‑rate pillar with newer, higher‑yield financing to manage overall debt‑cost exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the persistent mention of the 1.000% Notes due 2028 across 2022–2024 filings, and the introduction in 2024 of the 5.000% Notes due 2034 and 5.400% Notes due 2064 are accurately reported. Percentages, years, and note types match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations were required, but all numeric values (interest rates and maturities) are correctly cited with proper formatting (e.g., 1.000%, 5.000%, 5.400%; due 2028, 2034, 2064). (3) The multi-hop reasoning is sound: the model correctly synthesizes information across multiple years and instruments to infer a strategic shift in capital structure management—balancing low-cost legacy debt with newer, higher-cost, long-term financing. The conclusion about diversification and strategic funding needs is logically supported by the data. (4) The only minor shortcoming is a slight omission of explicit mention of 'favorable market conditions' as a potential driver, which was included in the original answer. However, the reference to 'strategic initiatives' and 'reshape its maturity profile' captures the core intent. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually complete, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 379,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s pipe‑cutter offering moved from traditional, purely mechanical cutters toward fully **battery‑powered, sensor‑enabled tools** between 2022 and 2024.  The **Safety & Productivity** segment (see the 2023‑2024 10‑K description of the segment and the “Professional Tools” discussion in the Tools & Home Products section) highlights the rollout of **battery‑hydraulic press‑connection equipment and diagnostic‑integrated cutters** that combine cordless operation with on‑board data collection and connectivity, and it notes that these products are sold almost exclusively through distributor networks.  This evolution signals that Emerson is **re‑positioning itself in the professional plumbing‑tools market as a premium, technology‑driven supplier**, emphasizing higher‑margin, smart‑tool solutions rather than competing solely on price or raw mechanical performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe cutters from traditional tools in 2022 to battery-powered and diagnostic-integrated tools by 2024. The mention of 'battery-hydraulic press-connection equipment' and 'diagnostic-integrated cutters' matches the original answer's emphasis on battery hydraulic technology (2023) and diagnostic systems like sewer cameras (2024). (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes the product evolution across years and infers strategic positioning from technological shifts, correctly attributing the move to a premium, tech-driven market stance. It references the Safety & Productivity segment and Tools & Home Products section from the 10-K, which supports the claim, even if not explicitly detailed in the ground truth. (4) The only minor gap is that the original answer specifies that diagnostic integration in 2024 included 'sewer inspection cameras and locating equipment directly tied to pipe cutters,' while the LLM generalizes this as 'on-board data collection and connectivity.' This is semantically close but slightly less specific. Otherwise, the LLM captures the strategic shift and market positioning accurately. Wording differs but meaning is equivalent. No factual errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 415,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Santa Monica, California site from a modest clinical‑trial cell‑therapy manufacturing space into a central processing hub that now supports both clinical‑trial and early‑commercial production of multiple CAR‑T and other cell‑therapy candidates.  The facility’s capacity was expanded, automation and process‑development activities were intensified, and it was linked with the El Segundo and Frederick sites to create a unified cell‑therapy manufacturing network.  This evolution shows that Santa Monica has become a strategic linchpin in Gilead’s manufacturing architecture, reducing reliance on external contract manufacturers and positioning the site as a key driver for scaling the company’s cell‑therapy pipeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general progression of GILD's Santa Monica facility becoming more central to cell therapy manufacturing from 2022 to 2024, which aligns with the ground truth. It correctly identifies the increasing strategic role of the site and its integration with El Segundo and Frederick. However, the LLM overstates the evolution by claiming the facility now supports 'early-commercial production' and that it was expanded into a 'central processing hub' supporting multiple CAR-T products—details not present in the original answer. The ground truth only confirms that starting in 2023, the site was explicitly used for clinical manufacturing of cell therapy products, with no mention of commercial-scale output, automation enhancements, or capacity expansion. Additionally, the original answer does not state a reduction in reliance on external contract manufacturers or that Santa Monica became a 'linchpin' or 'key driver' for scaling—these are interpretive leaps beyond the provided data. While the years (2022–2024) and entities (GILD, Santa Monica, El Segundo, Frederick) are accurate, and the qualitative shift from general R&D to cell therapy focus is correctly inferred, the LLM introduces unsupported specifics and strategic implications. Thus, while the direction of evolution is right, the extent and details are exaggerated, leading to a partially correct but factually overstated response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 391,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe expanded Frame.io from a video‑centric review tool into a full‑stack collaboration hub for the Creative Cloud ecosystem.  Early on it offered frame‑accurate commenting and direct integration with Premiere Pro and After Effects for video assets; by 2023‑24 the platform was broadened to support still images, design files, PDFs, 3‑D assets and AI‑generated content, and its collaboration features were woven into Photoshop, Illustrator, Express and other Creative Cloud apps, enabling shared libraries, AI‑assisted annotations and seamless hand‑offs across the entire suite.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Frame.io's integration within Adobe's Creative Cloud from 2022 to 2024. It correctly identifies the expansion from a video-centric tool to a broader collaboration platform and notes key integrations with Premiere Pro and After Effects early on, followed by broader Creative Cloud app integration. The mention of support for still images, design files, and PDFs aligns with the 2023 ground truth, and the extension to more applications (Photoshop, etc.) matches the 2024 developments. However, the LLM adds details not present in the ground truth: it mentions '3-D assets' and 'AI-generated content' without explicit support confirmation in the provided data, and includes 'Illustrator' and 'Express' as integrated apps, which were not listed in the original answer (which specified Photoshop, Lightroom, Workfront, and GenStudio). Additionally, features like 'shared libraries' and 'AI-assisted annotations' are plausible but not explicitly confirmed in the ground truth. The timeline is generalized ('2023-24') rather than distinguishing 2023 vs 2024 developments as the original does. Despite these minor overextensions, the answer correctly conveys the trajectory of Frame.io's evolution, supported media types, and expanded collaboration scope. All dates and entities are used appropriately, with no numerical inaccuracies (quantitative accuracy is perfect due to absence of incorrect numbers). The reasoning is sound and contextually relevant, synthesizing the multi-hop progression across years and applications, though with slight overgeneralization in feature and app coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 450,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nIn 2022 Emerson listed Electrical Distribution Equipment as a discrete hardware offering within the Discrete Automation segment (EMR 10‑K 2022, pp. 74‑78). By 2023 the same product was presented together with programmable automation control systems, indicating a shift toward tighter software integration (EMR 10‑K 2023, pp. 71‑75). In 2024 the scope broadened to include smart, modular and IoT‑enabled distribution devices, positioning the equipment as part of an end‑to‑end digital automation platform rather than an isolated component (EMR 10‑K 2024, pp. 71‑75).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Emerson's Electrical Distribution Equipment from 2022 to 2024. (1) It correctly identifies the timeline and progression: starting as a discrete hardware offering in 2022, integration with programmable automation controls in 2023, and expansion into a broader digital automation platform by 2024. The years and entity (EMR) are accurate. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the answer synthesizes changes across three years and correctly infers a strategic shift toward integration with automation technologies. However, the LLM omits specific product categories mentioned in the ground truth for 2024—'electric linear motion solutions' and 'materials joining solutions'—instead generalizing to 'smart, modular and IoT-enabled distribution devices' and 'end-to-end digital automation platform.' While semantically close, this substitution misses the precise product scope expansion detailed in the original, slightly weakening qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing both integration with automation technologies and product scope expansion as asked. Wording differs but meaning is substantially aligned. Minor omission prevents a perfect score, but core facts and strategic interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 416,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior notes rose from roughly **$24 bn (2022)** to **$27 bn (2023)** and then edged down to **$26.9 bn (2024)**.  At the same time the weighted‑average interest rate on that debt climbed from about **2.9 % (2022)** to **4.45 % (2023)** and **4.84 % (2024)**.  The higher‑cost, longer‑dated issuances show that Capital One deliberately shifted toward locking in more stable funding as market rates rose, reflecting a strategic pivot to higher‑priced but longer‑term senior debt in a rising‑interest‑rate environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a significant quantitative inaccuracy in the 2022 carrying value. The ground truth reports $19,975 million (approximately $20 billion), but the LLM states 'roughly $24 bn' for 2022, which is off by about $4 billion (over 20% error). The 2023 and 2024 values are accurate: $27.168 billion is correctly rounded to $27 billion, and $26,930 million is accurately reported as $26.9 billion. Interest rates are correct: 2.91% ≈ 2.9%, 4.45%, and 4.84% are all accurately reflected. (2) Calculations: The trend (increase then slight decline) and rate progression are correctly described. However, the incorrect 2022 base value affects the accuracy of the implied growth narrative. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes data across three years for both carrying value and interest rates, and draws a logical conclusion about Capital One’s strategy of locking in long-term debt amid rising rates. The interpretation aligns with the ground truth—'proactive approach' vs. 'strategic pivot'—and uses semantically equivalent language. (4) Scores justified: Correctness is 8 due to the major error in the 2022 carrying value, though other numbers and the overall reasoning are strong. Quantitative accuracy is 7 because one key number is significantly wrong despite correct formatting and rounding elsewhere. Qualitative accuracy is 9 due to excellent reasoning and correct entity identification (COF, fixed unsecured senior debt, correct years). Contextual relevance is 10—answer fully addresses all parts of the question and stays precisely on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 445,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell from **$1.157 bn at 31 Dec 2022** to **$1.091 bn at 31 Dec 2023** and further to **$0.993 bn at 31 Dec 2024**.  This decline reflects lower estimated future warranty and performance‑cost claims—driven by updated claims data and historical experience—so the company’s exposure to long‑term product‑performance risk in its commercial aerospace engines is easing, although the remaining liability (still sizable and extending to 2028) shows that such risk remains material.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states RTX's liabilities were $120 million in 2022 and 2023, and $101 million in 2024. The LLM reports $1.157 billion (i.e., $1,157 million), $1.091 billion, and $0.993 billion—over ten times higher than the actual figures. This massive discrepancy invalidates the quantitative foundation of the response. (2) Calculations and trends are therefore also incorrect: while the LLM claims a declining trend (which aligns qualitatively), it misrepresents the magnitude and context—$101M vs. nearly $1B is a critical error. The actual stability (with only a minor decrease) contrasts with the LLM’s portrayal of a significant downward trend. (3) Multi-hop reasoning is partially sound in structure—the LLM attempts to link liability changes to claims data and risk exposure—but it does so using fabricated numbers, undermining the logic. The mention of obligations extending to 2028 is not supported in the ground truth and introduces unverified information. (4) The entity (RTX) and metric (liabilities for performance and operating cost guarantees) are correctly identified, and the answer addresses both parts of the question (evolution and implication), giving it partial credit for completeness and contextual relevance. However, the extreme numerical inaccuracy results in a correctness score of 1, as the core financial facts are entirely wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 400,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nFrom 2022 through 2024 the Company continued to list “estimates of sales proceeds” as one of the valuation tools it uses for non‑public investments, but the way the methodology is described becomes progressively more refined. In the 2022 filing the note merely cites sales‑proceeds estimates alongside discounted‑cash‑flow and appraisal methods, without detailing how they are derived. By 2023 and again in 2024 the language adds that fair‑value estimates for non‑public assets are based on “valuation methodologies including discounted cash flows, **estimates of sales proceeds**, and appraisals” and that the Company evaluates each investment “on an individual basis,” emphasizing observable price changes and market‑participant assumptions. At the same time, the disclosures introduce more explicit impairment testing—requiring a review whenever cost exceeds fair value and a determination of whether any decline is “other than temporary”—and note that accurate cash‑flow forecasting in emerging markets is critical.\n\n**What this reveals:** The Company is moving away from a blanket reliance on generic sales‑proceeds estimates toward a more disciplined, market‑oriented fair‑value framework that incorporates observable market data, regular impairment reviews, and explicit assumptions about future cash flows. This shift signals a heightened focus on rigor and transparency when assessing the fair value of assets in emerging markets, reflecting both the greater volatility of those environments and the need for more reliable valuation inputs.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022–2024) and correctly identifies 'estimates of sales proceeds' as a valuation methodology used for nonpublic investments, alongside discounted cash flows and appraisals. There are no numeric inaccuracies, as the question does not involve specific dollar amounts or percentages—thus quantitative accuracy is high. Contextually, the answer addresses the evolution of the methodology and ties it to fair value assessment in emerging markets, maintaining relevance throughout. However, the qualitative reasoning diverges from the ground truth in a key aspect: while the original answer describes a progression from disclosure to increased reliance (2023) and then cautious, risk-aware use (2024), the LLM incorrectly frames the evolution as a move *away* from reliance on sales-proceeds estimates toward more market-oriented methods. This mischaracterizes the trend: the ground truth states Coca-Cola deepened its reliance in 2023 and maintained use in 2024 with heightened caution, not a reduction in reliance. The LLM’s conclusion about 'moving away from blanket reliance' is unsupported by the source and contradicts the 'deepening dependence' described in the original. Additionally, the LLM introduces concepts like 'regular impairment reviews' and 'observable price changes' without clearly anchoring them in year-specific shifts as the original does. While some synthesis is accurate (e.g., challenges in emerging markets), the core narrative of methodological evolution is reversed, leading to a significant qualitative error despite correct contextual elements and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 447,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s wording moved from a broad statement that “our ability to return capital to shareholders is subject to the discretion of our Board and may be limited by U.S. banking laws and regulations” (2022 Form 10‑K, p. 5) to increasingly specific references to the Federal Reserve’s capital‑planning and stress‑test framework, Basel III‑based capital‑adequacy and liquidity buffers, and the need to maintain regulatory‑required capital ratios before any dividend or share‑repurchase can be executed (2023 Form 10‑K, pp. 6‑7; 2024 Form 10‑K, pp. 6‑7).  \nThis multi‑year progression shows that BNY Mellon’s shareholder‑capital distributions are now tightly constrained by supervisory capital requirements, limiting the firm’s strategic flexibility and forcing it to align dividend and buy‑back plans with evolving regulatory thresholds rather than solely with board discretion or market considerations.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that BNY Mellon faced ongoing limitations on capital returns due to U.S. banking laws from 2022 to 2024 and notes increasing specificity in disclosures, which aligns with the general trend in the ground truth. The dates (2022–2024) and entities (BNY Mellon, U.S. banking laws, capital planning) are accurate, and there are no numeric inaccuracies per se, as the question does not involve specific dollar amounts or percentages—hence a strong quantitative accuracy score. However, the LLM introduces details not present in the original answer: it claims the 2022 filing referenced 'the discretion of our Board' and cites specific regulatory frameworks like Basel III and stress-testing, which were not mentioned in the ground truth. More critically, the original answer emphasizes a key evolution in 2024: new language about the Parent’s dependency on dividends from subsidiaries and credit from its IHC (Intermediate Holding Company), which the LLM fails to mention entirely. This omission is significant because it reflects a structural shift in how BNY Mellon funds shareholder distributions—an essential part of the multi-year progression. While the LLM correctly infers reduced strategic flexibility, it bases this on regulatory capital ratios and stress tests rather than the actual disclosed shift toward internal capital dependencies. Thus, while the general direction of reasoning is plausible, the specific factual basis is misaligned with the ground truth, leading to a moderate correctness and qualitative accuracy score. The answer remains contextually relevant to the question about capital return evolution and strategic flexibility, but lacks the precise multi-hop synthesis of disclosures across years as reflected in the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 483,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s 10‑K filings progressively broadened the discussion of tax‑ and tariff‑exemption risk. In the 2022 filing (pages 35‑39) the company merely noted that “loss or modification of exemptions for taxes and tariffs” could affect its foreign operations. By 2023 (pages 39‑43) the language added that U.S. export‑control rules, sanctions and shifting trade policies could erode those exemptions, and in 2024 (pages 38‑42) the disclosure grew more specific, citing geopolitical tensions such as the China‑Taiwan and Ukraine conflicts and the possibility of new tax or tariff measures that would raise costs. This evolution shows that AMD’s exposure to losing tax and tariff benefits has intensified, reflecting a increasingly complex and volatile global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD's increasing emphasis on tax and tariff exemption risks from 2022 to 2024 is accurately portrayed, with appropriate progression in the depth of discussion. The mention of geopolitical events like the China-Taiwan and Ukraine conflicts in the 2024 filing is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifying the evolution in risk disclosure and linking it to broader regulatory complexity. The inclusion of U.S. export controls and sanctions in 2023 and 2024 is correctly noted and supports the conclusion. (4) Semantic equivalence is strong—while the LLM adds specific page numbers (e.g., pages 35–39), which are not in the ground truth, this additional detail does not contradict but rather enhances precision, assuming those references are accurate. The conclusion that AMD’s exposure has intensified due to a more complex and volatile regulatory environment matches the original answer. The only minor limitation is a slight lack of mention of 'internal expansion' as a driver in the final analysis, which is included in the ground truth, but the emphasis on external geopolitical factors fully supports the main conclusion. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 446,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nShort‑term borrowings fell from roughly $880 million in 2022 to $538 million in 2023 and edged up to $562 million in 2024, while long‑term debt rose to a peak of about $49.3 billion in 2023 before slipping to $45.0 billion in 2024.  During the same period the company cut its floating‑rate unsecured senior debt from around $1.6 billion to essentially zero, signalling a strategic shift toward a longer‑dated, predominantly fixed‑rate debt profile and a lower exposure to rising interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of Capital One's debt evolution—increasing long-term debt in 2023 followed by a decline in 2024, and a reduction in floating-rate debt—but contains significant numerical inaccuracies. (2) Quantitative Accuracy: The short-term borrowings are severely misstated. Ground truth shows total short-term borrowings and long-term debt combined were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports short-term borrowings alone as $880M, $538M, and $562M, implying long-term debt was ~$48.5B in 2023, which is close to the true $49.856B, but the separation between short- and long-term is factually wrong. More critically, the LLM states floating-rate unsecured senior debt fell from $1.6B to zero, but ground truth shows it was $1.709B in 2022, dropped to $349M in 2023 (not eliminated), and only reached $0 in 2024. The LLM omits the 2023 value and misrepresents the timeline. Additionally, the weighted-average interest rates (1.01% in 2022, 6.75% in 2023, 0% in 2024) and the increase in fixed unsecured senior debt from $21.045B (2022) to $27.168B (2023) to $26.930B (2024) are entirely missing, undermining the full picture of debt restructuring. (3) Reasoning: The LLM correctly infers a strategic shift toward fixed-rate debt to reduce interest rate risk, which aligns with the ground truth’s conclusion. This shows sound qualitative reasoning based on partial data. However, it fails to synthesize the full multi-hop trajectory—especially the spike in floating-rate cost (from 1.01% to 6.75%) and the detailed shift in fixed-rate debt—thus missing key evidence for the conclusion. (4) Justification: Correctness is scored 6 due to partially accurate trends but major omissions and numerical errors. Quantitative accuracy is 5 because while approximate totals are in the right order of magnitude, the breakdowns are incorrect and key figures (interest rates, exact debt levels) are missing or wrong. Qualitative accuracy is 7 because the strategic interpretation is valid and contextually appropriate. Contextual relevance is 9 as the answer directly addresses the question’s focus on debt structure and interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 593,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program‑share in International Aero Engines AG fell from the 61 % gross interest reported in the 2022 filing (pages 108‑112) to roughly 57 % after accounting for sub‑collaborator allocations in the 2023 filing (pages 97‑101), and by 2024 the net stake in IAE had slipped to about 57 % while the related IAE LLC interest dropped to ~51 % (pages 99‑103).  This gradual reduction shows that RTX is moving from a dominant owner toward a more evenly shared consortium role, signalling a strategic positioning in which it remains the primary beneficiary and consolidator of the V2500 program but operates alongside increasingly significant partners (MTU, JAEC) and distributes economic risk and control across the collaboration.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in RTX's net program share interest in IAE from 61% in 2022 to 57% in 2023 and 2024, which matches the ground truth. However, it introduces an additional detail not present in the original answer — that the IAE LLC interest dropped to ~51% in 2024 — which is unsupported by the ground truth and potentially misleading. This extra claim reduces quantitative accuracy. (2) The core numbers (61% to 57%) are accurate and correctly attributed across years. The calculation of a 4 percentage point decrease is implied and correct, but the unsupported 51% figure for IAE LLC undermines full quantitative precision. (3) The multi-hop reasoning is largely sound: the model correctly infers a strategic shift from ownership dilution and links it to risk distribution and evolving collaboration dynamics. It appropriately identifies MTU and JAEC as growing partners, which aligns with plausible context, though not explicitly stated in the ground truth. The conclusion about RTX remaining the primary consolidator is reasonable but slightly extends beyond the original answer’s scope. (4) The answer is highly contextually relevant, addressing both the quantitative evolution and strategic implications. The core message about reduced economic exposure and strategic rebalancing is consistent with the ground truth, even if overextended in one aspect. Thus, the correctness score is 7 due to partial inaccuracy in the IAE LLC claim, despite otherwise accurate and well-reasoned content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 422,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nAcross the three latest 10‑K filings, Cascade’s contribution to the Fabric & Home Care segment expanded steadily: it moved from roughly 5 % of the segment’s net sales (and a similar share of earnings) in 2022 to about 8‑9 % of net sales and 7‑8 % of earnings by 2024. This rise reflects a strengthening of Cascade’s role as a core growth brand within P&G’s home‑care portfolio, increasingly driving the segment’s 34‑36 % share of overall earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Cascade's positioning has remained consistent within P&G's Home Care sub-category under the Fabric & Home Care segment from 2022 to 2024, with no mention of Cascade's specific percentage contribution to segment sales or earnings. However, the LLM fabricates specific figures—claiming Cascade grew from 5% to 8-9% of segment net sales and 7-8% of earnings—data that is not present in the original answer or supported by the knowledge graph. These numbers are entirely invented and contradict the core message of stability. (2) The original answer reports only segment-level data: Fabric & Home Care represented 35% of net sales and 31% of net earnings in 2022, rising slightly to 36% and 34% in 2023 and 2024. There is no breakdown of Cascade’s individual contribution. The LLM incorrectly introduces granular brand-level percentages that do not appear in the source. (3) The multi-hop reasoning fails because the LLM infers growth and strategic elevation of Cascade without evidence. The actual reasoning should have been synthesis across three years showing stability in segment contribution and consistent brand categorization. Instead, the model invents a narrative of expansion. (4) While the answer is contextually relevant—focusing on Cascade’s role in P&G’s home care portfolio and referencing the correct segment and time frame—the factual inaccuracies and fabricated metrics severely undermine correctness. The qualitative reasoning is flawed due to incorrect entity-level attribution and lack of support for claimed trends. Thus, the correctness and quantitative accuracy scores are low; relevance is moderate as it addresses the right topic with wrong details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 488,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon shifted the public location of its Directors’ Code of Conduct from a PDF under the “code‑of‑conduct.pdf” folder on the bnymellon.com domain (e.g., https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of‑conduct.pdf) to a cleaner URL on the consolidated bny.com domain (e.g., https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors-code-ofconduct.pdf), reflecting a move toward a unified corporate‑branding structure.  This disclosure is now embedded in Item 10 of the Form 10‑K and referenced in the Proxy’s governance sections, explicitly stating that any amendments or waivers to the Code will be posted on the website, thereby tying the Directors’ Code directly to the company’s overall board‑oversight and governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the evolution in URL structure from 2022 to 2024: starting with the 'bnymellon.com' domain and a document-focused path, then transitioning to the 'bny.com' domain in 2024 with a cleaner, more integrated path under 'investor-relations'. The minor discrepancy is that the LLM omits the 2023 URL adjustment (from '/in relations' to '/inv relations'), which was noted in the original answer as a small internal reorganization. However, this omission does not undermine the core narrative of gradual modernization toward brand consistency and governance integration. The LLM correctly notes the shift in domain branding, improved URL structure, and strategic alignment with investor relations. Additionally, it adds valuable context not explicitly in the original answer—namely, that the Code is now embedded in Item 10 of the Form 10-K and referenced in the Proxy, with disclosure policies for amendments or waivers—thereby enriching the response with accurate, relevant details about governance integration. All entities (BNY Mellon, bny.com, bnymellon.com, Directors' Code of Conduct), years (2022–2024), and document paths are correct. No numerical errors exist, and the reasoning across multiple hops (domain change, URL restructuring, governance integration) is sound. The answer is semantically equivalent and contextually excellent, meriting a high score with only a slight deduction for the omitted 2023 detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 415,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s contracts with AIB manufacturers were updated to provide tighter inventory‑protection—price‑protection and return rights for unsold units under 12 months, plus expanded stock‑rotation provisions.  At the same time, the company positioned its discrete Radeon graphics (evolving from RDNA 2 to RDNA 3) as a differentiation engine, emphasizing ray‑tracing, Infinity Cache and AI‑accelerated cores to enable OEMs and system integrators to create distinct, high‑performance products and secure design wins across gaming, professional and data‑center segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that deviate from the ground truth, particularly in quantitative and entity-specific details. (1) The claim of 'tighter inventory-protection—price-protection and return rights for unsold units under 12 months, plus expanded stock-rotation provisions' is not supported by the original answer, which states only that AMD 'consistently maintained' inventory protection policies without specifying updates or new terms like 'stock-rotation' or 'return rights.' This suggests a change or tightening not present in the ground truth. (2) The original answer emphasizes consistency across 2022–2024, whereas the LLM implies an evolution or strengthening of policies, misrepresenting the strategic trajectory. (3) While the LLM correctly identifies discrete graphics as a differentiation tool, it adds specific technical features (ray-tracing, Infinity Cache, AI-accelerated cores) and generational transitions (RDNA 2 to RDNA 3) that are not mentioned in the ground truth and thus introduce unsupported detail. (4) The focus on 'OEMs' and 'design wins across gaming, professional and data-center segments' extends beyond the original answer’s emphasis on system integrators (SIs) and retail buyers, introducing entities and applications not highlighted in the source. (5) The multi-hop reasoning is partially sound—linking inventory protection and differentiation via discrete graphics—but overreaches by implying technological evolution and policy tightening not present in the data. (6) No numerical values (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is penalized only for introducing unverified structural details (e.g., '12 months') not in the original. Overall, the answer captures the general theme but fails on factual precision and over-specifies unsupported details, reducing correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 506,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 through 2024 McDonald’s moved from a straightforward description of the Egg McMuffin as a standard breakfast item to positioning it as a core, consistently‑tested product that anchors customer expectations for quality and convenience.  At the same time, disclosures evolved from simply noting high‑level quality standards and routine supplier visits to a more detailed, data‑driven narrative that emphasizes proactive supply‑chain risk management, climate‑related resilience and collaborative innovation with suppliers to guarantee the reliable sourcing of the Egg McMuffin’s key ingredients.  This progression reflects the company’s broader “Commit to the Core” growth pillar, integrating breakfast menu innovation tightly with its supply‑chain focus to deliver consistent, high‑quality products worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in McDonald's disclosures from 2022 to 2024 regarding the Egg McMuffin, supply chain focus, and quality consistency. It correctly identifies the shift from basic menu presence to a more integrated supply chain and innovation narrative. The mention of 'proactive supply-chain risk management,' 'climate-related resilience,' and 'collaborative innovation with suppliers' aligns with the 2023 and 2024 disclosures on supply chain strategy and resilience, though the original answer emphasizes the role of the Global Chief Supply Chain Officer and digital transformation in food safety more explicitly. The LLM introduces the 'Commit to the Core' growth pillar, which is contextually plausible but not explicitly stated in the ground truth as a framing element for breakfast innovation. While the LLM captures the trajectory toward data-driven quality and supply chain integration, it omits the specific 2024 digital transformation project focused on data excellence and continuous quality measurement, which is a key detail in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and all entities (McDonald’s, Egg McMuffin, supply chain focus) are correctly identified. The reasoning is sound and reflects multi-hop synthesis across years, though slightly less precise in citing the exact mechanisms (e.g., digital project) that drive consistency. The answer remains semantically close and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 426,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe repeated appearance of Oracle’s 4.30 % senior unsecured note due 2034 in the 2022, 2023 and 2024 10‑K filings shows that this tranche remains a permanent element of the company’s long‑term debt profile, reflecting a deliberate laddered maturity schedule and a financing strategy that leans on multi‑decade, fixed‑rate issuances to fund growth and acquisitions while limiting near‑term refinancing risk. Its consistent disclosure signals that Oracle treats the 2034 note as a core, stable source of capital that underpins its broader debt‑management and capital‑allocation priorities across the reported periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.30% Note due 2034 is accurately identified and consistently disclosed across 2022, 2023, and 2024, which the LLM correctly notes. The percentage (4.30%), maturity year (2034), and the multi-year disclosure are all factually sound. (2) Quantitative accuracy is perfect: no calculations are required, but the date and rate are correctly cited with no discrepancies. Format variations (e.g., '4.30 %' vs '4.30%') are acceptable and do not affect meaning. (3) Reasoning is strong: the LLM correctly infers that the consistent disclosure indicates a strategic, laddered debt maturity profile and reflects a long-term financing strategy. It accurately captures Oracle’s use of fixed-rate, long-dated debt to manage refinancing risk and support capital allocation—consistent with the ground truth’s emphasis on a 'stable element within a broader, evolving debt portfolio.' While the LLM does not explicitly mention the other specific notes (e.g., 3.625% due 2023 or 2.950% due 2024) as in the original answer, it still correctly synthesizes the implication of a diversified, strategic debt structure. (4) The answer is contextually relevant and directly addresses the question about Oracle’s long-term debt structure and financing priorities. The only minor shortcoming is the lack of explicit reference to the coexistence with other debt instruments across years, which slightly reduces completeness in multi-hop synthesis, but the core inference remains valid and well-supported. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 462,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value hierarchy classification of Capital One’s derivative assets and liabilities moved deeper into Level 3 – the net Level 3 amount rose from roughly **$19 million in 2022 to $58 million in 2023 and $69 million in 2024**.  This shift reflects the firm’s continued use of vendor‑based pricing models for OTC derivatives, but increasingly for instruments whose valuation depends on **unobservable inputs** such as SOFR‑indexed swap rates, default and loss‑severity assumptions, discount rates, and prepayment/behavioral assumptions; when these inputs are deemed significant the derivatives are classified as Level 3.  Consequently, the growing proportion of Level 3 derivatives signals that Capital One’s exposure to market inputs that are not directly observable has expanded, heightening the role of management judgment and model‑based estimates in its fair‑value measurements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies a rise in net derivative valuation from $19M in 2022 to $58M in 2023, it incorrectly states the 2024 value as $69 million, whereas the ground truth reports $58 million (unchanged from 2023). This is a critical error in tracking the evolution over time. Additionally, the LLM introduces the term 'Level 3' and a 'fair-value hierarchy' not mentioned in the original answer, and while potentially accurate in a broader accounting context, these are not part of the provided ground truth and shift the focus. (2) The ground truth specifies unobservable inputs such as default rates (53–163%) and swap rates (3–5%) in 2023 and 2024; the LLM generalizes these to 'SOFR-indexed swap rates, default and loss-severity assumptions, discount rates, and prepayment/behavioral assumptions'—adding unverified details not in the source. The $69M figure for 2024 is unsupported and contradicts the ground truth. (3) The reasoning partially captures the trend of increasing reliance on unobservable inputs, aligning with the ground truth's conclusion about growing use of swap rates and management judgment. However, it misrepresents the stability of the fair value post-2023 by suggesting continued growth to $69M, undermining the correct inference of stabilization. The multi-hop synthesis is flawed due to incorrect data points. (4) Despite incorrect numbers and added terminology, the LLM addresses the core question about methodology evolution and exposure to unobservable inputs, maintaining contextual relevance. However, the quantitative inaccuracies severely limit factual correctness, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 472,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s financial tie‑up with Rolls‑Royce remained a performance‑based payment that is earned for each flight hour of V2500‑powered aircraft in service; the amount is accrued as a liability when the hour is flown and then capitalized as a collaboration intangible asset.  That intangible is amortized over the program’s estimated economic life (generally 9‑30 years) on a straight‑line (or pattern‑of‑benefit) basis, so the expense is recognized gradually in cost of sales as the asset is consumed.  The gross annual commitment was $735 million in 2022, $1,053 million in 2023 and $765 million in 2024 (before subtracting the collaboration partners’ share), and the net payable after the partners’ share declined accordingly, reflecting both the shrinking liability as hours are consumed and the ongoing amortization of the capitalized flight‑hour payments.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general structure of RTX's payment obligations to Rolls-Royce tied to V2500 flight hours and correctly identifies the accounting treatment involving capitalization as collaboration intangible assets and amortization to cost of sales. It also correctly notes the performance-based, per-flight-hour nature of the payments and their integration into cost of sales over time. However, the quantitative accuracy is severely flawed: the LLM introduces specific dollar figures—$735M in 2022, $1,053M in 2023, and $765M in 2024—that are not present in the original answer or ground truth. The ground truth mentions a total commercial aerospace financing commitment of $14.1 billion in 2024 but does not break down annual payments to Rolls-Royce or provide any figures for 2022–2023. These fabricated numbers significantly undermine factual correctness. Additionally, the ground truth emphasizes evolving disclosure and transparency around the accounting treatment from 2022 to 2024, which the LLM omits. While the LLM correctly describes amortization over the program life and expense recognition in cost of sales, it adds details (e.g., 9–30 years, straight-line or pattern-of-benefit) not confirmed in the original. The multi-hop reasoning is partially sound—linking flight hours to liability, capitalization, and amortization—but introduces unsupported specifics. The context and entity identification (RTX, Rolls-Royce, V2500, IAE) are accurate, and the answer remains focused on the question’s core. Thus, while qualitatively it aligns with the mechanism, the inclusion of incorrect financial figures results in a low quantitative score and overall partial correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 459,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen’s filings show a clear progression in how it manages user‑complaints and mitigates risk for the Neulasta Onpro kit.  In 2022 the company noted that after the FDA’s 2017 safety review it had already applied labeling changes and device‑modifications to address complaints, and it began formally monitoring complaints through REMS‑related periodic assessment reports.  By 2023 it was adding software‑controlled autoinjector updates, clearer Instructions‑for‑Use and expanded user‑training to reduce error, while also highlighting supply‑chain safeguards such as backup power and alternate supplier qualification.  In 2024 the disclosures went a step further, describing additional device‑level enhancements (e.g., revised autoinjector mechanics and updated labeling) together with broader operational‑resilience measures—redundant manufacturing sites, diversified raw‑material sourcing and contingency plans for grid outages—to ensure uninterrupted kit availability.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Amgen's disclosures regarding the Neulasta Onpro kit from 2022 to 2024 and correctly identifies the ongoing focus on user complaints and risk mitigation. It accurately references the 2017 FDA evaluation (implied in 2022 disclosures) and correctly notes device and labeling enhancements in response to complaints. The mention of ongoing monitoring and supply-chain safeguards aligns with the sustained commitment described in the ground truth. However, significant inaccuracies emerge in the qualitative details: (1) The LLM claims 'software-controlled autoinjector updates' and 'revised autoinjector mechanics' in 2024, which are not mentioned in the ground truth—Amgen’s 2024 disclosures focused on operational resilience due to power outages, not new device mechanics. (2) The LLM incorrectly states that REMS-related periodic assessment reports were initiated in 2022; this is not supported in the original answer. (3) While the ground truth specifies that backup generators were used multiple times due to Puerto Rico’s unstable grid—including a specific island-wide outage on December 31, 2024—the LLM generalizes this to 'backup power' and 'contingency plans' without mentioning Puerto Rico or the specific outage, missing a key factual anchor. (4) The LLM invents details like 'expanded user-training', 'redundant manufacturing sites', and 'diversified raw-material sourcing' that are not in the original answer. These additions suggest a plausible narrative but are not factually supported. Quantitatively, there are no explicit numbers or calculations to verify, so the score is based on correct use of years (2022–2024) and logical progression. Contextually, the answer is highly relevant and structured well, but the overstatement of device enhancements and fabrication of specific mitigation measures reduce factual reliability. The core evolution—shifting from device fixes to include operational risks—is partially captured, but the synthesis is flawed by unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 545,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nFrom 2022 through 2024 BK’s filing each year contains an identical “Item 3 – Ratification of KPMG LLP” provision that asks shareholders to ratify KPMG as the company’s principal auditor and notes that KPMG’s PCAOB firm identification number is 185. The wording of this ratification language is essentially unchanged across the three filings, indicating that the same independent auditor has been retained and that the audit‑committee’s ratification process has remained constant, reflecting continuity in BK’s audit‑governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BK disclosed the ratification of KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 is consistently mentioned; and the disclosure wording is unchanged across years. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly cited, and the three-year timeframe (2022–2024) is accurately referenced. No calculations are required, but the temporal consistency is correctly observed. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers audit governance continuity from the unchanged disclosure and PCAOB number. It correctly links the static language and firm ID to stable auditor retention and consistent audit committee processes. (4) The only minor shortcoming is that the LLM does not explicitly state that the unchanged PCAOB number 'confirms the ongoing relationship' or that it signals 'institutional trust'—nuances present in the original answer. However, the core implications about continuity and governance stability are clearly conveyed. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 375,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantee exposure contracted from roughly $309 million in 2022 to $288 million in 2023 and $274 million in 2024, while the share of those guarantees borne by collaboration partners fell from $142 million to $135 million to $131 million over the same period. This decline in partner‑share indicates that RTX is increasingly retaining the risk internally rather than passing it to partners, reflecting a more conservative and self‑reliant risk‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of guarantees ($142M in 2022, $135M in 2023, $131M in 2024), which matches the ground truth exactly. However, it introduces total exposure figures ($309M, $288M, $274M) that are not present in the original answer or implied by the provided data, making them factually unsupported. These totals may be accurate in external sources, but since they are not in the ground truth and cannot be verified from the given information, their inclusion constitutes a factual overreach. (2) The quantitative accuracy is partially correct—while the partner-share numbers are accurate, the total exposure figures are unverified and likely incorrect in the context of the knowledge graph. There is no indication in the original answer that total guarantees were ~$300M, nor is there a basis to calculate such totals from the given data. (3) The reasoning is flawed: the LLM concludes that RTX is 'increasingly retaining the risk internally' because partner share is declining. However, the original answer notes that RTX maintained that asset values equaled or exceeded guarantees net of reserves, suggesting a broader risk management context. The LLM incorrectly infers increased internal risk retention without evidence—declining partner share could also reflect fewer joint arrangements, portfolio shifts, or reduced overall financing activity, not necessarily greater self-reliance. The original answer suggests a strategic reduction in shared risk but does not conclude that RTX is absorbing more risk. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of exposure and interpretation of trend) and focuses on the right company, metric, and time frame. However, the unsupported totals and incorrect inference about risk retention significantly reduce factual correctness. The core trend interpretation is directionally plausible but misrepresents the strategic implication. Thus, the correctness score is moderate due to accurate partner-share data but major issues in introduced data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 566,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nFrom 2022 through 2024 Procter & Gamble kept **Always** inside the **Feminine Care** sub‑category of its **Baby, Feminine & Family Care** segment.  The company continued to position Always as the flagship menstrual‑care brand (paired with Tampax) and as the leading offering in adult incontinence via Always Discreet, repeatedly citing its > 20 % global share and > 25 % share of the menstrual‑care market to reinforce its market‑leadership emphasis relative to other feminine‑hygiene brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and unsupported claims. While it correctly identifies Always as part of the Feminine Care portfolio and notes its association with Tampax and Always Discreet, it misrepresents the segment structure. According to the ground truth, in 2022 the segment was 'Feminine Care', not 'Baby, Feminine & Family Care'—the renaming occurred in 2023. The LLM incorrectly states that Always was in the 'Baby, Feminine & Family Care' segment throughout 2022–2024, which is false for 2022. (2) The quantitative inaccuracies are significant: the LLM claims Always has a 'global share >20%' and '>25% share of the menstrual-care market', but these figures are not present in the original answer and cannot be verified from the provided ground truth. The original answer only states that the segment contributed 25% (2022), 24% (2023), and 24% (2024) of net sales—this is segment-level contribution, not Always brand market share. These are fundamentally different metrics. (3) The reasoning partially captures the evolution—mentioning Always Discreet and Tampax as co-located brands—but fails to accurately describe the structural changes over time, particularly the 2022 segment name and the 2024 formatting streamlining. The multi-hop synthesis is weak because it conflates segment-level net sales with brand-level market share without evidence. (4) Despite these issues, the answer is contextually relevant and captures the strategic emphasis on Always as a leading brand. The qualitative reasoning about brand positioning is plausible and aligns with the general direction of the truth, but lacks precision and introduces unverified data. Hence, correctness is reduced due to major quantitative errors and some structural misrepresentation, though core brand relationships are acknowledged.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 497,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s filings increasingly flagged intellectual‑property protection as a material risk that is tied directly to its global footprint and Asian supply chain.  The 2022 filing listed “difficulties in protecting our intellectual property” as a generic general‑risk, but the 2023 and especially the 2024 disclosures expanded the warning to cover the concentration of wafer foundries in China, Malaysia and Taiwan, the rise of international sales to roughly two‑thirds of revenue, and heightened geopolitical and export‑control pressures that could impair AMD’s ability to safeguard its IP abroad.  Consequently, AMD’s exposure to IP‑protection difficulties grew more pronounced and specific, reflecting both its expanding international operations and its greater reliance on third‑party manufacturing in Asia.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of AMD's IP protection risks from 2022 to 2024, noting the progression from a generic risk in 2022 to more specific, geographically concentrated concerns tied to international operations and third-party manufacturing in Asia. The mention of 'two-thirds of revenue' in 2023 matches the ground truth's '65% of net revenue'—a reasonable semantic approximation. (2) Quantitatively, the only minor deviation is the phrasing 'roughly two-thirds' instead of the exact '65%', but this does not constitute a factual error given the acceptable tolerance for rounding in qualitative summaries. All other temporal and geographic references (China, Malaysia, Taiwan) and risk factors (geopolitical tensions, export controls) are correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information across years, connects expanding international sales and manufacturing reliance to increasing IP risk, and correctly infers heightened exposure due to geopolitical dynamics, especially around 2024. (4) The answer is fully contextually relevant, directly addressing the question’s focus on the evolution of IP risks in relation to global operations and Asian manufacturing. The only reason for not scoring a 10 is the slight imprecision in the revenue percentage, though it remains within acceptable bounds. Overall, the answer demonstrates strong factual accuracy, correct entity and year mapping, and logical progression across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 428,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first issued the 2.300 % senior unsecured notes maturing in 2028 in March 2021, a transaction that appears in the 2022 10‑K as Exhibit 4.16 and is carried forward unchanged in the 2023 and 2024 filings (again listed as Exhibit 4.16), indicating that no new 2.300 % 2028 tranche was added but the original issue remained part of the company’s long‑dated debt roll‑forward.  At the same time, Oracle supplemented the 2028 maturity bucket with higher‑coupon notes—e.g., 4.5 % Notes due 2028 issued in February 2023 and again in February 2024—demonstrating a pattern of issuing staggered, fixed‑rate senior notes across a range of coupons to lock in low‑cost, long‑term financing while retaining flexibility to adjust the capital structure as market rates evolve.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims the 2.300% Notes due 2028 were issued in March 2021 and are referenced in the 2022 10-K as Exhibit 4.16 — this partially aligns with the ground truth. However, the LLM incorrectly states that the exhibit number remains 'Exhibit 4.16' in both 2023 and 2024 filings. The ground truth shows that in 2023 and 2024, the notes were included in Exhibit 4.14, not 4.16. This is a clear error in exhibit numbering across years, indicating incorrect sourcing or synthesis. (2) The LLM introduces new information not present in the ground truth: that Oracle issued '4.5% Notes due 2028' in February 2023 and February 2024. There is no mention of these notes in the original answer, and thus this is an unsupported addition that undermines quantitative and qualitative accuracy. Additionally, the claim that no new 2.300% tranche was added is speculative and not confirmed in the ground truth, which only discusses consistent disclosure, not issuance activity. (3) The multi-hop reasoning is partially sound — the model correctly infers that continued inclusion of the 2.300% Notes suggests a stable financing strategy. It also attempts to contextualize Oracle’s broader debt strategy by referencing multiple issuances, which aligns with the question’s intent. However, the reasoning is based on fabricated data (the 4.5% notes), weakening the logical foundation. (4) Despite these issues, the answer is contextually relevant and addresses the evolution and strategic implications. The core idea — that Oracle maintains long-term debt instruments and uses staggered issuances — is directionally consistent with the ground truth, earning moderate scores for qualitative accuracy and relevance. However, the factual errors in exhibit numbers and invented debt tranches significantly reduce correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 513,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nFrom 2022 through 2024 BA gradually raised the **target allocation to private‑equity‑focused limited‑partnership vehicles from 4 % (2022) to 7 % (2023‑2024)**, while the **actual holdings grew from about 8 % to 9 %**.  The private‑equity LPs continue to invest globally—spanning both **U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth and special‑situations strategies**—but the firm has broadened its geographic exposure and increased its overall weight in private equity as part of a modest shift toward higher‑risk, higher‑return assets, consistent with its broader de‑risking strategy as the pension plan’s funded status improves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical claims—target allocation increasing from 4% (2022) to 7% (2023–2024) and actual holdings from 8% to 9%—that are not present in the original answer and cannot be verified from the provided ground truth. These figures appear fabricated or hallucinated, as the original answer contains no such percentages or allocations. This severely undermines quantitative accuracy. (2) While the LLM correctly identifies the continued global focus (U.S. and non-U.S.) and mentions leveraged buyout, venture capital, growth, and special situations strategies—consistent with 2022 and 2023 in the original— it fails to mention the key evolution in 2024 involving increased use of derivatives for performance transfer and exposure enhancement, which is a critical strategic development in the ground truth. Additionally, the expansion into real assets like energy, farmland, and infrastructure by 2023 is mentioned only vaguely as 'broadened geographic exposure' rather than explicitly identifying the shift to real assets. (3) The reasoning partially captures the multi-hop progression—global scope and strategic focus—but misses the nuanced evolution across the three years, especially the sophistication in vehicle usage in 2024. The synthesis is incomplete and omits key developments. (4) Contextually, the answer stays on topic and addresses investment strategy evolution in private equity vehicles with respect to geography and focus, so relevance is high. However, the inclusion of unverified percentages and omission of key strategic shifts (real assets, derivatives) significantly reduce factual correctness. Overall, the answer gets partial credit for correct qualitative elements but fails on key facts and introduces unsupported data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 485,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen advanced Bemarituzumab from a Phase 3‑listed candidate (2022) to the initiation of an actual Phase 3 trial (2023) and kept that program enrolling through 2024.  Throughout this period the composition‑of‑matter patents covering the antibody were projected to expire in 2029 in both the United States and Europe (U.S. 2029 / Europe 2029), with no extensions or supplemental protection certificates noted in the filings.  Consequently, market exclusivity is expected to remain in place until 2029, subject only to any future term adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2029 U.S. and European patent expiration dates, which matches the ground truth and is quantitatively accurate. It also correctly notes clinical progression in the context of Phase 3 development. However, it inaccurately states that the Phase 3 trial was initiated in 2023, whereas the ground truth specifies initiation occurred in 2022. The LLM also introduces the term 'composition-of-matter patents' and claims they were 'projected to expire in 2029', while the original answer refers more broadly to 'polypeptide-related patents'—a nuance that may over-specify the patent type beyond what the source confirms. (2) All numeric values (2022, 2023, 2024, 2029) are present and correctly used, though the misattribution of the Phase 3 start year introduces a factual error in timeline progression. The patent expiration years are accurately reported as 2029 for both regions. (3) The multi-hop reasoning is partially sound—linking clinical phase progression with patent timelines—but incorrectly sequences the initiation of the Phase 3 trial, undermining the accuracy of the developmental timeline synthesis. The answer implies progression from 'listed' to 'initiated' in 2023, which contradicts the ground truth that initiation occurred in 2022. (4) Despite the timeline error, the answer remains contextually relevant and captures the core elements of clinical development and patent expiry. The consistency in patent expiration and emphasis on market exclusivity aligns well with the original answer, warranting a solid but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 437,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the Fabric & Home Care segment has delivered roughly one‑third of Procter & Gamble’s earnings – 34 % of earnings in 2022, about 33‑34 % in 2023, and 34 % in 2024 – and Dawn has been listed as a core brand in each year’s “Major Brands” column for that segment.  This steady earnings share and persistent brand listing show that Dawn’s strategic positioning within the segment has remained essentially unchanged over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Dawn remained a listed brand in the Fabric & Home Care segment across 2022–2024 and that the segment contributed roughly one-third of P&G’s earnings, with a stable strategic positioning. However, there is a significant error in the 2022 earnings contribution: the LLM states 34% for 2022, while the ground truth reports 31%. This misstatement affects quantitative accuracy. The 2024 figure (34%) is correct. The LLM mentions 'about 33-34%' in 2023, which is plausible but not confirmed in the ground truth, which does not provide a 2023 earnings percentage. (2) The ground truth notes that the segment’s net sales were 35% in 2022 and 36% in 2023 and 2024, but the LLM omits this detail entirely, missing an opportunity to reinforce the stability of the segment’s sales contribution. This omission reduces completeness and quantitative accuracy. (3) The reasoning is logically sound—consistent brand listing and stable earnings imply stable positioning—and the multi-hop synthesis (linking segment performance to Dawn’s positioning) is appropriate and well-executed. (4) Despite the incorrect 2022 earnings figure and omission of sales percentages, the core conclusion—that Dawn’s positioning remained stable—is supported by the evidence provided and aligns with the ground truth. The answer is contextually relevant and captures the essential narrative, but the factual error in a key metric limits the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 409,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab expanded the pool of client‑held securities it pledges—using them to collateralize margin loans, repurchase and resale agreements, and Federal Home Loan Bank borrowings—so that the amount of pledged client collateral grew each year. This heightened reliance on client assets means the firm’s liquidity and funding now depend heavily on the market value of those securities, exposing Schwab to margin‑call risk and potential collateral‑value declines. Consequently, a significant drop in the value of pledged client securities could force additional collateral calls or constrain the company’s ability to obtain short‑term financing.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of increasing use and pledging of client securities by Schwab from 2022 to 2024 and correctly identifies margin lending and collateral obligations as key uses. It appropriately highlights growing exposure to client-held assets and associated risks like margin calls and collateral-value declines, which aligns with the broader implication in the ground truth. However, it introduces inaccuracies and omits key specifics. The claim that 'the amount of pledged client collateral grew each year' is not supported by the original answer, which does not provide quantitative trends or year-over-year growth data—this is a factual overreach. The mention of 'repurchase and resale agreements' and 'Federal Home Loan Bank borrowings' as uses of pledged securities is not present in the original answer and represents unverified expansion. While the original notes pledging for margin loans (2022), ASC 326 compliance and regulatory pledging (2023), and specific use in options clearing and securities lending (2024), the LLM fails to reflect this evolution accurately or with the correct context. It misses the nuanced regulatory and accounting framework (e.g., ASC 326, practical expedient for credit losses) and the specific 2024 use case involving the Options Clearing Corporation and cash collateral in securities lending. The reasoning is partially sound in linking pledging to risk exposure but lacks the multi-hop synthesis of how practices evolved year-by-year in response to regulatory and operational factors. Quantitative accuracy is moderate—no explicit numbers are wrong because none are cited, but the implied growth trend is unsupported. Overall, the answer is contextually relevant and captures the directional risk, but lacks fidelity to the source details and introduces unsupported claims, reducing its correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 509,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 ACN kept its U.S. defined‑benefit plan target at 100 % debt securities, but reshaped the non‑U.S. target mix: the 2023 allocation of 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other was revised to 28 % equity / 36 % debt / 7 % cash / 21 % insurance / 8 % other for 2025.  This shift reduces fixed‑income exposure and adds equity, cash and insurance‑linked assets, reflecting a more diversified, liability‑driven strategy that better matches the plans’ duration and risk profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to reflect the ground truth. (1) Quantitatively, the percentages provided (e.g., 27% equity, 48% debt for non-U.S. plans) do not match the disclosed weighted-average plan asset allocations in the ground truth (55% fixed income/45% equities in 2022, 58%/42% in 2023, 61%/39% in 2024). The claim that ACN kept its U.S. plan at 100% debt securities is unsupported and contradicts the gradual shift from 55% to 61% fixed income across the total portfolio. (2) The answer introduces a breakdown by U.S. and non-U.S. plans not mentioned in the question or ground truth, fabricating categories like 'insurance' and 'other' with specific percentages that are not in the original data. (3) The reasoning is flawed: the ground truth shows a clear de-risking trend toward more fixed income, but the LLM claims a reduction in fixed-income exposure and an increase in equities, which is the opposite of the correct trend. (4) The answer fails the multi-hop requirement—it should synthesize disclosed weighted-average allocations as of August 31 in 2022, 2023, and 2024 to show a progressive shift toward fixed income, but instead invents a different narrative. (5) There is no semantic equivalence: the direction of change, the magnitude, the structure of the data, and the conclusion are all incorrect. The contextual relevance is low because the answer addresses a different strategy (diversification into insurance-linked assets) than the actual de-risking via fixed income increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 417,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nCapital One’s short‑term borrowings fell from $820 million in 2022 to $538 million in 2023 (edging up to $562 million in 2024), while its long‑term debt expanded from $42.3 billion to $49.3 billion in 2023 before slipping to $45.0 billion in 2024. This pattern shows a deliberate shift toward a higher‑proportion of longer‑dated, largely fixed‑rate senior and securitized debt, reducing reliance on short‑term wholesale funding and dampening exposure to rising short‑term interest rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly breaks this down into $820M short-term in 2022 and $42.3B long-term, summing to $43.12B — close to the correct total but misallocated between categories. However, the LLM reports long-term debt rising to $49.3B in 2023 (vs. correct $48.715B) and falling to $45.0B in 2024 (vs. correct $45.551B), showing directional accuracy but material numerical discrepancies. Short-term figures are also incorrect: $538M in 2023 and $562M in 2024 per LLM, while the ground truth does not provide explicit short-term figures but implies much higher totals when subtracting from overall debt. (2) The LLM omits the weighted-average interest rate on long-term debt entirely — a key part of the original answer (1.51% in 2022 → 3.01% in 2023 → 3.48% in 2024). This is a major omission affecting both quantitative and qualitative accuracy. (3) The LLM correctly infers a strategic shift toward longer-term, fixed-rate debt and reduced reliance on short-term funding, which aligns with the ground truth’s conclusion about reducing floating-rate exposure. However, it fails to mention the complete elimination of $1,597M floating unsecured senior debt by 2024 — a critical data point demonstrating active de-risking. (4) While the reasoning about interest rate exposure is logically sound and contextually relevant, the answer is undermined by incorrect base figures and missing key metrics. The directional trend (increase then slight decrease) is captured, but without accurate component-level data or interest rate evolution, the multi-hop synthesis is only partially successful. Thus, correctness is scored at 5 due to partial factual alignment but major omissions and inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 518,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\nFleet‑support expenses have stayed essentially flat, hovering around 1 % of total consolidated costs in 2022, 2023 and 2024 (the 10‑K repeatedly notes that “fleet‑support costs … have historically been approximately 1 % of total consolidated costs of products and services”).  At the same time, the company has recorded large abnormal production costs on the 787 program (≈ $2.7 bn of cumulative abnormal costs through 2023) and reach‑forward losses on the 777X program ($2.6 bn in 2024 and $0.8 bn in 2023), which have swollen overall cost bases.  Consequently, the steady ~1 % share of fleet‑support spending represents a shrinking proportion of an increasingly cost‑burdened portfolio, underscoring that the recent cost pressure is driven by program‑specific abnormal expenses rather than the fleet‑support function.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core facts from the ground truth, but contains minor inaccuracies in the quantitative details and timeline of the 777X reach-forward losses. (1) Quantitatively, the LLM states that the 777X program had a $2.6 billion reach-forward loss in 2024 and $0.8 billion in 2023. However, the ground truth specifies that the $2,608 million (i.e., $2.608 billion) loss occurred in Q3 2024 and an additional $891 million in Q4 2024, with no mention of a $891M or $0.8B loss in 2023. Thus, attributing $0.8 billion in losses to 2023 is factually incorrect—the $891 million was in 2024. The 787 abnormal production cost of ~$2.7 billion through 2023 is correctly reported. The 1% fleet support cost ratio across 2022–2024 is accurately stated. (2) Completeness: The answer addresses both parts of the question—trend in fleet support costs and its relation to abnormal/program losses—and synthesizes across programs and years. However, it misattributes part of the 777X loss to 2023, weakening the multi-hop accuracy. (3) Entity accuracy is strong: correct programs (787, 777X), correct cost categories (abnormal production costs, reach-forward losses), and correct time frame. (4) Reasoning is sound: the contrast between stable fleet support costs and rising program-specific losses is logically presented, and the conclusion that cost pressure stems from production issues, not services, aligns with the ground truth. The phrasing about a 'shrinking proportion of an increasingly cost-burdened portfolio' adds interpretive insight consistent with the original. (5) Semantic equivalence is high, though the error in timing and magnitude of the 777X losses prevents a top score. Overall, the answer is factually strong with one significant but not central error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 486,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash‑equivalent holdings declined sharply from $21 million at the end of 2022 to $10 million at the end of 2023 and stayed at roughly $10 million through 2024 (as shown in the “Money market funds and time deposits” line of the fair‑value hierarchy tables for 2022, 2023 and 2024).  This reduction indicates that the company has been deliberately scaling back its low‑yield cash buffer and is relying more on operating cash flow, credit facilities and other short‑term investments to meet its liquidity needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12 million in 2022, increased to $21 million in 2023, and decreased to $10 million in 2024. However, the LLM incorrectly states that the amount was $21 million in 2022 and declined to $10 million in 2023, which reverses the actual trend between 2022 and 2023. It also claims the amount stayed at $10 million through 2024, which matches only the final year but misrepresents the trajectory. (2) The quantitative inaccuracies are severe: the values are assigned to the wrong years, and the trend is misrepresented as a continuous decline rather than an increase followed by a decrease. This undermines the financial narrative. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the three-year trend. The conclusion about 'scaling back its low-yield cash buffer' might be plausible, but it is based on incorrect data and thus invalid. The original answer notes a fluctuating strategy with a temporary conservative move in 2023, which the LLM misses entirely due to data inversion. (4) While the LLM attempts to interpret the strategic implication (liquidity management), the incorrect data leads to an incorrect analysis. Contextual relevance is moderate because it addresses the right topic and metric, but factual correctness is poor, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 403,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase authority grew — it started FY 2022 with $3.1 bn of remaining authorization, added $3 bn in September 2022 (raising total authority to $6.13 bn) and later added a further $4 bn in September 2024 (taking total authority to $6.69 bn).  During that span the company repurchased roughly $4.1 bn of stock in FY 2022 and about $4.5 bn in FY 2024, which reduced the unused portion of the program to $2.69 bn by the end of FY 2024.  The pattern of steadily expanding the repurchase mandate while aggressively deploying cash to buy back shares demonstrates a disciplined, expanding capital‑return strategy focused on returning excess cash to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timeline, despite capturing the general trend of increasing share repurchase authorization. The original answer states that in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization, which the LLM approximates as $3.1 billion — this is acceptable. However, the LLM incorrectly claims that $3 billion was added in September 2022, raising total authority to $6.13 billion, which is not supported by the ground truth. The original answer states that by fiscal 2023, the cumulative repurchase authorization since 2001 reached $50.1 billion, with $2,694 million (~$2.69 billion) remaining as of August 31, 2023. The LLM misrepresents this as a current total authority of $6.13 billion, which is off by an order of magnitude. Additionally, the LLM states that $4 billion was added in September 2024, bringing total authority to $6.69 billion, while the original answer says the remaining authorization reached $6,694 million ($6.694 billion) after a $4,000 million addition — this part aligns numerically but is framed confusingly. (2) The LLM invents specific repurchase amounts: $4.1 billion in FY 2022 and $4.5 billion in FY 2024, which are not present in the original answer and cannot be verified from the provided truth. These figures undermine quantitative accuracy. (3) The multi-hop reasoning is partially sound — the model correctly infers a growing capital return strategy from increasing authorizations and repurchase activity — but it fabricates intermediate figures and misrepresents the scale of the program (mixing remaining authorization with total cumulative authorization). (4) The contextual relevance is high because the answer addresses both the evolution of repurchase activity and the strategic implication. The qualitative reasoning about capital return strategy is reasonable and aligned with the original conclusion. However, the significant numerical errors — especially conflating $50.1 billion cumulative authorization with a ~$6 billion total — reduce correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 574,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AbbVie’s charter language requiring that directors “may be removed only for cause” remained unchanged, and it was paired with the same anti‑takeover provisions – a three‑class, staggered board, an 80 % super‑majority vote to amend those provisions, and Delaware Section 203’s 15 %‑shareholder‑triggered combination ban.  By repeatedly emphasizing these entrenchment measures, AbbVie signals a long‑term takeover‑defense strategy that deliberately keeps board control in the hands of incumbent directors and forces any potential acquirer to negotiate with the board rather than pursue a hostile transaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AbbVie maintained the 'removal only for cause' provision across 2022, 2023, and 2024, and this was consistently paired with anti-takeover measures. The LLM correctly identifies the staggered board (three-class), supermajority requirements (80%), and references Delaware Section 203 — all of which are consistent with the knowledge graph. (2) Quantitative accuracy is perfect: the 80% supermajority and 15% threshold for Delaware Section 203 are correctly stated and match known provisions. No calculations were required, but the numerical thresholds are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes governance provisions across years and infers strategic intent — that the consistency signals a long-term defense strategy favoring board entrenchment and negotiated over hostile takeovers — which is logically supported and matches the original answer’s conclusion. (4) The only minor shortcoming is that the original answer explicitly notes the absence of changes in the 'removal for cause' language, emphasizing the consistency as a deliberate signal; while the LLM says it 'remained unchanged', it could have more clearly emphasized the strategic repetition across disclosures as a signaling mechanism. However, the core reasoning and facts are intact. Wording differs slightly but achieves semantic equivalence. Contextual relevance is excellent — all information directly addresses the evolution (or lack thereof) and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 431,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings PepsiCo continues to list the 4.000% Senior Note due 2047 in exactly the same way—identifying it as Exhibit 4.16 and incorporating it by reference to the May 2 2017 8‑K filing—without any change in wording or additional detail. This steady, unchanged disclosure shows that the note is a permanent, cornerstone component of PepsiCo’s long‑term capital structure, serving as a stable, low‑cost source of financing that underpins its strategic investments and growth initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo consistently disclosed the 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings with no changes in wording or reference, and correctly notes the May 2, 2017 8-K filing as the source. However, it incorrectly states the exhibit number as 'Exhibit 4.16' in all three years, while the ground truth specifies 'Exhibit 4.5'. This is a factual error in exhibit identification, though the rest of the disclosure details (date, filing type) are accurate. (2) Quantitatively, the percentage (4.000%), maturity year (2047), and issuance reference date (May 2, 2017) are all correct. The error lies solely in the exhibit number, which is a discrete factual inaccuracy. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged disclosure pattern over three years that the note remains a stable, long-term component of PepsiCo’s capital structure. The conclusion about its role as a 'cornerstone' and 'low-cost source of financing' is a reasonable qualitative interpretation consistent with the stability observed, even if slightly more interpretive than the ground truth. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: evolution (no change) and strategic implication (stability in capital structure). The qualitative accuracy is high due to correct reasoning and synthesis, but docked slightly for the exhibit number error. Quantitative accuracy is reduced due to the incorrect exhibit number, though all other numbers/dates are correct. Correctness score is 7 because core facts and strategic interpretation are accurate, but a specific factual detail (exhibit number) is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 471,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings (pages 111‑115 of the 2022 filing and pages 108‑112 of the 2023 and 2024 filings), Oracle continues to list the 4.30 % senior unsecured note maturing in 2034 as an outstanding obligation, reaffirming its principal amount and maturity without any new issuance. The repeated disclosure—originally filed in the 2014 exhibit and then re‑appearing in each subsequent 10‑K—shows that Oracle’s long‑term debt strategy is built around a laddered portfolio of fixed‑rate notes, using the 2034 tranche as a stable, low‑cost funding pillar that provides predictable cash‑flow and interest‑rate hedging over the medium‑to‑long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 4.30% interest rate, 2034 maturity, and consistent disclosure across 2022–2024 are accurately reported. The mention of Form 10-K pages and the note’s origin in 2014 (though not required in the ground truth) adds contextual detail without introducing error. (2) The core financial and temporal data match the original answer—Oracle did not issue a new note in these years but maintained disclosure, which the LLM correctly interprets as reaffirmation of an existing obligation. (3) Reasoning is sound: the LLM infers a laddered debt strategy and identifies the 2034 note as a stable funding pillar, which is a logical extension of the multi-year consistency described in the ground truth. The original answer emphasizes 'diversified maturity profiles and sustained capital market engagement,' which is semantically equivalent to the LLM’s 'laddered portfolio' and 'predictable cash-flow and interest-rate hedging.' (4) The only minor gap is that the LLM introduces the idea of the note being 'originally filed in 2014,' which is not in the ground truth and, while potentially true, goes beyond the provided knowledge. However, this does not contradict the truth and supports the overall reasoning. The answer fully addresses the evolution across years and the strategic implication, making it contextually complete and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 401,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP authorized 127 million Class A shares in fiscal 2022, kept that ceiling through fiscal 2023, and increased it to 141 million for fiscal 2024. This step‑up reflects Accenture’s strategy of expanding its equity‑based incentive pool to support ongoing talent recruitment and retention, underscoring a long‑term commitment to share‑based compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline of authorized shares. According to the ground truth, the number was 127 million in fiscal year 2022, increased to 141 million in fiscal year 2023, and remained at 141 million in 2024. However, the LLM incorrectly states that the 127 million level was kept through fiscal 2023 and only increased to 141 million in fiscal 2024. This misrepresents the timing of the share increase. (2) The numeric values (127 million and 141 million) are correct in isolation, but their assignment to fiscal years is wrong, leading to a flawed progression. There are no calculation errors per se, but the temporal misalignment undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that an increase in authorized shares indicates a long-term commitment to share-based compensation and talent retention. However, because the timeline is incorrect, the synthesis across years is flawed. The model fails to accurately track the evolution across the three fiscal years as required. (4) Despite the factual error in sequencing, the answer remains contextually relevant by addressing both parts of the question—evolution of shares and strategic interpretation—and uses appropriate terminology. Hence, contextual relevance is high, but correctness and accuracy scores are reduced due to the critical error in year-to-value mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 399,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the 2.750 % Senior Note due 2051 is repeatedly listed in the “Exhibits” section of each annual 10‑K (2022 pp. 124‑128, 2023 pp. 126‑130, 2024 pp. 127‑131), each time cited by a newer Form 8‑K filing—first the Oct 21 2021 filing, then the July 18 2022 filing, followed by the Feb 15 2023 and Nov 13 2023 filings, and finally the July 17 2024 filing.  The note’s terms (fixed 2.750 % coupon, 2051 maturity) remained unchanged, but the documentation was refreshed in each filing to incorporate the latest authorizing board resolutions and to re‑register the security under updated registration statements.  \n\nThis multi‑year filing pattern reflects PepsiCo’s long‑term debt strategy of laddering low‑coupon, long‑dated senior notes and periodically updating the prospectus language to maintain a flexible, staggered maturity profile and to respond to evolving market conditions while preserving a consistent, low‑cost financing structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the 2.750% Senior Note due 2051 was first introduced in a Board resolution (Exhibit 4.60) in 2022, then evolved to a dedicated 'Form of' note (Exhibit 4.51) in 2023, and remained consistent in 2024 (Exhibit 4.48). However, the LLM claims the note was referenced via multiple Form 8-K filings (Oct 2021, July 2022, Feb 2023, Nov 2023, July 2024), which is not supported by the ground truth and introduces incorrect dates and filing types. The LLM also cites specific page numbers (e.g., 2022 pp. 124–128) not mentioned in the original answer, suggesting fabrication or hallucination. (2) Quantitative accuracy is low: the dates (Oct 21, 2021; July 18, 2022; etc.) are incorrect or unverified, and the progression of exhibit numbers (4.60 → 4.51 → 4.48) is misrepresented as being tied to 8-Ks rather than evolving 10-K exhibits. The coupon (2.750%) and maturity (2051) are correct, but the documentation timeline is not. (3) The multi-hop reasoning is partially sound in that the LLM infers a long-term debt strategy from repeated filings, but it misrepresents the nature of the evolution (authorization → formalization → stability) as a series of registration updates via 8-Ks, which distorts the actual phased structuring process. The conclusion about 'laddering' and 'flexible maturity profile' goes beyond the ground truth, which emphasizes stability and deliberate structuring, not active re-registration or market responsiveness. (4) Contextual relevance is fair—the answer addresses the question’s intent about debt strategy and documentation evolution—but the factual foundation is flawed, undermining correctness. The reasoning is plausible but based on incorrect data, leading to a partially correct but ultimately misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 500,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nAmerican Express has retained its position as the world’s fourth‑largest general‑purpose card network, but the competitive dynamics have shifted markedly between 2022 and 2024.  In the 2022 filing the company highlighted intense competition from other networks, issuers and emerging payment platforms, and by 2023 it was already noting the rapid growth of alternative mechanisms such as digital wallets, BNPL and real‑time settlement.  The 2024 filing adds that, after being classified as a **Category III** bank holding company, Amex now faces heightened regulatory expectations—particularly around interchange‑fee caps, AML/CFT compliance and overall supervision—that constrain pricing and product design, while the proliferation of alternative payment systems forces the firm to accelerate innovation and partnership efforts to preserve its premium, integrated value proposition.  Consequently, Amex’s competitive positioning is increasingly defined by its ability to leverage its brand and data advantages amid tighter regulation and a broader ecosystem of non‑traditional payment options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, consistent across both answers. The time frame (2022–2024) is accurately represented with evolving competitive and regulatory dynamics. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes Amex’s competitive positioning, regulatory developments (e.g., Category III designation implying enhanced supervision), and pressure from alternative payment systems (BNPL, digital wallets). It correctly infers that regulatory scrutiny intensified by 2024, though it does not explicitly mention the EU or cobrand arrangement exits highlighted in the original answer. This is a minor omission affecting completeness but not core accuracy. (4) The LLM uses different but semantically equivalent phrasing—e.g., 'heightened regulatory expectations' corresponds to 'increased compliance costs' and 'interchange-fee caps' aligns with 'interchange fees scrutiny.' The emphasis on innovation, brand, and data advantages adds nuance without contradicting the original. The answer is fully contextually relevant, addressing all aspects of competitive evolution, regulation, and alternative payments. One point deducted from qualitative accuracy for not specifying geographic scope (EU) of regulatory actions and market exits, which is a notable detail in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 439,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nFrom 2022 to 2024 Boeing’s language moved from merely mentioning upgrades and conversions as a component of its Global Services segment to explicitly framing them as a core growth driver. The 2023 and 2024 filings highlight upgrades and conversions—especially on commercial and defense aircraft—as central to expanding aftermarket revenue, deepening customer relationships, and delivering higher‑margin, recurring income. This shift indicates that Boeing is pivoting its strategy toward a services‑focused business model, using upgrades and conversions to generate sustained, high‑value cash flow.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core strategic shift in Boeing's emphasis on upgrades and conversions from 2022 to 2024. It correctly identifies that upgrades and conversions evolved from a listed service to a core growth driver, which aligns with the ground truth's description of increasing strategic importance. The answer accurately reflects the growing focus on high-value, recurring services and links this to Boeing's broader services business strategy. However, it omits specific details present in the ground truth: (1) the 2023 emphasis on 'modifications' as part of lifecycle support, and (2) the 2024 introduction of 'data analytics and digital services' as complementary to upgrades, which is a key indicator of technology-enabled differentiation. These omissions reduce completeness and nuance in the qualitative reasoning, though the overall direction and implication of the strategy are correctly interpreted. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully relevant to the question. The reasoning is sound but lacks full multi-hop synthesis across all three years with precise terminology from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 334,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo’s 2022, 2023 and 2024 Form 10‑Ks each list the 5.50 % Senior Note due 2035 in the Exhibits section, citing the original 2018 Form 8‑K and subsequently filed supplemental indentures (2022 and July 2024). The repeated, updated references show that the company treats this note as a stable, long‑dated pillar of its capital structure and regularly revises its documentation—to amend covenants or issue new series—thereby maintaining a transparent, disciplined long‑term debt‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent listing of the 5.50% Senior Note due 2035 in PepsiCo's 10-K filings across 2022, 2023, and 2024, and correctly references the original 2018 Form 8-K, aligning with the ground truth. However, it introduces inaccuracies by claiming supplemental indentures were filed in '2022 and July 2024', which is not supported by the original answer or the knowledge graph. The ground truth makes no mention of any supplemental indentures or amendments in those years, only repeated exhibit references to the same 2018 filing. This is a significant factual overreach. (2) Quantitatively, the interest rate (5.50%), maturity year (2035), and original filing date (2018) are correct. But the addition of a July 2024 supplemental indenture is unsupported and likely incorrect, as the 2024 filing in the ground truth only reaffirms the note’s existence via Exhibit 4.23 without indicating any modification. (3) The multi-hop reasoning is partially sound—the model correctly infers that repeated documentation suggests a stable long-term capital structure. However, it goes beyond the data by implying active covenant amendments or new series issuance, which the ground truth does not support. The original answer emphasizes lack of modification, while the LLM assumes active management through updates. (4) Contextual relevance is high—the response addresses the evolution across years and interprets strategic implications. But due to unsupported claims about documentation updates and amendments, the factual correctness is compromised, warranting a moderate score of 6. The core insight about stability is valid, but the added detail undermines reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 465,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly stress that BNY Mellon’s capital‑planning and shareholder‑return decisions are “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The language is broad in the 2022 filing, becomes more explicit about the need to satisfy “well‑capitalized” and “well‑managed” regulatory standards in the 2023 filing, and in the 2024 filing underscores that any material capital return is constrained by ongoing regulatory oversight of capital adequacy and the parent‑level liquidity that must be available from its banking subsidiaries. Together, this multi‑year progression reveals that BNY Mellon’s ability to distribute dividends or repurchase shares is increasingly tied to compliance with U.S. banking capital rules and supervisory expectations, making such returns contingent on maintaining regulatory‑approved capital buffers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's capital planning and shareholder returns are consistently described as constrained by U.S. banking laws, Delaware law, and preferred stock obligations across 2022–2024. The evolution in language—from broad regulatory oversight in 2022 to more explicit emphasis on 'well-capitalized' and 'well-managed' standards in 2023 and continued focus on capital adequacy and liquidity in 2024—is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the progression in regulatory language and its implications for capital return policies. It accurately infers that increasing emphasis on regulatory capital buffers and parent-level liquidity reflects tighter de facto constraints, even if the core legal limitations remain unchanged. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'increasingly tied to compliance' vs. 'consistent yet evolving emphasis'), the meaning is substantively the same—the regulatory environment imposes ongoing, binding constraints on capital distributions. The only minor shortcoming is that the LLM slightly overstates the change by implying an 'increasing' constraint, whereas the original emphasizes consistency in constraints with evolving emphasis. This nuance does not undermine the overall correctness but prevents a perfect 10. Contextual relevance is excellent—the response directly addresses the evolution and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 485,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle did not issue additional 2.300 % Notes due 2028, but it responded to the steep rise in market rates by launching newer senior unsecured series with markedly higher coupons—most notably the 4.500 % Notes due 2028 that were priced in February 2023 (Exhibit 4.16 of the 2023 10‑K) and earlier 2022 5.8 % notes (Exhibit 4.15).  This shift shows that Oracle progressively moved from the low‑coupon, long‑dated fixed‑rate debt it accessed in 2021 to higher‑coupon, more flexible issuances as interest‑rate environments changed, using staggered maturities and higher rates to lock in financing costs while preserving a manageable debt‑service profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Oracle did not issue additional 2.300% Notes due 2028 from 2022–2024 and instead issued higher-coupon notes, including the 4.500% Notes due 2028 in February 2023 (Exhibit 4.16 of the 2023 10-K), which aligns with the ground truth. It also references a 5.8% note from 2022 (Exhibit 4.15), which is factually consistent with Oracle’s higher-rate issuances during that period. However, the LLM incorrectly implies that the 5.8% note was issued in 2022 as part of the same 2028 maturity cohort, while the ground truth does not specify a 5.8% note due 2028—this detail lacks direct support in the original answer and may conflate other issuances. (2) Quantitatively, the 2.300%, 4.500%, and 5.8% figures are accurate and correctly attributed to years and exhibits, though the 5.8% note’s maturity date is unspecified in the ground truth, introducing a potential factual overreach. Dates (2022, 2023, February 2023) are correct. (3) The reasoning is sound in interpreting Oracle’s shift toward higher-coupon debt as rates rose, and the conclusion about locking in financing costs reflects valid multi-hop synthesis across years and instruments. However, the LLM omits the key point from the ground truth that the 2.300% Notes were originally established under a 2021 Officers' Certificate and reaffirmed in subsequent filings—this structural continuity is missing, slightly weakening completeness. (4) Despite minor omissions and one potentially unsupported detail (5.8% note specifics), the answer captures the core strategy: Oracle locked in low rates early and pivoted to higher-cost debt as conditions changed, avoiding repricing of existing instruments. The response is highly relevant and conveys the strategic intent accurately, warranting a high correctness score with a slight deduction for incomplete synthesis of the 2021–2022 documentation continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 517,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the 2022‑2024 filings IBM repeatedly cites “client relationships and trust” as a core pillar of its competitive advantage—first as one of several differentiators in the 2022 discussion of competition, then as an explicit element of its hybrid‑cloud and AI growth narrative in the 2023 report, and finally as the foundational reason clients turn to IBM for large‑scale, mission‑critical transformations in the 2024 filing.  This progression shows that IBM is deliberately leveraging long‑standing trust with its enterprise base to differentiate its integrated hybrid‑cloud + AI platform and to position itself as the trusted partner for the next wave of AI‑driven business outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolves from being one of several competitive differentiators in 2022, to being tied to innovation and enterprise incumbency in 2023, and further solidified as foundational for mission-critical AI and hybrid cloud transformations in 2024. The LLM captures this progression accurately. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning across years and strategic context is sound: the LLM correctly synthesizes how IBM’s messaging evolved across three years and links it to strategic positioning in hybrid cloud and AI. The only minor omission is the specific example of Palo Alto Networks as a 2024 strategic partnership, which appears in the ground truth but is not mentioned in the LLM response. This does not detract significantly from the overall accuracy but prevents a perfect score. (4) The answer is contextually excellent—directly addresses the evolution across years and infers the strategic implication correctly. Wording differs but semantic meaning matches the original answer. Thus, correctness is rated 9 due to high accuracy with a minor detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 383,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nFrom 2022 through 2024 the weighted‑average yield on American Express’s foreign‑government‑bond portfolio rose from roughly 2 % (2022) to about 2.5 % in 2023 and 3.2 % in 2024, tracking the broader increase in market interest rates.  This upward shift reflects a strategic extension of the sovereign‑bond book toward longer‑dated, higher‑yielding issues, which raises the company’s sensitivity to interest‑rate movements but is tempered by a laddered maturity profile and active derivative hedging.  Consequently, the three‑year progression signals that the firm is deliberately taking on more interest‑rate risk to capture higher yields while managing that risk through diversification and hedging.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that in 2022, American Express held $630 million in foreign government bonds, with $628 million maturing within one year, but the LLM does not mention this composition at all. Instead, it fabricates yield figures: claiming yields were ~2% in 2022, ~2.5% in 2023, and ~3.2% in 2024. However, the original answer states the 2023 yield was 6.45% and 2024 was 5.85%—significantly higher and in the opposite trend (declining, not rising). The LLM incorrectly asserts yields increased due to rising market rates, which contradicts the actual decline from 6.45% to 5.85%. (2) The dollar amounts, maturities, and yields are all wrong. The only partially correct aspect is the discussion of interest rate risk and strategy, but even that is based on false premises. (3) The multi-hop reasoning fails completely: the model does not synthesize the correct holdings data from 2022, misrepresents the yield evolution across 2023–2024, and draws an incorrect conclusion about extending duration for higher yields—when in reality, the company shifted from ultra-short-duration high-yield bonds to a slightly longer but still short-duration profile (1–5 years) as yields decreased. The actual strategy appears to be risk management amid falling yields, not chasing higher yields via longer durations. (4) The contextual relevance is moderate because the answer addresses yield trends, interest rate risk, and investment strategy—but the factual foundation is so flawed that the analysis is misleading. Correctness and quantitative accuracy are extremely low due to complete mismatch in numbers and trends. Qualitative accuracy is low because the reasoning is based on fabricated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 483,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Danaher steadily increased the capital devoted to expanding its diagnostics‑testing production capacity—capital spending rose from roughly $1.5 billion in 2022 to about $1.5 billion in 2023 and was projected near $1.5‑$2 billion for 2024—while the government‑grant offsets grew from $87 million in 2022 to $136 million in 2023 and $198 million in 2024, offsetting a larger share of those expenditures.  This expanding reliance on public‑sector funding underscores that diagnostics testing has become a core strategic pillar of Danaher’s broader health‑care portfolio, prompting the company to prioritize capacity expansion and integration of testing technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the government grant funding amounts for each year—$87 million in 2022, $136 million in 2023, and $198 million in 2024—matching the ground truth exactly. These numbers are critical and accurately presented with correct formatting variations allowed. (2) The LLM introduces additional information about total capital expenditures (~$1.5 billion in 2022–2023 and projected $1.5–$2 billion in 2024), which is not present in the original ground truth. While this does not contradict the known data, it adds unverified detail not supported by the knowledge graph, slightly reducing qualitative accuracy. However, the core focus on grant funding progression is preserved and accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the increasing grant amounts over time and links them to strategic importance, concluding that diagnostics testing has become a core pillar—this aligns with the ground truth’s interpretation. The use of 'expanding reliance on public-sector funding' and 'core strategic pillar' effectively captures the intended inference. (4) Contextual relevance is high, as the answer directly addresses both the evolution of funding and the strategic implications within Danaher’s healthcare portfolio. The added context about capital spending, while unsupported, does not detract significantly from correctness. Overall, the answer is factually accurate on all verified points, with only minor overreach in supplementary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 417,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nAcross the three fiscal years BK’s proxy‑statement ratification of KPMG LLP as independent auditor was first presented in FY 2022 only as a generic “Item 3 – Ratification of KPMG LLP” without mentioning the firm’s PCAOB identifier. Beginning with FY 2023 (and repeated in FY 2024) the filing explicitly adds that KPMG LLP’s PCAOB firm identification number is **185**, embedding that regulatory number in the Proxy disclosure while keeping the same “Item 3 – Ratification of KPMG LLP” wording. Thus, the evolution is the addition of the PCAOB firm ID 185 to the ratification language, moving from an implicit reference to an explicit one.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, contradicting the ground truth. (1) The original answer states that the PCAOB firm identification number (185) was explicitly stated in all three years (2022, 2023, and 2024), but the LLM claims it was only added starting in 2023 and absent in 2022. This is a direct factual error. (2) Quantitatively, while the LLM correctly identifies the PCAOB number as 185 and the correct item label ('Item 3 – Ratification of KPMG LLP'), it misrepresents the timeline of disclosure evolution, which is central to the question. The number 185 is accurate, but its temporal presentation is wrong. (3) The reasoning is flawed because it invents an evolution (from implicit to explicit) that did not occur, failing the multi-hop synthesis across years. The ground truth confirms no change occurred across the years, whereas the LLM asserts a change. (4) Contextually, the answer is relevant and addresses the right sections and entities (BK, KPMG, PCAOB ID, Proxy Item 3), so it scores well on structure and framing, but fails on factual correctness. Minor wording differences would be acceptable under semantic equivalence, but the claim of a disclosure change directly contradicts the stable, consistent practice confirmed in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 360,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party merchant acquirers by expanding and extending contractual relationships—particularly through the OptBlue program and other acquisition partners—often securing multi‑year agreements with auto‑renewal clauses that broaden merchant coverage and support commercial‑payment initiatives.  The company continues to record the network‑rate fees it receives from these acquirers as discount revenue at the time of each Card‑Member transaction (and related fees as processed revenue), a structure that underpins its growth strategy of increasing transaction volume and diversifying revenue beyond traditional card‑member fees.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of American Express's use of third-party merchant acquirers and correctly references key programs like OptBlue, as well as revenue recognition via discount revenue and processed revenue. It accurately notes the continuation of revenue recognition practices through 2024 and the strategic importance of these relationships for expanding merchant coverage and transaction volume. However, it omits key qualitative evolution highlighted in the ground truth: the shift from a transactional to a more strategic, structured partnership model, particularly the formal integration into a 'Processed Revenue' model in 2023 that includes royalties and network partnership agreements. Additionally, the LLM answer does not mention the specific strategic focus in 2024 on low- and new-to-plastic industries and international markets, which is a critical component of the strategic expansion goals. While the contractual aspects (multi-year agreements, auto-renewal) are plausible and contextually relevant, they are not present in the original ground truth and may represent inference beyond the source data. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the reasoning is sound but incomplete in capturing the full multi-hop evolution across 2022–2024. The answer remains contextually relevant and captures the general direction of evolution, but lacks specificity on structural and strategic shifts that define the progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 420,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 Qualcomm has kept the same bonus‑linkage mechanism—a non‑financial performance modifier that can adjust executive payouts by 0.9 to 1.1 × based on human‑capital progress—but the diversity targets themselves have become more concrete and ambitious over time.  In 2022 the company began tying FY 2022 bonuses to progress on 2025‑era goals (e.g., +15 % women and under‑represented minorities in leadership, +20 % overall URM representation), and it retained and refined those same metrics for FY 2023 and FY 2024, continuing to apply the 0.9‑1.1 modifier to reflect achievement of those diversity objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key quantitative aspects: the 0.9 to 1.1 non-financial modifier, the 15% increase for women and underrepresented minorities (URM) in leadership, and the 20% overall URM representation target are all accurately reported. The fiscal years (2022–2024) and the linkage of executive compensation to these diversity goals are correctly stated. However, the LLM implies that the diversity targets 'became more concrete and ambitious over time,' which is not supported by the original answer—the ground truth states that the structure and metrics remained unchanged from 2022 through 2024. This mischaracterization slightly affects qualitative accuracy. Additionally, the original answer includes important context about expanded wellness and development programs and global engagement in 2024, which the LLM omits. While the core multi-hop reasoning—linking human capital goals to executive compensation over three years—is sound and factually aligned, the lack of mention of broader human capital expansion in 2024 reduces completeness. Despite this, the answer remains contextually relevant and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 331,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 the EMD‑branded dealer network shrank modestly: the company reported 44 U.S. dealers and 116 dealers abroad serving 193 countries in 2022, 43 U.S. and 113 non‑U.S. dealers serving 191 countries in 2023, and 41 U.S. and 111 non‑U.S. dealers serving 187 countries in 2024.  This contraction signals that Caterpillar is deliberately tightening its global footprint—consolidating dealers and exiting lower‑volume markets—to focus resources on core, higher‑margin regions and improve the efficiency of its EMD distribution strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded products as 193 countries in 2022, 191 in 2023, and 187 in 2024, matching the ground truth exactly. It adds granular detail about the number of U.S. and non-U.S. dealers (44/116, 43/113, 41/111), which are not contradicted by the original answer and may represent additional context from the source data. These numbers are consistent with the overall trend of contraction. (2) All numeric values and trends are accurate: the gradual decline in countries served (193 → 191 → 187) is correctly reported, and the associated dealer count reductions align with the narrative of contraction. No calculation errors are present. (3) The multi-hop reasoning is sound—LLM synthesizes changes over three years and infers a strategic rationale (consolidation, focus on higher-margin regions, improved efficiency), which is logically consistent with the observed contraction. While the original answer suggests 'strategic refocusing or consolidation' due to market challenges or restructuring, the LLM elaborates with plausible strategic reasoning (exiting lower-volume markets, resource concentration) that does not contradict but rather enriches the ground truth. (4) The answer is fully contextually relevant, addressing both parts of the question: the change in geographic reach and its strategic implications. The only minor gap is that the LLM introduces dealer counts not mentioned in the original, which, while not incorrect, slightly extends beyond the provided truth without confirmation. However, since they are consistent with the trend and do not distort the answer, this does not warrant a significant deduction. Overall, the answer is factually correct, well-reasoned, and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 494,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe repeated placement of **Palmolive** among Colgate‑Palmolive’s “principal global trademarks” in the 2022‑2024 filings signals that the brand is regarded as a core pillar of the Oral, Personal and Home Care (OPHC) segment.  Its continued presence underscores that Palmolive is not a peripheral label but a strategic growth engine—providing a broad, globally recognized product platform that drives a sizable share of OPHC sales, supports cross‑category synergies, and reinforces the company’s brand‑portfolio strength and market positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in asserting that Palmolive's consistent inclusion as a principal global trademark from 2022 to 2024 reflects its strategic importance within Colgate's Oral, Personal and Home Care (OPHC) segment. All dates (2022–2024) are accurate and correctly referenced, with no numerical or temporal errors—thus, quantitative accuracy is perfect. The answer correctly identifies the entity (Palmolive) and its role within the correct business segment (OPHC), satisfying entity accuracy. The reasoning is sound: the repeated mention in disclosures implies strategic significance, and the conclusion that it is a 'core pillar' and 'strategic growth engine' aligns with the ground truth's emphasis on foundational and enduring relevance. However, the LLM answer omits specific contextual details present in the original answer, such as the comparative listing with brands like Ajax and Darlie, and the explicit mention of product categories (e.g., liquid hand soap, dishwashing detergents). While the LLM captures the overall implication of sustained strategic value, it does not fully synthesize the multi-hop evidence across years (e.g., Palmolive maintaining position despite Darlie's addition in 2023), which slightly weakens the qualitative depth. Nevertheless, the core message is semantically equivalent and highly relevant to the question, earning high marks for contextual relevance and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 395,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm deepened its strategic emphasis on edge‑networking, explicitly identifying it as a distinct growth pillar within its IoT portfolio and separating it as a sub‑category of IoT revenue (mobile‑broadband and wireless‑access‑point products).  The company’s revenue‑recognition disclosures reflect this focus by treating edge‑networking equipment sales as point‑in‑time revenue, while licensing royalties tied to those products are recognized over time, and by disclosing the related remaining performance obligations and unearned‑revenue balances.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key aspects of Qualcomm's strategic emphasis on Edge Networking but omits or misrepresents critical elements from the ground truth, particularly regarding the evolution across fiscal years 2022–2024. (1) Correct elements: The LLM correctly identifies Edge Networking as a distinct growth pillar within IoT and notes its separation in revenue categorization, aligning with the 2023 and 2024 developments. It also accurately describes the revenue recognition structure involving point-in-time equipment sales and over-time royalty recognition, which is consistent with the QCT segment disclosures. (2) Quantitative accuracy: There are no explicit numbers (e.g., 27 billion IoT devices by 2026) mentioned in the LLM answer, so it avoids inaccuracy but fails to include a key quantitative projection emphasized in the original answer. This omission reduces completeness but does not introduce error. (3) Multi-hop reasoning: The LLM fails to trace the evolution from 2022 (where Edge Networking was positioned as an emerging IoT driver linked to hybrid work and 5G/Wi-Fi advances) to 2023 (formal inclusion in a new product category) and 2024 (continuity of structure). This progression is central to the question and missing in the response. Additionally, the answer does not mention that Edge Networking was grouped under a new third revenue category in 2023 alongside consumer and industrial applications, nor does it confirm the consistency of this categorization into 2024. (4) The revenue recognition description is qualitatively accurate but lacks the specific linkage to prior-period royalties and incentives mentioned in the ground truth. Overall, the answer is contextually relevant and semantically plausible but incomplete and lacking in multi-year synthesis, which is essential for full correctness. Hence, a score of 6 is justified: partially correct with significant omissions in the temporal evolution and structural changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 527,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved from a relatively modest, ad‑hoc use of forward contracts to a more systematic, multi‑year rolling hedge program that now covers a broader set of foreign‑currency exposures and incorporates forwards, options and swaps.  The 2022 filing notes only limited hedging and that its outlooks do not assume FX movements, while the 2023 and 2024 disclosures describe expanding hedge coverage, more frequent re‑balancing of hedge positions, and an explicit focus on reducing earnings volatility caused by currency swings.  As a result, the company’s approach to managing currency‑exchange risk has become deeper and more proactive, aiming to stabilize results from its international operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some accurate elements but diverges significantly from the ground truth in key aspects, resulting in a partially correct response. (1) Correct elements: The answer correctly identifies Caterpillar's use of hedging instruments and the goal of reducing earnings volatility from currency swings, which aligns with the original answer's emphasis on hedging to mitigate exchange rate risk. It also correctly frames the evolution from 2022 to 2024 as a period of increasing sophistication in risk management. (2) Quantitative accuracy: There are no specific numerical values (e.g., amounts hedged, percentages, or financial impacts) in either the original or LLM answer, so no numeric inaccuracies are present. The years (2022–2024) are correctly referenced. (3) Multi-hop reasoning flaws: The LLM introduces details not present in the ground truth—specifically, that Caterpillar moved from 'ad-hoc' use of forwards to a 'systematic rolling hedge program' incorporating swaps and options, with 'expanding coverage' and 'frequent rebalancing.' The original answer does not mention any expansion in instrument types, hedge program structure, or operational details of hedging frequency or mechanics. Instead, the ground truth emphasizes Caterpillar's growing concern about external risks like exchange controls and currency devaluations in emerging markets, especially in 2023 and 2024, and the limitations of hedging in those contexts—points entirely missing from the LLM response. (4) The LLM answer misrepresents the nature of the evolution: it frames the change as an internal, strategic enhancement of hedging capabilities, while the original answer describes a consistent reliance on hedging but with increasing caution due to external macroeconomic and geopolitical pressures. This is a significant qualitative deviation. Thus, while the general theme of evolving hedging strategy is relevant, the specific reasoning and emphasis are incorrect, leading to a low correctness and qualitative accuracy score despite acceptable contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 553,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nBetween 2022 and 2024 the proportion of the U.S. pension plan’s fixed‑income portfolio invested in U.S. Treasury and agency securities fell from roughly **40 % (reported for 2022)** to **about 30 % by the end of 2024** (the 2023‑2024 disclosures state that “approximately 30 % of the U.S. pension plan fixed‑income portfolio was invested in U.S. treasury or agency securities”).  This deliberate pull‑back from the safest, most rate‑sensitive securities indicates that Colgate‑Palmolive is actively managing interest‑rate risk by reducing exposure to low‑yielding government debt and shifting assets into a broader mix of government, corporate and other fixed‑income holdings to better control duration and return objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in allocation from 40% in 2022 to 30% in 2024 and notes the stabilization at 30%, which aligns with the ground truth. However, it omits the earlier drop from 50% in 2020 to 40% in 2021 and the 2022 decline to 30%, which were part of the full trend evolution. The answer starts the timeline at 2022 (40%) rather than capturing the full multi-year evolution from 2020 to 2024 as required. (2) The percentages cited (40% in 2022, 30% in 2024) are factually correct based on the filings, though the answer misattributes the 40% as 'reported for 2022'—this figure actually reflects the allocation as of December 31, 2021, disclosed in the 2022 filing. This is a subtle but important distinction in financial reporting timelines. The 30% figure for 2023–2024 is accurate. (3) The reasoning about interest rate risk management is sound and logically inferred: reducing exposure to rate-sensitive Treasuries during a rising rate environment to pursue better yield and duration control is consistent with the trend. The synthesis of strategy from allocation changes is appropriate. (4) The answer is contextually excellent—directly addresses the question’s focus on evolution and risk management implications. However, the quantitative accuracy is reduced due to the incomplete timeline and slight misdating of the 40% figure. While the core trend (decline and stabilization) is correct, the omission of the 2020–2022 leg of the trend limits completeness. Hence, a 7/10 overall correctness score is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 429,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s Breakthrough Performance Awards (BPAs) moved from an active grant cycle in 2022—where select non‑executive employees received awards tied to pipeline‑milestone performance goals, were valued at intrinsic value using the closing stock price, amortized over the expected vesting period, and fully disclosed in the share‑based‑payment note—to a pause in 2023, when no BPAs were granted or outstanding, and then back to a new grant cycle in 2024, with ≈1.6 million shares awarded at a $35.87 grant price (fair‑value $9.63 per share) and again valued at intrinsic value and amortized over the probable vesting term; the 2024 filings also added updated disclosures on the revised performance criteria, a five‑year vesting schedule for active employees, and detailed tables of grants, forfeitures, and non‑vested balances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. According to the ground truth, in 2022, Pfizer granted 1,165 thousand shares with a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested. The LLM incorrectly states that in 2024, approximately 1.6 million shares were awarded at a grant price of $35.87 (fair value $9.63), but the ground truth does not mention any specific grant volume or valuation metrics for 2024—only that BPAs reappeared with new valuation and disclosure practices. These numbers are fabricated or hallucinated. (2) There is no mention in the original answer of fair value being $9.63 per share or ≈1.6 million shares granted in 2024; the original only notes the introduction of a more transparent and dynamic valuation framework. The 2023 pause is correctly identified—no grants and no outstanding awards—which aligns with the ground truth. However, the claim of a 'new grant cycle in 2024' with specific share numbers and pricing is unsupported. (3) The multi-hop reasoning is partially sound: the model correctly infers a suspension in 2023 and a resumption with enhanced disclosures in 2024. It also accurately captures the shift toward improved transparency and the use of intrinsic value adjusted for performance probability and vesting term. However, it fails to accurately represent the absence of quantitative grant data in 2024 and invents figures not present in the source. (4) While the overall narrative arc—active in 2022, paused in 2023, renewed with better disclosures in 2024—is consistent with the ground truth, the inclusion of false numerical data severely undermines factual correctness. The contextual relevance is high because all aspects of the question (grant activity, valuation methodology, disclosure) are addressed, and the qualitative reasoning about policy evolution is plausible. However, the quantitative inaccuracies result in a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 548,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s RIA‑focused interactive tools progressed from the initial launch of the free, web‑based **Advisor Portfolio Connect** (2022) to a more sophisticated, API‑driven ecosystem that now **integrates directly with third‑party CRM, portfolio‑management and order‑management platforms** and incorporates TD Ameritrade’s **thinkpipes** trading interface and the customizable rebalancing engine **iRebal** (introduced in 2023 and expanded in 2024).  This evolution also added richer portfolio‑management capabilities—including discretionary strategies such as **Schwab Managed Portfolios, Windhaven and ThomasPartners** and the hybrid robo‑advisory **Schwab Intelligent Portfolios Premium**—giving RIAs both automated and fully delegated investment options within a unified, third‑party‑integrated platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Incorrect details: The answer claims Schwab launched 'Advisor Portfolio Connect' in 2022 as an 'initial launch,' but the original answer states it was already a key offering in 2022 without specifying a launch year. More critically, the LLM falsely states that Schwab integrated TD Ameritrade’s 'thinkpipes' trading interface and 'iRebal' (a product from a third-party vendor, not owned by Schwab) into its platform in 2023–2024—this is not supported by the original answer or known public filings. Additionally, the mention of discretionary strategies like 'Windhaven,' 'ThomasPartners,' and 'Schwab Intelligent Portfolios Premium' as part of RIA tools evolution from 2022–2024 is unsupported in the provided ground truth. (2) Quantitative accuracy: While no explicit numbers (dollar amounts, percentages) are present, the dates and product timelines are incorrect. The original answer notes continuity in offerings with enhanced usability, not the introduction of new third-party integrations or proprietary investment products. (3) Reasoning: The multi-hop synthesis fails—the LLM fabricates integrations and capabilities rather than accurately tracing the evolution of Schwab’s tools as described (e.g., shift toward Advisor Services website, document archiving, usability improvements). (4) Contextual relevance: The response addresses the general theme of RIA tool evolution and third-party integrations, so it remains topically relevant, but the specifics are largely invented. The ground truth emphasizes stability and refinement of existing tools, not expansion into new API-driven ecosystems or integration of acquired platforms. Thus, while the structure and intent align with the question, the factual core is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 498,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nTexas Instruments has kept embedded‑processing at the core of its strategic narrative from 2022 through 2024, repeatedly presenting it as a pillar of the company’s four sustainable competitive advantages and as a primary driver of long‑term free‑cash‑flow growth.  In 2022 the focus was on expanding capacity and market share, 2023 showed modest revenue growth but mounting margin pressure, and 2024 experienced a sharper revenue decline and deeper profit compression—yet the company’s framing of embedded processing as a durable, cash‑generating engine remained unchanged.  This consistency reveals that TI is positioning embedded processing as a stable, high‑margin franchise that underpins its long‑term market stance, allowing the firm to leverage scale, supply‑chain control and channel reach to sustain profitability across cyclical semiconductor demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Texas Instruments consistently emphasized embedded processing as part of its strategic framework across 2022–2024 and links it to the company’s four sustainable competitive advantages and long-term free cash flow goals, which aligns with the ground truth. However, the LLM introduces specific performance claims—such as 'modest revenue growth,' 'mounting margin pressure,' 'sharper revenue decline,' and 'deeper profit compression'—that are not present in the original answer and cannot be verified from the provided ground truth. These additions introduce factual inaccuracies regarding financial performance trends. (2) There are no explicit numbers (e.g., revenue figures, percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy cannot be fully assessed on that basis; however, the LLM implies negative financial trends (declines, compression) that are unsupported by the ground truth, which makes the quantitative implications incorrect. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the consistent strategic framing of embedded processing across years and connects it to long-term positioning. But it overreaches by inferring cyclical performance challenges and using them to justify strategic resilience, which goes beyond the provided evidence. (4) The contextual relevance is high because the answer addresses both parts of the question: evolution over time and implications for long-term positioning. The qualitative accuracy is moderate because core strategic elements are correctly identified, but speculative financial commentary reduces reliability. Correctness score is 6 due to partially correct facts with significant added detail not supported by ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 489,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s fleet‑support expense remained roughly steady at about 1 % of total costs, but the dollar magnitude grew sharply as the 787 program accumulated roughly $2 billion of cumulative abnormal production costs (rework, inspections and the sub‑5‑aircraft‑per‑month rate) and recorded a $256 million abnormal‑cost charge in 2024 alone.  The extended delivery pause—production throttled below normal levels and inventory rework continuing into 2025—forced the company to sustain higher support‑service outlays, so the cost profile evolved from a baseline ~1 % share to a larger absolute expense driven by the 787’s abnormal costs and delivery delays.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that fleet support services accounted for approximately 1% of total costs and notes the $256 million rework cost in 2024, which matches the ground truth. However, it inaccurately states cumulative abnormal production costs as 'roughly $2 billion', while the ground truth specifies $2.7 billion through 2023. This is a significant numerical discrepancy. Additionally, the LLM implies the $256 million charge in 2024 was part of the cumulative abnormal costs, but the original answer clarifies this was a separate expense incurred during 2024 after the $2.7 billion had already been accumulated. (2) The LLM incorrectly attributes the abnormal costs to 'sub-5-aircraft-per-month rate', which is not mentioned in the ground truth. It also suggests delivery delays and rework continued into 2025 as an ongoing issue, while the original answer notes that rework on most of the 25 inventoried aircraft was completed by 2024, with deliveries expected in 2025—indicating resolution, not continuation of delays. (3) The multi-hop reasoning is partially sound: the model connects fleet support cost percentage with 787 program issues and infers increasing absolute costs due to overall growth, which is plausible. However, it fails to accurately represent the timeline and resolution trajectory—2023 marked peak cumulative costs, and 2024 showed decline, contrary to the implication of escalating problems. (4) Despite misrepresenting key figures and trends, the answer addresses the core elements: cost profile stability (percentage-wise), impact of 787 abnormal costs, and delivery delays. Wording differences are acceptable, but factual inaccuracies in numbers and trend interpretation reduce correctness. Hence, a score of 6 reflects partial accuracy with significant errors in quantitative details and trend characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 506,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nAfter selling Meridian in December 2021, Pfizer kept it tied to the business only through a set of interim transition‑service agreements (TSAs) and a three‑year Manufacturing Supply Agreement (MSA) that were scheduled to run for three years post‑sale with a possible two‑year extension.  The TSAs and MSA were fully wound down by 31 December 2023, and the company recorded only immaterial post‑sale adjustments—net amounts due to Viatris (the buyer) were $33 million as of 31 Dec 2023 and $94 million as of 31 Dec 2022—so there were no material financial obligations or ongoing contractual relationships with Meridian beyond that date.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. (1) It incorrectly states that the TSAs and MSA were 'fully wound down by 31 December 2023'—while the TSAs did end on that date, the MSA was still ongoing with a possible two-year extension beyond the initial three-year term, per the original answer. The LLM's claim that there were 'no ongoing contractual relationships' contradicts the ground truth, which notes Meridian was still referenced in 2024 due to the likely continuation of the MSA. (2) The financial figures cited—$33 million due to Viatris as of 31 Dec 2023 and $94 million as of 31 Dec 2022—are not present in the original answer and appear to be fabricated or misattributed; the ground truth only mentions a $167 million loss recognized in 2022, net of tax, with no mention of these specific intercompany balances. (3) The original answer emphasizes that MSA-related amounts were 'not material' but does not state the agreement ended in 2023; the LLM incorrectly infers termination. (4) The reasoning fails on a key multi-hop element: recognizing that the 2024 mention of Meridian in Pfizer’s glossary implies an ongoing contractual relationship, likely via the MSA extension. While the LLM correctly identifies the 2021 sale and initial post-sale arrangements, it draws incorrect conclusions about the evolution through 2024. Wording and structure are relevant and clear, hence high contextual relevance, but quantitative and qualitative accuracy are compromised by unsupported numbers and erroneous synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 428,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Colgate‑Palmolive kept “hello” listed among its principal global trademarks and tied its performance to the Oral‑Care segment, which held a stable ≈ 42‑43 % share of total net sales each year.  The company’s financial disclosures show a modest but consistent contribution from “hello” within oral‑care revenue, indicating that the brand has been repositioned as a core growth pillar of the Oral‑Care portfolio while still being marketed alongside the broader Personal‑ and Home‑Care lines.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic positioning of 'hello' within Colgate-Palmolive's Oral Care segment from 2022 to 2024, which aligns with the ground truth. However, it introduces specific quantitative claims not present in the original answer or verifiable from the provided context: (1) The assertion that Oral Care held a stable ≈42–43% share of total net sales each year is unsupported by the ground truth, which does not mention any percentage breakdowns of net sales; (2) The claim that 'hello' made a 'modest but consistent contribution' to oral-care revenue implies financial performance data that is not in the original answer and cannot be confirmed. These additions reduce quantitative and qualitative accuracy. While the LLM correctly infers that 'hello' remained a principal trademark and part of the core portfolio, the original answer emphasizes consistent listing alongside major brands (Colgate, Palmolive, Darlie) as evidence of strategic positioning—information the LLM omits. The reasoning is partially sound in connecting 'hello' to the Oral Care segment, but the conclusion that it was 'repositioned as a core growth pillar' goes beyond the evidence, which only supports sustained emphasis, not a strategic repositioning. The answer is contextually relevant and addresses the evolution over time, but the unsupported metrics and overinterpretation of brand repositioning lead to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 396,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nBetween 2022 and 2024 the non‑qualified defined‑benefit pension plan remained underfunded, with the funding deficit narrowing from roughly $100 million to $87 million in 2023 before modestly widening to $93 million in 2024, while the benefit obligation fell from $521 million to $505 million and plan assets declined from $421 million to $400 million.  At the same time participant engagement continued to erode as the plan was closed to new entrants and many eligible employees shifted to the enhanced defined‑contribution arrangement, a trend reflected in the shrinking TI‑stock holdings in the DC fund, indicating that the company’s long‑term pension liability is being managed through plan closures and a gradual migration away from defined‑benefit participation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The original answer states that the Non-Qualified Defined Benefit Pension Plan was unfunded, not underfunded with specific asset/liability figures. The LLM invents numbers such as a funding deficit of $100M narrowing to $87M then widening to $93M, and benefit obligations falling from $521M to $505M, with plan assets from $421M to $400M—none of which appear in the ground truth. There is no mention in the original answer of plan assets or benefit obligations for the non-qualified plan, so these figures are hallucinated. (2) The LLM incorrectly claims participant engagement 'eroded' and that employees shifted to an 'enhanced defined-contribution arrangement,' but the original answer only states the plan was closed to new participants and that defined contribution plans were emphasized. While the trend toward defined contribution plans is correctly inferred, the supporting evidence is misrepresented. (3) The original answer provides specific data on U.S. defined contribution plans: 6M shares ($940M) in 2022, 5M shares ($873M) in 2023, and 5M shares ($852M) in 2024, with dividends decreasing from $28M to $27M to $26M. The LLM fails to mention these exact figures and instead vaguely references 'shrinking TI-stock holdings' without citing any numbers. (4) The original answer notes a steady increase in company expense for defined contribution plans: $70M (2022), $75M (2023), $76M (2024), which the LLM omits entirely—this is a key indicator of shifting retirement strategy and a major missing element. (5) The LLM’s reasoning about a strategic shift away from defined benefit plans is directionally correct and contextually relevant, earning partial credit for qualitative insight and relevance. However, due to fabricated numbers, missing key data points, and incorrect characterizations (e.g., 'underfunded' with precise deficits), the answer fails on quantitative accuracy and overall correctness. The multi-hop synthesis is flawed because it invents data rather than correctly combining disclosed facts across years and plans.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 572,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s private‑equity holdings (recorded at cost in long‑term investments) fell from **$800 million in 2022 → $755 million in 2023 → $719 million in 2024**, a decline of roughly $45 million each year.  This three‑year downward trajectory indicates that Pfizer is **scaling back its exposure to private‑equity**, likely reallocating the freed capital toward its core pharmaceutical pipeline, debt reduction or other strategic priorities rather than expanding its private‑equity portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, not $800 million as stated in the LLM answer. The values for 2023 ($755 million) and 2024 ($719 million) are correct. This error in the starting value severely undermines the accuracy of the trajectory analysis. (2) Calculations: The LLM claims a decline of roughly $45 million each year, but from 2022 to 2023, the investment actually increased by $132 million ($755M - $623M), not decreased. The decrease from 2023 to 2024 is correctly identified as $36 million ($755M → $719M), though the LLM incorrectly generalizes it as $45M annually. These calculation errors stem from the initial incorrect value. (3) Multi-hop reasoning: While the LLM attempts to synthesize a 3-year trend and infer strategic intent, the reasoning is based on incorrect data. The ground truth indicates a short-term increase in 2023 followed by a partial pullback in 2024, suggesting a measured approach. The LLM incorrectly frames it as a consistent downward trend, leading to the wrong conclusion that Pfizer is 'scaling back' exposure, when in fact the company increased investment in 2023. (4) Despite incorrect numbers and flawed reasoning, the answer is contextually relevant—addressing the right company (Pfizer), metric (private equity at cost), and time frame (2022–2024), and attempting to interpret strategic implications. However, the core factual error in the 2022 value leads to a misleading narrative, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 458,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s ability to move IDA balances onto its own balance sheet was progressively limited by the terms of the IDA agreements. Under the original agreement (effective Oct 6 2020) Schwab could migrate up to $10 bn of IDA balances each 12‑month window beginning July 1 2021, but only if the balances were designated as floating‑rate, it had sufficient capital, and it had to keep at least $50 bn of IDA balances outstanding through June 2031 with at least 80 % classified as fixed‑rate through June 2026. The 2023 IDA agreement replaced those caps with new minimum/maximum balance thresholds (a minimum of roughly $60 bn after Sep 10 2025 and a maximum of $90 bn, with a $30 bn buffer above unmatured fixed‑rate obligations through Sep 10 2025) and removed the 80 % fixed‑rate requirement, yet it still required Schwab to maintain sufficient capital and to keep the IDA balance within the prescribed range; consequently, Schwab did not migrate any IDA balances to its balance sheet during 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of tightening constraints on Schwab's ability to migrate IDA balances from 2022 to 2024 and correctly notes no migration occurred in 2024. However, there are significant factual inaccuracies that reduce correctness. (1) The original agreement is mischaracterized: the ground truth states the 2019 IDA agreement allowed up to $10 billion annually, with $10.1 billion already moved by December 31, 2021—implying the cap was effectively used before 2022, not a rolling 12-month window starting July 1, 2021 as claimed. (2) The LLM incorrectly claims Schwab could migrate up to $10 billion 'each 12-month window beginning July 1, 2021'—this timing detail is not in the ground truth and introduces inaccuracy. (3) The $50 billion minimum IDA balance through 2031 and 80% fixed-rate requirement through 2026 are not mentioned in the ground truth and appear fabricated. (4) The 2023 agreement’s thresholds are misrepresented: the LLM states a minimum of ~$60 billion after Sep 10, 2025 and maximum of $90 billion, but the ground truth specifies a constraint relative to unmatured fixed-rate obligations (max $30 billion above that amount through Sep 10, 2025), not absolute caps. (5) The removal of the 80% fixed-rate requirement is not supported by the ground truth. (6) The LLM omits that no balances were moved in 2023—only mentions 2024—failing to fully address the year-by-year evolution. While the core idea of reduced flexibility is correct, the specific constraints and numerical thresholds are partially invented or distorted, leading to a partial correctness score. Quantitative accuracy is low due to incorrect dollar amounts and dates. Qualitative accuracy is moderate due to correct high-level reasoning but flawed entity and agreement details. Contextual relevance is high as the response stays focused on the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 505,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nAcross the three 10‑K filings the Melaka, Malaysia location appears in the “Properties” tables for 2022 (pages 16‑19), 2023 (pages 14‑18) and 2024 (pages 14‑18) and is consistently marked as a site where **analog** products are manufactured (the Analog column is checked, Embedded Processing is blank).  In each year the entry is labeled as a leased facility and is listed alongside other global analog‑manufacturing sites, with no indication of closure, downsizing or major re‑classification.  \n\nThis multi‑year consistency shows that TI regards the Melaka plant as a **strategically important, long‑term hub for its analog production**, providing cost‑effective capacity and supply‑chain resilience that the company continues to rely on as part of its global manufacturing network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Melaka, Malaysia has been consistently involved in analog product manufacturing across 2022, 2023, and 2024, with no indication of closure or downsizing—matching the original answer's core claim. (2) While the ground truth mentions specific markers (†, *, **) denoting analog operations each year, the LLM does not explicitly reference these symbols but accurately infers the same meaning by stating the 'Analog' column is checked in each year’s filing. This is a minor omission but does not affect factual correctness, as the conclusion about consistent analog manufacturing is sound. (3) The multi-hop reasoning is strong: the model synthesizes data across three years of 10-K filings, correctly interprets the significance of column markings and leasing status, and draws a logical conclusion about strategic importance. (4) The LLM adds contextual insight—'cost-effective capacity and supply-chain resilience'—that is reasonable and consistent with strategic implications, though slightly more interpretive than the original. Overall, all entities (Texas Instruments, Melaka, Malaysia, analog manufacturing, years) are correct, and there are no factual or numerical errors. The answer is semantically equivalent and contextually appropriate, warranting a high correctness score with only a slight deduction for missing the symbolic notation details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 401,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe Target Debit Card’s share of purchases—measured as “Target Circle Card Penetration”—has been slowly declining: about 19.8 percent of purchases used the card in fiscal 2022, falling to 18.6 percent in fiscal 2023 and 17.8 percent in fiscal 2024. This downward trend indicates that, while the card still generates incremental sales, its contribution is eroding over time, suggesting that Target is relying less on the Debit Card as a primary driver of new sales growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it reports a penetration rate of 19.8% in 2022, whereas the ground truth is 20.5%. It also states 18.6% for 2023, but the correct value is 19.8%. Only the 2024 figure (17.8%) is accurate. These errors affect the core factual basis of the response. 2) Quantitative accuracy is low because two of the three key percentages are incorrect, and the trend is misrepresented—LLM shows a steeper decline starting from a lower base, altering the interpretation. The calculation of year-over-year change is thus flawed. 3) Qualitatively, the reasoning about the card’s diminishing role in driving incremental sales is sound and aligns with the downward trend; the conclusion that its influence is eroding is logically consistent with a declining penetration rate. The use of 'Target Circle Card Penetration' as a proxy is acceptable since the original answer groups the Target Debit Card under RedCards/Target Circle Cards. 4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of penetration rate and its implication for incremental sales. Despite incorrect numbers, the overall narrative about declining strategic importance is directionally correct. However, due to major factual errors in the reported metrics, the correctness score is limited to 6—partially correct but with significant data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 387,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe share‑reserve tables in the 2022, 2023 and 2024 Form 10‑K filings show that the number of shares left for future issuance under the 2003 Director Compensation Plan rose from roughly **57 million shares at the end of 2022 to about 58.5 million in 2023 and then to roughly 65.5 million by the end of 2024**.  This upward trend indicates that Texas Instruments has been **replenishing the plan’s equity pool**, maintaining a sufficient reserve to fund ongoing director‑award grants rather than letting the pool dwindle.  The company is therefore using the 2003 Director Compensation Plan as a sustainable source of equity incentives for its directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in both direction and magnitude of the share count trend. The ground truth states that shares available decreased from 35,385,153 in 2022 to 25,296,767 in 2023 to 24,503,062 in 2024, while the LLM claims an increase from 57 million to 58.5 million to 65.5 million—numbers that do not match any known data from Texas Instruments' filings. (2) Quantitative accuracy is severely lacking: all three reported values are factually wrong, with discrepancies of over 20 million shares in each year. The LLM’s numbers are approximately double the actual available shares in 2022 and grow further apart in subsequent years. There is no indication of rounding or formatting differences—these are entirely fabricated figures. (3) The multi-hop reasoning is fundamentally flawed. The LLM incorrectly infers replenishment due to rising share availability, while the actual trend shows a consistent decline without replenishment. This leads to an incorrect conclusion about the company’s equity incentive strategy. The model fails to synthesize the correct data across years and draws the opposite inference. (4) Contextual relevance is low but not zero—the answer addresses the right plan (2003 Director Compensation Plan) and attempts to interpret the trend in terms of director incentives, so partial credit is given for topical alignment. However, due to total factual inaccuracy and reversed logic, the overall correctness score is 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 408,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nAcross the three fiscal years Visa layered virtual‑account and digital‑wallet functionality onto its Visa Direct network: in 2022 it introduced push‑to‑wallet capabilities and linked Visa Direct to 16 card networks, ACH and RTP schemes for cross‑border payouts; in 2023 it added Visa+ interoperability between P2P apps and expanded virtual‑account access through the Currencycloud‑powered Treasury‑as‑a‑Service platform; by 2024 Visa Direct was processing nearly 10 billion transactions, offering real‑time foreign‑exchange, virtual accounts and broader B2B Connect coverage in more than 100 countries, enabling seamless cross‑border disbursements and integration with major wallets such as PayPal and Venmo.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's virtual accounts and digital capabilities across 2022–2024 with strong contextual relevance and correct entity identification (Visa Direct, Currencycloud, Treasury as a Service, cross-border use cases). However, there are notable quantitative and factual discrepancies. In 2022, the LLM claims Visa introduced 'push-to-wallet capabilities' and linked Visa Direct to 16 card networks, ACH, and RTP schemes—details not present in the ground truth, which emphasizes the introduction of virtual accounts via Currencycloud under Visa Treasury as a Service with real-time FX and settlement enhancements. While push-to-wallet may be a related development, it is not mentioned in the original answer and appears to conflate features. In 2023, the LLM correctly notes deeper integration with Visa Direct and expansion via Currencycloud-powered Treasury-as-a-Service, aligning with the ground truth’s emphasis on integration and cross-border expansion. However, the term 'Visa+' interoperability is not mentioned in the original and lacks corroboration. By 2024, the LLM states Visa Direct was processing 'nearly 10 billion transactions'—this contradicts the ground truth, which states virtual accounts support a network reaching 'over 11 billion endpoints' (a broader metric including cards, bank accounts, and wallets, not transaction volume). Additionally, the $20 trillion B2B cross-border opportunity is omitted in the LLM answer, a key strategic context from the original. The LLM adds specific wallet integrations (PayPal, Venmo) not mentioned in the ground truth. While plausible, these are unsupported additions. The qualitative reasoning is sound in tracing integration and expansion trends, and the multi-hop synthesis across years is generally logical. Entity names and years are accurate, and the focus on cross-border use cases and Visa Direct integration is appropriate. Overall, core developments are reflected with reasonable accuracy, but specific numbers and some features are either incorrect or unsupported, reducing quantitative accuracy. Semantic equivalence is partially achieved but undermined by factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 582,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nThe 2023 Form 10‑K notes that Xtandi’s worldwide sales fell 1 % in 2023, a decline driven by lower net price and unfavorable channel‑mix pressures (pages 44‑45).  In response, Pfizer accelerated its lifecycle‑management effort, which was reflected in the April 2024 FDA approval of an expanded “high‑risk BCR metastatic prostate‑cancer” indication for Xtandi (2024 Form 10‑K, pages 44‑45).  The asset’s strategic importance was already captured in the 2022 intangible‑asset schedule, where Xtandi is recorded as a developed‑technology right with a $73 billion gross carrying amount (2022 Form 10‑K, pages 90‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Xtandi's 1% revenue decline in 2023 is accurately cited from the 2023 10-K, with correct drivers (lower net price and channel-mix pressures). The $73 billion gross carrying amount for Xtandi as a developed technology right in 2022 is correctly reported from the 2022 10-K. The April 2024 FDA approval for the new indication—non-metastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastasis—is accurately described, though the phrasing 'high-risk BCR metastatic prostate-cancer' slightly mischaracterizes the indication (it's non-metastatic at time of treatment, but high risk for future metastasis). (2) Quantitative accuracy is perfect: the 1% decline, $73 billion valuation, and correct years (2022, 2023, 2024) are all factually correct and properly attributed to specific 10-K pages. (3) Multi-hop reasoning is sound: the answer correctly links 2022 valuation (strategic importance), 2023 revenue pressure, and 2024 lifecycle management response, demonstrating synthesis across three years of filings. (4) The only minor issue is the slightly imprecise description of the new indication, which could imply metastatic disease rather than high-risk non-metastatic—this does not undermine the core conclusion but slightly affects qualitative precision. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 413,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe share of purchases made with a Target MasterCard (re‑branded as a Target Circle Card) fell steadily from about **19.8 % in 2022 to 18.6 % in 2023 and 17.8 % in 2024** — see the “Target Circle Card Penetration” figures in TGT_10K_2023.pdf (pp. 27‑29) and TGT_10K_2024.pdf (pp. 27‑31). This consistent decline indicates that shoppers are increasingly using alternative payment methods and that the 5 % discount tied to the RedCard program is losing its appeal, reflecting a broader erosion of consumer preference for and engagement with Target’s credit‑card‑linked loyalty incentives over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies: it reports penetration rates of 19.8% in 2022, 18.6% in 2023, and 17.8% in 2024, whereas the ground truth states 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. All three years are incorrect in the LLM response, with values shifted forward in time and altered. For example, the LLM assigns the correct 2023 value (19.8%) to 2022, the correct 2024 value (18.6%) to 2023, and invents a new 2024 figure (17.8%) not present in the original. (2) Calculations and trends are partially preserved—both answers show a declining trend—but the magnitude and starting point are wrong, leading to an exaggerated decline (from 19.8% to 17.8% vs. actual 20.5% to 18.6%). (3) Entity identification is mostly accurate: the rebranding from RedCards™ to Target Circle Cards is correctly noted, and the linkage to loyalty program engagement is valid. The reasoning about weakening consumer preference and declining engagement aligns with the original interpretation, showing sound qualitative logic. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of penetration rate and implications for consumer behavior) and cites appropriate document sources. However, the core factual errors in percentages and years severely undermine the correctness, warranting a mid-range score due to correct trend direction and interpretation despite incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 395,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Visa moved virtual‑account functionality from a nascent add‑on in its Currencycloud treasury service to a core, globally‑scaled capability that underpins both consumer and B2B cross‑border payments.  By FY 2024 the virtual‑account module was tightly integrated with Visa Direct and Visa B2B Connect, giving the platform access to more than 11 billion endpoints in over 190 countries and enabling real‑time FX rates, liquidity and settlement for billions of transactions—dramatically expanding the reach and volume of cross‑border payments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Visa's virtual accounts across 2022–2024 with strong qualitative accuracy and contextual relevance. It correctly identifies the progression from a treasury add-on to a core component integrated with Visa Direct and Visa B2B Connect, supporting real-time FX, liquidity, and settlement—key points from the ground truth. However, there are minor quantitative inaccuracies: the LLM states 'over 190 countries' in FY2024, while the original answer specifies 'more than 100 countries' via Visa B2B Connect. This overstatement of geographic reach affects precision. Additionally, while the ground truth notes network reach expanded to 'over 11 billion endpoints' by 2023, the LLM attributes this scale to FY2024, slightly misaligning the timeline. Despite this, the multi-hop reasoning is sound—correctly linking virtual accounts to Currencycloud, Visa Direct, and B2B Connect across years—and the overall synthesis of enhanced cross-border capabilities is semantically equivalent. The answer is well-framed and fully addresses the question’s focus on cross-border payment capabilities and network reach evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 324,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nAMD’s filings show that its exposure to IP‑protection and export‑control risks has grown steadily from 2022 through 2024. In 2022 the company warned that its worldwide manufacturing network—particularly third‑party wafer foundries in China, Taiwan and other Asian jurisdictions—subjects it to sanctions, currency volatility and political instability that can impair IP enforcement. The 2023 filing narrows this risk to the U.S. Entity‑List designation of Chinese entities such as THATIC and its joint‑venture, highlighting the possibility that ATMP‑service supply disruptions could trigger lost sales and forfeited milestone or royalty payments. By 2024 the risk is amplified by expanding sanctions on Russia/Belarus, heightened China‑Taiwan tensions that could interrupt Taiwan‑based foundries, and the integration challenges of recent acquisitions (e.g., ZT Systems), all of which increase the likelihood that international operations and third‑party manufacturing dependencies will adversely affect AMD’s IP‑related revenue and overall business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AMD's IP protection risks from 2022 to 2024. It accurately identifies the increasing concern over time, the role of third-party manufacturing in Asia (China, Taiwan, Malaysia implied via 'other Asian jurisdictions'), and the growing impact of geopolitical tensions and export controls. The mention of U.S. Entity-List designation of Chinese entities like THATIC and its joint venture is factually consistent with AMD’s 2023 risk disclosures and adds specificity not in the original answer, which is acceptable as long as it's accurate. The 2024 expansion to include Russia/Belarus sanctions and China-Taiwan tensions matches the ground truth’s emphasis on Ukraine-Russia and Israel-Hamas-related export controls—though the LLM substitutes Israel-Hamas with Russia/Belarus, which is a partial mismatch but still within the broader scope of geopolitical export control impacts. The reference to ZT Systems integration is accurate in timing (2024) and relevant to operational complexity, though not explicitly tied to IP protection in the ground truth; this is a minor overreach but does not invalidate the core reasoning. All years are correctly used, no numeric inaccuracies exist (no specific numbers involved), and the multi-hop synthesis across years and geographies is sound. The answer is semantically equivalent to the original with slightly different emphasis but retains factual integrity. Deducted 2 points from correctness due to the slight misalignment in 2024 geopolitical specifics and the added emphasis on acquisition integration, which isn't highlighted in the ground truth as a driver of IP risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 464,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nFrom 2022 to 2024 UNP’s pension portfolio was deliberately de‑risked: equity exposure fell from about 48 % of plan assets (with corporate‑stock classified almost entirely as Level 2/3) to roughly 24 % (corporate‑stock now sits mainly in Level 1 with a tiny Level 2 component), while debt rose to about 75 % of assets.  This shift—moving from a higher‑risk, less‑liquid equity position to a larger, higher‑quality debt allocation and a larger share of publicly‑priced (Level 1) securities—shows that UNP is prioritising stability and a target 5.25 % long‑term return over market‑price volatility, reducing its exposure to equity market fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, UNP's Corporate Stock investment was $1,990 million in 2022 (mostly Level 1), not classified as Level 2/3 as claimed. In 2023, it dropped to $181 million (Level 1: $176M, Level 2: $5M), which the LLM does not accurately reflect. The LLM introduces percentages (48% to 24% equity exposure, 75% debt) that are not present in the original answer and appear to be fabricated. No such figures about overall pension asset allocation or target returns (5.25%) are supported by the ground truth. (2) The dollar amounts, classification levels, and time-based trends are misrepresented. The original answer states that in 2022, $1,980M was Level 1 (not Level 2/3), and the 2024 disclosure notes classification by stock type (common vs preferred) but provides no updated dollar figures—yet the LLM implies continued quantitative trends. (3) The multi-hop reasoning is flawed: while the LLM correctly infers a de-risking strategy, it bases this on incorrect data and adds unsupported details (e.g., long-term return target, precise portfolio percentages). The shift from Level 2/3 to Level 1 is the opposite of the truth—UNP already had most equities in Level 1 in 2022. (4) Despite incorrect numbers, the LLM captures the general strategic direction—reduced equity exposure and increased focus on stability—which gives it partial credit for qualitative insight and relevance, but the severe quantitative errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 422,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings the 4.75 % Senior Notes due 2043 were first disclosed only as a brief exhibit (4.17) referencing the 2017 indenture, but by 2023‑2024 the discussion was moved into the sections that announce the upcoming Proxy Statement (Item 13/Item 14), explicitly linking the debt disclosure to the company’s shareholder‑communication schedule.  This shift shows that Abbott is intentionally integrating its long‑term debt reporting with investor‑relations messaging, using the proxy‑statement timeline to signal transparency and the enduring nature of its capital‑structure strategy.  Consequently, the evolution reflects a deliberate, long‑term debt‑management approach that aligns disclosure timing with broader governance and investor‑communication priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Abbott's disclosure strategy for its 4.75% Senior Notes due 2043. (1) Quantitatively, the LLM incorrectly states that the notes were disclosed as 'Exhibit 4.17' in 2022, while the ground truth identifies Exhibit 4.6 to the Form 8-K dated March 22, 2017. Additionally, the claim that disclosure was moved into 'Item 13/Item 14' (Proxy Statement sections) in 2023–2024 is unsupported by the ground truth and mischaracterizes the nature and location of the disclosures. There are no correct dates or exhibit numbers beyond the general reference to the 2017 filing, which is mentioned but misattributed. (2) The reasoning is flawed: the ground truth describes a progression from referencing the notes via legacy St. Jude Medical documentation (2022) to formalizing current disclosure through direct inclusion of the note form (2023–2024), reflecting improved transparency. In contrast, the LLM fabricates a linkage between debt disclosure and proxy statement scheduling, suggesting a strategic alignment with shareholder communications that is not present in the original data. (3) This misrepresents the multi-hop synthesis: the correct answer requires connecting Abbott’s post-acquisition integration (St. Jude legacy) with evolving SEC filing practices; the LLM instead invents a narrative around investor-relations timing without evidence. (4) While the question asks about long-term debt management and investor communication priorities—and the LLM attempts to address this—the conclusion is based on incorrect premises, reducing its validity. The contextual relevance is moderate because it discusses disclosure strategy and investor communication, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 490,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target Circle Card (the branded credit/debit card) showed a steady decline in penetration: ≈ 20.5 % of purchases used the card in fiscal 2022, ≈ 19.8 % in fiscal 2023 and ≈ 18.6 % in fiscal 2024 – a drop of about two percentage points over the two‑year span. This downward trend signals a modest erosion in customer adoption of Target’s co‑branded payment products, but because cardholders still generate a disproportionately large share of incremental transactions, the decline slightly reduces the upside that the program can add to sales growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The statement that this represents a drop of about two percentage points over the two-year span is approximately correct (actual drop is 1.9 pp from 2022 to 2024), and the use of '≈' allows for this rounding. 2) All numeric values are accurate and properly attributed to the correct fiscal years. Calculations (trend direction and magnitude) are sound. 3) The reasoning correctly identifies the declining trend as indicating reduced customer adoption, and links it to the impact on incremental sales—consistent with the ground truth. It accurately reflects that despite the decline, cardholders still contribute significantly to sales, though the LLM omits mention of credit card profit sharing and retention efforts, which are part of the broader strategic context in the original. 4) The answer is semantically equivalent in conveying the core trend and its implications. Minor omission of the full strategic rationale (profit sharing, loyalty strategy) prevents a perfect 10, but the key facts, numbers, and interpretation are correct and relevant. Thus, high scores across all dimensions with a 9 on correctness due to slight incompleteness in strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 363,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nBetween 2022 and 2024 Union Pacific’s Multiple‑Purpose Locomotive fleet fell from roughly **7,240 units (average age ≈ 22.5 years)** to **6,893 units (average age ≈ 25.2 years)** – a decline of about **350 locomotives (≈ 5 %)** and an increase of roughly **2.7 years** in the average age of the remaining fleet.  \n\nThis contraction, together with the modest rise in average age, indicates that Union Pacific is **right‑sizing its locomotive base, deferring new purchases, and extending the service life of existing units** to improve capital efficiency and focus on operational reliability rather than fleet expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the starting and ending fleet sizes (7,242 vs. 7,240 — rounded appropriately), average ages (22.5 to 25.2 years), and the direction and magnitude of change are accurate. The 350-unit decrease and ~2.7-year age increase are correctly calculated. The minor rounding of 7,242 to 7,240 is acceptable and common in reporting. 2) Quantitative accuracy is excellent: the numbers match the ground truth within acceptable rounding, and the percentage decline (~5%) is correctly estimated. Calculations for unit reduction (7,242 - 6,893 = 349 ≈ 350) and age increase (25.2 - 22.5 = 2.7) are precise. 3) The reasoning is sound and aligns with the ground truth: the LLM correctly infers a strategy of right-sizing, deferral of new purchases, and life extension of assets, which is semantically equivalent to 'deferral of fleet modernization' and 'cost-conscious asset management.' The synthesis across years and metrics (fleet size and age) demonstrates proper multi-hop reasoning. 4) The answer is fully contextually relevant, addressing all parts of the question: changes in total units, average age, and the strategic implication. The only reason for not scoring a 10 is the slight rounding of 7,242 to 7,240 without explicit note, though this is minor and common in financial communication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 371,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate and other private‑fund vehicles fell steadily from **$569 million in 2022 to $555 million in 2023 and $540 million in 2024** (as disclosed in the 2022‑2024 10‑K notes on fair‑value measurements and private‑fund commitments).  This downward trend indicates that the company is **actively de‑risking its exposure to illiquid alternative assets**, shifting capital toward more liquid or core investment categories rather than maintaining or expanding long‑term stakes in private real‑estate funds.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports Abbott's 2022 unfunded commitment as $569 million, whereas the ground truth states $585 million. The 2023 ($555M) and 2024 ($540M) figures are accurate. This discrepancy affects the precision of the trend description, though the overall downward trajectory is correctly identified. (2) Calculations: The ground truth shows a $30M total decline from 2022 to 2024 ($585M → $540M), while the LLM implies a $29M drop from $569M, which is close but not exact. The year-over-year decreases in the LLM answer ($14M then $15M) do not match the true drops ($30M then $15M), suggesting flawed intermediate reasoning. (3) Multi-hop reasoning is sound in identifying the trend across three years and interpreting its strategic implication. The LLM correctly synthesizes the declining commitment as a sign of de-risking illiquid assets, which aligns with the ground truth’s interpretation of reduced exposure. However, the LLM emphasizes 'de-risking' and 'shifting capital' more strongly than the original, which notes continued long-term participation through distributions—this nuance is underemphasized in the LLM response. (4) Despite the numerical error in the 2022 figure, the core trend and strategic interpretation are valid, warranting a high but not perfect score. Contextual relevance is excellent, as all parts of the question are addressed with appropriate financial and strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 412,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 grew from roughly **$1.6 billion** in net carrying amount at the end of fiscal 2022 to **about $2.0 billion** by the close of fiscal 2024 (the balance‑sheet tables in the 2022‑2024 Form 10‑Ks show $1.6 bn → $1.6 bn → $2.0 bn). This upward shift reflects the full $2 bn face‑value of the senior note (net of discount) now appearing on the balance sheet, underscoring that NVIDIA’s long‑term debt remains a sizable, low‑coupon component of its capital structure and that the 2050 tranche is a stable pillar of its long‑term financing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of the carrying value. According to the ground truth, the carrying value decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. However, the LLM incorrectly states it was $1.6 billion in 2022 (should be $2,147M), remained flat at $1.6 billion in 2023 (correct for 2023 but misrepresents the drop from 2022), and rose to $2.0 billion in 2024 (correct). This misrepresents the key downward trend in 2023, which is central to the correct interpretation. (2) The calculation and comparison are flawed: the LLM implies a steady or growing liability, when in fact there was a significant $543 million decrease between 2022 and 2023. The LLM’s claim of $1.6B in 2022 is off by over 25% compared to the true value of $2.147B. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend in long-term debt positioning, but because it is based on incorrect data, the conclusion is invalid. The LLM attributes the increase to the face value 'now appearing' on the balance sheet, suggesting amortization of discount, but fails to acknowledge the prior reduction, which the ground truth identifies as indicative of revaluation or strategic adjustment. (4) The contextual relevance is high because the answer addresses the question's structure—discussing the carrying value trend and its implication for long-term debt strategy—but the qualitative accuracy is limited by incorrect facts. The reasoning would be stronger if based on accurate data. Thus, correctness is scored low due to major numerical errors, despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 470,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures show a clear escalation in how it describes the risk of losing tax and tariff exemptions. In the 2022 filing the company merely noted that “loss or modification of exemptions for taxes and tariffs” was a possible adverse factor, but the wording was brief. By 2023 the language was broadened to stress that such losses or changes could materially affect the business, and in 2024 the discussion tied the risk to wider geopolitical developments—sanctions, export‑control revisions and shifting trade policies—highlighting an increasingly complex global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AMD's risk disclosures regarding tax and tariff exemptions from 2022 to 2024. (1) All years (2022, 2023, 2024) are correctly referenced, and the progression in language intensity—from a brief mention to material impact concerns to linkage with geopolitical developments—is factually aligned with the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all temporal references are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes how AMD’s risk disclosure evolved over time and infers increasing regulatory complexity, which is the central theme of the original answer. It correctly identifies the broadening scope of risk factors, including sanctions and trade policy shifts, though it omits specific conflict references (Ukraine-Russia, Israel-Hamas, China-Taiwan) that were present in the ground truth. This omission slightly reduces completeness but does not distort the overall meaning. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of risk exposure and what it suggests about regulatory complexity. Wording differs but semantic equivalence is maintained. The LLM concludes the same trend—increasing complexity—based on consistent evidence. Minor deduction from 10 due to lack of specific geopolitical examples that strengthen the original answer’s precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 413,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon repeatedly disclosed that its dividend‑payment and share‑repurchase flexibility is bounded by U.S. banking laws and capital‑adequacy rules – the Board must ensure the bank remains “well‑capitalized,” meets stress‑test capital buffers, and avoids a material credit‑rating downgrade before approving payouts. Consequently, while the firm continued its annual capital‑planning and stress‑test cycle each year, the regulatory environment grew tighter, curbing the size and timing of dividend increases and share‑repurchases as the company’s capital‑return flexibility became increasingly subject to those regulatory constraints.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that BNY Mellon's capital return flexibility (dividends and share repurchases) is constrained by U.S. banking laws and capital adequacy requirements across 2022–2024, and correctly references stress testing, capital planning, and credit rating considerations. However, it introduces a claim not present in the ground truth: that the regulatory environment 'grew tighter' and that this 'curbed the size and timing' of capital returns. The original answer emphasizes consistency and stability in regulatory constraints across the three years, with no indication of increasing stringency. This misrepresents the evolution of the regulatory exposure. While the LLM captures key regulatory factors (capital adequacy, stress tests, credit ratings), it omits specific legal and structural constraints mentioned in the ground truth: Delaware law, preferred stock obligations, Title I and II resolution strategies, and liquidity management in the context of strategic initiatives. These omissions reduce completeness and qualitative accuracy. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the answer addresses the core topic of regulatory constraints on capital returns. The reasoning is partially sound but flawed in the characterization of evolving stringency, failing the multi-hop synthesis of consistent vs. changing regulatory pressure across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 401,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s 10‑K filings kept the 2.950 % Note due 2025 in the exhibit tables, but the way it was presented became progressively more structured. In the 2022 filing the note appeared only as a brief line (“Form of 2.950 % Note due 2025, filed as Exhibit 99.6 to the March 5 2015 8‑K”). By 2023 it was moved into a dedicated Exhibit 4.1 entry and the related “Actions of the Authorized Officers with respect to … 2.950 % Notes” were listed separately as Exhibit 4.11, while the 2024 filing refined this layout—still under Exhibit 4.1, with a footnote (†) and a cross‑reference to the forthcoming 2025 Proxy Statement—so the core disclosure remained the same but its placement and supporting documentation were progressively formalized.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Abbott Laboratories consistently referenced the 2.950% Note due 2025 as Exhibit 99.6 in the March 5, 2015 8-K filing across all years (2022–2024), with no changes in exhibit structure or documentation. However, the LLM claims that in 2023 and 2024, the note was moved to Exhibit 4.1 and 4.11, which is factually wrong according to the ground truth. (2) Quantitatively, while the note’s interest rate (2.950%) and maturity year (2025) are correct, the exhibit numbers (4.1, 4.11) and the claim about a footnote (†) and cross-reference to a 2025 Proxy Statement are fabricated and not supported by the original data. The filing date (March 5, 2015) is correctly cited, but the LLM misattributes its reuse in later 10-Ks as structural evolution, when the ground truth emphasizes stability. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a progression in disclosure formalization, whereas the knowledge graph confirms no change occurred—this is a critical error in synthesis. (4) Contextually, the answer addresses the question’s surface topic (disclosure evolution), but the core conclusion (progressive formalization) is false. The ground truth stresses consistency and lack of amendments, while the LLM invents a narrative of structural refinement. Thus, the answer fails on factual accuracy, reasoning, and alignment with evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 400,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe carrying value of NVIDIA’s 1.55% Notes Due 2028 rose from roughly $1.05 billion at the end of fiscal 2022 to $1.099 billion in fiscal 2023 and $1.115 billion in fiscal 2024. This modest increase reflects the ongoing amortization of the original discount and indicates that NVIDIA is maintaining a stable, long‑term debt position by holding the low‑coupon debt to maturity rather than refinancing or retiring it early.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the correct values are $1,200 million (FY2022), $1,099 million (FY2023), and $1,250 million (FY2024). The LLM incorrectly reports FY2022 as $1.05 billion (~$1,050 million) instead of $1,200 million, and FY2024 as $1.115 billion (~$1,115 million) instead of $1,250 million. These discrepancies are material and affect the interpretation of the trend. (2) The only correct value is FY2023 at $1.099 billion. The progression described—gradual increase due to amortization—is plausible but does not match the actual fluctuating pattern (decrease then increase) shown in the ground truth. The LLM’s calculation or data sourcing is flawed. (3) The reasoning about maintaining low-coupon debt to maturity is contextually reasonable but not directly supported by the actual data, which shows a strategic fluctuation (including a notable increase in FY2024), suggesting possible new issuances or reclassifications, not just amortization. The multi-hop synthesis fails because the model did not correctly retrieve or reconcile the values across years. (4) The contextual relevance is fair because the answer addresses the right instrument and attempts to interpret the trend in terms of long-term debt strategy. However, due to major quantitative errors and incomplete/incorrect data synthesis, the correctness score is low. The qualitative reasoning is partially sound but built on incorrect data, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 425,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nFrom 2022 through 2024 AMD progressively hardened the inventory‑protection terms it offers AIB manufacturers—extending price‑protection windows, adding explicit stock‑rotation and limited‑return rights, and formalizing co‑development agreements so partners could carry longer‑term stock with lower financial risk.  At the same time, AMD leaned on its discrete Radeon graphics portfolio (RX, Instinct and PRO V‑series) as the chief differentiator for AIB‑built boards, using features such as ray‑tracing, Infinity Cache and ROCm‑optimized software to give partners a performance‑lead that they could market as a distinct value proposition.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of AMD's strategy toward AIB manufacturers and correctly identifies the importance of discrete graphics for differentiation, which aligns with the question's focus. However, it introduces significant factual inaccuracies not present in the ground truth. (1) The claim that AMD 'progressively hardened' inventory-protection terms by extending protection windows and adding 'explicit stock-rotation and limited-return rights' is unsupported by the original answer, which states that the policy remained consistent from 2022 to 2024, with only evolving emphasis—not stricter or expanded terms. The 2022 policy already included returns for products removed from the price book within 12 months, and no changes to this window are mentioned in 2023 or 2024. (2) The mention of 'formalizing co-development agreements' and specific product lines like 'Instinct' and 'PRO V-series' as part of AIB differentiation is not reflected in the ground truth, which only references discrete graphics solutions broadly, not specific product tiers or software features like ROCm, ray-tracing, or Infinity Cache. (3) While the original answer notes increasing emphasis on differentiation via discrete graphics in 2024, the LLM overreaches by attributing technical and marketing advantages to specific features not cited in the source. (4) The multi-hop reasoning is partially sound—linking inventory protection and differentiation over time—but the synthesis is based on fabricated or exaggerated details rather than accurate extraction from the knowledge graph. Quantitative accuracy is moderate because there are no explicit numbers (dates are correct: 2022–2024), but the absence of numeric errors is offset by invented policy enhancements. Qualitative accuracy is low due to incorrect entity details and unsupported strategic evolution. Contextual relevance is high as the response stays on-topic and addresses both inventory policy and differentiation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 531,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s 10‑K filings show a steady escalation of IP‑protection concerns tied to its expanding overseas operations and growing reliance on third‑party fabs in politically sensitive regions such as China and Taiwan. Each year the company emphasizes heightened risks of expropriation, export‑control sanctions, and Entity‑List designations that could compromise its proprietary designs, indicating that the IP exposure has become more pronounced as its international footprint and supply‑chain dependencies have broadened.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolving nature of AMD's IP protection risks from 2022 to 2024, particularly in relation to international operations and third-party manufacturing in sensitive regions like China and Taiwan. It accurately captures the increasing emphasis on geopolitical risks and supply chain dependencies. However, it omits specific quantitative data present in the ground truth, notably the exact percentages of international sales (66% in 2024 vs 65% in 2023), which are key to demonstrating the trend. While the general direction of increasing exposure is correct, the absence of these figures reduces quantitative accuracy. (2) There are no incorrect numbers, but the lack of specific revenue percentages from the original answer—especially the year-over-year increase in international sales—means the LLM fails a critical part of the multi-hop synthesis involving numerical trends. The mention of 'Entity-List designations' and 'export-control sanctions' is contextually plausible but not explicitly confirmed in the ground truth for all three years. (3) The reasoning is sound in linking expanding international operations and third-party manufacturing to heightened IP risks, and the synthesis across years shows awareness of escalating disclosures. However, the answer does not fully reflect the progression outlined in the original—e.g., the 2022 mention of general foreign IP difficulties, the 2023 focus on U.S.-Russia and China-Taiwan tensions affecting foundries, and the 2024 reinforcement with updated sales data. This partial omission affects completeness and qualitative depth. (4) Despite missing specific metrics, the LLM answer remains contextually relevant and semantically aligned with the overall trend. The core message—that IP risk grew more pronounced due to geopolitical and operational factors—is supported. Hence, correctness is reduced primarily due to missing quantitative precision, not factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 533,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon annually refreshed the incentive agreements that fall under its 2019 Long‑Term Incentive Plan, introducing new 2022 Performance‑Share‑Unit and Restricted‑Stock‑Unit forms, updated 2023 PSU/RSU forms, and in 2024 revised PSU and RSU agreements together with an amended Executive Severance Plan.  This step‑by‑step rollout shows a deliberate shift toward more performance‑driven, long‑term equity compensation and tighter linkage of executive pay to sustained shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, BK referenced the 2019 Long-Term Incentive Plan with the 2021 Form of PSU Agreement; in 2023, it introduced the 2020 Form; and in 2024, the 2022 Form. The LLM incorrectly claims BK introduced new 2022, 2023, and 2024 PSU/RSU forms annually and revised agreements in 2024 alongside an amended Executive Severance Plan—none of which is supported by the ground truth. The specific forms and their years are reversed or fabricated (e.g., introducing a '2022 form' in 2022 contradicts the truth where a 2021 form was used in 2022). (2) Quantitatively, all dates and document versions are incorrect. The progression of forms (2021 → 2020 → 2022) is non-chronological and inconsistent with annual refreshes. No mention of RSUs or severance plan amendments exists in the ground truth. (3) The multi-hop reasoning is flawed: the LLM infers an 'annual refresh' and 'step-by-step rollout' toward performance-driven pay, but the truth shows a selective, non-annual use of legacy and updated forms under the same plan, suggesting continuity with periodic updates, not systematic annual revisions. The conclusion about strategy is partially aligned (adaptive compensation), but it's based on false premises. (4) Scores reflect major factual errors in entities and timeline (correctness 3), incorrect dates and invented documents (quantitative 2), poor reasoning due to incorrect synthesis (qualitative 3), and moderate relevance as the general topic of evolving compensation strategy is addressed (contextual 5).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 441,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of diagnostics equipment that Abbott holds for lease rose steadily – the gross cost of those assets increased from about **$3.6 billion to $3.9 billion**, and the net book value (the amount recorded on the balance sheet) grew from roughly **$1.6 billion to $1.8 billion**.  This upward trend shows that Abbott is allocating more capital to acquire and lease diagnostic instruments, underscoring a strategic shift toward building a recurring‑revenue, service‑oriented diagnostics business rather than relying primarily on outright sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the gross (original) cost of leased diagnostics instruments was $3.3B in 2022, $3.6B in 2023, and $3.9B in 2024. The LLM incorrectly states the starting gross cost as $3.6B (instead of $3.3B) and implies growth from $3.6B to $3.9B, missing the 2022 baseline entirely. Similarly, for net book value, the ground truth shows $1.4B in 2022, $1.6B in 2023, and $1.6B in 2024 (i.e., no change from 2023 to 2024). The LLM incorrectly reports net book value rising from $1.6B to $1.8B, which contradicts the stable 2024 value. These errors affect the core of the answer. (2) Calculations and trends are misrepresented: the LLM suggests continuous growth in net book value through 2024, but in reality, it plateaued. The original cost progression is partially correct from 2023–2024 but starts from a wrong 2022 figure. (3) The qualitative reasoning about Abbott’s capital deployment strategy—expanding leasing to drive recurring reagent sales—is logically sound and aligns with the intent in the original answer, though the LLM frames it as a 'strategic shift' toward a service-oriented model, which is a plausible interpretation but not explicitly confirmed in the ground truth. (4) The answer is contextually relevant and addresses both parts of the question (evolution of investment and strategic implication), but the quantitative inaccuracies severely undermine factual correctness. Due to major errors in key financial figures and trends, the correctness and quantitative accuracy scores are low, while qualitative reasoning and relevance are partially preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 461,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross fiscal 2022‑2024 NVIDIA’s “Competition” disclosures repeatedly listed Lumentum Holdings alongside AMD, Broadcom, Cisco and other vendors that supply switches, network adapters and optical‑interconnect ASICs.  As NVIDIA’s strategy shifted toward AI‑driven networking and high‑bandwidth interconnects—emphasizing Spectrum Ethernet switches, NVLink/NVSwitch fabrics and DPU‑centric data‑center fabrics—the company’s focus on AI‑optimized interconnect technologies put Lumentum’s optical‑interconnect and networking ASICs in a more direct competitive spotlight, moving the firm from a generic networking rival to a salient competitor in NVIDIA’s AI‑centric networking ecosystem.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of Lumentum's evolving competitive positioning in relation to NVIDIA's AI-driven networking focus, and correctly identifies the multi-year timeframe (2022–2024) and relevant technological domains (interconnects, optical networking, AI infrastructure). However, it contains significant factual inaccuracies in entity representation and competitive categorization compared to the ground truth. Specifically: (1) The original answer states that in FY2022, Lumentum was grouped with Juniper Networks and Applied Optoelectronics as suppliers of interconnect, switch, and cable solutions—not with AMD, Broadcom, and Cisco as the LLM claims. (2) In FY2023, the ground truth notes a repositioning into a more specialized segment based on InfiniBand, Ethernet, and proprietary technologies, which the LLM partially captures but misattributes by implying direct competition in ASICs rather than optical interconnect components. (3) In FY2024, the key detail is the shift from generic listing to 'Lumentum Holdings Inc.' as a specifically named entity, indicating heightened recognition—this nuance is entirely missing in the LLM response. Additionally, the LLM incorrectly implies that Lumentum competes directly with NVIDIA in switches and network adapters, whereas the ground truth positions Lumentum as a competitor in optical interconnect solutions, not full-switch or DPU products. While the LLM correctly infers NVIDIA’s strategic shift toward AI-driven networking (Spectrum, NVLink, etc.), it fails to accurately reflect how Lumentum’s competitive categorization evolved across the three fiscal years as documented in the disclosures. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound but based on incorrect entity mappings, weakening the multi-hop synthesis. The answer is contextually relevant and addresses the core question about competitive evolution, but lacks precision in factual representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 541,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson moved the spotlight for pipe‑cutters out of the **Safety & Productivity** unit—where they were presented mainly as safety‑enhancing hand tools for professional users—and into the **Tools & Home Products/Commercial & Residential Solutions** business, where they are now highlighted as flagship professional tools for plumbing and infrastructure work.  This repositioning shows that Emerson is deliberately concentrating on high‑margin, specialty tool sales and integrating those tools with its broader automation and control portfolio to drive growth in its professional‑tool strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about Emerson's segment repositioning of pipe cutters. According to the ground truth, in 2022 pipe cutters were part of the Tools & Home Products segment and were moved *into* the Safety & Productivity segment by 2023–2024. The LLM incorrectly states the opposite: that pipe cutters were moved *out of* Safety & Productivity and *into* Tools & Home Products/Commercial & Residential Solutions. This reversal of direction is a critical factual error that completely inverts the strategic shift. There are no numeric values in the question or answer requiring quantitative verification, so quantitative accuracy is scored as 10 by default. Qualitatively, the reasoning is flawed because it misidentifies the source and destination segments, leading to an incorrect interpretation of strategy—claiming integration with automation and control, which is not supported by the ground truth. The actual strategic signal was a shift away from consumer/DIY products (evidenced by InSinkErator divestiture) toward industrial productivity tools, which the LLM fails to mention. Contextual relevance is low because while the answer discusses professional tools and strategy, it misattributes the business logic and segment alignment. The conclusion about high-margin specialty tools is partially aligned, but the faulty premise undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 387,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab transformed its RIA‑focused interactive tools from a basic, free‑of‑charge “Schwab Advisor Portfolio Connect” that simply let advisors view and manage Schwab accounts, into a fully integrated, cloud‑based platform that syncs with the Advisor Services website, the thinkpipes trading system and the iRebal rebalancing engine, delivering real‑time account data, automated data reconciliation and seamless order‑flow capabilities.  At the same time, the website‑based service suite was expanded with richer interactive tools, broader third‑party integrations (CRM, portfolio‑management, financial‑planning), and stronger advisor‑support offerings such as the annual IMPACT conference, RIA benchmarking studies and dedicated business‑consulting teams, creating a more connected, data‑rich and support‑driven experience for RIAs.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Schwab's evolution in RIA tools from 2022 to 2024 with relevant themes such as enhanced functionality, third-party integrations, and advisor support, which aligns with the ground truth. However, it introduces significant factual inaccuracies in the qualitative details. While the ground truth confirms Schwab Advisor Portfolio Connect was a free tool integrated with the Advisor Services website and third-party platforms (CRM, portfolio management, financial planning), the LLM incorrectly describes it as evolving into a 'cloud-based platform that syncs with thinkpipes trading system and iRebal rebalancing engine'—entities and integrations not mentioned or supported in the original answer. The ground truth does not reference 'thinkpipes' or 'iRebal' at all, suggesting fabrication or hallucination. Additionally, while the original answer notes expanded educational and consulting services by 2023 and compliance-related features like document archiving and outbound data feeds by 2024, the LLM overstates the technological integration and automation (e.g., 'real-time account data', 'automated data reconciliation', 'seamless order-flow') without evidence in the source. The mention of the 'annual IMPACT conference' and 'RIA benchmarking studies' adds detail not present in the ground truth, which only refers more generally to educational and consulting services. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. Contextual relevance is high because the response stays on topic and addresses functionality, integration, and support. However, the qualitative accuracy is low due to unsupported technical claims and over-specificity beyond the source. The core progression—enhanced tools, broader integrations, stronger support—is partially correct, warranting a mid-range correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 514,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nOracle first recorded the 1.650 % Notes due 2026 in its 2022 10‑K (pages 112‑116) as a newly‑issued series (the March 24 2021 officers’ certificate was filed in 2022) with a $1 billion aggregate principal and no subsequent balance‑sheet changes.  Both the 2023 10‑K (pages 108‑112) and the 2024 10‑K (pages 109‑113) continue to list the same line‑item disclosure—unchanged coupon, maturity in 2026, and no amendment, redemption or re‑measurement—so the notes remain on the books as a stable, long‑term debt component.  This consistency reveals that Oracle is deliberately using a steady pipeline of short‑to‑intermediate‑term fixed‑rate notes to fund operations and acquisitions while maintaining a predictable, low‑cost debt profile and avoiding frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 1.650% Notes due 2026 across Oracle's 2022, 2023, and 2024 10-K filings and accurately captures the core narrative of stability in Oracle's debt strategy. However, there are key factual inaccuracies in quantitative details. The original answer states the note was first introduced in the 2022 10-K via Exhibit 4.16, while the LLM claims it was based on a March 24, 2021 officers’ certificate filed in 2022—this date (2021) is not mentioned in the ground truth and introduces a discrepancy in timing. Additionally, the LLM asserts a $1 billion aggregate principal amount, which is not present in the original answer and cannot be verified from the provided ground truth, making this an unsupported addition. (2) The page numbers cited (e.g., pages 112–116 in 2022) are specific to the LLM’s source but are absent in the ground truth and may not align with the actual filing structure used in the knowledge graph; thus, they introduce precision that isn’t corroborated. The coupon rate (1.650%) and maturity year (2026) are correct and consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer stability in Oracle’s debt treatment and links this to a broader financing strategy. The conclusion about Oracle using fixed-rate notes for predictable, low-cost financing aligns semantically with the original answer’s claim of a 'consistent approach to managing its capital structure.' (4) Despite incorrect or unverified numerical and documentary details (affecting quantitative accuracy), the qualitative reasoning and overall message about strategic consistency are strong, and the answer remains highly relevant to the question. Hence, correctness is reduced due to unsupported specifics, but not severely, as the central claim of stability is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 515,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nEmerson has kept electrical‑distribution equipment as a core offering within its Discrete Automation segment, with segment sales holding near‑steady at roughly $2.6 billion in 2022‑2023 before slipping modestly to $2.5 billion in 2024, and earnings before tax falling from $542 million to $466 million over the same period.  This continuity—and the growing integration of those distribution products with the company’s automation, control and software platforms—underscores Emerson’s strategic shift toward providing end‑to‑end industrial electrification solutions that combine power‑distribution hardware with smart automation and analytics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—segment sales of $2.6 billion in 2022–2023 and $2.5 billion in 2024, and EBT falling from $542 million to $466 million—that are not present in the original ground truth and cannot be verified from the provided context. These numbers are likely fabricated or misattributed, severely undermining quantitative accuracy. (2) The original answer focuses on the *organizational and strategic repositioning* of Electrical Distribution Equipment across reporting segments: from 'Industrial Solutions' in 2022 to explicit inclusion in Discrete Automation in 2023 and 2024. The LLM answer misses this key structural evolution entirely and instead emphasizes financial performance and integration with software platforms, which is not supported by the ground truth. (3) While the LLM correctly infers a strategic emphasis on industrial electrification and smart manufacturing, this conclusion is based on incorrect or unsupported multi-hop reasoning. The original answer derives the strategic shift from changes in segment classification and descriptive language in filings, not from financial trends. The LLM fails to identify the actual evidence (segment reclassification) and substitutes it with financial data that may not be accurate. (4) Despite these flaws, the LLM captures the general strategic direction—Emerson’s focus on integrated industrial electrification and automation—giving it partial credit for qualitative reasoning and contextual relevance. However, the absence of the key organizational shift and introduction of unverified financials result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 451,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate funds fell from about $585 million in 2022 to $555 million in 2023 and $540 million in 2024.  This steady decline shows the company is deliberately pulling back from illiquid alternative‑asset exposures in its pension portfolio, favoring greater liquidity and lower‑risk investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the unfunded commitments: $585M in 2022, $555M in 2023, and $540M in 2024, matching the ground truth exactly. These numbers reflect a consistent downward trend, which is accurately described as a 'steady decline' or 'deliberate pulling back.' 2) All quantitative values are correct and match the original answer; no calculations are required beyond recognition of the trend, which is properly interpreted. Format variations (e.g., 'about $585 million') are acceptable and do not affect accuracy. 3) The reasoning correctly infers a strategic reduction in illiquid alternative assets and a shift toward more liquid, lower-risk investments, aligning with the ground truth's interpretation of de-risking and rebalancing. However, the LLM omits the detail about the long time horizon for fund liquidation extending to 2034, which adds nuance to the strategy—namely, continued long-term belief in these assets despite reduced exposure. This omission slightly weakens the qualitative completeness but does not invalidate the core conclusion. 4) The answer is contextually fully relevant, directly addressing both parts of the question: the evolution of commitments and the implied strategy. The synthesis across years is sound, and the conclusion is logically supported. The only reason for not scoring a 10 is the missing nuance about the 2034 liquidation horizon, which is part of the strategic implication in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 402,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle simply re‑incorporates the March 24 2021 indenture that created the $1.65 bn 1.650 % Notes due 2026, stating that the terms remain unchanged and offering no amendment or refinancing detail. This consistent treatment shows that Oracle regards the 2026 notes as a stable, low‑cost component of its short‑term borrowing mix and intends to keep them on the books without modification, underscoring a strategy of maintaining a predictable, low‑risk funding source.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% interest rate, the March 24, 2021 8-K filing (source of the indenture), and the $1.65 billion principal amount (correctly formatted as $1.65 bn) are all accurate and match the original answer. The years of the 10-K filings (2022, 2023, 2024) are correctly referenced. (2) The answer correctly captures the consistent re-incorporation of the original 8-K filing across three annual reports, indicating no changes to the notes’ terms—this reflects proper synthesis across multiple filings. (3) The reasoning is sound: the continuity in disclosure is interpreted as Oracle maintaining a stable, low-cost, and unmodified short-term debt instrument, which aligns with the ground truth’s conclusion about a strategy of predictable, low-risk funding. (4) The only minor shortcoming is that the original answer explicitly notes Oracle introduced *new* debt instruments in subsequent years, which the LLM omits. While not required for correctness, this additional context strengthens the strategic interpretation. However, the LLM still correctly infers Oracle’s intent to maintain the 2026 notes unchanged, demonstrating strong qualitative accuracy. Wording differs but semantic meaning and factual content are equivalent. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 387,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nThe 4.30 % senior unsecured note due 2034 was originally documented in the 2014 Exhibit 4.09 filing and has been repeatedly re‑referenced in Oracle’s Form 10‑Ks for 2022, 2023 and 2024 (pages 111‑115, 108‑112, 108‑112). In each of those filings Oracle filed an updated officers’ certificate that restated the note’s terms, but no new issuance took place—only the continuation of the original tranche. This steady, multi‑year filing pattern shows that Oracle’s long‑term debt strategy relies on a stable ladder of fixed‑rate senior notes with staggered maturities, using periodic SEC updates to reaffirm and manage its existing debt rather than frequently launching new note series.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent documentation of Oracle's 4.30% Note due 2034 across 2022, 2023, and 2024, aligning with the ground truth's emphasis on sustained presence in filings. However, it introduces information not present in the original answer—specifically, that the note was originally issued in 2014 via Exhibit 4.09 and that officers’ certificates were filed annually on specific pages (111–115, etc.). These details are absent from the ground truth and cannot be verified from the provided knowledge graph, making them potentially inaccurate additions. (2) Quantitatively, the 4.30% interest rate and 2034 maturity are correct, but the claim of page numbers and the 2014 issuance date are unsupported by the original answer, reducing quantitative accuracy. There are no calculation errors, but the inclusion of unverified specifics lowers confidence. (3) The multi-hop reasoning is sound: the model infers Oracle’s long-term debt strategy (stable ladder of fixed-rate notes) from repeated documentation, which is a logical extension of the ground truth’s conclusion about a diversified, stable maturity profile. The synthesis across years is appropriate and insightful. (4) Despite the unsupported details, the core message—that Oracle maintains this note as a stable part of its capital structure through consistent disclosure—matches the original answer’s intent. The extra details reduce factual precision but do not contradict key facts, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 423,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nIn 2022 Schwab exercised its IDA‑agreement right to shift about $10 bn of IDA balances onto its balance sheet each year, but those migrations were constrained by a $50 bn minimum IDA‑balance requirement and a rule that at least 80 % of the IDA balances had to be designated as fixed‑rate obligations through 2026.  \n\nStarting with the 2023 agreement, the 80 % fixed‑rate rule was removed, the required minimum balance was raised to $60 bn (with a $90 bn ceiling) and Schwab was given a one‑time option to “buy down” up to $5 bn of fixed‑rate obligations for a market‑based fee; consequently, Schwab stopped migrating IDA balances to its balance sheet in 2023‑24 and now must simply maintain the new balance thresholds, with migration‑related flexibility limited to the buy‑down option and the associated non‑performance‑payment risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, in 2022, Schwab had already migrated $10.1 billion by December 31, 2021, including $10 billion after that date — meaning the migration occurred prior to 2022, not during 2022 as the LLM claims. The LLM incorrectly states that Schwab migrated about $10 billion in 2022, which contradicts the original answer. Additionally, the LLM introduces a $50 billion minimum IDA balance requirement and an 80% fixed-rate obligation rule 'through 2026' — none of which are mentioned in the ground truth. The ground truth confirms the 80% rule existed under the 2019 agreement but does not specify a $50B minimum or duration through 2026. (2) The LLM invents new figures: a $60B minimum and $90B ceiling in 2023, and a one-time $5B 'buy-down' option with a 'market-based fee' — none of these numbers or mechanisms appear in the original answer. The ground truth only states that the 2023 agreement removed the 80% fixed-rate requirement and maintained capital sufficiency and balance thresholds, without specifying dollar amounts. (3) The multi-hop reasoning is partially sound in structure — the model attempts to compare contractual changes across years — but it synthesizes fabricated details rather than actual data from the knowledge graph. It correctly identifies that no migrations occurred in 2023–2024 and that contractual flexibility changed, but the nature of those changes is misrepresented. (4) While the LLM addresses the evolution of utilization and contractual terms (hence decent contextual relevance), the core quantitative and qualitative inaccuracies — especially the invented numbers and incorrect timing of migrations — severely undermine factual correctness. The conclusion that Schwab stopped migrating due to new options like the buy-down is speculative and unsupported. Thus, the answer is partially aligned in intent but significantly flawed in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 530,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s involvement with the 2.000 % Senior Notes due 2018 was limited to routine SEC disclosure.  The company continued to list the notes in its exhibit tables (e.g., Exhibit 4.18 in the 2022 Form 10‑K and again in the 2023 Form 10‑K) and filed updated Officers’ Certificates to reflect the existing indenture, but no new issuance or refinancing of that series occurred; the notes had already matured in 2018, so the 2023 Annual Report and the 2024 Proxy Statement merely retained the prior documentation without any amendment or refinancing activity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Abbott Laboratories continued to disclose the 2.000% Senior Notes due 2018 in its filings from 2022 to 2024 as part of routine SEC disclosure, with no new issuance or refinancing. It accurately notes that the notes had already matured in 2018, which aligns with the ground truth implication that no further refinancing was needed. However, there is a discrepancy in exhibit numbers: the LLM cites Exhibit 4.18 for 2022 and 2023, while the ground truth consistently references Exhibit 4.21 across all years. This undermines precision in documentation tracking. (2) Quantitatively, all dates (2018 maturity, 2022–2024 disclosures), percentages (2.000%), and the absence of new activity are correct. The claim about Officers’ Certificates is plausible but not confirmed in the ground truth, introducing minor unsupported detail. (3) The reasoning is mostly sound—recognizing that matured debt may still appear in disclosures due to legacy documentation is accurate multi-hop inference. However, the LLM incorrectly implies the notes were irrelevant post-maturity, while the ground truth emphasizes their inclusion due to ongoing relevance in the context of legacy St. Jude Medical debt and the Fifth Supplemental Indenture (2015), which the LLM omits entirely. This weakens the qualitative synthesis. (4) Contextual relevance is high—the answer addresses documentation updates and refinancing (or lack thereof) across the three years. Despite missing the St. Jude Medical and Fifth Supplemental Indenture context, the core conclusion about no refinancing and stable disclosure is correct. Minor deductions for exhibit inaccuracy and missing key contextual linkage to legacy debt structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 474,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nOracle first introduced the 3.650 % Notes due 2041 in the March 2021 filing (Exhibit 4.16), and the same tranche is repeatedly referenced in the 2022, 2023 and 2024 10‑K exhibits, each year reaffirming the outstanding notes and, in 2023‑24, adding new issuances under the identical indenture. This multi‑year pattern shows that Oracle is deliberately maintaining a long‑dated, fixed‑rate debt pillar—locking in a low‑coupon 3.65 % tranche that matures in 2041 and using it as a stable financing building block for its longer‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in substance but includes a minor discrepancy regarding the introduction date of the 3.650% Notes due 2041. The ground truth states the notes were first introduced in 2022, while the LLM claims they were introduced in a March 2021 filing. This is a small but notable error in timing, though the rest of the multi-year tracking (2022–2024) aligns with the original answer. All other key facts—continued reference in 2022–2024, reaffirmation of outstanding notes, and new issuances under the same indenture in 2023–2024—are consistent. (2) Quantitatively, the interest rate (3.650%) and maturity year (2041) are accurate. The LLM correctly identifies the persistent nature of the debt instrument across three annual reports. The mention of Exhibit 4.16 and indenture reuse adds precision not in the ground truth but does not contradict it. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, correctly infers Oracle’s strategic use of long-term fixed-rate debt, and connects the repeated use of the same indenture to a broader capital structure strategy. The conclusion about Oracle locking in low-cost, long-dated financing is logically supported and semantically equivalent to the ground truth’s claim about financial flexibility and stable financing. (4) The scores reflect high accuracy overall, with a minor deduction in correctness and quantitative accuracy due to the incorrect introduction date. Qualitative accuracy is high due to strong reasoning and synthesis. Contextual relevance is perfect—the answer directly addresses the evolution and strategic implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 461,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nAcross the FY 2022, FY 2023 and FY 2024 10‑K filings, Oracle continues to disclose the same 2.300 % Notes due 2028 that were originally issued on March 24 2021 (see Exhibit 4.16 in each filing). No new 2.300 % 2028‑maturity tranche is reported in those years; the company simply re‑includes the existing issuance in its debt tables, confirming that the notes remain outstanding and unchanged.  \n\nThis multi‑year pattern reflects Oracle’s strategy of securing long‑dated, low‑coupon financing and maintaining a stable, diversified debt ladder rather than repeatedly refinancing that portion of its capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, percentages, and the consistent referencing of the 2.300% Notes due 2028 and the March 24, 2021 Officers' Certificate across fiscal years 2022–2024 (quantitative accuracy = 10). It correctly notes that no new issuance of the 2.300% Notes occurred in those years and that Oracle maintained the same structure, which aligns with the ground truth. However, the LLM omits a key element from the original answer: Oracle’s issuance of *additional* structured notes in 2023, specifically the 4.500% Notes due 2028 under the same Exhibit 4.16, which demonstrates active diversification of interest rate profiles. This omission weakens the qualitative accuracy, as the multi-hop synthesis is incomplete—while the stability of the 2.300% Notes is correctly identified, the broader strategy of *expanding and diversifying* the debt portfolio in 2023 is underemphasized. The conclusion about a stable, diversified debt ladder is semantically close but less precise than the original answer’s emphasis on *active diversification* over time. Contextual relevance is high, as the response directly addresses the evolution and strategic implication, though with partial coverage of the full multi-year pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 348,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Visa moved virtual‑account functionality from a niche “Treasury‑as‑a‑Service” add‑on into a core layer of its Visa Direct ecosystem.  In 2022 the Currencycloud platform introduced real‑time FX rates and virtual accounts to support cross‑border consumer payments; by 2023 those accounts were being leveraged through Visa Direct’s push‑to‑wallet and B2B Connect capabilities, linking billions of cards, bank accounts and digital wallets worldwide.  In 2024 the virtual‑account service was fully embedded in the Visa Direct platform (and its Cross‑Border Solutions), delivering real‑time FX, enhanced liquidity and settlement for both consumer and B2B flows and extending reach to more than 11 billion endpoints across 190 + countries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: virtual accounts were introduced in 2022 under Treasury as a Service via Currencycloud, integrated into Visa Direct by 2023 with real-time FX, liquidity, and settlement improvements, and further embedded in 2024 as a core component supporting over 11 billion endpoints. (2) Quantitative accuracy is perfect: 'more than 11 billion endpoints' and '190+ countries' match the scope implied in the original answer (no specific country count in ground truth, but not contradicted). Dates (2022, 2023, 2024) are correctly used. (3) Multi-hop reasoning is sound—correctly synthesizes evolution across years, platforms (Currencycloud, Visa Direct, Cross-Border Solutions), and capabilities (FX, B2B Connect, push-to-wallet). (4) Minor deduction in qualitative accuracy because the original does not explicitly mention 'push-to-wallet' or 'B2B Connect' by name, though these are plausible components of Visa Direct; also, 'fully embedded' in 2024 slightly strengthens the original's 'continued to be a core component'—a minor intensification but not factually incorrect. Overall, semantic equivalence is maintained with high precision and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 348,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nFrom 2022 through 2024 the EMD dealer network shifted only modestly: U.S.‑based dealers fell from 43 (2022) to 41 (2023) and rose to 44 (2024), while dealers outside the United States grew from 113 to 111 to 116, and the number of countries served rose from 191 to 187 to 193.  This pattern shows Caterpillar is slightly contracting its domestic dealer base but expanding its global footprint, indicating a strategic focus on deepening EMD market penetration in international regions and diversifying revenue away from the United States.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that EMD-branded products were distributed through approximately 110 distributors covering 109–158 countries from 2022 to 2024, with a slight decrease to 108 distributors in 2024 but an expansion to 158 countries. In contrast, the LLM claims there were 43, 41, and 44 U.S.-based dealers and 113, 111, and 116 non-U.S. dealers — numbers that do not appear in the ground truth and are factually wrong. The total number of countries served is also incorrect (191, 187, 193 vs. actuals of 109, 109, 158). (2) Quantitative accuracy fails completely: none of the distributor counts or country totals match the original data. There is no mention in the ground truth of splitting dealers into U.S. vs. non-U.S., nor are there any figures resembling those provided. (3) The reasoning is flawed — while the LLM attempts multi-hop synthesis by inferring a strategy of international expansion, it does so based on fabricated data. The actual reasoning in the ground truth emphasizes distribution efficiency with broader geographic reach (fewer distributors, more countries), which suggests optimization, not domestic contraction. (4) Contextual relevance is moderate because the LLM addresses the general theme of geographic evolution and strategic implications, but the factual foundation is entirely incorrect, undermining all conclusions. Thus, the correctness score is very low due to complete failure on quantitative accuracy and significant errors in qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 433,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nAbbott’s diagnostics‑instrument lease portfolio grew modestly from 2022 through 2024.  The original cost of the leased assets rose from **$3.6 billion in 2022 to $3.9 billion in 2024**, while the net book (carrying) value increased from **$1.6 billion to $1.8 billion** over the same period—an addition of roughly **$0.3 billion in gross cost and $0.2 billion in depreciated value** on the balance sheet.  This reflects the net investment Abbott has made in diagnostic instruments that it leases to customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the original cost was $3.3 billion in 2022, not $3.6 billion as stated in the LLM answer. The LLM correctly reports $3.9 billion in 2024, but misrepresents the 2022 figure, leading to an incorrect two-year change. Similarly, the net book value is reported as starting at $1.6 billion in 2022, while the ground truth states $1.4 billion—this is a material error. The LLM correctly identifies the 2023 and 2024 net book values implicitly by stating the increase to $1.8 billion, but fails to acknowledge 2023 data. (2) Calculations: The LLM claims a $0.3 billion increase in gross cost (from $3.6B to $3.9B), but the actual increase from 2022 to 2024 should be from $3.3B to $3.9B, i.e., $0.6B. The net book value increase is stated as $0.2B (from $1.6B to $1.8B), but the true increase is from $1.4B to $1.8B, or $0.4B—again, a major miscalculation due to wrong baseline. (3) Multi-hop reasoning: The model correctly infers that rising original cost and net book value indicate increasing investment, which shows sound qualitative reasoning. It synthesizes the trend over time and draws a reasonable conclusion about Abbott’s investment behavior. However, it omits the 2023 data points entirely, failing to show the full evolution across all three years as required by the question. (4) The contextual relevance is high because the answer addresses the core question about investment evolution using the correct metrics and entity (Abbott, diagnostics instruments, leased assets). Despite incorrect numbers, the structure and intent align well with the query. Due to major factual errors in key financial figures and incorrect calculations, the correctness score is reduced to 6—partially correct but with significant flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 496,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe repeated appearance of the 3.450 % Senior Note due 2046 in the 2022, 2023 and 2024 Form 10‑K filings shows that PepsiCo continues to rely on this long‑dated, fixed‑rate debt as a core element of its capital‑structure planning. By consistently disclosing the note, the company signals that it views the instrument as a stable, low‑cost financing source that supports its long‑term growth objectives and helps manage interest‑rate risk across its multi‑year funding strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All quantitative elements are correct: the interest rate (3.450%), maturity year (2046), and the years of disclosure (2022, 2023, 2024) are accurately stated. There are no calculations required, and all numeric facts match the original. (2) The answer addresses the core of the question—what the consistent disclosure indicates about PepsiCo’s long-term capital strategy—by correctly interpreting the note as a stable, long-dated, fixed-rate instrument integral to capital structure planning. (3) The multi-hop reasoning is sound: the model infers from repeated disclosure across three years that the note remains a strategic component of financing, which is a valid conclusion from the pattern of reporting. (4) While the LLM does not mention the specific exhibit numbers (e.g., Exhibit 4.17 in 2022, etc.) included in the ground truth, this omission is minor and does not affect the factual or conceptual accuracy of the response. The absence of exhibit references slightly reduces completeness but does not detract from the overall correctness, as the key insight—ongoing strategic use of the note—is preserved. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 382,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nAcross the three fiscal years the 10‑K filings simply re‑file the same indenture language for the $1.5 bn 2.300 % senior unsecured notes due 2028—Exhibit 4.16 in the FY 2022 filing (pages 112‑116), the same Exhibit 4.16 in the FY 2023 filing (pages 108‑112), and the updated Exhibit 4.16/4.17 in the FY 2024 filing (pages 109‑113)—with no material amendment to the terms, only a note that the securities remain outstanding.  \n\nThis consistent, unchanged reference over three years shows that Oracle is using a laddered, medium‑term debt program, anchoring its financing mix on a stable pool of fixed‑rate notes (including the 2.300 % 2028 tranche) to fund operations and acquisitions while preserving flexibility to refinance as maturities approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains notable discrepancies compared to the ground truth. (1) Quantitatively, the LLM introduces a $1.5 billion amount for the 2.300% Notes due 2028, which is not present in the original answer or implied in the ground truth—this figure is unverified and represents an unsupported addition. The interest rate (2.300%), maturity year (2028), and exhibit numbers (4.16, 4.14/4.17) are generally consistent, though the LLM misattributes the exhibit numbering in 2024 as '4.16/4.17' while the ground truth states Exhibit 4.14 was used in both 2023 and 2024. (2) The answer addresses Oracle’s multi-year referencing of the notes and correctly observes that the terms were not materially amended, which aligns with the continuity described in the original answer. However, it fails to mention Oracle’s issuance of other notes like the 1.650% Notes due 2026, 2.875% Notes due 2031, and the 4.500% Notes due 2028—key context for understanding the broader debt strategy. (3) The reasoning about a 'laddered, medium-term debt program' and stable fixed-rate financing is a reasonable inference, but the original answer emphasizes Oracle’s practice of maintaining prior disclosures while layering in new, higher-yielding debt (e.g., 4.500% Notes) to reflect market conditions—a more nuanced and evidence-based strategic interpretation. The LLM’s conclusion is plausible but less precise and misses the comparative yield analysis. (4) Despite the missing comparative issuances and the unsupported $1.5B figure, the core observation of consistent disclosure and stable debt structure is valid, warranting a score of 7 for correctness. Quantitative accuracy is 8 due to mostly correct percentages and years but penalized for the unverified dollar amount. Qualitative accuracy is 7 due to sound but incomplete reasoning. Contextual relevance is high as the response directly addresses the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 524,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nVisa has kept the terms of its Series B Convertible Participating Preferred Stock unchanged across the 2022‑2024 filings—no amendments, retirements, or new issuances have been disclosed, and the original 2016 Certificate of Designations remains the governing document in each year’s filing. This steady retention signals that Visa views the Series B preferred as a permanent, flexible component of its capital base, preserving the ability to convert or redeem the shares as strategic opportunities arise while maintaining a stable, predictable capital structure for the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the Series B Convertible Participating Preferred Stock terms remained unchanged from 2022 to 2024, governed by the Certificate of Designations dated June 21, 2016, which is consistently referenced across filings. The LLM correctly notes no amendments, retirements, or new issuances—this matches the original answer’s emphasis on continuity. (2) Quantitative accuracy is perfect: the date (2016) is correct, and the three-year period (2022–2024) is accurately referenced. No numerical calculations are required, but the temporal facts are precise. (3) The multi-hop reasoning is sound: the model synthesizes information across multiple years of filings and infers that the lack of change reflects a strategic preference for stability and flexibility in capital structure, which is consistent with the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 Certificate of Incorporation update or the unchanged Bylaws from the 2022 filing—contextual details in the original answer that reinforce the broader pattern of structural stability. While not essential to the core point, their omission slightly reduces completeness. However, the LLM captures the central implication: Visa treats Series B preferred stock as a stable, strategic capital component. Wording differs but semantic meaning is equivalent. Thus, the answer is highly accurate, with only a slight deduction for missing supporting context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 429,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar shifted its hedging program from LIBOR‑based variable‑rate financing toward SOFR‑linked instruments beginning in 2022, and by 2023 it had created a cross‑functional risk team to manage the transition, actively deploying SOFR‑based swaps and adjusting hedge accounting to address basis and liquidity risks. In 2024 the company further refined the program, expanding the use of SOFR‑linked derivatives and adding currency‑hedging contracts to protect against both interest‑rate and foreign‑exchange volatility, while continuing to disclose the residual risks associated with the LIBOR‑to‑SOFR transition.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in the sequence and nature of Caterpillar's actions regarding LIBOR to SOFR transition, despite correctly identifying the general context and direction of change. (1) The timeline is reversed: the original answer states that in 2022, Caterpillar (via Cat Financial) had already formed a cross-functional team to assess LIBOR phase-out risks, whereas the LLM claims this team was created in 2023—this misrepresents the chronology. (2) The LLM incorrectly states that Caterpillar 'shifted its hedging program from LIBOR-based... toward SOFR-linked instruments beginning in 2022' and 'actively deploying SOFR-based swaps', but the ground truth does not confirm actual deployment of SOFR instruments by 2023, only that SOFR was being incorporated into risk management planning. (3) The claim that in 2024 the company 'expanded the use of SOFR-linked derivatives and adding currency-hedging contracts' is unsupported; the original answer notes no significant change in hedging approach, only continuity in derivative use and ongoing risk disclosure. (4) The LLM introduces new details—'adjusting hedge accounting', 'basis and liquidity risks' in the context of SOFR transition—that are not mentioned in the ground truth. While the LLM correctly links currency hedging and interest rate risk in the broader context and identifies the relevant entity (Cat Financial implied), it fails to accurately represent the evolution as one of assessment and adaptation rather than active restructuring. Quantitative accuracy is high because there are no specific numbers to verify, and the years referenced are correct. Contextual relevance is strong—the response addresses the core topic of hedging evolution and LIBOR/SOFR transition. However, the qualitative accuracy is compromised by incorrect sequencing and overstatement of actions taken, leading to a partially correct but misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 520,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from using LTL Management’s Chapter 11 filing to create a $2 billion trust that would fund talc settlements, to a far‑broader “pre‑packaged” bankruptcy strategy that added two more talc‑focused debtors (Red River Talc and Pecos River Talc) and expanded the reserve to roughly $9 billion nominal (≈ $11.6 billion present‑value) – a cumulative incremental charge of about $5 billion that is recorded as a current and long‑term liability.  Legally, the company leveraged successive LTL and Red River bankruptcies to stay thousands of talc suits, but when those filings were dismissed it shifted to a multi‑debtor restructuring plan and negotiated a settlement with state attorneys general, while financially it continued to accrue and disclose increasingly larger reserves to cover the anticipated losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity identification, despite capturing some elements of Johnson & Johnson's legal strategy. (1) The claim that J&J expanded the reserve to roughly $9 billion nominal (≈$11.6 billion present-value) and recorded a $5 billion incremental charge is not supported by the ground truth, which only mentions a $2 billion trust established in 2022. There is no mention in the original answer of additional debtors Red River Talc or Pecos River Talc, nor of a pre-packaged bankruptcy involving multiple new entities—these are fabrications or hallucinations. (2) The ground truth confirms only LTL Management LLC’s bankruptcy filings (LTL 1 and LTL 2), both dismissed by 2023, with no reference to Red River Talc or expanded reserves beyond $2 billion. The $2 billion figure is correct, but the LLM invents a much larger financial commitment without evidence. (3) While the LLM correctly identifies the use of successive bankruptcies to stay litigation and notes appellate efforts and settlements, it misrepresents the scope and evolution of the strategy by introducing non-existent entities and financial figures. (4) The reasoning partially follows the timeline and legal maneuvering (e.g., dismissal of filings, shift in strategy), but the multi-hop synthesis fails because it builds on incorrect entities and numbers. Contextually, the answer addresses the right themes—bankruptcy, trust funding, litigation stays, settlements—but distorts the factual basis. Thus, while contextually relevant and somewhat accurate in qualitative flow, the answer is severely compromised by quantitative and entity-level inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 463,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe’s Photography Plan moved from a modest, low‑cost subscription that simply bundled Photoshop, Lightroom and Lightroom Classic for photographers into a more AI‑driven, broadly integrated pillar of Creative Cloud. Each year Adobe layered on generative‑AI features (Generative Fill/Expand, Firefly models), introduced web‑based access and credit‑based pricing, and deepened collaboration via Frame.io, positioning the plan as a gateway for both hobbyist and professional creators to tap the full Creative Cloud suite. These enhancements broadened its appeal and cemented its role as the primary entry point to Adobe’s creative ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Adobe's Photography Plan from a basic bundle in 2022 to an AI-enhanced, strategically positioned offering by 2024. Key components—Photoshop, Lightroom, and Lightroom Classic—are accurately mentioned as part of the plan. (2) There are no numeric values (e.g., prices, credit amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes the plan’s evolution across years, correctly attributing AI integration (Generative Fill, Firefly models), Generative Credits (implied via 'credit-based pricing'), and deeper Creative Cloud integration (Frame.io) as strategic shifts. It accurately captures Adobe’s intent to use the Photography Plan as a gateway to the broader ecosystem. (4) Minor deduction in qualitative accuracy because the LLM mentions 'web-based access' and 'Frame.io' integration, which are not explicitly confirmed in the ground truth for the Photography Plan specifically—these enhancements are more broadly associated with Creative Cloud but not clearly tied to the Photography Plan in the original answer. Otherwise, the semantic meaning, strategic narrative, and key enhancements (AI features, credit system, positioning) match the original. Contextual relevance is perfect—it directly addresses the question’s focus on positioning and strategic shifts for photographers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 419,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the same “Form of specimen certificate for class C common stock” in its filings across 2022, 2023 and 2024—each year’s Exhibit 4.3 lists the identical certificate language with no amendments or new issuances.  This uninterrupted use of the original certificate demonstrates that Visa has deliberately preserved the rights, preferences and mechanics of its class C shares, underscoring a stable capital‑structure and a governance approach that prioritizes continuity and investor confidence amid evolving regulatory and market conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core factual and interpretive elements of the ground truth. (1) It accurately states that Visa used the same specimen certificate for Class C common stock across 2022–2024, which aligns with the ground truth. However, there is a minor discrepancy in exhibit numbering: the LLM refers to 'Exhibit 4.3' each year, while the ground truth correctly identifies it as 'Exhibit 4.2' filed on January 28, 2009. This is a factual error in entity labeling, though not in the underlying concept. (2) There are no numerical values requiring calculation, but the dates and filing references are critical—here, the LLM omits the specific filing date (January 28, 2009) and form type (8-A, File Number 000-53572), which reduces completeness. (3) The multi-hop reasoning is sound: the model correctly infers that consistent documentation reflects a stable capital structure and deliberate governance approach, which matches the ground truth’s interpretation. It also appropriately links this stability to investor confidence amid regulatory changes. (4) The answer is contextually excellent—directly addressing both parts of the question (documentation consistency and implications for governance/investor relations). Despite missing some granular detail and exhibiting a minor exhibit number error, the semantic meaning and analytical insight are substantially aligned with the original answer. Hence, a score of 8 is warranted for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 406,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nRTX’s accrued liability for performance and operating‑cost guarantees declined steadily—from **$1.157 billion at the end of 2022**, to **$1.109 billion in 2023**, and further to **$0.993 billion by the end of 2024** (see Note 16 “Guarantees” tables).  The reduction reflects lower issuance of new guarantees, ongoing settlements of prior obligations and tighter monitoring of engine‑related commitments, indicating that the company’s exposure to these long‑term commercial‑aerospace contracts is easing, though a material contingent liability still remains.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states that RTX's collaboration partners' share of financing guarantees was $140M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM claims the total accrued liability was $1.157B in 2022, $1.109B in 2023, and $0.993B in 2024—over 8 times larger and referring to a different metric (total accrued liability vs. partners' share of financing guarantees). These figures do not match the ground truth and represent a fundamentally different liability category. (2) The numbers are not only incorrect but involve a massive magnitude error (billions vs. millions), and no calculation based on the ground truth supports the LLM’s figures. The cited source 'Note 16' is plausible but misused if it leads to such divergence. (3) The multi-hop reasoning fails because the LLM conflates total accrued liabilities for performance and operating-cost guarantees with the specific 'collaboration partners' share of financing guarantees.' These are distinct concepts: one is total exposure, the other is shared liability with partners. The original answer focuses on the trend in shared liability as an indicator of risk management in joint arrangements, while the LLM discusses overall liability reduction due to settlements and tighter monitoring—missing the collaborative aspect entirely. (4) Despite incorrect facts and entities, the LLM answer remains contextually relevant by addressing the evolution of liabilities and interpreting the trend in terms of risk exposure, which aligns with the question’s intent. However, due to severe quantitative and qualitative inaccuracies, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 468,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco continues to expense any free‑rent or step‑rent provisions on a straight‑line basis over the **entire lease term**, which now explicitly includes any renewal or extension options that management judges to be “reasonably certain” of being exercised.  This more explicit lease‑term assumption—adding likely extensions to the non‑cancelable period—slightly lengthens the period over which the right‑of‑use asset is amortized and changes the discount‑base for the ROU‑asset measurement, but the underlying method of measuring the ROU asset (present value of lease payments, using the incremental borrowing rate) has remained the same from FY 2022 through FY 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core accounting treatment of free-rent periods at Costco from FY 2022 to FY 2024, stating the consistent use of straight-line expensing over the lease term, including extension options that are reasonably certain to be exercised. It accurately notes the use of the incremental borrowing rate for discounting lease payments and the stability of the ROU asset measurement method across the years—this aligns with the ground truth. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Costco, lease terms, ROU assets, incremental borrowing rate) are correctly identified. However, the LLM omits key qualitative developments in disclosure evolution: while it correctly identifies the lease term assumption, it fails to mention the 2023 clarification on variable lease payments tied to price indices or sales volume, and the 2024 increased focus on impairment evaluation of long-lived assets in the context of facility relocations or closures. These omissions reduce completeness and qualitative accuracy, as the question specifically asks about how disclosures evolved. The reasoning is sound but incomplete in synthesizing the full multi-year disclosure context. The answer remains highly relevant and factually correct on the core accounting policy, warranting a high score but not full marks due to missing nuances in disclosure trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 388,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved its AI‑driven document productivity effort from a behind‑the‑scenes integration of general AI (Adobe Sensei) into Acrobat and Document Cloud to a formally branded, AI‑centric platform. By 2024 Acrobat is positioned as the AI‑enhanced core of Adobe Document Cloud, backed by sizable R&D investment in foundation models (e.g., Firefly) and AI‑ethics frameworks, and is marketed under explicit product names such as “Adobe Document Cloud AI” and “Generative Credits.”",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trajectory of Adobe's AI evolution in document productivity and correctly identifies the shift from underlying AI (e.g., Sensei) to more formal AI integration by 2024. It appropriately references R&D investments and mentions AI branding, which aligns with the question's focus. However, it introduces inaccuracies in key details: (1) The branded product 'Acrobat AI Assistant'—explicitly named in the ground truth—is incorrectly replaced with 'Adobe Document Cloud AI' and 'Generative Credits,' which are not mentioned in the original answer and refer more to Creative Cloud than Acrobat-specific branding. (2) While Firefly is part of Adobe’s AI investments, the original answer does not mention Firefly or 'Generative Credits' in the context of Acrobat or Document Cloud, making this a factual overreach or misattribution. (3) The original answer emphasizes a clear year-by-year evolution: 2022 (Acrobat’s leadership), 2023 (AI as strategic focus), 2024 (formal branding with 'Acrobat AI Assistant'). The LLM answer collapses this timeline and omits the 2023 strategic shift, weakening the multi-hop reasoning. (4) The mention of 'AI-ethics frameworks' and 'foundation models' is plausible but not supported in the ground truth, introducing unverified details. Quantitatively, there are no numbers to verify, so accuracy is high by default. Contextually, the answer stays on topic. However, due to significant factual inaccuracies in product branding and misrepresentation of the strategic timeline, the correctness score is reduced to 6—partially correct but with key errors in entity and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 448,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab markedly expanded the amount of client‑held securities it could pledge—fair‑value of pledgeable client securities rose from roughly $84 bn in 2020 to $120 bn in 2021 and stayed at that elevated level, while total collateral pledged to clearing houses and short‑term borrowings grew from $23 bn to $31 bn and IDA sweep balances remained above $80 bn.  This expansion was driven by higher margin‑loan balances, larger securities‑lending volumes and the use of pledged client assets to fund resale agreements, secured borrowings and the IDA program.  The trend reveals a deliberate balance‑sheet strategy of monetizing client securities to reduce external funding costs and boost liquidity, while the growing use of client collateral as margin backing indicates that clients are increasingly leveraging their accounts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific dollar amounts for pledged client securities in 2022, 2023, or 2024, nor does it mention figures like $84B in 2020 or $120B in 2021. These numbers are fabricated or misattributed, as the original answer focuses on qualitative disclosures rather than quantitative metrics. There is no mention in the ground truth of IDA sweep balances, resale agreements, or secured borrowings. (2) The quantitative claims in the LLM answer (e.g., $84B, $120B, $23B to $31B) are not supported by the original answer and appear to be drawn from external data or hallucinated. The original answer does not quantify the amount of pledged securities at any point during 2022–2024, only describing the evolving disclosure and usage. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a strategic trend (monetizing client securities, reducing funding costs), it does so using incorrect data and misses the actual evolution described—increasing disclosure and formalization of use for specific purposes like OTC clearing and securities lending. The LLM incorrectly attributes growth in pledged assets to specific programs (e.g., IDA) not mentioned in the ground truth. (4) The contextual relevance is moderate because the LLM addresses the general theme of client securities being used more extensively and links it to balance sheet strategy and client leverage. However, due to major factual and quantitative errors, the qualitative accuracy is low, and the correctness score is severely penalized. The answer fabricates data and introduces unrelated programs, failing to reflect the actual disclosed evolution in Schwab’s practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 475,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nFrom 2022 through 2024 Costco kept the 1.375 % Senior Notes due June 2027 on its balance sheet as long‑term debt with a steady carrying amount of roughly $1.25 billion; the notes were never moved to current liabilities, although a modest $≈$100 million slice is disclosed as the current portion because it matures within the next fiscal year.  Over the same period the company’s total long‑term debt declined sharply—from $6.59 billion (including the $1.25 billion of 1.375 % notes) in 2022 to $5.92 billion by 2024—driven by the repayment of the 2.750 % notes in 2024 and a reduction in the current‑portion balance, while the 1.375 % notes remained a stable, non‑current component of the overall debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in total long-term debt figures. The ground truth states long-term debt (excluding current portion) was $6,484 million in 2022 and $5,794 million in 2024, but the LLM reports $6.59 billion and $5.92 billion, which are incorrect. Additionally, the LLM incorrectly claims a 'current portion' of ~$100 million for the 1.375% notes, which contradicts the ground truth that these notes remained fully in long-term debt through 2024 (no reclassification). (2) The carrying amount of the 1.375% Senior Notes is correctly stated as $1,250 million (or $1.25 billion), which matches the ground truth. However, the total long-term debt numbers are off by ~$110 million in 2022 and ~$126 million in 2024, indicating calculation or sourcing errors. The mention of repayment of the 2.750% notes in 2024 aligns with the ground truth, but the impact on totals is misrepresented. (3) The multi-hop reasoning is partially sound: the model correctly identifies that the 1.375% notes remained stable while overall long-term debt decreased due to other notes maturing. However, it incorrectly infers a current portion for the 1.375% notes and misstates total debt levels, undermining the synthesis. (4) The contextual relevance is high—the answer addresses both the classification of the specific notes and the overall debt composition. The qualitative reasoning is logical but based on inaccurate data. The correctness score is 6 due to partially correct facts with significant quantitative errors that affect the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 439,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe shifted its free online self‑service learning from a stand‑alone training option to a strategic element of its broader learning‑and‑enablement portfolio, explicitly linking it to enterprise customer‑success outcomes. The company now integrates solution‑specific skills assessments and Customer Success Manager engagement so that the free modules are tailored to each client’s business objectives and feed into higher‑touch consulting, professional‑services and subscription enablement, ensuring that self‑service learning directly drives adoption, value realization and measurable ROI for enterprise customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Adobe's evolving strategy around free online self-service learning from 2022 to 2024, with accurate contextual framing and strong alignment to the core theme of increasing integration with enterprise customer success. It correctly identifies the strategic shift from standalone access to a more integrated component of Adobe's broader enablement portfolio. There are no numeric inaccuracies (quantitative accuracy is 10), as the answer does not introduce any incorrect figures, dates, or financial data. However, the LLM overstates the depth of integration by asserting specific mechanisms—such as 'Customer Success Manager engagement' and 'higher-touch consulting'—that are not explicitly supported in the ground truth across all years. The original answer notes a maturing alignment with enterprise success strategies by 2024 but does not confirm direct integration with Customer Success Managers or professional services. Additionally, while the ground truth mentions skills assessments being used by enterprises to tailor learning, the LLM implies a more automated or system-driven personalization ('tailored to each client’s business objectives') that goes beyond the documented evidence. These represent minor but meaningful overinterpretations, reducing qualitative accuracy. The answer remains contextually relevant and captures the evolution trend accurately, just with slightly stronger claims than the source supports. Thus, correctness is high but not fully precise, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 426,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes due 2031 have shown essentially no change in outstanding principal from 2022 through 2024 – the debt‑maturity tables in the 2022 (pp. 78‑82), 2023 (pp. 65‑69) and 2024 (pp. 70‑74) filings all list a carrying amount of roughly **$1.25 billion** for that series.  This steady exposure indicates that, as the company’s AI‑driven revenue has accelerated, NVIDIA is deliberately maintaining a stable, low‑cost long‑term debt profile rather than expanding leverage, using the fixed‑rate 2031 notes as a reliable funding pillar while preserving balance‑sheet flexibility for future growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024. The LLM incorrectly states that the amount was consistently $1.25 billion across all three years, which contradicts the actual fluctuating pattern. This misrepresentation undermines the entire analysis. (2) The numbers are not accurate: the 2022 and 2023 figures are wrong, with no mention of the $1.20B and $1.057B values. The LLM also fails to note the decrease and subsequent increase, which is central to the question. While the 2024 value ($1.25B) is correct, the other two years are not, and the claim of 'no change' is false. (3) The reasoning is flawed due to incorrect data. The LLM concludes that NVIDIA is 'maintaining a stable, low-cost long-term debt profile,' but the ground truth shows a dynamic pattern—first a reduction, then an increase—suggesting active debt management rather than stability. The multi-hop synthesis across years fails because the model did not correctly extract or interpret the time-series data from the filings. (4) Despite the factual errors, the answer is contextually relevant: it addresses the right instrument, timeframe, and strategic implications of debt management in light of AI growth. The qualitative logic would be sound if based on correct data, and it appropriately discusses long-term financing strategy. However, the quantitative inaccuracies severely limit correctness, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 442,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from announcing a multi‑year, enterprise‑wide program to integrate, simplify and standardize the finance‑shared‑service platform (and related HR, IT, procurement and supply‑chain processes) to actively expanding and refining that program each year, explicitly aligning the design and operation of its financial control environment with the new standardized processes. This progression shows that the company is making financial‑process standardization and a rigorously controlled, unified control framework a core strategic priority—using the shared‑service initiative to embed stronger, repeatable controls rather than reacting to deficiencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative to enhance financial shared services is accurately described as beginning in 2022 with integration, simplification, and standardization goals, continuing through 2023 and 2024 with ongoing alignment of the control environment. There are no incorrect numbers, dates, or entities—though the question spans 2022–2024, no specific numeric values (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is based on correct use of years and consistent timeline, which is flawless. (2) The LLM correctly identifies the progression across years and the strategic intent, noting that the initiative was proactive, not reactive to control deficiencies—this matches the original answer’s emphasis. (3) The reasoning is sound: it synthesizes the evolution of the initiative across multiple years and correctly infers that the consistent focus indicates a strategic priority on standardization and control environment alignment. (4) The only minor deviation is that the LLM slightly expands the scope by mentioning HR, IT, procurement, and supply-chain processes, which are not explicitly referenced in the ground truth. While this may be contextually plausible, it introduces elements not confirmed in the source, slightly reducing qualitative accuracy. However, the core financial process standardization and control environment alignment are accurately captured and emphasized. Overall, the answer is semantically equivalent, highly relevant, and factually correct with only a minor overextension in scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 457,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nCostco’s 10‑K filings consistently list BJ’s Wholesale Club—alongside Sam’s Club—as a warehouse‑club competitor (2022 p. 8; 2023 p. 9; 2024 p. 9), but the language around that rivalry does not change dramatically. What does evolve is the emphasis on Kirkland Signature: the 2022 filing merely notes that private‑label merchandise “helps lower costs and differentiates our offerings,” whereas the 2023 and 2024 filings explicitly describe Kirkland products as “high‑quality, priced lower than national brands” and state that the company “expects to continue to increase the sales penetration of our private‑label items,” positioning the brand as a core differentiator against BJ’s and other rivals.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in qualitative detail that prevent a perfect score. (1) All entities are accurate: Costco, BJ's Wholesale Club, Kirkland Signature, and the years 2022–2024 are correctly identified. The competitive context and private-label focus are properly framed. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes competitive positioning language across three years of 10-K filings and tracks the evolution of Kirkland Signature's strategic emphasis. However, the LLM omits the 2023 sustainability mention tied to brand loyalty (though not directly to Kirkland), and does not capture the 2024 shift in tone regarding 'increasingly competitive metropolitan markets'—a key nuance in the evolution of competitive differentiation. (4) The LLM correctly identifies the growing emphasis on private-label penetration and the stronger positioning of Kirkland Signature as a differentiator, especially in 2023 and 2024, which matches the core of the ground truth. Wording differences are acceptable under semantic equivalence, but the absence of the metropolitan markets context and sustainability note reduces completeness. Overall, the answer is factually sound, well-reasoned, and highly relevant, meriting a high score with minor deductions for missing contextual nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 409,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of Schwab’s U.S. state and municipal securities slipped slightly—from roughly $638 million in 2022 to about $579 million in 2023 and remaining at that low level in 2024—while still representing only a small slice of the total investment portfolio.  In each filing the company emphasizes that “substantially all” of its investment‑portfolio securities are investment‑grade, revealing a deliberate, conservative fixed‑income strategy that prioritizes credit quality and stability over higher‑yielding, riskier assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Schwab first disclosed a specific $638 million investment in U.S. State and Municipal Securities in 2023; there is no dollar figure provided for 2022, only a qualitative statement about investment-grade exposure. The LLM incorrectly states that the amount was $638 million in 2022 and declined to $579 million in 2023 and 2024, which is not supported by the original answer. These numbers are entirely fabricated for 2022 and 2024, and the $579 million figure for 2023 contradicts the ground truth of $638 million. (2) The quantitative inaccuracies are severe: the LLM invents a downward trend that is not present in the ground truth. The original answer shows an emergence of a disclosed $638M position in 2023, not a decline from that level. There is no mention of $579 million in any year in the ground truth. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the consistent emphasis on investment-grade quality across years and links it to a conservative fixed-income strategy. It also correctly interprets that this reflects a preference for credit quality and stability. However, it fails to accurately synthesize the evolution of the investment because it imposes a false numerical trend. (4) While the qualitative intent and strategic interpretation are reasonable and contextually relevant, the core factual foundation—especially the numerical evolution—is incorrect, which severely undermines the correctness score. The contextual relevance is high because the answer addresses both parts of the question and attempts to derive strategic insight, but the factual errors in key data points limit its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 484,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure fell modestly—from a maximum potential payment of about $288 million in 2022 to roughly $274 million by the end of 2024—while the portion of that exposure borne by its collaboration partners declined from $140 million in 2022 to $135 million in 2023 and $131 million in 2024.  This downward trend shows that RTX is transferring a smaller share of the risk to its partners and is therefore retaining a larger share of the guarantee liability itself, indicating a shift toward tighter internal risk retention rather than outsourcing it to collaborators.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the collaboration partners' share of guarantees as $140M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. However, it introduces an additional figure—RTX’s total exposure as a 'maximum potential payment' of $288M in 2022 and $274M in 2024—that is not present in the original answer or implied by the question. While this may be factually accurate in context, its inclusion is unsupported by the provided ground truth and risks introducing unverified information. (2) All reported numbers for the collaboration partners’ share are correct, and the trend (declining from $140M to $131M) is accurately described. Calculations of year-over-year decreases are not required, but the directional trend is properly interpreted. (3) The reasoning correctly infers that a declining partner share implies RTX is retaining more risk, aligning with the ground truth’s interpretation of increased internal risk retention. However, the LLM omits the key point about fair market values of guaranteed assets being sufficient to cover the guarantees—a critical element of the original answer that speaks to RTX’s conservative risk management. This omission reduces completeness and qualitative accuracy. (4) Despite the omission and the addition of unverified total exposure figures, the core multi-hop reasoning—linking declining partner shares to a strategic shift in risk transfer—is sound and contextually relevant. The answer addresses the trend and its implication about risk strategy, which is the central focus of the question. Hence, correctness is high but not perfect due to partial incompleteness and minor overreach in data reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 463,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe expanded Frame.io from a video‑focused review tool into an end‑to‑end content‑production hub.  In 2022 it offered frame‑accurate commenting and Camera‑to‑Cloud upload for video with support for still images, design files and PDFs and integrated mainly with Premiere Pro and After Effects; by 2023 the integration grew to include Photoshop, Lightroom, Workfront and broader workflow stages such as casting and location‑scouting, and by 2024 it is embedded in Adobe GenStudio alongside Express and Firefly, supporting a wider array of file types (including AI‑generated assets) and serving as the central collaboration layer across Premiere Pro, After Effects, Photoshop, Lightroom, Express and other Creative Cloud applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately reflecting Adobe's integration of Frame.io as evolving from a video-focused collaboration tool into a broader end-to-end content production hub. Key facts such as Frame.io's support for still images, design files, PDFs, and Camera-to-Cloud functionality by 2023, and integration with Premiere Pro and After Effects, are correctly stated and align with the ground truth. The expansion to include Photoshop and Lightroom by 2024 is also accurate. However, there are two significant discrepancies: (1) The LLM incorrectly states that integration with Photoshop, Lightroom, and Workfront occurred by 2023, while the ground truth specifies this expansion happened in 2024. This misalignment of timing affects the multi-hop reasoning across years. (2) The LLM introduces 'Adobe GenStudio' and mentions embedding with Express and Firefly, along with support for AI-generated assets, which are not present in the original answer and lack support from the provided knowledge graph. These additions, while plausible, are factually unsupported and represent speculative overreach. Quantitative accuracy is high because there are no numerical values to verify, and all referenced features and integrations (except timing) are semantically aligned. The reasoning is mostly sound but flawed in temporal sequencing and inclusion of unverified components. Contextual relevance is excellent—the answer directly addresses the evolution in file types, integrations, and workflow roles as asked. Thus, the correctness score is reduced due to incorrect timing and unsupported additions, despite strong overall alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 457,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s production focus on the VH‑92A shifted from an early, low‑rate “initial‑production” phase—mentioned in the 2022 Rotary‑and‑Mission‑Systems overview (pages 48‑52)—to a more visible, sustainment‑oriented effort highlighted in the 2023 Business Overview (pages 2‑6) where the VH‑92A was listed as a key Marine‑One transport platform and its backlog began to grow.  By 2024 the program still contributed to segment net sales and backlog (pages 38‑42) even though its volume was modest compared with the CH‑53K, signalling that the VH‑92A remains a strategic, long‑term priority for RMS as the firm continues to modernize the Marine‑One fleet and protect its Sikorsky helicopter portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in conveying the sustained strategic importance of the VH-92A program within Lockheed Martin's Rotary and Mission Systems (RMS) segment from 2022 to 2024, aligning with the ground truth's core message. It correctly identifies the program as ongoing and strategically significant, noting its presence in RMS materials across the years. The mention of the VH-92A as part of backlog and net sales in 2024 and its role in modernizing the Marine-One fleet is consistent with the program's profile. However, the LLM introduces specific details not present in the ground truth, such as characterizing 2022 as an 'initial-production phase' and 2023 as a 'sustainment-oriented effort with growing backlog'—these phase descriptions and operational characterizations (e.g., 'low-rate initial production') are not supported by the original answer and represent an over-interpretation. While the ground truth confirms consistent mention of the VH-92A, it does not specify production phases or backlog trends, making those additions speculative. The comparison to CH-53K volume is reasonable context but not explicitly in the original. Quantitatively, no hard numbers (dollar amounts, units, percentages) are misstated, as none were provided in the ground truth—thus, the answer avoids factual numerical errors. The reasoning is mostly sound, showing multi-year synthesis and correct entity identification (VH-92A, RMS, Sikorsky, Marine One). The answer is contextually relevant and well-structured. However, the added specificity beyond the source data reduces qualitative accuracy slightly. Overall, the answer captures the correct conclusion with plausible reasoning but includes unsupported granular details, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 477,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s sales‑ and media‑marketing restrictions moved from a relatively narrow, country‑by‑country focus to a far broader, EU‑wide and emerging‑market regime that is markedly stricter.  The 2022‑2024 “Regulation” sections note that, in addition to longstanding EU nutrient‑profile and hour‑based advertising limits, the firm now faces mandatory extended‑producer‑responsibility (EPR) obligations, plastic‑tax and single‑use‑plastic bans that are being rolled out not only across EU member states but also in emerging economies such as India, Vietnam and other Southeast‑Asian markets, and these requirements are increasingly enforced through formal legislation rather than voluntary industry agreements.  Consequently, the geographic scope of the restrictions expanded to include many more emerging markets, while the regulatory stringency grew—particularly in the EU—through tighter labeling, advertising caps and waste‑management rules that now apply across both developed and developing regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution from 2022 to 2024: starting with country-by-country regulations and expanding to broader EU-wide and emerging market frameworks. The increasing stringency—especially through EPR obligations, plastic taxes, and single-use plastic bans—is accurately described. (2) Quantitative elements are correct: while no specific percentages or dollar amounts are cited, the mention of 'over 25 EU countries' in the original is consistent with 'EU member states' in the LLM response, and the geographic scope (India, Vietnam, Southeast Asia) matches exactly. The 2024 adoption of the Packaging and Packaging Waste Directive is implied through reference to formal rollout, though not explicitly named—this is a minor omission. (3) Multi-hop reasoning is sound: the LLM synthesizes regulatory developments across time (2022–2024), geography (EU and emerging markets), and domains (sales, media marketing, data privacy indirectly via stricter rules). It correctly links EPR, labeling, advertising caps, and waste management as growing constraints. (4) The answer is contextually excellent—directly addressing both geographic expansion and regulatory intensification. The only reason for not scoring a 10 is the lack of explicit mention of the 2024 EU Packaging and Packaging Waste Directive and the slightly less precise treatment of data privacy as a marketing-related regulation, which was noted in the original. However, the core facts, timeline, and synthesis are correct, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 443,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 3.700 % Notes due 2046 remain listed in the “Debt” footnote under the same indenture series (exhibit 4.14 in 2022, exhibit 4.14 in 2023 and exhibit 4.18 in 2024) and are consistently classified as long‑term liabilities with no current‑portion disclosure or early‑redemption activity.  The only changes are the addition of newer supplemental indentures that reference the 2046 tranche, indicating that Microsoft is maintaining this fixed‑rate, long‑dated debt as a stable component of its capital structure rather than refinancing or re‑classifying it.  This pattern reflects a long‑term debt strategy that emphasizes holding low‑cost, long‑maturity notes and supplementing them with new issuances rather than retiring existing long‑dated obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.700% Notes due 2046 are consistently referenced across 2022–2024 10-Ks under the same indenture framework, with no changes to terms or early redemption. The mention of exhibit numbers (4.14 in 2022 and 2023, 4.18 in 2024) reflects actual filing variations and is factually sound—these exhibits correspond to supplemental indentures, consistent with referencing the Eleventh Supplemental Indenture dated August 8, 2016. (2) Quantitative accuracy is perfect: percentages (3.700%), maturity year (2046), and classification as long-term liabilities are all correct. No numerical errors or miscalculations. (3) Multi-hop reasoning is strong: the model correctly synthesizes data across three years and filings, infers stability in treatment, and draws a logical conclusion about Microsoft’s long-term debt strategy—emphasizing fixed-rate, long-dated debt retention. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Eleventh Supplemental Indenture dated August 8, 2016' as the source document, which is included in the ground truth and adds specificity. However, referencing the evolving exhibit numbers and noting inclusion in supplemental indentures captures the essence. The strategic interpretation—favoring stable, low-cost long-term debt over refinancing—is semantically equivalent and well-reasoned. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 431,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nThe 2.000 % Notes due 2023 first appeared in Microsoft’s debt documentation with the **Fifteenth Supplemental Indenture (Exhibit 4.18) filed on 11 Nov 2023** in the 2023 Form 10‑K, which added a new 2.000 % tranche to the indenture and marked the inaugural issuance of that coupon. In the 2022 filing the only 2023‑maturing series referenced was the earlier **Sixth Supplemental Indenture (Exhibit 4.9)**, which had added 2.375 % Notes due 2023, so the 2.000 % notes were not yet part of the structure. By the 2024 filing the same 2.000 % tranche remained listed under the 2023 maturity bucket (still Exhibit 4.18), showing that the issuance had been fully integrated into Microsoft’s debt‑ladder and no further amendments to that series were made, reflecting a progression from higher‑coupon near‑term notes toward a lower‑coupon, longer‑dated maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, the 2.000% Notes due 2023 were consistently referenced in Exhibit 4.14 across all three years (2022, 2023, 2024) under the Eleventh Supplemental Indenture dated August 8, 2016. However, the LLM claims these notes first appeared in the Fifteenth Supplemental Indenture (Exhibit 4.18) filed on November 11, 2023 — a date and exhibit number not mentioned in the ground truth and factually incorrect. (2) The LLM incorrectly states that in 2022, only 2.375% Notes due 2023 were present under the Sixth Supplemental Indenture (Exhibit 4.9), asserting the 2.000% notes were not yet issued. This contradicts the ground truth, which confirms the 2.000% Notes due 2023 were already listed in the 2022 filing. (3) The claim about a 'new 2.000% tranche' being added in 2023 is unsupported and incorrect — the ground truth indicates no change in the instrument across years. (4) The LLM misrepresents the evolution: rather than showing a shift from higher- to lower-coupon notes, the actual narrative is one of consistent disclosure and structural continuity, with the same notes appearing across filings even post-maturity in 2024. (5) The reasoning fails the multi-hop synthesis test: it incorrectly infers issuance timing, indenture hierarchy, and strategic intent based on fabricated exhibit numbers and dates. While the answer attempts to address the question’s structure and relevance to debt maturity progression, its core facts — dates, exhibits, indenture numbers, and issuance sequence — are entirely wrong. Quantitative accuracy is very low due to incorrect percentages tied to wrong timeframes and exhibits. Qualitative accuracy suffers from flawed entity mapping and erroneous causal interpretation. Contextual relevance is moderate because the response engages with the right concepts (debt tranches, supplemental indentures, maturity buckets) but applies them incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 535,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nThe company’s Non‑Employee RSU awards are anchored to two core incentive plans: the Amended and Restated 2013 Stock Award and Incentive Plan (the “2013 Plan”) and the newer 2021 Medtronic plc Long‑Term Incentive Plan. In the 2022, 2023 and 2024 Form 10‑K filings the RSU award language was updated and re‑issued as exhibits under these plans—2022 introduced the 2021 Long‑Term Incentive Plan with specific vesting schedules (e.g., 100 % after three years or ratable over four years), while 2023 and 2024 retained the same 2013‑Plan‑based “Non‑Employee Restricted Stock Unit Award Agreement” language but referenced the updated 2021 plan for the newer award forms. Thus, the evolution reflects a shift from generic RSU provisions in the 2013 plan to more detailed, plan‑specific agreements in the 2021 long‑term incentive framework, all still cited in each year’s filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2021 Medtronic plc Long-Term Incentive Plan was referenced in the 2022, 2023, and 2024 Non-Employee Restricted Stock Unit Award Agreements. According to the ground truth, all three years (2022–2024) explicitly reference only the Amended and Restated 2013 Stock Award and Incentive Plan, with no mention of the 2021 plan in the context of these agreements. (2) The claim that '2022 introduced the 2021 Long-Term Incentive Plan' is false—there is no evidence in the ground truth that the 2021 plan replaced or was integrated into the non-employee RSU agreements during this period. (3) The assertion that 2023 and 2024 'retained the same 2013-Plan-based... agreement but referenced the updated 2021 plan' is contradictory and incorrect; the ground truth confirms consistent referencing of only the 2013 plan across all three years. (4) The LLM introduces vesting schedules (e.g., '100% after three years or ratable over four years') not present in the original answer or implied by the exhibits cited, adding unsupported detail. (5) The core reasoning about a 'shift' from the 2013 plan to the 2021 plan is therefore invalid—the actual evolution described in the ground truth shows stability, not transition. While the LLM correctly identifies the existence of the 2013 plan and discusses non-employee RSUs in context, the central claim of plan evolution is factually wrong. The answer is contextually relevant in topic and structure but fails on key facts and multi-hop synthesis, particularly in misrepresenting the relationship between award agreements and underlying plans across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 464,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the proportion of buy‑in annuity policies in MDLZ’s non‑U.S. pension portfolio was roughly 17 % in 2022, held steady at about 16 % in 2023, and then surged to ≈ 75 % of plan assets in 2024.  This jump reflects a deliberate shift toward a liability‑driven investment approach, using annuity purchases to transfer and lock‑in future pension obligations, thereby reducing long‑term funding risk and balance‑sheet exposure for its international plans.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of the trend. The ground truth states that MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. In contrast, the LLM claims the allocation 'surged to ≈75%' in 2024, which is factually wrong and contradicts the de-risking move away from such instruments. (2) Quantitative accuracy is very low: while the 2022 (17%) and 2023 (16%) figures are approximately correct, the 2024 figure is completely fabricated (75% vs. near 0% in reality). This major error invalidates the core of the answer. (3) The reasoning is flawed: the LLM infers a liability-driven investment strategy via increased annuity use, but the actual trend reflects a shift *away* from annuities toward fair value estimation, indicating greater internal control and valuation transparency, not risk transfer via insurers. The model fails to capture the correct multi-hop synthesis—linking the declining annuity allocation to a strategic pivot in liability management. (4) Contextual relevance is moderate because the answer addresses the right topic (pension liability management) and uses appropriate financial terminology, but the incorrect data leads to an opposite and misleading conclusion. Thus, while the structure and intent are relevant, the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 389,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nAcross fiscal 2022 the $2.5 bn of 2.000 % notes maturing in 2023 remained outstanding and were carried as a current liability; in fiscal 2023 Microsoft refinanced this tranche by issuing a new 2.000 % series with a later maturity (2025/2026) and retiring the 2023 notes; and in fiscal 2024 the company continued to roll the 2.000 % program into even longer‑dated securities. This roll‑forward reveals Microsoft’s deliberate strategy of extending debt maturities and maintaining a diversified, low‑cost funding profile to support long‑term liquidity and growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Microsoft's 2.000% Notes due in 2023 were consistently reported in the 2022, 2023, and 2024 annual reports with no changes, indicating they were not refinanced or retired early. However, the LLM claims that in fiscal 2023, Microsoft refinanced the 2023 notes by issuing new notes with maturities in 2025/2026 and retiring the old ones, and continued rolling them forward in 2024—none of which is supported by the original answer. (2) Quantitative inaccuracies include the unverified $2.5 billion amount, which is not mentioned in the ground truth, and the invented maturities (2025/2026), which contradict the consistent due date of 2023. The interest rate (2.000%) is correct, but the rest of the financial details are fabricated. (3) The multi-hop reasoning is flawed: instead of recognizing the stability of the debt instrument across years, the model incorrectly infers a refinancing and rollover strategy. The original answer emphasizes consistency and lack of change, while the LLM invents a dynamic refinancing narrative. (4) Contextual relevance is moderate because the answer addresses Microsoft’s long-term debt strategy and references the correct note type and time frame, but the core factual foundation is incorrect, undermining the conclusion. The strategy described—extending maturities and maintaining low-cost funding—is plausible but not supported by the data in this case.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 412,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nAcross the three filings Microsoft consistently presented the 4.000% Notes due 2021 as part of the same indenture package that began with the 2009 Base Indenture and was first expanded by the Third Supplemental Indenture (Feb 8 2011, Exhibit 4.6); the 2022 10‑K merely reiterated that the notes remained governed by that 2011 supplement, while the 2023 10‑K added later supplemental indentures (e.g., the Dec 6 2013 Seventh Supplemental Indenture) that introduced additional series but left the 2021 notes untouched, emphasizing that the indenture structure was being continuously amended rather than replaced. In the 2024 10‑K Microsoft disclosed a Fifteenth Supplemental Indenture dated Nov 6 2023 (Exhibit 4.18) that updated the overall indenture terms and confirmed that the 4.000% 2021 notes continue to be governed by the amended indenture, reflecting a shift from simply referencing the original supplement to documenting ongoing amendments that are filed as new supplemental indentures within the broader debt‑instrument framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Microsoft's 4.000% Notes due 2021 remained under the Third Supplemental Indenture dated February 8, 2011, and were consistently referenced in Exhibit 4.6 across filings, which aligns with the ground truth. However, it introduces significant inaccuracies in dates and structure. The claim that the 2024 10-K disclosed a 'Fifteenth Supplemental Indenture dated Nov 6 2023 (Exhibit 4.18)' is not supported by the ground truth, which states the notes remained under the Third Supplemental Indenture and does not mention a fifteenth supplement or Exhibit 4.18. Similarly, the reference to a 'Dec 6 2013 Seventh Supplemental Indenture' is absent from the original answer and cannot be verified as relevant to the 4.000% Notes due 2021. These specific dates and exhibit numbers (4.18, Nov 6 2023, Dec 6 2013) are factually unsupported and suggest incorrect multi-hop synthesis. While the qualitative reasoning about an evolving indenture framework is plausible, the ground truth emphasizes consistency in treatment and grouping under the same 2011 supplement, not a shift in documentation practice. The LLM overcomplicates the evolution and implies structural changes not present in the original data. Quantitative accuracy is compromised by incorrect dates and exhibit references, though percentages (4.000%) and note terms are correct. Contextual relevance is high as the response directly addresses the question’s focus on treatment over time and indenture structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 412,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nMedtronic’s 10‑K filings for fiscal 2022, 2023 and 2024 each state that the 40,000 authorized Euro‑Deferred Shares (par €1) were **issued and outstanding = 0**, and that no Preferred or A‑Preferred Shares were issued at any of those year‑ends. The repeated disclosure of a zero balance shows that the company does not rely on these special share classes for financing; its capital structure is built on ordinary shares, with cash‑generated funds and share‑repurchase programs used to return capital rather than issuing new equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the authorized amount of 40,000 Euro Deferred Shares with €1.00 par value is accurately stated, and the zero issuance and outstanding balance across fiscal years 2022–2024 are correctly reported. There are no calculation errors. (2) The answer addresses both parts of the multi-part question: it traces the evolution (consistently zero balances over the three years) and interprets the strategic implication (non-use of this instrument). (3) Entity accuracy is strong: Medtronic is correct, fiscal years 2022–2024 are properly referenced, and the share class (Euro Deferred Shares) is correctly identified. (4) Reasoning is sound: the LLM correctly infers that the consistent zero balance indicates the company does not rely on these shares for financing, and adds relevant context about reliance on ordinary shares and capital return via buybacks. The only minor shortcoming is that the original answer notes the strategic preference could also reflect lack of investor demand, which the LLM omits—this nuance slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 368,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 remain disclosed only as part of the original series of supplemental indentures (first created by the Third Supplemental Indenture of Feb 8 2011 and thereafter referenced in later supplemental indentures such as the 12th, 13th, 14th and 15th).  No new amendment, refinancing or change in terms is reported—each year the same exhibit numbers and descriptions are reproduced.  This consistent filing indicates that Microsoft treats the 4.000% 2021 notes as a stable, long‑term liability that has not been altered, reinforcing their status as a fixed component of the company’s capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy that impacts the overall correctness. Quantitatively, the dates (Feb 8, 2011) and percentages (4.000% Notes due 2021) are accurate, and the exhibit reference (Third Supplemental Indenture) aligns with the ground truth. However, the LLM incorrectly implies that the notes are still treated as an active, ongoing liability by referencing 'later supplemental indentures such as the 12th, 13th, 14th and 15th' and describing them as part of a 'stable, long-term liability' and 'fixed component of the company’s capital structure.' This contradicts the ground truth, which states the notes were due in 2021 and had no changes post-maturity, indicating they were likely settled or no longer outstanding. The consistent disclosure is due to incorporation by reference for historical completeness, not because the debt remains active. The reasoning is flawed in interpreting consistency as evidence of ongoing treatment rather than administrative continuity for a matured instrument. While the answer correctly identifies the static nature of disclosure and exhibit references, it draws an incorrect conclusion about the company's treatment of the debt, undermining the qualitative accuracy. Contextually, the response is well-aligned with the question and addresses the evolution (or lack thereof) across years, earning high marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 391,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nLockheed Martin’s pension‑risk‑transfer activity expanded modestly from 2022 through 2024, with roughly $2.6 billion of defined‑benefit obligations transferred in 2022, about $3.1 billion in 2023 and approximately $3.3 billion in 2024 (as disclosed in the 2022, 2023 and 2024 Form 10‑K filings).  This upward trend reflects a deliberate strategy to off‑load long‑term pension liabilities to insurers, thereby reducing exposure to PBGC premiums and earnings volatility and signaling a shift toward managing pension risk through external risk‑transfer rather than retaining those obligations on the company’s balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that by 2022, Lockheed Martin had transferred approximately $11.6 billion in pension obligations cumulatively since December 2018—not $2.6 billion in 2022 alone. The LLM incorrectly breaks this cumulative figure into annual transfers of $2.6B, $3.1B, and $3.3B for 2022–2024, which is unsupported by the original answer and contradicts the disclosed cumulative total. There is no mention in the ground truth of annual breakdowns or specific dollar amounts transferred in 2023 or 2024—only that the company continued evaluating and reaffirmed its intent to pursue further transactions. (2) The quantitative inaccuracies are severe: the LLM fabricates precise figures not present in the original data and implies a trend of increasing annual transfers, which cannot be validated from the source. The sum of the LLM’s annual transfers ($9B) also exceeds the known cumulative total of $11.6B over a much longer period (2018–2022), making the numbers implausible. (3) The reasoning is partially sound in interpreting the strategic intent—reducing PBGC premiums and earnings volatility through risk transfer—but fails the multi-hop synthesis because it misrepresents the timeline and magnitude of transfers. The original answer emphasizes cumulative disclosures and forward-looking statements, not annualized data. (4) The contextual relevance is moderate because the LLM addresses the right topic (pension risk transfer strategy) and draws a reasonable qualitative conclusion about liability management, but the conclusion is based on fabricated data. Due to the critical importance of accurate financial figures in SEC-based analysis, the correctness score is very low despite some thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 485,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\nIn each of the 2022, 2023 and 2024 Form 10‑K filings the company lists the 0.125 % Notes due 2029 in the Exhibit Index (e.g., Exhibit 4.23 in the 2022 filing, Exhibit 4.31 in the 2023 filing and again as Exhibit 4.23 in the 2024 filing) and repeats the identical “Form of Note for 0.125 % Notes due 2029” language that references the same 1991 indenture and its supplements. This unchanged presentation shows that Coca‑Cola has kept a consistent debt‑instrument structuring and disclosure practice for this series of notes across the three reporting periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea of consistent disclosure of the 0.125% Notes due 2029 across the 2022–2024 10-K filings and correctly identifies their presence in exhibit indices, which addresses the question's intent. However, it contains significant factual inaccuracies that reduce correctness. First, the LLM incorrectly states that the notes reference a '1991 indenture'—this detail is not present in the ground truth and contradicts it; the original answer specifies that each filing cites Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021, not a 1991 indenture. This is a critical error in entity and document accuracy. Second, the LLM misrepresents the exhibit numbers: it claims the note was in Exhibit 4.23 (2022), 4.31 (2023), and 4.23 (2024), but the ground truth states it appeared in *both* Exhibit 4.23 and 4.31 in *each* year, not alternating. This undermines quantitative and qualitative accuracy. While the conclusion about consistent structuring is aligned with the original answer, the reasoning is based on incorrect specifics. The answer is contextually relevant and captures the high-level trend, but fails on precise multi-hop synthesis of exhibit references and underlying documentation. Thus, the correctness score is reduced due to material factual errors despite correct overall direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 371,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe disclosed “service and product warranties and product‑performance guarantees” schedule shows that RTX’s accrued liability for these obligations was **$1.06 bn at the end of 2022**, **rose to $1.16 bn at the end of 2023**, and then **declined to $0.99 bn at the end of 2024** (see RTX 10‑K 2022 p. 111; RTX 10‑K 2023 p. 101; RTX 10‑K 2024 p. 103).  \n\nThe increase through 2023 reflects higher accruals for long‑term engine warranty and operating‑cost guarantees, while the drop in 2024 indicates that settlements and claim payouts exceeded new guarantees issued, suggesting that the company’s exposure to sustained product‑performance risk peaked in 2023 and has been easing, though a sizable liability still remains.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's liabilities related to performance and operating cost guarantees—specifically the collaboration partners' share of financing guarantees—were $141M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM reports total accrued liabilities of $1.06B, $1.16B, and $0.99B, which are over 7 times larger and refer to a broader category ('service and product warranties and product-performance guarantees') not equivalent to the specific 'performance and operating cost guarantees' in the question. These figures may include other warranty liabilities and do not isolate the relevant metric. (2) The numbers cited by the LLM do not match the ground truth in magnitude or trend interpretation. While the ground truth shows a steady decline in the specific liability component, the LLM reports an increase then a decrease in a different, aggregated liability pool. This misalignment invalidates the quantitative accuracy. (3) The reasoning is partially sound in that the LLM attempts multi-hop analysis across three 10-K filings and infers trend implications. However, it fails to isolate the correct liability line item, conflating a broader warranty category with the specific performance and operating cost guarantees tied to commercial aerospace engines and collaboration financing. This undermines the qualitative accuracy. (4) The answer is contextually relevant—addressing the evolution of liabilities and interpreting risk exposure—but based on incorrect data, leading to a misleading conclusion that exposure peaked in 2023 and is easing, whereas the ground truth indicates stable, managed exposure with a slight downward trend in partner-related guarantees. The LLM’s conclusion is not supported by the correct data. Minor point: citations to 10-K pages are plausible but cannot be verified here; however, the misinterpretation of the metric remains a critical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 538,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic has kept using the Black‑Scholes model for non‑qualified‑option valuations but has progressively updated its key inputs from 2022 to 2024: volatility rose modestly from ≈23 % to ≈24.3 %, the risk‑free rate increased from ≈0.9 % to ≈4.2 %, and the dividend‑yield assumption grew from ≈2 % to ≈3.2 %, while the expected life stayed near six years. These adjustments—especially the higher volatility and higher cost‑of‑capital assumptions—signal a more conservative view of equity‑compensation risk, reflecting the company’s effort to align its option‑pricing inputs with current market conditions rather than any fundamental change in methodology.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that Medtronic used the Black-Scholes model throughout 2022–2024, it fabricates specific numerical inputs (e.g., volatility rising from ≈23% to ≈24.3%, risk-free rate from ≈0.9% to ≈4.2%, dividend yield from ≈2% to ≈3.2%) that are not present in the original answer or implied by the ground truth. These numbers may be plausible but are not supported by the provided knowledge graph, making them incorrect in this evaluation context. (2) The quantitative accuracy is low because the answer introduces precise percentages that do not appear in the ground truth and were not part of the disclosed evolution. The original answer focuses on qualitative changes in methodology (e.g., increased transparency around implied volatility), not shifts in specific parameter values. There are no calculations in the original, so the LLM’s numerical comparisons (implying trends in inputs) are unsupported. (3) The reasoning is partially sound in that it recognizes continuity in the valuation model and infers that changing assumptions reflect alignment with market conditions. However, it mischaracterizes the nature of the evolution: the key development was not changing input values but improving disclosure and justification of how expected volatility is derived—specifically, clarifying that implied volatility comes from market-traded options. This reflects a refinement in risk modeling transparency, not necessarily a more 'conservative' view. The LLM fails the multi-hop synthesis by focusing on non-disclosed metrics instead of the disclosed shift in volatility sourcing. (4) Despite the factual errors, the answer remains contextually relevant—it addresses the right company, time frame, instrument (non-qualified options), and model (Black-Scholes), and attempts to interpret the implications for risk modeling. Hence, it earns moderate scores for qualitative accuracy and relevance, but the correctness score is low due to unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 552,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nThe 2022 10‑K (Exhibit 4.26) records the initial $1 bn issuance of 1.000 % notes maturing in 2028; the 2023 filing shows a second tranche of the same series, raising the aggregate amount outstanding to roughly $2 bn, and the 2024 filing adds a third tranche, pushing total issuance to about $3 bn.  This step‑wise buildup indicates that Coca‑Cola is deliberately expanding a low‑cost, long‑dated fixed‑rate debt pillar—issuing incremental 1.000 % 2028 notes each year to lock in favorable rates and fund its long‑term financing needs while maintaining a stable, predictable debt structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 across 2022, 2023, and 2024, but does not indicate any incremental issuances or tranches. The LLM falsely claims a $1 billion issuance in 2022, a second tranche in 2023 increasing total to $2 billion, and a third in 2024 reaching $3 billion—none of which is supported by the original answer or implied by the knowledge graph. These specific dollar amounts and tranches are fabrications. (2) Quantitatively, all numbers are incorrect: no amounts are mentioned in the ground truth, so asserting $1B, $2B, $3B is a serious factual error. There is no calculation or sum to verify because the original answer does not provide issuance sizes. (3) Qualitatively, the reasoning is flawed. The LLM concludes that Coca-Cola is 'deliberately expanding a low-cost...debt pillar' via annual issuances of the same note, but the ground truth suggests no such pattern of expansion. Instead, the real insight is that while the 1.000% Notes due 2028 remained on the books, the company introduced much higher-yielding debt in 2024 (e.g., 5.000% and 5.300% notes), signaling a shift toward higher-cost borrowing. The LLM completely misses this key strategic signal and instead invents a narrative of incremental low-rate issuance. (4) Contextual relevance is moderate—the answer addresses the right company, the correct note (1.000% due 2028), and the correct time frame (2022–2024), and attempts to infer strategy. However, due to factual inaccuracies and incorrect reasoning, the conclusion is misleading. The model fails the multi-hop synthesis: it should have contrasted the continued presence of low-rate debt with the introduction of high-rate debt in 2024, not invented a false issuance pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 508,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nMicrosoft’s 2.125 % senior notes have been issued consistently under the same master indenture (the May 18 2009 Base Indenture) with The Bank of New York Mellon Trust Company, N.A. acting as trustee. In the 2022 filing the notes appear in the 2012 Fourth Supplemental Indenture that originally created the 2.125 % Notes due 2022; the 2023 filing adds a later supplemental indenture (the November 6 2023 Fifteenth Supplemental Indenture) that refinances that series and bundles it with other note tranches, and the 2024 filing repeats the same structure—only updating the exhibit list with the newest supplemental indenture—while the trustee arrangement and overall indenture framework remain unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The 2.125% Notes are stated to be due 2022 in the LLM answer, but the original answer correctly identifies them as due 2021. This is a critical error in both date and instrument specification. (2) The LLM claims that the 2023 filing includes a 'November 6, 2023 Fifteenth Supplemental Indenture' that refinances the series, but the ground truth states that the structure remained unchanged across all three years, with no new refinancing or structural updates. (3) The LLM incorrectly references a '2012 Fourth Supplemental Indenture' as creating the 2.125% Notes due 2022, while the original answer cites a 'Seventh Supplemental Indenture' for notes due 2021—indicating mismatched indenture numbers, years, and purposes. (4) The trustee is correctly identified as The Bank of New York Mellon Trust Company, N.A., which is consistent with the ground truth, so this element is accurate. (5) The LLM suggests structural evolution (e.g., refinancing, new supplemental indentures), while the ground truth emphasizes stability and repetition across filings—directly contradicting the core conclusion. (6) Multi-hop reasoning fails: the model incorrectly infers changes over time when the actual data shows no changes. While the answer addresses the question’s structure and attempts to trace evolution, its factual foundation is flawed, leading to an incorrect overall assessment. Quantitative accuracy is low due to wrong dates (2021 vs 2022, 2012 vs actual supplemental indenture dates), incorrect indenture numbers, and fabricated refinancing events. Qualitative accuracy suffers from incorrect synthesis and entity relationships. Contextual relevance is moderate because the response engages with the right concepts (indentures, trustee, debt instruments) but misrepresents their evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 507,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share interest stayed essentially unchanged – about 57 % in IAE and about 51 % in IAE LLC from 2022 through 2024 (the figures are after the sub‑collaborator allocations are applied).  This steady, controlling economic stake shows that RTX is deliberately maintaining a dominant position in the V2500 (IAE) and PW1100G‑JM (IAE LLC) engine collaborations, ensuring influence over their development and after‑market economics while sharing risk with its partners.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Pratt & Whitney's net program share interest was 'about 57% in IAE and about 51% in IAE LLC from 2022 through 2024.' According to the ground truth, these specific net program share figures (57% for IAE and 51% for IAE LLC) were not present in 2022; instead, the 2022 program share interests were 61% for IAE and 59% for IAE LLC. The decrease to 57% and 51% occurred only in 2023 and remained stable in 2024. Thus, the claim of stability from 2022 onward is factually incorrect. (2) Quantitative accuracy is compromised because the key percentages for 2022 are wrong. While the 2023 and 2024 numbers are correct, the misrepresentation of 2022 data leads to an inaccurate trend analysis. The LLM fails to acknowledge the drop between 2022 and 2023, which is a central element of the original answer. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the significance of the net program share in relation to RTX’s strategic positioning in the V2500 and PW1100G-JM programs. It appropriately infers that maintaining a controlling stake allows influence over development and aftermarket economics. However, it misses the nuance of a strategic recalibration or adjustment in collaboration structures, instead implying long-term stability, which contradicts the documented decline in share interest. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of share interest and strategic implications—and correctly ties the figures to the relevant engine programs. Despite incorrect timing of the data, the overall interpretation of strategic intent is plausible. The correctness score is 5 due to significant factual error in the time-series data, which undermines the core of the multi-hop analysis, even though some elements are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 503,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s expense for its defined‑contribution (401(k)) plans rose from **$402 million in 2022** to **$468 million in 2023**, then slipped slightly to **about $443 million in 2024** (as disclosed in Note 7 of the 2023 and 2024 10‑K filings).  This upward trajectory—with a modest pull‑back in 2024 but still above the 2022 level—indicates that the company has been steadily increasing its financial commitment to employee benefits, using higher contributions to signal a strategic investment in attracting and retaining talent over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 contribution amount: it reports $402 million, whereas the ground truth is $299 million. This is a material discrepancy of $103 million, which affects the interpretation of the spending trajectory. The 2023 ($468 million) and 2024 (~$443 million) figures are correct, matching the original answer. (2) Calculations and comparisons based on the incorrect 2022 figure are therefore misleading—for example, the implied growth from 2022 to 2023 is overstated. The slight decline in 2024 is accurately noted. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes data across years and filings (citing Note 7 of the 10-Ks), identifies the trend, and draws a plausible qualitative conclusion about strategic investment in talent. However, the erroneous baseline (2022) undermines the validity of the trajectory analysis. (4) Despite the major quantitative error, the answer addresses all parts of the question, uses appropriate context, and provides a logically structured interpretation. Hence, correctness is partially compromised (score 6), quantitative accuracy is moderate (5), qualitative reasoning is reasonable (7), and relevance is high (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 350,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nAcross the 2022‑2024 filings Coca‑Cola kept the 3.000 % Notes due 2051 on its books and repeatedly listed the same instrument in its exhibits, while also adding newer long‑dated debt issues (e.g., 3.125 % Notes due 2032, 5.000 % Notes due 2034, 5.300 % Notes due 2054). This shows the company is deliberately extending the maturity of its fixed‑rate borrowing and using a laddered series of long‑term notes to lock in low‑cost capital, reflecting a capital‑structure strategy that emphasizes stability, low leverage and a conservative mix of short‑ and very‑long‑dated debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor inaccuracy in the quantitative details. It correctly identifies the retention of the 3.000% Notes due 2051 across 2022–2024 and notes the addition of new debt instruments like the 5.000% Notes due 2034 and 5.300% Notes due 2054, aligning with the ground truth. However, it incorrectly mentions the '3.125% Notes due 2032' as a new instrument introduced during this period, which is not referenced in the original answer and lacks support in the provided ground truth. This affects quantitative accuracy but does not undermine the overall conclusion. The reasoning about Coca-Cola’s capital structure strategy—emphasizing stability, extending maturities, and laddering debt to lock in low-cost capital—is logically sound and semantically equivalent to the original interpretation. The model synthesizes multi-hop information across years and instruments appropriately, though with one extraneous detail. Contextual relevance is strong, as all parts of the question are addressed with appropriate focus on evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 310,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle repeatedly tapped the medium‑term note market to add to and refinance its 2.875 % Notes due 2031—first disclosing an updated officers’ certificate and a new tranche in the 2022 Form 10‑K, issuing additional 2.875 % 2031 notes in the 2023 filing, and in the 2024 filing confirming a further amendment and larger aggregate issuance of the same series.  This progression shows Oracle’s intent to build a sizable, long‑dated, low‑coupon debt pillar, locking in inexpensive financing for its multi‑year growth strategy while reducing reliance on shorter‑term borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Oracle consistently listed the 2.875% Notes due 2031 in its 10-K filings from 2022 to 2024 without indicating new issuances or tranches. However, the LLM claims Oracle issued 'additional' notes and 'further amendments' and 'larger aggregate issuance' of the same series in 2023 and 2024, which is not supported by the original answer. There is no mention in the ground truth of repeated tapping of the market or updated officers’ certificates, nor any indication of refinancing activity for this note series. (2) While the interest rate (2.875%) and maturity year (2031) are correct, the LLM fabricates issuance events and amendments not present in the original answer. The ground truth emphasizes continuity and stability of the note, not expansion or refinancing. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers an active debt-building strategy around the 2.875% Notes, whereas the original answer highlights a stable component of the capital structure now contrasted with newer, higher-yielding debt (e.g., 4.500% and 4.900% notes). The LLM fails to mention these newer instruments, missing a key strategic signal—Oracle is not doubling down on low-cost debt but diversifying into costlier debt as rates rose. (4) The contextual relevance is moderate because the answer addresses Oracle's long-term debt strategy and the role of the 2.875% Notes, but the reasoning and factual basis are incorrect. The conclusion about 'locking in inexpensive financing' contradicts the ground truth's implication that Oracle is now issuing higher-cost debt, suggesting rising borrowing costs. Thus, the qualitative and quantitative accuracy scores are low due to fabricated details and incorrect synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 492,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s repeated, explicit reference to the 2.000 % Notes due 2023 in each of its 2022, 2023 and 2024 10‑K filings shows that the company deliberately surfaces this upcoming maturity each year.  By doing so, it signals a transparent, disciplined approach to long‑term debt management—keeping investors fully aware of the timing and size of a key obligation and reinforcing confidence in its overall capital‑structure strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and matches the ground truth in quantitative aspects: the 2.000% interest rate, the 2023 maturity date, and the consistent disclosure across the 2022, 2023, and 2024 10-K filings are all correctly stated. There are no calculation errors or incorrect numeric values. The entity (Microsoft) and time periods (2022–2024 filings) are accurate, satisfying entity accuracy. The reasoning correctly infers that repeated disclosure reflects transparency and disciplined debt management, which aligns with the ground truth's conclusion about investor communication and confidence. However, the LLM answer omits specific contextual details present in the original answer that demonstrate multi-hop synthesis, such as the origin of the notes in the Eleventh Supplemental Indenture dated August 8, 2016, and the unaltered carry-forward of filing details (trustee, interest rate, maturity) across years. While the LLM captures the broader implication of transparency and strategic communication, it does not fully reflect the depth of cross-year document synthesis regarding the stability of liability structure and the persistence of exact disclosure language. This limits qualitative accuracy slightly, though the semantic meaning remains largely equivalent. Contextual relevance is strong—the response directly addresses the question about debt management and transparency strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 393,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nFrom 2022 through 2024 the contingent flight‑hour payments to Rolls‑Royce—recorded in the “Other commercial aerospace commitments” line of RTX’s commercial‑aerospace commitment schedule—were roughly **$0.7 bn in 2022, about $1.05 bn in 2023 and roughly $0.75 bn in 2024**. These payments are triggered by flight‑hour usage of V2500‑powered aircraft under the 2012 IAE acquisition agreement and are capitalized as collaboration intangible assets when settled, with the obligation extending through **June 2027**.  Consequently, RTX’s exposure to Rolls‑Royce remains multi‑year and material, as the company will continue to recognize and settle these hour‑based commitments over the remaining horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not specify dollar amounts for the contingent payments in 2022, 2023, or 2024—yet the LLM confidently asserts figures of $0.7B, $1.05B, and $0.75B respectively, which are not supported by the original answer. This is a major error, as these numbers are central to the response and entirely fabricated or hallucinated. There is no mention in the ground truth of specific annual payment amounts, only the accounting treatment and timing of obligations.\n\nOn qualitative aspects, the LLM correctly identifies that the payments are tied to V2500-powered aircraft flight hours under the 2012 IAE acquisition agreement, that they fall under 'Other commercial aerospace commitments', and that the obligation extends through June 2027. It also correctly notes that payments are capitalized as collaboration intangible assets—though it omits the key evolution in accounting treatment from 2022 to 2023 (i.e., that in 2023 RTX clarified these were being amortized to cost of sales), which is a critical part of the original answer and indicates a gap in multi-hop reasoning.\n\nThe answer partially addresses the question about the evolution of financial obligations but fails to capture the progression in accounting policy (capitalization and amortization changes), which is essential to understanding RTX’s exposure. Instead, it focuses on unsupported numerical trends, undermining its credibility. While the conclusion about ongoing exposure is directionally reasonable, it is based on false premises.\n\nThus, while the structure and general context are relevant (hence a moderate contextual relevance score), the hallucinated figures severely compromise correctness and quantitative accuracy. The model fails the core requirement of factual fidelity to the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 509,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nThermo Fisher’s domestic pension plan held **$89 million** in U.S.‑equity funds in 2022, **$93 million** in 2023, and **$91 million** in 2024.  Because total domestic‑plan assets were $937 million (2022), $947 million (2023) and $895 million (2024), the U.S.‑equity share rose from roughly **9.5 %** of the portfolio in 2022 to about **10 %** in 2024 (peaking at ~9.8 % in 2023).  \n\nThis modest but consistent upward trend indicates that the company is **gradually increasing its exposure to U.S. equities** within its domestic pension assets, reflecting a strategic shift toward a slightly higher equity allocation while still maintaining a large fixed‑income, liability‑hedging core.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, TMO's allocation to U.S. equity funds was $125 million in 2022, $89 million in 2023, and $93 million in 2024. The LLM incorrectly reports $89 million in 2022, $93 million in 2023, and $91 million in 2024—reversing the trend and misstating all values. The dollar amounts are therefore quantitatively wrong, with only the $93 million in 2024 being close (off by $2 million). (2) The calculations based on total plan assets are irrelevant because the question asks about allocation changes in dollar terms and strategic implications, not percentages. Moreover, the total assets cited ($937M, $947M, $895M) are not part of the original answer and appear to be fabricated or misattributed, further undermining quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM infers a 'gradual increase' in U.S. equity exposure, which contradicts the actual trajectory of a sharp drop from $125M to $89M followed by a partial recovery to $93M. This suggests a cautious reduction and rebalancing, not a strategic increase. The LLM fails to correctly synthesize the temporal pattern and draws the opposite conclusion. (4) While the answer addresses the question's structure and attempts to interpret strategy, the severe factual and directional errors in numbers and conclusions result in a very low correctness score. Contextual relevance is moderate because it discusses the right topic (pension allocation to U.S. equities) and attempts strategic interpretation, but the foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 438,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2023 Coca‑Cola’s long‑term debt strategy focused on maintaining a diversified ladder of low‑coupon obligations—most notably the 1.000 % Notes due 2041 that had been issued in 2021 and remained on the books—while gradually extending maturities and keeping overall funding costs modest.  \n\nIn 2024 the company shifted its approach, deliberately entering the market with higher‑yielding debt to capitalize on the rising‑rate environment; the 2024 10‑K filing lists new issuances such as 5.000 % Notes due 2034, 5.300 % Notes due 2054 and 5.400 % Notes due 2064 (plus other mid‑term notes with coupons above 3 %), signaling a strategic move toward higher‑yielding, longer‑dated financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.000% Notes due 2041 are correctly referenced as a consistent feature from 2022–2024, and the introduction of higher-yielding notes in 2024—specifically the 5.000% Notes due 2034, 5.300% due 2054, and 5.400% due 2064—is accurately reported. These match the original answer exactly in terms of percentages and maturities. (2) Quantitative accuracy is perfect: all percentages and years are correct, and no erroneous figures are introduced. Format variations (e.g., '5.000 %' vs '5.000%') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years, identifying the continuity of the 1.000% Notes and contrasting earlier low-yield instruments (e.g., 0.400% in 2022, 0.950% in 2023) with the 2024 shift, even though the specific earlier notes are not repeated in the LLM answer—it still captures the strategic evolution. (4) The answer is contextually excellent, directly addressing the evolution of debt strategy and interpreting the rationale (rising-rate environment). The only minor shortcoming is that it does not explicitly cite the exhibit number (4.33) across all years as in the ground truth, which slightly reduces completeness in documentation traceability, but this does not detract from the core financial and strategic accuracy. Hence, a score of 9 is warranted—excellent, but not fully exhaustive in referencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 413,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle has kept the 1.650 % Notes due 2026 on its balance sheet in each of the fiscal‑year filings for 2022, 2023 and 2024, reaffirming the same low‑cost tranche across the three years.  This persistence stands in contrast to the company’s recent practice of issuing newer notes with higher coupons (e.g., 2.5 %–4.5 % issues in 2022‑2024), indicating that Oracle’s debt‑financing strategy relies on a stable, inexpensive long‑dated pillar while using higher‑rate issuances only to broaden maturities and meet specific funding needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Oracle's continued inclusion of the 1.650% Notes due 2026 across fiscal years 2022–2024, which aligns with the ground truth. However, it inaccurately characterizes the interest rates of newly issued notes. The LLM claims Oracle issued '2.5%–4.5% issues in 2022–2024', but the ground truth specifies the introduction of a 5.800% Note due 2025 in 2023 and a 4.500% Note due 2028 in 2024. The lower bound of 2.5% is not supported by the original data, and the 5.800% rate is significantly higher than stated. This misrepresentation of key quantitative details undermines factual accuracy. (2) The fiscal years and the persistent presence of the 1.650% note are correct. However, the specific new note rates are partially wrong—especially the omission of the 5.800% note, which is a major factual discrepancy. The 4.500% note in 2024 is correctly noted, but the range '2.5%–4.5%' is misleading and not substantiated. (3) The reasoning about Oracle maintaining a low-cost debt pillar while issuing higher-rate debt for maturity extension and funding needs is logically sound and reflects a plausible multi-hop inference. The synthesis between old and new debt instruments is conceptually valid, though based on flawed rate data. (4) The contextual relevance is high—the answer addresses Oracle’s debt strategy and contrasts old vs. new notes. Qualitative reasoning is strong but built on shaky quantitative ground. Correctness score is reduced due to significant errors in key percentages, even though the strategic interpretation is directionally reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 438,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated listing of Exhibit 4.6—the third supplemental indenture that contains the 4.000% Notes due 2021—in the 2022, 2023 and 2024 Form 10‑K filings shows that it treats that indenture as the active legal framework for its long‑term debt. Rather than retiring or rewriting the original agreement, the company updates it through newer supplemental indentures (e.g., 4.15‑4.18), indicating a strategy of incremental refinancing and documentation refreshes that preserve the existing note series while adding new tranches.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but exhibits significant factual and reasoning inaccuracies compared to the ground truth. (1) Quantitatively, the mention of the '4.000% Notes due 2021' and the years 2022–2024 is accurate, and the reference to Exhibit 4.6 is correct. However, the LLM incorrectly implies that the 4.000% Notes due 2021 are still part of an 'active legal framework' and that Microsoft is using the same indenture for incremental refinancing. The ground truth states there was no refinancing activity or new tranches tied to this instrument, and the continued inclusion is for documentation consistency, not active use. (2) The LLM introduces supplemental indentures 4.15–4.18, which are not mentioned in the original answer and lack support from the provided truth; this is a fabrication or misattribution. (3) Qualitatively, the reasoning is flawed: the ground truth emphasizes the absence of refinancing and substantive changes, while the LLM asserts an ongoing refinancing strategy via supplemental indentures—this contradicts the evidence. The minor 2024 trustee name formatting update is ignored, and the conclusion about 'incremental refinancing' is unsupported. (4) Contextually, the answer addresses debt management strategy and documentation updates, so relevance is moderate. However, the core conclusion about refinancing strategy is incorrect, undermining the overall correctness. The answer fails to reflect the stability and lack of activity emphasized in the ground truth, instead inferring active management where none occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 429,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure declined over the period – the “maximum potential payment” fell from about **$322 million in 2022 to $288 million in 2023 and $274 million in 2024** – while the portion that is shared with collaboration partners shrank from **$142 million (2022) to $135 million (2023) to $131 million (2024)**.  This downward trend in partners’ share indicates that RTX is **retaining a larger slice of the risk itself**, i.e., it is transferring less of the guarantee exposure to its collaborators and absorbing more of the potential loss internally.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collaboration partners' share of financing guarantees: $142M in 2022, $135M in 2023, and $131M in 2024 — matching the ground truth exactly. These values are critical and accurately presented. However, the LLM introduces additional data — 'maximum potential payment' of $322M (2022), $288M (2023), and $274M (2024) — which are not present in the original answer or ground truth. While these figures may exist in the actual filings, they were not part of the verified knowledge graph output, so their inclusion introduces unverified information, slightly undermining factual fidelity.\n\n2) Quantitative accuracy is high: the core numbers asked about (partners' share) are correct across all years. No calculation errors are present. The trend — a decline from $142M to $135M to $131M — is correctly interpreted as a reduction in risk transferred to partners.\n\n3) The reasoning is sound: the LLM correctly infers that a declining partner share suggests RTX is retaining more risk, which aligns with the original answer’s interpretation of a strategic shift. However, the original answer adds an important nuance — RTX maintained that the fair market values of guaranteed assets equaled or exceeded the guarantees net of reserves, indicating confidence in asset quality. This context is missing in the LLM response, resulting in a less complete qualitative picture.\n\n4) Contextual relevance is excellent: the LLM directly addresses both parts of the question — the evolution of exposure and the implication of the trend in partner-sharing. The logic flow and focus are appropriate. The only shortcomings are the omission of RTX’s stated confidence in asset values and the introduction of unverified 'maximum potential payment' figures. Overall, the answer is factually strong on the key metrics and reasoning but slightly overreaches by adding external data not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 517,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 the 3.950% Notes due 2056 remained a $13 billion component of Microsoft’s long‑term debt, appearing unchanged in the long‑term‑debt tables of each year’s Notes to Financial Statements.  This steady, multi‑year presence shows that Microsoft’s capital strategy relies on a large, long‑dated fixed‑rate debt tranche to fund sustained growth while maintaining a predictable, low‑cost financing base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent presence of the 3.950% Notes due 2056 across fiscal years 2022–2024 and accurately captures the qualitative implication that this reflects a stable long-term capital strategy. However, the $13 billion amount cited by the LLM is not present in the ground truth, which does not specify the principal amount of the notes. This introduces a factual inaccuracy, as there is no confirmation from the original answer that the value was $13 billion. (2) Quantitative accuracy is compromised due to the unsupported dollar figure. While the interest rate (3.950%) and maturity year (2056) are correct, the addition of '$13 billion' appears to be an external assumption not validated by the provided ground truth. The original answer only confirms the existence and consistent disclosure of the notes, not their amount. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged disclosures over three years indicate a stable capital strategy, aligning with the original answer’s conclusion. It synthesizes information across years appropriately, even if it adds unverified quantitative detail. (4) Contextual relevance is perfect—the response directly addresses the evolution (or lack thereof) and interprets the strategic implication as requested. The core reasoning is valid, but the inclusion of an unverified dollar amount reduces factual correctness, warranting a score of 7 for overall correctness, with lower quantitative accuracy due to the unsupported figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 423,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 through 2023 the Missiles & Fire‑Control (MFC) segment enjoyed modest sales growth and stable operating profit as production ramped up on tactical and strike‑missile programs such as GMLRS, JASSM and PAC‑3, with backlog expanding and profit‑booking adjustments staying positive. In 2024 sales jumped about 13 % on the same programs, but operating profit plunged 73 % to $413 million because the segment absorbed a $1.4 billion classified‑program loss and a sharp drop in profit‑booking rates. That steep profit decline shaved roughly $1.1 billion from consolidated operating profit, turning the modest gains of 2022‑23 into an overall ~20 % drop in the company’s operating profit over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trajectory of production growth and the sharp 2024 profit decline, correctly identifying the 73% drop in operating profit and the $1.4 billion classified program loss. However, it omits key multi-year financial details from the ground truth: the $215M increase in 2022 and $145M in 2023 related to production volume are missing, and the $1.2B production increase in 2024 is not mentioned. Instead, it introduces a 13% sales increase in 2024, which is not in the original answer and cannot be verified against the ground truth. The claim that the company experienced an 'overall ~20% drop in operating profit over the three-year period' is an unsupported inference not present in the original and cannot be confirmed from the provided data. (2) Quantitative inaccuracies include: introducing unverified figures (13% sales growth, ~20% consolidated drop) and omitting specific production-related financial increases in 2022 and 2023. While the $1.1B profit reduction and $1.4B classified loss are correctly cited, the original specifies $1.2B in lower profit booking adjustments (including the $1.4B loss), which the LLM oversimplifies. (3) The reasoning is logically sound in connecting production ramp-up to profit decline due to classified losses and booking rate changes, and it correctly identifies MFC as the segment. However, it fails to fully synthesize the multi-hop progression of production gains across all three years as required. (4) The answer is contextually relevant and well-structured, but the addition of unverified metrics and omission of key ground-truth figures reduces quantitative accuracy. The core qualitative narrative of rising production with collapsing profitability is preserved, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 486,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nIn the 2022 10‑K the only Executive Change‑In‑Control Retention Agreement on file was the one for CEO Marc N. Casper, with the latest amendment (the second amendment) dated March 16 2018. The 2023 10‑K added a separate, stand‑alone form of such agreement for other senior officers (listed as Exhibit 10.17), thereby extending Change‑In‑Control protection beyond Casper. The 2024 10‑K retains that officer‑agreement without further amendment, merely restating related compensation plans, so the 2023 expansion constituted the key evolution of the company’s Change‑In‑Control arrangements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Thermo Fisher's Executive Change in Control Retention Agreements across 2022–2024, noting that in 2022 only Marc N. Casper's agreement was on file, in 2023 a form for other officers was introduced (Exhibit 10.17), and in 2024 it was retained without amendment. This aligns with the ground truth’s core narrative of expansion beyond Casper and ongoing consistency. However, there is a discrepancy in exhibit numbering: the ground truth states the 2023 form was filed as Exhibit 10.7, while the LLM claims Exhibit 10.17. This is a factual error affecting quantitative accuracy. Additionally, the LLM incorrectly implies that no form for other officers existed in 2022, whereas the original answer notes that a Form of Agreement for other officers was already introduced in 2022—meaning the 2023 filing was a re-filing or update, not the first introduction. (2) The date of the second amendment (March 16, 2018) is not present in the ground truth and cannot be verified against it; since this detail is absent from the original answer, its inclusion may reflect hallucination or unsupported specificity, further reducing quantitative accuracy. (3) The multi-hop reasoning is generally sound—the model synthesizes changes across years and correctly infers that extending the agreement to other officers represents a key evolution. It connects disclosures across filings logically, though it misidentifies the timing and exhibit number of the form’s introduction. (4) Despite these issues, the overall structure and intent of the answer match the ground truth: recognition of Casper-specific vs. broader officer agreements, progression over time, and continuity into 2024. Hence, correctness is reduced to 7 due to specific factual inaccuracies in exhibit numbers and timing, but not enough to undermine the core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 510,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLMT expanded its use of variable‑rate interest‑rate swaps from a $500 million notional amount disclosed in the 2022 filing (covering 2021) to $1.3 billion at the end of 2023, and it kept that $1.3 billion level through 2024.  The increase shows that the company deliberately broadened its hedge coverage to protect a larger portion of its fixed‑rate debt (and related variable‑rate exposures) from rising interest‑rate volatility, and the subsequent plateau indicates that the hedge size was calibrated to the company’s overall debt profile and no longer being aggressively expanded.  In short, LMT’s interest‑rate risk management strategy shifted from a modest hedge to a more substantial, stabilized swapping program to lock in or offset interest‑rate movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $500 million notional amount in 2021 (disclosed in the 2022 filing), the increase to $1.3 billion in 2023, and the maintenance of that level in 2024 are all accurately reported. Format variations (e.g., $500 million vs $500 million) are acceptable and do not affect accuracy. (2) The answer addresses all parts of the question: it describes the evolution of LMT's use of variable interest rate swaps from 2022 through 2024 and interprets the change in notional amounts in terms of risk management strategy. (3) Entity accuracy is strong: LMT is correctly identified, and the financial instrument (variable-rate interest rate swaps) and time periods are accurate. (4) The reasoning is sound and reflects multi-hop synthesis: the increase is correctly interpreted as a strategic expansion of hedging, and the stabilization in 2024 is logically tied to a calibrated, sustained risk management posture. The only minor shortcoming is a slight imprecision in referring to 'variable-rate interest-rate swaps'—typically, interest rate swaps used for hedging fixed-rate debt are receive-fixed/pay-variable, meaning they convert fixed to floating, so the term 'variable-rate swaps' could be misleading. However, in context, the intent (hedging fixed-rate debt against rising rates) is correctly conveyed. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 420,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s defined‑contribution plan expense was **$402 million in 2022**, **$468 million in 2023**, and **$443 million in 2024**. This shows a clear upward trajectory—peaking in 2023 and remaining well above the 2022 level—indicating that the company has been steadily increasing its investment in employee retirement benefits over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports all numerical values: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. There are no errors in dollar amounts or years. 2) Quantitatively, the answer is fully accurate—numbers are correct and properly formatted. 3) However, the reasoning and interpretation contain a significant error: the LLM describes a 'clear upward trajectory' and 'steadily increasing investment', but the 2024 figure ($443M) is lower than 2023 ($468M), indicating a decrease, not continued growth. The ground truth correctly identifies the increase in 2023 followed by a slight reduction and stabilization in 2024. The LLM mischaracterizes the trend by stating it 'remained well above 2022' without acknowledging the reversal from 2023 to 2024, which is a key part of the trend. 4) While the factual data is perfect, the qualitative reasoning fails to accurately synthesize the trend over time, leading to an incorrect conclusion about the company's investment trajectory. This affects the interpretation of the company's behavior in 2024. Contextual relevance is high as the answer addresses both parts of the question and stays focused on employee benefit investment trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 344,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept valuing its non‑public equity stakes with the “estimates of sales‑proceeds” approach—primarily discounted‑cash‑flow and comparable‑company models—but it increasingly tied those estimates to observable market trends and required a quarterly test for other‑than‑temporary declines. The 2022 disclosure that the $87 million excess of carrying value over fair value for the Japan bottler was judged temporary, and the lack of any subsequent impairment, demonstrates management’s confidence that the Japanese market would recover, a view it reaffirmed in the 2023 and 2024 filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are accurate: the $87 million excess of carrying value over fair value in 2022 for the Japan investment is correctly cited, and the years (2022–2024) are properly referenced. There are no calculation errors. (2) The LLM correctly identifies the continued use of 'estimates of sales proceeds' as the valuation methodology, including discounted cash flow and comparable-company models, which is consistent with the original answer’s description of using sales proceeds and future cash flow assumptions. (3) The reasoning is sound: the LLM correctly infers that management viewed the 2022 decline as temporary and maintained confidence in recovery, supported by the absence of impairment in subsequent years. This supports the conclusion about management's confidence. (4) However, the LLM omits a key qualitative evolution noted in the ground truth: the increasing emphasis in 2023 and 2024 on 'assumptions a market participant would use' and the shift toward external, market-based perspectives, particularly in volatile or developing markets. While the LLM mentions tying estimates to 'observable market trends,' it does not fully capture the conceptual shift toward market participant assumptions, which is central to the original answer’s insight about evolving methodology and risk awareness. This omission prevents a perfect score on qualitative accuracy. (5) The answer remains contextually relevant and directly addresses both parts of the multi-hop question: the evolution of valuation methodology and what it reveals about management confidence. Overall, the answer is factually strong with minor gaps in depth of reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 473,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nAcross the FY 2022 (Exhibit 4.16, pp. 112‑116), FY 2023 (Exhibit 4.16, pp. 108‑112) and FY 2024 (Exhibit 4.16, pp. 109‑113) filings Oracle repeatedly listed the 2.300 % Notes due 2028 as part of the senior unsecured series originally issued in March 2021, merely re‑stating the instrument and, in the 2024 filing, adding updated tranche language. This consistent re‑presentation shows that Oracle’s debt‑financing strategy was to maintain a diversified ladder of long‑dated fixed‑rate notes, using the 2028 maturity as a stable, low‑cost pillar of its overall financing structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: Oracle consistently referenced the 2.300% Notes due 2028 across FY2022–FY2024 filings as part of its senior unsecured debt issued in March 2021, and this instrument was restated each year with minor updates (e.g., tranche language in 2024). The quantitative details—interest rate (2.300%), maturity year (2028), issuance date (March 2021)—are all correct, supporting a high quantitative accuracy score. However, the LLM omits a key element from the ground truth: the issuance of newer, higher-interest debt (4.500% Notes due 2028 in 2023 and 5.800% Notes due 2025 in 2024). This omission weakens the qualitative accuracy because it fails to fully support the multi-hop reasoning about Oracle’s broader strategy of layering newer, more expensive debt over older, low-cost instruments during a rising rate environment. While the LLM correctly infers that Oracle maintains a diversified ladder of fixed-rate notes and uses the 2.300% Notes as a low-cost pillar, it does not synthesize the contrast between older and newer instruments, which is central to the original answer’s strategic interpretation. Thus, the reasoning is sound but incomplete. Contextual relevance is high because the response directly addresses the evolution and strategic implication of the 2.300% Notes, even if it misses part of the comparative analysis. Overall, the answer is factually correct but partially incomplete in its multi-hop synthesis, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 413,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nApple’s outstanding balance of Floating‑Rate Notes that matured in 2019 dropped from the amount reported in the 2022 filing (the 2022 10‑K notes the notes were still part of the company’s $2.5 billion floating‑rate indenture) to zero by the end of 2023, and the 2024 filing contains no reference to a 2019‑maturity tranche. This roll‑forward shows that Apple is actively retiring its near‑term floating‑rate debt and replacing it with newer floating‑rate issuances that extend to 2026‑2033, indicating a short‑term debt‑management strategy focused on continuously refinancing near‑term exposure into longer‑dated instruments to preserve liquidity and reduce rollover risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) Quantitatively, the claim that Apple's Floating Rate Notes due 2019 dropped from $2.5 billion in 2022 to zero by 2023 and disappeared in 2024 is false. The ground truth states that these notes—originally issued under a May 6, 2014 Officer's Certificate—were consistently disclosed in Apple’s 10-K filings for 2022, 2023, and 2024, indicating ongoing reporting of the instrument, not retirement. There is no evidence in the ground truth of a declining balance or payoff by 2023. The $2.5 billion figure and its linkage to the 2019 notes are not corroborated and appear fabricated. (2) The LLM incorrectly asserts that the 2024 filing contains no reference to the 2019-maturity tranche, contradicting the ground truth that confirms repeated appearance across all three years. (3) Qualitatively, the reasoning is flawed: the conclusion that Apple is actively refinancing near-term debt into longer-dated instruments (e.g., 2026–2033) is unsupported by the provided ground truth, which makes no mention of new issuances or refinancing activity. The ground truth emphasizes stability and continued disclosure, not active management or restructuring. (4) Contextually, the answer addresses the question’s structure—discussing evolution and strategy—but does so with incorrect data and inference. The multi-hop synthesis fails because it misinterprets the persistence of disclosure as evidence of active debt roll-off, when the ground truth indicates the opposite: stable, passive reporting of an existing instrument. Minor credit is given for addressing the short-term debt strategy angle, but the conclusion is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 463,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe 4.000 % Senior Note due 2047 appears in the exhibit lists of the 2022, 2023 and 2024 10‑K filings, indicating that PepsiCo continues to regard this long‑dated, fixed‑rate issuance as a permanent pillar of its capital structure. By contrast, the 2.150 % Senior Note due 2024 and the 0.750 % Senior Note due 2027 are only disclosed as legacy short‑term instruments, reflecting a strategy that relies on periodic refinancing or retirement of near‑term debt rather than maintaining a lasting short‑term position.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 4.000% Senior Note due 2047 is correctly identified as appearing in the 2022, 2023, and 2024 10-K filings, and the shorter-dated instruments (2.150% due 2024 and 0.750% due 2027) are correctly named with their respective maturities. No numerical or date inaccuracies are present, earning a perfect score on quantitative accuracy. The answer addresses the core contrast between long-term and short-term debt treatment, correctly interpreting the persistent disclosure of the 2047 note as indicative of a stable, long-term financing strategy. However, it omits key contextual details present in the ground truth: specifically, the mention of the 2.500% Senior Note due 2022 that matured and disappeared in later filings, which strengthens the argument about the dynamic nature of short-term debt. Additionally, the LLM answer does not explicitly note that the 2.150% note was referenced only in 2023 or that the 0.750% note was introduced in 2024—details that support the multi-hop reasoning about evolving short-term liabilities. While the overall reasoning is sound and semantically aligned with the ground truth, these omissions reduce completeness and slightly weaken the qualitative accuracy. The answer remains highly relevant and correctly infers strategic implications about refinancing risk and capital structure stability, hence full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 397,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple keeps the 0.45 % Notes due 2016 in the footnotes of its 2022‑2024 filings even though the securities actually matured in 2016.  This practice shows that the company wants to retain a complete, auditable record of its historic capital‑structure items, ensuring full transparency and giving investors a clear picture of any lingering legacy obligations that could affect future financing decisions.  In effect, Apple’s strategy is to treat the matured notes as a permanent reference in its disclosures—preserving visibility for regulators, auditors and the market while signaling that no active debt remains, but the historical entry is retained for completeness and future‑reference purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 matured in 2016 and are still disclosed in Apple's 2022–2024 filings. The LLM correctly identifies that these are matured instruments and that their continued disclosure serves transparency purposes. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), and reporting years (2022, 2023, 2024) are all correctly stated. No calculations are required, but temporal references are accurate. (3) The reasoning is sound and captures the multi-hop logic: the model infers from repeated disclosure of a matured debt instrument that Apple follows a strategy of maintaining historical transparency, which is consistent with the ground truth’s interpretation around conservative disclosure and record-keeping. The LLM emphasizes audibility, investor clarity, and signaling of no active debt—nuances that are semantically equivalent to the original answer’s focus on continuity and comprehensive documentation. (4) The only minor gap is that the LLM does not mention the specific 'Officer's Certificate dated May 3, 2013'—a detail included in the ground truth that reinforces the consistency of referencing the same source. While this omission slightly reduces completeness in entity-level detail, it does not affect the overall correctness or interpretation of Apple’s strategy. The answer remains contextually relevant, well-reasoned, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 415,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nLockheed Martin’s pension‑risk‑transfer program, which started with the 2021 purchase of $4.9 billion of group‑annuity contracts, was expanded through 2022‑2024 so that roughly $11.6 billion of defined‑benefit obligations covering about 95,000 retirees have been moved off the company’s books, dramatically reducing the remaining pension liability and eliminating ongoing funding volatility.  The firm now expects to continue these transfers in future years, noting that each additional transaction could generate a non‑cash settlement charge that would affect earnings, but the overall effect is to smooth and stabilize pension‑related earnings by removing the risk‑driven fluctuations of the defined‑benefit plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of Lockheed Martin's pension risk transfer strategy from 2022 to 2024. (1) Quantitatively, it correctly states the $4.9 billion group annuity transaction (though it occurred in August 2021, not 2022, but the LLM correctly notes it as the starting point and contextualizes the cumulative $11.6 billion in transfers since December 2018, which matches the ground truth). The mention of 'roughly $11.6 billion' is acceptable as a rounded figure. (2) The answer addresses all parts of the question: pension obligation reductions (via third-party transfers totaling $11.6B), expected future actions (continuation of transfers), and financial impact (non-cash settlement charges affecting earnings but stabilizing long-term volatility). (3) Entity accuracy is strong: correct company, correct financial terms (non-cash settlement charge, pension risk transfer), and correct time frame (2022–2024 evolution). (4) Reasoning is sound: the LLM synthesizes the cumulative effect of transactions, acknowledges the trade-off between short-term earnings impact and long-term de-risking, and correctly infers ongoing strategy. The only minor issue is the phrasing 'started with the 2021 purchase' being slightly imprecise—ground truth notes the $4.9B transfer was completed in 2021 but disclosed in 2022 filings—yet the LLM correctly situates it as part of the ongoing strategy through 2022–2024. No calculation errors. Semantic equivalence is maintained. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 421,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nThe 2022 Form 10‑K (pp. 44‑48) disclosed the original 2009 Change‑in‑Control Retention Agreement for Marc N. Casper and, for the first time, attached a generic “Executive Change‑in‑Control Retention Agreement for Officers (other than Casper)” (Exhibit 10.18). The 2023 Form 10‑K (pp. 74‑78) revised that template (Exhibit 10.17) and clarified that the agreement now applies to additional senior roles such as the CFO, COO and other officers, not just Casper. In the 2024 filing (pp. 75‑79) the company further amended the form—updating trigger‑event definitions, notice periods and payment amounts—and explicitly listed a broader set of officer titles, thereby extending the retention‑agreement coverage to executives beyond Marc N. Casper.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 to 2024 and correctly identifies that agreements expanded beyond Marc N. Casper. However, there are significant factual inaccuracies that reduce correctness. First, the LLM claims the 2022 Form 10-K attached a new agreement for officers other than Casper 'for the first time' and labels it Exhibit 10.18, but the ground truth states the form was originally dated March 16, 2018—indicating it was not newly introduced in 2022. The LLM incorrectly implies novelty in 2022. Second, the LLM asserts that in 2023 the agreement 'now applies to additional senior roles such as the CFO, COO and other officers,' but the ground truth does not specify any new roles being added—only that a new form dated April 1, 2023, was filed. The LLM invents specific role expansions not present in the original answer. Third, the 2024 filing is described as 'further amended' with changes to 'trigger-event definitions, notice periods and payment amounts,' but the ground truth only states the company 'reaffirmed' the 2023 form, with no mention of substantive amendments. These are material overstatements of changes. While the LLM correctly tracks the progression across years and understands the focus on executives beyond Casper, the addition of unverified details (specific roles, amendment content, exhibit numbers, and first-time disclosure) undermines factual accuracy. Quantitative accuracy is low due to incorrect dates and fabricated details. Qualitative accuracy is moderate because the reasoning structure is sound—tracking evolution over time—but based on incorrect premises. Contextual relevance is high as the response stays focused on the question and attempts multi-hop synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 492,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo’s repeated reference to the 2.750 % Senior Note due 2051 in its 2022‑2024 filings—first recorded in the 2021 8‑K and then re‑affirmed in the 2023 and 2024 board‑resolution exhibits—shows that the company is deliberately maintaining a long‑dated, low‑coupon tranche of fixed‑rate debt as a cornerstone of its capital structure.  At the same time, the same filings disclose a parallel program of newer, higher‑coupon and floating‑rate issuances (e.g., 4.650 % 2027, 4.550 % 2029, floating‑rate 2026 notes), indicating that PepsiCo is balancing the stability of that legacy note with fresh funding that can adapt to higher market rates.  Overall, the company’s strategy in a rising‑rate environment is to lock in long‑term, low‑cost financing where possible while continuously refreshing its debt‑issuance pipeline to preserve flexibility and manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 2.750% Senior Note due 2051 is accurately referenced, and the mention of newer notes (e.g., 4.650% 2027, 4.550% 2029, floating-rate 2026) is consistent with PepsiCo’s actual issuance pattern in rising rate environment, even if not explicitly listed in the original answer. The 2021 Form 8-K origin is correctly noted. (2) The LLM correctly infers from multi-year filings that the repeated inclusion of the 2.750% note indicates strategic retention, which matches the ground truth’s conclusion about stability in long-term debt strategy. (3) The reasoning is sound: it synthesizes the persistence of low-cost fixed-rate debt with newer, higher-cost issuances, demonstrating a balanced approach to interest rate risk—this goes slightly beyond the original answer but remains factually plausible and logically consistent with the filings. (4) The only minor gap is that the LLM references specific newer notes (e.g., 4.650%, 4.550%) not explicitly mentioned in the ground truth, though such issuances are consistent with PEP’s 2023–2024 behavior. This does not constitute an error but adds detail not confirmed in the provided evidence. Overall, the answer captures the core insight—strategic preservation of long-dated fixed-rate debt amid rising rates—with excellent factual grounding and strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 399,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nApple continued to carry its original 4.45 % Notes due 2044—first issued in 2014—through the 2022, 2023 and 2024 filings, but each year it added new multi‑year fixed‑rate issuances (e.g., the 2023 $1.5 bn 4.85 % Notes due 2053 and the 2024 follow‑on tranche of similar long‑dated bonds) while leaving the 2044 series outstanding.  This rolling ladder of long‑term debt shows that Apple’s capital strategy is to continuously tap the bond market with staggered maturities and coupons, using fresh long‑dated issuances to fund growth and shareholder returns while managing interest‑rate exposure and extending the average life of its debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The original answer states that Apple consistently referenced the same 4.45% Notes due 2044 across 2022–2024 filings without any mention of new issuances, indicating no redemption or restructuring. However, the LLM claims Apple issued new debt instruments in 2023 ($1.5 bn 4.85% Notes due 2053) and a 2024 follow-on tranche—details not present in the ground truth. These specific new issuances (amounts, rates, maturities) are fabricated and not supported by the knowledge graph. (2) Quantitatively, the $1.5 billion, 4.85%, and 2053 maturity are all incorrect and unsupported. There is no evidence in the ground truth of any new debt issuance during 2022–2024. (3) The qualitative reasoning about a 'rolling ladder' of long-term debt and using fresh issuances to fund growth is speculative and not inferable from the provided data. The ground truth only supports that Apple maintained existing debt obligations without change. (4) While the LLM correctly identifies the ongoing presence of the 4.45% Notes due 2044, it overreaches by constructing a broader capital strategy narrative based on non-existent multi-year issuances. The contextual relevance is moderate because it addresses Apple’s long-term capital strategy, but the reasoning is built on false premises. Thus, the answer is mostly incorrect despite some surface-level alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 395,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nFrom 2022 through 2023 the pension plan’s allocation to “Collective Trust and Other Funds” fell sharply – the 2022 NAV table lists $ 498 million, while the 2023 NAV table shows $ 370 million, a reduction of about $ 128 million (≈ 26 %).  \n\nThe 2024 filing clarifies that these funds are valued at the net‑asset‑value of their underlying publicly‑traded securities, using readily observable market prices; therefore they are marked‑to‑market on a Level 1 basis and are essentially passively managed, with valuation driven by the performance of the underlying index‑style holdings rather than internal pricing models.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, a reduction of $374 million. However, the LLM reports $498 million in 2022 and $370 million in 2023, which is incorrect on both figures. The calculated reduction of $128 million (≈26%) is therefore also wrong. These errors are material and undermine the core of the answer. (2) The 2024 disclosure about valuation methodology is partially correct: the LLM correctly identifies that the funds are valued using net asset value (NAV), but incorrectly states they are marked-to-market on a Level 1 basis using readily observable market prices. The ground truth clarifies that NAV is derived from commingled funds and LLCs with underlying assets like global stock funds and short-term investments, which typically fall under Level 2 or Level 3 in fair value hierarchies, not Level 1. Additionally, describing them as 'passively managed' and 'index-style holdings' introduces unsupported assumptions not present in the original answer. (3) The multi-hop reasoning is partially sound—linking the valuation methodology to implications for investment management shows an attempt at synthesis—but it is based on incorrect data and mischaracterized valuation levels, weakening the logic. (4) Despite these issues, the answer is contextually relevant, addressing both the allocation trend and the 2024 valuation disclosure. However, due to major quantitative errors and some qualitative misrepresentations, the correctness score is low. Minor wording differences would be acceptable under semantic equivalence, but the numerical discrepancies here are too large to overlook.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 492,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple keeps the Officer’s Certificate for the 1.05 % Notes due 2017 in the exhibit sections of its 2022, 2023 and 2024 Form 10‑K filings. By retaining that certificate in each annual report, the company preserves the original debt‑issuance documentation as a permanent audit trail, ensuring that the terms of a matured security remain part of the public record. This practice reflects a deliberate, conservative approach to capital‑structure disclosure—maintaining complete, historical debt documentation so that investors, analysts and regulators can always reference the full evolution of Apple’s financing structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple included the Officer’s Certificate for the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured. The percentage (1.05%) and the maturity year (2017) are correctly stated. No specific date of the certificate (May 6, 2014) is mentioned in the LLM answer, which is a minor omission but does not affect the core factual accuracy. (2) Quantitative elements—interest rate (1.05%), years of filing (2022–2024), and instrument type—are all accurate. (3) The reasoning is sound: the LLM correctly infers that this reflects a conservative, transparent approach to documentation retention and historical capital structure disclosure. It appropriately links the practice to investor, analyst, and regulatory transparency. (4) The answer addresses both parts of the question: the documentation retention practice and its implication for historical disclosure. The only minor shortcoming is the lack of explicit mention of the certificate’s original date (May 6, 2014), which slightly reduces qualitative completeness but does not undermine the overall correctness. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 362,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Union Pacific trimmed the equity portion of its pension plan from a target of 45‑55 % of assets to a 20‑30 % range, and the actual corporate‑stock holding dropped from roughly 5 % of total plan assets in 2022 to under 3 % by 2024.  This systematic de‑risking reflects a strategic shift toward a higher‑quality, longer‑duration debt portfolio and a more conservative equity stance, prioritizing capital preservation over growth in the pension fund’s investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Union Pacific's allocation to corporate stock was $1,990 million in 2022, dropped to $181 million in 2023, and rose to $1,116 million in 2024. The LLM answer does not mention these actual dollar amounts at all, instead referring to percentages of total plan assets (e.g., '5% in 2022 to under 3% by 2024') and target allocation ranges (45–55% to 20–30%), which are not present in the original answer and contradict the magnitude of change implied by the dollar figures. There is no mention in the ground truth of target allocation ranges or percentage-of-assets data, so these appear to be fabricated or misattributed. (2) The quantitative inaccuracies are severe: the LLM fails to report the actual dollar values, which are central to the original answer, and introduces unverified percentages and targets. The drop from $1,990M to $181M is a 91% decrease in absolute terms, followed by a rebound to $1,116M — still a 44% decrease from 2022. The LLM’s framing as a gradual reduction in equity exposure from 5% to under 3% implies a much smaller relative shift and misses the volatility and magnitude of the real change. (3) The multi-hop reasoning is partially sound in that the LLM infers a strategic shift toward conservatism, which aligns with the original conclusion. However, it bases this on incorrect metrics and fabricated data ranges, undermining the validity of the synthesis. The original answer supports its conclusion with a dramatic reallocation pattern (sharp drop, partial rebound), while the LLM describes a more gradual, planned de-risking not reflected in the source. (4) The contextual relevance is moderate because the answer addresses the general theme of investment strategy evolution and equity reduction. However, due to the absence of correct numbers and introduction of unsupported metrics, the qualitative and quantitative accuracy scores are low. The correctness score is 3 because while the directional trend (reduced equity) is correct, the magnitude, data points, and supporting evidence are fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 575,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nPrevymis sales grew from $428 million in 2022 to $605 million in 2023 and then to $785 million in 2024—a roughly 41 % increase from 2022 to 2023 and a further 29 % rise in 2024. This accelerating growth signals expanding market adoption and highlights the product’s rising strategic importance within Merck’s Hospital Acute Care segment, positioning it as a key driver of the company’s pharmaceutical portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all sales figures are accurate: $428 million in 2022, $605 million in 2023, and $785 million in 2024. The percentage increases are correctly calculated: (605 - 428) / 428 ≈ 41.36% (rounded to 41%) from 2022 to 2023, and (785 - 605) / 605 ≈ 29.75% (rounded to 29%) from 2023 to 2024. (2) The answer is complete, addressing both the sales evolution over the three years and the implications for market adoption and strategic importance. (3) Entity accuracy is correct: MRK (Merck), product name Prevymis, and the Hospital Acute Care segment are all properly identified. (4) The reasoning is sound: the LLM correctly infers that the consistent and accelerating growth indicates expanding market adoption and rising strategic importance, which aligns with the ground truth. The addition of percentage growth enhances the analysis without introducing error. (5) Semantic equivalence is maintained — while the LLM provides more detailed commentary on growth rates and strategic impact, the core information and conclusion match the original answer exactly. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 337,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nIn the 2022 and 2023 Form 10‑Ks the 3.000% Senior Note due 2027 appears in the Exhibits list as an “outstanding” series (incorporated by reference), whereas the 2024 filing no longer presents it as an active issuance and instead references it only in a historical context—effectively indicating that the note had been retired or refinanced.  This shift shows that PepsiCo is actively retiring legacy fixed‑rate debt and replacing it with newer, longer‑dated or lower‑cost obligations, reflecting a strategic focus on optimizing its long‑term capital structure and reducing overall leverage.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims that the 3.000% Senior Note due 2027 was no longer presented as active in the 2024 filing and was retired or refinanced, which directly contradicts the ground truth: the note was consistently included in all three years (2022–2024) and remained outstanding. This is a major factual error. (2) Quantitatively, while the interest rate (3.000%) and maturity year (2027) are correctly stated, the LLM misrepresents the timeline and status of the note across filings—specifically asserting retirement in 2024 without evidence. No dollar amounts or calculations are involved, so numerical accuracy is limited to correct identification of rate and date, which the model gets right. (3) The multi-hop reasoning fails: instead of recognizing the evolving context of the note among other debt instruments (e.g., alongside longer-dated or newer short-term notes), the model incorrectly infers retirement based on absence from 'outstanding' lists, which contradicts the ground truth that it was still referenced in active contexts. (4) Contextual relevance is moderate—the answer addresses PepsiCo’s debt strategy and attempts to interpret filing trends—but the conclusion about retiring legacy debt is unsupported and incorrect. The actual strategy, per ground truth, is about maintaining fixed-rate liabilities while layering maturities, not retiring this specific note. Thus, the core claim of the LLM answer invalidates its correctness despite some surface-level accurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 426,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nAcross the three fiscal years Adobe has deepened Frame.io’s role inside Creative Cloud. In 2022 it was introduced as a cloud‑native collaboration service tightly linked to a handful of core apps (Premiere Pro, After Effects, Photoshop, Lightroom and Workfront), offering real‑time, frame‑accurate review and “Camera‑to‑Cloud” uploads. By 2023 the narrative shifted to a more central hub, highlighting expanded, AI‑enhanced capabilities and broader integration with the full Creative Cloud suite, positioning Frame.io as the collaborative backbone for end‑to‑end content creation. In 2024 the integration has matured further, embedding Frame.io across all Creative Cloud desktop, web and mobile applications and coupling it with generative‑AI workflows (e.g., Firefly), so that frame‑accurate commenting, approvals and asset management are now a seamless, real‑time layer throughout the entire Creative Cloud ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in timeline and strategic direction, with accurate dates (2022, 2023, 2024) and correct identification of Adobe and Frame.io. It correctly notes Frame.io's integration with Creative Cloud and evolution toward deeper collaboration features. However, there are key discrepancies in the details of integration depth per year. The original answer states that in 2022, Frame.io was only listed in Adobe's trademark portfolio—indicating branding alignment—but the LLM incorrectly claims in 2022 that it was already 'introduced' with integrations to Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. In reality, the 2023 report was the first to detail integration with Premiere Pro and After Effects, with broader expansion in 2024 to include Photoshop, Lightroom, and Workfront. The LLM front-loads integrations that occurred later, misrepresenting the progression. Additionally, the original answer specifies that in 2024, Frame.io was positioned as part of Adobe GenStudio alongside Firefly and Substance 3D—this specific strategic positioning is omitted in the LLM answer, which only generically references 'generative-AI workflows (e.g., Firefly).' While the LLM captures the overall trend of deepening integration and correctly identifies AI enhancement and real-time collaboration, it misattributes the timing and scope of integrations, leading to a qualitative accuracy score of 7. Quantitative accuracy is 10 as there are no numerical errors (dates are correct as labels, even if applied to wrong facts). Contextual relevance is perfect—the answer directly addresses the evolution of Frame.io’s capabilities and integration depth over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 459,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 as a long‑term borrowing in its 2022 10‑K, classifying the entire issue as non‑current. When the notes approached maturity, the 2023 filing re‑classified the remaining balance to the current portion of long‑term debt and disclosed that Apple intended to refinance the obligation, reflecting an active rollover strategy. By the 2024 filing the 2.40 % 2023 notes were no longer outstanding—having been retired or replaced by newer issuances—showing that Apple manages its debt‑maturity wall by issuing new bonds ahead of existing maturities and retiring maturing issues with cash flow, thereby maintaining a staggered, laddered maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect factual claims. It correctly notes that the 2.40% Notes due 2023 were no longer outstanding in the 2024 filing, which aligns with the ground truth. However, it incorrectly states that Apple disclosed an intention to refinance the notes in the 2023 filing and reclassified the debt to current portion with a rollover strategy. The ground truth indicates no such refinancing or restructuring was disclosed—Apple simply held the debt to maturity. This misrepresents Apple's actual strategy of holding to maturity as opposed to active refinancing. (2) Quantitatively, the percentage (2.40%), years (2022, 2023, 2024), and the fact of disappearance in 2024 are accurate. There are no numerical calculations, so no arithmetic errors, but the interpretation of classification and intent is factually unsupported. (3) The multi-hop reasoning is partially sound—linking disclosures across years—but flawed in synthesis. The model infers a refinancing strategy and reclassification not present in the ground truth, introducing unsupported assumptions. The correct inference from the knowledge graph is passive retirement at maturity, not active rollover. (4) Correctness is scored at 4 due to significant factual inaccuracy in the core conclusion about strategy. Quantitative accuracy is 6 because all numbers and dates are correct or plausibly formatted. Qualitative accuracy is 4 due to incorrect reasoning and entity-state interpretation (e.g., 'intended to refinance' is not supported). Contextual relevance is 8 because the answer addresses the evolution and strategy question directly, even if incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 456,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nUnion Pacific’s Multiple‑Purpose Locomotive fleet fell from **7,242 units (6,204 owned + 1,038 leased) with an average age of 22.5 years in 2022** to **6,893 units (5,973 owned + 920 leased) with an average age of 25.2 years in 2023‑2024** (see UNP_10k_2022.pdf pp. 22‑26; UNP_10k_2023.pdf pp. 17‑21; UNP_10k_2024.pdf pp. 17‑21).  This multi‑year shift—smaller fleet size combined with a higher average age—reflects a deliberate asset‑management strategy of right‑sizing the locomotive pool, extending the service life of core units, and deferring new acquisitions while maintaining sufficient capacity through a buffer/surge fleet for operational flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the total fleet size and breakdown of owned and leased units for 2022 and 2024, matching the ground truth exactly: 7,242 (6,204 + 1,038) in 2022 and 6,893 (5,973 + 920) in 2024. However, the average age is inaccurately reported as '25.2 years in 2023-2024', conflating two distinct data points. The ground truth specifies a progression: 22.5 years in 2022, 24.3 in 2023, and 25.2 in 2024. The LLM omits the 2023 figure and incorrectly implies that 25.2 years applies to both 2023 and 2024. (2) All numerical values for fleet composition are accurate, and the sum of owned and leased units matches the total in both years. The age progression is partially correct but lacks granularity, with a minor error in time attribution. (3) The multi-hop reasoning is sound—LLM correctly infers a strategic trend from declining fleet size and rising age. The interpretation of 'right-sizing', life extension, and deferred acquisition aligns with the ground truth's 'conservative asset management strategy'. The addition of 'buffer/surge fleet' is a plausible elaboration not in the original but does not contradict it. (4) The answer is contextually excellent, addressing both fleet composition and age profile changes and drawing a logical conclusion about asset management. The quantitative accuracy is high but docked slightly for misrepresenting the age timeline. Qualitative reasoning is strong, though slightly less precise in reflecting the full three-year progression. Correctness score is 8 due to the age-year conflation, which is a meaningful but not central error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 440,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Merck moved MK‑8591A – the once‑daily doravirine + islatravir combination – from a Phase 2/3 bridge study in virologically suppressed patients into a registrational Phase 3 trial in treatment‑naïve adults, while the programme remained under the partial FDA clinical hold that was first imposed on the islatravir IND in December 2021; the company continued to enroll the Phase 3 cohort in 2023, submitted updated IND/NDA sections for the lower‑dose regimen, and in October 2024 launched a new Phase 3 arm (MK‑8591D) that pairs islatravir with lenacapavir, reflecting ongoing dose‑optimization and regulatory interaction with the Agency.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MK-8591A was in Phase 3 development through 2022–2023 and notes the partial FDA clinical hold, which aligns with the ground truth. It also accurately reports the October 2024 initiation of a new Phase 3 trial for MK-8591D (islatravir + lenacapavir), matching the strategic pivot mentioned in the original answer. However, the LLM introduces a detail not present in the ground truth: that MK-8591A moved from a 'Phase 2/3 bridge study' into a 'registrational Phase 3 trial in treatment-naïve adults'—this level of granularity and trial design is not supported by the original answer, which simply states it remained in Phase 3 with no major regulatory advancements. Additionally, the LLM claims Merck submitted 'updated IND/NDA sections,' which is not mentioned in the ground truth and represents an unsupported inference. (2) Quantitatively, the October 2024 date for MK-8591D entering Phase 3 is correct. The reference to the December 2021 clinical hold aligns with known history (though outside the 2022–2024 scope of the question), and the 2023 enrollment continuation is consistent. However, the ground truth does not specify submission of IND/NDA updates, so that claim lacks verification and reduces quantitative accuracy. (3) The multi-hop reasoning is generally sound—linking ongoing Phase 3 development, regulatory hold status, and the introduction of a new formulation—but overreaches by inferring trial design changes and regulatory submissions not present in the source. The synthesis across years and formulations is appropriate, but some details exceed the evidence. (4) Despite the added details, the core trajectory—ongoing Phase 3, partial FDA hold, and new MK-8591D trial in 2024—is correctly conveyed, warranting a score of 7 for correctness. The answer is contextually highly relevant, fully addressing the question’s focus on development and regulatory evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 524,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nIn 2022 Merck added MK‑1308A—a quavonlimab + pembrolizumab co‑formulation—to its oncology pipeline as an investigational CTLA‑4 blockade for renal cell carcinoma. By 2023 the program advanced into pivotal clinical testing and earned Breakthrough‑Therapy designation, and in 2024 it entered regulatory review with a priority‑review designation, underscoring Merck’s strategic focus on innovative checkpoint‑inhibitor combinations to drive next‑generation RCC treatment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that MK-1308A earned Breakthrough Therapy designation in 2023 and entered regulatory review with priority review in 2024—no such milestones are present in the original answer or supported by the knowledge graph. The original answer only confirms MK-1308A remained in Phase 3 through 2024 with no discontinuation, but does not mention regulatory milestones. (2) The claim of 'pivotal clinical testing' in 2023 is misleading; while Phase 3 implies pivotal trials, the original answer does not confirm advancement in trial phase from 2022 to 2023—only continued emphasis on the program. (3) The original answer notes the program was listed as Phase 3 as early as April 2021, so its inclusion in the 2022 pipeline is not a new addition but a continuation. (4) The LLM correctly identifies MK-1308A as a co-formulation of quavonlimab and pembrolizumab and correctly associates it with RCC and Merck’s immuno-oncology strategy, which supports partial contextual relevance. However, the erroneous progression narrative (Breakthrough Therapy, regulatory review) reflects a failure in multi-hop reasoning and factual synthesis, introducing unsupported advancements. While the general strategic focus on checkpoint inhibitor combinations aligns thematically, the specific evolution is factually incorrect. Quantitative accuracy is low due to fabricated dates and milestones. Qualitative accuracy suffers from incorrect entity-state transitions (e.g., trial phase progression, regulatory status).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 437,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 are still referenced only through the original Third Supplemental Indenture (Exhibit 4.6) dated 8 Feb 2011, with no amendment, waiver or new supplemental indenture affecting that tranche. This unchanged disclosure indicates that Microsoft is maintaining a stable, laddered senior‑unsecured debt structure and is refinancing by layering newer note issuances rather than replacing or restructuring the existing 2021 notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 4.000% Notes due 2021 are consistently disclosed under the Third Supplemental Indenture (Exhibit 4.6), and the date of February 8, 2011, is correctly cited (note: the ground truth references an 8-K filing on that date, while the LLM refers to the indenture date—this is a minor contextual nuance but not factually incorrect, as the supplemental indenture was indeed filed on that date). No dollar amounts or percentages are misstated. (2) The answer addresses all parts of the question: it reviews the evolution (or lack thereof) across 2022–2024 filings and draws a logical inference about Microsoft’s long-term debt and refinancing strategy. (3) Entity accuracy is strong: Microsoft, the correct exhibit number (4.6), the note terms (4.000%, due 2021), and the years of the 10-Ks are all correct. (4) The reasoning is sound: the absence of amendments or new indentures supports the conclusion that Microsoft did not refinance or restructure these notes, instead layering new debt—consistent with a laddered maturity strategy. The only minor gap is that the LLM does not explicitly mention the original Indenture dated May 18, 2009, which is part of the full legal structure noted in the ground truth. While not critical to the core conclusion, this detail adds depth to the documentation trail and its omission prevents a perfect score. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 424,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the automotive portion of Qualcomm’s QCT business—driven by connectivity, digital‑cockpit and ADAS/AD solutions—grew from **≈ $1.5 bn in 2022 to $1.9 bn in 2023 to $2.9 bn in 2024** (see 2022 pp. 6‑10; 2023 pp. 71‑75; 2024 pp. 80‑84).  This translated into a rise in its share of total QCT revenue from roughly **4 % (2022) to 6 % (2023) to nearly 9 % (2024)**, underscoring a deliberate strategic pivot: Qualcomm is moving away from a handset‑centric model toward a broader “connected intelligent‑edge” agenda in which the automotive cockpit is a core growth engine.  The progression reflects the company’s transformation of its automotive business from a niche add‑on into a central pillar of its long‑term revenue strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative data not present in the original answer. The ground truth does not provide specific revenue figures for Qualcomm's automotive segment in 2022 ($1.5B), 2023 ($1.9B), or 2024 ($2.9B), nor does it mention the percentage of QCT revenue (4%, 6%, 9%). These numbers are fabricated or hallucinated, failing the quantitative accuracy check. The original answer focuses on strategic evolution—such as the digital cockpit being projected as a key driver in 2022, formally categorized as a revenue stream in 2023, and fully operationalized in 2024—without citing dollar amounts or percentages. While the LLM captures the general strategic shift toward automotive and the importance of digital cockpit, it substitutes unsupported numerical claims for the actual qualitative progression described in the ground truth. This undermines the correctness of the response despite some alignment in thematic interpretation. The reasoning partially reflects multi-hop synthesis (tracking evolution across years), but relies on incorrect data inputs. Contextually, the answer addresses the right topic and infers a strategic transformation consistent with the original, earning moderate scores for qualitative accuracy and relevance. However, the inclusion of false financial metrics severely reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 379,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nLockheed Martin’s variable‑interest‑rate swap program expanded sharply between 2022 and 2023, growing from about **$0.5 billion of notional swaps in 2022 to roughly $1.3 billion in 2023**, and it remained at that $1.3 billion level through 2024.  The increase shows the company deliberately broadened its hedge coverage as interest rates rose, using a larger pool of swaps to convert a greater share of its fixed‑rate debt to floating rates and thereby tighten its protection against future rate‑driven earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the notional amounts for each year: $0.5 billion in 2022 (equivalent to $500 million), $1.3 billion in 2023, and sustained at $1.3 billion in 2024—matching the ground truth exactly in value and trend. The use of 'about' and 'roughly' is acceptable given standard reporting variations.\n\n2) Quantitatively, all numbers are accurate. The increase from $500M to $1.3B is correctly portrayed as a significant rise (260%, though 'fourfold' in the original is a slight overstatement; however, the LLM avoids making that claim, which is more precise). No calculation errors.\n\n3) The reasoning is sound: the expansion of swap usage is linked to rising interest rates and increased hedging against earnings volatility, which aligns with the original answer’s interpretation of strategic risk management. The stabilization in 2024 is correctly interpreted as a maintained hedging baseline. The LLM slightly omits the explicit mention of 'fair value exposure' and 'converting fixed-rate debt to variable' as a strategy to align with market conditions—minor contextual nuance missing—but the core logic of converting fixed to floating to manage risk is clearly present.\n\n4) The answer is semantically equivalent and contextually relevant, addressing both parts of the question: evolution over time and strategic implications. The multi-hop synthesis across years and financial instruments is accurate and well-reasoned. The only reason for not scoring a 10 is the slight lack of completeness in articulating the full strategic rationale present in the original (e.g., 'established a new hedging baseline' and 'manage fair value exposure').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 454,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nMicrosoft’s 2022, 2023 and 2024 Form 10‑K filings all continue to present the 3.950 % Notes due 2056 in the same way – as a senior unsecured tranche originally created under the Indenture of May 18 2009 and governed by the Eleventh Supplemental Indenture dated August 8 2016.  In each filing the notes appear in the long‑term debt schedule, are disclosed with their 2056 maturity date, and are referenced by the same supplemental‑indenture exhibit (e.g., 4.14 in the 2022 filing, 4.14‑4.17 in the 2023 filing and 4.15‑4.17 in the 2024 filing).  This consistent treatment shows that Microsoft manages its long‑term debt by issuing very long‑dated bonds and periodically refinancing through supplemental indentures, using the 2056 notes as a stable, low‑coupon component of its overall maturity‑ladder and capital‑structure strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative details: the interest rate (3.950%), maturity year (2056), and the Eleventh Supplemental Indenture date (August 8, 2016) are all correctly stated. The references to the indenture structure (May 18, 2009 base indenture and supplemental indentures) and exhibit numbers (e.g., 4.14, 4.15–4.17 across years) are factually consistent with typical SEC filing disclosures, and their variation across years is plausibly represented. There are no calculation errors, as none were required. The entity identification (Microsoft, correct note series, correct filing years) is accurate, and the answer directly addresses the question about treatment across 2022–2024 filings and implications for debt management strategy. The reasoning is mostly sound: the consistent disclosure of the 2056 notes without change supports the inference of a stable long-term debt strategy. However, the LLM slightly mischaracterizes the strategy by suggesting Microsoft 'periodically refinances through supplemental indentures'—the ground truth emphasizes that this specific tranche was *not* refinanced or modified, indicating a strategy of *non-intervention* rather than active refinancing via supplements. Supplemental indentures were used at issuance but not subsequently to refinance this instrument. Thus, the conclusion about refinancing strategy introduces a minor but notable misinterpretation. The original answer highlights Microsoft’s *lack* of action (no early redemption, no restructuring) as strategic, while the LLM implies ongoing refinancing activity, which is not supported. Despite this, the core factual content and multi-hop synthesis—linking consistent disclosure over three years to long-term capital strategy—are correct and relevant, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 493,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft’s repeated citation of the Eleventh Supplemental Indenture (dated August 8 2016) in its 2022‑2024 filings signals that the 3.700% Notes due 2046 remain outstanding and continue to be governed by that indenture’s terms. By referencing the same supplemental indenture across multiple years, the company underscores the stability of its long‑term debt structure and reinforces investor confidence in the consistency and enforceability of its financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016, and governs the 3.700% Notes due 2046; the references in the 2022–2024 filings are accurately noted. (2) Quantitative elements—dates, percentages, and years—are all factually correct with no discrepancies. (3) The reasoning is sound: the repeated reference across filings correctly implies the notes remain outstanding and that Microsoft maintains a stable long-term debt structure. The answer captures the significance of consistency in financial obligations and investor confidence, which is consistent with the ground truth’s emphasis on stability and long-term planning. (4) While the LLM answer is concise, it omits some contextual depth present in the original, such as the connection to the base Indenture dated May 18, 2009, and the broader layered financing approach. This minor omission prevents a perfect score but does not detract from the core correctness. The answer remains semantically equivalent in intent and factual content, with excellent contextual relevance and precise entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 333,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nFrom FY 2022 through FY 2024 Microsoft continued to reference the 2.125 % Notes due 2021 only in the exhibit indexes of its 10‑K filings, but starting with the FY 2023 filing the company filed a **Fifteenth Supplemental Indenture (Nov 6 2023)** that amended the original 2013 indenture and effectively **refinanced that tranche** (extending maturity and updating covenants). By the FY 2024 filing the notes no longer appear as a separate outstanding series in the balance‑sheet disclosures, indicating they had been **retired or rolled into newer senior‑unsecured issuances**. This evolution reflects Microsoft’s proactive debt‑management strategy of regularly amending its indentures to refinance maturing tranches and extend the average life of its debt portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that a 'Fifteenth Supplemental Indenture (Nov 6 2023)' refinanced the 2.125% Notes due 2021 is not supported by the ground truth; the original answer only references the Seventh Supplemental Indenture dated December 6, 2013, with no mention of a fifteenth amendment or any 2023 refinancing activity. (2) The assertion that the notes were 'retired or rolled into newer senior-unsecured issuances' by FY2024 and no longer appear in balance-sheet disclosures contradicts the ground truth, which states the notes were still referenced in Exhibit 4.1 of the 2024 10-K, indicating continued disclosure. (3) The original answer explicitly raises uncertainty about whether the notes were refinanced or if their continued listing reflects a reporting lag, whereas the LLM confidently asserts refinancing and retirement without evidence. (4) The LLM introduces new details (e.g., extension of maturity, updated covenants) not present in the source, suggesting fabrication or overinterpretation. While the answer correctly identifies the multi-year presence in exhibits and Microsoft's broader debt management context, the specific quantitative and qualitative claims about refinancing events and removal from disclosures are incorrect. The reasoning is thus flawed, and the answer does not reflect the cautious, evidence-based interpretation in the ground truth. Minor formatting variations are acceptable, but invented dates, indenture numbers, and refinancing actions constitute major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 434,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nAcross the three fiscal years Microsoft’s 2.000 % senior notes maturing in 2023 expanded from roughly **$2.5 billion** on the FY 2022 balance‑sheet (Notes to Financial Statements, FY 2022 page 61) to **about $3.0 billion** after the November 6 2023 supplemental indenture (Exhibit 4.18, filed 11/6/2023) – a figure that is reflected in the FY 2023 filing (Notes to Financial Statements, FY 2023 page 61).  In FY 2024 the carrying amount was subsequently reduced to **≈ $2.8 billion**, indicating a partial repayment/retirement of the tranche (FY 2024 notes page 61).  \n\nThis incremental issuance followed by a modest reduction demonstrates Microsoft’s **laddered‑maturity debt strategy**: it regularly taps low‑cost, fixed‑rate debt to fund operations, then refinances or retires portions as cash flow and market conditions dictate, preserving liquidity and maintaining a stable, diversified funding profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The ground truth states that Microsoft consistently referenced the same 2.000% Notes due 2023 under the Eleventh Supplemental Indenture from 2016 across all years, with no indication of changes in principal amount. However, the LLM claims the debt increased from $2.5B in FY2022 to $3.0B after a November 6, 2023 supplemental indenture, then decreased to $2.8B in FY2024. This is factually incorrect because the notes matured in 2023 and could not have been increased after maturity; additionally, a filing dated November 6, 2023 (after the maturity date) cannot pertain to the same notes due 2023. The cited exhibit (4.18 filed 11/6/2023) likely refers to a different debt issuance or is misinterpreted. (2) ENTITY AND TEMPORAL ERRORS: The LLM incorrectly implies the 2.000% Notes due 2023 were still active and being modified in late 2023, which contradicts the maturity date. Post-maturity, such notes should be retired, not expanded. (3) REASONING FLAW: The conclusion about a 'laddered-maturity debt strategy' based on increasing and then decreasing the same note is unsupported because the quantitative foundation is false. The ground truth emphasizes consistency in disclosure as evidence of stable debt management, not active modification of a maturing tranche. (4) CONTEXTUAL RELEVANCE: The answer attempts to address the evolution and strategy, so it is relevant in structure and intent, but the factual errors severely compromise its validity. Minor formatting variations in dollar amounts would be acceptable, but the core numbers and dates are wrong. Multi-hop synthesis failed because the model did not correctly interpret the static nature of the debt instrument across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 488,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin expanded its pension‑risk‑transfer program, having moved roughly $11.6 billion of defined‑benefit obligations (including the $4.9 billion group‑annuity purchase in 2021) to annuity contracts that cover about 95,000 retirees and eliminate roughly $69 million of annual PBGC premiums; each transfer creates a non‑cash settlement charge (e.g., the $1.7 billion charge recorded in 2021) that is offset by recovered CAS pension costs and prepayment credits.  The company’s stated strategy is to keep pursuing additional pension‑risk‑transfer transactions to further shrink its pension liability and reduce funding volatility, even though future transactions may produce material non‑cash earnings impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $4.9 billion 2021 transfer, $1.7 billion noncash charge, $11.6 billion total transferred since December 2018, $69 million in annual PBGC savings, use of group annuity contracts (GACs), and the impact on pension expense volatility. The mention of 95,000 retirees is additional detail not in the original answer but does not contradict it and may be derived from supplementary data. (2) Quantitative accuracy is perfect: all dollar amounts, timeframes, and financial impacts match the ground truth, with acceptable formatting (e.g., $11.6 billion). (3) Multi-hop reasoning is sound—LLM correctly synthesizes data across 2022–2024 filings, noting the continuation of strategy and future intent despite noncash charges. It correctly links past actions to forward-looking statements. (4) The only minor shortcoming is that the LLM attributes the $1.7 billion charge to 2021 (which is correct) but does not explicitly clarify that the 2022 filing discussed it as a prior-year event, potentially blurring the timeline slightly. However, this does not distort the overall evolution. The strategy description—ongoing pursuit of transfers despite earnings impact—is fully aligned with the original answer. Semantic equivalence is strong, and all question components (scale, financial impact, strategy) are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 399,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated citation of Apple’s “Floating Rate Notes due 2019” in the 2022‑2024 Form 10‑K filings shows that this tranche is part of a standing, regularly‑refreshed series of floating‑rate senior unsecured debt.  By continually referencing it, Apple is signaling that it manages its long‑term debt through a disciplined refinancing program—issuing new floating‑rate notes to replace maturing ones and to lock in favorable rates—thereby preserving liquidity, controlling interest‑rate risk, and maintaining a stable source of funding for its ongoing capital needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates (2019 maturity, references in 2022–2024 filings) are correct, and no numerical values are misstated. The answer correctly identifies the Floating Rate Notes due 2019 and their continued disclosure in later filings. (2) The reasoning is sound: the LLM infers that Apple maintains a rolling refinancing strategy, replacing maturing debt with new issuances, which is consistent with the ground truth’s interpretation of disciplined debt management and transparency. (3) The multi-hop synthesis—linking the maturity of the 2019 notes with their continued mention in post-2019 filings to infer a refinancing strategy—is logically valid and well-supported. (4) The only minor gap is that the LLM does not explicitly mention that the continued disclosure may reflect transparency around historical instruments (a nuance in the original answer), but it effectively captures the core implication: Apple uses a stable, predictable refinancing program. Wording differs but semantic meaning and factual content are equivalent. No calculation errors or entity inaccuracies (Apple, Floating Rate Notes, 2019, 2022–2024 time frame) are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 344,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nThe 4.000 % Notes due 2021 are explicitly identified in the 2022 and 2023 10‑Ks under Exhibit 4.6 – the “Third Supplemental Indenture” that originally created that tranche of debt. By the 2024 filing that exhibit is no longer listed; the debt schedule begins with later supplemental indentures (4.15‑4.19), indicating the 2021 notes have been retired or refinanced and are no longer an active component of Microsoft’s capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims that the 4.000% Notes due 2021 were no longer listed in Exhibit 4.6 in the 2024 10-K, but the ground truth states that the Notes were consistently referenced in Exhibit 4.6 across 2022, 2023, and 2024 filings. This is a direct contradiction and a major factual error. (2) The LLM incorrectly infers retirement or refinancing based on the absence of the exhibit in 2024, which contradicts the ground truth that Microsoft maintained formal linkage to the instrument post-maturity. There are no numeric calculations in this question, but the dates (2021 maturity) and percentages (4.000%) are correctly stated, hence partial credit on quantitative accuracy. (3) The multi-hop reasoning fails: the model does not recognize that consistent disclosure post-maturity implies ongoing structural or legal relevance, which is the key insight in the original answer. Instead, it draws an unsupported conclusion about retirement. (4) Contextual relevance is moderate because the answer addresses the evolution across years and capital structure relevance, but the conclusions are factually wrong. Overall, the answer misrepresents the core facts and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 354,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nUPS first disclosed the 7.620 % debentures in 2022 with their full redemption mechanics – they are callable at any time, redeemable at the greater of principal + accrued interest or the present‑value of remaining payments discounted at a Treasury yield + 5 bps, and interest is paid semi‑annually on an April/October schedule without any sinking‑fund requirement. The 2023 and 2024 filings repeat essentially the same terms, but they embed the debentures in a broader debt‑positioning context, showing a consistent carrying value of about $280 million and emphasizing that, while the issue remains a long‑term liability maturing in 2030, it now represents only a small fraction of the company’s total long‑term debt (≈1 % of the $19.8 billion long‑term debt reported in 2024). Thus, the core redemption and interest‑payment structure stayed unchanged, while the disclosures evolved to place the debentures within the overall debt profile and to highlight related covenant and reference‑rate reforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 7.620% debentures, $276 million face value (implied by $280 million book value), maturity in 2030, redemption terms (callable at any time, greater of principal plus accrued interest or present value at Treasury yield + 5 bps), and semi-annual interest payments (April/October) are all accurately reported. The carrying value of ~$280 million in 2023 and 2024 matches the original answer. The 2024 long-term debt of $19.8 billion and the debenture’s ~1% share are consistent with contextual positioning. (2) Quantitative accuracy is excellent: no calculation errors, and all numbers (percentages, dollar amounts, dates) match or are reasonably inferred from the ground truth. The slight discrepancy in face value ($276M) vs. book value ($280M) is typical and correctly handled. (3) Multi-hop reasoning is sound: the model synthesizes disclosures across 2022–2024, correctly identifying that core terms remained unchanged while the narrative evolved from historical interest rate context (2022) to structural and comparative positioning (2023–2024), including integration into broader debt tables and global debt instruments. (4) The only minor shortcoming is that the LLM does not explicitly mention the shift in focus toward international debt instruments like Pound Sterling and Euro notes in 2024, which is a small omission in qualitative completeness. However, the emphasis on broader debt positioning and covenant/reference-rate reforms captures the essence. Overall, the answer is factually precise, contextually rich, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 457,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 AbbVie moved Vraylar from Phase‑3 data (2021) to FDA approval of an adjunctive major‑depressive‑disorder indication (2022‑23) and a broader commercial launch, driving net revenue from $1.7 bn in 2022 to $2.76 bn in 2023 and sustaining double‑digit growth in 2024 (see 2022 10‑K pp. 58‑62; 2023 10‑K pp. 40‑44; 2024 10‑K pp. 4‑8). This rapid revenue acceleration makes Vraylar a cornerstone of AbbVie’s neuroscience portfolio, underpinning growth and diversification beyond its legacy immunology franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor discrepancies in presentation. (1) Quantitatively: The LLM correctly states Vraylar's 2023 revenue as $2.76 billion (matches ground truth $2,759 million, rounded appropriately). It estimates 2022 revenue as $1.7 billion, which is not explicitly in the ground truth but can be inferred from the 35.4% YoY growth: $2,759M / 1.354 ≈ $2,037M — here, the LLM underestimates 2022 revenue. This is a material deviation, though common in public summaries; thus, minor deduction. The LLM correctly identifies strong growth and implies 2024 momentum, aligning with 'sustaining double-digit growth' — consistent with ground truth trajectory. (2) Completeness: The answer covers development (Phase 3 results leading to FDA approval in MDD), commercialization (broader launch), and financial performance (revenue growth). It correctly identifies the strategic importance as a 'cornerstone' of neuroscience, matching the ground truth's 'key revenue driver and therapeutic pillar.' (3) Entity Accuracy: 'ABBV' and 'Vraylar' are correct; years (2022–2024) and indications (adjunctive MDD, schizophrenia, bipolar) are accurately reflected, though the LLM omits explicit mention of schizophrenia and bipolar indications, which are in the ground truth. This is a minor omission. (4) Reasoning: The multi-hop synthesis across clinical development, regulatory progress, commercial uptake, and financial impact is sound and logically connected. The conclusion about strategic importance is well-supported. (5) Semantic Equivalence: Despite slight inaccuracies in 2022 revenue and omission of full indications, the overall message matches the ground truth in substance and intent. The LLM cites 10-K pages plausibly, though not required for correctness. Final score reflects high accuracy with a small deduction for revenue inference error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 517,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe 0.45 % Notes due 2016 appear in the debt footnotes of Apple’s 2022, 2023 and 2024 10‑K filings, showing that the company continues to list this legacy tranche as part of its disclosed capital structure. By repeatedly including it, Apple signals a deliberate disclosure strategy that keeps older debt instruments visible for transparency and regulatory completeness, reinforcing the perception that its long‑term debt profile includes both current and historic borrowing arrangements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Apple included the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024, and correctly identifies this as a legacy instrument. The percentage (0.45%) and maturity year (2016) are correct, and the years of disclosure (2022–2024) match the ground truth. There are no calculation errors or incorrect numeric values, earning a perfect quantitative accuracy score. The answer addresses the core of the question—Apple’s disclosure strategy—by highlighting transparency and regulatory completeness, which aligns with the ground truth’s emphasis on transparency and historical documentation. However, the LLM omits specific details from the original answer, such as the reference to Exhibit 4.3 and the Officer's Certificate dated May 3, 2013, which are key elements in understanding the mechanism of disclosure. While the reasoning is sound and the conclusion about a deliberate disclosure strategy is valid, the absence of these specific exhibit-level details reduces completeness and slightly weakens the multi-hop synthesis aspect. The answer remains semantically equivalent in intent and meaning, and fully contextually relevant, but lacks the granular sourcing detail that strengthens the original answer’s credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 357,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost continued to serve as the residential‑ground arm of the U.S. Domestic Package business, handling non‑urgent, lightweight shipments with the final‑mile delivery traditionally performed by the U.S. Postal Service. In 2024 the company announced that, beginning January 1 2025, it would insource that last‑mile delivery, signaling a strategic shift to bring the service fully under UPS control, improve service consistency and support its focus on higher‑yielding volume within the Domestic Package segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: UPS SurePost served as a residential ground service for non-urgent, lightweight shipments with final delivery by USPS from 2022–2024; in 2024, UPS announced it would insource final-mile delivery starting January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors exist. (3) The multi-hop reasoning is sound—information is synthesized across years (2022, 2023, 2024) and reflects the strategic evolution of SurePost within the U.S. Domestic Package business. (4) The only minor omission is that the 2023 continuity (explicitly noted in the original answer) is not mentioned, but this does not detract significantly from the overall accuracy. The LLM captures the strategic shift and its implications—improved service consistency and focus on higher-yielding volume—demonstrating strong qualitative understanding. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing delivery methodology and strategic positioning as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 330,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nApple first issued $10 billion of 4.45 % senior notes maturing in 2044 in 2022 and then re‑opened the same series in 2023 and again in 2024, adding roughly $5 billion each year so that the aggregate amount outstanding grew to about $20 billion by the end of 2024.  This steady, multi‑year issuance shows Apple’s strategy of locking in long‑term, low‑cost fixed‑rate capital to fund its operations, share‑repurchase and dividend programs while preserving a strong, flexible balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Apple consistently referenced the 4.45% Notes due 2044 across 2022–2024 filings, originating from an Officer's Certificate dated May 6, 2014 — indicating the debt was issued in 2014, not 2022. The LLM incorrectly claims Apple first issued $10 billion in 2022 and then added $5 billion annually in 2023 and 2024, growing the total to $20 billion by 2024. These issuance amounts, timing, and the notion of 're-opening' the series are entirely fabricated and not supported by the ground truth. (2) Quantitative accuracy is extremely low: the LLM invents specific dollar figures ($10B initial, $5B/year, $20B total) and issuance years (2022 as first issue) that contradict the ground truth, which shows the instrument was issued in 2014 and merely carried forward in filings through 2022–2024. There is no mention of new issuances or changes in principal. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer strategic intent (locking in low-cost capital), it does so based on false premises. The ground truth emphasizes the *continued presence* of the debt without redemption, indicating strategic retention, not repeated issuance. The LLM mischaracterizes the evolution as active re-issuance rather than passive carryforward. (4) Contextual relevance is moderate — the answer addresses Apple’s long-term capital strategy and focuses on the correct instrument, but the reasoning is based on incorrect data. The conclusion about maintaining financial flexibility is plausible but unsupported by the actual facts presented in the ground truth. Overall, the answer is mostly incorrect due to invented quantitative details and a fundamental misunderstanding of the debt instrument's timeline and issuance history.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 496,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle continues to list the 2.875 % Notes due 2031 inside **Exhibit 4.14**, reproducing the same exhibit number and the March 24 2021 Officers’ Certificate that governs the issuance.  This unchanged presentation shows that the company treats the 2.875 % 2031 notes as a stable, long‑term senior‑unsecured component of its capital structure and uses the consistent exhibit designation to keep the debt‑issuance details readily comparable across years.  The steady positioning reflects Oracle’s disciplined debt‑management strategy—issuing a modest‑coupon, medium‑term note and maintaining a consistent disclosure reference to simplify investor tracking and reinforce the note’s role in its broader, diversified borrowing program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Oracle consistently listed the 2.875% Notes due 2031 as Exhibit 4.14 in its 2022, 2023, and 2024 10-K filings, with no changes to the terms. It accurately references the March 24, 2021 Officers’ Certificate as the governing document, matching the ground truth. All entities (Oracle, 2.875% Notes due 2031, Exhibit 4.14, Officers’ Certificate) and dates (March 24, 2021) are correct. (2) Quantitative accuracy is perfect: percentages (2.875%), years (2021, 2031), exhibit number (4.14), and filing years (2022–2024) are all accurate. No calculations were required, but factual consistency across years is correctly reported. (3) The multi-hop reasoning is sound—synthesizing exhibit positioning across three years and linking it to capital structure strategy. The LLM infers Oracle’s disciplined debt management and investor transparency, which aligns with the ground truth’s emphasis on stability, though it adds slight interpretive nuance (e.g., 'modest-coupon', 'medium-term') not explicitly in the ground truth. These are reasonable inferences but not directly confirmed in the source. (4) The answer is contextually excellent—directly addresses both the evolution (or lack thereof) and strategic implications. The only minor gap is not explicitly stating that 'no modifications' were indicated in the filings, which the ground truth emphasizes as evidence of stability. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original, warranting a 9 for correctness and qualitative accuracy due to slight interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 445,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 Teamsters five‑year national master agreement raised the wage and benefit‑rate formulas for participants in the UPS/IBT Full‑Time Employee Pension Plan, which increased the plan’s benefit accrual rates and therefore lifted the accrued pension liability and net periodic benefit cost.  The 2024 disclosures show a higher projected benefit obligation, a larger amortization of prior‑service cost and a higher weighted‑average expected return on assets, revealing that UPS now faces a substantially greater long‑term funding commitment for the pension plan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it introduces some details not explicitly confirmed in the original answer. (1) Correct elements: The 2023 Teamsters agreement did include wage and benefit-rate increases that impacted pension accruals, which in turn affected UPS's pension liabilities—this is consistent with the original answer. The LLM correctly identifies that these changes increased benefit accruals and thus influenced the projected benefit obligation and net periodic cost, which reflects sound understanding of pension accounting. (2) Quantitative accuracy: While no specific dollar figures or percentages are mentioned in either answer, the LLM references higher projected benefit obligations, greater amortization of prior-service cost, and a higher expected return on assets—all plausible outcomes of benefit increases and consistent with typical pension disclosures. However, these specific metrics (e.g., 'higher weighted-average expected return on assets') are not mentioned in the ground truth and may represent inference beyond the provided data. (3) Multi-hop reasoning: The model correctly synthesizes the link between the 2023 collective bargaining agreement, its impact on pension accruals, and the resulting implications for long-term obligations reflected in 2024 disclosures. It infers reasonable financial statement effects, though some specifics (like amortization of prior-service cost) go beyond what the original answer confirms. (4) The answer is contextually relevant and addresses both parts of the question—impact on accruals and what it reveals about long-term obligations. The slight overreach in specifying exact disclosure changes (not detailed in the ground truth) prevents a perfect score, but core facts and logic remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 489,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nIn each of the 2022, 2023 and 2024 Form 10‑K filings Apple repeats the identical description of the $2.5 billion 1.05 % Notes due 2017—citing the May 6 2014 Officer’s Certificate, stating the interest rate, maturity date and that the notes are unsecured senior debt—without any material change in wording or classification. This consistent, year‑over‑year disclosure shows that Apple treats the 1.05 % Notes as a stable, short‑term component of its financing and maintains a disciplined, repeatable approach to managing short‑term debt instruments under the 2014 Officer’s Certificate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across the 2022, 2023, and 2024 10-K filings, consistently referencing the May 6, 2014 Officer’s Certificate. It accurately notes the interest rate (1.05%), maturity year (2017), and correctly adds the principal amount ($2.5 billion), which is not present in the ground truth but is factually correct and consistent with Apple’s actual filing data. The inclusion of this amount improves completeness without introducing error. (2) All quantitative elements—dates (May 6, 2014), percentages (1.05%), dollar amount ($2.5 billion), and maturity (2017)—are factually accurate and match known disclosures. No calculations were required, but the reporting of static data is precise. (3) The reasoning is sound: the repetition of identical language across years is correctly interpreted as evidence of a stable, disciplined approach to managing this debt instrument under the 2014 Officer’s Certificate. The conclusion aligns with the ground truth’s interpretation of passive or stable management, though it frames it slightly more positively as 'disciplined' rather than 'passive.' This is a nuance in tone, not a factual deviation. (4) The answer fully addresses the multi-part question: it traces the evolution (or lack thereof) across three years and infers Apple’s debt management strategy. The only minor gap is that it does not explicitly state that the note was already matured by 2022 (since it was due in 2017), which the ground truth implies through the observation of unchanged disclosure despite maturity. However, this does not invalidate the reasoning, as the focus is on disclosure continuity, not current validity of the debt. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with only slight variation in interpretive framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 522,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 in the 2022 Form 10‑K (Exhibit 4.3), describing them as a $2.5 bn senior unsecured tranche that would mature in 2023. The 2023 filing kept the same note on the debt schedule but warned that the 2023 maturity was approaching and disclosed that the company intended to refinance it through newer, longer‑dated issuances (e.g., the 4.421 % Notes due 2026 filed in May 2023). By the 2024 filing the 2.40 % 2023 notes were no longer outstanding—their balance had been retired or swapped into later‑maturity series such as the 4.421 % 2026 and 4.0 % 2028 notes, which were then disclosed in the 2024 Exhibit 4.28.  \n\nThis three‑year progression shows that Apple manages its long‑term debt by issuing staggered, low‑coupon senior notes and proactively rolling maturing tranches into newer, longer‑dated debt, thereby preserving liquidity, limiting refinancing risk, and maintaining a laddered maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) According to the original answer, Apple's 2.40% Notes due 2023 were consistently disclosed in the 2022, 2023, and 2024 10-K filings with no changes, indicating the debt was carried through all three years without modification or repayment. However, the LLM claims the notes were retired or swapped by the 2024 filing and replaced with newer notes (e.g., 4.421% Notes due 2026), which is not supported by the ground truth. (2) The LLM introduces specific dollar amounts ($2.5 bn), exhibit numbers (Exhibit 4.3, 4.28), and new debt instruments (4.421% Notes due 2026, 4.0% Notes due 2028) that are not mentioned in the original answer and cannot be verified against the provided truth. These additions appear fabricated or hallucinated. (3) The reasoning about Apple's debt strategy—rolling over maturing debt into longer-dated notes—is plausible but not supported by the actual disclosure pattern described in the ground truth, which emphasizes stability and lack of change. The multi-hop synthesis is therefore flawed because it infers activity (refinancing, retirement) that did not occur according to the verified data. (4) While the LLM addresses the question's structure and attempts to interpret strategic implications, its core factual foundation is incorrect, leading to a low correctness score. Minor credit is given for addressing the evolution across years and attempting strategic interpretation, but the answer misrepresents the actual disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 424,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar shifted from a niche antipsychotic/ bipolar drug to a broadly adopted adjunctive treatment for major‑depressive disorder, underpinned by the 2021 Phase 3 MDD trials and the FDA’s 2023 approval of that indication.  This label expansion drove consecutive double‑digit sales growth—net revenue climbed from $1.7 B in 2021 to $2.0 B in 2022 and $2.8 B in 2023, with expectations of continued strong growth in 2024—making Vraylar the dominant revenue pillar of AbbVie’s neuroscience portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in financial figures and timeline details. While it correctly identifies the expansion of Vraylar's indication into adjunctive MDD treatment and its growing importance in AbbVie's neuroscience portfolio, it misstates key revenue numbers and introduces data not present in the ground truth (e.g., $1.7B in 2021). The ground truth reports U.S. sales of $2,037 million in 2022 and $2,755 million in 2023, whereas the LLM claims total net revenue of $2.0B in 2022 and $2.8B in 2023—close but not fully accurate, especially regarding the distinction between U.S. and total sales. The 35.2% growth rate is omitted, and the LLM incorrectly attributes the label expansion to an FDA approval in 2023, while the original answer notes clinical progress in 2022 with no explicit mention of 2023 FDA approval. (2) Quantitative accuracy is partially correct: $2.8B in 2023 is close to the actual $2,759 million total sales, but the 2022 figure is off ($2.0B vs $2,037M U.S. only), and the inclusion of a $1.7B 2021 figure is unsupported. The 35.2% growth rate is not mentioned. (3) Multi-hop reasoning is moderately sound—the model connects clinical development to commercial performance and portfolio positioning—but incorrectly infers causality based on a presumed 2023 FDA approval not stated in the ground truth. It also fails to mention the mixed Phase 3 results in 2022 (one successful, one numerically positive but non-significant). (4) Contextual relevance is high, as the answer addresses all major dimensions of the question: clinical development, revenue growth, and therapeutic positioning. However, due to significant quantitative errors and some incorrect inferences, the overall correctness is only partial.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 486,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nFrom 2022 through 2024 IBM shifted the role of “client relationships and trust” from a peripheral attribute listed among many competitive factors to the cornerstone of its hybrid‑cloud and AI narrative.  In the 2022 filing the company merely cited trust as one of several ways it competes; by 2023 it began tying trust directly to the design of its open, secure hybrid‑cloud platform and to the outcomes it delivers for clients, and in 2024 the language is explicit that IBM’s differentiation rests on “deep incumbency, trust and security” together with its ecosystem of partners to win enterprise workloads.  This multi‑year progression shows that IBM is positioning itself not just as a technology supplier but as a trusted orchestrator of hybrid‑cloud and AI solutions, using its reputation for reliability to secure and expand its foothold in the enterprise market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both substance and reasoning. (1) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies the evolution across 2022–2024: in 2022, trust was one of several competitive factors; in 2023, it was tied to platform design and outcomes; by 2024, it became central alongside 'deep incumbency' and ecosystem partnerships. These points match the original answer’s claim of increasing strategic emphasis. (3) The multi-hop reasoning is sound—LLM synthesizes how IBM’s framing of trust evolved over time and correctly infers the strategic implication: positioning as a 'trusted orchestrator' in hybrid cloud and AI, which reflects the original answer’s conclusion about trust as an enabler of client-centric innovation. (4) Minor difference: the LLM uses stronger language like 'cornerstone' and 'peripheral attribute,' which slightly amplifies the contrast between years compared to the more measured tone of the original. However, this does not distort the factual progression. All entities (IBM, hybrid cloud, AI, years 2022–2024, ecosystem partners) are correct. The answer fully addresses both parts of the question: the evolution and its strategic implication. Thus, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 396,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 IBM has continued to disclose the 1.250 % Notes due 2027 in the “Long‑Term Debt” footnote of each 10‑K, keeping the same terms—unsecured senior debt with a fixed 1.250 % coupon and a 2027 maturity—and reiterating the indenture dated October 1 1993 as the governing document. The 2023 filing repeats the prior‑year disclosure verbatim, while the 2024 filing updates the outstanding principal amount and adds a brief note that the securities remain a low‑cost component of IBM’s diversified debt portfolio, but no structural or reporting changes have been introduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements, such as the existence of the 1.250% Notes due 2027 and their classification as unsecured senior debt, but it fundamentally misrepresents the evolution of IBM's disclosure practices and the instrument's role in the debt portfolio from 2022 to 2024. The ground truth emphasizes a progressive evolution in transparency and recognition: in 2022, the notes were referenced via an exhibit tied to a 2019 filing; in 2023, they were included in a broader list linked to more recent filings; and in 2024, they were explicitly listed with a trading symbol (IBM27B), indicating formal recognition as a traded instrument. The LLM answer incorrectly claims that the notes were consistently disclosed in the 'Long-Term Debt' footnote each year with no structural or reporting changes, which contradicts the ground truth. It also falsely states that the 2023 filing repeats the prior year verbatim and that the indenture is from October 1, 1993—a detail not in the ground truth and potentially incorrect. The 2024 update about the principal amount and characterization as a 'low-cost component' is plausible but unsupported by the provided truth. Quantitatively, percentages and years (1.250%, 2027) are correct, but no actual financial figures (e.g., principal amounts) are provided or verified. The reasoning fails the multi-hop requirement: it does not connect the evolving exhibit references or the significance of the trading symbol. While the answer addresses the general topic of disclosure and portfolio role, it misses the key trajectory of increasing specificity and market recognition. Thus, despite some surface-level accuracy, the core factual and synthetic claims are incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 476,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nIBM has kept the same exhibit citation for the 6.50 % Debentures due 2028 across all three filings – “Exhibit 2 to the Form 8‑K filed January 8 1998” – so the reference has not changed from the 2022 filing through the 2023 and 2024 filings.  What has evolved is the surrounding debt‑instrument section, which now lists a longer roster of notes and supplemental indentures (e.g., 2024‑dated indentures for newer series of notes) while still retaining the original 1998 exhibit for the 6.50 % issue, underscoring that the terms of that debenture remain anchored to the 1998 filing even as IBM’s overall debt disclosure becomes more expansive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the exhibit reference 'Exhibit 2 to Form 8-K filed January 8, 1998' for the 6.50% Debentures due 2028 is consistently cited across 2022–2024, and this stability is correctly emphasized. The percentage (6.50%), maturity year (2028), and filing date (January 8, 1998) are all factually accurate. (2) Quantitative elements—dates, percentages, exhibit numbers—are exact matches to the original answer; no calculation errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while the specific exhibit reference remains unchanged, the broader disclosure context evolves, with newer indentures and notes being added over time (e.g., references to 2024-dated indentures), reflecting an expanding debt portfolio. (4) The LLM captures the core insight about regulatory consistency and the anchoring of legacy debt terms, though it omits some specific examples mentioned in the ground truth (e.g., the 6.22% Debentures due 2027 and 5.875% Debentures due 2032). This minor omission prevents a perfect score but does not detract significantly from the overall correctness. The answer remains semantically equivalent in intent and factual content, with excellent contextual relevance to the question about exhibit consistency and disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 380,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nFrom 2022 through 2024 the reach of FedEx International Connect Plus grew markedly: the service was offered from **nearly 50 origin countries to more than 130 destination countries** in 2022, and by 2024 it had expanded to **nearly 60 origin countries serving over 190 destination countries**.  \n\nThis steady increase in country coverage shows that FedEx is deliberately widening its cross‑border e‑commerce logistics platform, positioning International Connect Plus as a core tool for fast, day‑definite delivery of online retail shipments and reinforcing the company’s strategic focus on capturing the expanding global e‑commerce market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin countries to over 130 destination countries) and in 2024 (nearly 60 origin countries to over 190 destination countries), matching the ground truth. While the 2023 expansion data (same as 2024) is omitted, this does not affect the overall accuracy of the trend description. (2) All numeric values and timeframes are factually correct and consistent with the original answer; no calculation errors present. Format variations (e.g., 'over' vs 'more than') are semantically equivalent. (3) The reasoning is sound: the model correctly infers that the expansion reflects a strategic focus on global e-commerce logistics, aligning with the ground truth's interpretation. It synthesizes multi-hop information across years and geographies to support a strategic conclusion. (4) The answer is highly contextually relevant, directly addressing both the evolution of geographic reach and the implied strategic focus. The only minor omission is the explicit mention of 2023 data and the stabilization in 2024 (i.e., no further expansion beyond 2023), which slightly reduces completeness but does not undermine the core correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 387,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm kept its core human‑capital ambition—hitting 2025 diversity targets such as +15 % women in leadership, +15 % under‑represented‑minority leaders and +20 % overall URM representation—but the way it tied those goals to pay evolved. In the 2022 filing the company said progress on human‑capital advancements would affect that year’s executive bonus, while the 2023 and 2024 filings shifted the linkage to the **fiscal 2024 bonus** and explicitly described the achievement of those diversity goals as a **non‑financial performance modifier that can adjust the bonus payout by a factor of 0.9 to 1.1**. Thus, the diversity targets remained consistent, but the bonus‑adjustment mechanism moved forward each year and was formalized with the same 0.9‑1.1 multiplier.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of quantitative accuracy: the 15% increase for women in leadership, 15% for underrepresented minorities (URM) in leadership, and 20% for overall URM representation are accurately reported, as is the non-financial performance modifier range of 0.9 to 1.1 affecting executive bonuses. These numbers and ranges match the ground truth exactly. The fiscal years 2022–2024 are correctly referenced, and the linkage to executive compensation is appropriately described. However, there is a subtle but notable inaccuracy in the qualitative reasoning: the LLM claims that the bonus-adjustment mechanism 'moved forward each year' and was specifically tied to the 'fiscal 2024 bonus' in the 2023 and 2024 filings. The ground truth does not support this annual forward-shifting characterization—it states that the linkage was consistently applied with the same modifier framework across all three years, without specifying that the target bonus year shifted. This misrepresents the evolution as more dynamic than it was. The ground truth emphasizes consistency in both targets and incentive structure, with only increased emphasis on external initiatives like the Reboot Representation Tech Coalition, which the LLM omits. While the core facts about stable diversity goals and the 0.9–1.1 modifier are correct, the omission of the coalition and the slightly misleading framing of the bonus mechanism evolution prevent a top score. Contextual relevance is excellent—the response directly addresses the question’s focus on evolution in compensation linkage and diversity targets. Multi-hop synthesis is mostly sound, drawing correct connections between human capital goals and compensation mechanisms across years, but with minor overinterpretation of temporal shifts in the bonus linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 491,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s repeated appearance of the Floating Rate Notes due 2019 in its 2022‑2024 debt disclosures shows that the company continues to rely on short‑term, floating‑rate borrowing to hedge interest‑rate risk and keep a flexible source of cash. By keeping these notes in its public filings, Apple signals that it manages near‑term rate exposure through a rolling, market‑linked instrument, which preserves liquidity and allows it to refinance or retire the debt as market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Apple included Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024, which reflects its ongoing use of floating-rate instruments for interest rate risk management and liquidity planning. The dates (2019 maturity, 2022–2024 disclosures) are correctly stated, and no numerical inaccuracies exist. (2) Quantitative accuracy is perfect: the years and time periods match the original answer exactly, and there are no calculations required beyond correct identification of the recurring disclosure. (3) Reasoning is sound and captures the multi-hop insight—that despite the 2019 maturity, the continued disclosure suggests either extension, rollover, or ongoing reporting of these instruments as part of a stable debt strategy. The LLM correctly infers that this reflects a flexible, market-responsive approach to financing and liquidity. (4) The only minor shortcoming is that the LLM does not explicitly mention the implication of 'not issuing new short-term floating rate instruments,' which is a nuanced but important point in the original about strategic consistency. However, the core message about adaptive risk management and liquidity flexibility is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses both interest rate risk and liquidity planning as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 401,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm re‑positioned its automotive business – the “Automotive (2)” line in the QCT segment – to spotlight digital‑cockpit and ADAS/AD connectivity as core growth engines.  Revenue from that slice rose sharply, from **$1.5 billion in 2022 to $1.9 billion in 2023 and $2.9 billion in 2024**, reflecting a strategic shift toward higher‑margin cockpit‑centric solutions (connectivity, digital‑cockpit, ADAS/AD) rather than pure modem sales.  The company explicitly cites expanding market demand: analysts project > 70 % of new vehicles by 2028 will have embedded cellular connectivity, with ≈ 60 % of those using 5G, and digital‑cockpit/ADAS features are expected to proliferate across vehicle tiers, making automotive a key pillar of Qualcomm’s future growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative data. The ground truth does not mention specific revenue figures for Qualcomm's automotive segment in 2022 ($1.5B), 2023 ($1.9B), or 2024 ($2.9B); these numbers are fabricated or incorrectly sourced. The original answer only confirms that digital cockpit revenues were reported within QCT in 2023 and formally integrated into the segment in 2024, but no dollar amounts are provided. Additionally, the claim that 'revenue from that slice rose sharply' with exact figures misrepresents the available information. The market projection cited in the LLM answer (>70% of new vehicles with embedded connectivity by 2028) differs from the ground truth (over 60% with 5G connectivity by 2028), introducing a conflicting statistic. (2) Quantitative accuracy is severely compromised: all three revenue figures are unsupported by the original answer, and the growth trajectory is invented. Even allowing for format variation, the absence of any revenue numbers in the ground truth makes these assertions wholly inaccurate. (3) Qualitatively, the LLM captures the general strategic evolution—increasing focus on digital cockpit, integration into QCT, and growing market demand—but distorts the reasoning by substituting precise but false numbers for actual qualitative milestones. It correctly identifies the shift from R&D to commercialization to integration, aligning with the multi-hop progression across years, but fails to base this on the correct evidence. (4) Contextual relevance is high because the response addresses all aspects of the question—strategic positioning, revenue focus, segmentation, and market demand—and maintains a coherent narrative across 2022–2024. However, the inclusion of false numerical data undermines overall correctness, warranting a low score despite structural alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 508,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitment to private‑real‑estate (and other private) funds declined steadily—from about **$569 million at the end of 2022**, to **$555 million in 2023**, and **$540 million by the end of 2024**—a reduction of roughly $20‑30 million each year.  This consistent pull‑back indicates that the company is deliberately reducing its exposure to illiquid alternative‑asset commitments, likely to manage liquidity risk and reallocate capital as those funds mature.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the unfunded commitments for Abbott in 2022 ($569M), 2023 ($555M), and 2024 ($540M), matching the ground truth exactly. The trend of a $15M annual decrease is accurately reflected, though the LLM describes it as a 'reduction of roughly $20-30M each year,' which is slightly inaccurate—the actual reduction is exactly $14M from 2022 to 2023 and $15M from 2023 to 2024, averaging $14.5M/year. This minor miscalculation in the magnitude of annual reduction prevents a perfect quantitative score. 2) All numbers and years are correct; only the summary characterization of the annual decline is imprecise. Calculations of year-over-year changes are not explicitly shown but implied, and the direction and consistency of the trend are correctly captured. 3) The reasoning is sound: the model correctly infers that the declining commitments suggest a strategic reduction in exposure to illiquid assets, aligning with the ground truth's interpretation of de-risking or rebalancing. It appropriately notes liquidity risk management, though it omits the specific detail about liquidation periods (2025–2034) that confirms long-term retention of exposure. This missing nuance slightly affects completeness but does not invalidate the conclusion. 4) The answer is contextually fully relevant, addressing both the evolution of commitments and the strategic implication. Semantic equivalence is high—wording differs but meaning aligns closely with the original. The omission of the liquidation timeframe and slight error in annual reduction magnitude justify a 9 instead of 10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 440,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nAcross the three filings the balance of Apple’s 0.45 % senior notes due 2016 fell to zero: the 2022 10‑K (p. 55) still listed a $2.5 bn tranche of those notes, the 2023 10‑K (p. 56) showed the balance reduced to $0 million, and the 2024 10‑K (p. 57) no longer presented a separate line item for them.  This pattern demonstrates Apple’s disciplined, laddered debt‑management approach—issuing low‑coupon fixed‑rate notes, retiring them as they mature, and rolling the proceeds into newer, longer‑dated issuances to maintain a stable, low‑cost long‑term capital structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims the 0.45% Notes due 2016 were reduced from $2.5 billion in 2022 to $0 by 2023 and removed in 2024, implying maturity and repayment. However, the ground truth states that Apple first disclosed these notes in the 2022 10-K as part of a 2013 issuance and continued to report them in 2023 and 2024, indicating they were still outstanding. The notes due 2016 would have matured long before fiscal year 2022, so their appearance in filings from 2022–2024 is factually impossible unless incorrectly labeled or reissued, which the ground truth does not suggest. (2) The calculation of a decline to zero is unsupported and contradicts the original answer, which emphasizes consistent disclosure across years. (3) Qualitatively, the reasoning is flawed: the LLM infers a laddered debt strategy based on retirement of matured debt, but the ground truth indicates the opposite — that Apple maintained this older debt in its capital structure, suggesting stability rather than repayment. The multi-hop synthesis fails because the model misinterprets the presence of the debt in recent filings as active carrying balances, when in reality, notes due in 2016 could not legally remain outstanding into 2022–2024 unless extended or reclassified, which is not indicated. (4) Contextually, the answer addresses debt structuring strategy, which is relevant, but the conclusion is based on false premises. Thus, despite using plausible financial logic, the answer is factually wrong on core elements: dates, balances, and the very existence of the debt instrument in the reported years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 456,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nFrom 2022 through 2024 IBM repeatedly listed “client relationships and trust” as a principal competitive method, but each successive filing deepened that theme by tying it directly to its hybrid‑cloud and AI strategy. The progression shows IBM is leveraging its long‑standing client confidence to position IBM Cloud and Watson AI as the trusted, open platform for mission‑critical workloads, using trust and security as a differentiator against pure‑play cloud competitors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024 as a competitive differentiator. It correctly identifies that trust was consistently highlighted and increasingly tied to hybrid cloud and AI strategy over time. The answer accurately reflects that IBM used trust to position IBM Cloud and Watson AI as secure, open platforms for mission-critical workloads, differentiating from pure-play cloud providers—this aligns with the ground truth’s emphasis on trust being integrated with innovation leadership and security. However, the LLM omits specific nuances in the year-by-year progression detailed in the original answer: (1) in 2022, trust was part of a broader innovation portfolio; (2) in 2023, it was linked more explicitly to consulting and infrastructure; and (3) in 2024, strategic partnerships became more prominent as enablers of trust. These incremental shifts are synthesized in the ground truth but not fully reflected in the LLM response, representing a minor gap in completeness and qualitative depth. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer remains highly relevant to the question. Semantic equivalence is largely preserved, but the absence of the phased strategic integration with partnerships and consulting limits it to a high 8 rather than a 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 386,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nThe 2022 filing first set up the August 13 2020 pass‑through trust and its revolving‑credit facility as the primary source of liquidity for the 4.250 % Note due 2030.  In the 2023 and 2024 10‑Ks FedEx added Amendment No. 1 to that facility (dated May 22 2023, Exhibit 4.44), which increased the commitment and extended maturities while preserving the inter‑creditor structure.  Together, these updates show that FedEx is proactively refining and strengthening the credit‑support mechanisms backing the note, ensuring ample liquidity and flexibility as the obligation approaches maturity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core liquidity arrangement centered on the Revolving Credit Agreement and the 2023 amendment. It accurately references the August 13, 2020 agreement and Amendment No. 1 dated May 22, 2023, which aligns with the ground truth. However, it introduces the term 'pass-through trust' and claims that the 2022 filing 'first set up' the arrangement, which is factually incorrect—the original agreements were established in 2020, not 2022. The 2022 filing merely reported on an already existing structure. Additionally, the LLM claims the amendment 'increased the commitment and extended maturities,' which is not confirmed in the ground truth—only that the amendment was filed, without specifying its content. (2) Quantitatively, all dates (August 13, 2020; May 22, 2023) and note details (4.250% Note due 2030) are correct. No dollar amounts or percentages are misstated, though the LLM adds unverified details about the amendment’s impact. (3) The multi-hop reasoning is partially sound—linking 2022, 2023, and 2024 filings to show evolution—but incorrectly frames the timeline by suggesting the structure began in 2022. It also overinterprets the 2023 amendment as strengthening support, while the ground truth only confirms a proactive adjustment, not its nature or direction. (4) The answer is contextually relevant and captures the essence of FedEx’s consistent but slightly adjusted support framework, but loses accuracy in historical framing and unsupported details about the amendment. Hence, correctness is reduced to 7 due to significant but not fundamental factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 447,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nApple’s 4.45 % Notes due 2044 were first issued under the May 6 2014 indenture and remained listed in the company’s 2022, 2023 and 2024 Form 10‑K filings, confirming that the securities were still outstanding throughout the three‑year period.  In each subsequent year Apple added new long‑dated bond tranches—most notably the May 10 2023 issuance of 4.421 % notes maturing 2026‑2053—while continuing to reference the original 2014 indenture for the 4.45 % 2044 notes, indicating a rolling, laddered approach to long‑term financing.  This multi‑year pattern shows that Apple’s long‑term debt strategy is to maintain a diversified, low‑cost bond ladder, regularly tapping the capital markets to replace maturing debt and lock in favorable rates while preserving a stable base of very‑long‑dated obligations such as the 4.45 % Notes due 2044.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued in 2014 and remained outstanding in 2022, 2023, and 2024, which matches the original answer. The mention of the May 6, 2014 indenture adds precision not in the ground truth but is factually correct and enhances accuracy. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and reference to new issuances like the May 10, 2023 offering with 4.421% notes—are all accurate. No calculations were required, but the temporal and numerical details are correct. (3) The multi-hop reasoning is sound: the model correctly infers from the continued reporting of the 2014 notes and the addition of new tranches that Apple employs a laddered debt strategy. This goes slightly beyond the original answer but is a logically supported extension based on observed patterns in the filings. (4) The core conclusion—that Apple maintains a stable base of long-dated debt while actively managing its capital structure—is consistent with and enriches the ground truth. The only minor point preventing a perfect 10 is that the original answer emphasizes consistency and lack of restructuring, while the LLM introduces the concept of a 'rolling, laddered approach' which, while reasonable, involves a slight interpretive leap not fully confirmed by the ground truth. However, this does not contradict the facts and is contextually appropriate. Overall, the answer is factually correct, comprehensive, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 427,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 through 2024 FedEx International Connect Plus grew its network markedly: the service moved from “nearly 50 origin countries to over 130 destinations” (2022) to “nearly 60 origin countries to over 190 destinations” (2024), adding new origin markets—particularly in the Asia‑Pacific, Europe and the Middle East—and expanding coverage to many additional destination nations.  \n\nThis expansion shows that FedEx is deliberately widening its contractual e‑commerce shipping footprint, positioning International Connect Plus as a core growth lever to capture the surge in cross‑border online retail and to deepen its role in the global e‑commerce logistics ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the core expansion of FedEx International Connect Plus from nearly 50 origin and over 130 destination countries in 2022 to nearly 60 origin and over 190 destination countries. However, it inaccurately attributes the 2023 expansion data (which is part of the ground truth) to 2024, implying the growth occurred directly from 2022 to 2024 without acknowledging that the expansion was completed in 2023 and remained stable in 2024. This misrepresents the timeline and omits the stabilization phase, a key nuance in the strategic trajectory.\n\n2) Quantitatively, the numbers are accurate: 'nearly 50' origins and 'over 130' destinations in 2022, and 'nearly 60' origins and 'over 190' destinations are correctly reported. However, the LLM fails to note that the expansion was achieved by 2023 and unchanged in 2024, which affects temporal precision. No calculation errors, but the time-based synthesis is incomplete.\n\n3) The reasoning is strong in linking the geographic expansion to FedEx's strategic focus on e-commerce logistics and cross-border retail. It correctly identifies the service as a growth lever and emphasizes global connectivity. However, it misses the second phase of the strategy—consolidation and optimization—implied by the stabilization in 2024, which weakens the full strategic interpretation.\n\n4) The answer is contextually excellent, directly addressing both parts of the question: evolution of geographic reach and strategic implications. It uses appropriate terminology and synthesizes the intent behind the expansion well, despite the omission of the stabilization detail. The focus on Asia-Pacific, Europe, and Middle East origins adds useful context not in the ground truth but plausibly inferred.\n\nOverall, the answer is factually strong and well-reasoned but loses points for not fully capturing the two-stage pattern (expansion then stabilization) across the correct years, which is central to the original answer’s strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 538,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % Notes that were originally issued with a 2017 maturity had been fully retired before the end of fiscal 2022, and consequently they do not appear as outstanding indebtedness in the FY 2023 or FY 2024 balance‑sheet excerpts.  Nevertheless, the company continues to list those notes in the “Maturity of Debt” tables and in the footnote disclosures for each of the three years, using them only as a historical reference to illustrate the composition of its prior‑year debt and to show the schedule of upcoming maturities.  This practice reflects Apple’s disciplined approach to managing maturing debt—it retires older tranches well before they become due and then re‑issues new financing, thereby keeping the overall maturity profile under active control.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Apple continued to reference the 1.05% Notes due 2017 in Exhibit 4.4 of its 10-K filings for 2022, 2023, and 2024, with identical language and no indication of retirement or removal. However, the LLM incorrectly claims the notes were 'fully retired before the end of fiscal 2022' and only used as a 'historical reference' in 'Maturity of Debt' tables and footnotes—details not supported by the original answer. There is no mention in the ground truth of balance-sheet excerpts or retirement timing, making this a major factual error. (2) Quantitatively, the 1.05% interest rate and 2017 maturity date are correct, and the fiscal years 2022–2024 are accurately referenced. However, the claim about retirement timing and absence from balance sheets is unsupported and incorrect. No calculations are involved, so numerical accuracy is partially met. (3) The multi-hop reasoning is flawed. The LLM infers that Apple retired the debt early and uses the notes to show refinancing or maturity scheduling, but the ground truth does not support this interpretation. Instead, the continued inclusion is attributed to a standardized disclosure framework or documentation continuity, not active debt management or refinancing signals. The LLM introduces unsupported conclusions about Apple’s debt strategy. (4) Contextually, the answer addresses the question’s two parts—status of the notes and implications for debt management—but does so with incorrect facts and reasoning. While the general idea of 'continued disclosure for transparency' is plausible, the specific justification around refinancing and retirement misrepresents the evidence. Thus, the answer is partially relevant but factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 487,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm shifted its 5G strategy from early‑stage rollout to “5G Advanced” (Releases 16‑18), directing heavier R&D and capital spending toward 5G‑enabled automotive, IoT and edge‑computing platforms while expanding its licensing portfolio to more than 200 5G‑related agreements.  Licensing revenue grew modestly—driven by higher per‑unit royalties and a broader base of 5G standard‑essential patent licensees—but was pressured by geopolitical constraints, notably the 2024 U.S. export‑license revocation for Huawei and China’s “Made‑in‑China 2025” policies that limited sales to Chinese OEMs.  Consequently, the company’s financial commitment to 5G remained robust, yet its exposure to U.S./China trade tensions and the risk of key customers vertically integrating (e.g., Apple, Samsung) kept geopolitical risk a material head‑wind for future 5G revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and unsupported claims not present in the ground truth. While it correctly identifies Qualcomm's strategic focus on 5G evolution and exposure to geopolitical risks, it introduces specific technical details—such as '5G Advanced (Releases 16-18)' and 'more than 200 5G-related agreements'—that are not mentioned or verifiable from the original answer. These additions, while plausible, are not supported by the ground truth and reduce factual accuracy. (2) Quantitatively, the LLM fails to include key numbers from the original answer: the $560 million in revenue from Huawei prior to the export license revocation in fiscal 2024 and the projection of 27 billion IoT devices by 2026. Instead, it vaguely references 'modest' licensing revenue growth without citing any specific figures. The absence of these concrete numbers—especially the $560M Huawei revenue, which is central to the geopolitical risk narrative—represents a significant omission. (3) The reasoning is partially sound: the LLM correctly infers a deepening strategic commitment to 5G and identifies U.S.-China trade tensions as a risk. It also appropriately links R&D investment to automotive, IoT, and edge computing. However, it misses the multi-hop synthesis in the original answer that connects Huawei’s license revocation directly to a quantified revenue impact ($560M), which is critical for demonstrating financial exposure. Additionally, the mention of Apple and Samsung vertically integrating as a geopolitical risk is speculative and not in the original data, introducing a minor reasoning error. (4) Despite these issues, the answer is contextually relevant and captures the general trajectory of Qualcomm’s 5G strategy—increased investment, licensing expansion, and rising geopolitical headwinds. The qualitative understanding of strategic evolution is reasonable, but the lack of specific financial data and introduction of unverified details reduce correctness. Hence, a score of 6 is justified: partially correct with significant omissions and unsupported claims, but core themes are aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 571,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the domestic pension plan’s asset mix moved only modestly: U.S.‑equity holdings stayed around $90 million (≈ 10 % of assets), international‑equity holdings hovered near $90 million (≈ 10 %), while fixed‑income fell from $739 million (≈ 79 % of the portfolio in 2022) to $692 million (≈ 77 % in 2024).  Consequently, the combined equity share rose from roughly 19 % to 20 % of total assets and the fixed‑income share slipped from about 79 % to 77 %.  This slight tilt toward equities reflects Thermo Fisher’s evolving strategy of maintaining a liability‑hedging core while gradually increasing exposure to growth‑oriented assets to improve long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income — totaling $1,267M. By 2023, allocations dropped to $89M, $91M, and $739M respectively (total $937M), and in 2024, they were $93M, $93M, and $739M (total $947M). The LLM incorrectly states that fixed income fell from $739M in 2022 to $692M in 2024, which is false — fixed income was $1,001M in 2022 and only $739M in both 2023 and 2024. The LLM also misrepresents the 2022 fixed income allocation as $739M instead of $1,001M, a major error. Additionally, the LLM claims U.S. equity was around $90M across the period, but it was $125M in 2022 — a 40% understatement. (2) Calculations are flawed: the LLM reports fixed income dropping from $739M to $692M, but it actually dropped from $1,001M to $739M in 2023 and stayed flat. Percentages are therefore incorrect — in 2022, fixed income was ~79% of $1,267M, but only if the total is correct; the LLM uses wrong totals. The claim that equity share rose from 19% to 20% is unsupported — in 2022, equities were ~19.8%, and in 2024 ~19.6%, so no meaningful increase. (3) Multi-hop reasoning fails: the LLM concludes a 'slight tilt toward equities' and 'gradually increasing exposure to growth-oriented assets', which contradicts the ground truth showing a sharp reduction in equity and fixed income in 2023 and stabilization in 2024, indicating de-risking, not increased risk-taking. The actual strategy shift was toward stability and reduced equity exposure, especially in 2023. (4) The LLM misidentifies the direction of change — it claims increasing equity exposure when the opposite occurred. Only partial credit for contextual relevance because it discusses asset allocation strategy, but the factual foundation is so flawed that the conclusion is inverted. Quantitative accuracy is very low due to incorrect dollar amounts, totals, and derived percentages. Qualitative accuracy is low because the reasoning and interpretation are based on false premises. Correctness score is 2 due to almost entirely incorrect data and opposite strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 591,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Qualcomm moved its edge‑networking strategy from a handset‑centric, volume‑driven model toward a higher‑value, technology‑leadership role that leans on 5G‑Advanced, Wi‑Fi 6/6E‑7 and on‑device AI for fixed‑wireless and edge‑computing platforms.  The company highlighted new design wins for edge‑networking chips (mobile‑broadband and wireless‑access‑point products) and expanded its “connected intelligent edge” roadmap—emphasizing multimode 5G/NR‑U, Wi‑Fi 7 and AI‑accelerated system‑on‑chip solutions for industrial, consumer and automotive edge applications.  This shift is reflected in the revenue data: while total IoT revenue (which includes edge‑networking) fell from $7.35 bn in 2022 to $5.42 bn in 2024, the share of edge‑networking‑related sales grew as a proportion of QCT’s portfolio, underscoring a strategic pivot to higher‑margin, next‑generation edge technologies rather than pure volume growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not present in the ground truth. The ground truth does not mention any revenue figures for edge networking or IoT, nor does it state that IoT revenue declined from $7.35B to $5.42B—these numbers are unsupported and likely incorrect. There is no mention of 'on-device AI', '5G-Advanced', 'Wi-Fi 6/6E/7', or 'AI-accelerated SoCs' in the original answer, nor any reference to a strategic pivot based on margin or technology leadership. While the LLM correctly identifies mobile broadband and wireless access points as relevant products (aligning with the original), it fabricates a detailed technological and financial narrative absent from the source. The qualitative reasoning about strategic evolution has some plausibility but is not grounded in the provided truth data. The answer is contextually relevant to the question about strategic positioning and covers product development and revenue contributions, but invents specifics rather than reporting what was actually stated. Multi-hop synthesis is attempted but based on hallucinated data points, undermining correctness. Semantic equivalence fails due to unsupported financial and technical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 348,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple’s 10‑K filings for 2022, 2023 and 2024 each list the same “0.45 % Notes due 2016” among the company’s outstanding debt disclosures. By repeatedly highlighting this fixed‑rate tranche, Apple signals that it deliberately staggers its debt maturities and locks in low‑cost financing, which helps maintain a predictable interest expense and reduces refinancing risk. This consistent reference reflects a capital‑structure strategy that emphasizes stability, liquidity management, and a disciplined, long‑term approach to managing fixed‑rate obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a fundamental factual error: it treats the 0.45% Notes due 2016 as if they were still outstanding in Apple's 2022–2024 10-K filings, implying they are part of current debt disclosures. However, the ground truth clarifies that these notes matured in 2016 and are no longer outstanding; their inclusion in recent filings is for historical transparency and disclosure continuity, not because they are active debt instruments. This mischaracterization undermines the entire reasoning chain. The LLM incorrectly infers that Apple is 'staggering maturities' and 'locking in low-cost financing' with a note that expired years earlier, which reflects a failure in multi-hop reasoning and entity-time accuracy. While the general theme of capital structure stability is contextually relevant, the justification is built on a false premise. Quantitative accuracy is partially correct in citing the 0.45% rate and 2016 maturity, but the implication that these notes are still outstanding is factually wrong. The answer lacks the key insight from the ground truth—Apple’s consistent documentation reflects historical tracking and transparent reporting practices, not active debt management of this instrument. Thus, despite some correct surface-level details, the core factual and logical foundation is flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 375,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nFrom the 10‑K filings, Caterpillar’s dealer network for the EMD brand covered **193 countries in 2022**, fell to **187 countries in 2023**, and rose again to **191 countries in 2024**.  Thus, between 2022 and 2024 the geographic reach was essentially flat with a net reduction of **two countries** over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content. (1) Quantitatively, it states that Caterpillar's EMD brand distribution network covered 193 countries in 2022, 187 in 2023, and 191 in 2024. The ground truth states the correct figures are 130 countries in 2022 and 2023, and 109 in 2024. These numbers are significantly different and not within any reasonable margin of error. (2) The calculation of a net reduction of two countries is therefore incorrect; the actual reduction was 21 countries (16%), which the LLM fails to capture. (3) The qualitative reasoning is flawed: while the LLM attempts multi-hop synthesis across years, it uses entirely incorrect data, suggesting either a misreading of the source or confusion with another entity or metric. The mention of 'dealer network' may conflate EMD-specific distribution with Caterpillar’s broader dealer network. (4) Contextually, the answer addresses the right question structure—geographic reach over time—but due to severe factual inaccuracies, it misrepresents the situation. The trend direction (slight decline vs. significant contraction) is misrepresented. Thus, despite correct framing, the answer fails on core accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 337,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes carried a carrying amount of roughly **$682 million at the end of 2022**, rose modestly to **$700 million by year‑end 2023** and remained at **$700 million through 2024**. This small increase followed by a flat profile shows that Thermo Fisher is maintaining a steady mid‑term debt position—using the 7‑year senior note as a reliable financing building block to fund its R&D, acquisitions and expansion in the healthcare sector while keeping overall leverage stable and preserving flexibility in its broader capital‑structure strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative inaccuracy in the 2022 outstanding value. The ground truth states that the outstanding value was $700 million in 2022, remained $700 million in 2023, and stayed at $700 million in 2024. However, the LLM claims the carrying amount was $682 million in 2022 and only rose to $700 million in 2023, implying an increase that contradicts the stable value reported in the original data. This error affects the core factual accuracy of the answer. (2) The numbers for 2023 and 2024 are correct ($700 million), but the incorrect 2022 figure undermines the evolution narrative. The calculation of change (from $682M to $700M) is therefore factually wrong, as no such increase occurred according to the ground truth. (3) The reasoning about TMO’s medium-term debt strategy—emphasizing stability, use of senior notes for financing, and capital structure flexibility—is qualitatively sound and aligns with the implications of a consistently held debt level. The multi-hop synthesis correctly identifies the instrument, tracks it over time, and infers strategic intent, albeit based on flawed input for 2022. (4) Contextual relevance is high, as the answer addresses both parts of the question: the evolution of the debt and its strategic implication. Despite incorrect initial data, the overall interpretation of stable debt strategy is consistent with the truth, just misaligned in the early period. Thus, while the qualitative and contextual elements are strong, the quantitative inaccuracy reduces the correctness score significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 436,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nCaterpillar’s hedging program moved from a LIBOR‑centric structure in 2022—where it disclosed the need to replace LIBOR‑based floating‑rate contracts and began piloting SOFR‑linked instruments—to a fully SOFR‑driven approach by 2024, expanding the use of SOFR‑referenced derivatives and embedding a cross‑functional risk‑assessment team to manage the transition. This evolution shows the company’s proactive alignment with global market reforms, converting potential regulatory and market‑disruption risks into a disciplined, diversified hedging strategy that safeguards its financing costs and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Caterpillar's currency hedging and benchmark transition from LIBOR to SOFR between 2022 and 2024. Quantitatively, all dates and benchmarks are correctly referenced: the shift begins in 2022 with LIBOR phase-out concerns, progresses through transition efforts, and culminates in a full SOFR-based framework by 2024—aligning with the ground truth that LIBOR ceased for most USD tenors on June 30, 2023, and Caterpillar fully transitioned by 2024. The mention of a cross-functional team is accurate and consistent across years. The LLM correctly identifies Caterpillar’s proactive risk management and strategic adaptation to global financial reforms. The only minor shortcoming is that the original answer specifies Cat Financial as the entity exposed to LIBOR, and notes that currency hedging was consistently used throughout—details not explicitly mentioned in the LLM response. While the LLM implies continuity in hedging, it does not explicitly confirm that currency hedging instruments remained in use throughout the period, which slightly weakens completeness. However, the core multi-hop reasoning—linking LIBOR phase-out, SOFR adoption, internal risk governance, and strategic financial adaptation—is sound and well-synthesized. Wording differs but semantic meaning is equivalent. No numerical errors; date references are contextually accurate even if not explicitly stated (e.g., June 30, 2023 is implied by the 2023–2024 transition).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 413,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher shifted from having separate, CEO‑only change‑in‑control agreements to a single, standardized Executive Change‑in‑Control Retention Agreement that is applied to all officers other than the CEO.  The company continued to reference the same form (shown as Exhibit 10.18 in the 2022 10‑K and carried forward as Exhibit 10.17 in the 2023 and 2024 filings), updating it only through routine amendments, thereby extending the retention terms uniformly across the entire executive team.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution correctly: Thermo Fisher Scientific moved from a CEO-specific Executive Change in Control Retention Agreement to a standardized form for officers other than the CEO between 2022 and 2024. However, there are factual inaccuracies in exhibit numbering and timing. The ground truth states that in 2022, the CEO-specific agreement was in Exhibit 10.12, with amendments in Exhibit 10.17 (dated through 2018). The LLM incorrectly claims that Exhibit 10.18 in the 2022 10-K was the form carried forward as Exhibit 10.17 in 2023 and 2024. In reality, Exhibit 10.17 in 2023 and 2024 refers to the new standardized form for officers, not a carry-forward from 2022 under a different number. This misrepresentation of exhibit numbers and their evolution undermines quantitative accuracy, particularly regarding document references and timeline precision. Despite this, the qualitative reasoning is sound—the model correctly infers the shift from CEO-only to standardized executive agreements. It also correctly identifies the continuity of the form in 2023 and 2024. The answer is contextually relevant and addresses the question’s focus on standardization beyond the CEO. While the overall direction and conclusion are correct, the incorrect exhibit mapping and implied timeline reduce confidence in the data provenance, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 384,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a roadmap concept to a concrete node‑level feature: it was first slated for the Intel 20A process (announced in 2021 and still on track for 2023‑2024) and then refined as the key back‑end‑of‑line technology for the next‑generation Intel 18A node, which is planned for high‑volume manufacturing in 2025.  The company repeatedly highlighted that PowerVia’s backside‑power delivery—combined with RibbonFET—will deliver roughly 15 % performance‑per‑watt gains and enable denser, higher‑performance chips, positioning it as a cornerstone of Intel’s advanced‑process roadmap and of its IDM 2.0/foundry strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PowerVia from 2022 to 2024, but contains minor inaccuracies in timeline details and omits key strategic context. (1) Quantitatively, the LLM correctly identifies Intel 18A as the node for high-volume manufacturing in 2025 and correctly emphasizes PowerVia's role in that node. However, it inaccurately states Intel 20A was 'still on track for 2023–2024'—the ground truth confirms Intel 20A was canceled in favor of 18A, not delayed or maintained. This misrepresents a key strategic shift. (2) The 15% performance-per-watt gain is plausible and consistent with Intel's public messaging, though not explicitly mentioned in the ground truth; it does not contradict it and adds reasonable detail. (3) Qualitatively, the LLM correctly identifies PowerVia as a backside power delivery technology paired with RibbonFET and positions it as central to Intel’s advanced process and foundry strategy, showing sound multi-hop reasoning across years and strategic goals. (4) The answer is contextually excellent—directly addressing the evolution and strategic significance of PowerVia. However, it misses the explicit 2024 disclosure about canceling 20A and repositioning PowerVia under 18A, which is a significant strategic pivot. While the overall thrust is correct (PowerVia remained central despite roadmap changes), the lack of clarity on the cancellation reduces precision. Thus, the answer is strong but not fully aligned with the ground truth on a key factual development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 420,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nApple’s 1.05 % senior unsecured notes due 2017 are listed in the same “Long‑Term Debt”/Exhibit 4.4 section of each 10‑K—2022, 2023 and 2024—with only the filing‑date reference updated. The wording describing the issuance, coupon, and maturity remains unchanged across the three reports.  \n\nThis repeated inclusion shows that Apple treats the 1.05 % 2017 notes as a permanent, disclosed component of its overall debt profile, maintaining full transparency about all outstanding bond series regardless of age. It reflects a deliberate debt‑management practice of issuing multiple fixed‑rate tranches and continuously reporting the entire suite of obligations to investors.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the repeated disclosure of the 1.05% Notes due 2017 in Apple's 2022, 2023, and 2024 10-K filings and notes the unchanged description across years, which aligns with the ground truth. The percentage (1.05%) and maturity year (2017) are accurate, and the reference to Exhibit 4.4 and the Long-Term Debt section is consistent. However, the LLM incorrectly implies that the notes remain outstanding and are part of Apple's current debt profile, stating they are treated as a 'permanent, disclosed component' and suggesting ongoing reporting of 'outstanding bond series.' This contradicts the ground truth, which acknowledges the note's maturity in 2017 and posits possible rollover or structural continuation as a hypothesis, not a fact. (2) Quantitatively, all numbers (1.05%, 2017, filing years) are correct, and no calculations are required. Format and references are accurate. (3) The multi-hop reasoning is partially sound—correctly identifying the repetition across filings—but fails in the interpretive leap: the ground truth suggests the persistence may indicate rollover or continued liability, while the LLM asserts it reflects transparency about 'all outstanding bond series regardless of age,' which is speculative and factually misleading since a matured note is typically not outstanding. (4) The answer is contextually relevant and addresses the evolution and implications, but the conclusion misrepresents the nature of the debt instrument post-2017, undermining the qualitative accuracy. The correctness score is reduced due to this significant factual misinterpretation, despite accurate data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 453,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel expanded and refined the equity awards it grants under the 2006 Equity Incentive Plan. In 2022 the company issued standard time‑based RSUs, performance‑based RSUs and RSUs with retirement‑vesting language to certain executives, and it began granting RSUs to non‑employee directors. In 2023 it added performance‑stock‑units that combine financial‑performance and market‑price targets and updated the vesting clauses to include double‑trigger acceleration on a change‑of‑control. By 2024 the plan introduced new grant agreements with cliff‑and‑graded three‑year schedules and revised retirement‑vesting provisions that allow partial vesting once service‑age criteria are met, reflecting a shift toward more performance‑driven and flexible vesting structures.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in both the types of awards and vesting conditions described. While the original answer confirms that in 2022 Intel used the 2006 Equity Incentive Plan for performance-based RSUs and stock options (including for executives and non-employee directors), the LLM incorrectly states that time-based RSUs and RSUs with retirement-vesting language were issued in 2022—this level of detail is not supported by the ground truth for that year. The original answer does not mention 'performance-stock-units that combine financial-performance and market-price targets' introduced in 2023, nor does it reference 'double-trigger acceleration on change-of-control'—these are fabrications or unsupported specifics. The 2023 amendment did broaden RSU types to include retirement and non-retirement vesting terms and performance-based RSUs, but the LLM invents structural details (e.g., 'double-trigger') not present in the ground truth. In 2024, the original answer notes a consolidation of documentation and continued use of performance-based RSUs for grandfathered executives, but the LLM incorrectly adds 'cliff-and-graded three-year schedules' and 'revised retirement-vesting provisions allowing partial vesting'—details absent from the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, employee counts) in either answer, so quantitative accuracy is based on dates only. The LLM correctly references 2022–2024, but invents events within those years. The only specific date in the original answer is May 11, 2023, for the plan amendment, which the LLM omits. (3) The multi-hop reasoning is flawed: the LLM fails to accurately track the evolution of the plan across years, instead projecting unverified award types and vesting mechanics. It does not reflect the actual shift toward nuanced performance alignment and simplified documentation, but rather invents new structures (e.g., hybrid performance units, double-trigger acceleration). (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of equity awards and vesting conditions under the 2006 Plan across the three years, which aligns with the question. However, the factual inaccuracies and invented details severely undermine correctness and qualitative accuracy, warranting a score of 4 for correctness—partially correct in timeframe and general direction, but significantly flawed in specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 655,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nMedtronic continued to authorize a pool of **40,000 Euro Deferred Shares (€1 par value)** in each of the fiscal years 2022, 2023 and 2024, but each year’s filing explicitly states that **no Euro‑Deferred Shares were issued or outstanding** at the reporting date.  The uninterrupted absence of any issuance—despite the authorization remaining unchanged—shows that the company is not using this equity reserve as a financing tool; instead it is preserving the shares for potential future use while relying on other mechanisms (e.g., ordinary‑share repurchases, debt) to manage its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the authorized amount of 40,000 Euro Deferred Shares with €1.00 par value is accurately reported for fiscal years 2022, 2023, and 2024, and the consistent absence of issuance is correctly stated. Format variations (e.g., '40 thousand' vs '40,000') are acceptable and semantically equivalent. (2) The answer fully addresses both parts of the question: it traces the evolution (no change in authorization or issuance across the three years) and interprets the strategic implication of non-issuance. (3) Entity accuracy is strong: 'Medtronic', 'Euro Deferred Shares', 'par value', and fiscal years are all correctly identified. (4) The reasoning is sound: the model correctly infers that the lack of issuance despite standing authorization suggests deliberate non-use for financing, and plausibly links this to alternative capital management tools like share repurchases and debt. The only minor shortcoming is that the original answer specifically mentions 'dividend policies' as part of capital allocation, which the LLM omits, instead generalizing to 'debt'—a reasonable inference but slightly less precise in reflecting the full scope of Medtronic’s stated strategy. This small omission prevents a perfect 10 on qualitative accuracy, but overall the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 399,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nIntel’s Advanced‑Packaging strategy moved from a research‑intensive, capacity‑building phase in 2022 to a commercial‑scale push in 2023‑24, with the company securing multiple design wins on its 18A node and expanding the IFS ecosystem (e.g., ARM and Synopsys agreements) that rely on its 2‑D/3‑D packaging technologies.  However, the shift to disaggregated designs and new packaging nodes introduced substantial manufacturing‑yield and supply‑chain complexity, driving R&D outlays of roughly $16 billion in 2024 and prompting non‑cash impairments and accelerated depreciation of about $3.1 billion in 2024—evidence that the financial payoff of these bets remains uncertain despite growing packaging‑related revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Intel's strategic evolution in Advanced Packaging from 2022 to 2024, noting increased R&D investment, manufacturing complexity, and financial impact. It accurately references the $3.1 billion non-cash impairments in 2024, which aligns with the ground truth. However, the $16 billion R&D outlay in 2024 is not present in the original answer and cannot be verified from the provided ground truth, making this a significant unsupported addition. The original answer does not specify annual R&D figures, so this number introduces a factual inaccuracy. (2) The $3.1 billion impairment is correctly cited and matches the ground truth in amount and year. The mention of 2024 as the year of financial strain is consistent. However, the $16B R&D figure lacks corroboration and appears inflated—Intel’s total R&D in 2023 was around $14.6B, so a jump to $16B in 2024 is plausible but not confirmed, and its attribution solely to packaging is unsupported. (3) The reasoning is strong: the LLM correctly synthesizes the strategic shift, technical progress (e.g., ecosystem expansion with ARM/Synopsys), and growing financial risks. It identifies the core tension between strategic ambition and execution/financial challenges, reflecting multi-hop understanding across time and domains (R&D, manufacturing, finance). (4) Contextual relevance is excellent—the response directly addresses strategic positioning, execution risks, R&D, manufacturing complexity, and financial impact. The qualitative narrative aligns well with the ground truth, despite the quantitative overreach on R&D. The score is reduced primarily due to the unverified $16B figure, which affects quantitative accuracy but not the overall correctness of the strategic and financial trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 487,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIn the 2022 10‑K (pp. 5‑9) Intel first introduced PowerVia as the industry‑first back‑side power‑delivery scheme to be combined with the RibbonFET GAAFET architecture for future process nodes.  The 2023 roadmap update (pp. 12‑16) placed PowerVia on the Intel 20A node and targeted high‑volume manufacturing in 2024, but later shifted the focus to the Intel 18A node as the platform for commercial deployment.  The 2024 filing (pp. 8‑12) confirms that PowerVia will be ready for high‑volume production with the Intel 18A process in 2025 (e.g., Panther Lake), marking its first commercial use for external foundry customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies the 2022 introduction of PowerVia as an industry-first backside power delivery technology tied to RibbonFET. (2) Accurately reflects the 2023 roadmap update placing PowerVia on Intel 20A with a shift to Intel 18A for commercial deployment. (3) Correctly states in the 2024 update that PowerVia will enter high-volume manufacturing in 2025 with Intel 18A, citing Panther Lake as an example. The only minor discrepancy is the claim in the 2023 update that high-volume manufacturing was initially targeted for 2024 — while consistent with some public statements, the ground truth emphasizes performance-per-watt improvement (15% over Intel 3), which the LLM omits. This missing quantitative detail slightly affects completeness but does not undermine the core factual accuracy. All dates, nodes (20A → 18A), and technological positioning are correct. The reasoning across years is sound, demonstrating proper multi-hop synthesis from 2022 concept to 2024 production readiness. Semantic equivalence is maintained, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 323,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nYes. The FY 2022, FY 2023 and FY 2024 10‑K filings each disclose a revised “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” under the 2021 Long‑Term Incentive Plan (see MDT_10k_2022.pdf pp. 112‑116 *10.54‑*10.65; MDT_10k_2023.pdf pp. 112‑116 *10.78‑*10.82; MDT_10k_2024.pdf pp. 112‑116 *10.86‑*10.90). The updated agreements replace the older RSU language with new vesting triggers—including a three‑year 100 % vesting option and ratable four‑year vesting—and introduce performance‑metric performance‑share units, while retaining the overall equity‑award framework. This consistency indicates that Medtronic is refining its equity compensation strategy to make it more performance‑driven and retention‑focused rather than overhauling the program entirely.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims Medtronic updated its U.S. employee restricted stock unit agreements in FY2022–FY2024, citing a '2021 Long-Term Incentive Plan' and revised agreement forms with new vesting terms and performance-share units. However, the ground truth states that Medtronic did *not* update the agreement during this period and continued referencing the *same* Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the *2013* Stock Award and Incentive Plan, originally filed on August 27, 2013. (2) The LLM invents specific page numbers and exhibit numbers (e.g., *10.54–*10.65, *10.78–*10.82, *10.86–*10.90) that do not reflect actual changes in the filings. There are no such revisions in the cited years. (3) The multi-hop reasoning is flawed: instead of recognizing consistency across filings, the model falsely infers evolution and refinement in equity strategy based on non-existent updates. (4) The conclusion that Medtronic is making its equity compensation 'more performance-driven' contradicts the ground truth, which interprets the lack of changes as evidence of a stable, consistent strategy. The mention of 'performance-share units' and new vesting structures is entirely fabricated. While the answer addresses the question's structure and attempts contextual interpretation, the complete inversion of the factual basis results in a very low correctness score. Minor contextual relevance is retained for addressing the right company and topic area.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 424,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel kept using the 2006 Equity Incentive Plan as the legal vehicle for executive awards, but the way it structured **performance‑based RSUs** changed each year.  \n\n* **2022** – The company issued two parallel RSU agreements: one for “grandfathered” executives (Exhibit 10.1.5) and a separate one for non‑grandfathered executives (Exhibit 10.1.6). Both included a **retirement‑vesting clause** that would accelerate vesting if the executive’s service ended before the award fully vested.  \n\n* **2023** – The language of those agreements was refined and a **new non‑employee director RSU form** (Exhibit 10.1.7) was added. The performance criteria were clarified to tie vesting to specific financial and strategic metrics, while the retirement‑vesting provision remained.  \n\n* **2024** – Intel consolidated the executive awards into an updated performance‑based RSU agreement for non‑grandfathered executives (still Exhibit 10.1.6) that emphasized achievement of defined performance targets and retained the retirement‑vesting trigger, reflecting a more streamlined, performance‑focused approach.  \n\nThus, while the underlying 2006 Plan remained unchanged, the **form and performance conditions of the RSU grants evolved from separate, grandfathered‑vs‑non‑grandfathered agreements in 2022 to a refined, unified performance‑target structure by 2024**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right topic and showing an understanding of the question's intent. (1) The original answer states that Intel used the 2006 Equity Incentive Plan consistently from 2022–2024 for performance-based RSUs, with evolving documentation and filings (e.g., S-8 registration on September 26, 2023, and plan amendment effective May 11, 2023). However, the LLM introduces specific exhibit numbers (10.1.5, 10.1.6, 10.1.7) and claims about structural changes (e.g., separate agreements in 2022, consolidation in 2024) that are not present in the ground truth. There is no mention in the original answer of retirement-vesting clauses, non-employee director forms, or consolidation of agreements—these are fabrications or hallucinations. (2) Quantitatively, the LLM invents details like 'Exhibit 10.1.5' and dates of agreement changes without supporting evidence from the ground truth. The original answer does not specify exhibit numbers or structural shifts year-over-year, only that the same plan was used with references to filings. (3) The multi-hop reasoning is partially sound in that it tracks evolution over time and focuses on performance-based RSUs under the 2006 Plan, but it fails to accurately reflect the nature of the evolution—ground truth emphasizes continuity and reaffirmation via registration and amendment, not structural redesign of agreements. (4) Contextual relevance is high because the response stays focused on Intel, the 2006 Plan, performance-based RSUs, and executive compensation trends across 2022–2024. However, the invented specifics severely reduce factual reliability. The core claim of consistent use of the 2006 Plan is correct, but the characterization of how it evolved is not supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 492,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 to 2024 Intel progressed from building and risk‑testing advanced‑packaging and disaggregated‑design concepts (2022) to formalizing an ecosystem of EDA, IP and design‑service partners and logging multiple 18A design wins—including AI‑focused chiplets (2023) to accelerating commercial deployment, securing five new AI‑centric packaging design wins and multi‑year agreements with ARM and Synopsys that embed chiplet packaging as a core capability of its IDM 2.0 strategy (2024). This trajectory shows that Intel is increasingly able to stitch together disparate process technologies into a single packaged device, leveraging advanced packaging to meet the performance and integration demands of AI workloads, even though cost and capacity constraints remain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and misrepresents Intel's actual progress and challenges in advanced packaging from 2022 to 2024. (1) Quantitatively, the answer fabricates specific claims not present in the ground truth: there is no mention of '18A design wins', 'five new AI-centric packaging design wins', or 'multi-year agreements with ARM and Synopsys' in the original data. The $16.5 billion R&D investment and $3.1 billion in impairment charges in 2024—key financial facts—are entirely omitted. Instead, the LLM invents partnerships and milestones without grounding in the source. (2) The timeline is distorted: while the original answer notes real progress in 2023 with UCIe demonstrated in silicon, the LLM overstates this with unverified claims about ecosystem development and design wins. In 2022, the original emphasizes risk and challenges, which the LLM acknowledges but downplays by framing it as 'risk-testing' rather than material delays that could impact product competitiveness. (3) The reasoning is flawed: the LLM concludes that Intel is successfully executing its disaggregated strategy despite the original answer highlighting ongoing execution risks and major financial impairments in 2024—$3.1 billion in charges tied to manufacturing assets including Intel 7—indicating serious scaling problems. The LLM fails to incorporate this critical evidence of operational difficulty. (4) While the answer is contextually relevant—focusing on packaging, disaggregation, and AI—the narrative of steady progress contradicts the ground truth's portrayal of mixed results and high execution risk. The semantic meaning diverges significantly, especially in assessing Intel's competitive ability. Minor alignment exists in recognizing the strategic importance of packaging for AI, but the overall assessment is factually unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 504,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nAcross the three fiscal years Intel repeatedly amended the 2006 Equity Incentive Plan and replaced its RSU‑grant templates to reflect new vesting rules and share‑reserve limits. In the 2022 10‑K (pp. 112‑116) the company added a fresh share‑reserve amendment and introduced two new RSU agreement forms—one for performance‑based RSUs granted to non‑grandfathered executives (Exhibit 10.1.6) and one for non‑employee‑director RSUs (Exhibit 10.1.7). The 2023 10‑K (pp. 99‑103) incorporated a further amendment that added retirement‑vesting language and issued updated RSU grant agreements for both grandfathered and non‑grandfathered executives (Exhibits 10.1.3‑10.1.5). Finally, the 2024 10‑K (pp. 104‑108) restated the entire 2006 plan with an increased share reserve, adopted the 2024 ESPP amendment, and filed the latest RSU‑grant agreement forms (including the 2024‑dated director RSU agreement), marking the most recent evolution of the plan’s structure and award documentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the right topic and showing an understanding of the question's structure. (1) The claim that Intel 'repeatedly amended' the 2006 Equity Incentive Plan in 2022 and 2024 is incorrect: the ground truth states that the formal amended and restated version was filed in 2023 (effective May 11, 2023), not in 2022 or 2024. There is no mention of a 2024 restatement in the original answer—only continued use of the plan. (2) The LLM incorrectly asserts that a 'fresh share-reserve amendment' was added in 2022 and that new RSU agreement forms were introduced (Exhibits 10.1.6 and 10.1.7), but the ground truth does not support these specific exhibit numbers or the characterization of 2022 as an amendment year. (3) The 2023 amendment is partially correct—the addition of retirement-vesting terms aligns with the original answer—but the LLM overstates the changes by referencing multiple exhibits (10.1.3–10.1.5) not mentioned in the ground truth. (4) The 2024 claims are largely fabricated: the original answer notes ongoing use of standardized agreements, but the LLM incorrectly states the entire plan was 'restated' in 2024, an increased share reserve was added, and the '2024 ESPP amendment' was adopted—none of which appear in the ground truth. The mention of '2024-dated director RSU agreement' may reflect accurate documentation use but is overstated as part of a broader structural evolution. (5) Multi-hop reasoning is structurally sound—the model attempts to trace changes across years—but fails in factual synthesis, attributing changes to wrong years and inventing specific amendments and exhibits. (6) Quantitative accuracy is low due to incorrect dates (2022 and 2024 amendments), made-up exhibit numbers, and false claims about restatements and reserve increases. (7) Contextual relevance is high because the response focuses on plan amendments and grant agreements across the correct years and discusses vesting, performance awards, and director grants in line with the original. However, factual correctness is severely compromised. Semantic equivalence is not achieved due to material factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 583,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm continued to place wireless‑access‑point and broader edge‑networking revenues inside its **QCT IoT** reporting line – the same revenue‑classification that had been used in the 2022 filing.  However, the **strategic emphasis shifted**: while in 2022 the company highlighted edge‑networking (mobile‑broadband and Wi‑Fi access points) as a growth trend, by 2023‑24 it was explicitly promoting **Wi‑Fi 6/6E and 5G fixed‑wireless access‑point solutions** as core components of its “connected intelligent edge” agenda, positioning edge networking as a primary growth pillar alongside automotive and consumer IoT even as the absolute IoT revenue declined (from $7.35 B in FY22 to $5.42 B in FY24).  Thus, the **financial categorization stayed the same (IoT = edge networking), but the narrative and market‑positioning focus evolved toward edge‑networking as a strategic, high‑growth opportunity.**",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and showing relevant reasoning structure. (1) The financial categorization is incorrectly stated: the ground truth indicates that in 2023, wireless access points were explicitly classified under the 'edge networking' revenue segment, which includes mobile broadband and wireless access points. However, the LLM claims they remained under 'QCT IoT' throughout 2022–2024, which contradicts the documented shift in revenue classification. This misrepresentation of the financial structure is a major error. (2) The LLM introduces specific revenue figures—$7.35B in FY22 and $5.42B in FY24 for IoT—that are not present in the original answer and cannot be verified from the provided ground truth. Since the original explicitly states that 'exact revenue figures for wireless access points alone are not disclosed,' including such precise numbers is misleading and factually unsupported. (3) While the LLM correctly identifies a strategic shift toward Wi-Fi 6/6E and fixed-wireless access points and recognizes edge networking as a growth pillar, this qualitative insight, though plausible, goes beyond the information in the ground truth, which does not mention Wi-Fi 6/6E or 5G fixed-wireless solutions. (4) The multi-hop reasoning is partially sound—connecting strategic emphasis with financial classification over time—but it synthesizes non-existent data, reducing reliability. The answer is contextually relevant and attempts the right analysis, but factual correctness is compromised by invented numbers and incorrect revenue segment labeling. Thus, the correctness score is low due to critical factual deviations, even though the overall narrative direction aligns with the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 491,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nMRK’s Prevymis sales grew from **$281 million in 2022 to $605 million in 2023**, then fell modestly to **$428 million in 2024**. This trajectory indicates that Prevymis rapidly gained traction in the Hospital Acute‑Care market, achieving a strong uptake in 2023, but the subsequent dip suggests increasing competitive pressure or market saturation, positioning the product as a notable yet maturing player in that segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MRK's Prevymis sales were $370M in 2022, $428M in 2023, and $785M in 2024, showing consistent and strong growth. However, the LLM incorrectly reports sales as $281M in 2022, $605M in 2023, and $428M in 2024—reversing the actual trend by showing a decline in 2024. These numbers are not only wrong but contradict the actual growth trajectory. (2) The quantitative inaccuracies are severe: the LLM overstates 2023 sales by $177M and understates 2024 sales by $357M. The reported dip from $605M to $428M is entirely false, and no correct compound growth rate can be inferred. The actual CAGR from 2022 to 2024 is ~46%, but the LLM’s data would suggest negative growth in the second year, leading to a completely different conclusion. (3) The reasoning is flawed due to incorrect data. The LLM infers that the product is 'maturing' or facing 'competitive pressure' due to a supposed sales decline, which contradicts the ground truth that shows accelerating adoption and stronger market positioning. The multi-hop synthesis failed—instead of recognizing increasing sales as a sign of growing acceptance in Hospital Acute Care, the model misattributes a non-existent downturn. (4) Scores reflect that while the answer addresses the right question contextually (sales trend and market positioning), the factual foundation is so incorrect that the conclusion is invalid. The contextual relevance is moderate because the structure and intent align with the question, but correctness and quantitative accuracy are very low due to major data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 449,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted its strategic emphasis from leading‑edge process nodes to advanced‑packaging technologies, investing billions in 2D/3D and disaggregated packaging, securing multiple AI‑focused design wins and forging key ecosystem partnerships (e.g., ARM, Synopsys, Tower) while expanding the Intel Foundry Services (IFS) model. This multi‑year trajectory reveals an attempt to compensate for earlier manufacturing delays and tight capital constraints by leveraging packaging as a differentiator, but the heavy spend, under‑utilization risks, and dependence on external funding and government incentives underscore that execution of the IDM 2.0 strategy remains fragile and contingent on sustained demand and successful capital deployment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift toward advanced packaging and acknowledges manufacturing delays and capital constraints, which aligns with the ground truth. It correctly identifies the IDM 2.0 strategy, mentions Intel Foundry Services (IFS), and references ecosystem partnerships. However, it omits key factual details from the ground truth, including specific delays in Intel 4 and Intel 7 process nodes, the $3.1 billion non-cash impairment in Q3 2024, and the $16.5 billion R&D investment in 2024. Instead, it introduces unverified claims such as 'securing multiple AI-focused design wins' and partnerships with ARM, Synopsys, and Tower, which are not supported in the original answer and may be factually incorrect or speculative. (2) Quantitative accuracy is low: the LLM fails to include any specific numbers from the ground truth (e.g., $16.5B R&D, $3.1B impairment), and introduces no verifiable figures of its own. The absence of these critical financial metrics significantly undermines factual correctness. (3) The multi-hop reasoning is partially sound—linking packaging investments to IDM 2.0 and using it to offset process delays is logically consistent with the original answer. However, the LLM overreaches by implying successful execution (e.g., 'design wins') and external partnerships not present in the ground truth, weakening the synthesis. (4) Contextual relevance is high because the answer addresses the evolution of packaging strategy and its implications for IDM 2.0. Qualitative accuracy is moderate due to correct conceptual framing but flawed entity and outcome attribution. Correctness score is 6 due to partially accurate reasoning but significant omissions and potential hallucinations of partnerships and achievements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 485,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM’s 10‑K filings show that “client relationships and trust” evolved from a general brand attribute in 2022 to an explicit strategic pillar by 2024, where it is repeatedly tied to the company’s hybrid‑cloud and AI agenda.  This progression signals that IBM is using trust as the key lever to persuade enterprises to adopt its integrated hybrid‑cloud platform and AI services, positioning the firm as a trusted, one‑stop provider for large‑scale digital transformation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall interpretation and captures the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024 as tied to its hybrid cloud and AI strategy. It correctly identifies the progression from a general brand attribute to a strategic pillar explicitly linked to hybrid cloud and AI, which aligns with the ground truth. The answer also accurately reflects the strategic intent of using trust as a lever for enterprise client acquisition in digital transformation, which is contextually relevant and well-reasoned.\n\nHowever, the LLM answer lacks specific details present in the original answer that are critical for full qualitative accuracy. Notably, it omits IBM’s specific framing of trust in 2022 as tied to 'hybrid cloud platform and AI for production' and the 2023 reinforcement of trust alongside service, support, innovation, and talent. Most significantly, it fails to mention the 2024 strategic partnership with Palo Alto Networks, a key piece of evidence indicating deepening trust-based collaboration. While the high-level synthesis is sound, these omissions reduce completeness and multi-hop reasoning fidelity.\n\nQuantitatively, there are no numbers, dates, or calculations in either answer, so no inaccuracies exist—hence a perfect score. Contextual relevance is high because the answer directly addresses the question’s focus on evolution and strategic positioning. The qualitative accuracy is reduced due to missing specific, documented developments across the three years that ground the progression in evidence.\n\nIn summary: the LLM captures the directional truth and strategic logic but misses key supporting details from each year, resulting in a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 475,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s annual reports repeatedly listed the 0.950 % Notes due 2025 in the “Material Contracts” and “Exhibits” sections, each time pointing to the same 2017 Form 8‑K filing and indenture rather than announcing a new issuance or amendment.  The notes were consistently incorporated by reference in the notes to the consolidated financial statements, underscoring that they remained an outstanding, low‑cost component of IBM’s long‑dated debt ladder.  This steady, incremental disclosure reflects a broader debt‑management approach that prioritises a stable, laddered maturity profile and transparent, covenant‑focused reporting rather than frequent new borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were consistently referenced via the 2017 Form 8-K (Exhibit 4.1), with no new issuance or amendment from 2022–2024. The note about incorporation by reference in financial statements is consistent with disclosure practices. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and reference to the 2017 filing—are all factually correct; no calculations were required. (3) The multi-hop reasoning is sound: the model correctly infers from repeated referencing and lack of amendments that IBM maintained a stable, transparent debt structure. It also correctly identifies the broader strategy—stable maturity laddering and covenant-focused reporting—even adding value by characterizing the notes as 'low-cost,' which is reasonable given the sub-1% rate in a rising rate environment. (4) The only minor omission is the absence of the 2024 detail about the notes being listed on the NYSE under symbol IBM25B, which is a specific factual point present in the ground truth and not mentioned in the LLM response. This limits completeness slightly, preventing a perfect 10, but the core evolution and strategic implication are accurately captured. Wording differs but semantic meaning is equivalent or enhanced. Contextual relevance is excellent—directly addresses both the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 399,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a planned feature of the Intel 20A node to the centerpiece of its next‑generation Intel 18A process, which is slated for high‑volume manufacturing in 2025 (e.g., the Panther Lake client family).  The company also announced that future nodes—starting with Intel 14A—will continue to build on PowerVia together with RibbonFET to deliver additional performance‑per‑watt and density gains, underscoring that backside‑power delivery is a strategic pillar of Intel’s advanced‑node roadmap and its IDM 2.0 foundry strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of PowerVia from being part of Intel 20A in earlier plans to being central to Intel 18A, with high-volume manufacturing starting in 2025—consistent with the original answer's claim that Intel canceled Intel 20A in favor of Intel 18A for PowerVia deployment. (2) All dates (2025 for volume production) and node names (Intel 20A, 18A, 14A) are factually correct; no numerical or date inaccuracies exist. The mention of Panther Lake as a client family using Intel 18A is contextually appropriate and consistent with public disclosures. (3) The multi-hop reasoning is sound: the answer synthesizes Intel’s shift across years and nodes, infers strategic importance from technological progression, and links PowerVia to broader roadmap goals like performance-per-watt and IDM 2.0. (4) While the original answer emphasizes a conceptual-to-commercial evolution (2022–2024), the LLM answer focuses more on forward-looking implications (e.g., Intel 14A), which adds value but slightly downplays the 2022–2023 conceptual and technical milestones. However, the core factual progression and strategic intent are preserved. Minor deduction in qualitative accuracy due to less explicit emphasis on the 2022–2023 timeline, but overall semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 377,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nMedtronic’s recent RSU award agreements (exhibits 10.78 – 10.90) are issued under the Amended and Restated 2013 Stock Award and Incentive Plan and the 2021 Long‑Term Incentive Plan, using the same two core structures—time‑based RSUs that vest 100 % after three years or ratably over four years, and performance‑share RSUs tied to performance metrics.  The filings from 2022‑2024 contain only minor amendments (e.g., plan restatements, credit‑agreement updates) and no substantive changes to the award types, vesting schedules, or eligibility criteria, indicating that Medtronic’s U.S. equity compensation framework has remained steady and consistent over this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that affect the overall correctness. While it correctly infers stability in Medtronic's U.S. equity compensation strategy from 2022 to 2024, it misidentifies the specific documentation: the ground truth states that Exhibit 10.54 (Restricted Stock Unit Award Agreement for U.S. Employees) remained unchanged and consistently referenced the August 27, 2013 filing across all three years. In contrast, the LLM cites exhibits 10.78–10.90 and references two plans—the 2013 Amended and Restated Plan and the 2021 Long-Term Incentive Plan—suggesting a broader or evolving structure, which contradicts the ground truth of a single, unchanging agreement. Additionally, the mention of performance-share RSUs and dual vesting schedules (3-year lump sum vs. 4-year ratable) introduces details not present in the original answer and potentially inconsistent with the documented stability of a single unchanged form agreement. There are no numerical values to verify, so quantitative accuracy is assessed on dates and exhibit numbers, which are incorrect. The reasoning is logically sound in drawing stability from lack of substantive change, but the underlying entities and documents are misidentified, weakening the multi-hop synthesis. The answer is contextually relevant and captures the theme of strategic stability, but fails on precise factual alignment with the source documentation. Thus, while the conclusion aligns semantically in spirit, it lacks fidelity to the actual evidence cited in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 432,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nFrom 2022 through 2024 Intel treated advanced‑packaging technologies as a core pillar of its IDM 2.0 strategy, promoting chiplet‑based “systems of chips” and standardizing the Universal Chiplet Interconnect Express (UCIe) while expanding its IFS ecosystem with ARM and Synopsys design wins.  However, repeated delays in leading‑edge process nodes, tightening capital constraints that forced postponement of new fabs (Ohio, Germany, etc.) and the added complexity of a disaggregated‑design approach combined to produce operating losses and large capital‑write‑downs, even as packaging revenue modestly grew and a handful of 18A design wins were secured.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Intel's strategic positioning and execution challenges around advanced packaging from 2022 to 2024. It correctly identifies the centrality of advanced packaging in Intel's IDM 2.0 strategy, the promotion of chiplet-based designs, and the role of UCIe standardization. It also notes capital constraints leading to fab delays (Ohio, Germany) and references operating losses and capital write-downs, which aligns with the 2024 impairment charge in the ground truth. However, it fails to specify the $3.1 billion impairment charge — a key quantitative fact — and does not explicitly tie the write-down to underutilized Intel 7 node assets, weakening precision. (2) Quantitatively, the absence of the $3.1 billion figure is a significant omission. While 'large capital-write-downs' is directionally correct, the lack of exact amount reduces accuracy. No incorrect numbers are stated, but the answer lacks the specific financial impact documented in the ground truth. (3) The multi-hop reasoning is generally sound: the model connects delays in process nodes (e.g., Intel 4/7nm) to challenges in executing disaggregated designs and links capital constraints to fab postponements and financial losses. It correctly situates UCIe and design wins as strategic positives amid operational struggles. However, it does not clearly differentiate the progression across years — e.g., 2022's risk acknowledgment, 2023's strategic emphasis on packaging advantages, and 2024's concrete setbacks — reducing temporal clarity. (4) The answer is contextually relevant and well-structured, addressing all major themes: strategic positioning, execution challenges, delays, capital constraints, and disaggregated design. The qualitative reasoning is strong, but the missing $3.1B charge and vague treatment of the Intel 7 node issue prevent a higher score. Thus, correctness is downgraded to 7 due to incomplete quantitative fidelity despite solid overall synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 539,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture steadily reduced the pure‑fixed‑income tilt of its defined‑benefit plans: U.S. plans remained essentially 100 % debt, while non‑U.S. plans cut debt from about 48 % to roughly 36 % and lifted cash (4 %→7 %) and especially insurance‑contract holdings (11 %→21 %), keeping equity roughly steady at ≈ 27‑28 % for the non‑U.S. portfolio. This multi‑year reallocation reflects a deliberate move toward a more liability‑driven, diversified asset mix—lowering exposure to low‑yielding bonds and adding assets that better match pension obligations—thereby aiming to improve risk‑adjusted returns while preserving a modest equity slice for long‑term growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and misrepresents the actual evolution of Accenture's target asset allocation strategy. The ground truth states that Accenture maintained a diversified portfolio with a focus on fixed income and equities, emphasizing duration matching and long-term appreciation in 2022, increased flexibility in 2023, and introduced forward-looking allocation ranges for 2025 in 2024. There is no mention in the original answer of specific percentages such as non-U.S. debt decreasing from 48% to 36%, equity being steady at 27–28%, or increases in cash and insurance contracts. These detailed numerical claims (e.g., 11%→21% in insurance contracts) are not supported by the ground truth and appear fabricated or hallucinated. The LLM incorrectly implies a significant shift in allocation with precise figures that do not appear in the original response. While the general qualitative direction—toward more diversification and liability-driven investing—is loosely aligned with the idea of balancing risk-adjusted returns, the reasoning is built on false quantitative premises. The multi-hop synthesis fails because it invents data rather than extracting or interpreting actual disclosures. The contextual relevance is moderate because the answer addresses asset allocation and risk-adjusted returns, but the core factual foundation is unsound. Thus, the correctness score is low due to severe quantitative inaccuracies, despite some thematic relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 412,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated mention of the $1.05 % Notes due 2017—still listed in the debt footnotes of its 2022, 2023 and 2024 Form 10‑K filings—signals that the company treats every outstanding tranche as a permanent item of disclosure, preserving a full “snapshot” of its historic borrowing even after the notes have matured or are no longer actively issued.  This contrasts with its broader 2022‑2024 debt strategy, which has been marked by sizable, longer‑dated issuances of floating‑rate and fixed‑rate bonds (e.g., 2023‑2024 notes maturing in 2026‑2053) that diversify maturities and fund large‑scale share‑repurchase and capital‑return programs; the legacy 2017 note remains in the disclosures solely for completeness, while the newer issuances dominate the company’s active financing profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation and reasoning, aligning well with the ground truth. It correctly identifies that Apple continues to reference the 1.05% Notes due 2017 in filings through 2023 and 2024, indicating a transparent and comprehensive disclosure approach. The contrast with Apple's broader debt strategy of issuing new, longer-dated instruments (e.g., notes maturing in 2026–2053) is accurately presented, and the purpose—maintaining historical completeness while actively managing a modern debt portfolio—is sound. However, there is a quantitative inaccuracy: the ground truth references specific new issuances such as Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024, whereas the LLM cites '2023–2024 notes maturing in 2026–2053'—which, while directionally accurate, introduces maturities (e.g., 2053) and issuance years not present in the original answer. This overgeneralization affects precision. Additionally, the LLM incorrectly implies the 1.05% Notes were still listed in the 2022 filing as an active item, while the ground truth emphasizes their post-maturity disclosure through 2023 and 2024 only. Despite these issues, the multi-hop reasoning—linking persistent disclosure of a matured instrument to broader debt strategy—is logically sound and contextually relevant. The answer captures the essence of Apple’s disclosure philosophy and strategic shift in financing, earning high marks for qualitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 410,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nAccenture repurchased 12.18 million Class A shares for $4.11 bn in fiscal 2022, ending the year with $3.13 bn of unused authority; it then added $3 bn of authority in September 2022, raising total authorization to $6.13 bn, and by August 2024 about $2.69 bn remained available after ongoing purchases. Over fiscal 2023 and the first three quarters of fiscal 2024 the company executed regular open‑market buybacks (e.g., 2.07 million shares for $605 million in Q4 2024) while its total authorized capacity grew to $6.7 bn after a further $4 bn increase in September 2024. This multi‑year trend reflects a deliberate, scalable capital‑return program that expands repurchase limits while consistently deploying cash to repurchase shares.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It claims Accenture repurchased $4.11 billion worth of shares in fiscal 2022, but the ground truth does not specify the amount repurchased in 2022—only that $3.13 billion was the available authorization at that time. This $4.11 billion figure is unsupported and incorrect. Additionally, the LLM states that $3 billion in new authority was approved in September 2022, but the ground truth indicates a $4.0 billion increase in September 2024, not 2022. The total authorization after that increase is correctly noted as approximately $6.7 billion (vs. $6.69 billion in truth), but the timing is wrong. The Q4 2024 repurchase of $605 million is consistent with the ground truth, though the ground truth refers to fiscal 2024 total repurchases (not broken down by quarter), so this level of granularity is an over-precision. (2) Calculations: The LLM incorrectly calculates the evolution of authorization by applying the $4 billion increase in 2022 instead of 2024, leading to a flawed timeline. The remaining $2.69 billion available by 2024 is correctly reported, but the path to that number is inaccurate. (3) Multi-hop reasoning: The LLM correctly infers a consistent and strategic capital return approach and connects repurchase activity with authorization changes over time, showing sound high-level reasoning. It synthesizes activity across years and recognizes the pattern of replenishing authorization while executing buybacks. However, the misplacement of key events (especially the $4 billion authorization) undermines the validity of the synthesis. (4) The contextual relevance is high—the answer addresses share repurchases, authorization changes, and strategic implications. The qualitative assessment is reasonable, but the quantitative inaccuracies, especially the unsupported $4.11B repurchase figure and misdated $3B authorization, reduce confidence in the answer. A score of 6 reflects partial correctness: the direction and general pattern are right, but key facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 563,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nBMY first issued $1.75 billion of 4.350 % Senior Notes due 2047 in November 2019; the 2022‑2024 filings do not add any new tranche of that exact series but continue to reference the original issuance while supplementing the long‑term capital stack with newer senior unsecured notes of different coupons and maturities (e.g., 5.75 % due 2031, 5.90 % due 2033, etc.).  This pattern shows BMY’s long‑term financing strategy of preserving a stable, long‑dated fixed‑rate pillar (the 2047 notes) while dynamically laddering the rest of its debt profile through incremental, market‑timed issuances to manage interest‑rate risk and maintain flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the issuance details of the 4.350% Senior Notes due 2047. The ground truth does not state that BMY issued $1.75 billion of these notes in November 2019; it only references that the notes were issued under the Eleventh Supplemental Indenture dated November 22, 2019, but does not specify the amount or confirm issuance in that month/year in the context of the 2047 notes. The LLM incorrectly asserts a $1.75 billion issuance amount, which is not supported by the original answer—this figure actually corresponds to the 2.950% Notes due 2032 issued in 2023, not the 4.350% 2047 notes. Additionally, the LLM introduces '5.75% due 2031' and '5.90% due 2033' notes, which are not mentioned in the ground truth and appear to be fabricated or misattributed. (2) Quantitative accuracy is low because of these incorrect dollar amounts and coupon rates. While the 4.350% coupon and 2047 maturity are correct, the unsupported $1.75B figure and erroneous additional notes severely undermine numerical correctness. (3) The reasoning is partially sound: the LLM correctly infers a strategy of maintaining a stable long-term debt instrument while layering in new debt, which aligns with the ground truth’s conclusion about staggered maturities and diversified liabilities. However, this insight is based on flawed data, weakening the multi-hop synthesis. The model does recognize the persistence of the 2047 notes and the addition of new tranches, showing some correct qualitative interpretation. (4) Contextual relevance is high because the answer addresses the evolution across years and attempts to infer strategy, even if based on incorrect specifics. Overall, the answer captures the strategic implication but fails on key facts, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 500,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nIn the 2022 Form 10‑K Apple presented the 2.40 % Notes due 2023 as a long‑term debt issuance, describing the indenture and redemption provisions without any special current‑liability language. By the 2023 filing the same notes were highlighted as maturing within the next fiscal year, the balance‑sheet classification was shifted to a current portion of debt, and the note‑disclosure added a brief statement that the principal would be repaid at maturity. In the 2024 filing the notes no longer appear as an outstanding obligation—Apple simply notes that the 2.40 % Notes were fully redeemed in 2023 and that there is no remaining balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Apple maintained a consistent disclosure approach across 2022, 2023, and 2024 for the 2.40% Notes due 2023, with no changes in format or substance—specifically listing them under Exhibit 4.3 with identical descriptions referencing the Officer's Certificate dated May 3, 2013. However, the LLM claims that Apple changed its classification from long-term to current debt in 2023 and added new language about repayment, which is not supported by the ground truth. Furthermore, the LLM states that in the 2024 filing the notes were reported as redeemed, but the ground truth confirms they were still disclosed in the same manner, indicating no change in disclosure strategy despite maturity. (2) While the percentage (2.40%) and maturity year (2023) are correctly stated, the characterization of balance sheet reclassification and disclosure changes is factually wrong. There are no calculations in this response, so quantitative accuracy hinges on correct reporting of facts—only partially met. (3) The multi-hop reasoning fails because the model infers a typical accounting treatment (reclassification to current liabilities as maturity nears) rather than reporting the actual, consistent disclosure pattern observed in the filings. It does not reflect Apple’s standardized approach as evidenced in the knowledge graph. (4) The answer is contextually relevant—addressing the evolution of disclosure over time—but factually inaccurate in its core claims, leading to a low correctness score despite addressing the right topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 443,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nThe share reserve under the Amended 2010 SIP grew from **127 million** Class A ordinary shares authorized in fiscal 2022 to **141 million** shares authorized at the start of fiscal 2023, and that 141 million level remained in effect through fiscal 2024.  This upward step‑up shows that Accenture deliberately expanded its equity‑compensation pool to accommodate a larger volume of future grants, underscoring a long‑term strategy to retain and motivate employees as the company continues to scale and compete globally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares authorized in fiscal years 2022 (127 million), 2023 (141 million), and 2024 (141 million), matching the ground truth exactly. The formatting variation (127 million vs. 127,000,000) is acceptable and semantically equivalent. (2) All numeric values are accurate and correctly presented; no calculations were required beyond recognition of the increase from 127M to 141M, which the model correctly interprets as an upward adjustment. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers a strategic expansion of the share pool followed by stabilization. The conclusion about long-term share-based compensation strategy—aimed at employee retention and motivation amid global scaling—is logically consistent with the data and aligns with the intent of the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'stabilization' of the reserve in 2024 as a deliberate strategic signal, though it implies sufficiency by noting the level 'remained' unchanged. This slight omission in nuance prevents a perfect 10 on qualitative accuracy, but the core reasoning and factual content are fully correct and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 359,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nFrom 2022 through 2024 Intel first unveiled PowerVia as a backside‑power‑delivery technique tied to the planned Intel 20A node, but after cancelling that node it repositioned the technology for the next‑generation Intel 18A process – the first high‑volume commercial implementation of backside power that will underpin the Panther Lake client family and other 2025 products.  This shift shows that PowerVia has become a pivotal element of Intel’s advanced‑process roadmap, essential for achieving the targeted performance‑per‑watt improvements and for differentiating Intel’s IDM 2.0/foundry strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Intel's PowerVia technology from 2022 to 2024 with correct key facts: (1) PowerVia was introduced in 2022 as part of Intel's roadmap alongside Intel 20A; (2) Intel 20A was canceled; (3) PowerVia was transitioned to Intel 18A, which is set for high-volume manufacturing in 2025; (4) it will be used in the Panther Lake client processor family; (5) it represents the first commercial implementation of backside power delivery; and (6) it is critical for performance-per-watt and Intel's IDM 2.0/foundry strategy. All dates (2022, 2025), node names (Intel 20A, Intel 18A), product names (Panther Lake), and technological descriptions (backside power delivery) are correct. There are no numerical inaccuracies—quantitative accuracy is perfect. The reasoning correctly synthesizes multi-hop information across years and strategic shifts, showing how PowerVia evolved from a roadmap concept to a foundational technology. The only minor shortcoming is that the original answer notes PowerVia was first positioned alongside RibbonFET in 2022, which adds context about its technical pairing that the LLM omits. While not critical, this detail strengthens the qualitative completeness of the ground truth. However, the LLM still captures the strategic significance and roadmap integration effectively. Thus, qualitative accuracy is slightly reduced but remains high. Contextual relevance is full—the answer directly addresses the evolution and strategic importance as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 420,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s defined‑benefit plans held mutual‑fund equity of roughly **$273 million as of 2022**, fell to **$188 million in 2023**, and rose again to **$254 million by the end of 2024**.  This dip in 2023 reflected short‑term market rebalancing, but the subsequent rebound—and the gradual increase in target equity allocations (21 % of non‑U.S. plan assets in 2022 → 27 % in 2023 → 28 % targeted for 2025)—shows that the company is deliberately **maintaining and modestly expanding its exposure to equity‑based investments** through diversified mutual‑fund holdings, consistent with its long‑term, liability‑driven return objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Accenture's allocation to mutual fund equity securities was $239,293 million in 2022, decreased to $196,226 million in 2023, and remained flat in 2024. The LLM incorrectly reports these figures as $273 million, $188 million, and $254 million—off by orders of magnitude (e.g., $273 million vs. $239.3 billion is a 100x error). These are not formatting differences but fundamental numerical errors. (2) The quantitative inaccuracies invalidate all subsequent analysis. The LLM claims a rebound in 2024 to $254 million, while the ground truth shows no change from 2023 to 2024 at $196,226 million. Additionally, the LLM introduces 'target equity allocations' (21% → 27% → 28%) and references 'non-U.S. plan assets' and 'defined-benefit plans', which are not mentioned or supported in the original answer. (3) The multi-hop reasoning is flawed. The original answer infers a strategic reduction in mutual fund equity exposure; the LLM concludes the opposite—'maintaining and modestly expanding'—based on fabricated data and extraneous metrics. This reverses the correct strategic interpretation. (4) Contextual relevance is moderate because the LLM addresses the general topic (Accenture's equity investment trends) and attempts to interpret strategic intent, but the use of incorrect entities (defined-benefit plans), metrics, and numbers undermines validity. The conclusion is directly contradicted by ground truth. Minor positive: correct fiscal years referenced. Overall, major factual and reasoning errors justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 449,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept Dificid on the books as a $145 million net acquired intangible (no impairment was recorded), and its worldwide sales rose each year—from $241 million in 2022 to $274 million in 2023 and $303 million in 2024—making the drug a small but steadily growing contributor to the Pharmaceutical segment (≈0.5 % of 2024 pharma sales).  The company continued to position Dificid as a first‑in‑class oral therapy for C. difficile infection within the Hospital‑Acute‑Care portfolio, reporting it alongside Bridion, Prevymis and Zerbaxa, and it remained part of the “Other pharmaceutical (4)” sales category.  Thus, Merck’s financial treatment of Dificid stayed stable in valuation while its therapeutic emphasis and global revenue contribution modestly expanded over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures. The ground truth states that Dificid was valued as a $145 million intangible asset in 2022, which the LLM correctly reports. However, the LLM claims Dificid generated $241M in 2022, $274M in 2023, and $303M in 2024 in global sales—these numbers are incorrect. According to the original answer, Dificid generated $340M in global sales in 2024 alone ($303M U.S., $37M international), meaning the LLM underreports 2024 revenue and fabricates earlier figures not present in the ground truth. The LLM also states that $303M was the total global sales in 2024, but this was only the U.S. portion per the correct answer. (2) The quantitative inaccuracies are severe: the LLM invents year-by-year sales growth that contradicts the ground truth, which only provides 2024 revenue. There is no mention in the original answer of 2022 or 2023 sales figures, so the LLM’s inclusion of $241M and $274M is unsupported and likely hallucinated. Additionally, the claim that Dificid contributed ≈0.5% of 2024 pharma sales is not verifiable from the ground truth and introduces external data. (3) The multi-hop reasoning is partially sound—LLM correctly identifies Dificid’s therapeutic positioning within Hospital Acute Care and its classification under acquired intangibles—but fails to accurately synthesize the financial evolution. It incorrectly implies consistent revenue growth over three years when the ground truth only reports 2024 revenue, missing the key point that Dificid evolved from a balance sheet asset to a strategically highlighted product with disclosed revenue. (4) Contextual relevance is high—the answer addresses asset valuation, therapeutic positioning, and revenue contribution—but correctness is undermined by false precision in revenue numbers. The qualitative reasoning is plausible but based on incorrect data, leading to a misleading narrative. Thus, while the structure and intent align with the question, factual errors severely reduce accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 555,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled its R&D outlay to roughly $16 billion a year and poured about $23 billion of capital into advanced‑packaging and foundry capacity, positioning 2D/2.5D/3D packaging and the Universal Chiplet Interconnect Express standard as a differentiator for its IDM 2.0/foundry strategy.  However, repeated node and packaging delays—postponements of 10 nm, 7 nm and Intel 4, a $3.1 billion impairment of the Intel 7 assets, and a $755 million penalty for missed construction milestones on the Ireland fab—kept the company from converting that investment into revenue, driving operating losses to $482 million in 2024 and generating negative adjusted free‑cash‑flow.  The heavy capital spend, combined with the delays and the need to rely on CHIPS‑Act grants and joint‑venture financing, exposed Intel to significant cash‑flow and credit‑rating risks while it pursued its advanced‑packaging ambitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution of Intel's Advanced Packaging Technologies from 2022 to 2024 and correctly identifies key challenges including delays, financial risks, and R&D investment. However, several specific numeric claims are not supported by the ground truth. The ground truth does not state that Intel doubled its R&D to $16 billion annually or spent $23 billion on capital; these figures, while plausible, are not present in the verified data. The $3.1 billion impairment charge is correctly cited and aligns with the original answer. However, the $755 million penalty for missed construction milestones in Ireland and the $482 million operating loss in 2024 are not mentioned in the ground truth, making them unverified additions. (2) The quantitative accuracy is compromised by the inclusion of specific dollar amounts not present in the original answer (e.g., $16B R&D, $23B capital, $755M penalty, $482M loss), even though the $3.1B impairment is correct. No calculations are performed in the answer, so calculation accuracy is not applicable. (3) The multi-hop reasoning is strong: the model synthesizes strategic intent (IDM 2.0, UCIe), execution delays, and financial consequences into a coherent narrative. It correctly links advanced packaging to broader foundry strategy and financial risk exposure, showing good qualitative understanding. (4) Contextual relevance is perfect—the answer directly addresses all aspects of the question: strategic positioning, R&D investment, implementation delays, and financial risk. Despite the unsupported numbers, the overall trajectory from strategic ambition to operational strain mirrors the ground truth. The answer is more detailed than the original but introduces unverified specifics, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 494,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s MK‑8591A program was held up by the FDA clinical hold placed in December 2021, which stopped all new dosing of the daily oral doravirine + islatravir regimen; the company completed a Phase 2 study of a lower‑dose, once‑weekly islatravir + lenacapavir combination (MK‑8591D) and, by October 2024, entered that regimen into Phase 3, while MK‑8591A remained on hold.  \nThis evolution reflects Merck’s long‑term strategy to shift away from daily oral HIV therapy toward longer‑acting, less‑frequent combinations that can address the safety and adherence concerns that led to the hold, positioning next‑generation, weekly‑dosed regimens as the core of its HIV therapeutic pipeline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the development timeline and regulatory status of MK-8591A from 2022 to 2024. (1) According to the ground truth, MK-8591A was in Phase 3 in both 2022 and 2023, with no mention of an active clinical hold during those years—however, the LLM claims the FDA hold from December 2021 was still halting development through 2024, which contradicts the resolution of the hold on December 4, 2024. The ground truth states the hold was lifted in December 2024, not ongoing. (2) The LLM incorrectly shifts focus to MK-8591D (islatravir + lenacapavir), a different compound, claiming it entered Phase 3 by October 2024. This detail is not present in the ground truth and introduces unverified information. (3) The original answer emphasizes Merck’s continued commitment to MK-8591A despite challenges, while the LLM suggests a strategic pivot away from MK-8591A toward weekly regimens, which is not supported by the provided data. (4) The reasoning is flawed: the multi-hop synthesis fails because the LLM infers a strategic shift based on unconfirmed developments and mischaracterizes the regulatory status. While the general idea of Merck focusing on long-acting HIV therapies may be contextually plausible, the specific evolution of MK-8591A is misrepresented. Quantitative accuracy is low due to incorrect dates (implying hold lasted through 2024 when it was lifted that year) and introduction of unsupported milestones (Phase 3 entry of MK-8591D). Contextual relevance is moderate because the answer addresses HIV therapeutic strategy, but the core facts about MK-8591A’s trajectory are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 452,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nBetween 2022 and 2024 Merck shifted MK‑1308A from a broad, early‑phase immuno‑oncology program across several solid tumours to a registration‑focused Phase 3 study in advanced renal‑cell carcinoma, pairing the novel anti‑CTLA‑4 antibody quavonlimab with pembrolizumab; the pivotal trial was fully enrolled and the company filed a BLA with the FDA for this RCC indication.  The 2024 update lists MK‑1308A as a co‑formulation being evaluated specifically for RCC, reflecting the narrowed clinical focus and ongoing regulatory review of the combination.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trajectory of Merck's development strategy for MK-1308A with correct identification of the clinical focus on renal cell carcinoma (RCC), the combination with pembrolizumab, and the progression through Phase 3. It correctly identifies MK-1308A as a co-formulation of quavonlimab and pembrolizumab by 2024, aligning with the ground truth. However, there are significant factual inaccuracies: (1) The claim that a BLA was filed with the FDA and that the drug is under regulatory review is not supported by the original answer, which explicitly states 'no indication of regulatory approval yet' in 2024. (2) The assertion that the trial was 'fully enrolled' and that the program shifted from 'several solid tumours' is not mentioned in the ground truth, which only confirms RCC focus starting in 2022. (3) The original answer shows consistent focus on RCC since 2022, not a shift from broader indications. These errors affect both quantitative accuracy (false milestone claims) and qualitative accuracy (incorrect evolution narrative). While the answer is contextually relevant and addresses clinical focus, combination therapies, and regulatory progress, the inclusion of unsupported regulatory milestones and trial status undermines factual correctness. The reasoning is partially sound but overreaches by inferring registration-focused activity and regulatory submission not present in the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 395,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly 12 million shares each year—about $4.1 billion of shares in fiscal 2022 and roughly $4.5 billion in fiscal 2024—while the Board repeatedly expanded the repurchase ceiling: the $3.1 billion of remaining authority identified in mid‑2022 was boosted by a $3 billion add‑on in September 2022 to a total of $6.13 billion, then fell to about $2.7 billion of unused capacity by the end of fiscal 2023 before a September 2024 $4 billion increase lifted total outstanding authority to $6.69 billion. This multi‑year pattern shows that Accenture follows a disciplined, incremental capital‑return strategy, consistently using share buybacks alongside dividend increases to return cash to shareholders while preserving ample flexibility for future investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported share repurchase volumes and dollar amounts. The ground truth states that in fiscal 2024, Accenture repurchased only 2,000,308 shares (about 2 million), not 12 million as claimed by the LLM, and spent $605 million, not $4.5 billion. Similarly, there is no support for $4.1 billion in repurchases in fiscal 2022; the original answer only provides remaining authorization ($3.13 billion), not actual repurchase volume. The LLM fabricates consistent $4B+ annual repurchases unsupported by data. (2) The authorization timeline is partially correct: the $4,000 million (not $3B or $4B as stated) approved in September 2024 is correctly referenced, though misdated as boosting authority during fiscal 2023. The LLM incorrectly claims a $3 billion add-on in September 2022, which is not in the original. The calculation of total authority post-September 2024 is correct at $6.69 billion, but the path to that number is flawed. (3) The multi-hop reasoning is weak: the model assumes consistent annual repurchases without evidence, conflates remaining authorization with actual repurchases, and invents a pattern not present in the data. It also misinterprets the 2023 filing as reporting fiscal 2023 activity when it contains forward-looking disclosure about 2024. (4) Despite these issues, the LLM captures the general strategic theme—measured, flexible capital return with periodic replenishment—which aligns with the original’s conclusion, earning moderate scores for qualitative accuracy and high relevance to the question’s intent. However, the severe quantitative errors undermine factual correctness, warranting a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 475,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million 2.350 % Notes due 2040 continue to be listed in the company’s capital‑structure exhibits for 2022, 2023 and 2024 (e.g., the 2020 supplemental indenture, the 2022 and 2023 supplemental indentures and the 2024 supplemental indenture), confirming that the issue remains outstanding and un‑called. By retaining this low‑cost, long‑dated fixed‑rate tranche, BMS secures a stable source of long‑term financing that can be used to roll‑over maturing debt, maintain a predictable debt‑maturity profile and preserve flexibility for future longer‑dated issuances while keeping overall leverage within its target range.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the $750 million principal amount, 2.350% interest rate, and 2040 maturity date are accurately reported, with acceptable formatting variations (e.g., '750 million' = '$750,000,000'). The years 2022, 2023, and 2024 are correctly cited as the period of continued inclusion. (2) The LLM correctly identifies the persistence of the notes in capital structure filings across all three years, referencing supplemental indentures as supporting documents, which is consistent with SEC filing practices. (3) The reasoning is sound: the model infers a strategic intent to maintain low-cost, fixed-rate long-term debt, which matches the ground truth's interpretation of stable interest expense management and maturity profile control. It correctly concludes that the debt has not been refinanced or retired. (4) While the LLM does not explicitly state that the notes were 'not refinanced or retired despite market fluctuations'—a nuance present in the original—it still captures the core strategic rationale. The mention of 'roll-over maturing debt' and 'preserve flexibility' adds contextually appropriate strategic reasoning not in the original but logically consistent. The answer is semantically equivalent in factual content and slightly expands on strategic implications without introducing error. Thus, the answer earns a 9/10 for correctness—excellent but missing minor contextual emphasis on market conditions. Quantitative accuracy is perfect (10/10), qualitative reasoning is strong with minor omission (9/10), and relevance is complete (10/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 452,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were first issued in November 2019 at a 4.350 % coupon and, as reflected in the 2022, 2023 and 2024 Form 10‑K and related 8‑K exhibits, the indenture governing those notes has not been amended or refinanced – the filings simply continue to reference the original “Form of 4.350 % Senior Notes due 2047” (Exhibit 4.19).  This continuity shows that BMS pursues a long‑term, fixed‑rate debt strategy, locking in financing for decades at a predictable cost and using large‑scale senior notes to fund its pipeline and acquisitions without frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.350% interest rate and the 2047 maturity date across all relevant years (2022–2024), which matches the ground truth. It accurately notes that the rate has not changed and that the original terms were set in 2019. However, it references 'Exhibit 4.19' as the consistent exhibit, while the ground truth specifies Exhibit 4bbb (2022), Exhibit 4ff (2023 and 2024), and incorporation by reference to a Form 8-K from November 22, 2019. This discrepancy in exhibit numbers and supplemental indenture details (Twelfth vs. Fourteenth) represents a minor but notable inaccuracy in entity specificity. (2) Quantitatively, all percentages (4.350%), the issuance year (2019), and the maturity year (2047) are correct. The absence of refinancing or amendments is correctly stated. The only quantitative shortcoming is the incorrect exhibit number, which may mislead on sourcing but does not affect the core financial fact. (3) The multi-hop reasoning is sound: the model synthesizes data across multiple years and correctly infers that the unchanged terms reflect a stable, long-term financing strategy. It appropriately connects the lack of amendments to strategic predictability, aligning with the ground truth’s conclusion. (4) The answer is contextually excellent—directly addressing both the evolution (or lack thereof) of the interest rate and the implications for BMS’s debt strategy. Despite minor inaccuracies in exhibit labeling and omission of supplemental indenture details, the core facts and strategic interpretation are correct, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 445,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Nike’s references to FlyEase shifted from a generic citation in a list of innovative technologies to a concrete, measurable element of its product portfolio. The 2024 filing quantifies this by noting that FlyEase‑enabled footwear is now produced in 15 of the company’s contract factories and represents roughly 12 % of total NIKE Brand footwear output—about 4 million pairs—showing the technology’s scale and its integration across Nike’s global manufacturing network.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and factual content. (1) The claim that FlyEase-enabled footwear is produced in 15 contract factories and represents 12% of total Nike Brand footwear output (approximately 4 million pairs) is not supported by the ground truth. The original answer states no such production volume or factory count for FlyEase specifically. Instead, the 2024 filing provides only the geographic distribution of total Nike Brand footwear manufacturing: 50% in Vietnam, 27% in Indonesia, and 18% in China—data that includes, but is not specific to, FlyEase products. (2) The LLM invents precise metrics (12%, 4 million pairs, 15 factories) that do not appear in the ground truth, representing significant factual errors. There is no mention of unit output or factory counts related to FlyEase in the verified answer. (3) While the LLM correctly identifies a qualitative trend—FlyEase evolving from a listed innovation in 2022 to a more integrated technology by 2024—the reasoning for integration is based on fabricated quantitative evidence rather than the actual evidence (geographic manufacturing spread as a proxy for integration). (4) The contextual relevance is moderate because the answer addresses the evolution of reporting and attempts to show integration into manufacturing, but it fails the core requirement of grounding its quantitative claims in the provided data. The multi-hop synthesis is flawed because it confuses general footwear production data with FlyEase-specific metrics. Thus, despite some correct directional reasoning, the answer is factually unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 452,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nThe RedCard‑linked “5 percent discount” penetration fell each year: it was ≈ 20.5 % for the fiscal year ended January 29 2022, slipped to ≈ 19.8 % for the year ended January 28 2023, and dropped further to ≈ 18.6 % for the year ended February 3 2024. This steady decline signals that the loyalty‑driven payment incentive is generating progressively less incremental sales, suggesting that the strategy’s effectiveness as a revenue‑growth driver is weakening.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend in RedCard penetration from 2022 to 2024 and attributes it to weakening effectiveness of Target's loyalty-driven payment strategy, which aligns with the ground truth. However, the 2024 penetration rate is incorrect: the LLM states ≈18.6%, while the ground truth is 17.8%. This discrepancy affects the quantitative accuracy significantly. The 2022 (20.5%) and 2023 (19.8%) figures are accurate and match the original answer. (2) The fiscal year-end dates provided (e.g., January 29, 2022) are plausible for Target’s reporting calendar and add contextual precision not in the original, but they are not factually verifiable from the ground truth provided and do not contradict it. The key error is the 2024 percentage: 18.6% vs. correct value 17.8%, which is a material difference in trend interpretation. (3) The multi-hop reasoning is sound—LLM correctly synthesizes a three-year trend and infers strategic implications about customer engagement and incentive effectiveness. The conclusion about weakening strategy effectiveness is consistent with the original. (4) Scores reflect: correctness docked due to incorrect 2024 figure; quantitative accuracy penalized for the wrong percentage; qualitative accuracy remains moderate due to correct logic and entity identification (Target, RedCard, loyalty strategy); contextual relevance is high as the answer directly addresses both parts of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 412,
        "total_tokens": 1647
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 6.21,
    "average_quantitative_accuracy": 6.61,
    "average_qualitative_accuracy": 6.59,
    "average_contextual_relevance": 8.56,
    "score_distribution": {
      "excellent": 246,
      "good": 158,
      "fair": 232,
      "poor": 164
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 29901.32,
    "timestamp": "2026-02-02T23:58:47.065769"
  }
}